data_5n9u_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5n9u _Structure_validation_residue.Date_analyzed 2017-03-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 75.9 mt -125.19 118.66 26.54 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.651 1.981 . . . . 0.0 109.582 -173.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -116.42 132.98 56.53 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.183 0.993 . . . . 0.0 109.589 173.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.7 pt -128.69 135.99 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 118.93 0.786 . . . . 0.0 110.957 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.0 m -111.95 122.27 47.3 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.097 0.959 . . . . 0.0 109.922 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.54 161.18 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.147 0.979 . . . . 0.0 112.018 -166.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -56.73 117.54 4.01 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.168 1.387 . . . . 0.0 111.753 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.11 148.67 39.51 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.138 155.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.16 151.12 47.63 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.132 0.968 . . . . 0.0 112.573 175.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.9 t -65.97 123.54 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.327 0.651 . . . . 0.0 109.311 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.91 -17.54 2.21 Favored Glycine 0 CA--C 1.54 1.612 0 N-CA-C 116.297 1.279 . . . . 0.0 116.297 -176.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.04 72.55 55.11 Favored Pre-proline 0 CA--C 1.548 0.867 0 CA-C-N 119.098 1.449 . . . . 0.0 111.622 -175.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.35 -14.67 45.37 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.135 2.557 . . . . 0.0 115.265 -167.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -84.4 -0.39 52.54 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.0 pt -135.15 165.28 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.65 1.18 . . . . 0.0 112.081 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.0 mt -73.66 146.45 44.53 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.185 0.994 . . . . 0.0 111.665 173.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.48 -159.05 8.67 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.992 1.282 . . . . 0.0 112.15 167.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.472 ' CG ' ' HZ2' ' A' ' 209' ' ' LYS . 62.5 t0 -59.11 98.22 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 122.934 1.35 . . . . 0.0 113.788 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.2 t -153.26 95.85 2.91 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.425 1.49 . . . . 0.0 108.718 142.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.86 -20.01 64.38 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.163 1.909 . . . . 0.0 112.391 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -65.93 -37.34 85.8 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.669 1.188 . . . . 0.0 112.846 172.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 95.1 m -64.81 -38.15 90.0 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.723 -1.235 . . . . 0.0 112.142 169.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -65.92 -25.56 67.2 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 118.519 -0.753 . . . . 0.0 112.73 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -58.23 -43.42 87.76 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.603 1.161 . . . . 0.0 113.244 168.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.02 -40.13 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.287 1.035 . . . . 0.0 110.792 -175.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.8 mt -61.59 -40.55 95.17 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.917 -0.489 . . . . 0.0 111.684 170.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 tp -60.55 -47.71 84.98 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.775 1.23 . . . . 0.0 113.34 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.1 p -73.06 -33.42 65.66 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.9 1.227 . . . . 0.0 113.46 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.52 -40.82 96.33 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.525 -0.735 . . . . 0.0 111.986 173.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -80.34 -23.69 40.39 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.419 ' CD ' HH21 ' A' ' 189' ' ' ARG . 52.2 tp10 -65.0 -45.08 87.08 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.073 -1.017 . . . . 0.0 111.597 164.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.492 ' HZ1' ' ND2' ' A' ' 84' ' ' ASN . 64.9 mttm -68.85 -23.38 64.23 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.241 -0.912 . . . . 0.0 112.671 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.0 mtmm 59.64 19.56 8.19 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.351 1.861 . . . . 0.0 112.407 -170.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.4 tt -74.15 140.23 76.54 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.2 1.4 . . . . 0.0 109.884 -171.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -66.87 132.32 28.07 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 121.803 1.668 . . . . 0.0 112.02 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -141.65 169.88 16.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.085 1.754 . . . . 0.0 111.169 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.699 ' HE2' ' NE2' ' A' ' 40' ' ' HIS . 52.1 tttt -130.59 127.77 39.7 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.069 1.747 . . . . 0.0 109.015 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.59 ' C ' ' HD2' ' A' ' 40' ' ' HIS . 27.6 t -114.17 138.16 50.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.157 0.983 . . . . 0.0 112.939 -170.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.699 ' NE2' ' HE2' ' A' ' 38' ' ' LYS . 6.1 m170 -126.31 108.9 11.68 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.965 1.706 . . . . 0.0 108.416 -171.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.6 mt -76.89 107.66 9.38 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.267 0.627 . . . . 0.0 110.494 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.4 mm -91.34 119.45 38.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.654 1.181 . . . . 0.0 109.379 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -69.14 126.3 29.35 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.292 -0.632 . . . . 32.609999999999999 109.292 161.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.9 mt -88.58 -18.47 28.01 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.122 0.786 . . . . 40.049999999999997 113.122 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.55 -20.43 71.6 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 118.79 0.723 . . . . 41.469999999999999 114.344 172.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -147.49 90.44 1.86 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.836 1.655 . . . . 47.170000000000002 108.688 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -84.82 135.0 40.63 Favored Pre-proline 0 N--CA 1.469 0.491 0 C-N-CA 124.142 0.977 . . . . 41.270000000000003 110.034 -170.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -59.26 140.45 94.73 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.343 2.029 . . . . 40.289999999999999 111.737 171.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.06 -40.56 89.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.195 0.813 . . . . 42.390000000000001 113.195 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 31.7 p-90 -65.97 -13.41 59.76 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.233 1.198 . . . . 37.079999999999998 114.233 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -67.49 -26.88 66.58 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.242 -1.537 . . . . 35.880000000000003 112.62 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.9 mt -70.66 -21.08 62.65 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.368 0.877 . . . . 33.609999999999999 113.368 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.72 -16.36 61.19 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.192 0.997 . . . . 33.789999999999999 112.57 171.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.3 mt -102.58 -43.39 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.13 1.372 . . . . 33.159999999999997 110.7 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.4 t -124.8 104.24 30.49 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 125.451 1.5 . . . . 33.579999999999998 110.376 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.29 -19.64 38.12 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.51 2.14 . . . . 37.899999999999999 113.769 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -83.77 -5.87 59.3 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.77 1.026 . . . . 38.990000000000002 113.77 168.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.91 14.22 65.23 Favored Glycine 0 CA--C 1.534 1.276 0 O-C-N 120.878 -1.139 . . . . 35.469999999999999 114.773 -172.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -91.89 156.28 17.59 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.262 1.425 . . . . 34.490000000000002 112.818 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.0 m -109.44 156.49 39.42 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 126.096 1.759 . . . . 23.530000000000001 110.935 159.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.02 153.78 80.62 Favored 'Cis proline' 0 C--N 1.348 0.508 0 CA-C-O 122.299 0.875 . . . . 22.879999999999999 113.352 -10.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.6 p -143.71 146.74 20.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 113.304 -1.771 . . . . 0.0 107.31 159.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.01 163.62 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.596 0.758 . . . . 0.0 110.444 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -111.35 121.78 46.14 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.934 1.294 . . . . 0.0 109.748 157.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 95.8 mt -106.23 115.35 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.3 1.44 . . . . 0.0 107.693 170.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.414 ' O ' ' HE2' ' A' ' 68' ' ' LYS . 2.5 t70 53.25 43.58 31.31 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 122.529 1.156 . . . . 0.0 113.655 -167.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.2 t70 66.89 -7.97 0.44 Allowed 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -171.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.414 ' HE2' ' O ' ' A' ' 66' ' ' ASP . 20.4 mmtt -91.83 127.97 37.49 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 119.472 -2.018 . . . . 0.0 111.744 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 27.8 p-90 -74.6 147.57 41.53 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -167.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.0 t -141.57 126.11 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.204 1.801 . . . . 0.0 108.563 171.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -109.96 166.57 10.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.633 1.573 . . . . 0.0 111.534 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.0 t0 67.01 114.07 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.064 2.146 . . . . 22.16 113.935 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.2 p -64.0 -29.21 70.39 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 115.317 1.599 . . . . 21.16 115.317 -163.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -71.08 -29.88 65.85 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 120.135 1.334 . . . . 24.969999999999999 112.163 171.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.2 t -75.09 -42.05 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 O-C-N 120.623 -1.298 . . . . 23.850000000000001 111.645 170.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.01 -45.55 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.345 1.058 . . . . 23.68 110.63 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.9 t -63.1 -43.32 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.09 0.956 . . . . 22.84 111.353 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.97 93.33 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 118.654 0.661 . . . . 23.329999999999998 113.505 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 70.6 mt -77.08 -41.21 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 117.946 0.873 . . . . 23.309999999999999 112.278 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.1 mt -62.97 -37.05 85.55 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.132 1.333 . . . . 23.48 112.48 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -89.27 9.24 26.65 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.333 1.234 . . . . 24.239999999999998 114.333 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -123.04 -42.0 2.3 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.857 1.263 . . . . 39.259999999999998 112.654 173.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -126.25 65.57 1.23 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.77 1.628 . . . . 24.449999999999999 111.456 -167.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.492 ' ND2' ' HZ1' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -141.62 165.38 28.71 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 124.815 1.246 . . . . 0.0 110.694 175.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.01 -27.17 8.67 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.965 2.443 . . . . 0.0 114.939 -174.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -77.68 160.91 73.58 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 118.93 0.786 . . . . 0.0 110.06 168.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -52.32 139.01 55.41 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.546 2.164 . . . . 0.0 114.642 -175.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -69.99 147.09 60.64 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.449 2.766 . . . . 0.0 111.29 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.2 mt -131.49 9.87 4.74 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.103 1.361 . . . . 0.0 113.232 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.88 41.89 0.1 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.305 1.842 . . . . 0.0 114.578 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 90.5 m -105.78 103.39 43.72 Favored Pre-proline 0 N--CA 1.472 0.669 0 C-N-CA 125.107 1.363 . . . . 0.0 110.314 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -86.56 112.5 1.05 Allowed 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 124.148 3.232 . . . . 0.0 111.516 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -82.9 -170.46 0.92 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.863 3.042 . . . . 0.0 111.888 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.549 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 15.4 mp0 -52.32 -33.33 42.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.211 2.204 . . . . 0.0 113.171 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -57.92 -23.66 54.43 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.458 1.503 . . . . 0.0 114.14 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.55 -27.12 67.49 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.099 -1.001 . . . . 0.0 113.099 172.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 86.2 p -65.75 -47.95 73.53 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.153 -0.967 . . . . 0.0 112.149 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.2 t -77.33 -37.94 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 121.274 -0.891 . . . . 0.0 111.444 174.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.22 -31.34 80.51 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 121.265 -0.897 . . . . 0.0 114.137 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 89.0 p -73.06 -14.55 61.43 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -86.72 -39.83 15.63 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.536 1.135 . . . . 0.0 112.586 167.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.47 -37.52 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.289 1.436 . . . . 0.0 111.418 173.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -53.4 -54.38 45.94 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.915 1.686 . . . . 0.0 114.24 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.78 -34.83 0.87 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.118 2.545 . . . . 0.0 113.303 170.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.0 p -65.9 -31.06 71.77 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.403 1.456 . . . . 0.0 112.631 -173.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -79.58 -20.89 45.88 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.249 -1.532 . . . . 0.0 113.71 172.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.459 ' CG2' ' HZ3' ' A' ' 156' ' ' LYS . 85.6 t -72.9 -38.2 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 120.399 -1.438 . . . . 0.0 110.744 164.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.414 ' HZ1' ' CG ' ' A' ' 114' ' ' ASP . 52.8 tptt -69.58 -27.67 65.32 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 176.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -59.39 -41.46 89.45 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.097 1.359 . . . . 0.0 111.855 170.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.5 mt -80.14 4.19 18.14 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.819 1.648 . . . . 0.0 114.81 172.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -136.76 35.48 2.64 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 127.97 2.508 . . . . 0.0 111.277 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 p -82.23 58.02 3.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.585 1.954 . . . . 0.0 113.69 -169.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.53 -45.84 91.15 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.162 0.985 . . . . 0.0 110.096 161.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.414 ' CG ' ' HZ1' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -65.6 119.52 60.82 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 128.157 2.583 . . . . 0.0 107.71 155.043 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.16 135.09 68.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.935 1.757 . . . . 0.0 115.843 -159.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -68.16 -32.62 73.01 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 117.779 -1.105 . . . . 0.0 112.115 170.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.74 -32.06 68.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.166 1.386 . . . . 0.0 114.024 174.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.05 -34.86 9.39 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.744 0.688 . . . . 0.0 113.499 172.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 61.4 m -64.94 -40.6 95.28 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.409 1.084 . . . . 0.0 112.107 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -59.58 -27.46 66.28 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.358 1.863 . . . . 0.0 113.655 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -69.2 -18.34 63.9 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.127 0.971 . . . . 0.0 112.885 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.18 -35.8 13.64 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.857 0.863 . . . . 0.0 112.551 165.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.6 mt -65.95 -34.6 78.49 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.69 -36.38 82.73 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.714 0.688 . . . . 0.0 112.076 173.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.77 -30.66 32.24 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.249 0.62 . . . . 0.0 112.425 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.16 -46.86 88.79 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.131 0.972 . . . . 0.0 111.741 166.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.0 mt -65.21 -40.69 94.48 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.774 -1.108 . . . . 0.0 112.128 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -62.66 -42.11 99.43 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.291 1.405 . . . . 0.0 112.576 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.69 -35.78 82.15 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.216 0.607 . . . . 0.0 112.257 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.2 tp -72.84 -54.46 8.75 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.68 0.792 . . . . 0.0 111.529 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -63.1 -35.4 80.14 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.498 1.919 . . . . 0.0 113.906 -173.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.34 -33.64 81.61 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 123.914 0.768 . . . . 0.0 113.731 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -94.98 -28.64 15.04 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.6 mt -66.25 -32.23 73.52 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.594 -1.316 . . . . 0.0 113.272 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -66.37 -11.0 48.95 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.55 -29.27 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.737 0.815 . . . . 0.0 111.928 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -94.65 -37.31 11.38 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.605 1.162 . . . . 0.0 113.303 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.33 -69.97 0.23 Allowed Glycine 0 CA--C 1.542 1.735 0 CA-C-O 116.609 -2.217 . . . . 0.0 116.525 166.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -102.04 -33.86 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.987 0 N-CA-C 117.825 2.202 . . . . 0.0 117.825 -156.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -134.16 156.68 47.89 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.416 1.462 . . . . 0.0 112.93 -167.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.4 mt -70.46 -12.91 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.67 -1.64 46.23 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 165.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.07 -135.15 10.19 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 120.154 1.343 . . . . 0.0 113.738 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -62.4 -25.36 67.89 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -144.08 164.09 31.65 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.141 1.376 . . . . 0.0 110.403 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.3 mt -61.36 122.12 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 123.433 0.693 . . . . 0.0 110.467 169.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.7 p -140.21 -160.56 1.08 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.45 1.5 . . . . 0.0 108.901 160.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -49.5 -32.82 13.0 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -166.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.3 t -71.86 -37.48 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 120.725 1.602 . . . . 0.0 113.003 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -63.11 -44.04 96.78 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.34 -0.85 . . . . 0.0 111.587 167.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.5 mt -64.98 -27.36 68.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.009 0.524 . . . . 0.0 111.97 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 73.6 m -75.9 -31.94 59.41 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 120.201 -1.562 . . . . 0.0 113.654 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 68.6 mt -124.9 -33.84 2.88 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -162.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.61 -50.08 79.18 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -169.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -68.89 -25.7 32.52 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.479 1.452 . . . . 0.0 113.518 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.459 ' HZ3' ' CG2' ' A' ' 107' ' ' VAL . 20.4 ttmm -72.63 -29.47 63.5 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.224 -0.922 . . . . 0.0 112.198 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 38.0 mt -71.67 -44.09 64.89 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.788 0.835 . . . . 0.0 112.058 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -63.85 -38.5 91.33 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -64.19 -34.7 78.69 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.438 -1.414 . . . . 0.0 112.573 173.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.7 tp -68.83 -47.04 67.02 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.252 -0.905 . . . . 0.0 111.178 174.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -52.3 -45.18 65.43 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.442 1.497 . . . . 0.0 112.225 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.1 t -75.2 -58.88 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.919 0.888 . . . . 0.0 113.119 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.76 -36.07 37.74 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.993 -1.067 . . . . 0.0 113.463 -167.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.2 tp -72.83 -31.81 65.05 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.578 -0.702 . . . . 0.0 111.28 171.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.83 -27.98 37.96 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.837 1.208 . . . . 0.0 114.704 170.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -67.53 -19.49 65.3 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -141.5 -27.18 0.68 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -149.87 80.85 1.38 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.522 1.529 . . . . 0.0 109.355 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.9 75.85 0.08 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.388 1.475 . . . . 0.0 112.403 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -71.73 112.96 16.06 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.127 1.771 . . . . 0.0 112.32 -168.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.31 137.52 19.0 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.546 2.164 . . . . 0.0 111.845 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 46.7 mm -87.57 113.93 56.52 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.329 1.052 . . . . 0.0 109.025 164.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -71.06 155.86 60.85 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.254 1.969 . . . . 0.0 111.779 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.59 -12.39 44.79 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -62.05 -31.44 71.85 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.209 1.004 . . . . 0.0 112.835 166.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.2 mt -84.19 57.18 4.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.464 1.906 . . . . 0.0 110.835 167.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -22.86 64.6 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.62 1.168 . . . . 0.0 113.297 -161.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -75.52 -52.49 10.52 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.257 0.935 . . . . 0.0 110.303 165.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 33.7 t -57.53 -46.69 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 119.234 0.925 . . . . 0.0 112.711 -174.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.7 tp -64.36 -27.95 69.37 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -93.61 -29.48 15.44 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.143 -0.973 . . . . 0.0 113.272 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -64.0 -36.92 85.56 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.271 1.428 . . . . 0.0 112.925 173.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.5 mt -60.01 -37.43 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 O-C-N 121.336 -0.852 . . . . 0.0 111.641 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -67.01 -28.26 68.1 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.047 -1.658 . . . . 0.0 112.475 173.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.1 mt -71.5 -20.59 62.04 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.473 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 68.9 mt -65.65 -21.6 66.57 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 120.17 1.35 . . . . 0.0 112.751 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -85.71 19.1 2.57 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.456 1.502 . . . . 0.0 113.308 170.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.8 p -142.81 178.65 7.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.797 2.039 . . . . 0.0 112.947 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.419 HH21 ' CD ' ' A' ' 32' ' ' GLU . 65.7 mtp85 59.74 171.88 0.08 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.619 1.968 . . . . 0.0 113.561 -170.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 53.1 mp0 -64.83 -47.91 76.29 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.422 1.089 . . . . 0.0 110.286 159.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -39.29 89.78 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.681 1.992 . . . . 0.0 115.707 -170.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -96.67 -53.26 3.62 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.483 1.038 . . . . 0.0 111.746 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -62.31 -37.37 85.31 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -168.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.88 -22.85 66.55 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.15 0.886 . . . . 0.0 113.034 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 7.0 p -90.55 -7.09 53.81 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.647 1.179 . . . . 0.0 113.2 -173.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -60.61 114.68 3.12 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.458 1.503 . . . . 0.0 111.063 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -70.11 162.56 28.03 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.051 0.94 . . . . 0.0 112.579 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -75.39 125.81 29.74 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.848 -0.533 . . . . 0.0 110.684 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -73.84 -32.1 63.5 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -155.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.37 -36.42 83.66 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.812 1.245 . . . . 0.0 111.162 167.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -83.69 -8.43 59.28 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.009 1.724 . . . . 0.0 113.309 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.2 t -78.47 -51.89 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.347 1.059 . . . . 0.0 109.913 158.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 62.2 mt -62.32 -48.03 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.015 0.926 . . . . 0.0 111.974 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -5.39 41.74 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.874 1.27 . . . . 0.0 114.15 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -90.33 -32.75 9.25 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 121.133 -0.979 . . . . 0.0 113.134 164.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -83.22 -32.56 26.43 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.13 1.772 . . . . 0.0 114.802 -174.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -48.83 -55.15 21.55 Favored Pre-proline 0 N--CA 1.481 1.121 0 CA-C-N 120.254 1.388 . . . . 0.0 114.35 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.19 -20.8 32.34 Favored 'Trans proline' 0 C--N 1.351 0.678 0 CA-C-N 120.806 1.324 . . . . 0.0 111.979 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.472 ' HZ2' ' CG ' ' A' ' 19' ' ' ASP . 45.6 mtpt -84.54 2.69 40.06 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.148 1.779 . . . . 0.0 114.274 174.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 63.4 t -66.58 -29.97 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 120.886 -1.134 . . . . 0.0 110.219 152.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -96.2 -52.34 4.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 117.183 -1.389 . . . . 0.0 114.265 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.865 2.066 . . . . 0.0 113.089 -177.239 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.912 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.99 136.73 34.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.903 1.281 . . . . 0.0 110.771 -170.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -139.21 151.42 46.54 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.412 1.485 . . . . 0.0 108.845 166.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.54 140.73 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.206 1.002 . . . . 0.0 109.148 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.9 m -113.56 122.29 46.8 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.086 0.954 . . . . 0.0 109.38 171.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -136.59 157.92 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.887 1.275 . . . . 0.0 110.699 -164.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -57.7 115.43 2.79 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.611 0.365 . . . . 0.0 110.839 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.49 151.24 27.9 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.964 154.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.73 151.53 33.68 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.256 1.026 . . . . 0.0 112.515 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.6 t -70.86 135.98 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 166.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.53 -33.85 1.37 Allowed Glycine 0 CA--C 1.539 1.538 0 CA-C-O 118.585 -1.119 . . . . 0.0 115.218 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.96 67.85 12.1 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.861 1.264 . . . . 0.0 112.529 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -65.71 -7.47 16.59 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.268 2.645 . . . . 0.0 114.685 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -81.17 -0.1 38.84 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.493 1.517 . . . . 0.0 114.452 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.4 pt -133.34 162.08 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.994 1.318 . . . . 0.0 111.546 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.8 mt -63.6 150.96 42.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.725 0.81 . . . . 0.0 111.648 168.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.0 -166.32 10.91 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.557 1.551 . . . . 0.0 111.949 166.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -56.61 107.96 0.44 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.4 t -158.89 103.48 1.59 Allowed Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.281 139.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -64.57 -20.82 65.9 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.294 1.996 . . . . 0.0 112.633 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -68.38 -26.41 65.55 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.906 -1.121 . . . . 0.0 112.829 172.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 81.7 m -74.04 -37.09 64.42 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.614 -1.304 . . . . 0.0 112.055 170.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -62.24 -26.8 68.58 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 118.339 -0.839 . . . . 0.0 112.938 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.541 HH11 ' CG ' ' A' ' 74' ' ' ASP . 59.1 mtp180 -57.01 -42.8 81.02 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.118 0.967 . . . . 0.0 112.471 170.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.78 -41.46 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.284 1.434 . . . . 0.0 111.381 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -58.94 -42.92 90.96 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.972 0.509 . . . . 0.0 111.401 172.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.02 -50.53 73.39 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.306 1.042 . . . . 0.0 112.748 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 p -75.71 -38.34 58.67 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -175.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.1 mt -65.91 -39.75 90.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.566 0.621 . . . . 0.0 111.32 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -77.85 -25.56 48.81 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -67.13 -48.66 67.41 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 120.741 -1.224 . . . . 0.0 111.325 169.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -76.93 -0.33 23.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.016 1.726 . . . . 0.0 114.436 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm 57.79 20.67 6.71 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.785 1.634 . . . . 0.0 114.677 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.77 128.8 91.7 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.504 1.122 . . . . 0.0 109.035 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.73 140.68 23.78 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.467 2.112 . . . . 0.0 111.737 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -145.11 152.03 39.43 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.604 1.562 . . . . 0.0 110.089 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -77.55 131.51 37.9 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.064 -1.022 . . . . 0.0 109.339 158.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.6 t -103.95 94.42 5.4 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.927 0.891 . . . . 0.0 110.755 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -81.26 99.06 8.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.775 0.83 . . . . 0.0 109.615 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.0 mt -66.98 108.79 2.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.528 0.731 . . . . 0.0 109.039 170.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.7 mm -120.66 114.88 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.529 1.132 . . . . 0.0 109.303 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -76.56 90.5 3.33 Favored 'General case' 0 C--O 1.22 -0.455 0 O-C-N 120.775 -1.203 . . . . 32.609999999999999 108.42 165.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.06 -7.34 1.76 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 117.173 2.286 . . . . 40.049999999999997 117.173 -170.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.56 -37.85 89.95 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 119.651 1.114 . . . . 41.469999999999999 111.762 165.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -105.58 47.77 0.86 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 129.452 3.101 . . . . 47.170000000000002 111.177 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -73.92 126.68 89.22 Favored Pre-proline 0 N--CA 1.475 0.779 0 O-C-N 119.695 -1.878 . . . . 41.270000000000003 111.689 -174.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.86 159.55 52.22 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.468 2.112 . . . . 40.289999999999999 110.982 170.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -62.45 -29.21 70.35 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.776 1.028 . . . . 42.390000000000001 113.776 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.4 t90 -56.28 -35.24 67.27 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.969 1.308 . . . . 37.079999999999998 113.957 168.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -79.41 -33.92 42.25 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.949 -1.094 . . . . 35.880000000000003 112.82 174.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 mt -71.02 -21.05 62.33 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.76 1.022 . . . . 33.609999999999999 113.76 173.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -66.38 -47.93 71.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.446 0.698 . . . . 33.789999999999999 110.752 166.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.6 mt -72.1 -33.21 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.308 1.043 . . . . 33.159999999999997 112.183 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.4 t -137.78 81.93 27.53 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 127.069 2.147 . . . . 33.579999999999998 110.507 -173.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -63.9 -23.51 68.29 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.231 2.621 . . . . 37.899999999999999 113.778 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -74.27 -10.94 60.09 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.805 -1.185 . . . . 38.990000000000002 113.845 167.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.89 22.58 76.65 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.463 1.506 . . . . 35.469999999999999 115.131 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -110.72 159.3 17.74 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.872 1.669 . . . . 34.490000000000002 113.921 -169.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.7 155.14 63.52 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.645 1.578 . . . . 23.530000000000001 111.85 172.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -63.51 152.75 71.37 Favored 'Cis proline' 0 C--N 1.349 0.575 0 CA-C-O 121.813 0.672 . . . . 22.879999999999999 112.611 -11.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.2 p -139.24 144.43 29.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.568 161.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.59 162.48 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 121.348 -0.845 . . . . 0.0 111.528 -169.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -123.21 63.91 1.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.103 1.761 . . . . 0.0 109.791 -174.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 81.4 mt -74.01 121.21 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.824 0.85 . . . . 0.0 108.76 -175.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.5 t0 55.15 35.89 25.79 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 121.862 -0.524 . . . . 0.0 111.447 -164.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t0 67.19 -8.74 0.43 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 127.628 2.371 . . . . 0.0 115.345 -170.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.3 mttt -83.93 133.56 34.7 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.443 1.497 . . . . 0.0 111.875 -173.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.2 m0 -73.72 128.6 35.94 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.018 1.327 . . . . 0.0 111.679 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.0 t -142.5 128.1 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.332 1.453 . . . . 0.0 109.776 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -103.53 175.18 5.56 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.692 1.597 . . . . 0.0 111.729 172.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.7 t0 66.44 108.79 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.829 2.452 . . . . 22.16 114.786 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.4 p -61.42 -23.95 66.19 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 115.226 1.565 . . . . 21.16 115.226 -168.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.541 ' CG ' HH11 ' A' ' 25' ' ' ARG . 38.1 m-20 -73.61 -37.47 65.41 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.745 1.157 . . . . 24.969999999999999 113.07 171.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -69.92 -39.0 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.409 -0.807 . . . . 23.850000000000001 111.039 171.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 89.6 mt -63.58 -44.11 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.302 1.041 . . . . 23.68 111.224 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.1 -41.07 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.181 0.993 . . . . 22.84 111.482 171.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.89 -12.64 49.27 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 115.786 1.074 . . . . 23.329999999999998 115.786 174.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 89.6 mt -102.38 -53.05 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 118.913 1.357 . . . . 23.309999999999999 111.011 168.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.6 -33.06 73.24 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.622 0.971 . . . . 23.48 113.622 -172.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -90.57 -2.91 57.88 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.71 1.004 . . . . 24.239999999999998 113.71 -173.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.488 ' CD ' ' HZ2' ' A' ' 83' ' ' LYS . 10.1 tt0 -117.33 -54.44 2.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.442 1.497 . . . . 39.259999999999998 112.05 172.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.488 ' HZ2' ' CD ' ' A' ' 82' ' ' GLU . 64.9 mttp -93.71 59.22 2.81 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.92 1.288 . . . . 24.449999999999999 112.152 -164.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -135.84 163.64 49.01 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.77 1.628 . . . . 0.0 110.997 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.15 -23.53 21.17 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.411 2.074 . . . . 0.0 112.562 172.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -74.57 147.02 84.36 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.039 1.336 . . . . 0.0 112.206 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -59.44 135.14 62.95 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.841 2.361 . . . . 0.0 113.645 -173.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.68 136.5 49.96 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.909 2.406 . . . . 0.0 113.867 -167.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 mt -103.83 -0.26 29.42 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.935 1.694 . . . . 0.0 112.088 169.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.81 51.64 0.5 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.559 1.944 . . . . 0.0 110.569 161.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -129.74 61.31 57.21 Favored Pre-proline 0 N--CA 1.467 0.41 0 C-N-CA 127.003 2.121 . . . . 0.0 109.104 -169.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -80.77 123.16 4.61 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.256 1.971 . . . . 0.0 111.23 -155.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -72.54 175.96 9.43 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.1 2.533 . . . . 0.0 111.504 167.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -59.38 -20.56 55.76 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -53.72 -24.87 16.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.472 1.509 . . . . 0.0 114.223 167.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.04 -31.29 71.68 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.719 -1.238 . . . . 0.0 112.993 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.0 p -69.04 -25.5 64.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.426 1.09 . . . . 0.0 112.975 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.4 t -89.24 -43.44 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.321 1.448 . . . . 0.0 110.57 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.65 -29.56 75.06 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.014 1.292 . . . . 0.0 114.631 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 88.9 p -66.88 -20.5 65.93 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.498 1.149 . . . . 0.0 114.019 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.413 ' HZ2' ' CD ' ' A' ' 126' ' ' GLU . 36.7 mtmt -94.83 -34.43 12.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.501 1.52 . . . . 0.0 112.874 172.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.1 mt -67.38 -37.98 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.511 0.724 . . . . 0.0 111.521 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -58.93 -47.97 97.67 Favored Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 120.303 -1.498 . . . . 0.0 114.136 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.52 -30.7 6.2 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.693 2.262 . . . . 0.0 113.976 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.3 p -70.72 -29.8 66.17 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.996 1.725 . . . . 0.0 112.761 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -62.22 -41.36 98.32 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.345 -1.472 . . . . 0.0 113.071 161.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.4 t -63.73 -37.48 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 120.248 1.385 . . . . 0.0 111.339 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.438 ' HZ1' ' CG ' ' A' ' 114' ' ' ASP . 65.1 tttt -67.31 -37.65 83.69 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.607 0.763 . . . . 0.0 112.339 172.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -70.62 -30.22 66.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.408 1.083 . . . . 0.0 112.427 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.5 mt -83.42 1.38 41.81 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.73 1.612 . . . . 0.0 114.352 169.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -146.78 38.56 1.01 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.526 1.53 . . . . 0.0 113.082 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 m -73.8 63.71 0.9 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -161.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.34 -35.84 76.31 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.981 1.312 . . . . 0.0 111.798 165.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.438 ' CG ' ' HZ1' ' A' ' 108' ' ' LYS . 12.0 t0 -81.89 119.05 74.34 Favored Pre-proline 0 CA--C 1.553 1.06 0 CA-C-O 117.125 -1.417 . . . . 0.0 107.221 153.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.66 150.92 26.73 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.419 2.746 . . . . 0.0 116.735 -153.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -66.34 -42.36 88.23 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.568 -174.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.12 -24.37 60.6 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.402 1.081 . . . . 0.0 113.417 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.31 -35.81 25.59 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.19 -0.944 . . . . 0.0 112.805 168.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 92.7 m -67.44 -27.19 66.84 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.655 -0.909 . . . . 0.0 112.687 169.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -58.75 -44.09 90.46 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 125.388 1.475 . . . . 0.0 111.814 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -70.44 -37.6 74.4 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.534 -0.729 . . . . 0.0 111.996 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.89 -16.09 63.67 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.2 tp -92.13 -40.71 10.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.379 1.471 . . . . 0.0 111.612 169.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.5 mt -65.02 -42.38 94.44 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.201 1.4 . . . . 0.0 113.558 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.495 ' CD ' ' HZ3' ' A' ' 128' ' ' LYS . 10.1 mm-40 -65.27 -35.19 80.27 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.88 1.673 . . . . 0.0 112.469 -176.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.413 ' CD ' ' HZ2' ' A' ' 101' ' ' LYS . 80.5 mm-40 -73.71 -37.26 65.21 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.43 -0.794 . . . . 0.0 112.83 172.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.3 mt -65.69 -36.4 83.53 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.688 -1.258 . . . . 0.0 112.656 171.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.495 ' HZ3' ' CD ' ' A' ' 125' ' ' GLU . 79.6 mttt -64.57 -42.78 95.43 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.734 1.152 . . . . 0.0 111.253 173.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.21 -38.41 91.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.401 0.68 . . . . 0.0 112.131 175.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.6 tp -65.04 -52.81 53.74 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.045 0.938 . . . . 0.0 111.846 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -65.9 -38.41 88.66 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.214 1.405 . . . . 0.0 113.425 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -62.07 -36.05 92.35 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 119.284 -0.731 . . . . 0.0 113.845 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -87.45 -31.74 19.86 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 117.913 0.857 . . . . 0.0 112.879 175.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 12.8 mt -61.42 -36.23 79.76 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.004 -1.06 . . . . 0.0 113.436 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -65.21 -2.71 3.16 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.3 t -104.23 -27.76 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.591 1.556 . . . . 0.0 112.946 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -93.67 -50.94 5.15 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -168.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 158.95 172.41 26.02 Favored Glycine 0 CA--C 1.535 1.298 0 O-C-N 121.362 -0.836 . . . . 0.0 114.586 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -73.48 -15.25 24.9 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 124.669 3.579 . . . . 0.0 115.987 -163.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -89.95 167.45 12.8 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.379 0.99 . . . . 0.0 111.61 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -12.18 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.472 -1.393 . . . . 0.0 113.204 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.613 ' CB ' ' HG1' ' A' ' 147' ' ' THR . . . -100.65 -4.1 29.04 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.8 1.408 . . . . 0.0 114.8 166.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 110.12 -122.95 6.51 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 119.871 1.214 . . . . 0.0 113.201 -175.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -70.43 -18.72 63.01 Favored 'General case' 0 CA--C 1.541 0.635 0 O-C-N 120.847 -1.384 . . . . 0.0 114.108 -168.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -141.35 155.74 45.9 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.907 1.683 . . . . 0.0 110.711 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 58.9 mt -62.73 129.31 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.592 0.757 . . . . 0.0 109.244 163.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.613 ' HG1' ' CB ' ' A' ' 142' ' ' ALA . 13.9 p -129.36 -175.41 3.57 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.8 0.84 . . . . 0.0 111.961 168.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.79 -19.1 3.83 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 172.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.6 t -70.32 -43.57 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.998 -1.064 . . . . 0.0 111.9 172.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -60.02 -45.19 93.61 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.471 1.108 . . . . 0.0 112.312 169.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 34.2 mt -61.06 -20.74 62.92 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 177.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.2 m -85.98 -43.99 12.71 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.37 -0.831 . . . . 0.0 112.047 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 29.5 mt -98.34 -33.53 11.03 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -168.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.49 -49.58 93.0 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.56 -22.35 18.34 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 121.095 1.427 . . . . 0.0 113.223 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -71.25 -33.25 69.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 117.47 -1.252 . . . . 0.0 112.077 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 68.9 mt -66.41 -43.17 86.49 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 169.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -58.33 -39.72 80.19 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.653 0.661 . . . . 0.0 111.588 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -70.81 -22.68 62.32 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.3 mt -71.98 -51.38 22.2 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.112 0.869 . . . . 0.0 111.496 168.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -64.8 -28.16 69.38 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.524 0.729 . . . . 0.0 112.461 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.3 t -94.21 -72.24 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.854 1.262 . . . . 0.0 113.159 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.98 -48.72 11.87 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.333 -0.854 . . . . 0.0 113.057 -158.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 63.4 tp -66.84 -34.0 76.84 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.825 -0.607 . . . . 0.0 111.074 166.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.38 -30.13 57.98 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.285 1.421 . . . . 0.0 115.505 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -64.34 -26.16 68.35 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 173.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -117.21 -28.09 6.28 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.547 1.139 . . . . 0.0 113.584 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -143.87 94.28 2.57 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.358 2.263 . . . . 0.0 108.032 167.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -68.35 80.68 0.25 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.077 0.951 . . . . 0.0 110.347 168.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -71.0 117.22 54.3 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.447 1.099 . . . . 0.0 110.966 -171.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.39 107.09 1.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.868 1.712 . . . . 0.0 110.352 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 30.5 mm -57.13 115.13 9.58 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 124.399 1.08 . . . . 0.0 108.445 169.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.59 146.62 92.79 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.6 1.534 . . . . 0.0 111.744 -174.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.88 -17.48 64.34 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 120.887 -1.133 . . . . 0.0 114.058 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -62.18 -35.33 78.49 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.807 1.243 . . . . 0.0 112.786 167.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 36.1 mt -80.54 50.81 1.36 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.802 1.641 . . . . 0.0 111.232 165.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -34.42 70.56 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.532 1.133 . . . . 0.0 111.746 -171.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -80.5 -37.86 30.89 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.255 1.022 . . . . 0.0 112.943 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 43.9 t -64.68 -40.61 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 119.512 1.051 . . . . 0.0 111.017 172.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.57 -41.2 96.44 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -65.47 -42.72 91.96 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 171.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -65.0 -33.27 75.65 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.431 1.092 . . . . 0.0 112.959 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 58.3 mt -58.62 -32.36 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.039 -1.038 . . . . 0.0 111.704 170.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -83.13 -11.63 57.76 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.33 -1.481 . . . . 0.0 113.613 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.81 -18.9 60.9 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 117.963 -1.018 . . . . 0.0 113.448 160.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 74.0 mt -66.06 -13.59 60.26 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.033 1.288 . . . . 0.0 114.281 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -106.35 10.74 31.52 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.931 1.292 . . . . 0.0 112.776 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.0 p -114.46 177.57 4.6 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.222 1.809 . . . . 0.0 113.763 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 52.8 mtp85 57.11 -166.31 0.14 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.813 1.645 . . . . 0.0 111.201 -172.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -79.69 -33.77 40.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.449 0.7 . . . . 0.0 110.243 161.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 56.2 p -75.75 -66.85 0.73 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.909 1.683 . . . . 0.0 113.944 -162.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -61.68 -41.43 97.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.137 0.881 . . . . 0.0 112.268 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -56.68 -27.99 59.92 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -87.26 -11.2 50.35 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 11.8 p -74.76 -14.85 60.76 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.61 1.55 . . . . 0.0 112.931 173.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -59.49 134.45 57.02 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.773 1.229 . . . . 0.0 111.763 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -109.74 176.99 4.87 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.267 1.427 . . . . 0.0 110.562 168.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.69 113.84 8.18 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.812 -1.18 . . . . 0.0 109.352 168.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -57.57 -31.5 66.2 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -167.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.94 -40.28 88.44 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.481 1.112 . . . . 0.0 112.009 173.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -85.52 -3.12 58.77 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.133 1.773 . . . . 0.0 112.935 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 42.1 t -86.69 -48.84 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.753 1.221 . . . . 0.0 109.971 162.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.6 mt -57.96 -52.01 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.923 1.289 . . . . 0.0 111.512 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.3 -12.89 61.89 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.25 -32.34 10.67 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.148 -0.97 . . . . 0.0 113.371 171.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 57.1 t90 -80.26 -35.65 35.7 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.096 1.759 . . . . 0.0 114.224 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -51.05 -47.76 86.57 Favored Pre-proline 0 CA--C 1.552 1.027 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.82 -25.94 27.81 Favored 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 121.275 1.491 . . . . 0.0 113.688 172.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -76.06 -11.95 60.03 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 117.296 -1.335 . . . . 0.0 114.562 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 48.3 t -59.04 -23.33 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 119.151 0.887 . . . . 0.0 111.114 160.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -104.08 -7.94 19.87 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 177.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.294 0 C-N-CA 125.141 1.376 . . . . 0.0 112.935 -175.927 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.915 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 84.2 mt -125.22 128.42 48.29 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.131 1.772 . . . . 0.0 110.981 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -119.94 143.26 48.09 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.913 0.885 . . . . 0.0 108.784 158.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.2 pt -129.09 147.85 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.439 1.096 . . . . 0.0 109.966 176.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.3 m -120.14 120.96 37.71 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.348 1.459 . . . . 0.0 109.205 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -133.32 160.38 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.978 1.311 . . . . 0.0 111.781 -168.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.61 118.22 7.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.519 0.728 . . . . 0.0 111.56 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.02 151.95 33.28 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.08 0.552 . . . . 0.0 111.599 161.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.73 140.6 58.88 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.161 0.981 . . . . 0.0 113.029 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.5 t -66.25 121.86 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.95 -14.79 18.32 Favored Glycine 0 CA--C 1.538 1.498 0 CA-C-O 118.464 -1.187 . . . . 0.0 115.881 -173.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.26 62.72 62.43 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 119.053 1.426 . . . . 0.0 112.022 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -65.39 -5.48 11.44 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.186 2.591 . . . . 0.0 114.962 -171.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -77.92 -3.18 40.5 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.425 1.89 . . . . 0.0 114.734 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.2 pt -136.13 165.69 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.947 1.299 . . . . 0.0 112.346 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.51 144.77 53.72 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.305 1.042 . . . . 0.0 111.565 171.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.21 -174.53 13.81 Favored Glycine 0 N--CA 1.469 0.857 0 C-N-CA 125.145 1.355 . . . . 0.0 114.489 175.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -62.73 105.29 0.63 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.4 t -163.18 95.07 1.11 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.485 1.514 . . . . 0.0 109.454 159.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.09 -22.97 75.16 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.837 1.691 . . . . 0.0 113.542 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -63.29 -32.72 74.2 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.606 -1.309 . . . . 0.0 113.432 169.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 67.4 m -72.2 -37.12 69.31 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.808 -1.183 . . . . 0.0 112.014 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -63.84 -22.51 66.95 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 117.57 -1.205 . . . . 0.0 112.994 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.465 HH12 ' CG ' ' A' ' 74' ' ' ASP . 64.3 mtp180 -57.98 -43.06 86.3 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.641 1.11 . . . . 0.0 112.644 169.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -80.76 -36.82 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.574 1.15 . . . . 0.0 111.673 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.4 -41.53 94.08 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 122.118 -0.364 . . . . 0.0 111.002 169.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.1 tp -61.15 -52.33 65.32 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.044 0.938 . . . . 0.0 112.604 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.9 p -75.45 -33.71 60.9 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 62.2 mt -73.52 -29.86 62.74 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.159 -0.963 . . . . 0.0 112.919 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.474 ' CD ' ' HZ2' ' A' ' 194' ' ' LYS . 81.3 mm-40 -76.29 -34.14 59.08 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 169.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.16 -43.44 82.28 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.5 1.046 . . . . 0.0 112.768 172.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -73.6 1.53 9.91 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.791 -1.099 . . . . 0.0 113.573 166.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 pttt 46.85 22.3 0.19 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 127.952 2.501 . . . . 0.0 114.588 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.3 tt -91.03 131.16 37.88 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 125.325 1.45 . . . . 0.0 109.401 -164.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.56 119.3 6.3 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.462 1.441 . . . . 0.0 111.981 -173.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -129.72 154.12 47.49 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.693 1.597 . . . . 0.0 111.263 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -101.2 120.24 39.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.599 1.16 . . . . 0.0 110.064 176.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.5 t -95.24 112.79 24.45 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.479 0.712 . . . . 0.0 112.402 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -89.84 114.36 26.1 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.023 1.329 . . . . 0.0 110.337 169.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 98.8 mt -73.72 109.03 6.92 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.285 1.034 . . . . 0.0 110.13 166.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.0 mm -99.33 117.66 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.941 0.896 . . . . 0.0 110.33 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -77.16 52.67 0.92 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.51 1.524 . . . . 32.609999999999999 112.731 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.86 0.83 0.07 Allowed 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 120.378 3.473 . . . . 40.049999999999997 120.378 -151.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.65 -41.04 85.24 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 120.217 1.371 . . . . 41.469999999999999 111.467 159.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -99.85 62.7 1.17 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 128.025 2.53 . . . . 47.170000000000002 110.094 166.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.6 pttm -78.78 128.62 76.35 Favored Pre-proline 0 N--CA 1.476 0.845 0 O-C-N 119.907 -1.745 . . . . 41.270000000000003 110.868 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -62.37 154.4 64.15 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.845 2.363 . . . . 40.289999999999999 113.436 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -59.89 -42.13 93.11 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.455 -0.778 . . . . 42.390000000000001 112.928 172.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -65.88 -19.33 65.84 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.926 1.084 . . . . 37.079999999999998 113.926 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -76.07 -29.61 58.04 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.849 -1.157 . . . . 35.880000000000003 112.226 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.0 mt -69.12 -27.79 65.89 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.158 0.89 . . . . 33.609999999999999 112.46 170.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -73.79 -3.77 30.58 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.102 1.361 . . . . 33.789999999999999 113.036 173.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.3 mt -111.26 -43.14 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 126.223 1.809 . . . . 33.159999999999997 110.558 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -116.92 96.11 48.21 Favored Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 125.734 1.613 . . . . 33.579999999999998 110.855 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.17 -24.58 58.75 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.263 1.975 . . . . 37.899999999999999 113.062 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -76.38 -9.33 58.56 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.479 1.512 . . . . 38.990000000000002 113.54 172.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.92 4.32 33.68 Favored Glycine 0 CA--C 1.536 1.347 0 O-C-N 120.31 -1.494 . . . . 35.469999999999999 115.351 -169.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -77.05 152.06 35.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.712 1.605 . . . . 34.490000000000002 112.436 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.2 152.32 45.8 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.021 1.728 . . . . 23.530000000000001 110.723 156.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -66.18 156.03 80.83 Favored 'Cis proline' 0 C--N 1.348 0.51 0 CA-C-O 122.022 0.759 . . . . 22.879999999999999 112.799 -6.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.14 146.16 24.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.233 -1.348 . . . . 0.0 107.836 161.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.9 m -129.07 163.63 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.449 0.7 . . . . 0.0 110.975 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -120.98 75.66 1.16 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 126.046 1.738 . . . . 0.0 110.0 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 86.4 mt -68.48 119.9 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 57.66 33.8 23.69 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -172.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.272 23.0 t70 71.65 -0.31 3.21 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 127.455 2.302 . . . . 0.0 114.727 -170.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -107.76 130.22 54.98 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 119.232 -2.168 . . . . 0.0 112.76 -176.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -72.35 146.14 47.29 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -163.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.1 t -144.38 131.13 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 126.374 1.87 . . . . 0.0 109.015 175.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -120.94 163.09 18.78 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.093 1.757 . . . . 0.0 112.806 -174.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . 0.272 50.0 m-20 58.77 122.65 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 128.12 2.568 . . . . 22.16 114.464 -169.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.8 p -65.12 -24.79 67.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 115.522 1.675 . . . . 21.16 115.522 -162.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.465 ' CG ' HH12 ' A' ' 25' ' ' ARG . 38.8 m-20 -69.78 -37.1 76.23 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.065 1.302 . . . . 24.969999999999999 113.217 171.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.5 t -71.7 -39.07 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 121.27 -0.894 . . . . 23.850000000000001 110.669 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.38 -47.95 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.911 0.885 . . . . 23.68 111.0 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.23 -40.44 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.865 0.866 . . . . 22.84 111.117 174.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.65 -48.84 68.7 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 119.266 0.939 . . . . 23.329999999999998 113.531 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.4 mt -72.88 -41.19 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 117.954 0.877 . . . . 23.309999999999999 112.003 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.44 -33.85 76.91 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.853 1.206 . . . . 23.48 112.883 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -91.99 -10.96 37.41 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.287 1.218 . . . . 24.239999999999998 114.287 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -94.84 -40.63 9.63 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.521 1.128 . . . . 39.259999999999998 112.356 167.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -131.44 84.54 2.18 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.683 1.193 . . . . 24.449999999999999 111.611 -163.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -138.72 163.21 48.32 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 125.764 1.626 . . . . 0.0 110.737 165.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.88 -26.38 9.62 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.72 2.28 . . . . 0.0 112.696 172.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -82.93 151.66 64.33 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 124.054 0.942 . . . . 0.0 109.877 161.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -58.2 151.79 57.09 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.293 2.662 . . . . 0.0 117.078 -160.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.44 146.82 51.05 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.432 2.755 . . . . 0.0 112.992 174.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.8 mt -134.05 20.71 3.77 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.141 1.776 . . . . 0.0 112.366 172.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.21 51.82 0.24 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.891 1.676 . . . . 0.0 111.973 169.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.6 p -125.96 72.71 70.26 Favored Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 125.633 1.573 . . . . 0.0 110.016 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.43 117.31 5.07 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.747 2.298 . . . . 0.0 110.369 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -80.22 -170.41 1.0 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.814 3.009 . . . . 0.0 111.401 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -51.71 -33.87 36.3 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.135 1.374 . . . . 0.0 114.253 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -52.76 -30.08 30.81 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.743 1.617 . . . . 0.0 114.371 173.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.75 -29.2 69.97 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.16 -0.963 . . . . 0.0 113.322 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.2 m -71.68 -12.71 61.46 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 99.2 t -114.57 -37.63 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.499 1.52 . . . . 0.0 110.894 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.95 -30.93 76.76 Favored Glycine 0 CA--C 1.533 1.217 0 O-C-N 120.819 -1.176 . . . . 0.0 114.096 172.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 91.6 p -65.59 -22.42 66.68 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -85.14 -40.26 16.95 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.588 1.555 . . . . 0.0 112.036 172.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 81.1 mt -68.84 -36.19 73.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.935 1.294 . . . . 0.0 111.164 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -56.24 -44.34 99.67 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 125.097 1.359 . . . . 0.0 114.589 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -84.78 -31.36 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.525 2.817 . . . . 0.0 114.229 169.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 p -71.12 -26.93 63.23 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 121.148 1.794 . . . . 0.0 113.549 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -60.99 -38.93 87.72 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.859 -1.15 . . . . 0.0 112.521 162.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 41.3 t -69.03 -33.75 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 120.989 -1.07 . . . . 0.0 111.737 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.439 ' HZ1' ' CG ' ' A' ' 114' ' ' ASP . 65.0 tttt -63.37 -46.88 84.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.087 0.858 . . . . 0.0 111.552 168.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -63.25 -40.55 97.74 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.499 1.12 . . . . 0.0 112.689 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.7 mt -76.96 -1.35 28.22 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.425 1.49 . . . . 0.0 114.708 171.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -135.12 40.31 2.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.035 1.734 . . . . 0.0 111.405 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 p -73.73 54.28 0.48 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.809 2.444 . . . . 0.0 115.283 -162.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 97.6 mttt -61.63 -34.54 75.84 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.607 1.563 . . . . 0.0 111.932 161.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.439 ' CG ' ' HZ1' ' A' ' 108' ' ' LYS . 17.5 t0 -88.5 111.77 45.86 Favored Pre-proline 0 CA--C 1.553 1.077 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 157.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.27 150.49 25.47 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.126 2.55 . . . . 0.0 117.184 -154.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -66.2 -47.85 72.57 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.379 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -62.56 -26.82 68.77 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.8 -38.42 13.93 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 121.156 -0.965 . . . . 0.0 113.387 171.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.6 m -68.02 -34.85 77.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.579 1.151 . . . . 0.0 112.987 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -61.17 -38.12 85.36 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.753 1.621 . . . . 0.0 112.966 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -63.76 -44.87 92.16 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.262 0.625 . . . . 0.0 111.668 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.45 -34.27 76.85 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.75 -40.56 88.34 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.099 0.559 . . . . 0.0 112.225 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.4 mt -64.9 -35.1 80.06 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.888 0.767 . . . . 0.0 112.837 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.5 ' CD ' ' HZ2' ' A' ' 128' ' ' LYS . 26.4 mm-40 -72.4 -37.7 68.63 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.472 1.033 . . . . 0.0 113.0 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -71.62 -33.94 69.4 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.928 -1.108 . . . . 0.0 112.868 170.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.1 mt -65.7 -34.98 79.46 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.636 -1.29 . . . . 0.0 112.347 170.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.5 ' HZ2' ' CD ' ' A' ' 125' ' ' GLU . 79.6 mttt -65.89 -41.47 91.51 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.24 1.382 . . . . 0.0 111.952 170.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.56 -34.24 76.55 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.214 0.606 . . . . 0.0 112.124 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.66 -58.15 3.58 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.167 0.987 . . . . 0.0 111.584 170.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.76 -34.54 78.41 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.448 1.499 . . . . 0.0 114.022 -169.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.9 -38.68 89.76 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.045 0.831 . . . . 0.0 113.301 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -89.09 -25.87 21.67 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.714 0.806 . . . . 0.0 112.638 176.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.51 -32.35 73.65 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 120.562 -1.337 . . . . 0.0 112.923 172.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -67.7 -10.18 50.13 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 172.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 26.4 t -86.97 -31.81 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.129 0.972 . . . . 0.0 111.874 168.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -95.71 -30.21 13.86 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -173.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 102.39 -109.86 3.64 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 117.425 -1.764 . . . . 0.0 115.139 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -79.69 -26.73 4.49 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.682 2.921 . . . . 0.0 117.385 -146.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -130.85 163.08 28.2 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.159 1.345 . . . . 0.0 112.441 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.62 -8.36 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -168.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.626 ' CB ' ' HG1' ' A' ' 147' ' ' THR . . . -95.92 -2.88 46.29 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 159.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 118.55 -118.39 4.01 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.653 1.115 . . . . 0.0 113.672 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -70.9 -23.91 62.37 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.651 1.18 . . . . 0.0 113.394 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -141.66 171.1 14.53 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.433 1.893 . . . . 0.0 111.059 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.8 mt -70.8 138.57 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.669 1.187 . . . . 0.0 109.431 168.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.626 ' HG1' ' CB ' ' A' ' 142' ' ' ALA . 12.2 p -140.09 -171.63 3.23 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 121.284 -0.885 . . . . 0.0 111.46 164.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.01 -18.88 1.56 Allowed 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 171.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.6 t -72.87 -42.92 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 O-C-N 120.701 -1.249 . . . . 0.0 112.325 172.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -62.09 -43.85 97.94 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.524 1.129 . . . . 0.0 111.993 168.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.3 mt -64.34 -10.82 26.79 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.0 m -97.97 -45.02 6.43 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.512 1.125 . . . . 0.0 112.308 173.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.22 -36.15 12.15 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.67 -48.22 97.6 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -172.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -72.14 -25.22 19.33 Favored 'Trans proline' 0 C--N 1.351 0.678 0 CA-C-N 120.875 1.348 . . . . 0.0 113.371 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -74.05 -30.11 62.24 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 117.423 -1.275 . . . . 0.0 112.429 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 57.1 mt -67.94 -38.2 82.54 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.132 0.878 . . . . 0.0 112.832 167.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -63.78 -52.13 61.71 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.079 0.854 . . . . 0.0 112.253 172.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -62.65 -26.62 68.73 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.945 0.898 . . . . 0.0 112.358 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.2 tp -71.82 -52.66 16.37 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.938 -1.101 . . . . 0.0 113.184 170.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -58.56 -34.22 70.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.321 0.964 . . . . 0.0 112.656 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 97.4 t -82.87 -62.12 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.184 0.994 . . . . 0.0 112.763 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.55 -35.01 25.1 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -165.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.92 -35.85 59.61 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.742 -0.599 . . . . 0.0 111.397 169.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.16 -25.27 53.81 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.266 0.936 . . . . 0.0 115.234 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -60.26 -31.89 70.65 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.166 1.386 . . . . 0.0 114.675 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -125.2 -20.8 4.76 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -147.08 84.0 1.58 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.997 2.119 . . . . 0.0 107.119 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -66.91 85.24 0.12 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.389 0.676 . . . . 0.0 110.186 171.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 34.7 t90 -83.82 113.15 45.62 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.084 1.354 . . . . 0.0 110.997 -168.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.42 118.3 5.6 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.82 1.68 . . . . 0.0 110.545 -176.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 47.0 mm -67.63 113.82 16.38 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 159.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -66.33 155.45 69.92 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.723 1.615 . . . . 0.0 111.094 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.14 -22.56 66.94 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.378 1.071 . . . . 0.0 113.765 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -67.07 -22.72 65.83 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.479 1.112 . . . . 0.0 113.953 170.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 67.5 mt -85.71 55.09 3.36 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.322 1.449 . . . . 0.0 110.742 165.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.2 m -67.69 -27.03 66.49 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.499 1.119 . . . . 0.0 112.932 -161.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 33.9 t60 -73.03 -52.44 14.38 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.855 0.752 . . . . 0.0 110.338 168.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 79.0 t -58.78 -41.14 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.344 0.975 . . . . 0.0 112.226 -173.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 62.7 tp -60.46 -42.1 95.5 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.574 1.15 . . . . 0.0 112.831 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -76.74 -36.96 56.78 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.514 0.726 . . . . 0.0 112.848 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -63.39 -36.47 83.82 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.941 1.296 . . . . 0.0 112.629 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.85 -34.59 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.457 -0.777 . . . . 0.0 111.789 171.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -82.9 -14.6 53.89 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.432 -1.418 . . . . 0.0 113.515 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 23.3 mt -71.54 -18.49 62.26 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.816 -1.177 . . . . 0.0 113.618 162.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 60.4 mt -65.9 -20.54 66.26 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.759 1.163 . . . . 0.0 113.347 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -93.98 11.11 30.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.955 1.302 . . . . 0.0 113.058 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 10.5 p -119.94 174.96 6.14 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.913 2.085 . . . . 0.0 112.333 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? 60.66 177.12 0.1 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.473 1.509 . . . . 0.0 111.64 -170.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 0.5 OUTLIER -70.98 -41.71 70.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.783 153.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 85.6 p -54.75 -68.64 0.17 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.153 1.381 . . . . 0.0 114.682 -170.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -70.66 -43.4 69.21 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.059 -1.026 . . . . 0.0 112.247 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -59.79 -32.76 70.91 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -172.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.474 ' HZ2' ' CD ' ' A' ' 31' ' ' GLU . 56.4 mtpt -81.0 -7.76 59.63 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.4 p -77.89 -13.15 59.98 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.067 1.303 . . . . 0.0 113.426 169.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -64.43 86.21 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.883 1.673 . . . . 0.0 112.96 -167.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.48 137.95 57.77 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.343 1.057 . . . . 0.0 110.21 164.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.24 128.04 35.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.618 0.767 . . . . 0.0 112.022 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -59.61 -34.66 73.04 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -162.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -65.23 -37.96 88.89 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.981 -1.075 . . . . 0.0 112.453 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -82.24 -7.52 59.63 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 171.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.58 -47.45 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 118.706 0.685 . . . . 0.0 110.05 163.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 65.0 mt -64.52 -52.59 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.889 1.276 . . . . 0.0 111.742 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.9 -11.53 60.68 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.24 -34.15 8.95 Favored Glycine 0 CA--C 1.535 1.304 0 O-C-N 120.942 -1.099 . . . . 0.0 113.36 168.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -75.6 -35.82 60.46 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.064 1.746 . . . . 0.0 113.524 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -51.51 -51.7 66.93 Favored Pre-proline 0 N--CA 1.477 0.899 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -174.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.39 -24.41 43.06 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 CA-C-N 121.476 1.563 . . . . 0.0 113.451 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -74.96 -8.25 55.94 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.412 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 60.2 t -60.59 -27.06 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 120.064 1.302 . . . . 0.0 110.624 160.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -103.2 -34.48 8.81 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 116.656 -1.64 . . . . 0.0 115.1 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.258 0 O-C-N 125.234 1.584 . . . . 0.0 113.015 179.292 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.922 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.1 mt -105.46 138.2 42.04 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.81 1.644 . . . . 0.0 112.683 -169.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -125.93 143.99 50.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.959 1.304 . . . . 0.0 109.456 157.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.4 pt -129.0 137.18 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.136 0.975 . . . . 0.0 110.287 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.8 m -109.68 123.97 50.4 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.555 1.142 . . . . 0.0 109.473 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -136.5 162.0 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.156 1.382 . . . . 0.0 111.311 -166.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -64.0 121.31 13.8 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.14 -0.975 . . . . 0.0 111.746 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.61 143.18 38.45 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.019 0.527 . . . . 0.0 111.035 157.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.28 138.01 58.35 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.648 0.737 . . . . 0.0 111.685 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -68.91 134.92 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.85 -32.75 1.69 Allowed Glycine 0 CA--C 1.537 1.427 0 CA-C-O 118.821 -0.989 . . . . 0.0 114.952 -172.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.6 60.67 19.75 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.839 1.255 . . . . 0.0 113.151 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.22 -3.95 9.59 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.976 2.451 . . . . 0.0 115.676 -171.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -73.23 -8.1 54.35 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 170.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.0 pt -131.16 163.63 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.643 1.177 . . . . 0.0 112.513 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.3 mt -63.41 138.68 58.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.14 0.976 . . . . 0.0 111.541 172.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.99 -168.19 13.47 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.034 1.302 . . . . 0.0 114.118 173.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -60.59 103.85 0.29 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 174.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.6 t -156.81 102.9 1.95 Allowed Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.149 141.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.54 -20.9 60.41 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.716 2.278 . . . . 0.0 112.862 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -66.22 -29.86 70.2 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 120.666 -1.271 . . . . 0.0 113.534 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 88.0 m -70.43 -36.64 74.11 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.536 -1.352 . . . . 0.0 112.076 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -67.68 -21.69 65.32 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 118.119 -0.944 . . . . 0.0 112.307 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.513 HH12 ' CG ' ' A' ' 74' ' ' ASP . 64.6 mtp180 -58.76 -45.07 90.6 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.359 1.064 . . . . 0.0 112.579 166.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -73.55 -43.01 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.557 1.143 . . . . 0.0 111.045 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.6 mt -57.66 -44.19 85.51 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.743 0.417 . . . . 0.0 111.54 172.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.4 tp -60.7 -48.42 81.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.106 0.962 . . . . 0.0 112.623 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.7 -36.06 67.77 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -174.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.7 mt -73.88 -41.45 62.16 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.323 0.51 . . . . 0.0 111.493 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -77.91 -14.43 59.55 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 176.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -76.55 -46.91 24.4 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.206 -1.559 . . . . 0.0 111.578 164.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -74.82 -12.81 60.47 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm 64.88 9.51 5.41 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 127.467 2.307 . . . . 0.0 114.886 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.3 tp -67.24 129.73 93.75 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.595 1.158 . . . . 0.0 110.481 175.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.39 147.95 33.16 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.658 2.239 . . . . 0.0 112.775 -174.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -147.23 151.48 36.76 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.316 1.446 . . . . 0.0 111.071 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -80.25 147.41 31.21 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.551 -0.718 . . . . 0.0 109.484 159.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -127.42 116.53 20.59 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.646 0.778 . . . . 0.0 111.24 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -104.05 110.73 23.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.668 1.587 . . . . 0.0 109.667 -175.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -74.0 106.48 5.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.579 1.152 . . . . 0.0 110.256 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 mm -95.14 116.06 35.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.791 0.837 . . . . 0.0 110.54 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -75.99 49.87 0.57 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.02 1.728 . . . . 32.609999999999999 112.853 174.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pp -60.4 3.07 0.08 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 120.532 3.53 . . . . 40.049999999999997 120.532 -148.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.22 -36.01 70.66 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 120.236 1.38 . . . . 41.469999999999999 111.787 158.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -101.98 67.46 1.08 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.043 2.137 . . . . 47.170000000000002 109.327 163.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -80.8 119.5 76.32 Favored Pre-proline 0 N--CA 1.474 0.754 0 O-C-N 119.603 -1.936 . . . . 41.270000000000003 111.636 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -62.92 154.8 64.29 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.656 2.237 . . . . 40.289999999999999 114.397 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -63.32 -42.07 98.96 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.991 0.916 . . . . 42.390000000000001 113.217 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 33.2 p-90 -64.25 -23.81 67.44 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.054 -1.029 . . . . 37.079999999999998 113.601 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -81.97 -31.62 31.07 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.252 -0.905 . . . . 35.880000000000003 112.462 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 mt -69.03 -26.9 65.23 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.198 0.908 . . . . 33.609999999999999 112.699 170.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -68.96 -15.19 63.42 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.373 1.069 . . . . 33.789999999999999 113.485 168.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.0 mt -99.31 -44.97 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.267 1.427 . . . . 33.159999999999997 110.602 172.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.4 t -112.77 100.17 50.0 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 125.907 1.683 . . . . 33.579999999999998 110.543 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.85 -19.23 46.9 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.209 1.939 . . . . 37.899999999999999 113.968 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -85.53 -9.21 57.71 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.267 -0.895 . . . . 38.990000000000002 113.279 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.66 19.23 62.52 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 120.67 -1.269 . . . . 35.469999999999999 114.645 -171.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -85.45 155.48 21.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.118 1.767 . . . . 34.490000000000002 111.509 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.7 m -110.89 154.52 43.31 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.171 1.788 . . . . 23.530000000000001 110.134 156.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -64.89 154.94 76.39 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 CA-C-O 122.019 0.758 . . . . 22.879999999999999 112.824 -9.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.43 147.45 22.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.013 -1.449 . . . . 0.0 107.363 156.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.15 165.71 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.649 -0.657 . . . . 0.0 110.373 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -122.79 97.6 5.52 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.441 1.497 . . . . 0.0 108.808 170.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 82.3 mt -86.82 121.3 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.137 0.975 . . . . 0.0 108.922 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 52.67 38.0 24.99 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.034 0.934 . . . . 0.0 112.834 -164.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 65.64 17.08 10.78 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.129 2.171 . . . . 0.0 116.319 -172.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -117.39 128.23 54.82 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 119.981 -1.699 . . . . 0.0 111.639 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -67.97 145.8 54.18 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -164.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -144.13 129.44 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.973 2.109 . . . . 0.0 108.679 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.69 165.55 12.69 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.672 1.589 . . . . 0.0 112.622 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.0 t0 65.54 115.65 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 128.079 2.552 . . . . 22.16 114.269 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.2 p -61.75 -25.57 67.54 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.325 1.602 . . . . 21.16 115.325 -165.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.513 ' CG ' HH12 ' A' ' 25' ' ' ARG . 31.8 m-20 -71.93 -35.77 69.75 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.876 1.216 . . . . 24.969999999999999 113.415 170.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.5 t -72.57 -39.01 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 121.432 -0.792 . . . . 23.850000000000001 111.114 172.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.18 -48.66 87.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.332 1.053 . . . . 23.68 110.914 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.43 -37.38 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.176 0.991 . . . . 22.84 111.467 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.92 -13.16 51.57 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.525 1.059 . . . . 23.329999999999998 115.585 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.6 mt -102.39 -48.46 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 118.925 1.362 . . . . 23.309999999999999 111.275 167.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.9 mt -62.52 -27.45 69.16 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.305 1.224 . . . . 23.48 114.305 -171.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -91.4 -0.3 57.62 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.785 1.032 . . . . 24.239999999999998 113.785 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -129.13 -25.51 2.73 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.544 1.138 . . . . 39.259999999999998 113.545 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -126.68 73.6 1.41 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.946 1.698 . . . . 24.449999999999999 111.923 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -141.32 165.33 29.59 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 126.112 1.765 . . . . 0.0 109.806 169.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.09 -26.45 18.14 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.333 2.022 . . . . 0.0 113.7 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.5 pm0 -75.46 160.89 78.57 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.458 1.103 . . . . 0.0 112.716 168.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.84 145.09 99.52 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.524 2.149 . . . . 0.0 113.915 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.78 145.19 62.07 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.162 2.575 . . . . 0.0 113.844 -174.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.1 mt -108.87 6.75 25.68 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.211 1.804 . . . . 0.0 112.926 169.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.4 50.57 0.17 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.85 2.06 . . . . 0.0 113.536 173.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 74.7 p -120.16 75.29 22.48 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 125.039 1.336 . . . . 0.0 110.214 170.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.09 117.93 5.27 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.346 2.031 . . . . 0.0 109.913 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.28 -173.26 1.71 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.661 2.907 . . . . 0.0 111.935 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.1 mp0 -51.13 -32.14 21.8 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.393 2.277 . . . . 0.0 113.632 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -54.79 -25.81 30.59 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.314 1.446 . . . . 0.0 114.109 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -29.35 70.58 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.742 -1.224 . . . . 0.0 113.363 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.1 p -67.99 -17.85 64.55 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.8 t -108.91 -41.57 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.581 1.552 . . . . 0.0 110.731 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.63 -30.76 77.68 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.844 1.211 . . . . 0.0 114.124 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.8 p -67.29 -19.0 65.43 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 171.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -87.51 -38.6 15.89 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.077 1.351 . . . . 0.0 112.168 169.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 69.1 mt -68.05 -37.13 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.558 1.143 . . . . 0.0 110.877 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -56.69 -45.79 99.9 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.535 1.534 . . . . 0.0 115.058 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -81.62 -32.78 0.78 Allowed 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 123.148 2.565 . . . . 0.0 113.69 170.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 56.9 p -73.18 -24.99 60.61 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 120.523 1.511 . . . . 0.0 114.127 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -58.83 -42.14 88.56 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.858 -1.151 . . . . 0.0 112.204 160.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.6 t -72.6 -31.53 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.467 -0.77 . . . . 0.0 111.862 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.446 ' HZ1' ' CG ' ' A' ' 114' ' ' ASP . 62.3 tttt -62.86 -47.24 84.24 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.004 0.82 . . . . 0.0 111.348 169.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -64.65 -39.82 94.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.157 0.983 . . . . 0.0 112.313 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 50.8 mt -68.42 -0.35 4.84 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.228 1.411 . . . . 0.0 114.736 168.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -142.56 36.58 1.47 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.116 1.766 . . . . 0.0 112.266 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.06 62.3 0.3 Allowed 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -166.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 90.8 mttt -63.75 -33.84 76.55 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.557 1.543 . . . . 0.0 110.957 158.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.446 ' CG ' ' HZ1' ' A' ' 108' ' ' LYS . 14.3 t0 -86.55 117.32 68.49 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 125.67 1.588 . . . . 0.0 107.941 158.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -51.95 149.65 20.06 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.421 2.747 . . . . 0.0 117.316 -159.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.429 ' ND2' ' HZ2' ' A' ' 168' ' ' LYS . 10.4 p-10 -70.39 -45.77 65.34 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.824 -172.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -68.3 -26.11 65.48 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.027 -1.671 . . . . 0.0 114.333 -172.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.62 -33.54 42.51 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 120.643 -1.285 . . . . 0.0 113.338 169.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 89.6 m -70.4 -35.37 73.42 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.422 1.089 . . . . 0.0 112.355 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -64.07 -39.85 94.99 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.546 1.539 . . . . 0.0 112.438 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -64.06 -46.7 83.2 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.517 0.599 . . . . 0.0 112.102 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.87 -36.25 83.3 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.4 tp -68.34 -42.34 79.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.25 1.02 . . . . 0.0 112.331 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 41.9 mt -66.66 -37.66 85.26 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.798 0.839 . . . . 0.0 113.253 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.506 ' CD ' ' HZ3' ' A' ' 128' ' ' LYS . 34.8 mm-40 -69.99 -36.32 75.08 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.762 1.165 . . . . 0.0 112.786 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -72.79 -33.96 66.61 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 120.799 -1.188 . . . . 0.0 112.51 170.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.2 mt -63.43 -35.14 79.44 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.2 -1.563 . . . . 0.0 112.512 169.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.506 ' HZ3' ' CD ' ' A' ' 125' ' ' GLU . 81.5 mttt -65.88 -40.38 91.53 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.31 1.414 . . . . 0.0 111.917 171.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.14 -35.92 82.36 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 118.435 0.562 . . . . 0.0 112.314 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.2 tp -69.57 -56.92 5.98 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.373 1.069 . . . . 0.0 111.468 170.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -66.41 -35.47 80.39 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.191 1.396 . . . . 0.0 114.028 -171.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.83 -34.81 79.53 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.207 0.908 . . . . 0.0 113.513 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -89.34 -30.47 18.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.446 0.699 . . . . 0.0 112.874 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.46 -33.77 76.29 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.807 -1.183 . . . . 0.0 113.449 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -64.88 -8.0 13.66 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 172.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.0 t -99.58 -35.16 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.915 1.286 . . . . 0.0 112.221 168.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -86.46 -28.41 23.5 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -173.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.63 -157.54 32.85 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 118.198 -1.335 . . . . 0.0 113.653 -173.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.8 -9.94 19.8 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.371 3.38 . . . . 0.0 117.473 -119.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -110.98 161.39 15.91 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 119.643 1.11 . . . . 0.0 111.323 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.08 -10.79 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 O-C-N 120.427 -1.421 . . . . 0.0 113.162 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.58 ' CB ' ' HG1' ' A' ' 147' ' ' THR . . . -99.19 -2.04 37.78 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 161.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 107.25 -110.43 3.23 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 119.976 1.262 . . . . 0.0 113.652 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -73.49 -26.3 60.84 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -167.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -142.03 167.05 23.04 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.352 1.861 . . . . 0.0 111.163 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 26.2 mt -65.42 130.19 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.161 0.584 . . . . 0.0 109.997 163.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.58 ' HG1' ' CB ' ' A' ' 142' ' ' ALA . 11.8 p -135.07 -171.59 2.84 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.178 0.991 . . . . 0.0 110.866 166.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.96 -19.59 2.74 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.0 t -73.71 -43.35 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.877 1.217 . . . . 0.0 112.309 173.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.4 -46.02 91.91 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.994 -1.066 . . . . 0.0 112.113 168.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.3 mt -62.44 -17.9 60.45 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.334 0.654 . . . . 0.0 112.421 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 51.4 m -86.61 -50.92 6.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.931 0.892 . . . . 0.0 112.335 171.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.9 mt -90.54 -33.6 15.86 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -167.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.88 -49.6 92.82 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.86 -21.87 24.17 Favored 'Trans proline' 0 C--N 1.351 0.669 0 CA-C-N 121.144 1.444 . . . . 0.0 113.14 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -77.18 -28.66 54.09 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 117.584 -1.198 . . . . 0.0 112.549 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 53.7 mt -70.17 -39.22 75.42 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.758 0.823 . . . . 0.0 112.899 165.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -60.23 -46.75 88.69 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.885 0.766 . . . . 0.0 111.732 171.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -64.78 -23.71 67.33 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.951 0.9 . . . . 0.0 113.353 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 12.1 tp -80.05 -45.09 18.93 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.997 -1.064 . . . . 0.0 112.659 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.53 -37.25 86.9 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.177 0.899 . . . . 0.0 111.596 173.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.2 t -80.71 -63.92 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.51 -50.88 8.34 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.408 -0.808 . . . . 0.0 112.136 -162.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.35 -35.44 77.43 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.671 0.388 . . . . 0.0 111.382 174.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.16 -25.28 46.76 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.063 1.316 . . . . 0.0 115.7 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -65.34 -25.81 67.76 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -126.93 -18.87 4.56 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.429 ' HZ2' ' ND2' ' A' ' 116' ' ' ASN . 21.8 tptt -147.76 80.55 1.49 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.895 2.078 . . . . 0.0 107.595 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -64.19 89.27 0.06 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.885 0.874 . . . . 0.0 110.669 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 33.3 t90 -88.29 117.37 68.31 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.073 0.949 . . . . 0.0 112.208 -162.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -73.58 112.53 3.55 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.199 1.933 . . . . 0.0 110.649 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 97.5 mt -71.77 108.34 3.92 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 159.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -68.55 161.01 46.92 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.415 1.41 . . . . 0.0 112.453 -166.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.32 -28.11 66.5 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.716 1.606 . . . . 0.0 114.063 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -68.16 -22.59 64.84 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.219 1.408 . . . . 0.0 114.086 173.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 71.0 mt -84.67 52.11 2.3 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.483 1.513 . . . . 0.0 110.36 165.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.0 m -63.27 -30.11 71.31 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.472 1.109 . . . . 0.0 112.601 -160.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 66.8 t-80 -77.24 -48.3 17.89 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.542 0.61 . . . . 0.0 111.534 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 66.0 t -60.36 -40.08 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 118.683 0.674 . . . . 0.0 111.618 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.0 tp -64.03 -43.24 96.16 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.338 1.055 . . . . 0.0 113.108 176.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -70.82 -32.99 70.22 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.372 -0.83 . . . . 0.0 112.838 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -63.31 -27.4 69.3 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.333 1.053 . . . . 0.0 112.843 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 29.2 mm -56.11 -34.82 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 120.868 -1.145 . . . . 0.0 111.935 169.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -90.91 -6.3 54.33 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.925 -1.109 . . . . 0.0 113.617 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 74.3 mt -73.43 -22.87 60.1 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 117.617 -1.182 . . . . 0.0 113.461 157.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 66.3 mt -62.57 -23.89 67.25 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.723 1.147 . . . . 0.0 113.283 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -96.11 9.01 42.27 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.514 1.126 . . . . 0.0 113.267 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.9 p -121.22 177.26 5.23 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.705 2.002 . . . . 0.0 113.417 -168.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.5 mtp85 54.88 -169.15 0.07 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.218 1.407 . . . . 0.0 110.276 -166.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.13 -34.22 37.94 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.05 -1.031 . . . . 0.0 110.17 159.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 77.6 p -72.45 -56.32 5.6 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.363 1.465 . . . . 0.0 114.115 -161.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -68.52 -44.56 74.38 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.984 0.811 . . . . 0.0 112.044 171.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -54.69 -34.23 62.03 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.69 1.196 . . . . 0.0 113.88 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -79.68 -14.85 58.47 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.5 p -79.88 -2.6 44.33 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.621 1.555 . . . . 0.0 113.93 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -68.91 75.93 0.31 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.235 1.814 . . . . 0.0 112.358 -173.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -59.34 132.19 53.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.263 0.625 . . . . 0.0 109.523 163.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.67 130.73 47.96 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.094 0.558 . . . . 0.0 112.024 -165.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -59.63 -39.72 85.26 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -160.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -62.31 -38.69 90.37 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.083 -1.01 . . . . 0.0 112.277 174.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -84.66 -5.93 59.34 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.308 1.443 . . . . 0.0 113.343 177.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 75.4 t -82.61 -46.8 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.982 0.913 . . . . 0.0 110.215 161.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.5 mt -61.89 -51.37 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.572 1.149 . . . . 0.0 111.845 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.73 -15.16 63.1 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.216 1.006 . . . . 0.0 113.693 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.47 -37.5 14.29 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 120.899 -1.125 . . . . 0.0 112.895 169.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 17.5 t90 -77.1 -35.49 56.4 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.186 1.794 . . . . 0.0 114.015 -174.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -49.56 -52.42 50.39 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.89 -24.5 39.9 Favored 'Trans proline' 0 C--N 1.353 0.799 0 CA-C-N 121.452 1.554 . . . . 0.0 113.461 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -78.29 -7.21 56.95 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 117.193 -1.384 . . . . 0.0 114.316 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.409 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 58.3 t -63.0 -30.83 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 120.037 1.29 . . . . 0.0 110.315 159.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -94.9 -34.66 12.34 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 115.745 1.758 . . . . 0.0 115.745 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 CA-C-O 117.604 -1.189 . . . . 0.0 113.163 172.516 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 61.9 mt -101.59 142.15 33.39 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.807 1.243 . . . . 0.0 113.26 -170.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -129.04 145.89 51.15 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.617 1.567 . . . . 0.0 109.02 157.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.5 pt -130.65 136.84 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.604 1.162 . . . . 0.0 109.647 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.7 m -111.73 119.27 38.07 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.777 1.231 . . . . 0.0 109.085 173.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.3 m -134.87 162.9 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.255 1.422 . . . . 0.0 111.229 -166.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -61.5 120.99 11.6 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.374 -0.829 . . . . 0.0 112.108 -175.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.34 149.61 31.68 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.049 0.54 . . . . 0.0 111.603 159.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.63 134.28 52.94 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.014 0.911 . . . . 0.0 112.111 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.7 t -67.36 126.27 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 173.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.54 -14.62 22.97 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-O 118.587 -1.118 . . . . 0.0 115.605 -172.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.88 61.65 29.85 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 119.161 1.48 . . . . 0.0 112.13 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.47 -6.89 14.53 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.966 2.444 . . . . 0.0 115.795 -167.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -80.9 -1.21 42.51 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.9 pt -131.83 164.97 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.731 1.212 . . . . 0.0 112.114 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.94 143.69 57.46 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.239 1.016 . . . . 0.0 111.409 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.9 -173.48 13.48 Favored Glycine 0 N--CA 1.471 0.991 0 C-N-CA 125.176 1.37 . . . . 0.0 113.905 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -60.55 106.5 0.56 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.6 t -165.07 97.86 0.84 Allowed Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.776 157.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -62.92 -21.09 72.93 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.244 1.963 . . . . 0.0 113.041 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -66.68 -29.66 69.72 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 120.655 -1.278 . . . . 0.0 113.59 171.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 98.8 m -71.47 -37.76 71.31 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.578 -1.326 . . . . 0.0 112.179 171.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.0 -24.29 67.85 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 117.95 -1.024 . . . . 0.0 112.875 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.473 HH12 ' CG ' ' A' ' 74' ' ' ASP . 53.5 mtp180 -57.78 -46.97 83.84 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.46 1.027 . . . . 0.0 112.389 170.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.5 t -74.67 -40.6 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.042 1.337 . . . . 0.0 111.31 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.4 mt -61.38 -42.73 99.19 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.251 0.621 . . . . 0.0 111.545 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.1 tp -61.68 -49.12 77.77 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.076 0.95 . . . . 0.0 112.083 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.75 -43.2 69.31 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -174.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.66 -38.92 84.43 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.571 -0.706 . . . . 0.0 112.46 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -80.17 -20.09 45.63 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -69.79 -48.93 57.35 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.798 -1.189 . . . . 0.0 110.641 166.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -70.26 -9.61 56.47 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.46 1.904 . . . . 0.0 114.23 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm 61.85 18.92 10.2 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.48 1.912 . . . . 0.0 115.01 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -75.25 131.59 77.87 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 123.941 0.896 . . . . 0.0 109.613 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -74.66 143.71 30.65 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.662 2.242 . . . . 0.0 112.496 174.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -146.11 151.52 37.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.849 1.66 . . . . 0.0 110.072 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -78.66 130.59 36.04 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.318 -0.863 . . . . 0.0 109.196 163.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 t -111.92 108.64 18.07 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.535 0.734 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -100.79 112.46 24.87 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.728 1.211 . . . . 0.0 109.966 -177.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.13 112.13 13.47 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.156 0.982 . . . . 0.0 110.263 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.4 mm -102.29 116.04 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.321 1.048 . . . . 0.0 110.4 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -77.15 57.7 1.46 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.163 1.385 . . . . 32.609999999999999 111.977 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.14 4.59 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 120.083 3.364 . . . . 40.049999999999997 120.083 -154.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -69.3 -46.46 56.92 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 120.905 1.684 . . . . 41.469999999999999 110.871 156.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -93.03 63.02 3.67 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.214 2.606 . . . . 47.170000000000002 110.629 168.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 pttm -79.78 119.01 75.38 Favored Pre-proline 0 N--CA 1.476 0.827 0 O-C-N 119.921 -1.737 . . . . 41.270000000000003 111.386 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -64.13 155.7 63.4 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.699 2.266 . . . . 40.289999999999999 114.182 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tp60 -62.27 -39.48 93.05 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.672 0.99 . . . . 42.390000000000001 113.672 174.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -64.73 -23.95 67.41 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.069 0.766 . . . . 37.079999999999998 113.069 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -83.27 -32.13 26.57 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.655 0.782 . . . . 35.880000000000003 112.536 172.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.2 mt -67.26 -26.47 66.58 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.159 0.89 . . . . 33.609999999999999 112.672 170.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -71.63 -8.11 52.03 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.883 1.273 . . . . 33.789999999999999 113.858 168.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.7 mt -106.46 -44.65 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.597 1.559 . . . . 33.159999999999997 110.603 171.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.6 t -112.25 98.79 44.35 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 125.792 1.637 . . . . 33.579999999999998 110.956 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.49 -18.18 43.53 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.364 2.043 . . . . 37.899999999999999 113.408 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -83.75 -8.71 59.19 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.727 1.01 . . . . 38.990000000000002 113.727 170.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.93 8.57 49.54 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 120.87 -1.144 . . . . 35.469999999999999 115.067 -169.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -84.71 157.8 20.97 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.267 1.427 . . . . 34.490000000000002 112.491 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.2 m -113.58 156.22 43.78 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 126.383 1.873 . . . . 23.530000000000001 110.592 160.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -66.12 156.81 80.17 Favored 'Cis proline' 0 C--N 1.348 0.501 0 CA-C-O 122.015 0.756 . . . . 22.879999999999999 112.403 -10.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.4 p -141.05 147.26 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 159.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.11 163.71 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 121.43 -0.794 . . . . 0.0 110.611 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 mtpt -121.27 92.1 3.67 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.181 1.393 . . . . 0.0 109.054 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.3 mt -82.09 119.67 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.688 0.795 . . . . 0.0 108.907 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.75 38.82 27.41 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 122.284 1.04 . . . . 0.0 112.675 -165.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.3 t70 66.11 12.7 8.68 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.063 2.145 . . . . 0.0 116.476 -172.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -110.84 127.8 55.55 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 119.8 -1.813 . . . . 0.0 111.651 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -66.69 144.66 56.23 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -167.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.7 t -143.25 128.35 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.625 1.97 . . . . 0.0 108.593 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -112.69 166.5 11.29 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.746 1.618 . . . . 0.0 112.24 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.0 t0 65.11 113.62 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.821 2.449 . . . . 22.16 114.067 -175.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.7 p -62.74 -21.65 65.97 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 115.274 1.583 . . . . 21.16 115.274 -166.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.473 ' CG ' HH12 ' A' ' 25' ' ' ARG . 30.0 m-20 -71.46 -38.17 71.31 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.843 1.201 . . . . 24.969999999999999 113.056 169.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -70.49 -40.07 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.16 -0.962 . . . . 23.850000000000001 110.842 172.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.58 -48.62 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.955 0.902 . . . . 23.68 111.15 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.74 -38.54 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.611 0.764 . . . . 22.84 111.547 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.37 -39.95 95.42 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.531 -0.594 . . . . 23.329999999999998 113.596 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.7 mt -76.87 -48.22 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 118.379 1.09 . . . . 23.309999999999999 111.638 174.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.7 mt -62.32 -33.32 74.46 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.747 1.158 . . . . 23.48 113.399 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -92.66 -3.18 55.33 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 115.229 1.566 . . . . 24.239999999999998 115.229 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.515 ' CD ' ' HZ2' ' A' ' 83' ' ' LYS . 6.5 tt0 -108.56 -35.43 6.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.913 1.285 . . . . 39.259999999999998 112.489 169.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.515 ' HZ2' ' CD ' ' A' ' 82' ' ' GLU . 63.7 mttp -125.47 70.98 1.19 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.513 1.525 . . . . 24.449999999999999 111.628 -167.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -136.99 167.59 20.4 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.641 1.976 . . . . 0.0 109.373 168.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.38 -33.44 38.16 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.677 1.585 . . . . 0.0 112.336 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -75.15 151.99 86.09 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.282 1.033 . . . . 0.0 111.976 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.2 144.62 29.11 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.543 2.829 . . . . 0.0 115.215 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.62 136.92 34.62 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.562 2.175 . . . . 0.0 112.249 -174.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.3 mt -108.55 8.18 27.09 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.934 1.294 . . . . 0.0 111.944 167.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.55 46.33 0.07 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.42 2.288 . . . . 0.0 112.696 163.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.1 p -123.9 67.52 42.16 Favored Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 125.452 1.501 . . . . 0.0 109.8 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.86 119.61 6.65 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.232 1.955 . . . . 0.0 109.951 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.97 -173.88 1.84 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.213 2.609 . . . . 0.0 111.775 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.3 mp0 -51.2 -33.89 29.47 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.65 2.38 . . . . 0.0 113.333 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -52.53 -28.87 22.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.913 1.685 . . . . 0.0 114.119 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.99 -28.97 70.17 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.931 -1.105 . . . . 0.0 113.513 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.6 p -67.53 -19.92 65.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.461 1.105 . . . . 0.0 113.568 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.6 t -102.0 -42.79 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.481 1.513 . . . . 0.0 110.68 175.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.27 -31.67 81.52 Favored Glycine 0 CA--C 1.532 1.102 0 O-C-N 120.842 -1.161 . . . . 0.0 114.594 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.2 p -66.24 -19.05 65.71 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -87.78 -39.26 15.04 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.934 1.294 . . . . 0.0 112.549 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.5 mt -66.37 -34.72 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.942 0.897 . . . . 0.0 110.906 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -56.13 -48.91 95.87 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 117.452 -1.261 . . . . 0.0 114.189 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.42 -31.56 2.66 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.926 2.417 . . . . 0.0 114.316 170.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 p -70.84 -27.8 64.12 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 121.279 1.854 . . . . 0.0 113.281 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -57.83 -47.8 81.61 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.107 -0.996 . . . . 0.0 112.084 161.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.73 -34.93 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 119.114 0.87 . . . . 0.0 111.918 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.426 ' HZ1' ' CG ' ' A' ' 114' ' ' ASP . 63.2 tttt -63.09 -45.21 93.17 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.677 0.671 . . . . 0.0 111.464 170.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -64.12 -39.02 93.13 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.765 0.826 . . . . 0.0 112.44 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.6 mt -69.86 -7.36 39.51 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.979 1.711 . . . . 0.0 115.124 170.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.464 ' HZ2' ' C ' ' A' ' 212' ' ' ALA . 77.2 mttt -139.88 41.17 1.98 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.287 1.835 . . . . 0.0 111.663 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.4 m -68.46 56.47 0.08 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.285 1.834 . . . . 0.0 115.738 -168.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -69.38 -35.69 76.06 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.88 1.272 . . . . 0.0 111.265 165.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.426 ' CG ' ' HZ1' ' A' ' 108' ' ' LYS . 22.0 t0 -81.87 114.82 53.25 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 153.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -54.71 154.19 21.56 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.192 2.594 . . . . 0.0 117.093 -154.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -69.34 -37.31 77.61 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 117.278 -1.344 . . . . 0.0 112.4 -172.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -67.3 -37.78 83.93 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 121.157 1.799 . . . . 0.0 113.825 -171.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.57 -31.54 60.63 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 120.645 -1.285 . . . . 0.0 112.905 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 91.7 m -69.77 -31.68 69.76 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.913 0.885 . . . . 0.0 112.62 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -70.31 -41.08 73.77 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 127.206 2.202 . . . . 0.0 111.953 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.29 -47.09 83.78 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.802 -0.561 . . . . 0.0 111.878 170.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.41 -31.27 72.38 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.6 tp -73.71 -45.36 52.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.669 1.188 . . . . 0.0 112.086 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 49.0 mt -64.67 -38.82 92.29 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.185 0.994 . . . . 0.0 113.126 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.511 ' CD ' ' HZ2' ' A' ' 128' ' ' LYS . 29.1 mm-40 -69.99 -37.58 75.76 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 120.113 1.324 . . . . 0.0 113.275 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.28 -30.97 62.34 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.588 -1.32 . . . . 0.0 112.433 170.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.3 mt -64.87 -32.68 74.49 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.235 -1.541 . . . . 0.0 112.958 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.511 ' HZ2' ' CD ' ' A' ' 125' ' ' GLU . 81.9 mttt -67.38 -40.68 85.7 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 120.298 1.408 . . . . 0.0 111.66 170.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.65 -32.76 73.87 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.97 0.508 . . . . 0.0 112.343 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.9 tp -71.56 -58.47 3.47 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.011 0.924 . . . . 0.0 111.538 169.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -67.28 -31.39 71.68 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -169.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.99 -31.87 69.47 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 119.248 -0.751 . . . . 0.0 113.401 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -91.6 -28.83 17.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.695 0.798 . . . . 0.0 113.033 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.11 -36.61 84.18 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.804 1.184 . . . . 0.0 112.456 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -67.67 -3.14 8.23 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 173.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.0 t -100.78 -38.38 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.876 1.27 . . . . 0.0 112.122 166.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -91.89 -22.93 19.8 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -171.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.9 -141.34 31.57 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 118.527 -1.152 . . . . 0.0 113.735 -175.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.7 -10.47 28.7 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 125.056 3.838 . . . . 0.0 117.728 -114.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -123.16 169.26 11.42 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.931 1.292 . . . . 0.0 111.791 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -72.68 -7.16 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.411 -1.431 . . . . 0.0 112.828 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.577 ' CB ' ' HG1' ' A' ' 147' ' ' THR . . . -109.58 16.9 21.87 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.075 1.75 . . . . 0.0 114.079 162.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.25 -109.53 3.39 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.534 1.064 . . . . 0.0 113.627 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -55.84 -39.77 71.9 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.462 1.505 . . . . 0.0 113.736 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -147.46 166.38 27.42 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.032 1.733 . . . . 0.0 110.638 -168.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 16.8 mt -61.92 135.34 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 120.89 0.376 . . . . 0.0 110.117 163.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.577 ' HG1' ' CB ' ' A' ' 142' ' ' ALA . 19.1 p -136.76 -170.86 2.78 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.311 1.044 . . . . 0.0 110.439 163.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.79 -19.66 4.62 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.5 t -69.97 -46.4 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 120.169 1.35 . . . . 0.0 111.836 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.6 -46.49 89.64 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.855 1.262 . . . . 0.0 112.312 172.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.6 mt -64.08 -8.87 13.33 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.781 0.832 . . . . 0.0 112.839 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.1 m -101.03 -47.6 4.71 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.668 1.187 . . . . 0.0 112.564 173.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 38.3 mt -90.78 -35.0 15.1 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -170.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.0 97.32 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -173.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.78 -20.55 17.31 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 120.741 1.301 . . . . 0.0 113.448 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -75.91 -31.16 59.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 117.411 -1.281 . . . . 0.0 112.322 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 77.0 mt -64.97 -40.29 94.77 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.054 0.843 . . . . 0.0 112.726 166.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -60.75 -46.36 90.74 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.416 0.627 . . . . 0.0 111.711 173.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -66.6 -22.97 66.12 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 125.123 1.369 . . . . 0.0 113.421 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.4 mt -72.31 -58.48 3.37 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.072 1.306 . . . . 0.0 113.097 165.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -61.73 -31.81 72.0 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 118.646 0.657 . . . . 0.0 111.509 -173.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.9 t -86.74 -64.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 124.548 1.139 . . . . 0.0 112.907 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.66 -55.65 4.51 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.715 -0.616 . . . . 0.0 112.197 -160.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.1 tp -61.98 -32.56 73.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.62 0.368 . . . . 0.0 111.642 170.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -55.46 -27.13 47.06 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.201 1.382 . . . . 0.0 115.793 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -65.98 -24.43 66.78 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -125.34 -19.43 5.07 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -144.87 82.58 1.68 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.507 1.923 . . . . 0.0 108.254 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -61.38 90.02 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.535 1.134 . . . . 0.0 110.482 171.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -92.81 116.77 67.04 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.696 0.799 . . . . 0.0 111.907 -163.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.4 117.33 5.03 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.701 1.6 . . . . 0.0 110.319 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.78 109.93 4.64 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 149.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -66.62 164.38 29.23 Favored 'Trans proline' 0 C--N 1.35 0.643 0 CA-C-N 120.74 1.3 . . . . 0.0 112.488 -165.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -25.94 63.92 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.807 1.643 . . . . 0.0 113.911 177.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -70.55 -24.51 62.8 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.998 1.719 . . . . 0.0 114.283 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.3 mt -86.98 50.47 2.02 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.833 1.653 . . . . 0.0 110.251 166.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.6 m -59.65 -36.67 76.86 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.954 1.302 . . . . 0.0 113.03 -156.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -81.75 -38.94 24.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.874 -0.584 . . . . 0.0 112.091 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.72 -39.36 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 121.622 -0.673 . . . . 0.0 111.785 172.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 46.5 tp -63.61 -45.7 89.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.989 0.916 . . . . 0.0 112.697 175.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -66.52 -32.07 73.2 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.315 -0.866 . . . . 0.0 112.639 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -63.65 -28.82 70.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.729 0.812 . . . . 0.0 112.89 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 18.7 mt -58.36 -35.54 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 120.65 -1.281 . . . . 0.0 111.234 171.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -84.6 -9.72 58.04 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.461 -1.399 . . . . 0.0 113.998 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.99 -22.01 62.23 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.107 -0.949 . . . . 0.0 113.178 160.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 56.4 mt -65.29 -18.81 65.61 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.628 1.104 . . . . 0.0 113.754 -177.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -98.56 6.93 46.73 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.833 1.253 . . . . 0.0 112.933 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.8 p -117.68 -179.44 3.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.322 1.849 . . . . 0.0 113.715 -165.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 53.97 -162.27 0.12 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.567 1.547 . . . . 0.0 110.8 -169.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -82.99 -38.12 23.08 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 124.118 0.967 . . . . 0.0 109.241 159.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 77.5 p -71.05 -60.51 2.19 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 126.093 1.757 . . . . 0.0 114.086 -161.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -63.82 -44.28 93.72 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.506 0.593 . . . . 0.0 112.175 173.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -55.41 -36.62 66.65 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.085 0.954 . . . . 0.0 113.334 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -76.75 -15.47 59.75 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.6 p -76.28 -11.74 59.96 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.513 1.506 . . . . 0.0 113.088 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -65.45 89.49 0.1 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.687 1.595 . . . . 0.0 112.609 -168.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.64 131.32 48.59 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.665 -0.683 . . . . 0.0 109.308 155.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.75 135.23 57.52 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.384 0.674 . . . . 0.0 111.78 -174.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -60.74 -37.6 82.33 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -157.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -38.2 87.14 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.935 -1.103 . . . . 0.0 113.149 172.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -76.81 -7.72 55.97 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 171.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.9 t -82.89 -49.56 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.774 0.83 . . . . 0.0 110.612 161.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.5 mt -59.92 -48.32 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.342 1.057 . . . . 0.0 111.5 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.25 -14.44 62.61 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.09 -33.67 9.42 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 120.917 -1.114 . . . . 0.0 113.364 170.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -78.95 -34.02 44.77 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.837 1.655 . . . . 0.0 113.885 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -51.34 -50.33 76.8 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.19 -24.92 27.17 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 121.637 1.558 . . . . 0.0 113.49 172.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -78.18 -10.39 59.62 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.147 1.379 . . . . 0.0 114.267 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.74 -31.03 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 119.249 0.931 . . . . 0.0 110.389 158.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -96.38 -20.12 18.7 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 177.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.464 ' C ' ' HZ2' ' A' ' 111' ' ' LYS . . . . . . . . 0 C--O 1.251 1.158 0 C-N-CA 125.707 1.603 . . . . 0.0 112.629 -176.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.984 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.5 mt -111.85 139.63 47.17 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.421 1.488 . . . . 0.0 111.999 -175.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.512 ' CD ' ' HZ2' ' A' ' 38' ' ' LYS . 26.6 mt-10 -139.78 134.88 32.42 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.984 1.313 . . . . 0.0 108.136 173.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.8 pt -127.57 142.34 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 120.999 -1.063 . . . . 0.0 110.5 -174.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.9 m -117.58 120.25 37.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.757 1.223 . . . . 0.0 109.689 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.27 163.03 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.998 1.319 . . . . 0.0 111.517 -165.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -59.54 116.2 3.83 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.609 -0.682 . . . . 0.0 110.865 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.06 149.78 33.89 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.935 154.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.05 146.88 49.02 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.203 1.002 . . . . 0.0 112.197 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 51.3 t -68.87 133.75 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 167.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.38 -33.9 1.56 Allowed Glycine 0 CA--C 1.537 1.453 0 CA-C-O 118.516 -1.158 . . . . 0.0 115.357 -174.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.13 69.03 9.75 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.824 1.25 . . . . 0.0 112.61 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -63.41 -11.84 27.74 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.271 2.647 . . . . 0.0 114.816 -173.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -81.4 0.65 36.51 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.063 1.745 . . . . 0.0 114.737 175.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 pt -133.96 164.76 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.795 1.238 . . . . 0.0 111.801 174.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.39 146.7 54.56 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.59 0.756 . . . . 0.0 111.454 169.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -124.2 -164.28 11.92 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 125.25 1.405 . . . . 0.0 112.494 166.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -60.89 108.67 0.89 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 118.22 1.01 . . . . 0.0 113.593 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.1 t -157.63 108.26 1.81 Allowed Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.119 139.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HG3' ' HD1' ' A' ' 159' ' ' HIS . 72.5 Cg_endo -65.54 -21.5 59.78 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.14 1.893 . . . . 0.0 112.39 176.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -68.5 -29.9 68.61 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.61 0.764 . . . . 0.0 112.297 173.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 73.1 m -72.26 -37.58 69.05 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.372 -1.455 . . . . 0.0 112.669 168.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.53 -25.13 67.09 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 118.112 -0.947 . . . . 0.0 113.141 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.493 HH11 ' CG ' ' A' ' 74' ' ' ASP . 32.8 mtp180 -58.61 -43.3 89.56 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.319 1.048 . . . . 0.0 112.407 169.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.2 t -76.98 -37.43 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.855 1.262 . . . . 0.0 111.302 -176.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.55 -45.26 91.33 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.138 0.575 . . . . 0.0 111.478 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.68 -50.91 69.28 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.827 1.251 . . . . 0.0 112.408 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 p -63.08 -50.5 70.31 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.6 -35.8 73.18 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.438 ' HG2' ' HH ' ' A' ' 37' ' ' TYR . 72.1 mm-40 -76.53 -23.18 53.64 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 171.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -68.86 -46.23 69.01 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.072 1.305 . . . . 0.0 110.983 170.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -70.35 -7.24 41.18 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.48 1.512 . . . . 0.0 114.92 169.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.9 mmtm 61.46 15.39 6.61 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 126.032 1.733 . . . . 0.0 114.863 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.7 mt -72.69 128.6 88.1 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 123.598 0.759 . . . . 0.0 109.306 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.44 138.12 32.03 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.183 1.922 . . . . 0.0 111.516 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.438 ' HH ' ' HG2' ' A' ' 31' ' ' GLU . 47.4 p90 -141.67 153.44 44.7 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.231 1.412 . . . . 0.0 110.556 173.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.512 ' HZ2' ' CD ' ' A' ' 4' ' ' GLU . 54.9 mttt -78.22 122.8 26.16 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.317 -0.864 . . . . 0.0 109.804 166.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.3 t -97.74 93.79 6.58 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.593 0.757 . . . . 0.0 111.559 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -82.83 105.68 14.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.903 0.881 . . . . 0.0 110.292 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.1 mt -73.24 113.95 10.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.944 0.898 . . . . 0.0 109.918 171.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.2 mm -108.97 115.8 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.739 1.216 . . . . 0.0 110.086 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -73.98 79.58 1.68 Allowed 'General case' 0 C--O 1.221 -0.411 0 O-C-N 121.4 -0.813 . . . . 32.609999999999999 109.756 166.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pp -65.05 0.7 1.17 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 117.601 2.445 . . . . 40.049999999999997 117.601 -165.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.51 -27.6 67.26 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-N 119.612 1.096 . . . . 41.469999999999999 112.871 161.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -120.45 53.91 1.08 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.934 2.894 . . . . 47.170000000000002 109.529 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -73.06 116.48 51.0 Favored Pre-proline 0 N--CA 1.472 0.667 0 O-C-N 119.757 -1.839 . . . . 41.270000000000003 110.317 -176.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.22 160.58 46.83 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.648 2.232 . . . . 40.289999999999999 112.144 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -61.46 -34.03 74.75 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.302 1.223 . . . . 42.390000000000001 114.302 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 30.5 p-90 -67.5 -21.37 65.5 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.691 -1.256 . . . . 37.079999999999998 114.097 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -82.74 -34.42 27.17 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.425 -0.797 . . . . 35.880000000000003 112.321 169.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.78 -24.97 65.38 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.551 0.74 . . . . 33.609999999999999 112.385 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -72.73 -1.45 16.47 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.794 1.637 . . . . 33.789999999999999 114.376 166.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.6 mt -115.73 -41.7 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.348 1.459 . . . . 33.159999999999997 110.314 173.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.1 t -114.43 100.4 52.9 Favored Pre-proline 0 N--CA 1.471 0.591 0 C-N-CA 125.808 1.643 . . . . 33.579999999999998 111.281 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.99 -20.55 44.53 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.941 2.428 . . . . 37.899999999999999 113.418 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.76 -0.08 57.52 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.396 1.079 . . . . 38.990000000000002 113.716 171.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.92 23.68 72.78 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.607 1.575 . . . . 35.469999999999999 115.866 176.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -104.15 158.63 16.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.889 1.675 . . . . 34.490000000000002 112.789 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.3 m -115.24 150.08 43.8 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.648 1.579 . . . . 23.530000000000001 111.151 164.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -68.46 153.62 89.27 Favored 'Cis proline' 0 C--N 1.349 0.562 0 CA-C-O 121.724 0.635 . . . . 22.879999999999999 112.629 -9.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.1 p -135.63 147.77 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 113.577 -1.647 . . . . 0.0 107.294 156.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.7 m -129.69 161.75 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.654 0.781 . . . . 0.0 110.474 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -116.03 98.93 6.91 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.428 1.491 . . . . 0.0 109.118 167.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 66.8 mt -87.49 114.85 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.415 1.086 . . . . 0.0 108.536 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.58 36.84 28.23 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 121.866 0.841 . . . . 0.0 112.457 -169.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.251 11.2 t0 66.77 10.72 7.75 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 128.292 2.637 . . . . 0.0 116.316 -170.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -104.12 123.18 46.8 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 119.412 -2.055 . . . . 0.0 110.688 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -69.36 143.49 53.71 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -170.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.4 t -142.86 126.66 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 126.695 1.998 . . . . 0.0 108.585 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -110.38 164.95 12.18 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.62 1.568 . . . . 0.0 112.136 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.2 t0 67.57 113.45 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.342 2.257 . . . . 22.16 114.191 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.5 p -65.16 -22.14 66.88 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 115.356 1.613 . . . . 21.16 115.356 -158.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.493 ' CG ' HH11 ' A' ' 25' ' ' ARG . 33.8 m-20 -70.47 -35.68 73.43 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.899 1.227 . . . . 24.969999999999999 112.696 170.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.62 -41.71 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 121.092 -1.005 . . . . 23.850000000000001 110.745 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.0 mt -63.75 -46.5 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.841 0.856 . . . . 23.68 111.227 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.1 t -63.15 -40.54 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.021 0.928 . . . . 22.84 111.314 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.19 -47.26 89.06 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 118.462 0.574 . . . . 23.329999999999998 113.1 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 75.9 mt -73.43 -47.24 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 117.846 0.823 . . . . 23.309999999999999 112.165 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.56 -32.23 73.79 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.046 1.294 . . . . 23.48 112.748 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -89.57 -14.37 35.21 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 114.614 1.338 . . . . 24.239999999999998 114.614 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.511 ' CD ' ' HE3' ' A' ' 83' ' ' LYS . 68.8 tt0 -89.54 -33.57 16.69 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.283 1.433 . . . . 39.259999999999998 112.606 165.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.511 ' HE3' ' CD ' ' A' ' 82' ' ' GLU . 65.2 mttt -135.3 85.33 2.16 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.619 1.168 . . . . 24.449999999999999 112.09 -161.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -150.42 166.02 16.09 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.149 1.78 . . . . 0.0 109.191 168.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.76 -33.36 44.31 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 121.919 1.746 . . . . 0.0 112.103 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -73.95 149.31 87.56 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.231 1.012 . . . . 0.0 111.649 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -52.31 143.02 44.96 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.408 2.739 . . . . 0.0 115.02 -172.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.98 133.49 29.22 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.673 2.249 . . . . 0.0 111.934 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 34.1 mt -103.34 8.51 38.16 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.608 1.163 . . . . 0.0 111.83 168.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.49 49.17 0.11 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.281 1.832 . . . . 0.0 112.373 163.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.7 p -123.31 65.07 29.47 Favored Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 125.381 1.473 . . . . 0.0 109.885 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.76 119.83 6.85 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.181 1.921 . . . . 0.0 109.962 -173.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -73.89 -176.37 2.57 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.917 2.412 . . . . 0.0 111.532 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -53.93 -29.23 41.46 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.184 2.194 . . . . 0.0 113.5 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -52.72 -28.5 22.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.8 1.64 . . . . 0.0 114.045 170.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.64 -29.41 70.65 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.658 1.117 . . . . 0.0 113.358 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 59.7 p -66.9 -25.16 66.25 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.789 0.836 . . . . 0.0 113.097 174.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.0 t -94.87 -42.04 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.978 1.311 . . . . 0.0 110.814 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.47 -31.09 79.58 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.7 1.143 . . . . 0.0 114.421 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 72.3 p -66.35 -20.6 66.13 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.762 1.281 . . . . 0.0 114.211 171.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -92.2 -33.26 14.76 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.113 1.365 . . . . 0.0 112.827 172.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.8 mt -70.45 -37.09 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.986 0.914 . . . . 0.0 111.655 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.446 ' CE1' ' HE2' ' A' ' 156' ' ' LYS . 83.0 t80 -54.68 -45.85 99.47 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.032 1.333 . . . . 0.0 114.505 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.78 -32.52 1.09 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.016 2.478 . . . . 0.0 114.069 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.2 p -71.76 -26.62 62.52 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 121.34 1.882 . . . . 0.0 113.207 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -58.4 -45.89 87.47 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.695 -1.253 . . . . 0.0 112.413 160.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.46 -31.72 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 121.374 -0.828 . . . . 0.0 112.069 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.476 ' HZ3' ' CG ' ' A' ' 114' ' ' ASP . 56.0 tttt -64.67 -44.15 91.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.689 0.677 . . . . 0.0 111.365 168.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -67.79 -37.1 81.57 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.5 mt -64.21 -11.32 29.91 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.787 1.635 . . . . 0.0 114.435 167.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.45 ' HZ2' ' C ' ' A' ' 212' ' ' ALA . 78.4 mttt -142.31 41.03 1.62 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.641 1.976 . . . . 0.0 112.543 -173.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.1 m -68.6 59.73 0.09 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -165.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 94.4 mttt -71.28 -35.75 71.44 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.562 -1.336 . . . . 0.0 111.995 168.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.476 ' CG ' ' HZ3' ' A' ' 108' ' ' LYS . 15.4 t0 -81.01 112.78 35.4 Favored Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 152.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -57.24 158.68 17.62 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.977 2.451 . . . . 0.0 117.29 -148.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -56.91 -51.64 68.32 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.478 -174.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -79.67 -21.67 44.45 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -163.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.89 -36.08 29.5 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 121.355 -0.841 . . . . 0.0 112.772 165.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 62.3 m -66.81 -30.89 71.2 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.641 0.776 . . . . 0.0 112.799 171.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -65.24 -42.69 93.12 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 125.736 1.614 . . . . 0.0 111.841 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -65.62 -43.13 90.5 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.724 -0.61 . . . . 0.0 111.766 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.05 -25.68 68.22 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 174.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 49.8 tp -82.47 -42.63 18.24 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.848 1.259 . . . . 0.0 112.27 172.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 33.9 mt -67.23 -39.17 86.19 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.668 1.187 . . . . 0.0 113.241 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.49 ' CD ' ' HZ3' ' A' ' 128' ' ' LYS . 14.2 mm-40 -67.01 -34.97 78.89 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.046 1.293 . . . . 0.0 112.389 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -72.29 -38.55 68.73 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.027 -1.046 . . . . 0.0 112.765 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.1 mt -64.98 -33.14 75.32 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.585 -1.322 . . . . 0.0 113.03 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.49 ' HZ3' ' CD ' ' A' ' 125' ' ' GLU . 81.1 mttt -66.4 -41.38 89.39 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.673 1.124 . . . . 0.0 111.51 171.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.8 -35.82 81.85 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.965 0.506 . . . . 0.0 112.203 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.4 tp -68.67 -56.45 8.14 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.068 0.947 . . . . 0.0 111.677 171.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -67.43 -31.63 71.95 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.71 1.204 . . . . 0.0 114.157 -172.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.21 -31.63 73.96 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.154 -0.803 . . . . 0.0 113.543 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -87.45 -33.71 18.95 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 117.888 0.844 . . . . 0.0 112.804 170.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.77 -34.91 78.23 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.041 1.291 . . . . 0.0 113.259 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -68.5 0.93 3.47 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 172.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.8 t -111.07 -37.42 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.599 1.559 . . . . 0.0 112.108 166.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -90.55 -17.16 27.49 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -172.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.98 -143.66 32.5 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-O 118.725 -1.041 . . . . 0.0 114.586 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.35 -18.45 49.91 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 124.794 3.663 . . . . 0.0 117.772 -119.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -118.16 171.03 8.39 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.399 1.08 . . . . 0.0 111.552 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.88 -6.04 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 120.146 -1.597 . . . . 0.0 113.037 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.52 ' CB ' ' HG1' ' A' ' 147' ' ' THR . . . -108.82 15.15 23.78 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.258 1.823 . . . . 0.0 114.301 162.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.81 -108.14 3.03 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 120.564 -1.335 . . . . 0.0 113.242 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -51.72 -41.61 61.64 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.882 1.673 . . . . 0.0 113.887 -172.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -152.93 165.25 36.1 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.868 1.667 . . . . 0.0 110.233 -166.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.9 mt -64.75 132.39 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.195 0.598 . . . . 0.0 109.939 166.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.52 ' HG1' ' CB ' ' A' ' 142' ' ' ALA . 24.5 p -138.91 -170.72 2.92 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.843 1.257 . . . . 0.0 110.699 168.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.05 -17.49 3.98 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.1 t -71.03 -45.06 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 119.978 1.263 . . . . 0.0 111.795 172.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.88 -45.72 92.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.859 1.264 . . . . 0.0 111.905 172.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.66 -17.34 60.32 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.216 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.8 m -91.65 -48.05 7.04 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.861 1.21 . . . . 0.0 112.619 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.6 mt -94.49 -36.84 11.68 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -167.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.52 -47.86 97.7 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.22 -21.14 20.54 Favored 'Trans proline' 0 C--N 1.351 0.682 0 CA-C-N 120.808 1.324 . . . . 0.0 113.426 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.446 ' HE2' ' CE1' ' A' ' 103' ' ' PHE . 67.5 mttm -81.0 -27.81 35.74 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.907 -1.121 . . . . 0.0 112.89 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.8 mt -64.83 -43.33 93.42 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.364 0.665 . . . . 0.0 112.204 164.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -59.7 -44.68 93.59 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.225 0.466 . . . . 0.0 111.877 172.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.407 ' HD1' ' HG3' ' A' ' 21' ' ' PRO . 10.5 t-160 -63.9 -31.37 72.53 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 71.6 mt -74.01 -49.01 26.28 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 118.004 -0.998 . . . . 0.0 113.488 171.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -61.4 -31.1 71.01 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.219 0.918 . . . . 0.0 112.203 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 95.6 t -88.95 -66.97 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.812 1.245 . . . . 0.0 113.27 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.59 -48.78 8.04 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -160.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 30.8 tp -62.83 -33.39 75.13 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.614 166.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -55.05 -28.65 49.69 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.937 1.256 . . . . 0.0 115.713 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -66.17 -22.23 66.36 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -128.04 -22.2 3.52 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -142.79 86.1 1.92 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.378 1.871 . . . . 0.0 108.486 167.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -61.58 86.03 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.178 1.391 . . . . 0.0 110.947 171.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -88.64 121.5 69.97 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.789 -163.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.71 109.93 2.77 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.579 1.519 . . . . 0.0 110.147 170.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.3 mm -59.36 108.34 1.33 Allowed Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 142.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -68.35 164.93 30.62 Favored 'Trans proline' 0 C--N 1.35 0.642 0 CA-C-N 120.553 1.233 . . . . 0.0 112.638 -165.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.52 -24.79 63.95 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.269 1.427 . . . . 0.0 113.27 171.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -66.39 -26.86 67.45 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.834 1.253 . . . . 0.0 113.775 171.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 67.6 mt -87.25 49.68 1.86 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.715 1.606 . . . . 0.0 111.065 169.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.23 -33.47 74.66 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.282 1.033 . . . . 0.0 113.343 -155.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -81.63 -37.66 27.2 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.785 0.721 . . . . 0.0 112.115 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.67 -39.57 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 121.587 -0.696 . . . . 0.0 111.613 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 43.0 tp -65.67 -40.24 92.16 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -68.48 -38.52 81.1 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.546 -0.721 . . . . 0.0 112.323 171.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -63.78 -29.38 70.59 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.252 1.021 . . . . 0.0 113.292 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 78.1 mt -59.07 -32.05 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 120.548 -1.345 . . . . 0.0 111.856 170.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -84.45 -10.68 57.29 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.473 -1.392 . . . . 0.0 113.607 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.94 -17.65 61.46 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.581 161.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.43 -14.26 61.93 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.671 1.123 . . . . 0.0 113.244 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -103.89 5.61 35.85 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.902 1.281 . . . . 0.0 113.316 174.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.6 p -111.33 -179.05 3.61 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.11 2.164 . . . . 0.0 113.964 -167.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 54.12 -159.72 0.16 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.489 1.516 . . . . 0.0 110.628 -172.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -85.8 -41.01 15.42 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.781 1.232 . . . . 0.0 109.139 160.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 78.4 p -68.55 -60.42 2.43 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 126.293 1.837 . . . . 0.0 114.436 -162.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -62.25 -45.37 93.61 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.518 0.599 . . . . 0.0 112.085 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -56.86 -35.48 68.93 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.304 1.042 . . . . 0.0 113.457 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -76.9 -13.45 59.99 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 176.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.6 p -77.83 -10.77 59.73 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.402 1.455 . . . . 0.0 113.384 171.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -67.24 83.31 0.14 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.683 1.593 . . . . 0.0 112.852 -170.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.26 131.02 49.03 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.298 1.039 . . . . 0.0 109.919 161.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.27 129.96 44.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.317 0.647 . . . . 0.0 111.346 -171.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 31.0 mp0 -59.08 -39.14 81.21 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -157.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -60.39 -36.95 79.29 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.872 1.269 . . . . 0.0 112.687 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -85.12 -6.69 59.29 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.568 1.547 . . . . 0.0 113.092 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 39.6 t -86.79 -44.5 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.215 162.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.1 mt -58.18 -51.2 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.696 1.199 . . . . 0.0 111.347 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.76 -15.0 62.64 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -83.78 -33.25 22.11 Favored Glycine 0 CA--C 1.533 1.216 0 O-C-N 120.874 -1.141 . . . . 0.0 113.175 169.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 44.9 t90 -84.93 -35.26 22.21 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.121 2.169 . . . . 0.0 114.675 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -53.42 -47.35 96.56 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.9 -24.27 29.2 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.498 1.466 . . . . 0.0 113.656 172.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -75.48 -11.68 60.08 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 117.672 -1.156 . . . . 0.0 114.014 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.414 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 48.1 t -59.39 -21.95 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.264 0.938 . . . . 0.0 110.934 160.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -106.73 -10.12 16.22 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 172.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.45 ' C ' ' HZ2' ' A' ' 111' ' ' LYS . . . . . . . . 0 C--O 1.248 0.986 0 C-N-CA 126.674 1.99 . . . . 0.0 112.386 -173.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.851 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 49.0 mt -103.45 143.6 32.49 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.446 1.117 . . . . 0.0 113.107 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -151.65 128.38 10.87 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.533 1.933 . . . . 0.0 108.382 172.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 pt -126.43 140.77 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.898 0.879 . . . . 0.0 109.92 -170.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.4 m -106.44 122.71 46.82 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.513 0.725 . . . . 0.0 109.335 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.39 164.0 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.597 1.559 . . . . 0.0 110.924 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -62.01 119.01 8.04 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.536 -0.727 . . . . 0.0 111.316 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.53 153.69 27.96 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.339 153.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.37 143.6 57.78 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.091 0.948 . . . . 0.0 112.18 170.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.6 t -70.51 136.65 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 168.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.78 -35.0 1.41 Allowed Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.814 -0.992 . . . . 0.0 114.775 -172.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.61 69.03 6.07 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 125.177 1.391 . . . . 0.0 112.478 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.37 -11.44 28.24 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.527 2.818 . . . . 0.0 115.413 -172.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -92.5 9.07 36.0 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.5 pt -130.32 163.09 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.593 1.157 . . . . 0.0 111.264 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.4 mt -62.68 146.02 53.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.299 0.64 . . . . 0.0 111.109 166.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.86 -169.16 12.47 Favored Glycine 0 N--CA 1.474 1.201 0 C-N-CA 125.233 1.397 . . . . 0.0 112.605 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -59.61 108.2 0.7 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.8 t -157.91 103.08 1.76 Allowed Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.637 1.175 . . . . 0.0 109.163 144.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -63.71 -18.95 66.29 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.249 2.633 . . . . 0.0 112.572 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -71.07 -30.6 66.78 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.4 -0.813 . . . . 0.0 112.602 172.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.3 m -70.35 -38.97 74.93 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.598 -1.314 . . . . 0.0 112.415 168.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -60.33 -26.89 66.91 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 118.143 -0.932 . . . . 0.0 113.155 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.504 HH12 ' CG ' ' A' ' 74' ' ' ASP . 46.6 mtp180 -57.89 -45.39 86.49 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.122 0.969 . . . . 0.0 112.52 171.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.54 -39.51 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.089 1.356 . . . . 0.0 111.322 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.82 -41.36 91.13 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.213 0.605 . . . . 0.0 111.258 172.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.4 tp -63.17 -54.5 36.6 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.06 1.344 . . . . 0.0 112.447 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.0 p -69.82 -38.31 76.52 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.462 1.028 . . . . 0.0 113.467 -171.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.6 mt -71.36 -38.96 71.54 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.412 ' HG2' ' HH ' ' A' ' 37' ' ' TYR . 65.7 mm-40 -75.62 -22.57 56.75 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 171.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -69.36 -47.01 65.61 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 120.536 -1.353 . . . . 0.0 111.145 170.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -69.74 -6.52 32.47 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.76 1.624 . . . . 0.0 114.652 169.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm 59.81 16.54 5.7 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.723 1.609 . . . . 0.0 114.804 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.9 mt -71.39 125.9 91.81 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.13 136.46 24.63 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.119 1.879 . . . . 0.0 111.4 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.412 ' HH ' ' HG2' ' A' ' 31' ' ' GLU . 37.8 p90 -136.17 151.08 49.37 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.664 1.585 . . . . 0.0 110.573 175.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -73.76 139.15 45.03 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.45 -0.781 . . . . 0.0 109.035 161.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.3 t -125.2 93.24 3.82 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.733 0.813 . . . . 0.0 111.162 -175.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -74.85 113.42 12.12 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.835 0.854 . . . . 0.0 110.464 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.8 mt -72.95 101.29 3.16 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.504 1.122 . . . . 0.0 110.02 164.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mm -97.1 111.29 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.629 0.771 . . . . 0.0 109.892 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -78.06 70.07 4.37 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.252 -0.905 . . . . 32.609999999999999 110.552 168.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.01 8.33 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 117.758 2.503 . . . . 40.049999999999997 117.758 -166.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.94 -44.46 91.67 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-N 119.825 1.193 . . . . 41.469999999999999 111.26 155.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -102.74 72.47 1.22 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.583 1.953 . . . . 47.170000000000002 110.068 166.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -81.24 110.96 20.62 Favored Pre-proline 0 N--CA 1.475 0.778 0 O-C-N 120.234 -1.541 . . . . 41.270000000000003 110.872 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.21 158.15 45.43 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.868 2.379 . . . . 40.289999999999999 112.481 -174.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -59.12 -34.5 72.11 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.419 1.266 . . . . 42.390000000000001 114.419 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -64.83 -32.15 73.72 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.188 0.904 . . . . 37.079999999999998 113.287 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -75.35 -34.53 61.17 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.689 -1.257 . . . . 35.880000000000003 112.782 170.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.89 -28.89 67.1 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.401 1.0 . . . . 33.609999999999999 113.285 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -68.61 -30.47 69.22 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.907 1.683 . . . . 33.789999999999999 112.537 170.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.7 mt -85.04 -33.15 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.96 1.304 . . . . 33.159999999999997 111.623 173.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.1 t -131.62 94.7 25.1 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 126.027 1.731 . . . . 33.579999999999998 110.586 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.86 -15.87 40.8 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.611 2.207 . . . . 37.899999999999999 113.842 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -81.87 -8.09 59.66 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.546 0.943 . . . . 38.990000000000002 113.546 168.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.28 13.42 64.92 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 120.933 -1.104 . . . . 35.469999999999999 114.789 -173.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -91.72 150.94 20.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.176 1.39 . . . . 34.490000000000002 112.763 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.7 m -110.96 153.94 43.6 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 126.176 1.79 . . . . 23.530000000000001 110.74 159.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -66.68 156.68 82.36 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-O 121.975 0.74 . . . . 22.879999999999999 112.925 -8.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 p -144.99 142.27 22.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.164 -1.38 . . . . 0.0 107.872 162.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 m -129.58 146.83 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.513 0.725 . . . . 0.0 110.67 -171.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -105.74 78.72 1.37 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.433 1.493 . . . . 0.0 109.724 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 34.4 mt -71.8 114.5 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.902 0.881 . . . . 0.0 109.564 -176.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 t70 52.47 39.36 27.61 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.96 0.885 . . . . 0.0 112.429 -165.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.8 t0 69.9 7.74 6.37 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 128.075 2.55 . . . . 0.0 116.622 -173.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -103.49 127.06 50.96 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 119.768 -1.833 . . . . 0.0 111.512 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.0 p-90 -70.18 142.48 52.46 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -170.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -143.04 128.4 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 127.722 2.409 . . . . 0.0 108.286 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.74 168.37 9.62 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.606 1.562 . . . . 0.0 112.131 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.9 t0 66.55 113.19 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.66 2.384 . . . . 22.16 114.346 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.3 p -63.11 -24.3 67.84 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 115.215 1.561 . . . . 21.16 115.215 -161.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.504 ' CG ' HH12 ' A' ' 25' ' ' ARG . 37.2 m-20 -73.18 -35.46 66.4 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.179 1.354 . . . . 24.969999999999999 113.307 170.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.62 -38.51 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 121.09 -1.006 . . . . 23.850000000000001 110.856 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.88 -45.94 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.314 1.046 . . . . 23.68 111.233 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.1 t -61.81 -41.4 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.26 1.024 . . . . 22.84 111.299 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.55 -20.26 55.61 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.782 -1.01 . . . . 23.329999999999998 114.932 175.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 98.5 mt -106.5 -44.14 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 119.073 1.436 . . . . 23.309999999999999 112.38 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.4 mt -65.72 -32.78 74.51 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 120.251 1.387 . . . . 23.48 112.947 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.13 -11.77 40.26 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 114.237 1.199 . . . . 24.239999999999998 114.237 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.438 ' OE2' ' HE3' ' A' ' 83' ' ' LYS . 75.0 tt0 -92.41 -41.07 10.52 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.103 1.361 . . . . 39.259999999999998 112.554 165.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.438 ' HE3' ' OE2' ' A' ' 82' ' ' GLU . 74.6 mttt -124.51 90.01 3.18 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.662 1.185 . . . . 24.449999999999999 111.977 -164.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -151.8 165.69 16.88 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.833 1.653 . . . . 0.0 109.474 168.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.21 -30.34 31.2 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.003 1.802 . . . . 0.0 112.031 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -73.7 152.87 89.39 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.82 1.248 . . . . 0.0 112.086 171.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -51.81 142.87 40.63 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.74 2.96 . . . . 0.0 115.053 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.31 131.53 25.17 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.272 1.981 . . . . 0.0 111.533 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.6 mt -105.29 4.48 31.05 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.223 1.409 . . . . 0.0 112.185 171.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.71 51.51 0.14 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.698 1.999 . . . . 0.0 112.178 162.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.1 p -123.79 70.76 49.11 Favored Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 125.021 1.329 . . . . 0.0 109.236 170.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.07 122.48 9.07 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.282 1.988 . . . . 0.0 110.227 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -73.98 179.59 5.58 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.874 2.383 . . . . 0.0 111.221 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.6 mp0 -55.09 -29.75 58.25 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.624 1.97 . . . . 0.0 113.08 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -53.77 -28.14 33.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.994 1.318 . . . . 0.0 113.842 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.27 -29.96 71.19 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.624 1.102 . . . . 0.0 113.21 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.9 p -68.45 -21.95 64.61 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.2 t -99.9 -41.11 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.835 1.254 . . . . 0.0 111.081 176.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.67 -31.52 81.07 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.729 -1.232 . . . . 0.0 114.435 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.9 p -69.62 -18.58 63.61 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -90.46 -32.66 16.29 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.842 1.257 . . . . 0.0 112.881 169.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 71.0 mt -70.27 -36.0 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.778 0.831 . . . . 0.0 111.629 173.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -55.44 -46.74 99.66 Favored Pre-proline 0 CA--C 1.547 0.829 0 O-C-N 120.379 -1.451 . . . . 0.0 114.344 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.65 -31.67 2.44 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.933 2.422 . . . . 0.0 114.116 171.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.6 p -71.46 -28.12 63.73 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 121.034 1.743 . . . . 0.0 113.005 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -58.72 -44.51 90.45 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 120.655 -1.278 . . . . 0.0 112.305 161.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.5 t -65.86 -35.05 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 119.639 1.109 . . . . 0.0 111.887 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.427 ' HZ1' ' CG ' ' A' ' 114' ' ' ASP . 60.9 tttt -66.54 -39.02 88.36 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.031 0.832 . . . . 0.0 112.047 171.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -70.11 -29.85 66.91 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.284 1.034 . . . . 0.0 112.426 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.9 mt -76.99 -9.06 58.44 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.673 1.589 . . . . 0.0 114.517 168.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -142.63 38.55 1.51 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.92 1.288 . . . . 0.0 112.839 -170.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.4 m -75.07 63.01 1.22 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -162.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -65.26 -38.07 89.15 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.05 1.34 . . . . 0.0 111.136 163.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.427 ' CG ' ' HZ1' ' A' ' 108' ' ' LYS . 19.6 t0 -83.89 115.97 62.43 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 154.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.59 154.24 70.15 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.675 2.917 . . . . 0.0 115.759 -144.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -66.9 -42.64 85.12 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 114.42 -1.264 . . . . 0.0 112.993 -165.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.71 -22.33 54.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.656 1.182 . . . . 0.0 113.32 -174.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.82 -34.6 27.12 Favored Glycine 0 CA--C 1.532 1.155 0 O-C-N 120.973 -1.079 . . . . 0.0 112.813 165.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 99.4 m -68.44 -27.09 65.87 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.596 -0.944 . . . . 0.0 112.729 171.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.59 -44.44 96.26 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.841 1.657 . . . . 0.0 111.928 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -66.7 -41.84 87.36 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.43 0.692 . . . . 0.0 112.059 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.77 -25.05 67.09 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 174.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.9 tp -82.51 -41.71 19.36 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.685 1.194 . . . . 0.0 112.17 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 26.9 mt -65.23 -40.08 93.61 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.713 1.205 . . . . 0.0 113.566 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -68.23 -33.83 75.12 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.927 1.239 . . . . 0.0 112.727 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -73.48 -38.76 65.31 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.063 -1.023 . . . . 0.0 112.722 170.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.1 mt -63.57 -35.55 80.86 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.782 -1.199 . . . . 0.0 112.849 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -65.06 -44.29 89.46 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.137 0.975 . . . . 0.0 111.598 172.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.61 -36.02 81.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.333 0.653 . . . . 0.0 112.224 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.1 tp -69.35 -56.95 6.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.377 1.071 . . . . 0.0 111.97 172.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.47 -30.57 69.45 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -171.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.33 -32.01 67.23 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.144 -0.809 . . . . 0.0 113.487 172.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -89.15 -33.88 16.9 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 117.75 0.775 . . . . 0.0 113.006 172.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.55 -35.95 81.07 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.912 1.233 . . . . 0.0 113.042 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.6 mtmt -65.81 -6.9 13.34 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 174.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.6 t -102.5 -36.72 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.961 1.305 . . . . 0.0 112.173 169.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -89.22 -19.32 25.55 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.31 -140.63 35.9 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.939 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -70.86 -15.71 32.95 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.785 3.657 . . . . 0.0 117.343 -108.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -122.08 170.98 9.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.926 1.29 . . . . 0.0 110.908 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.254 2.9 tt -77.9 7.29 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 119.855 -1.778 . . . . 0.0 113.132 -175.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.406 ' CB ' ' HG1' ' A' ' 147' ' ' THR . . . -114.61 6.95 15.91 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.91 2.484 . . . . 0.0 114.035 163.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.93 -122.33 6.64 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.82 -1.175 . . . . 0.0 113.185 -172.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -54.0 -36.69 63.22 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -169.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -146.76 157.87 43.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.318 1.447 . . . . 0.0 110.977 -166.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 56.0 mt -67.48 132.67 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.517 0.727 . . . . 0.0 110.414 171.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.406 ' HG1' ' CB ' ' A' ' 142' ' ' ALA . 30.0 p -143.5 -171.62 3.54 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.483 1.513 . . . . 0.0 111.15 176.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -54.58 -17.89 3.8 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.61 -42.48 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 120.211 1.369 . . . . 0.0 111.759 172.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.64 -45.08 95.56 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.933 1.293 . . . . 0.0 112.326 168.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.8 mt -62.08 -24.24 66.99 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 122.039 -0.413 . . . . 0.0 111.769 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.9 m -83.46 -50.56 8.18 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.887 -1.133 . . . . 0.0 112.597 175.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.3 mt -94.86 -36.0 11.82 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -165.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.8 -49.17 94.39 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.56 -22.5 15.8 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 120.725 1.295 . . . . 0.0 113.483 178.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -78.2 -28.92 48.16 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 117.714 -1.136 . . . . 0.0 112.859 174.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 46.7 mt -65.69 -44.65 85.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.89 0.876 . . . . 0.0 112.395 166.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -57.22 -41.66 79.91 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.161 0.505 . . . . 0.0 111.792 170.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -68.0 -29.61 68.67 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 9.2 mt -69.68 -52.48 25.35 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.419 1.008 . . . . 0.0 111.913 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -61.43 -35.51 77.78 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.017 0.927 . . . . 0.0 112.029 -174.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.7 t -90.56 -62.82 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.395 1.078 . . . . 0.0 113.14 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.21 -56.83 3.81 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.601 -0.687 . . . . 0.0 112.42 -162.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.42 -33.12 74.86 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.439 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.64 -23.29 49.28 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.129 1.347 . . . . 0.0 115.778 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -69.95 -22.26 63.19 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -124.94 -25.19 3.93 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -139.34 90.52 2.42 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.825 1.65 . . . . 0.0 108.353 166.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -65.3 83.78 0.05 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.583 1.153 . . . . 0.0 109.979 170.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -86.8 117.38 68.57 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.852 -169.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.34 110.63 2.9 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.585 1.524 . . . . 0.0 109.835 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.8 mm -55.39 109.32 1.54 Allowed Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 151.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -64.51 158.34 50.18 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 121.278 1.319 . . . . 0.0 112.442 -166.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.71 -19.06 64.63 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -66.36 -25.0 66.59 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.424 1.09 . . . . 0.0 113.693 168.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 62.5 mt -87.06 47.88 1.57 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.232 1.813 . . . . 0.0 111.388 170.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.7 -31.76 73.03 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.987 -1.071 . . . . 0.0 113.823 -155.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -80.45 -38.12 30.66 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.092 -1.005 . . . . 0.0 111.862 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 87.0 t -61.46 -42.32 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 121.436 -0.79 . . . . 0.0 111.559 171.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.8 -29.44 69.92 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -80.9 -37.45 29.65 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.595 -0.691 . . . . 0.0 112.507 170.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -63.76 -31.13 72.21 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.476 1.11 . . . . 0.0 113.473 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 79.6 mt -56.96 -37.1 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.139 -0.976 . . . . 0.0 111.904 169.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -77.5 -16.34 58.77 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 119.975 -1.703 . . . . 0.0 112.878 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 66.6 mt -77.0 -12.76 59.98 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 117.461 -1.257 . . . . 0.0 113.473 166.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.83 -18.9 65.61 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.414 1.461 . . . . 0.0 112.924 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -93.15 2.17 56.81 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 173.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.4 p -105.97 -179.57 3.98 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.168 2.187 . . . . 0.0 113.828 -170.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 43.8 mtp85 55.09 -161.95 0.15 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.347 1.459 . . . . 0.0 110.655 -172.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -86.03 -40.68 15.53 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.101 1.36 . . . . 0.0 109.209 157.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 72.5 p -70.7 -53.15 16.74 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.713 1.605 . . . . 0.0 114.727 -160.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -67.01 -46.17 75.3 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.17 0.896 . . . . 0.0 111.855 171.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 193' ' ' LYS . 26.7 ttmt -55.89 -38.28 69.98 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -74.46 -12.5 60.51 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.7 p -77.75 -11.74 59.91 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.329 1.422 . . . . 0.0 113.267 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -67.32 86.23 0.17 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.778 1.631 . . . . 0.0 112.721 -169.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.35 136.11 57.93 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.797 0.839 . . . . 0.0 109.99 159.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.2 132.47 53.77 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.104 0.562 . . . . 0.0 111.547 -173.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -60.02 -37.46 79.83 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.636 1.346 . . . . 0.0 114.636 -159.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.44 -38.28 83.59 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.901 -1.124 . . . . 0.0 112.462 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -86.49 -4.85 59.24 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.782 1.633 . . . . 0.0 112.998 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.3 t -85.02 -48.81 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.707 1.203 . . . . 0.0 109.89 162.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.8 mt -59.27 -53.37 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.852 1.261 . . . . 0.0 111.63 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.39 -15.53 62.37 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -81.78 -33.84 26.3 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 120.898 -1.126 . . . . 0.0 113.012 170.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 32.5 t90 -82.95 -32.75 26.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.521 1.928 . . . . 0.0 114.634 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -50.07 -48.84 78.19 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.53 -23.94 31.27 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.773 1.649 . . . . 0.0 113.71 173.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.08 -11.07 60.01 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.775 1.23 . . . . 0.0 113.901 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 57.6 t -58.95 -27.85 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 119.236 0.926 . . . . 0.0 110.688 161.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -97.91 -36.37 10.18 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 171.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.743 0 C-N-CA 126.052 1.741 . . . . 0.0 113.639 -177.344 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.891 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 79.7 mt -109.72 131.81 54.72 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.391 1.076 . . . . 0.0 112.298 -175.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -122.21 145.6 48.05 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.574 1.15 . . . . 0.0 108.489 153.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.2 pt -130.22 138.84 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.967 0.907 . . . . 0.0 109.504 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.9 m -106.98 119.82 40.39 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.179 0.992 . . . . 0.0 109.621 173.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.81 163.8 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.018 1.327 . . . . 0.0 111.111 -169.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -60.58 119.14 7.5 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.758 -0.589 . . . . 0.0 111.23 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.41 147.01 31.18 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.051 151.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.93 139.47 58.75 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.757 0.789 . . . . 0.0 111.942 172.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.2 t -71.86 134.25 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 168.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.91 -27.74 2.97 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-O 118.665 -1.075 . . . . 0.0 114.677 -170.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -129.26 65.41 74.19 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-N 118.582 1.191 . . . . 0.0 112.564 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.12 -12.39 32.2 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.315 2.677 . . . . 0.0 115.468 -170.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -85.97 5.71 31.95 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.1 pt -132.37 163.33 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.733 1.213 . . . . 0.0 111.84 173.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.74 145.47 49.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.136 0.575 . . . . 0.0 110.888 166.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.63 -163.53 11.17 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.878 1.228 . . . . 0.0 111.981 166.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -56.96 105.4 0.21 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.6 t -157.64 107.4 1.81 Allowed Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.841 140.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.11 -14.29 42.83 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.178 2.585 . . . . 0.0 113.198 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -77.76 -29.39 50.98 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.207 -0.933 . . . . 0.0 112.401 171.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 99.7 m -70.81 -37.85 73.26 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.083 -1.636 . . . . 0.0 112.451 167.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -59.42 -26.69 65.38 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 118.399 -0.81 . . . . 0.0 113.006 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.491 HH12 ' CG ' ' A' ' 74' ' ' ASP . 53.8 mtp180 -58.14 -44.11 87.68 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.526 1.131 . . . . 0.0 112.641 171.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.5 t -77.0 -39.57 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.101 1.36 . . . . 0.0 111.299 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.31 -44.44 92.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.327 0.651 . . . . 0.0 111.121 171.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.0 tp -60.78 -53.75 53.55 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.991 1.316 . . . . 0.0 112.77 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 p -71.55 -36.85 71.11 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.708 1.14 . . . . 0.0 113.574 -173.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.17 -39.03 68.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.841 -0.599 . . . . 0.0 112.051 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.48 ' HG2' ' HH ' ' A' ' 37' ' ' TYR . 64.0 mm-40 -77.99 -17.39 57.2 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 172.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -70.16 -52.88 20.06 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.999 1.272 . . . . 0.0 110.896 167.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -73.24 -1.75 19.07 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.291 1.836 . . . . 0.0 114.468 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm 58.03 18.8 5.42 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.409 1.884 . . . . 0.0 115.106 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 58.5 mt -72.69 125.07 91.4 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 123.896 0.878 . . . . 0.0 108.868 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.72 144.84 35.88 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.473 2.116 . . . . 0.0 112.167 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.48 ' HH ' ' HG2' ' A' ' 31' ' ' GLU . 42.3 p90 -148.18 154.54 40.25 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.271 1.428 . . . . 0.0 111.01 177.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -78.55 121.1 24.18 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.332 -0.855 . . . . 0.0 109.686 163.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.8 t -95.42 94.41 7.8 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.538 0.735 . . . . 0.0 111.14 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -81.07 105.67 12.47 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.547 0.739 . . . . 0.0 110.067 178.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.9 mt -68.61 107.37 2.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.293 1.037 . . . . 0.0 109.963 168.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -105.05 114.9 45.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.125 0.97 . . . . 0.0 110.056 177.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -74.46 80.73 1.92 Allowed 'General case' 0 C--O 1.221 -0.437 0 O-C-N 121.438 -0.789 . . . . 32.609999999999999 109.629 165.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 pp -62.68 -4.26 1.94 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 116.622 2.082 . . . . 40.049999999999997 116.622 -170.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.65 -28.53 67.14 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-N 119.283 0.947 . . . . 41.469999999999999 112.576 166.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -116.42 54.15 0.85 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.31 2.644 . . . . 47.170000000000002 109.681 174.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -72.11 114.48 29.6 Favored Pre-proline 0 CA--C 1.546 0.803 0 O-C-N 119.745 -1.847 . . . . 41.270000000000003 111.059 -168.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.18 161.05 41.49 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.627 2.218 . . . . 40.289999999999999 112.209 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -61.85 -31.0 71.22 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.02 1.119 . . . . 42.390000000000001 114.02 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -61.52 -33.73 74.32 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.304 -0.873 . . . . 37.079999999999998 113.069 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -78.44 -35.14 47.24 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.22 -0.925 . . . . 35.880000000000003 112.769 172.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.14 -23.53 63.98 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.869 1.063 . . . . 33.609999999999999 113.869 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -67.48 -42.34 83.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.731 1.212 . . . . 33.789999999999999 111.418 168.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.7 mt -74.81 -32.78 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.348 1.059 . . . . 33.159999999999997 112.038 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.8 t -137.74 94.11 11.87 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 126.327 1.851 . . . . 33.579999999999998 111.351 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.83 -22.42 36.67 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.847 2.365 . . . . 37.899999999999999 113.586 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -78.93 -10.79 59.92 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.896 -1.128 . . . . 38.990000000000002 113.299 167.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.36 25.92 74.5 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.96 1.743 . . . . 35.469999999999999 115.015 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -105.21 149.14 26.21 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.938 1.369 . . . . 34.490000000000002 112.014 -172.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.5 m -106.84 146.68 33.58 Favored Pre-proline 0 N--CA 1.47 0.543 0 C-N-CA 123.913 0.885 . . . . 23.530000000000001 110.153 164.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.35 150.65 86.53 Favored 'Cis proline' 0 C--N 1.346 0.431 0 CA-C-N 119.032 0.69 . . . . 22.879999999999999 113.156 -7.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 p -138.76 145.54 27.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 113.618 -1.628 . . . . 0.0 107.16 156.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.77 160.8 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 O-C-N 121.449 -0.782 . . . . 0.0 111.13 -172.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.6 mtpt -119.85 73.47 0.97 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.258 1.423 . . . . 0.0 108.951 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.5 mt -71.49 117.3 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.443 1.097 . . . . 0.0 109.582 -174.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.4 t0 56.7 30.53 17.72 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 121.904 -0.498 . . . . 0.0 111.97 -165.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.8 t0 73.1 4.91 5.05 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 129.04 2.936 . . . . 0.0 116.37 -169.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -102.31 132.07 48.5 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.525 -1.36 . . . . 0.0 111.547 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -67.25 136.01 54.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.776 0.83 . . . . 0.0 113.056 -168.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -143.56 126.92 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.967 1.707 . . . . 0.0 109.449 170.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -107.08 172.04 7.04 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.832 1.653 . . . . 0.0 111.91 174.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 t0 65.69 111.48 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.89 2.476 . . . . 22.16 114.57 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.3 p -64.04 -21.41 66.5 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 115.696 1.739 . . . . 21.16 115.696 -161.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.491 ' CG ' HH12 ' A' ' 25' ' ' ARG . 35.6 m-20 -75.84 -31.74 59.47 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.494 1.497 . . . . 24.969999999999999 113.666 170.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.8 t -73.33 -38.64 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.932 -1.105 . . . . 23.850000000000001 110.823 170.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.22 -44.77 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.217 1.007 . . . . 23.68 110.962 174.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.4 t -62.59 -46.13 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.373 1.069 . . . . 22.84 111.378 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.09 -45.12 83.14 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 118.869 0.759 . . . . 23.329999999999998 112.99 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 99.1 mt -75.4 -46.48 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.709 -0.877 . . . . 23.309999999999999 112.388 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.6 mt -69.86 -30.09 67.48 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.23 1.377 . . . . 23.48 113.591 -176.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -89.99 -13.18 36.65 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.335 0.865 . . . . 24.239999999999998 113.335 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.51 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 56.6 tt0 -91.81 -47.08 7.53 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.758 1.623 . . . . 39.259999999999998 112.568 167.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.51 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 84.0 mttt -117.52 83.57 2.01 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.719 1.207 . . . . 24.449999999999999 112.024 -161.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -149.25 165.85 16.68 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.275 1.43 . . . . 0.0 110.274 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -70.05 -25.23 27.49 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.152 1.901 . . . . 0.0 112.438 172.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -73.29 156.18 89.34 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.45 1.5 . . . . 0.0 112.155 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -57.24 143.81 92.49 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.218 2.612 . . . . 0.0 114.21 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.57 130.98 24.84 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.436 2.091 . . . . 0.0 112.424 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.0 mt -110.32 1.56 18.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.425 1.49 . . . . 0.0 112.333 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.67 50.08 0.18 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.676 1.99 . . . . 0.0 111.891 160.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 67.9 p -125.12 70.54 61.54 Favored Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 125.63 1.572 . . . . 0.0 109.045 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -69.59 128.75 16.64 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.98 1.786 . . . . 0.0 111.194 -165.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.0 177.31 7.24 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.419 2.746 . . . . 0.0 111.318 170.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -55.58 -31.16 61.96 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 120.924 -1.11 . . . . 0.0 113.897 173.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -53.43 -25.59 16.56 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.293 1.437 . . . . 0.0 113.973 172.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.15 -33.92 74.18 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.577 1.08 . . . . 0.0 113.184 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 84.1 p -68.99 -24.28 64.21 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.385 1.074 . . . . 0.0 113.78 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 t -92.75 -40.74 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.264 1.425 . . . . 0.0 110.111 176.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.96 -30.97 79.02 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.83 1.681 . . . . 0.0 114.45 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 89.8 p -69.27 -17.53 63.75 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.024 1.412 . . . . 0.0 113.77 171.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -95.56 -33.15 12.51 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.105 1.362 . . . . 0.0 112.386 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 69.2 mt -70.2 -36.79 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.607 0.763 . . . . 0.0 111.979 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -56.19 -47.71 98.32 Favored Pre-proline 0 CA--C 1.545 0.758 0 O-C-N 120.223 -1.548 . . . . 0.0 113.898 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.65 -30.38 3.08 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.546 2.164 . . . . 0.0 114.045 171.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.3 p -72.57 -27.16 62.03 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 121.193 1.815 . . . . 0.0 113.273 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -59.03 -46.72 87.5 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.662 -1.274 . . . . 0.0 111.839 160.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.8 t -65.17 -32.65 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.336 0.971 . . . . 0.0 111.951 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.447 ' HZ3' ' CG ' ' A' ' 114' ' ' ASP . 72.2 tttt -67.73 -39.39 84.27 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.174 0.897 . . . . 0.0 112.393 168.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -70.71 -28.29 64.63 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.469 1.107 . . . . 0.0 112.783 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 20.6 mt -77.01 -15.24 59.69 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.869 1.668 . . . . 0.0 114.147 167.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.458 ' HZ3' ' C ' ' A' ' 212' ' ' ALA . 80.5 mttt -137.68 38.95 2.41 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.848 1.259 . . . . 0.0 112.533 -170.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.3 m -73.85 66.0 1.09 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -162.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -67.81 -39.36 83.98 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.401 1.08 . . . . 0.0 111.522 164.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.447 ' CG ' ' HZ3' ' A' ' 108' ' ' LYS . 13.6 t0 -79.44 111.77 23.4 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 153.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.48 155.85 66.62 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.578 2.852 . . . . 0.0 115.452 -143.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -65.3 -42.51 92.99 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.838 -1.074 . . . . 0.0 113.437 -165.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.75 -21.98 61.67 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.84 -36.9 17.72 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 120.998 -1.064 . . . . 0.0 112.495 167.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 98.4 m -67.82 -27.55 66.81 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.82 0.848 . . . . 0.0 113.042 172.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -58.76 -45.95 88.57 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.795 1.638 . . . . 0.0 111.616 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -68.68 -40.46 80.1 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.792 0.837 . . . . 0.0 111.433 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.91 -24.9 66.93 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.6 tp -82.92 -40.75 19.74 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.864 1.265 . . . . 0.0 111.94 172.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.9 mt -63.45 -41.36 98.63 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.676 1.191 . . . . 0.0 113.351 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.49 ' CD ' ' HZ3' ' A' ' 128' ' ' LYS . 13.7 mm-40 -66.58 -35.64 80.7 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.063 1.301 . . . . 0.0 112.774 -176.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -71.79 -39.5 69.85 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.122 -0.986 . . . . 0.0 112.592 171.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.6 mt -64.28 -33.6 76.19 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.837 -1.164 . . . . 0.0 113.121 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.49 ' HZ3' ' CD ' ' A' ' 125' ' ' GLU . 80.8 mttt -66.7 -44.28 82.11 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.588 1.086 . . . . 0.0 111.577 173.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.84 81.56 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.558 0.743 . . . . 0.0 112.218 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.2 tp -68.07 -56.75 7.75 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.27 1.028 . . . . 0.0 111.846 172.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.96 -33.44 74.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.576 1.15 . . . . 0.0 113.879 -171.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.42 -34.02 67.56 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.36 -0.689 . . . . 0.0 113.324 173.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -92.67 -29.35 16.13 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 77.4 mt -64.23 -33.74 76.5 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 120.465 -1.397 . . . . 0.0 113.225 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -65.94 -7.63 17.87 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.35 -38.37 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.144 1.378 . . . . 0.0 112.169 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -82.17 -17.38 46.46 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -172.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.2 -164.86 42.57 Favored Glycine 0 CA--C 1.542 1.721 0 CA-C-O 117.718 -1.601 . . . . 0.0 114.42 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.0 -10.67 23.09 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 125.281 3.987 . . . . 0.0 118.144 -119.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -110.32 167.21 10.37 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.175 0.99 . . . . 0.0 110.893 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.2 tt -75.57 6.86 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 120.275 -1.516 . . . . 0.0 112.997 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.454 ' CB ' ' HG1' ' A' ' 147' ' ' THR . . . -116.2 2.79 13.37 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 128.146 2.579 . . . . 0.0 114.422 165.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.93 -117.85 5.7 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.083 1.325 . . . . 0.0 113.251 -173.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -62.45 -35.81 80.44 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -168.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -142.49 162.32 35.76 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.76 1.624 . . . . 0.0 110.484 -171.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.8 mt -62.83 135.68 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.07 0.462 . . . . 0.0 110.528 165.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.454 ' HG1' ' CB ' ' A' ' 142' ' ' ALA . 28.7 p -138.59 -174.33 3.8 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.502 1.521 . . . . 0.0 110.814 171.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.95 -19.31 1.73 Allowed 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 169.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 18.4 t -74.27 -40.32 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 120.179 1.354 . . . . 0.0 112.496 174.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -61.5 -44.33 97.28 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.863 -1.148 . . . . 0.0 112.003 167.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.9 mt -62.19 -26.99 68.66 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 122.193 -0.317 . . . . 0.0 111.533 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 52.3 m -79.35 -47.43 15.81 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.845 -1.159 . . . . 0.0 112.694 175.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 51.5 mt -100.01 -37.98 8.77 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -164.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.24 88.48 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -173.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.97 -28.57 19.27 Favored 'Trans proline' 0 C--N 1.351 0.705 0 CA-C-N 120.784 1.316 . . . . 0.0 113.12 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -72.81 -30.55 64.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.611 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 51.6 mt -65.97 -46.61 77.45 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.741 0.816 . . . . 0.0 112.975 169.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -58.33 -36.31 73.22 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.828 0.823 . . . . 0.0 112.323 170.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -73.98 -22.79 59.49 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.867 -1.146 . . . . 0.0 113.76 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.33 -49.78 45.94 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.561 1.073 . . . . 0.0 111.398 162.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -58.1 -37.11 73.9 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.389 1.476 . . . . 0.0 112.479 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 70.4 t -96.87 -62.66 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.236 1.014 . . . . 0.0 113.545 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.05 -54.2 6.83 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.463 -0.773 . . . . 0.0 112.622 -164.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 38.6 tp -65.71 -34.69 78.78 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 119.349 -0.358 . . . . 0.0 111.155 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.03 -29.24 59.17 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.23 1.395 . . . . 0.0 115.336 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -66.48 -22.01 66.19 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -122.29 -21.19 5.92 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -148.33 94.94 2.38 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.291 1.836 . . . . 0.0 108.797 165.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -67.99 78.74 0.22 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.895 1.278 . . . . 0.0 111.171 173.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -76.98 118.2 70.23 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.24 1.016 . . . . 0.0 111.91 -168.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -73.37 110.36 3.04 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.949 1.766 . . . . 0.0 110.662 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 14.0 mm -58.03 115.42 11.14 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 160.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -63.13 153.49 73.6 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 121.634 1.556 . . . . 0.0 112.633 -172.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -61.15 -22.66 64.9 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 169.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -68.11 -25.45 65.32 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 170.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 47.4 mt -86.12 50.91 2.07 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.251 1.42 . . . . 0.0 111.104 167.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.8 -26.87 68.53 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.315 1.046 . . . . 0.0 113.315 -160.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -75.62 -50.66 14.85 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.017 0.826 . . . . 0.0 111.074 171.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 86.3 t -59.17 -39.93 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.757 0.823 . . . . 0.0 111.572 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.4 tp -61.01 -36.01 78.37 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.675 1.19 . . . . 0.0 113.397 174.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -81.0 -37.25 29.48 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -62.61 -33.92 75.99 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.687 1.195 . . . . 0.0 112.872 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.8 mt -59.89 -35.83 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.033 -1.042 . . . . 0.0 112.104 171.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -74.08 -17.83 60.9 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.225 -1.547 . . . . 0.0 112.941 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 51.0 mt -74.88 -15.95 60.69 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 118.339 -0.838 . . . . 0.0 113.148 168.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.6 mt -67.99 -17.69 64.5 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 120.011 1.278 . . . . 0.0 113.828 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -95.09 6.59 48.65 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.419 -1.425 . . . . 0.0 113.477 171.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.7 p -107.69 -179.07 3.8 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.956 1.703 . . . . 0.0 113.222 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 44.8 mtp85 56.46 -164.33 0.15 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.655 1.582 . . . . 0.0 111.335 -172.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -84.62 -41.15 16.66 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.964 1.306 . . . . 0.0 109.276 157.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 77.4 p -70.16 -54.67 11.91 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.867 1.667 . . . . 0.0 114.631 -159.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -67.46 -45.94 74.49 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.701 0.682 . . . . 0.0 111.977 171.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -56.63 -39.03 72.93 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.172 -0.955 . . . . 0.0 113.517 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -74.04 -8.84 57.61 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.4 p -77.51 -14.47 59.67 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.401 1.455 . . . . 0.0 113.231 170.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -65.85 101.59 0.67 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.639 1.109 . . . . 0.0 111.636 -174.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.24 159.96 30.2 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.671 0.788 . . . . 0.0 110.496 156.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.38 127.55 33.09 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.076 -0.39 . . . . 0.0 110.359 172.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 199' ' ' GLU . 1.9 pm0 -63.86 -31.75 73.03 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -161.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -61.89 -39.85 93.37 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.997 -1.064 . . . . 0.0 112.424 171.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -81.89 -2.25 50.55 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.552 -1.343 . . . . 0.0 114.242 173.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 85.4 t -85.83 -44.7 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.402 1.081 . . . . 0.0 110.294 163.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.2 mt -64.51 -56.63 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.864 1.266 . . . . 0.0 111.526 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.7 -13.65 62.28 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.474 1.11 . . . . 0.0 113.825 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -86.44 -36.54 9.56 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.808 -1.183 . . . . 0.0 113.484 170.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -78.04 -31.31 50.31 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.688 1.595 . . . . 0.0 113.615 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -53.59 -47.97 94.68 Favored Pre-proline 0 CA--C 1.553 1.066 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -175.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.93 -23.75 29.65 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 121.681 1.588 . . . . 0.0 113.919 171.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -74.33 -8.61 56.85 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 117.595 -1.193 . . . . 0.0 114.204 175.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 45.7 t -60.59 -21.36 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 119.274 0.943 . . . . 0.0 111.268 160.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -105.72 -12.17 16.01 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 170.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.458 ' C ' ' HZ3' ' A' ' 111' ' ' LYS . . . . . . . . 0 C--O 1.246 0.882 0 C-N-CA 125.394 1.478 . . . . 0.0 112.653 -170.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.892 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 74.8 mt -115.74 137.3 52.22 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.249 1.42 . . . . 0.0 111.188 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -130.59 144.37 51.37 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.681 1.192 . . . . 0.0 108.723 160.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.3 pt -128.62 135.35 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.999 0.92 . . . . 0.0 109.34 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 79.2 m -110.84 117.29 33.01 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.493 1.117 . . . . 0.0 109.459 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.9 m -132.45 158.78 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.773 1.229 . . . . 0.0 111.09 -165.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -59.62 114.99 3.01 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.986 -0.446 . . . . 0.0 110.685 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.94 149.65 29.3 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.984 154.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.96 142.89 57.18 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.921 0.867 . . . . 0.0 113.057 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.91 129.15 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 163.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.66 -18.99 12.4 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-O 118.405 -1.219 . . . . 0.0 115.41 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.67 65.97 26.55 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 119.114 1.457 . . . . 0.0 112.286 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -64.82 -5.16 9.97 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.705 2.937 . . . . 0.0 115.489 -172.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -89.96 3.63 52.54 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.6 pt -133.8 164.57 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.201 1.4 . . . . 0.0 111.704 173.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.19 150.03 39.94 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.817 0.847 . . . . 0.0 111.922 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.49 -164.86 10.09 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.592 1.568 . . . . 0.0 111.834 165.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -57.78 104.28 0.18 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.6 t -153.37 106.41 2.58 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 113.74 -1.573 . . . . 0.0 110.212 136.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -67.62 -15.3 44.44 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.822 2.348 . . . . 0.0 112.761 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -74.44 -29.39 61.46 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.374 -0.829 . . . . 0.0 112.369 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 89.1 m -70.15 -37.08 75.14 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.326 -1.484 . . . . 0.0 112.816 167.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -60.41 -28.08 67.97 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.457 HH11 ' CG ' ' A' ' 74' ' ' ASP . 57.3 mtp180 -56.76 -40.05 75.12 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.678 1.191 . . . . 0.0 112.691 171.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.3 -40.61 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.138 1.375 . . . . 0.0 111.52 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.51 -43.54 93.36 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.951 0.5 . . . . 0.0 111.132 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.8 tp -59.15 -46.59 87.97 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.353 1.061 . . . . 0.0 113.268 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.2 p -78.44 -37.96 42.4 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.35 -36.91 77.35 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.484 0.584 . . . . 0.0 111.621 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -77.98 -18.33 56.1 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -75.43 -46.33 33.38 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.142 -1.599 . . . . 0.0 111.534 166.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -76.52 -5.03 45.8 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.071 1.348 . . . . 0.0 114.343 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm 58.68 20.27 7.61 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.325 1.85 . . . . 0.0 114.477 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.1 mt -70.98 130.54 88.18 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.217 -0.896 . . . . 0.0 108.679 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.01 139.38 29.81 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.331 2.021 . . . . 0.0 111.99 173.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -144.67 154.42 42.75 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.857 1.663 . . . . 0.0 110.194 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -81.94 125.48 30.81 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.177 -0.952 . . . . 0.0 110.019 162.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.5 t -93.16 95.75 9.6 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.515 0.726 . . . . 0.0 110.999 169.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -79.97 99.06 7.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.676 0.79 . . . . 0.0 109.583 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.75 109.72 2.98 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.945 0.898 . . . . 0.0 109.599 169.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mm -120.23 111.88 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.736 1.215 . . . . 0.0 109.15 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -77.5 89.42 3.85 Favored 'General case' 0 C--O 1.222 -0.368 0 O-C-N 120.68 -1.263 . . . . 32.609999999999999 108.602 166.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.42 1.79 0.19 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 117.519 2.415 . . . . 40.049999999999997 117.519 -175.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -69.95 -24.02 76.68 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-N 119.918 1.235 . . . . 41.469999999999999 112.734 161.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -128.11 66.84 1.36 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.974 2.51 . . . . 47.170000000000002 108.823 171.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -80.63 116.49 62.45 Favored Pre-proline 0 N--CA 1.473 0.684 0 O-C-N 120.055 -1.653 . . . . 41.270000000000003 110.551 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.15 161.65 44.98 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.689 2.26 . . . . 40.289999999999999 111.638 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -61.82 -29.83 70.42 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.028 1.121 . . . . 42.390000000000001 114.028 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -60.72 -33.02 72.27 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.269 1.028 . . . . 37.079999999999998 113.362 170.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -79.38 -36.61 38.95 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.951 -1.093 . . . . 35.880000000000003 112.599 173.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.7 mt -68.12 -25.54 65.35 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.343 0.868 . . . . 33.609999999999999 113.343 174.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -64.14 -47.37 80.18 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.606 1.563 . . . . 33.789999999999999 111.457 168.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.2 mt -72.39 -37.38 57.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.894 0.877 . . . . 33.159999999999997 111.625 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.1 t -126.75 92.19 45.39 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 126.177 1.791 . . . . 33.579999999999998 110.746 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.03 -17.47 36.34 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.856 2.371 . . . . 37.899999999999999 113.965 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.461 ' CD ' ' HZ2' ' A' ' 59' ' ' LYS . 7.4 mt-10 -76.48 -11.58 59.9 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.102 -0.999 . . . . 38.990000000000002 113.533 165.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.98 21.35 76.8 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.548 1.07 . . . . 35.469999999999999 114.561 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HZ2' ' CD ' ' A' ' 57' ' ' GLU . 83.6 mttt -104.08 150.5 24.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.451 1.501 . . . . 34.490000000000002 113.688 -173.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.19 153.96 40.76 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 125.93 1.692 . . . . 23.530000000000001 111.046 162.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -63.66 149.37 68.0 Favored 'Cis proline' 0 C--N 1.347 0.48 0 CA-C-O 121.852 0.688 . . . . 22.879999999999999 112.608 -12.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.38 146.95 28.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 113.985 -1.461 . . . . 0.0 107.494 156.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.1 m -134.7 165.26 31.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 123.565 0.746 . . . . 0.0 111.004 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -124.06 71.7 1.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.757 1.623 . . . . 0.0 109.424 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.5 mt -74.74 117.51 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.395 1.078 . . . . 0.0 108.994 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.0 t0 53.8 40.47 31.56 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 121.227 0.537 . . . . 0.0 110.967 -164.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 t0 67.54 -5.84 0.73 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.445 2.298 . . . . 0.0 115.608 -172.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -92.77 135.51 34.06 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.261 -1.525 . . . . 0.0 112.296 -172.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -68.1 131.41 45.37 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.634 1.174 . . . . 0.0 112.465 -170.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.1 t -141.09 129.61 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.165 1.386 . . . . 0.0 109.588 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.29 171.14 7.65 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.929 1.691 . . . . 0.0 111.425 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.9 t0 66.08 111.17 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.527 2.331 . . . . 22.16 114.162 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.9 p -64.09 -21.65 66.62 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 115.15 1.537 . . . . 21.16 115.15 -162.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.457 ' CG ' HH11 ' A' ' 25' ' ' ARG . 38.0 m-20 -74.1 -34.01 63.82 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.023 1.283 . . . . 24.969999999999999 113.421 169.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -72.27 -38.71 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.086 -1.009 . . . . 23.850000000000001 110.785 171.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.56 -44.94 99.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.234 1.014 . . . . 23.68 111.072 175.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.6 t -62.99 -44.65 99.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.384 1.074 . . . . 22.84 111.286 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.43 -35.04 70.18 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 118.633 0.651 . . . . 23.329999999999998 113.91 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 94.8 mt -85.11 -49.9 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 118.339 1.07 . . . . 23.309999999999999 112.122 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.4 mt -65.75 -32.32 73.8 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.809 1.186 . . . . 23.48 113.314 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -90.88 -1.26 57.85 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.627 0.973 . . . . 24.239999999999998 113.627 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.526 ' CD ' ' HZ3' ' A' ' 83' ' ' LYS . 5.6 tt0 -110.88 -53.62 2.68 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.113 1.365 . . . . 39.259999999999998 112.092 167.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.526 ' HZ3' ' CD ' ' A' ' 82' ' ' GLU . 51.5 mttm -97.06 58.98 1.61 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.384 1.074 . . . . 24.449999999999999 112.847 -161.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -132.64 162.9 54.46 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.996 1.318 . . . . 0.0 111.355 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.08 -26.55 21.34 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.291 1.994 . . . . 0.0 112.398 172.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -72.96 150.57 90.4 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.467 1.107 . . . . 0.0 111.697 171.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -57.24 144.13 91.63 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.048 2.498 . . . . 0.0 115.032 -172.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.72 119.01 5.84 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.768 2.312 . . . . 0.0 113.222 -173.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.5 mt -89.45 2.04 55.06 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.504 1.121 . . . . 0.0 112.654 170.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.05 50.97 0.29 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.647 1.979 . . . . 0.0 110.949 159.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.8 p -125.03 62.78 38.38 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 126.246 1.818 . . . . 0.0 110.132 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -75.64 127.86 10.56 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.825 2.35 . . . . 0.0 111.164 -163.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.51 -176.9 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.532 2.822 . . . . 0.0 111.771 171.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -53.79 -29.31 39.75 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.038 1.335 . . . . 0.0 114.153 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -56.38 -21.61 25.96 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.103 1.361 . . . . 0.0 114.393 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.53 -30.92 71.97 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 120.16 1.346 . . . . 0.0 113.368 173.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.5 p -68.03 -23.79 65.02 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.421 -0.8 . . . . 0.0 113.119 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -95.23 -41.23 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.188 1.395 . . . . 0.0 110.868 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.84 -29.7 76.02 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.446 1.498 . . . . 0.0 114.398 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 88.2 p -67.91 -18.59 64.83 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.729 1.264 . . . . 0.0 114.049 170.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -95.5 -33.35 12.46 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.402 1.481 . . . . 0.0 112.873 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.1 mt -69.82 -37.52 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.642 0.777 . . . . 0.0 111.805 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -56.25 -47.97 97.84 Favored Pre-proline 0 CA--C 1.546 0.811 0 O-C-N 120.406 -1.434 . . . . 0.0 114.028 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.62 -30.83 3.66 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.709 2.273 . . . . 0.0 113.779 171.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.6 p -72.25 -28.05 62.89 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 121.386 1.903 . . . . 0.0 113.277 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -59.88 -45.42 92.55 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.668 -1.27 . . . . 0.0 112.192 161.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.1 t -68.49 -32.23 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.23 -0.919 . . . . 0.0 111.953 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.476 ' HZ1' ' CG ' ' A' ' 114' ' ' ASP . 66.1 tttt -67.11 -41.97 85.31 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.914 0.886 . . . . 0.0 111.836 169.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -63.65 -39.48 94.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.257 1.023 . . . . 0.0 111.693 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.28 -5.4 31.98 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 169.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.459 ' HZ3' ' C ' ' A' ' 212' ' ' ALA . 82.7 mttt -141.78 42.5 1.71 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.846 1.658 . . . . 0.0 111.617 -177.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.0 m -70.05 61.57 0.19 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.239 1.816 . . . . 0.0 115.53 -165.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.18 -37.06 72.18 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.647 1.179 . . . . 0.0 111.738 167.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.476 ' CG ' ' HZ1' ' A' ' 108' ' ' LYS . 6.5 t0 -81.38 115.4 56.29 Favored Pre-proline 0 CA--C 1.552 1.027 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 152.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.58 153.68 73.53 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.423 2.749 . . . . 0.0 115.084 -147.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -64.7 -42.83 95.0 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.425 -165.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.23 -17.18 60.92 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.403 1.081 . . . . 0.0 113.763 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -86.91 -39.33 7.56 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 121.442 -0.787 . . . . 0.0 112.68 166.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 54.0 m -65.46 -25.93 67.72 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.671 -0.899 . . . . 0.0 112.953 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -58.32 -44.83 88.79 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.908 1.683 . . . . 0.0 111.759 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -71.81 -38.93 70.16 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.523 0.729 . . . . 0.0 111.4 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.84 -23.88 66.77 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 171.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.4 tp -83.21 -41.21 18.67 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.727 1.211 . . . . 0.0 111.914 170.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 23.3 mt -64.2 -41.58 97.0 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.932 1.293 . . . . 0.0 113.478 -177.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.499 ' CD ' ' HZ3' ' A' ' 128' ' ' LYS . 11.4 mm-40 -65.15 -36.19 83.45 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.277 1.399 . . . . 0.0 112.598 -176.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -72.88 -38.75 66.87 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.229 -0.919 . . . . 0.0 112.691 172.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.31 -33.83 76.73 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.85 -1.156 . . . . 0.0 113.033 172.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.499 ' HZ3' ' CD ' ' A' ' 125' ' ' GLU . 79.5 mttt -66.71 -44.65 81.05 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.868 1.213 . . . . 0.0 111.614 172.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.14 86.05 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.511 0.724 . . . . 0.0 112.225 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.4 tp -66.46 -58.16 5.83 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.316 1.446 . . . . 0.0 111.903 170.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.05 -37.08 84.94 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.512 1.125 . . . . 0.0 113.777 -170.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.35 -36.02 74.36 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.235 -0.758 . . . . 0.0 113.528 178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -93.71 -26.33 17.06 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 23.0 mt -63.72 -31.94 73.27 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.592 -1.318 . . . . 0.0 113.584 172.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -64.16 -3.11 2.45 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 171.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.2 t -109.46 -36.5 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.505 1.522 . . . . 0.0 112.704 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -83.65 -28.67 28.23 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 -162.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 144.86 174.92 17.56 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 120.069 1.304 . . . . 0.0 113.926 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.77 -4.01 14.1 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 125.008 3.805 . . . . 0.0 116.417 -164.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -106.24 167.18 9.99 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.433 1.015 . . . . 0.0 110.964 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.0 4.67 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 120.627 -1.296 . . . . 0.0 113.214 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.413 ' CB ' ' HG1' ' A' ' 147' ' ' THR . . . -121.54 16.01 11.2 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.772 2.429 . . . . 0.0 113.649 167.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.34 -110.44 3.49 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 120.838 -1.164 . . . . 0.0 113.022 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -58.06 -34.85 70.55 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -168.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -155.34 162.33 40.86 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.941 1.696 . . . . 0.0 110.895 -156.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 13.9 mt -63.87 132.61 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 164.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.413 ' HG1' ' CB ' ' A' ' 142' ' ' ALA . 29.3 p -132.66 -177.16 4.36 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.354 1.462 . . . . 0.0 110.474 169.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.13 -20.92 2.82 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 167.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.6 t -73.44 -41.01 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 120.704 -1.248 . . . . 0.0 112.325 173.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.69 -42.7 99.29 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.618 1.167 . . . . 0.0 112.233 168.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.7 mt -62.61 -23.2 66.93 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.6 m -83.08 -45.56 13.85 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.041 -1.037 . . . . 0.0 112.537 175.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 39.3 mt -100.15 -35.79 9.54 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -166.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.38 -49.53 92.9 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -70.43 -27.07 23.72 Favored 'Trans proline' 0 C--N 1.35 0.623 0 CA-C-N 120.942 1.372 . . . . 0.0 113.026 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -74.88 -28.39 60.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.444 -1.265 . . . . 0.0 112.654 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.0 mt -66.56 -45.86 77.95 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.824 0.85 . . . . 0.0 112.937 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -57.56 -39.64 77.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.293 0.637 . . . . 0.0 111.837 170.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -70.13 -20.97 63.14 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 9.6 mt -76.1 -51.23 12.68 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.837 1.199 . . . . 0.0 111.172 167.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.75 -34.57 74.64 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.405 1.082 . . . . 0.0 112.283 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 96.5 t -87.64 -75.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.198 0.999 . . . . 0.0 112.462 174.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.26 -52.39 16.58 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.886 -1.133 . . . . 0.0 112.153 -154.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.0 tp -68.25 -25.44 65.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.459 0.704 . . . . 0.0 112.543 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.22 -25.67 48.19 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.745 1.164 . . . . 0.0 115.508 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -68.46 -21.24 64.64 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -120.47 -30.61 4.51 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.97 1.308 . . . . 0.0 112.774 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -147.93 94.63 2.37 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.231 1.812 . . . . 0.0 108.668 169.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -67.96 78.15 0.22 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.483 1.113 . . . . 0.0 110.668 168.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -73.16 118.69 70.74 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 124.404 1.082 . . . . 0.0 111.385 -169.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.16 107.51 2.27 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.031 1.821 . . . . 0.0 110.674 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 35.2 mm -60.04 113.43 7.32 Favored Pre-proline 0 CA--C 1.541 0.635 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 163.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -63.33 154.3 68.97 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.741 1.628 . . . . 0.0 112.846 -170.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.48 -23.75 67.53 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.628 1.171 . . . . 0.0 113.241 171.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -65.8 -28.45 69.02 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.665 1.186 . . . . 0.0 113.398 170.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 43.6 mt -84.49 52.68 2.43 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.054 1.342 . . . . 0.0 110.794 166.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.39 -25.82 68.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.085 0.954 . . . . 0.0 112.532 -165.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -75.67 -49.89 17.05 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.914 0.779 . . . . 0.0 111.781 171.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 62.6 t -59.98 -39.36 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.541 0.737 . . . . 0.0 111.207 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 47.7 tp -65.24 -41.33 94.44 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.272 1.029 . . . . 0.0 113.356 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -69.04 -41.24 77.93 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.627 -0.67 . . . . 0.0 112.322 172.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -65.65 -31.81 73.03 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.585 1.154 . . . . 0.0 112.772 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 53.4 mt -58.09 -35.33 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 120.918 -1.114 . . . . 0.0 111.881 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -82.28 -13.31 57.2 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.368 -1.458 . . . . 0.0 113.749 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.0 mt -73.94 -18.14 60.93 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 117.576 -1.202 . . . . 0.0 113.499 160.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.7 mt -66.3 -19.55 65.85 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.51 1.505 . . . . 0.0 113.922 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -95.85 10.81 35.92 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.873 -1.142 . . . . 0.0 113.132 174.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.9 p -119.9 179.3 4.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.079 1.752 . . . . 0.0 113.374 -171.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 50.6 mtp85 56.77 -167.62 0.12 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.489 1.516 . . . . 0.0 110.143 -168.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -81.87 -35.32 29.42 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 122.043 -0.41 . . . . 0.0 110.889 157.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.6 p -69.38 -58.43 4.02 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.692 1.597 . . . . 0.0 114.763 -163.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -67.71 -43.51 79.87 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.149 0.886 . . . . 0.0 112.123 173.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -53.68 -35.33 60.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.922 1.289 . . . . 0.0 113.865 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.76 -7.39 59.22 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 7.8 p -73.24 -21.74 60.56 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.474 1.488 . . . . 0.0 112.518 170.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -60.27 127.29 31.08 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.9 1.28 . . . . 0.0 112.101 -170.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -93.42 173.71 7.57 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.424 1.09 . . . . 0.0 110.558 165.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.83 123.41 21.9 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.84 164.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -57.96 -35.05 70.61 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -165.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -61.39 -39.26 90.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.742 1.217 . . . . 0.0 112.396 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -82.34 0.87 39.74 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.858 -1.151 . . . . 0.0 113.988 173.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.9 t -85.39 -54.76 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.313 0.645 . . . . 0.0 109.98 161.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -46.22 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.123 0.874 . . . . 0.0 112.616 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.5 -10.68 60.14 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -90.07 -31.73 10.58 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 120.861 -1.149 . . . . 0.0 113.301 169.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 16.4 t90 -87.14 -30.8 20.78 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.101 1.76 . . . . 0.0 114.22 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -48.74 -49.47 66.09 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.54 -24.9 35.45 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.651 1.567 . . . . 0.0 113.839 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -74.23 -7.36 52.43 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.55 1.14 . . . . 0.0 114.056 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 59.1 t -61.91 -22.14 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 119.518 1.054 . . . . 0.0 111.505 159.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -106.91 -11.7 15.65 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 171.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.459 ' C ' ' HZ3' ' A' ' 111' ' ' LYS . . . . . . . . 0 C--O 1.248 1.017 0 C-N-CA 124.484 1.114 . . . . 0.0 113.181 -173.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.834 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 73.3 mt -115.5 143.14 45.75 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.334 1.454 . . . . 0.0 110.809 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -138.01 149.39 46.03 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.679 1.191 . . . . 0.0 108.831 159.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 pt -130.85 139.05 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.082 0.953 . . . . 0.0 109.202 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.7 m -110.68 125.99 54.05 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.892 0.877 . . . . 0.0 109.635 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.98 157.81 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.858 1.263 . . . . 0.0 110.792 -166.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -60.5 115.26 3.45 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.053 -0.405 . . . . 0.0 110.371 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.97 153.16 27.63 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.06 155.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.76 147.26 46.81 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.199 0.999 . . . . 0.0 112.753 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.71 134.05 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 167.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.69 -26.72 1.64 Allowed Glycine 0 CA--C 1.54 1.594 0 CA-C-O 118.883 -0.954 . . . . 0.0 115.442 -173.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.61 72.38 77.97 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-N 118.603 1.201 . . . . 0.0 112.159 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.03 -12.3 33.99 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.246 2.63 . . . . 0.0 114.927 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -82.94 2.89 32.35 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.6 pt -135.38 161.26 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.101 1.36 . . . . 0.0 111.503 177.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.26 149.92 40.57 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.612 0.765 . . . . 0.0 111.516 167.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.27 -168.41 11.29 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.632 1.587 . . . . 0.0 111.656 166.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -59.06 105.29 0.31 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 118.61 1.205 . . . . 0.0 114.161 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.2 t -152.01 107.3 2.84 Favored Pre-proline 0 CA--C 1.552 1.025 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.207 135.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -67.75 -15.85 45.1 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.815 2.343 . . . . 0.0 112.874 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -72.13 -28.53 63.32 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.065 -1.022 . . . . 0.0 112.381 171.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.09 -37.28 75.36 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.277 -1.514 . . . . 0.0 112.997 168.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -60.76 -27.25 67.83 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.475 HH12 ' CG ' ' A' ' 74' ' ' ASP . 60.1 mtp180 -57.18 -40.87 78.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.56 1.144 . . . . 0.0 112.452 172.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -78.87 -40.29 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.137 1.375 . . . . 0.0 111.546 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.5 mt -59.13 -43.6 92.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.982 0.513 . . . . 0.0 111.328 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.22 -48.49 81.42 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.068 0.947 . . . . 0.0 113.08 -177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.6 p -76.49 -37.4 56.87 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.3 mt -70.34 -36.99 74.56 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.391 0.541 . . . . 0.0 111.775 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -77.56 -20.08 54.67 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -74.11 -47.42 36.39 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.243 -1.535 . . . . 0.0 111.654 167.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -76.74 -4.36 42.97 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.802 1.241 . . . . 0.0 114.022 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm 58.65 19.58 6.89 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 126.377 1.871 . . . . 0.0 114.426 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.0 mt -72.84 127.37 89.73 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 118.152 -0.928 . . . . 0.0 108.641 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.31 143.13 34.68 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.405 2.07 . . . . 0.0 112.191 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -146.98 155.2 42.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.959 1.704 . . . . 0.0 109.92 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -80.36 131.64 35.66 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.046 -1.034 . . . . 0.0 109.789 158.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 t -99.41 94.23 6.32 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.999 0.92 . . . . 0.0 110.505 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -77.43 100.73 6.1 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.711 0.767 . . . . 0.0 109.479 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 99.4 mt -67.28 107.0 2.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.558 1.143 . . . . 0.0 109.241 170.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.3 mm -118.62 108.4 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.671 1.189 . . . . 0.0 109.059 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -75.46 90.03 2.7 Favored 'General case' 0 C--O 1.219 -0.552 0 O-C-N 120.716 -1.24 . . . . 32.609999999999999 108.216 165.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 pp -63.51 1.77 0.51 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 117.837 2.532 . . . . 40.049999999999997 117.837 -171.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.66 -19.56 79.72 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-N 119.896 1.226 . . . . 41.469999999999999 112.874 160.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -126.13 49.86 1.94 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 129.914 3.286 . . . . 47.170000000000002 109.36 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -78.27 118.15 70.51 Favored Pre-proline 0 N--CA 1.472 0.627 0 O-C-N 119.464 -2.023 . . . . 41.270000000000003 111.253 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.52 160.01 50.91 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.647 2.232 . . . . 40.289999999999999 111.623 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -62.12 -28.94 69.99 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.851 -1.155 . . . . 42.390000000000001 113.853 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 81.8 t90 -61.73 -32.24 72.46 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.508 0.929 . . . . 37.079999999999998 113.508 170.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -79.76 -33.83 40.33 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.819 -1.176 . . . . 35.880000000000003 112.619 172.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.0 mt -68.64 -23.72 64.46 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.449 0.907 . . . . 33.609999999999999 113.449 173.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -65.89 -41.88 90.97 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.894 1.278 . . . . 33.789999999999999 111.974 167.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.0 mt -74.11 -35.89 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 124.306 1.042 . . . . 33.159999999999997 111.654 175.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.4 t -133.08 92.9 24.12 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 126.121 1.768 . . . . 33.579999999999998 110.96 -175.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.73 -15.36 37.17 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.636 2.224 . . . . 37.899999999999999 113.901 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.442 ' CD ' ' HZ2' ' A' ' 59' ' ' LYS . 7.0 mt-10 -76.55 -13.0 60.11 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.004 -1.06 . . . . 38.990000000000002 113.438 165.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.69 16.98 72.6 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.932 -1.105 . . . . 35.469999999999999 114.595 -172.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.442 ' HZ2' ' CD ' ' A' ' 57' ' ' GLU . 72.8 mttt -100.12 155.23 17.85 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.399 1.48 . . . . 34.490000000000002 114.266 -173.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.0 m -115.39 157.26 44.44 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 126.713 2.005 . . . . 23.530000000000001 111.125 163.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -62.16 149.57 59.59 Favored 'Cis proline' 0 C--N 1.349 0.575 0 CA-C-O 122.327 0.886 . . . . 22.879999999999999 112.861 -13.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.09 146.66 22.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 113.8 -1.546 . . . . 0.0 107.303 163.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.59 163.58 30.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 123.522 0.729 . . . . 0.0 111.416 -169.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -120.95 69.27 0.89 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.547 1.939 . . . . 0.0 109.749 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.9 mt -75.05 119.15 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.745 0.818 . . . . 0.0 108.848 -175.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 46.8 t0 54.14 39.95 31.2 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.147 0.498 . . . . 0.0 111.019 -164.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.4 t0 68.65 -6.75 0.8 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 127.362 2.265 . . . . 0.0 115.638 -171.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -92.98 136.72 33.0 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.293 -1.504 . . . . 0.0 112.568 -170.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -64.01 127.95 33.68 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.311 1.444 . . . . 0.0 112.874 -175.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -141.59 132.66 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.526 1.53 . . . . 0.0 109.558 170.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -112.63 173.56 6.32 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.731 1.612 . . . . 0.0 111.621 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.1 t0 67.04 110.58 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 127.628 2.371 . . . . 22.16 114.485 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.5 p -62.97 -24.96 68.14 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 115.322 1.601 . . . . 21.16 115.322 -164.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.475 ' CG ' HH12 ' A' ' 25' ' ' ARG . 36.9 m-20 -72.04 -36.43 69.64 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.189 1.359 . . . . 24.969999999999999 112.998 170.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.69 -38.69 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.23 -0.919 . . . . 23.850000000000001 110.95 173.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.12 -44.04 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.374 1.07 . . . . 23.68 111.213 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.68 -42.79 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.476 1.11 . . . . 22.84 111.318 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.97 -26.97 61.55 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.215 -0.77 . . . . 23.329999999999998 114.565 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 87.7 mt -92.49 -50.76 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 118.718 1.259 . . . . 23.309999999999999 112.059 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.5 mt -65.55 -29.46 70.09 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.618 1.099 . . . . 23.48 113.452 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -89.24 -2.02 58.31 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.697 0.999 . . . . 24.239999999999998 113.697 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.403 ' OE2' ' HE3' ' A' ' 83' ' ' LYS . 38.7 tt0 -115.06 -47.63 2.86 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.679 1.592 . . . . 39.259999999999998 112.513 173.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.403 ' HE3' ' OE2' ' A' ' 82' ' ' GLU . 84.2 mttt -104.92 64.45 0.72 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.977 1.311 . . . . 24.449999999999999 112.415 -165.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -138.64 164.15 41.83 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.366 1.466 . . . . 0.0 110.713 174.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.69 -26.27 23.38 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.23 1.954 . . . . 0.0 112.655 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -74.64 154.71 87.44 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.043 1.337 . . . . 0.0 111.872 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -56.16 140.79 87.77 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.992 2.461 . . . . 0.0 113.635 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.97 133.93 35.27 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.215 1.943 . . . . 0.0 112.139 -176.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.9 mt -107.61 1.52 23.29 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.628 1.571 . . . . 0.0 112.065 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.8 49.53 0.23 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.769 2.027 . . . . 0.0 111.497 159.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 44.8 p -123.42 67.28 36.59 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 125.077 1.351 . . . . 0.0 109.012 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -74.19 124.2 8.85 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.393 2.062 . . . . 0.0 110.032 -165.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.73 -176.79 2.18 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.72 2.28 . . . . 0.0 111.133 170.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.491 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 23.0 mp0 -56.06 -30.08 61.43 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.406 2.282 . . . . 0.0 112.785 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -54.72 -23.86 19.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.167 1.787 . . . . 0.0 114.203 171.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.47 -33.42 73.74 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.981 -1.074 . . . . 0.0 113.213 173.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 59.5 p -70.13 -20.52 63.16 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.9 t -92.8 -42.31 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.276 1.43 . . . . 0.0 110.342 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.99 -30.21 77.08 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.122 1.344 . . . . 0.0 114.587 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 97.7 p -66.94 -19.75 65.78 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.603 1.202 . . . . 0.0 113.958 171.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -95.79 -32.99 12.44 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.477 1.511 . . . . 0.0 112.814 172.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 61.9 mt -68.31 -37.85 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.55 0.74 . . . . 0.0 111.559 173.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -58.11 -47.29 99.12 Favored Pre-proline 0 CA--C 1.547 0.847 0 O-C-N 120.314 -1.492 . . . . 0.0 114.274 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.23 -30.33 5.59 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.703 2.269 . . . . 0.0 113.893 172.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.8 p -71.75 -27.96 63.32 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 121.009 1.731 . . . . 0.0 112.962 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -62.29 -42.34 99.27 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.329 -1.482 . . . . 0.0 112.787 161.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.45 -37.5 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-N 120.002 1.274 . . . . 0.0 111.348 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HZ1' ' CG ' ' A' ' 114' ' ' ASP . 65.3 tttt -65.97 -38.17 87.87 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.897 0.879 . . . . 0.0 112.2 172.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -71.79 -28.14 63.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.48 1.112 . . . . 0.0 112.646 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.8 mt -83.61 -2.74 56.75 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.555 1.542 . . . . 0.0 114.403 168.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -144.64 39.53 1.26 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.253 1.421 . . . . 0.0 112.925 -175.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 m -73.25 65.73 0.85 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -162.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.401 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 95.9 mttt -70.68 -35.5 72.85 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.92 1.288 . . . . 0.0 111.875 166.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.45 ' CG ' ' HZ1' ' A' ' 108' ' ' LYS . 8.1 t0 -79.52 117.79 69.03 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-O 117.102 -1.428 . . . . 0.0 107.431 152.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -53.89 149.62 33.27 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.27 2.647 . . . . 0.0 116.53 -154.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.38 -41.85 93.29 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.101 -170.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.62 -19.64 59.07 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.453 1.101 . . . . 0.0 113.634 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.79 -37.53 13.27 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 121.046 -1.034 . . . . 0.0 112.485 166.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 63.9 m -65.8 -29.4 69.89 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.011 0.924 . . . . 0.0 112.99 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -57.38 -43.64 83.79 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.67 1.588 . . . . 0.0 111.769 174.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -70.35 -40.31 74.14 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.891 0.876 . . . . 0.0 111.533 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.48 -21.89 65.5 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 173.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.7 tp -84.59 -40.3 17.67 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.078 1.351 . . . . 0.0 111.882 170.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.2 mt -64.15 -41.55 97.12 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.937 1.295 . . . . 0.0 113.449 -176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.01 -34.44 78.1 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.492 1.496 . . . . 0.0 112.87 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.52 -36.76 60.46 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.27 -0.894 . . . . 0.0 112.914 171.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.5 mt -64.89 -36.2 83.61 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.742 -1.224 . . . . 0.0 112.823 172.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -64.53 -42.99 95.4 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.456 1.103 . . . . 0.0 111.309 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.57 -37.5 87.56 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.39 0.676 . . . . 0.0 112.345 176.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 tp -66.62 -55.27 16.09 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.386 1.075 . . . . 0.0 111.643 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -66.68 -38.54 87.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.021 1.328 . . . . 0.0 113.766 -170.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.67 -33.68 83.35 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.24 -0.755 . . . . 0.0 113.494 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -91.23 -31.06 16.3 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 117.77 0.785 . . . . 0.0 113.004 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 16.0 mt -62.27 -31.69 72.3 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.564 -1.335 . . . . 0.0 113.247 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -65.36 0.59 1.4 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 172.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.2 t -109.32 -25.75 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.854 1.661 . . . . 0.0 113.22 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -106.11 -9.43 16.97 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 -161.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 122.33 171.2 13.84 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 119.863 1.211 . . . . 0.0 113.604 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -78.06 -4.69 14.6 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.683 3.589 . . . . 0.0 116.122 -160.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -98.8 167.41 10.78 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.082 -1.011 . . . . 0.0 111.649 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.4 mt -69.86 -4.16 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 120.576 -1.328 . . . . 0.0 113.055 174.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.469 ' CB ' ' HG1' ' A' ' 147' ' ' THR . . . -121.68 27.83 7.98 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.033 1.733 . . . . 0.0 113.707 165.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.42 -108.81 2.71 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.256 0.931 . . . . 0.0 113.023 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -60.28 -33.28 72.1 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -172.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -148.2 163.51 36.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.157 1.383 . . . . 0.0 111.694 -167.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 51.8 mt -64.79 135.21 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.602 0.761 . . . . 0.0 109.645 164.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.469 ' HG1' ' CB ' ' A' ' 142' ' ' ALA . 29.3 p -135.33 -176.56 4.31 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.914 1.286 . . . . 0.0 111.258 169.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.41 -22.3 2.9 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 167.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.0 t -72.12 -42.47 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 120.945 -1.097 . . . . 0.0 112.005 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -61.35 -43.67 98.48 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 120.964 -1.085 . . . . 0.0 112.373 169.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 25.1 mt -61.65 -21.91 64.82 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 24.8 m -82.0 -47.85 12.16 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.187 -0.946 . . . . 0.0 112.135 175.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 26.8 mt -97.05 -34.4 11.18 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -167.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.77 -49.24 94.9 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -174.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.06 -28.4 15.99 Favored 'Trans proline' 0 C--N 1.35 0.617 0 CA-C-N 120.996 1.391 . . . . 0.0 112.998 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -68.88 -30.52 69.04 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 117.487 -1.244 . . . . 0.0 112.572 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 56.3 mt -68.24 -45.5 73.05 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -56.98 -39.73 75.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.188 0.595 . . . . 0.0 111.477 170.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -70.46 -18.91 62.99 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.5 mt -76.44 -52.6 9.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.681 1.128 . . . . 0.0 111.261 166.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -62.97 -29.9 71.17 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.145 0.978 . . . . 0.0 112.395 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 76.0 t -89.64 -70.72 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.921 1.289 . . . . 0.0 113.168 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.32 -52.39 7.76 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.83 -0.544 . . . . 0.0 112.351 -158.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 42.8 tp -65.76 -31.08 71.87 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 118.948 -0.549 . . . . 0.0 111.344 171.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -55.64 -28.3 51.34 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.177 1.37 . . . . 0.0 115.804 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -71.08 -15.31 62.52 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -126.2 -28.45 3.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.604 1.162 . . . . 0.0 112.807 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -145.63 97.06 2.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.805 2.042 . . . . 0.0 108.518 164.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -68.34 78.93 0.26 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.204 1.002 . . . . 0.0 110.561 166.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -68.76 118.13 57.76 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.095 0.958 . . . . 0.0 110.956 -173.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.19 100.85 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.954 1.77 . . . . 0.0 110.301 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.4 mm -55.3 111.51 3.14 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.664 1.186 . . . . 0.0 108.119 167.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -63.24 149.93 89.98 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.323 1.349 . . . . 0.0 112.519 -168.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.29 -19.53 65.48 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.849 -1.157 . . . . 0.0 113.429 172.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -62.41 -36.02 81.03 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.99 1.316 . . . . 0.0 112.732 167.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 45.7 mt -80.75 52.55 1.72 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.59 1.556 . . . . 0.0 111.12 166.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -26.61 67.85 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.52 1.128 . . . . 0.0 112.353 -170.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -77.83 -48.58 16.15 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.457 -0.777 . . . . 0.0 112.069 174.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.75 -39.46 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.862 0.865 . . . . 0.0 110.944 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 56.1 tp -63.43 -40.61 97.63 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.816 0.847 . . . . 0.0 113.026 175.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -69.56 -41.89 75.26 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.466 0.706 . . . . 0.0 112.533 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -64.55 -32.39 74.02 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.533 1.133 . . . . 0.0 112.538 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.13 -35.03 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 120.993 -1.067 . . . . 0.0 111.851 169.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 40.7 mmtt -80.43 -16.79 53.57 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.332 -1.48 . . . . 0.0 112.867 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.66 -18.67 62.84 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.152 -0.928 . . . . 0.0 113.434 162.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 73.8 mt -66.29 -18.24 65.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.117 1.326 . . . . 0.0 113.988 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -98.04 9.32 43.11 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.763 1.225 . . . . 0.0 112.41 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.0 p -116.27 179.14 4.08 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.363 1.465 . . . . 0.0 113.622 -170.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.4 mtp85 57.17 -163.67 0.18 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.578 1.551 . . . . 0.0 110.079 -169.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -84.31 -31.11 25.04 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.966 -0.459 . . . . 0.0 111.428 156.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 35.2 p -75.36 -59.16 2.87 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.968 1.307 . . . . 0.0 114.351 -160.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -64.85 -42.33 94.97 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.799 0.727 . . . . 0.0 112.0 172.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -53.36 -33.8 55.04 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.308 1.443 . . . . 0.0 114.028 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -86.83 -8.14 57.59 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 4.1 p -73.73 -18.59 60.97 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.346 1.43 . . . . 0.0 112.425 169.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -58.94 132.49 54.15 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.833 1.253 . . . . 0.0 111.863 -175.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -106.85 176.96 5.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.048 1.339 . . . . 0.0 110.465 169.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.47 116.53 9.99 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.155 -0.965 . . . . 0.0 109.571 167.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -57.11 -34.44 68.35 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -167.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.65 -40.69 79.87 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.673 1.189 . . . . 0.0 111.778 174.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -86.53 -3.16 58.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.331 1.852 . . . . 0.0 112.809 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 25.8 t -84.99 -49.25 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.279 1.032 . . . . 0.0 110.091 159.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 12.7 mt -60.98 -54.59 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.509 1.123 . . . . 0.0 111.691 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.71 -15.98 63.25 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.269 1.027 . . . . 0.0 113.389 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.47 -27.44 43.34 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 118.616 -1.102 . . . . 0.0 113.48 171.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -90.0 -34.96 15.79 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.476 1.911 . . . . 0.0 114.262 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -48.1 -48.94 62.82 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.2 -24.83 27.23 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 121.577 1.518 . . . . 0.0 114.022 174.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -74.96 -6.64 50.38 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 175.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.401 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 61.5 t -60.29 -18.42 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.181 -0.95 . . . . 0.0 111.416 158.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -118.79 17.19 13.52 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.554 1.942 . . . . 0.0 115.052 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.922 0 C-N-CA 125.168 1.387 . . . . 0.0 110.386 171.395 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.414 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 99.0 mtp . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 117.845 -1.074 . . . . 0.0 109.995 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.64 -177.53 0.09 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.239 1.816 . . . . 0.0 115.053 171.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 75.9 mt -125.19 118.66 26.54 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.651 1.981 . . . . 0.0 109.582 -173.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -116.42 132.98 56.53 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.183 0.993 . . . . 0.0 109.589 173.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.7 pt -128.69 135.99 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 118.93 0.786 . . . . 0.0 110.957 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.0 m -111.95 122.27 47.3 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.097 0.959 . . . . 0.0 109.922 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.54 161.18 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.147 0.979 . . . . 0.0 112.018 -166.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -56.73 117.54 4.01 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.168 1.387 . . . . 0.0 111.753 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.11 148.67 39.51 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.138 155.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.16 151.12 47.63 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.132 0.968 . . . . 0.0 112.573 175.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.9 t -65.97 123.54 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.327 0.651 . . . . 0.0 109.311 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.91 -17.54 2.21 Favored Glycine 0 CA--C 1.54 1.612 0 N-CA-C 116.297 1.279 . . . . 0.0 116.297 -176.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.04 72.55 55.11 Favored Pre-proline 0 CA--C 1.548 0.867 0 CA-C-N 119.098 1.449 . . . . 0.0 111.622 -175.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.35 -14.67 45.37 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.135 2.557 . . . . 0.0 115.265 -167.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -84.4 -0.39 52.54 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.0 pt -135.15 165.28 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.65 1.18 . . . . 0.0 112.081 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.0 mt -73.66 146.45 44.53 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.185 0.994 . . . . 0.0 111.665 173.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.48 -159.05 8.67 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.992 1.282 . . . . 0.0 112.15 167.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.472 ' CG ' ' HZ2' ' A' ' 209' ' ' LYS . 62.5 t0 -59.11 98.22 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 122.934 1.35 . . . . 0.0 113.788 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.2 t -153.26 95.85 2.91 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.425 1.49 . . . . 0.0 108.718 142.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.86 -20.01 64.38 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.163 1.909 . . . . 0.0 112.391 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -65.93 -37.34 85.8 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.669 1.188 . . . . 0.0 112.846 172.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 95.1 m -64.81 -38.15 90.0 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.723 -1.235 . . . . 0.0 112.142 169.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -65.92 -25.56 67.2 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 118.519 -0.753 . . . . 0.0 112.73 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -58.23 -43.42 87.76 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.603 1.161 . . . . 0.0 113.244 168.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.02 -40.13 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.287 1.035 . . . . 0.0 110.792 -175.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.8 mt -61.59 -40.55 95.17 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.917 -0.489 . . . . 0.0 111.684 170.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 tp -60.55 -47.71 84.98 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.775 1.23 . . . . 0.0 113.34 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.1 p -73.06 -33.42 65.66 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.9 1.227 . . . . 0.0 113.46 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.52 -40.82 96.33 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.525 -0.735 . . . . 0.0 111.986 173.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -80.34 -23.69 40.39 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.419 ' CD ' HH21 ' A' ' 189' ' ' ARG . 52.2 tp10 -65.0 -45.08 87.08 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.073 -1.017 . . . . 0.0 111.597 164.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.492 ' HZ1' ' ND2' ' A' ' 84' ' ' ASN . 64.9 mttm -68.85 -23.38 64.23 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.241 -0.912 . . . . 0.0 112.671 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.0 mtmm 59.64 19.56 8.19 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.351 1.861 . . . . 0.0 112.407 -170.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.4 tt -74.15 140.23 76.54 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.2 1.4 . . . . 0.0 109.884 -171.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -66.87 132.32 28.07 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 121.803 1.668 . . . . 0.0 112.02 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -141.65 169.88 16.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.085 1.754 . . . . 0.0 111.169 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.699 ' HE2' ' NE2' ' A' ' 40' ' ' HIS . 52.1 tttt -130.59 127.77 39.7 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.069 1.747 . . . . 0.0 109.015 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.59 ' C ' ' HD2' ' A' ' 40' ' ' HIS . 27.6 t -114.17 138.16 50.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.157 0.983 . . . . 0.0 112.939 -170.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.699 ' NE2' ' HE2' ' A' ' 38' ' ' LYS . 6.1 m170 -126.31 108.9 11.68 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.965 1.706 . . . . 0.0 108.416 -171.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.6 mt -76.89 107.66 9.38 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.267 0.627 . . . . 0.0 110.494 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.4 mm -91.34 119.45 38.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.654 1.181 . . . . 0.0 109.379 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -69.14 126.3 29.35 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.292 -0.632 . . . . 32.609999999999999 109.292 161.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.9 mt -88.58 -18.47 28.01 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.122 0.786 . . . . 40.049999999999997 113.122 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.55 -20.43 71.6 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 118.79 0.723 . . . . 41.469999999999999 114.344 172.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -147.49 90.44 1.86 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.836 1.655 . . . . 47.170000000000002 108.688 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -84.82 135.0 40.63 Favored Pre-proline 0 N--CA 1.469 0.491 0 C-N-CA 124.142 0.977 . . . . 41.270000000000003 110.034 -170.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -59.26 140.45 94.73 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.343 2.029 . . . . 40.289999999999999 111.737 171.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.06 -40.56 89.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.195 0.813 . . . . 42.390000000000001 113.195 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 31.7 p-90 -65.97 -13.41 59.76 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.233 1.198 . . . . 37.079999999999998 114.233 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -67.49 -26.88 66.58 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.242 -1.537 . . . . 35.880000000000003 112.62 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.9 mt -70.66 -21.08 62.65 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.368 0.877 . . . . 33.609999999999999 113.368 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.72 -16.36 61.19 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.192 0.997 . . . . 33.789999999999999 112.57 171.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.3 mt -102.58 -43.39 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.13 1.372 . . . . 33.159999999999997 110.7 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.4 t -124.8 104.24 30.49 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 125.451 1.5 . . . . 33.579999999999998 110.376 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.29 -19.64 38.12 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.51 2.14 . . . . 37.899999999999999 113.769 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -83.77 -5.87 59.3 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.77 1.026 . . . . 38.990000000000002 113.77 168.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.91 14.22 65.23 Favored Glycine 0 CA--C 1.534 1.276 0 O-C-N 120.878 -1.139 . . . . 35.469999999999999 114.773 -172.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -91.89 156.28 17.59 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.262 1.425 . . . . 34.490000000000002 112.818 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.0 m -109.44 156.49 39.42 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 126.096 1.759 . . . . 23.530000000000001 110.935 159.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.02 153.78 80.62 Favored 'Cis proline' 0 C--N 1.348 0.508 0 CA-C-O 122.299 0.875 . . . . 22.879999999999999 113.352 -10.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.6 p -143.71 146.74 20.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 113.304 -1.771 . . . . 0.0 107.31 159.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.01 163.62 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.596 0.758 . . . . 0.0 110.444 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -111.35 121.78 46.14 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.934 1.294 . . . . 0.0 109.748 157.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 95.8 mt -106.23 115.35 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.3 1.44 . . . . 0.0 107.693 170.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.414 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 2.5 t70 53.25 43.58 31.31 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 122.529 1.156 . . . . 0.0 113.655 -167.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.2 t70 66.89 -7.97 0.44 Allowed 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -171.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.414 ' HE2' ' O ' ' A' ' 66' ' ' ASP . 20.4 mmtt -91.83 127.97 37.49 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 119.472 -2.018 . . . . 0.0 111.744 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 27.8 p-90 -74.6 147.57 41.53 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -167.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.0 t -141.57 126.11 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.204 1.801 . . . . 0.0 108.563 171.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -109.96 166.57 10.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.633 1.573 . . . . 0.0 111.534 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.0 t0 67.01 114.07 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.064 2.146 . . . . 22.16 113.935 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.2 p -64.0 -29.21 70.39 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 115.317 1.599 . . . . 21.16 115.317 -163.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -71.08 -29.88 65.85 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 120.135 1.334 . . . . 24.969999999999999 112.163 171.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.2 t -75.09 -42.05 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 O-C-N 120.623 -1.298 . . . . 23.850000000000001 111.645 170.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.01 -45.55 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.345 1.058 . . . . 23.68 110.63 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.9 t -63.1 -43.32 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.09 0.956 . . . . 22.84 111.353 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.97 93.33 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 118.654 0.661 . . . . 23.329999999999998 113.505 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 70.6 mt -77.08 -41.21 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 117.946 0.873 . . . . 23.309999999999999 112.278 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.1 mt -62.97 -37.05 85.55 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.132 1.333 . . . . 23.48 112.48 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -89.27 9.24 26.65 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.333 1.234 . . . . 24.239999999999998 114.333 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -123.04 -42.0 2.3 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.857 1.263 . . . . 39.259999999999998 112.654 173.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -126.25 65.57 1.23 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.77 1.628 . . . . 24.449999999999999 111.456 -167.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.492 ' ND2' ' HZ1' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -141.62 165.38 28.71 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 124.815 1.246 . . . . 0.0 110.694 175.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.01 -27.17 8.67 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.965 2.443 . . . . 0.0 114.939 -174.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -77.68 160.91 73.58 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 118.93 0.786 . . . . 0.0 110.06 168.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -52.32 139.01 55.41 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.546 2.164 . . . . 0.0 114.642 -175.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -69.99 147.09 60.64 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.449 2.766 . . . . 0.0 111.29 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.2 mt -131.49 9.87 4.74 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.103 1.361 . . . . 0.0 113.232 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.88 41.89 0.1 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.305 1.842 . . . . 0.0 114.578 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 90.5 m -105.78 103.39 43.72 Favored Pre-proline 0 N--CA 1.472 0.669 0 C-N-CA 125.107 1.363 . . . . 0.0 110.314 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -86.56 112.5 1.05 Allowed 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 124.148 3.232 . . . . 0.0 111.516 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -82.9 -170.46 0.92 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.863 3.042 . . . . 0.0 111.888 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.549 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 15.4 mp0 -52.32 -33.33 42.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.211 2.204 . . . . 0.0 113.171 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -57.92 -23.66 54.43 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.458 1.503 . . . . 0.0 114.14 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.55 -27.12 67.49 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.099 -1.001 . . . . 0.0 113.099 172.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 86.2 p -65.75 -47.95 73.53 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.153 -0.967 . . . . 0.0 112.149 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.2 t -77.33 -37.94 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 121.274 -0.891 . . . . 0.0 111.444 174.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.22 -31.34 80.51 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 121.265 -0.897 . . . . 0.0 114.137 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 89.0 p -73.06 -14.55 61.43 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -86.72 -39.83 15.63 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.536 1.135 . . . . 0.0 112.586 167.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.47 -37.52 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.289 1.436 . . . . 0.0 111.418 173.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -53.4 -54.38 45.94 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.915 1.686 . . . . 0.0 114.24 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.78 -34.83 0.87 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.118 2.545 . . . . 0.0 113.303 170.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.0 p -65.9 -31.06 71.77 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.403 1.456 . . . . 0.0 112.631 -173.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -79.58 -20.89 45.88 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.249 -1.532 . . . . 0.0 113.71 172.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.459 ' CG2' ' HZ3' ' A' ' 156' ' ' LYS . 85.6 t -72.9 -38.2 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 120.399 -1.438 . . . . 0.0 110.744 164.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.414 ' HZ1' ' CG ' ' A' ' 114' ' ' ASP . 52.8 tptt -69.58 -27.67 65.32 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 176.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -59.39 -41.46 89.45 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.097 1.359 . . . . 0.0 111.855 170.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.5 mt -80.14 4.19 18.14 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.819 1.648 . . . . 0.0 114.81 172.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -136.76 35.48 2.64 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 127.97 2.508 . . . . 0.0 111.277 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 p -82.23 58.02 3.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.585 1.954 . . . . 0.0 113.69 -169.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.53 -45.84 91.15 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.162 0.985 . . . . 0.0 110.096 161.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.414 ' CG ' ' HZ1' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -65.6 119.52 60.82 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 128.157 2.583 . . . . 0.0 107.71 155.043 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.16 135.09 68.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.935 1.757 . . . . 0.0 115.843 -159.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -68.16 -32.62 73.01 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 117.779 -1.105 . . . . 0.0 112.115 170.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.74 -32.06 68.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.166 1.386 . . . . 0.0 114.024 174.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.05 -34.86 9.39 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.744 0.688 . . . . 0.0 113.499 172.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 61.4 m -64.94 -40.6 95.28 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.409 1.084 . . . . 0.0 112.107 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -59.58 -27.46 66.28 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.358 1.863 . . . . 0.0 113.655 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -69.2 -18.34 63.9 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.127 0.971 . . . . 0.0 112.885 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.18 -35.8 13.64 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.857 0.863 . . . . 0.0 112.551 165.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.6 mt -65.95 -34.6 78.49 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.69 -36.38 82.73 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.714 0.688 . . . . 0.0 112.076 173.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.77 -30.66 32.24 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.249 0.62 . . . . 0.0 112.425 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.16 -46.86 88.79 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.131 0.972 . . . . 0.0 111.741 166.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.0 mt -65.21 -40.69 94.48 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.774 -1.108 . . . . 0.0 112.128 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -62.66 -42.11 99.43 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.291 1.405 . . . . 0.0 112.576 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.69 -35.78 82.15 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.216 0.607 . . . . 0.0 112.257 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.2 tp -72.84 -54.46 8.75 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.68 0.792 . . . . 0.0 111.529 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -63.1 -35.4 80.14 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.498 1.919 . . . . 0.0 113.906 -173.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.34 -33.64 81.61 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 123.914 0.768 . . . . 0.0 113.731 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -94.98 -28.64 15.04 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.6 mt -66.25 -32.23 73.52 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.594 -1.316 . . . . 0.0 113.272 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -66.37 -11.0 48.95 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.55 -29.27 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.737 0.815 . . . . 0.0 111.928 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -94.65 -37.31 11.38 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.605 1.162 . . . . 0.0 113.303 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.33 -69.97 0.23 Allowed Glycine 0 CA--C 1.542 1.735 0 CA-C-O 116.609 -2.217 . . . . 0.0 116.525 166.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -102.04 -33.86 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.987 0 N-CA-C 117.825 2.202 . . . . 0.0 117.825 -156.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -134.16 156.68 47.89 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.416 1.462 . . . . 0.0 112.93 -167.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.4 mt -70.46 -12.91 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.67 -1.64 46.23 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 165.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.07 -135.15 10.19 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 120.154 1.343 . . . . 0.0 113.738 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -62.4 -25.36 67.89 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -144.08 164.09 31.65 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.141 1.376 . . . . 0.0 110.403 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.3 mt -61.36 122.12 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 123.433 0.693 . . . . 0.0 110.467 169.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.7 p -140.21 -160.56 1.08 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.45 1.5 . . . . 0.0 108.901 160.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -49.5 -32.82 13.0 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -166.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.3 t -71.86 -37.48 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 120.725 1.602 . . . . 0.0 113.003 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -63.11 -44.04 96.78 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.34 -0.85 . . . . 0.0 111.587 167.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.5 mt -64.98 -27.36 68.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.009 0.524 . . . . 0.0 111.97 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 73.6 m -75.9 -31.94 59.41 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 120.201 -1.562 . . . . 0.0 113.654 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 68.6 mt -124.9 -33.84 2.88 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -162.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.61 -50.08 79.18 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -169.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -68.89 -25.7 32.52 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.479 1.452 . . . . 0.0 113.518 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.459 ' HZ3' ' CG2' ' A' ' 107' ' ' VAL . 20.4 ttmm -72.63 -29.47 63.5 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.224 -0.922 . . . . 0.0 112.198 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 38.0 mt -71.67 -44.09 64.89 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.788 0.835 . . . . 0.0 112.058 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -63.85 -38.5 91.33 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -64.19 -34.7 78.69 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.438 -1.414 . . . . 0.0 112.573 173.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.7 tp -68.83 -47.04 67.02 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.252 -0.905 . . . . 0.0 111.178 174.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -52.3 -45.18 65.43 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.442 1.497 . . . . 0.0 112.225 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.1 t -75.2 -58.88 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.919 0.888 . . . . 0.0 113.119 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.76 -36.07 37.74 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.993 -1.067 . . . . 0.0 113.463 -167.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.2 tp -72.83 -31.81 65.05 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.578 -0.702 . . . . 0.0 111.28 171.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.83 -27.98 37.96 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.837 1.208 . . . . 0.0 114.704 170.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -67.53 -19.49 65.3 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -141.5 -27.18 0.68 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -149.87 80.85 1.38 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.522 1.529 . . . . 0.0 109.355 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.9 75.85 0.08 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.388 1.475 . . . . 0.0 112.403 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -71.73 112.96 16.06 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.127 1.771 . . . . 0.0 112.32 -168.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.31 137.52 19.0 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.546 2.164 . . . . 0.0 111.845 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 46.7 mm -87.57 113.93 56.52 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.329 1.052 . . . . 0.0 109.025 164.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -71.06 155.86 60.85 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.254 1.969 . . . . 0.0 111.779 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.59 -12.39 44.79 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -62.05 -31.44 71.85 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.209 1.004 . . . . 0.0 112.835 166.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.2 mt -84.19 57.18 4.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.464 1.906 . . . . 0.0 110.835 167.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -22.86 64.6 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.62 1.168 . . . . 0.0 113.297 -161.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -75.52 -52.49 10.52 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.257 0.935 . . . . 0.0 110.303 165.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 33.7 t -57.53 -46.69 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 119.234 0.925 . . . . 0.0 112.711 -174.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.7 tp -64.36 -27.95 69.37 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -93.61 -29.48 15.44 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.143 -0.973 . . . . 0.0 113.272 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -64.0 -36.92 85.56 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.271 1.428 . . . . 0.0 112.925 173.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.5 mt -60.01 -37.43 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 O-C-N 121.336 -0.852 . . . . 0.0 111.641 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -67.01 -28.26 68.1 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.047 -1.658 . . . . 0.0 112.475 173.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.1 mt -71.5 -20.59 62.04 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.473 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 68.9 mt -65.65 -21.6 66.57 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 120.17 1.35 . . . . 0.0 112.751 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -85.71 19.1 2.57 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.456 1.502 . . . . 0.0 113.308 170.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.8 p -142.81 178.65 7.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.797 2.039 . . . . 0.0 112.947 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.419 HH21 ' CD ' ' A' ' 32' ' ' GLU . 65.7 mtp85 59.74 171.88 0.08 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.619 1.968 . . . . 0.0 113.561 -170.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 53.1 mp0 -64.83 -47.91 76.29 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.422 1.089 . . . . 0.0 110.286 159.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -39.29 89.78 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.681 1.992 . . . . 0.0 115.707 -170.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -96.67 -53.26 3.62 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.483 1.038 . . . . 0.0 111.746 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -62.31 -37.37 85.31 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -168.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.88 -22.85 66.55 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.15 0.886 . . . . 0.0 113.034 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 7.0 p -90.55 -7.09 53.81 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.647 1.179 . . . . 0.0 113.2 -173.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -60.61 114.68 3.12 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.458 1.503 . . . . 0.0 111.063 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -70.11 162.56 28.03 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.051 0.94 . . . . 0.0 112.579 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -75.39 125.81 29.74 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.848 -0.533 . . . . 0.0 110.684 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -73.84 -32.1 63.5 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -155.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.37 -36.42 83.66 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.812 1.245 . . . . 0.0 111.162 167.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -83.69 -8.43 59.28 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.009 1.724 . . . . 0.0 113.309 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.2 t -78.47 -51.89 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.347 1.059 . . . . 0.0 109.913 158.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 62.2 mt -62.32 -48.03 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.015 0.926 . . . . 0.0 111.974 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -5.39 41.74 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.874 1.27 . . . . 0.0 114.15 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -90.33 -32.75 9.25 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 121.133 -0.979 . . . . 0.0 113.134 164.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -83.22 -32.56 26.43 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.13 1.772 . . . . 0.0 114.802 -174.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -48.83 -55.15 21.55 Favored Pre-proline 0 N--CA 1.481 1.121 0 CA-C-N 120.254 1.388 . . . . 0.0 114.35 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.19 -20.8 32.34 Favored 'Trans proline' 0 C--N 1.351 0.678 0 CA-C-N 120.806 1.324 . . . . 0.0 111.979 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.472 ' HZ2' ' CG ' ' A' ' 19' ' ' ASP . 45.6 mtpt -84.54 2.69 40.06 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.148 1.779 . . . . 0.0 114.274 174.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 63.4 t -66.58 -29.97 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 120.886 -1.134 . . . . 0.0 110.219 152.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -96.2 -52.34 4.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 117.183 -1.389 . . . . 0.0 114.265 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.865 2.066 . . . . 0.0 113.089 -177.239 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.461 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 90.0 mtp . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 118.468 -0.777 . . . . 0.0 110.746 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.63 -161.51 0.25 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.917 1.287 . . . . 0.0 113.292 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.99 136.73 34.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.903 1.281 . . . . 0.0 110.771 -170.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -139.21 151.42 46.54 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.412 1.485 . . . . 0.0 108.845 166.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.54 140.73 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.206 1.002 . . . . 0.0 109.148 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.9 m -113.56 122.29 46.8 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.086 0.954 . . . . 0.0 109.38 171.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -136.59 157.92 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.887 1.275 . . . . 0.0 110.699 -164.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -57.7 115.43 2.79 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.611 0.365 . . . . 0.0 110.839 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.49 151.24 27.9 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.964 154.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.73 151.53 33.68 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.256 1.026 . . . . 0.0 112.515 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.6 t -70.86 135.98 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 166.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.53 -33.85 1.37 Allowed Glycine 0 CA--C 1.539 1.538 0 CA-C-O 118.585 -1.119 . . . . 0.0 115.218 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.96 67.85 12.1 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.861 1.264 . . . . 0.0 112.529 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -65.71 -7.47 16.59 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.268 2.645 . . . . 0.0 114.685 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -81.17 -0.1 38.84 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.493 1.517 . . . . 0.0 114.452 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.4 pt -133.34 162.08 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.994 1.318 . . . . 0.0 111.546 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.8 mt -63.6 150.96 42.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.725 0.81 . . . . 0.0 111.648 168.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.0 -166.32 10.91 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.557 1.551 . . . . 0.0 111.949 166.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -56.61 107.96 0.44 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.4 t -158.89 103.48 1.59 Allowed Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.281 139.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -64.57 -20.82 65.9 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.294 1.996 . . . . 0.0 112.633 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -68.38 -26.41 65.55 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.906 -1.121 . . . . 0.0 112.829 172.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 81.7 m -74.04 -37.09 64.42 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.614 -1.304 . . . . 0.0 112.055 170.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -62.24 -26.8 68.58 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 118.339 -0.839 . . . . 0.0 112.938 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.541 HH11 ' CG ' ' A' ' 74' ' ' ASP . 59.1 mtp180 -57.01 -42.8 81.02 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.118 0.967 . . . . 0.0 112.471 170.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.78 -41.46 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.284 1.434 . . . . 0.0 111.381 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -58.94 -42.92 90.96 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.972 0.509 . . . . 0.0 111.401 172.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.02 -50.53 73.39 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.306 1.042 . . . . 0.0 112.748 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 p -75.71 -38.34 58.67 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -175.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.1 mt -65.91 -39.75 90.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.566 0.621 . . . . 0.0 111.32 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -77.85 -25.56 48.81 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -67.13 -48.66 67.41 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 120.741 -1.224 . . . . 0.0 111.325 169.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -76.93 -0.33 23.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.016 1.726 . . . . 0.0 114.436 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm 57.79 20.67 6.71 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.785 1.634 . . . . 0.0 114.677 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.77 128.8 91.7 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.504 1.122 . . . . 0.0 109.035 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.73 140.68 23.78 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.467 2.112 . . . . 0.0 111.737 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -145.11 152.03 39.43 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.604 1.562 . . . . 0.0 110.089 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -77.55 131.51 37.9 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.064 -1.022 . . . . 0.0 109.339 158.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.6 t -103.95 94.42 5.4 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.927 0.891 . . . . 0.0 110.755 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -81.26 99.06 8.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.775 0.83 . . . . 0.0 109.615 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.0 mt -66.98 108.79 2.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.528 0.731 . . . . 0.0 109.039 170.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.7 mm -120.66 114.88 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.529 1.132 . . . . 0.0 109.303 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -76.56 90.5 3.33 Favored 'General case' 0 C--O 1.22 -0.455 0 O-C-N 120.775 -1.203 . . . . 32.609999999999999 108.42 165.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.06 -7.34 1.76 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 117.173 2.286 . . . . 40.049999999999997 117.173 -170.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.56 -37.85 89.95 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 119.651 1.114 . . . . 41.469999999999999 111.762 165.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -105.58 47.77 0.86 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 129.452 3.101 . . . . 47.170000000000002 111.177 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -73.92 126.68 89.22 Favored Pre-proline 0 N--CA 1.475 0.779 0 O-C-N 119.695 -1.878 . . . . 41.270000000000003 111.689 -174.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.86 159.55 52.22 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.468 2.112 . . . . 40.289999999999999 110.982 170.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -62.45 -29.21 70.35 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.776 1.028 . . . . 42.390000000000001 113.776 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.4 t90 -56.28 -35.24 67.27 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.969 1.308 . . . . 37.079999999999998 113.957 168.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -79.41 -33.92 42.25 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.949 -1.094 . . . . 35.880000000000003 112.82 174.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 mt -71.02 -21.05 62.33 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.76 1.022 . . . . 33.609999999999999 113.76 173.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -66.38 -47.93 71.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.446 0.698 . . . . 33.789999999999999 110.752 166.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.6 mt -72.1 -33.21 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.308 1.043 . . . . 33.159999999999997 112.183 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.4 t -137.78 81.93 27.53 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 127.069 2.147 . . . . 33.579999999999998 110.507 -173.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -63.9 -23.51 68.29 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.231 2.621 . . . . 37.899999999999999 113.778 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -74.27 -10.94 60.09 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.805 -1.185 . . . . 38.990000000000002 113.845 167.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.89 22.58 76.65 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.463 1.506 . . . . 35.469999999999999 115.131 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -110.72 159.3 17.74 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.872 1.669 . . . . 34.490000000000002 113.921 -169.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.7 155.14 63.52 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.645 1.578 . . . . 23.530000000000001 111.85 172.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -63.51 152.75 71.37 Favored 'Cis proline' 0 C--N 1.349 0.575 0 CA-C-O 121.813 0.672 . . . . 22.879999999999999 112.611 -11.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.2 p -139.24 144.43 29.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.568 161.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.59 162.48 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 121.348 -0.845 . . . . 0.0 111.528 -169.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -123.21 63.91 1.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.103 1.761 . . . . 0.0 109.791 -174.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 81.4 mt -74.01 121.21 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.824 0.85 . . . . 0.0 108.76 -175.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.461 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 45.5 t0 55.15 35.89 25.79 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 121.862 -0.524 . . . . 0.0 111.447 -164.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t0 67.19 -8.74 0.43 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 127.628 2.371 . . . . 0.0 115.345 -170.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.3 mttt -83.93 133.56 34.7 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.443 1.497 . . . . 0.0 111.875 -173.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.2 m0 -73.72 128.6 35.94 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.018 1.327 . . . . 0.0 111.679 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.0 t -142.5 128.1 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.332 1.453 . . . . 0.0 109.776 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -103.53 175.18 5.56 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.692 1.597 . . . . 0.0 111.729 172.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.7 t0 66.44 108.79 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.829 2.452 . . . . 22.16 114.786 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.4 p -61.42 -23.95 66.19 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 115.226 1.565 . . . . 21.16 115.226 -168.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.541 ' CG ' HH11 ' A' ' 25' ' ' ARG . 38.1 m-20 -73.61 -37.47 65.41 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.745 1.157 . . . . 24.969999999999999 113.07 171.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -69.92 -39.0 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.409 -0.807 . . . . 23.850000000000001 111.039 171.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 89.6 mt -63.58 -44.11 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.302 1.041 . . . . 23.68 111.224 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.1 -41.07 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.181 0.993 . . . . 22.84 111.482 171.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.89 -12.64 49.27 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 115.786 1.074 . . . . 23.329999999999998 115.786 174.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 89.6 mt -102.38 -53.05 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 118.913 1.357 . . . . 23.309999999999999 111.011 168.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.6 -33.06 73.24 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.622 0.971 . . . . 23.48 113.622 -172.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -90.57 -2.91 57.88 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.71 1.004 . . . . 24.239999999999998 113.71 -173.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.488 ' CD ' ' HZ2' ' A' ' 83' ' ' LYS . 10.1 tt0 -117.33 -54.44 2.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.442 1.497 . . . . 39.259999999999998 112.05 172.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.488 ' HZ2' ' CD ' ' A' ' 82' ' ' GLU . 64.9 mttp -93.71 59.22 2.81 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.92 1.288 . . . . 24.449999999999999 112.152 -164.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -135.84 163.64 49.01 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.77 1.628 . . . . 0.0 110.997 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.15 -23.53 21.17 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.411 2.074 . . . . 0.0 112.562 172.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -74.57 147.02 84.36 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.039 1.336 . . . . 0.0 112.206 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -59.44 135.14 62.95 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.841 2.361 . . . . 0.0 113.645 -173.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.68 136.5 49.96 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.909 2.406 . . . . 0.0 113.867 -167.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 mt -103.83 -0.26 29.42 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.935 1.694 . . . . 0.0 112.088 169.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.81 51.64 0.5 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.559 1.944 . . . . 0.0 110.569 161.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -129.74 61.31 57.21 Favored Pre-proline 0 N--CA 1.467 0.41 0 C-N-CA 127.003 2.121 . . . . 0.0 109.104 -169.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -80.77 123.16 4.61 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.256 1.971 . . . . 0.0 111.23 -155.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -72.54 175.96 9.43 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.1 2.533 . . . . 0.0 111.504 167.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -59.38 -20.56 55.76 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -53.72 -24.87 16.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.472 1.509 . . . . 0.0 114.223 167.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.04 -31.29 71.68 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.719 -1.238 . . . . 0.0 112.993 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.0 p -69.04 -25.5 64.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.426 1.09 . . . . 0.0 112.975 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.4 t -89.24 -43.44 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.321 1.448 . . . . 0.0 110.57 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.65 -29.56 75.06 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.014 1.292 . . . . 0.0 114.631 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 88.9 p -66.88 -20.5 65.93 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.498 1.149 . . . . 0.0 114.019 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.413 ' HZ2' ' CD ' ' A' ' 126' ' ' GLU . 36.7 mtmt -94.83 -34.43 12.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.501 1.52 . . . . 0.0 112.874 172.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.1 mt -67.38 -37.98 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.511 0.724 . . . . 0.0 111.521 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -58.93 -47.97 97.67 Favored Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 120.303 -1.498 . . . . 0.0 114.136 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.52 -30.7 6.2 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.693 2.262 . . . . 0.0 113.976 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.3 p -70.72 -29.8 66.17 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.996 1.725 . . . . 0.0 112.761 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -62.22 -41.36 98.32 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.345 -1.472 . . . . 0.0 113.071 161.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.4 t -63.73 -37.48 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 120.248 1.385 . . . . 0.0 111.339 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.438 ' HZ1' ' CG ' ' A' ' 114' ' ' ASP . 65.1 tttt -67.31 -37.65 83.69 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.607 0.763 . . . . 0.0 112.339 172.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -70.62 -30.22 66.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.408 1.083 . . . . 0.0 112.427 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.5 mt -83.42 1.38 41.81 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.73 1.612 . . . . 0.0 114.352 169.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -146.78 38.56 1.01 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.526 1.53 . . . . 0.0 113.082 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 m -73.8 63.71 0.9 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -161.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.34 -35.84 76.31 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.981 1.312 . . . . 0.0 111.798 165.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.438 ' CG ' ' HZ1' ' A' ' 108' ' ' LYS . 12.0 t0 -81.89 119.05 74.34 Favored Pre-proline 0 CA--C 1.553 1.06 0 CA-C-O 117.125 -1.417 . . . . 0.0 107.221 153.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.66 150.92 26.73 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.419 2.746 . . . . 0.0 116.735 -153.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -66.34 -42.36 88.23 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.568 -174.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.12 -24.37 60.6 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.402 1.081 . . . . 0.0 113.417 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.31 -35.81 25.59 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.19 -0.944 . . . . 0.0 112.805 168.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 92.7 m -67.44 -27.19 66.84 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.655 -0.909 . . . . 0.0 112.687 169.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -58.75 -44.09 90.46 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 125.388 1.475 . . . . 0.0 111.814 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -70.44 -37.6 74.4 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.534 -0.729 . . . . 0.0 111.996 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.89 -16.09 63.67 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.2 tp -92.13 -40.71 10.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.379 1.471 . . . . 0.0 111.612 169.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.5 mt -65.02 -42.38 94.44 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.201 1.4 . . . . 0.0 113.558 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.495 ' CD ' ' HZ3' ' A' ' 128' ' ' LYS . 10.1 mm-40 -65.27 -35.19 80.27 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.88 1.673 . . . . 0.0 112.469 -176.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.413 ' CD ' ' HZ2' ' A' ' 101' ' ' LYS . 80.5 mm-40 -73.71 -37.26 65.21 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.43 -0.794 . . . . 0.0 112.83 172.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.3 mt -65.69 -36.4 83.53 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.688 -1.258 . . . . 0.0 112.656 171.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.495 ' HZ3' ' CD ' ' A' ' 125' ' ' GLU . 79.6 mttt -64.57 -42.78 95.43 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.734 1.152 . . . . 0.0 111.253 173.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.21 -38.41 91.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.401 0.68 . . . . 0.0 112.131 175.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.6 tp -65.04 -52.81 53.74 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.045 0.938 . . . . 0.0 111.846 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -65.9 -38.41 88.66 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.214 1.405 . . . . 0.0 113.425 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -62.07 -36.05 92.35 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 119.284 -0.731 . . . . 0.0 113.845 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -87.45 -31.74 19.86 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 117.913 0.857 . . . . 0.0 112.879 175.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 12.8 mt -61.42 -36.23 79.76 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.004 -1.06 . . . . 0.0 113.436 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -65.21 -2.71 3.16 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.3 t -104.23 -27.76 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.591 1.556 . . . . 0.0 112.946 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -93.67 -50.94 5.15 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -168.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 158.95 172.41 26.02 Favored Glycine 0 CA--C 1.535 1.298 0 O-C-N 121.362 -0.836 . . . . 0.0 114.586 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -73.48 -15.25 24.9 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 124.669 3.579 . . . . 0.0 115.987 -163.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -89.95 167.45 12.8 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.379 0.99 . . . . 0.0 111.61 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -12.18 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.472 -1.393 . . . . 0.0 113.204 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.613 ' CB ' ' HG1' ' A' ' 147' ' ' THR . . . -100.65 -4.1 29.04 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.8 1.408 . . . . 0.0 114.8 166.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 110.12 -122.95 6.51 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 119.871 1.214 . . . . 0.0 113.201 -175.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -70.43 -18.72 63.01 Favored 'General case' 0 CA--C 1.541 0.635 0 O-C-N 120.847 -1.384 . . . . 0.0 114.108 -168.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -141.35 155.74 45.9 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.907 1.683 . . . . 0.0 110.711 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 58.9 mt -62.73 129.31 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.592 0.757 . . . . 0.0 109.244 163.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.613 ' HG1' ' CB ' ' A' ' 142' ' ' ALA . 13.9 p -129.36 -175.41 3.57 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.8 0.84 . . . . 0.0 111.961 168.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.79 -19.1 3.83 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 172.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.6 t -70.32 -43.57 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.998 -1.064 . . . . 0.0 111.9 172.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -60.02 -45.19 93.61 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.471 1.108 . . . . 0.0 112.312 169.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 34.2 mt -61.06 -20.74 62.92 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 177.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.2 m -85.98 -43.99 12.71 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.37 -0.831 . . . . 0.0 112.047 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 29.5 mt -98.34 -33.53 11.03 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -168.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.49 -49.58 93.0 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.56 -22.35 18.34 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 121.095 1.427 . . . . 0.0 113.223 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -71.25 -33.25 69.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 117.47 -1.252 . . . . 0.0 112.077 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 68.9 mt -66.41 -43.17 86.49 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 169.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -58.33 -39.72 80.19 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.653 0.661 . . . . 0.0 111.588 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -70.81 -22.68 62.32 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.3 mt -71.98 -51.38 22.2 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.112 0.869 . . . . 0.0 111.496 168.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -64.8 -28.16 69.38 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.524 0.729 . . . . 0.0 112.461 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.3 t -94.21 -72.24 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.854 1.262 . . . . 0.0 113.159 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.98 -48.72 11.87 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.333 -0.854 . . . . 0.0 113.057 -158.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 63.4 tp -66.84 -34.0 76.84 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.825 -0.607 . . . . 0.0 111.074 166.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.38 -30.13 57.98 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.285 1.421 . . . . 0.0 115.505 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -64.34 -26.16 68.35 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 173.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -117.21 -28.09 6.28 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.547 1.139 . . . . 0.0 113.584 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -143.87 94.28 2.57 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.358 2.263 . . . . 0.0 108.032 167.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -68.35 80.68 0.25 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.077 0.951 . . . . 0.0 110.347 168.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -71.0 117.22 54.3 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.447 1.099 . . . . 0.0 110.966 -171.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.39 107.09 1.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.868 1.712 . . . . 0.0 110.352 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 30.5 mm -57.13 115.13 9.58 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 124.399 1.08 . . . . 0.0 108.445 169.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.59 146.62 92.79 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.6 1.534 . . . . 0.0 111.744 -174.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.88 -17.48 64.34 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 120.887 -1.133 . . . . 0.0 114.058 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -62.18 -35.33 78.49 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.807 1.243 . . . . 0.0 112.786 167.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 36.1 mt -80.54 50.81 1.36 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.802 1.641 . . . . 0.0 111.232 165.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -34.42 70.56 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.532 1.133 . . . . 0.0 111.746 -171.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -80.5 -37.86 30.89 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.255 1.022 . . . . 0.0 112.943 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 43.9 t -64.68 -40.61 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 119.512 1.051 . . . . 0.0 111.017 172.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.57 -41.2 96.44 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -65.47 -42.72 91.96 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 171.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -65.0 -33.27 75.65 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.431 1.092 . . . . 0.0 112.959 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 58.3 mt -58.62 -32.36 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.039 -1.038 . . . . 0.0 111.704 170.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -83.13 -11.63 57.76 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.33 -1.481 . . . . 0.0 113.613 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.81 -18.9 60.9 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 117.963 -1.018 . . . . 0.0 113.448 160.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 74.0 mt -66.06 -13.59 60.26 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.033 1.288 . . . . 0.0 114.281 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -106.35 10.74 31.52 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.931 1.292 . . . . 0.0 112.776 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.0 p -114.46 177.57 4.6 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.222 1.809 . . . . 0.0 113.763 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 52.8 mtp85 57.11 -166.31 0.14 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.813 1.645 . . . . 0.0 111.201 -172.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -79.69 -33.77 40.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.449 0.7 . . . . 0.0 110.243 161.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 56.2 p -75.75 -66.85 0.73 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.909 1.683 . . . . 0.0 113.944 -162.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -61.68 -41.43 97.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.137 0.881 . . . . 0.0 112.268 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -56.68 -27.99 59.92 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -87.26 -11.2 50.35 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 11.8 p -74.76 -14.85 60.76 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.61 1.55 . . . . 0.0 112.931 173.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -59.49 134.45 57.02 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.773 1.229 . . . . 0.0 111.763 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -109.74 176.99 4.87 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.267 1.427 . . . . 0.0 110.562 168.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.69 113.84 8.18 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.812 -1.18 . . . . 0.0 109.352 168.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -57.57 -31.5 66.2 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -167.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.94 -40.28 88.44 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.481 1.112 . . . . 0.0 112.009 173.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -85.52 -3.12 58.77 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.133 1.773 . . . . 0.0 112.935 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 42.1 t -86.69 -48.84 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.753 1.221 . . . . 0.0 109.971 162.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.6 mt -57.96 -52.01 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.923 1.289 . . . . 0.0 111.512 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.3 -12.89 61.89 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.25 -32.34 10.67 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.148 -0.97 . . . . 0.0 113.371 171.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 57.1 t90 -80.26 -35.65 35.7 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.096 1.759 . . . . 0.0 114.224 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -51.05 -47.76 86.57 Favored Pre-proline 0 CA--C 1.552 1.027 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.82 -25.94 27.81 Favored 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 121.275 1.491 . . . . 0.0 113.688 172.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -76.06 -11.95 60.03 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 117.296 -1.335 . . . . 0.0 114.562 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 48.3 t -59.04 -23.33 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 119.151 0.887 . . . . 0.0 111.114 160.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -104.08 -7.94 19.87 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 177.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.294 0 C-N-CA 125.141 1.376 . . . . 0.0 112.935 -175.927 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 75.3 mtp . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 117.739 -1.124 . . . . 0.0 109.675 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.22 -174.71 0.11 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.025 1.73 . . . . 0.0 115.094 173.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 84.2 mt -125.22 128.42 48.29 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.131 1.772 . . . . 0.0 110.981 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -119.94 143.26 48.09 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.913 0.885 . . . . 0.0 108.784 158.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.2 pt -129.09 147.85 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.439 1.096 . . . . 0.0 109.966 176.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.3 m -120.14 120.96 37.71 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.348 1.459 . . . . 0.0 109.205 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -133.32 160.38 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.978 1.311 . . . . 0.0 111.781 -168.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.61 118.22 7.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.519 0.728 . . . . 0.0 111.56 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.02 151.95 33.28 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.08 0.552 . . . . 0.0 111.599 161.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.73 140.6 58.88 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.161 0.981 . . . . 0.0 113.029 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.5 t -66.25 121.86 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.95 -14.79 18.32 Favored Glycine 0 CA--C 1.538 1.498 0 CA-C-O 118.464 -1.187 . . . . 0.0 115.881 -173.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.26 62.72 62.43 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 119.053 1.426 . . . . 0.0 112.022 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -65.39 -5.48 11.44 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.186 2.591 . . . . 0.0 114.962 -171.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -77.92 -3.18 40.5 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.425 1.89 . . . . 0.0 114.734 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.2 pt -136.13 165.69 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.947 1.299 . . . . 0.0 112.346 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.51 144.77 53.72 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.305 1.042 . . . . 0.0 111.565 171.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.21 -174.53 13.81 Favored Glycine 0 N--CA 1.469 0.857 0 C-N-CA 125.145 1.355 . . . . 0.0 114.489 175.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -62.73 105.29 0.63 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.4 t -163.18 95.07 1.11 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.485 1.514 . . . . 0.0 109.454 159.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.09 -22.97 75.16 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.837 1.691 . . . . 0.0 113.542 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -63.29 -32.72 74.2 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.606 -1.309 . . . . 0.0 113.432 169.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 67.4 m -72.2 -37.12 69.31 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.808 -1.183 . . . . 0.0 112.014 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -63.84 -22.51 66.95 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 117.57 -1.205 . . . . 0.0 112.994 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.465 HH12 ' CG ' ' A' ' 74' ' ' ASP . 64.3 mtp180 -57.98 -43.06 86.3 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.641 1.11 . . . . 0.0 112.644 169.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -80.76 -36.82 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.574 1.15 . . . . 0.0 111.673 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.4 -41.53 94.08 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 122.118 -0.364 . . . . 0.0 111.002 169.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.1 tp -61.15 -52.33 65.32 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.044 0.938 . . . . 0.0 112.604 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.9 p -75.45 -33.71 60.9 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 62.2 mt -73.52 -29.86 62.74 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.159 -0.963 . . . . 0.0 112.919 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.474 ' CD ' ' HZ2' ' A' ' 194' ' ' LYS . 81.3 mm-40 -76.29 -34.14 59.08 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 169.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.16 -43.44 82.28 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.5 1.046 . . . . 0.0 112.768 172.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -73.6 1.53 9.91 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.791 -1.099 . . . . 0.0 113.573 166.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 pttt 46.85 22.3 0.19 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 127.952 2.501 . . . . 0.0 114.588 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.3 tt -91.03 131.16 37.88 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 125.325 1.45 . . . . 0.0 109.401 -164.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.56 119.3 6.3 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.462 1.441 . . . . 0.0 111.981 -173.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -129.72 154.12 47.49 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.693 1.597 . . . . 0.0 111.263 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -101.2 120.24 39.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.599 1.16 . . . . 0.0 110.064 176.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.5 t -95.24 112.79 24.45 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.479 0.712 . . . . 0.0 112.402 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -89.84 114.36 26.1 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.023 1.329 . . . . 0.0 110.337 169.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 98.8 mt -73.72 109.03 6.92 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.285 1.034 . . . . 0.0 110.13 166.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.0 mm -99.33 117.66 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.941 0.896 . . . . 0.0 110.33 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -77.16 52.67 0.92 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.51 1.524 . . . . 32.609999999999999 112.731 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.86 0.83 0.07 Allowed 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 120.378 3.473 . . . . 40.049999999999997 120.378 -151.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.65 -41.04 85.24 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 120.217 1.371 . . . . 41.469999999999999 111.467 159.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -99.85 62.7 1.17 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 128.025 2.53 . . . . 47.170000000000002 110.094 166.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.6 pttm -78.78 128.62 76.35 Favored Pre-proline 0 N--CA 1.476 0.845 0 O-C-N 119.907 -1.745 . . . . 41.270000000000003 110.868 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -62.37 154.4 64.15 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.845 2.363 . . . . 40.289999999999999 113.436 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -59.89 -42.13 93.11 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.455 -0.778 . . . . 42.390000000000001 112.928 172.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -65.88 -19.33 65.84 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.926 1.084 . . . . 37.079999999999998 113.926 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -76.07 -29.61 58.04 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.849 -1.157 . . . . 35.880000000000003 112.226 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.0 mt -69.12 -27.79 65.89 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.158 0.89 . . . . 33.609999999999999 112.46 170.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -73.79 -3.77 30.58 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.102 1.361 . . . . 33.789999999999999 113.036 173.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.3 mt -111.26 -43.14 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 126.223 1.809 . . . . 33.159999999999997 110.558 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -116.92 96.11 48.21 Favored Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 125.734 1.613 . . . . 33.579999999999998 110.855 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.17 -24.58 58.75 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.263 1.975 . . . . 37.899999999999999 113.062 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -76.38 -9.33 58.56 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.479 1.512 . . . . 38.990000000000002 113.54 172.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.92 4.32 33.68 Favored Glycine 0 CA--C 1.536 1.347 0 O-C-N 120.31 -1.494 . . . . 35.469999999999999 115.351 -169.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -77.05 152.06 35.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.712 1.605 . . . . 34.490000000000002 112.436 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.2 152.32 45.8 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.021 1.728 . . . . 23.530000000000001 110.723 156.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -66.18 156.03 80.83 Favored 'Cis proline' 0 C--N 1.348 0.51 0 CA-C-O 122.022 0.759 . . . . 22.879999999999999 112.799 -6.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.14 146.16 24.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.233 -1.348 . . . . 0.0 107.836 161.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.9 m -129.07 163.63 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.449 0.7 . . . . 0.0 110.975 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -120.98 75.66 1.16 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 126.046 1.738 . . . . 0.0 110.0 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 86.4 mt -68.48 119.9 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.42 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 1.0 OUTLIER 57.66 33.8 23.69 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -172.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.272 23.0 t70 71.65 -0.31 3.21 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 127.455 2.302 . . . . 0.0 114.727 -170.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -107.76 130.22 54.98 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 119.232 -2.168 . . . . 0.0 112.76 -176.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -72.35 146.14 47.29 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -163.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.1 t -144.38 131.13 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 126.374 1.87 . . . . 0.0 109.015 175.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -120.94 163.09 18.78 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.093 1.757 . . . . 0.0 112.806 -174.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . 0.272 50.0 m-20 58.77 122.65 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 128.12 2.568 . . . . 22.16 114.464 -169.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.8 p -65.12 -24.79 67.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 115.522 1.675 . . . . 21.16 115.522 -162.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.465 ' CG ' HH12 ' A' ' 25' ' ' ARG . 38.8 m-20 -69.78 -37.1 76.23 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.065 1.302 . . . . 24.969999999999999 113.217 171.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.5 t -71.7 -39.07 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 121.27 -0.894 . . . . 23.850000000000001 110.669 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.38 -47.95 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.911 0.885 . . . . 23.68 111.0 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.23 -40.44 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.865 0.866 . . . . 22.84 111.117 174.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.65 -48.84 68.7 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 119.266 0.939 . . . . 23.329999999999998 113.531 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.4 mt -72.88 -41.19 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 117.954 0.877 . . . . 23.309999999999999 112.003 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.44 -33.85 76.91 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.853 1.206 . . . . 23.48 112.883 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -91.99 -10.96 37.41 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.287 1.218 . . . . 24.239999999999998 114.287 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -94.84 -40.63 9.63 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.521 1.128 . . . . 39.259999999999998 112.356 167.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -131.44 84.54 2.18 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.683 1.193 . . . . 24.449999999999999 111.611 -163.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -138.72 163.21 48.32 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 125.764 1.626 . . . . 0.0 110.737 165.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.88 -26.38 9.62 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.72 2.28 . . . . 0.0 112.696 172.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -82.93 151.66 64.33 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 124.054 0.942 . . . . 0.0 109.877 161.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -58.2 151.79 57.09 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.293 2.662 . . . . 0.0 117.078 -160.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.44 146.82 51.05 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.432 2.755 . . . . 0.0 112.992 174.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.8 mt -134.05 20.71 3.77 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.141 1.776 . . . . 0.0 112.366 172.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.21 51.82 0.24 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.891 1.676 . . . . 0.0 111.973 169.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.6 p -125.96 72.71 70.26 Favored Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 125.633 1.573 . . . . 0.0 110.016 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.43 117.31 5.07 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.747 2.298 . . . . 0.0 110.369 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -80.22 -170.41 1.0 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.814 3.009 . . . . 0.0 111.401 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -51.71 -33.87 36.3 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.135 1.374 . . . . 0.0 114.253 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -52.76 -30.08 30.81 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.743 1.617 . . . . 0.0 114.371 173.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.75 -29.2 69.97 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.16 -0.963 . . . . 0.0 113.322 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.2 m -71.68 -12.71 61.46 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 99.2 t -114.57 -37.63 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.499 1.52 . . . . 0.0 110.894 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.95 -30.93 76.76 Favored Glycine 0 CA--C 1.533 1.217 0 O-C-N 120.819 -1.176 . . . . 0.0 114.096 172.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 91.6 p -65.59 -22.42 66.68 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -85.14 -40.26 16.95 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.588 1.555 . . . . 0.0 112.036 172.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 81.1 mt -68.84 -36.19 73.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.935 1.294 . . . . 0.0 111.164 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -56.24 -44.34 99.67 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 125.097 1.359 . . . . 0.0 114.589 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -84.78 -31.36 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.525 2.817 . . . . 0.0 114.229 169.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 p -71.12 -26.93 63.23 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 121.148 1.794 . . . . 0.0 113.549 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -60.99 -38.93 87.72 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.859 -1.15 . . . . 0.0 112.521 162.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 41.3 t -69.03 -33.75 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 120.989 -1.07 . . . . 0.0 111.737 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.439 ' HZ1' ' CG ' ' A' ' 114' ' ' ASP . 65.0 tttt -63.37 -46.88 84.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.087 0.858 . . . . 0.0 111.552 168.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -63.25 -40.55 97.74 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.499 1.12 . . . . 0.0 112.689 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.7 mt -76.96 -1.35 28.22 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.425 1.49 . . . . 0.0 114.708 171.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -135.12 40.31 2.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.035 1.734 . . . . 0.0 111.405 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 p -73.73 54.28 0.48 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.809 2.444 . . . . 0.0 115.283 -162.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 97.6 mttt -61.63 -34.54 75.84 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.607 1.563 . . . . 0.0 111.932 161.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.439 ' CG ' ' HZ1' ' A' ' 108' ' ' LYS . 17.5 t0 -88.5 111.77 45.86 Favored Pre-proline 0 CA--C 1.553 1.077 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 157.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.27 150.49 25.47 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.126 2.55 . . . . 0.0 117.184 -154.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -66.2 -47.85 72.57 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.379 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -62.56 -26.82 68.77 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.8 -38.42 13.93 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 121.156 -0.965 . . . . 0.0 113.387 171.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.6 m -68.02 -34.85 77.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.579 1.151 . . . . 0.0 112.987 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -61.17 -38.12 85.36 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.753 1.621 . . . . 0.0 112.966 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -63.76 -44.87 92.16 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.262 0.625 . . . . 0.0 111.668 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.45 -34.27 76.85 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.75 -40.56 88.34 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.099 0.559 . . . . 0.0 112.225 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.4 mt -64.9 -35.1 80.06 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.888 0.767 . . . . 0.0 112.837 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.5 ' CD ' ' HZ2' ' A' ' 128' ' ' LYS . 26.4 mm-40 -72.4 -37.7 68.63 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.472 1.033 . . . . 0.0 113.0 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -71.62 -33.94 69.4 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.928 -1.108 . . . . 0.0 112.868 170.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.1 mt -65.7 -34.98 79.46 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.636 -1.29 . . . . 0.0 112.347 170.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.5 ' HZ2' ' CD ' ' A' ' 125' ' ' GLU . 79.6 mttt -65.89 -41.47 91.51 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.24 1.382 . . . . 0.0 111.952 170.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.56 -34.24 76.55 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.214 0.606 . . . . 0.0 112.124 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.66 -58.15 3.58 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.167 0.987 . . . . 0.0 111.584 170.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.76 -34.54 78.41 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.448 1.499 . . . . 0.0 114.022 -169.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.9 -38.68 89.76 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.045 0.831 . . . . 0.0 113.301 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -89.09 -25.87 21.67 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.714 0.806 . . . . 0.0 112.638 176.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.51 -32.35 73.65 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 120.562 -1.337 . . . . 0.0 112.923 172.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -67.7 -10.18 50.13 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 172.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 26.4 t -86.97 -31.81 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.129 0.972 . . . . 0.0 111.874 168.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -95.71 -30.21 13.86 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -173.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 102.39 -109.86 3.64 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 117.425 -1.764 . . . . 0.0 115.139 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -79.69 -26.73 4.49 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.682 2.921 . . . . 0.0 117.385 -146.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -130.85 163.08 28.2 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.159 1.345 . . . . 0.0 112.441 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.62 -8.36 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -168.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.626 ' CB ' ' HG1' ' A' ' 147' ' ' THR . . . -95.92 -2.88 46.29 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 159.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 118.55 -118.39 4.01 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.653 1.115 . . . . 0.0 113.672 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -70.9 -23.91 62.37 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.651 1.18 . . . . 0.0 113.394 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -141.66 171.1 14.53 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.433 1.893 . . . . 0.0 111.059 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.8 mt -70.8 138.57 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.669 1.187 . . . . 0.0 109.431 168.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.626 ' HG1' ' CB ' ' A' ' 142' ' ' ALA . 12.2 p -140.09 -171.63 3.23 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 121.284 -0.885 . . . . 0.0 111.46 164.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.01 -18.88 1.56 Allowed 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 171.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.6 t -72.87 -42.92 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 O-C-N 120.701 -1.249 . . . . 0.0 112.325 172.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -62.09 -43.85 97.94 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.524 1.129 . . . . 0.0 111.993 168.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.3 mt -64.34 -10.82 26.79 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.0 m -97.97 -45.02 6.43 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.512 1.125 . . . . 0.0 112.308 173.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.22 -36.15 12.15 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.67 -48.22 97.6 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -172.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -72.14 -25.22 19.33 Favored 'Trans proline' 0 C--N 1.351 0.678 0 CA-C-N 120.875 1.348 . . . . 0.0 113.371 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -74.05 -30.11 62.24 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 117.423 -1.275 . . . . 0.0 112.429 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 57.1 mt -67.94 -38.2 82.54 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.132 0.878 . . . . 0.0 112.832 167.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -63.78 -52.13 61.71 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.079 0.854 . . . . 0.0 112.253 172.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -62.65 -26.62 68.73 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.945 0.898 . . . . 0.0 112.358 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.2 tp -71.82 -52.66 16.37 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.938 -1.101 . . . . 0.0 113.184 170.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -58.56 -34.22 70.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.321 0.964 . . . . 0.0 112.656 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 97.4 t -82.87 -62.12 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.184 0.994 . . . . 0.0 112.763 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.55 -35.01 25.1 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -165.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.92 -35.85 59.61 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.742 -0.599 . . . . 0.0 111.397 169.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.16 -25.27 53.81 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.266 0.936 . . . . 0.0 115.234 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -60.26 -31.89 70.65 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.166 1.386 . . . . 0.0 114.675 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -125.2 -20.8 4.76 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -147.08 84.0 1.58 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.997 2.119 . . . . 0.0 107.119 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -66.91 85.24 0.12 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.389 0.676 . . . . 0.0 110.186 171.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 34.7 t90 -83.82 113.15 45.62 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.084 1.354 . . . . 0.0 110.997 -168.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.42 118.3 5.6 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.82 1.68 . . . . 0.0 110.545 -176.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 47.0 mm -67.63 113.82 16.38 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 159.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -66.33 155.45 69.92 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.723 1.615 . . . . 0.0 111.094 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.14 -22.56 66.94 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.378 1.071 . . . . 0.0 113.765 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -67.07 -22.72 65.83 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.479 1.112 . . . . 0.0 113.953 170.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 67.5 mt -85.71 55.09 3.36 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.322 1.449 . . . . 0.0 110.742 165.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.2 m -67.69 -27.03 66.49 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.499 1.119 . . . . 0.0 112.932 -161.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 33.9 t60 -73.03 -52.44 14.38 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.855 0.752 . . . . 0.0 110.338 168.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 79.0 t -58.78 -41.14 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.344 0.975 . . . . 0.0 112.226 -173.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 62.7 tp -60.46 -42.1 95.5 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.574 1.15 . . . . 0.0 112.831 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -76.74 -36.96 56.78 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.514 0.726 . . . . 0.0 112.848 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -63.39 -36.47 83.82 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.941 1.296 . . . . 0.0 112.629 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.85 -34.59 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.457 -0.777 . . . . 0.0 111.789 171.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -82.9 -14.6 53.89 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.432 -1.418 . . . . 0.0 113.515 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 23.3 mt -71.54 -18.49 62.26 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.816 -1.177 . . . . 0.0 113.618 162.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 60.4 mt -65.9 -20.54 66.26 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.759 1.163 . . . . 0.0 113.347 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -93.98 11.11 30.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.955 1.302 . . . . 0.0 113.058 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 10.5 p -119.94 174.96 6.14 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.913 2.085 . . . . 0.0 112.333 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? 60.66 177.12 0.1 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.473 1.509 . . . . 0.0 111.64 -170.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 0.5 OUTLIER -70.98 -41.71 70.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.783 153.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 85.6 p -54.75 -68.64 0.17 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.153 1.381 . . . . 0.0 114.682 -170.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -70.66 -43.4 69.21 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.059 -1.026 . . . . 0.0 112.247 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -59.79 -32.76 70.91 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -172.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.474 ' HZ2' ' CD ' ' A' ' 31' ' ' GLU . 56.4 mtpt -81.0 -7.76 59.63 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.4 p -77.89 -13.15 59.98 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.067 1.303 . . . . 0.0 113.426 169.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -64.43 86.21 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.883 1.673 . . . . 0.0 112.96 -167.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.48 137.95 57.77 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.343 1.057 . . . . 0.0 110.21 164.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.24 128.04 35.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.618 0.767 . . . . 0.0 112.022 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -59.61 -34.66 73.04 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -162.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -65.23 -37.96 88.89 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.981 -1.075 . . . . 0.0 112.453 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -82.24 -7.52 59.63 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 171.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.58 -47.45 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 118.706 0.685 . . . . 0.0 110.05 163.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 65.0 mt -64.52 -52.59 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.889 1.276 . . . . 0.0 111.742 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.9 -11.53 60.68 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.24 -34.15 8.95 Favored Glycine 0 CA--C 1.535 1.304 0 O-C-N 120.942 -1.099 . . . . 0.0 113.36 168.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -75.6 -35.82 60.46 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.064 1.746 . . . . 0.0 113.524 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -51.51 -51.7 66.93 Favored Pre-proline 0 N--CA 1.477 0.899 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -174.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.39 -24.41 43.06 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 CA-C-N 121.476 1.563 . . . . 0.0 113.451 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -74.96 -8.25 55.94 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.412 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 60.2 t -60.59 -27.06 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 120.064 1.302 . . . . 0.0 110.624 160.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -103.2 -34.48 8.81 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 116.656 -1.64 . . . . 0.0 115.1 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.258 0 O-C-N 125.234 1.584 . . . . 0.0 113.015 179.292 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.569 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 88.1 mtp . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 117.799 -1.096 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.62 -178.25 0.16 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.886 1.675 . . . . 0.0 115.01 176.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.1 mt -105.46 138.2 42.04 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.81 1.644 . . . . 0.0 112.683 -169.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -125.93 143.99 50.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.959 1.304 . . . . 0.0 109.456 157.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.4 pt -129.0 137.18 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.136 0.975 . . . . 0.0 110.287 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.8 m -109.68 123.97 50.4 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.555 1.142 . . . . 0.0 109.473 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -136.5 162.0 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.156 1.382 . . . . 0.0 111.311 -166.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -64.0 121.31 13.8 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.14 -0.975 . . . . 0.0 111.746 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.61 143.18 38.45 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.019 0.527 . . . . 0.0 111.035 157.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.28 138.01 58.35 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.648 0.737 . . . . 0.0 111.685 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -68.91 134.92 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.85 -32.75 1.69 Allowed Glycine 0 CA--C 1.537 1.427 0 CA-C-O 118.821 -0.989 . . . . 0.0 114.952 -172.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.6 60.67 19.75 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.839 1.255 . . . . 0.0 113.151 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.22 -3.95 9.59 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.976 2.451 . . . . 0.0 115.676 -171.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -73.23 -8.1 54.35 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 170.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.0 pt -131.16 163.63 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.643 1.177 . . . . 0.0 112.513 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.3 mt -63.41 138.68 58.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.14 0.976 . . . . 0.0 111.541 172.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.99 -168.19 13.47 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.034 1.302 . . . . 0.0 114.118 173.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -60.59 103.85 0.29 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 174.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.6 t -156.81 102.9 1.95 Allowed Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.149 141.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.54 -20.9 60.41 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.716 2.278 . . . . 0.0 112.862 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -66.22 -29.86 70.2 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 120.666 -1.271 . . . . 0.0 113.534 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 88.0 m -70.43 -36.64 74.11 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.536 -1.352 . . . . 0.0 112.076 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -67.68 -21.69 65.32 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 118.119 -0.944 . . . . 0.0 112.307 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.513 HH12 ' CG ' ' A' ' 74' ' ' ASP . 64.6 mtp180 -58.76 -45.07 90.6 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.359 1.064 . . . . 0.0 112.579 166.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -73.55 -43.01 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.557 1.143 . . . . 0.0 111.045 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.6 mt -57.66 -44.19 85.51 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.743 0.417 . . . . 0.0 111.54 172.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.4 tp -60.7 -48.42 81.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.106 0.962 . . . . 0.0 112.623 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.7 -36.06 67.77 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -174.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.7 mt -73.88 -41.45 62.16 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.323 0.51 . . . . 0.0 111.493 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -77.91 -14.43 59.55 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 176.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -76.55 -46.91 24.4 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.206 -1.559 . . . . 0.0 111.578 164.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -74.82 -12.81 60.47 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm 64.88 9.51 5.41 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 127.467 2.307 . . . . 0.0 114.886 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.3 tp -67.24 129.73 93.75 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.595 1.158 . . . . 0.0 110.481 175.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.39 147.95 33.16 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.658 2.239 . . . . 0.0 112.775 -174.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -147.23 151.48 36.76 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.316 1.446 . . . . 0.0 111.071 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -80.25 147.41 31.21 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.551 -0.718 . . . . 0.0 109.484 159.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -127.42 116.53 20.59 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.646 0.778 . . . . 0.0 111.24 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -104.05 110.73 23.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.668 1.587 . . . . 0.0 109.667 -175.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -74.0 106.48 5.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.579 1.152 . . . . 0.0 110.256 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 mm -95.14 116.06 35.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.791 0.837 . . . . 0.0 110.54 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -75.99 49.87 0.57 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.02 1.728 . . . . 32.609999999999999 112.853 174.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pp -60.4 3.07 0.08 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 120.532 3.53 . . . . 40.049999999999997 120.532 -148.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.22 -36.01 70.66 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 120.236 1.38 . . . . 41.469999999999999 111.787 158.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -101.98 67.46 1.08 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.043 2.137 . . . . 47.170000000000002 109.327 163.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -80.8 119.5 76.32 Favored Pre-proline 0 N--CA 1.474 0.754 0 O-C-N 119.603 -1.936 . . . . 41.270000000000003 111.636 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -62.92 154.8 64.29 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.656 2.237 . . . . 40.289999999999999 114.397 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -63.32 -42.07 98.96 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.991 0.916 . . . . 42.390000000000001 113.217 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 33.2 p-90 -64.25 -23.81 67.44 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.054 -1.029 . . . . 37.079999999999998 113.601 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -81.97 -31.62 31.07 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.252 -0.905 . . . . 35.880000000000003 112.462 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 mt -69.03 -26.9 65.23 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.198 0.908 . . . . 33.609999999999999 112.699 170.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -68.96 -15.19 63.42 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.373 1.069 . . . . 33.789999999999999 113.485 168.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.0 mt -99.31 -44.97 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.267 1.427 . . . . 33.159999999999997 110.602 172.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.4 t -112.77 100.17 50.0 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 125.907 1.683 . . . . 33.579999999999998 110.543 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.85 -19.23 46.9 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.209 1.939 . . . . 37.899999999999999 113.968 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -85.53 -9.21 57.71 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.267 -0.895 . . . . 38.990000000000002 113.279 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.66 19.23 62.52 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 120.67 -1.269 . . . . 35.469999999999999 114.645 -171.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -85.45 155.48 21.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.118 1.767 . . . . 34.490000000000002 111.509 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.7 m -110.89 154.52 43.31 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.171 1.788 . . . . 23.530000000000001 110.134 156.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -64.89 154.94 76.39 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 CA-C-O 122.019 0.758 . . . . 22.879999999999999 112.824 -9.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.43 147.45 22.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.013 -1.449 . . . . 0.0 107.363 156.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.15 165.71 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.649 -0.657 . . . . 0.0 110.373 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -122.79 97.6 5.52 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.441 1.497 . . . . 0.0 108.808 170.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 82.3 mt -86.82 121.3 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.137 0.975 . . . . 0.0 108.922 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.569 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER 52.67 38.0 24.99 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.034 0.934 . . . . 0.0 112.834 -164.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 65.64 17.08 10.78 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.129 2.171 . . . . 0.0 116.319 -172.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -117.39 128.23 54.82 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 119.981 -1.699 . . . . 0.0 111.639 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -67.97 145.8 54.18 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -164.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -144.13 129.44 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.973 2.109 . . . . 0.0 108.679 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.69 165.55 12.69 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.672 1.589 . . . . 0.0 112.622 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.492 ' CG ' ' H13' ' A' ' 301' ' ' GSH . 13.0 t0 65.54 115.65 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 128.079 2.552 . . . . 22.16 114.269 -176.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.2 p -61.75 -25.57 67.54 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.325 1.602 . . . . 21.16 115.325 -165.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.513 ' CG ' HH12 ' A' ' 25' ' ' ARG . 31.8 m-20 -71.93 -35.77 69.75 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.876 1.216 . . . . 24.969999999999999 113.415 170.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.5 t -72.57 -39.01 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 121.432 -0.792 . . . . 23.850000000000001 111.114 172.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.18 -48.66 87.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.332 1.053 . . . . 23.68 110.914 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.43 -37.38 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.176 0.991 . . . . 22.84 111.467 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.92 -13.16 51.57 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.525 1.059 . . . . 23.329999999999998 115.585 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.6 mt -102.39 -48.46 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 118.925 1.362 . . . . 23.309999999999999 111.275 167.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.9 mt -62.52 -27.45 69.16 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.305 1.224 . . . . 23.48 114.305 -171.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -91.4 -0.3 57.62 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.785 1.032 . . . . 24.239999999999998 113.785 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -129.13 -25.51 2.73 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.544 1.138 . . . . 39.259999999999998 113.545 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -126.68 73.6 1.41 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.946 1.698 . . . . 24.449999999999999 111.923 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -141.32 165.33 29.59 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 126.112 1.765 . . . . 0.0 109.806 169.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.09 -26.45 18.14 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.333 2.022 . . . . 0.0 113.7 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.5 pm0 -75.46 160.89 78.57 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.458 1.103 . . . . 0.0 112.716 168.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.84 145.09 99.52 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.524 2.149 . . . . 0.0 113.915 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.78 145.19 62.07 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.162 2.575 . . . . 0.0 113.844 -174.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.1 mt -108.87 6.75 25.68 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.211 1.804 . . . . 0.0 112.926 169.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.4 50.57 0.17 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.85 2.06 . . . . 0.0 113.536 173.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 74.7 p -120.16 75.29 22.48 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 125.039 1.336 . . . . 0.0 110.214 170.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.09 117.93 5.27 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.346 2.031 . . . . 0.0 109.913 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.28 -173.26 1.71 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.661 2.907 . . . . 0.0 111.935 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.1 mp0 -51.13 -32.14 21.8 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.393 2.277 . . . . 0.0 113.632 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -54.79 -25.81 30.59 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.314 1.446 . . . . 0.0 114.109 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -29.35 70.58 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.742 -1.224 . . . . 0.0 113.363 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.1 p -67.99 -17.85 64.55 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.8 t -108.91 -41.57 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.581 1.552 . . . . 0.0 110.731 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.63 -30.76 77.68 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.844 1.211 . . . . 0.0 114.124 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.8 p -67.29 -19.0 65.43 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 171.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -87.51 -38.6 15.89 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.077 1.351 . . . . 0.0 112.168 169.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 69.1 mt -68.05 -37.13 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.558 1.143 . . . . 0.0 110.877 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -56.69 -45.79 99.9 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.535 1.534 . . . . 0.0 115.058 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -81.62 -32.78 0.78 Allowed 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 123.148 2.565 . . . . 0.0 113.69 170.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 56.9 p -73.18 -24.99 60.61 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 120.523 1.511 . . . . 0.0 114.127 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -58.83 -42.14 88.56 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.858 -1.151 . . . . 0.0 112.204 160.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.6 t -72.6 -31.53 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.467 -0.77 . . . . 0.0 111.862 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.446 ' HZ1' ' CG ' ' A' ' 114' ' ' ASP . 62.3 tttt -62.86 -47.24 84.24 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.004 0.82 . . . . 0.0 111.348 169.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -64.65 -39.82 94.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.157 0.983 . . . . 0.0 112.313 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 50.8 mt -68.42 -0.35 4.84 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.228 1.411 . . . . 0.0 114.736 168.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -142.56 36.58 1.47 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.116 1.766 . . . . 0.0 112.266 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.06 62.3 0.3 Allowed 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -166.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 90.8 mttt -63.75 -33.84 76.55 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.557 1.543 . . . . 0.0 110.957 158.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.446 ' CG ' ' HZ1' ' A' ' 108' ' ' LYS . 14.3 t0 -86.55 117.32 68.49 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 125.67 1.588 . . . . 0.0 107.941 158.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -51.95 149.65 20.06 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.421 2.747 . . . . 0.0 117.316 -159.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.429 ' ND2' ' HZ2' ' A' ' 168' ' ' LYS . 10.4 p-10 -70.39 -45.77 65.34 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.824 -172.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -68.3 -26.11 65.48 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.027 -1.671 . . . . 0.0 114.333 -172.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.62 -33.54 42.51 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 120.643 -1.285 . . . . 0.0 113.338 169.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 89.6 m -70.4 -35.37 73.42 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.422 1.089 . . . . 0.0 112.355 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -64.07 -39.85 94.99 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.546 1.539 . . . . 0.0 112.438 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -64.06 -46.7 83.2 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.517 0.599 . . . . 0.0 112.102 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.87 -36.25 83.3 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.4 tp -68.34 -42.34 79.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.25 1.02 . . . . 0.0 112.331 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 41.9 mt -66.66 -37.66 85.26 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.798 0.839 . . . . 0.0 113.253 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.506 ' CD ' ' HZ3' ' A' ' 128' ' ' LYS . 34.8 mm-40 -69.99 -36.32 75.08 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.762 1.165 . . . . 0.0 112.786 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -72.79 -33.96 66.61 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 120.799 -1.188 . . . . 0.0 112.51 170.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.2 mt -63.43 -35.14 79.44 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.2 -1.563 . . . . 0.0 112.512 169.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.506 ' HZ3' ' CD ' ' A' ' 125' ' ' GLU . 81.5 mttt -65.88 -40.38 91.53 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.31 1.414 . . . . 0.0 111.917 171.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.14 -35.92 82.36 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 118.435 0.562 . . . . 0.0 112.314 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.2 tp -69.57 -56.92 5.98 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.373 1.069 . . . . 0.0 111.468 170.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -66.41 -35.47 80.39 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.191 1.396 . . . . 0.0 114.028 -171.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.83 -34.81 79.53 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.207 0.908 . . . . 0.0 113.513 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -89.34 -30.47 18.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.446 0.699 . . . . 0.0 112.874 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.46 -33.77 76.29 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.807 -1.183 . . . . 0.0 113.449 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -64.88 -8.0 13.66 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 172.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.0 t -99.58 -35.16 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.915 1.286 . . . . 0.0 112.221 168.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -86.46 -28.41 23.5 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -173.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.63 -157.54 32.85 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 118.198 -1.335 . . . . 0.0 113.653 -173.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.8 -9.94 19.8 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.371 3.38 . . . . 0.0 117.473 -119.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -110.98 161.39 15.91 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 119.643 1.11 . . . . 0.0 111.323 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.08 -10.79 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 O-C-N 120.427 -1.421 . . . . 0.0 113.162 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.58 ' CB ' ' HG1' ' A' ' 147' ' ' THR . . . -99.19 -2.04 37.78 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 161.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 107.25 -110.43 3.23 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 119.976 1.262 . . . . 0.0 113.652 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -73.49 -26.3 60.84 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -167.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -142.03 167.05 23.04 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.352 1.861 . . . . 0.0 111.163 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 26.2 mt -65.42 130.19 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.161 0.584 . . . . 0.0 109.997 163.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.58 ' HG1' ' CB ' ' A' ' 142' ' ' ALA . 11.8 p -135.07 -171.59 2.84 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.178 0.991 . . . . 0.0 110.866 166.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.96 -19.59 2.74 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.0 t -73.71 -43.35 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.877 1.217 . . . . 0.0 112.309 173.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.4 -46.02 91.91 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.994 -1.066 . . . . 0.0 112.113 168.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.3 mt -62.44 -17.9 60.45 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.334 0.654 . . . . 0.0 112.421 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 51.4 m -86.61 -50.92 6.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.931 0.892 . . . . 0.0 112.335 171.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.9 mt -90.54 -33.6 15.86 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -167.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.88 -49.6 92.82 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.86 -21.87 24.17 Favored 'Trans proline' 0 C--N 1.351 0.669 0 CA-C-N 121.144 1.444 . . . . 0.0 113.14 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -77.18 -28.66 54.09 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 117.584 -1.198 . . . . 0.0 112.549 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 53.7 mt -70.17 -39.22 75.42 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.758 0.823 . . . . 0.0 112.899 165.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -60.23 -46.75 88.69 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.885 0.766 . . . . 0.0 111.732 171.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -64.78 -23.71 67.33 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.951 0.9 . . . . 0.0 113.353 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 12.1 tp -80.05 -45.09 18.93 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.997 -1.064 . . . . 0.0 112.659 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.53 -37.25 86.9 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.177 0.899 . . . . 0.0 111.596 173.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.2 t -80.71 -63.92 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.51 -50.88 8.34 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.408 -0.808 . . . . 0.0 112.136 -162.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.35 -35.44 77.43 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.671 0.388 . . . . 0.0 111.382 174.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.16 -25.28 46.76 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.063 1.316 . . . . 0.0 115.7 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -65.34 -25.81 67.76 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -126.93 -18.87 4.56 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.429 ' HZ2' ' ND2' ' A' ' 116' ' ' ASN . 21.8 tptt -147.76 80.55 1.49 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.895 2.078 . . . . 0.0 107.595 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -64.19 89.27 0.06 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.885 0.874 . . . . 0.0 110.669 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 33.3 t90 -88.29 117.37 68.31 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.073 0.949 . . . . 0.0 112.208 -162.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -73.58 112.53 3.55 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.199 1.933 . . . . 0.0 110.649 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 97.5 mt -71.77 108.34 3.92 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 159.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -68.55 161.01 46.92 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.415 1.41 . . . . 0.0 112.453 -166.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.32 -28.11 66.5 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.716 1.606 . . . . 0.0 114.063 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -68.16 -22.59 64.84 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.219 1.408 . . . . 0.0 114.086 173.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 71.0 mt -84.67 52.11 2.3 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.483 1.513 . . . . 0.0 110.36 165.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.0 m -63.27 -30.11 71.31 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.472 1.109 . . . . 0.0 112.601 -160.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 66.8 t-80 -77.24 -48.3 17.89 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.542 0.61 . . . . 0.0 111.534 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 66.0 t -60.36 -40.08 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 118.683 0.674 . . . . 0.0 111.618 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.0 tp -64.03 -43.24 96.16 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.338 1.055 . . . . 0.0 113.108 176.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -70.82 -32.99 70.22 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.372 -0.83 . . . . 0.0 112.838 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -63.31 -27.4 69.3 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.333 1.053 . . . . 0.0 112.843 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 29.2 mm -56.11 -34.82 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 120.868 -1.145 . . . . 0.0 111.935 169.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -90.91 -6.3 54.33 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.925 -1.109 . . . . 0.0 113.617 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 74.3 mt -73.43 -22.87 60.1 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 117.617 -1.182 . . . . 0.0 113.461 157.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 66.3 mt -62.57 -23.89 67.25 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.723 1.147 . . . . 0.0 113.283 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -96.11 9.01 42.27 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.514 1.126 . . . . 0.0 113.267 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.9 p -121.22 177.26 5.23 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.705 2.002 . . . . 0.0 113.417 -168.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.5 mtp85 54.88 -169.15 0.07 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.218 1.407 . . . . 0.0 110.276 -166.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.13 -34.22 37.94 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.05 -1.031 . . . . 0.0 110.17 159.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 77.6 p -72.45 -56.32 5.6 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.363 1.465 . . . . 0.0 114.115 -161.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -68.52 -44.56 74.38 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.984 0.811 . . . . 0.0 112.044 171.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -54.69 -34.23 62.03 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.69 1.196 . . . . 0.0 113.88 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -79.68 -14.85 58.47 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.5 p -79.88 -2.6 44.33 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.621 1.555 . . . . 0.0 113.93 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -68.91 75.93 0.31 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.235 1.814 . . . . 0.0 112.358 -173.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -59.34 132.19 53.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.263 0.625 . . . . 0.0 109.523 163.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.67 130.73 47.96 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.094 0.558 . . . . 0.0 112.024 -165.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -59.63 -39.72 85.26 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -160.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -62.31 -38.69 90.37 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.083 -1.01 . . . . 0.0 112.277 174.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -84.66 -5.93 59.34 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.308 1.443 . . . . 0.0 113.343 177.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 75.4 t -82.61 -46.8 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.982 0.913 . . . . 0.0 110.215 161.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.5 mt -61.89 -51.37 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.572 1.149 . . . . 0.0 111.845 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.73 -15.16 63.1 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.216 1.006 . . . . 0.0 113.693 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.47 -37.5 14.29 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 120.899 -1.125 . . . . 0.0 112.895 169.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 17.5 t90 -77.1 -35.49 56.4 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.186 1.794 . . . . 0.0 114.015 -174.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -49.56 -52.42 50.39 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.89 -24.5 39.9 Favored 'Trans proline' 0 C--N 1.353 0.799 0 CA-C-N 121.452 1.554 . . . . 0.0 113.461 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -78.29 -7.21 56.95 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 117.193 -1.384 . . . . 0.0 114.316 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.409 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 58.3 t -63.0 -30.83 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 120.037 1.29 . . . . 0.0 110.315 159.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -94.9 -34.66 12.34 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 115.745 1.758 . . . . 0.0 115.745 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 CA-C-O 117.604 -1.189 . . . . 0.0 113.163 172.516 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' GSH . . . . . 0.492 ' H13' ' CG ' ' A' ' 72' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.563 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 81.4 mtp . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.647 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.57 178.4 0.16 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.116 1.766 . . . . 0.0 114.609 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 61.9 mt -101.59 142.15 33.39 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.807 1.243 . . . . 0.0 113.26 -170.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -129.04 145.89 51.15 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.617 1.567 . . . . 0.0 109.02 157.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.5 pt -130.65 136.84 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.604 1.162 . . . . 0.0 109.647 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.7 m -111.73 119.27 38.07 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.777 1.231 . . . . 0.0 109.085 173.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.3 m -134.87 162.9 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.255 1.422 . . . . 0.0 111.229 -166.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -61.5 120.99 11.6 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.374 -0.829 . . . . 0.0 112.108 -175.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.34 149.61 31.68 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.049 0.54 . . . . 0.0 111.603 159.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.63 134.28 52.94 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.014 0.911 . . . . 0.0 112.111 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.7 t -67.36 126.27 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 173.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.54 -14.62 22.97 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-O 118.587 -1.118 . . . . 0.0 115.605 -172.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.88 61.65 29.85 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 119.161 1.48 . . . . 0.0 112.13 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.47 -6.89 14.53 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.966 2.444 . . . . 0.0 115.795 -167.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -80.9 -1.21 42.51 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.9 pt -131.83 164.97 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.731 1.212 . . . . 0.0 112.114 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.94 143.69 57.46 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.239 1.016 . . . . 0.0 111.409 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.9 -173.48 13.48 Favored Glycine 0 N--CA 1.471 0.991 0 C-N-CA 125.176 1.37 . . . . 0.0 113.905 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -60.55 106.5 0.56 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.6 t -165.07 97.86 0.84 Allowed Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.776 157.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -62.92 -21.09 72.93 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.244 1.963 . . . . 0.0 113.041 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -66.68 -29.66 69.72 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 120.655 -1.278 . . . . 0.0 113.59 171.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 98.8 m -71.47 -37.76 71.31 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.578 -1.326 . . . . 0.0 112.179 171.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.0 -24.29 67.85 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 117.95 -1.024 . . . . 0.0 112.875 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.473 HH12 ' CG ' ' A' ' 74' ' ' ASP . 53.5 mtp180 -57.78 -46.97 83.84 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.46 1.027 . . . . 0.0 112.389 170.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.5 t -74.67 -40.6 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.042 1.337 . . . . 0.0 111.31 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.4 mt -61.38 -42.73 99.19 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.251 0.621 . . . . 0.0 111.545 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.1 tp -61.68 -49.12 77.77 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.076 0.95 . . . . 0.0 112.083 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.75 -43.2 69.31 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -174.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.66 -38.92 84.43 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.571 -0.706 . . . . 0.0 112.46 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -80.17 -20.09 45.63 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -69.79 -48.93 57.35 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.798 -1.189 . . . . 0.0 110.641 166.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -70.26 -9.61 56.47 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.46 1.904 . . . . 0.0 114.23 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm 61.85 18.92 10.2 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.48 1.912 . . . . 0.0 115.01 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -75.25 131.59 77.87 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 123.941 0.896 . . . . 0.0 109.613 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -74.66 143.71 30.65 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.662 2.242 . . . . 0.0 112.496 174.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -146.11 151.52 37.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.849 1.66 . . . . 0.0 110.072 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -78.66 130.59 36.04 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.318 -0.863 . . . . 0.0 109.196 163.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 t -111.92 108.64 18.07 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.535 0.734 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -100.79 112.46 24.87 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.728 1.211 . . . . 0.0 109.966 -177.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.13 112.13 13.47 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.156 0.982 . . . . 0.0 110.263 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.4 mm -102.29 116.04 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.321 1.048 . . . . 0.0 110.4 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -77.15 57.7 1.46 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.163 1.385 . . . . 32.609999999999999 111.977 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.14 4.59 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 120.083 3.364 . . . . 40.049999999999997 120.083 -154.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -69.3 -46.46 56.92 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 120.905 1.684 . . . . 41.469999999999999 110.871 156.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -93.03 63.02 3.67 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.214 2.606 . . . . 47.170000000000002 110.629 168.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 pttm -79.78 119.01 75.38 Favored Pre-proline 0 N--CA 1.476 0.827 0 O-C-N 119.921 -1.737 . . . . 41.270000000000003 111.386 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -64.13 155.7 63.4 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.699 2.266 . . . . 40.289999999999999 114.182 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tp60 -62.27 -39.48 93.05 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.672 0.99 . . . . 42.390000000000001 113.672 174.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -64.73 -23.95 67.41 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.069 0.766 . . . . 37.079999999999998 113.069 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -83.27 -32.13 26.57 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.655 0.782 . . . . 35.880000000000003 112.536 172.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.2 mt -67.26 -26.47 66.58 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.159 0.89 . . . . 33.609999999999999 112.672 170.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -71.63 -8.11 52.03 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.883 1.273 . . . . 33.789999999999999 113.858 168.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.7 mt -106.46 -44.65 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.597 1.559 . . . . 33.159999999999997 110.603 171.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.6 t -112.25 98.79 44.35 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 125.792 1.637 . . . . 33.579999999999998 110.956 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.49 -18.18 43.53 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.364 2.043 . . . . 37.899999999999999 113.408 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -83.75 -8.71 59.19 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.727 1.01 . . . . 38.990000000000002 113.727 170.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.93 8.57 49.54 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 120.87 -1.144 . . . . 35.469999999999999 115.067 -169.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -84.71 157.8 20.97 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.267 1.427 . . . . 34.490000000000002 112.491 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.2 m -113.58 156.22 43.78 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 126.383 1.873 . . . . 23.530000000000001 110.592 160.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -66.12 156.81 80.17 Favored 'Cis proline' 0 C--N 1.348 0.501 0 CA-C-O 122.015 0.756 . . . . 22.879999999999999 112.403 -10.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.4 p -141.05 147.26 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 159.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.11 163.71 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 121.43 -0.794 . . . . 0.0 110.611 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 mtpt -121.27 92.1 3.67 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.181 1.393 . . . . 0.0 109.054 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.3 mt -82.09 119.67 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.688 0.795 . . . . 0.0 108.907 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.563 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 0.9 OUTLIER 52.75 38.82 27.41 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 122.284 1.04 . . . . 0.0 112.675 -165.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.3 t70 66.11 12.7 8.68 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.063 2.145 . . . . 0.0 116.476 -172.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -110.84 127.8 55.55 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 119.8 -1.813 . . . . 0.0 111.651 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -66.69 144.66 56.23 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -167.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.7 t -143.25 128.35 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.625 1.97 . . . . 0.0 108.593 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -112.69 166.5 11.29 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.746 1.618 . . . . 0.0 112.24 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.0 t0 65.11 113.62 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.821 2.449 . . . . 22.16 114.067 -175.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.7 p -62.74 -21.65 65.97 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 115.274 1.583 . . . . 21.16 115.274 -166.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.473 ' CG ' HH12 ' A' ' 25' ' ' ARG . 30.0 m-20 -71.46 -38.17 71.31 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.843 1.201 . . . . 24.969999999999999 113.056 169.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -70.49 -40.07 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.16 -0.962 . . . . 23.850000000000001 110.842 172.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.58 -48.62 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.955 0.902 . . . . 23.68 111.15 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.74 -38.54 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.611 0.764 . . . . 22.84 111.547 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.37 -39.95 95.42 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.531 -0.594 . . . . 23.329999999999998 113.596 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.7 mt -76.87 -48.22 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 118.379 1.09 . . . . 23.309999999999999 111.638 174.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.7 mt -62.32 -33.32 74.46 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.747 1.158 . . . . 23.48 113.399 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -92.66 -3.18 55.33 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 115.229 1.566 . . . . 24.239999999999998 115.229 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.515 ' CD ' ' HZ2' ' A' ' 83' ' ' LYS . 6.5 tt0 -108.56 -35.43 6.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.913 1.285 . . . . 39.259999999999998 112.489 169.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.515 ' HZ2' ' CD ' ' A' ' 82' ' ' GLU . 63.7 mttp -125.47 70.98 1.19 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.513 1.525 . . . . 24.449999999999999 111.628 -167.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -136.99 167.59 20.4 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.641 1.976 . . . . 0.0 109.373 168.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.38 -33.44 38.16 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.677 1.585 . . . . 0.0 112.336 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -75.15 151.99 86.09 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.282 1.033 . . . . 0.0 111.976 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.2 144.62 29.11 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.543 2.829 . . . . 0.0 115.215 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.62 136.92 34.62 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.562 2.175 . . . . 0.0 112.249 -174.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.3 mt -108.55 8.18 27.09 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.934 1.294 . . . . 0.0 111.944 167.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.55 46.33 0.07 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.42 2.288 . . . . 0.0 112.696 163.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.1 p -123.9 67.52 42.16 Favored Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 125.452 1.501 . . . . 0.0 109.8 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.86 119.61 6.65 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.232 1.955 . . . . 0.0 109.951 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.97 -173.88 1.84 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.213 2.609 . . . . 0.0 111.775 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.3 mp0 -51.2 -33.89 29.47 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.65 2.38 . . . . 0.0 113.333 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -52.53 -28.87 22.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.913 1.685 . . . . 0.0 114.119 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.99 -28.97 70.17 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.931 -1.105 . . . . 0.0 113.513 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.6 p -67.53 -19.92 65.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.461 1.105 . . . . 0.0 113.568 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.6 t -102.0 -42.79 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.481 1.513 . . . . 0.0 110.68 175.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.27 -31.67 81.52 Favored Glycine 0 CA--C 1.532 1.102 0 O-C-N 120.842 -1.161 . . . . 0.0 114.594 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.2 p -66.24 -19.05 65.71 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -87.78 -39.26 15.04 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.934 1.294 . . . . 0.0 112.549 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.5 mt -66.37 -34.72 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.942 0.897 . . . . 0.0 110.906 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -56.13 -48.91 95.87 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 117.452 -1.261 . . . . 0.0 114.189 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.42 -31.56 2.66 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.926 2.417 . . . . 0.0 114.316 170.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 p -70.84 -27.8 64.12 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 121.279 1.854 . . . . 0.0 113.281 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -57.83 -47.8 81.61 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.107 -0.996 . . . . 0.0 112.084 161.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.73 -34.93 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 119.114 0.87 . . . . 0.0 111.918 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.426 ' HZ1' ' CG ' ' A' ' 114' ' ' ASP . 63.2 tttt -63.09 -45.21 93.17 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.677 0.671 . . . . 0.0 111.464 170.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -64.12 -39.02 93.13 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.765 0.826 . . . . 0.0 112.44 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.6 mt -69.86 -7.36 39.51 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.979 1.711 . . . . 0.0 115.124 170.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.464 ' HZ2' ' C ' ' A' ' 212' ' ' ALA . 77.2 mttt -139.88 41.17 1.98 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.287 1.835 . . . . 0.0 111.663 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.4 m -68.46 56.47 0.08 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.285 1.834 . . . . 0.0 115.738 -168.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -69.38 -35.69 76.06 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.88 1.272 . . . . 0.0 111.265 165.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.426 ' CG ' ' HZ1' ' A' ' 108' ' ' LYS . 22.0 t0 -81.87 114.82 53.25 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 153.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -54.71 154.19 21.56 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.192 2.594 . . . . 0.0 117.093 -154.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -69.34 -37.31 77.61 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 117.278 -1.344 . . . . 0.0 112.4 -172.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -67.3 -37.78 83.93 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 121.157 1.799 . . . . 0.0 113.825 -171.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.57 -31.54 60.63 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 120.645 -1.285 . . . . 0.0 112.905 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 91.7 m -69.77 -31.68 69.76 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.913 0.885 . . . . 0.0 112.62 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -70.31 -41.08 73.77 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 127.206 2.202 . . . . 0.0 111.953 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.29 -47.09 83.78 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.802 -0.561 . . . . 0.0 111.878 170.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.41 -31.27 72.38 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.6 tp -73.71 -45.36 52.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.669 1.188 . . . . 0.0 112.086 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 49.0 mt -64.67 -38.82 92.29 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.185 0.994 . . . . 0.0 113.126 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.511 ' CD ' ' HZ2' ' A' ' 128' ' ' LYS . 29.1 mm-40 -69.99 -37.58 75.76 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 120.113 1.324 . . . . 0.0 113.275 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.28 -30.97 62.34 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.588 -1.32 . . . . 0.0 112.433 170.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.3 mt -64.87 -32.68 74.49 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.235 -1.541 . . . . 0.0 112.958 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.511 ' HZ2' ' CD ' ' A' ' 125' ' ' GLU . 81.9 mttt -67.38 -40.68 85.7 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 120.298 1.408 . . . . 0.0 111.66 170.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.65 -32.76 73.87 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.97 0.508 . . . . 0.0 112.343 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.9 tp -71.56 -58.47 3.47 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.011 0.924 . . . . 0.0 111.538 169.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -67.28 -31.39 71.68 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -169.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.99 -31.87 69.47 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 119.248 -0.751 . . . . 0.0 113.401 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -91.6 -28.83 17.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.695 0.798 . . . . 0.0 113.033 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.11 -36.61 84.18 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.804 1.184 . . . . 0.0 112.456 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -67.67 -3.14 8.23 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 173.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.0 t -100.78 -38.38 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.876 1.27 . . . . 0.0 112.122 166.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -91.89 -22.93 19.8 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -171.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.9 -141.34 31.57 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 118.527 -1.152 . . . . 0.0 113.735 -175.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.7 -10.47 28.7 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 125.056 3.838 . . . . 0.0 117.728 -114.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -123.16 169.26 11.42 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.931 1.292 . . . . 0.0 111.791 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -72.68 -7.16 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.411 -1.431 . . . . 0.0 112.828 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.577 ' CB ' ' HG1' ' A' ' 147' ' ' THR . . . -109.58 16.9 21.87 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.075 1.75 . . . . 0.0 114.079 162.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.25 -109.53 3.39 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.534 1.064 . . . . 0.0 113.627 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -55.84 -39.77 71.9 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.462 1.505 . . . . 0.0 113.736 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -147.46 166.38 27.42 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.032 1.733 . . . . 0.0 110.638 -168.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 16.8 mt -61.92 135.34 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 120.89 0.376 . . . . 0.0 110.117 163.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.577 ' HG1' ' CB ' ' A' ' 142' ' ' ALA . 19.1 p -136.76 -170.86 2.78 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.311 1.044 . . . . 0.0 110.439 163.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.79 -19.66 4.62 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.5 t -69.97 -46.4 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 120.169 1.35 . . . . 0.0 111.836 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.6 -46.49 89.64 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.855 1.262 . . . . 0.0 112.312 172.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.6 mt -64.08 -8.87 13.33 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.781 0.832 . . . . 0.0 112.839 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.1 m -101.03 -47.6 4.71 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.668 1.187 . . . . 0.0 112.564 173.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 38.3 mt -90.78 -35.0 15.1 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -170.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.0 97.32 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -173.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.78 -20.55 17.31 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 120.741 1.301 . . . . 0.0 113.448 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -75.91 -31.16 59.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 117.411 -1.281 . . . . 0.0 112.322 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 77.0 mt -64.97 -40.29 94.77 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.054 0.843 . . . . 0.0 112.726 166.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -60.75 -46.36 90.74 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.416 0.627 . . . . 0.0 111.711 173.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -66.6 -22.97 66.12 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 125.123 1.369 . . . . 0.0 113.421 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.4 mt -72.31 -58.48 3.37 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.072 1.306 . . . . 0.0 113.097 165.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -61.73 -31.81 72.0 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 118.646 0.657 . . . . 0.0 111.509 -173.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.9 t -86.74 -64.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 124.548 1.139 . . . . 0.0 112.907 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.66 -55.65 4.51 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.715 -0.616 . . . . 0.0 112.197 -160.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.1 tp -61.98 -32.56 73.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.62 0.368 . . . . 0.0 111.642 170.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -55.46 -27.13 47.06 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.201 1.382 . . . . 0.0 115.793 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -65.98 -24.43 66.78 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -125.34 -19.43 5.07 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -144.87 82.58 1.68 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.507 1.923 . . . . 0.0 108.254 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -61.38 90.02 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.535 1.134 . . . . 0.0 110.482 171.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -92.81 116.77 67.04 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.696 0.799 . . . . 0.0 111.907 -163.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.4 117.33 5.03 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.701 1.6 . . . . 0.0 110.319 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.78 109.93 4.64 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 149.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -66.62 164.38 29.23 Favored 'Trans proline' 0 C--N 1.35 0.643 0 CA-C-N 120.74 1.3 . . . . 0.0 112.488 -165.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -25.94 63.92 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.807 1.643 . . . . 0.0 113.911 177.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -70.55 -24.51 62.8 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.998 1.719 . . . . 0.0 114.283 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.3 mt -86.98 50.47 2.02 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.833 1.653 . . . . 0.0 110.251 166.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.6 m -59.65 -36.67 76.86 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.954 1.302 . . . . 0.0 113.03 -156.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -81.75 -38.94 24.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.874 -0.584 . . . . 0.0 112.091 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.72 -39.36 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 121.622 -0.673 . . . . 0.0 111.785 172.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 46.5 tp -63.61 -45.7 89.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.989 0.916 . . . . 0.0 112.697 175.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -66.52 -32.07 73.2 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.315 -0.866 . . . . 0.0 112.639 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -63.65 -28.82 70.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.729 0.812 . . . . 0.0 112.89 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 18.7 mt -58.36 -35.54 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 120.65 -1.281 . . . . 0.0 111.234 171.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -84.6 -9.72 58.04 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.461 -1.399 . . . . 0.0 113.998 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.99 -22.01 62.23 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.107 -0.949 . . . . 0.0 113.178 160.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 56.4 mt -65.29 -18.81 65.61 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.628 1.104 . . . . 0.0 113.754 -177.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -98.56 6.93 46.73 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.833 1.253 . . . . 0.0 112.933 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.8 p -117.68 -179.44 3.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.322 1.849 . . . . 0.0 113.715 -165.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 53.97 -162.27 0.12 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.567 1.547 . . . . 0.0 110.8 -169.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -82.99 -38.12 23.08 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 124.118 0.967 . . . . 0.0 109.241 159.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 77.5 p -71.05 -60.51 2.19 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 126.093 1.757 . . . . 0.0 114.086 -161.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -63.82 -44.28 93.72 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.506 0.593 . . . . 0.0 112.175 173.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -55.41 -36.62 66.65 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.085 0.954 . . . . 0.0 113.334 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -76.75 -15.47 59.75 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.6 p -76.28 -11.74 59.96 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.513 1.506 . . . . 0.0 113.088 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -65.45 89.49 0.1 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.687 1.595 . . . . 0.0 112.609 -168.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.64 131.32 48.59 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.665 -0.683 . . . . 0.0 109.308 155.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.75 135.23 57.52 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.384 0.674 . . . . 0.0 111.78 -174.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -60.74 -37.6 82.33 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -157.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -38.2 87.14 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.935 -1.103 . . . . 0.0 113.149 172.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -76.81 -7.72 55.97 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 171.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.9 t -82.89 -49.56 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.774 0.83 . . . . 0.0 110.612 161.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.5 mt -59.92 -48.32 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.342 1.057 . . . . 0.0 111.5 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.25 -14.44 62.61 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.09 -33.67 9.42 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 120.917 -1.114 . . . . 0.0 113.364 170.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -78.95 -34.02 44.77 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.837 1.655 . . . . 0.0 113.885 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -51.34 -50.33 76.8 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.19 -24.92 27.17 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 121.637 1.558 . . . . 0.0 113.49 172.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -78.18 -10.39 59.62 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.147 1.379 . . . . 0.0 114.267 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.74 -31.03 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 119.249 0.931 . . . . 0.0 110.389 158.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -96.38 -20.12 18.7 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 177.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.464 ' C ' ' HZ2' ' A' ' 111' ' ' LYS . . . . . . . . 0 C--O 1.251 1.158 0 C-N-CA 125.707 1.603 . . . . 0.0 112.629 -176.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.569 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 86.4 mtp . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 117.203 -1.38 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.03 177.91 0.17 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.11 1.764 . . . . 0.0 115.469 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.5 mt -111.85 139.63 47.17 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.421 1.488 . . . . 0.0 111.999 -175.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.512 ' CD ' ' HZ2' ' A' ' 38' ' ' LYS . 26.6 mt-10 -139.78 134.88 32.42 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.984 1.313 . . . . 0.0 108.136 173.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.8 pt -127.57 142.34 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 120.999 -1.063 . . . . 0.0 110.5 -174.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.9 m -117.58 120.25 37.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.757 1.223 . . . . 0.0 109.689 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.27 163.03 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.998 1.319 . . . . 0.0 111.517 -165.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -59.54 116.2 3.83 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.609 -0.682 . . . . 0.0 110.865 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.06 149.78 33.89 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.935 154.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.05 146.88 49.02 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.203 1.002 . . . . 0.0 112.197 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 51.3 t -68.87 133.75 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 167.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.38 -33.9 1.56 Allowed Glycine 0 CA--C 1.537 1.453 0 CA-C-O 118.516 -1.158 . . . . 0.0 115.357 -174.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.13 69.03 9.75 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.824 1.25 . . . . 0.0 112.61 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -63.41 -11.84 27.74 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.271 2.647 . . . . 0.0 114.816 -173.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -81.4 0.65 36.51 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.063 1.745 . . . . 0.0 114.737 175.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 pt -133.96 164.76 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.795 1.238 . . . . 0.0 111.801 174.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.39 146.7 54.56 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.59 0.756 . . . . 0.0 111.454 169.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -124.2 -164.28 11.92 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 125.25 1.405 . . . . 0.0 112.494 166.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -60.89 108.67 0.89 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 118.22 1.01 . . . . 0.0 113.593 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.1 t -157.63 108.26 1.81 Allowed Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.119 139.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HG3' ' HD1' ' A' ' 159' ' ' HIS . 72.5 Cg_endo -65.54 -21.5 59.78 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.14 1.893 . . . . 0.0 112.39 176.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -68.5 -29.9 68.61 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.61 0.764 . . . . 0.0 112.297 173.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 73.1 m -72.26 -37.58 69.05 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.372 -1.455 . . . . 0.0 112.669 168.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.53 -25.13 67.09 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 118.112 -0.947 . . . . 0.0 113.141 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.493 HH11 ' CG ' ' A' ' 74' ' ' ASP . 32.8 mtp180 -58.61 -43.3 89.56 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.319 1.048 . . . . 0.0 112.407 169.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.2 t -76.98 -37.43 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.855 1.262 . . . . 0.0 111.302 -176.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.55 -45.26 91.33 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.138 0.575 . . . . 0.0 111.478 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.68 -50.91 69.28 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.827 1.251 . . . . 0.0 112.408 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 p -63.08 -50.5 70.31 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.6 -35.8 73.18 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.438 ' HG2' ' HH ' ' A' ' 37' ' ' TYR . 72.1 mm-40 -76.53 -23.18 53.64 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 171.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -68.86 -46.23 69.01 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.072 1.305 . . . . 0.0 110.983 170.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -70.35 -7.24 41.18 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.48 1.512 . . . . 0.0 114.92 169.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.9 mmtm 61.46 15.39 6.61 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 126.032 1.733 . . . . 0.0 114.863 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.7 mt -72.69 128.6 88.1 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 123.598 0.759 . . . . 0.0 109.306 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.44 138.12 32.03 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.183 1.922 . . . . 0.0 111.516 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.438 ' HH ' ' HG2' ' A' ' 31' ' ' GLU . 47.4 p90 -141.67 153.44 44.7 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.231 1.412 . . . . 0.0 110.556 173.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.512 ' HZ2' ' CD ' ' A' ' 4' ' ' GLU . 54.9 mttt -78.22 122.8 26.16 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.317 -0.864 . . . . 0.0 109.804 166.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.3 t -97.74 93.79 6.58 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.593 0.757 . . . . 0.0 111.559 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -82.83 105.68 14.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.903 0.881 . . . . 0.0 110.292 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.1 mt -73.24 113.95 10.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.944 0.898 . . . . 0.0 109.918 171.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.2 mm -108.97 115.8 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.739 1.216 . . . . 0.0 110.086 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -73.98 79.58 1.68 Allowed 'General case' 0 C--O 1.221 -0.411 0 O-C-N 121.4 -0.813 . . . . 32.609999999999999 109.756 166.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pp -65.05 0.7 1.17 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 117.601 2.445 . . . . 40.049999999999997 117.601 -165.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.51 -27.6 67.26 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-N 119.612 1.096 . . . . 41.469999999999999 112.871 161.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -120.45 53.91 1.08 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.934 2.894 . . . . 47.170000000000002 109.529 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -73.06 116.48 51.0 Favored Pre-proline 0 N--CA 1.472 0.667 0 O-C-N 119.757 -1.839 . . . . 41.270000000000003 110.317 -176.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.22 160.58 46.83 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.648 2.232 . . . . 40.289999999999999 112.144 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -61.46 -34.03 74.75 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.302 1.223 . . . . 42.390000000000001 114.302 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 30.5 p-90 -67.5 -21.37 65.5 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.691 -1.256 . . . . 37.079999999999998 114.097 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -82.74 -34.42 27.17 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.425 -0.797 . . . . 35.880000000000003 112.321 169.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.78 -24.97 65.38 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.551 0.74 . . . . 33.609999999999999 112.385 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -72.73 -1.45 16.47 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.794 1.637 . . . . 33.789999999999999 114.376 166.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.6 mt -115.73 -41.7 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.348 1.459 . . . . 33.159999999999997 110.314 173.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.1 t -114.43 100.4 52.9 Favored Pre-proline 0 N--CA 1.471 0.591 0 C-N-CA 125.808 1.643 . . . . 33.579999999999998 111.281 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.99 -20.55 44.53 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.941 2.428 . . . . 37.899999999999999 113.418 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.76 -0.08 57.52 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.396 1.079 . . . . 38.990000000000002 113.716 171.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.92 23.68 72.78 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.607 1.575 . . . . 35.469999999999999 115.866 176.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -104.15 158.63 16.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.889 1.675 . . . . 34.490000000000002 112.789 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.3 m -115.24 150.08 43.8 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.648 1.579 . . . . 23.530000000000001 111.151 164.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -68.46 153.62 89.27 Favored 'Cis proline' 0 C--N 1.349 0.562 0 CA-C-O 121.724 0.635 . . . . 22.879999999999999 112.629 -9.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.1 p -135.63 147.77 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 113.577 -1.647 . . . . 0.0 107.294 156.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.7 m -129.69 161.75 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.654 0.781 . . . . 0.0 110.474 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -116.03 98.93 6.91 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.428 1.491 . . . . 0.0 109.118 167.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 66.8 mt -87.49 114.85 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.415 1.086 . . . . 0.0 108.536 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.569 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 0.9 OUTLIER 56.58 36.84 28.23 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 121.866 0.841 . . . . 0.0 112.457 -169.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.251 11.2 t0 66.77 10.72 7.75 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 128.292 2.637 . . . . 0.0 116.316 -170.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -104.12 123.18 46.8 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 119.412 -2.055 . . . . 0.0 110.688 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -69.36 143.49 53.71 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -170.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.4 t -142.86 126.66 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 126.695 1.998 . . . . 0.0 108.585 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -110.38 164.95 12.18 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.62 1.568 . . . . 0.0 112.136 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.2 t0 67.57 113.45 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.342 2.257 . . . . 22.16 114.191 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.415 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 26.5 p -65.16 -22.14 66.88 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 115.356 1.613 . . . . 21.16 115.356 -158.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.493 ' CG ' HH11 ' A' ' 25' ' ' ARG . 33.8 m-20 -70.47 -35.68 73.43 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.899 1.227 . . . . 24.969999999999999 112.696 170.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.62 -41.71 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 121.092 -1.005 . . . . 23.850000000000001 110.745 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.0 mt -63.75 -46.5 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.841 0.856 . . . . 23.68 111.227 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.1 t -63.15 -40.54 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.021 0.928 . . . . 22.84 111.314 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.19 -47.26 89.06 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 118.462 0.574 . . . . 23.329999999999998 113.1 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 75.9 mt -73.43 -47.24 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 117.846 0.823 . . . . 23.309999999999999 112.165 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.56 -32.23 73.79 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.046 1.294 . . . . 23.48 112.748 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -89.57 -14.37 35.21 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 114.614 1.338 . . . . 24.239999999999998 114.614 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' CD ' ' HE3' ' A' ' 83' ' ' LYS . 68.8 tt0 -89.54 -33.57 16.69 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.283 1.433 . . . . 39.259999999999998 112.606 165.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.511 ' HE3' ' CD ' ' A' ' 82' ' ' GLU . 65.2 mttt -135.3 85.33 2.16 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.619 1.168 . . . . 24.449999999999999 112.09 -161.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -150.42 166.02 16.09 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.149 1.78 . . . . 0.0 109.191 168.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.76 -33.36 44.31 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 121.919 1.746 . . . . 0.0 112.103 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -73.95 149.31 87.56 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.231 1.012 . . . . 0.0 111.649 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -52.31 143.02 44.96 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.408 2.739 . . . . 0.0 115.02 -172.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.98 133.49 29.22 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.673 2.249 . . . . 0.0 111.934 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 34.1 mt -103.34 8.51 38.16 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.608 1.163 . . . . 0.0 111.83 168.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.49 49.17 0.11 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.281 1.832 . . . . 0.0 112.373 163.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.7 p -123.31 65.07 29.47 Favored Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 125.381 1.473 . . . . 0.0 109.885 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.76 119.83 6.85 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.181 1.921 . . . . 0.0 109.962 -173.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -73.89 -176.37 2.57 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.917 2.412 . . . . 0.0 111.532 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -53.93 -29.23 41.46 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.184 2.194 . . . . 0.0 113.5 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -52.72 -28.5 22.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.8 1.64 . . . . 0.0 114.045 170.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.64 -29.41 70.65 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.658 1.117 . . . . 0.0 113.358 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 59.7 p -66.9 -25.16 66.25 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.789 0.836 . . . . 0.0 113.097 174.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.0 t -94.87 -42.04 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.978 1.311 . . . . 0.0 110.814 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.47 -31.09 79.58 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.7 1.143 . . . . 0.0 114.421 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 72.3 p -66.35 -20.6 66.13 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.762 1.281 . . . . 0.0 114.211 171.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -92.2 -33.26 14.76 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.113 1.365 . . . . 0.0 112.827 172.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.8 mt -70.45 -37.09 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.986 0.914 . . . . 0.0 111.655 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.446 ' CE1' ' HE2' ' A' ' 156' ' ' LYS . 83.0 t80 -54.68 -45.85 99.47 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.032 1.333 . . . . 0.0 114.505 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.78 -32.52 1.09 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.016 2.478 . . . . 0.0 114.069 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.2 p -71.76 -26.62 62.52 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 121.34 1.882 . . . . 0.0 113.207 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -58.4 -45.89 87.47 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.695 -1.253 . . . . 0.0 112.413 160.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.46 -31.72 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 121.374 -0.828 . . . . 0.0 112.069 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.476 ' HZ3' ' CG ' ' A' ' 114' ' ' ASP . 56.0 tttt -64.67 -44.15 91.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.689 0.677 . . . . 0.0 111.365 168.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -67.79 -37.1 81.57 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.5 mt -64.21 -11.32 29.91 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.787 1.635 . . . . 0.0 114.435 167.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.45 ' HZ2' ' C ' ' A' ' 212' ' ' ALA . 78.4 mttt -142.31 41.03 1.62 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.641 1.976 . . . . 0.0 112.543 -173.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.1 m -68.6 59.73 0.09 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -165.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 94.4 mttt -71.28 -35.75 71.44 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.562 -1.336 . . . . 0.0 111.995 168.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.476 ' CG ' ' HZ3' ' A' ' 108' ' ' LYS . 15.4 t0 -81.01 112.78 35.4 Favored Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 152.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -57.24 158.68 17.62 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.977 2.451 . . . . 0.0 117.29 -148.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -56.91 -51.64 68.32 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.478 -174.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -79.67 -21.67 44.45 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -163.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.89 -36.08 29.5 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 121.355 -0.841 . . . . 0.0 112.772 165.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 62.3 m -66.81 -30.89 71.2 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.641 0.776 . . . . 0.0 112.799 171.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -65.24 -42.69 93.12 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 125.736 1.614 . . . . 0.0 111.841 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -65.62 -43.13 90.5 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.724 -0.61 . . . . 0.0 111.766 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.05 -25.68 68.22 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 174.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 49.8 tp -82.47 -42.63 18.24 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.848 1.259 . . . . 0.0 112.27 172.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 33.9 mt -67.23 -39.17 86.19 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.668 1.187 . . . . 0.0 113.241 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.49 ' CD ' ' HZ3' ' A' ' 128' ' ' LYS . 14.2 mm-40 -67.01 -34.97 78.89 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.046 1.293 . . . . 0.0 112.389 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -72.29 -38.55 68.73 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.027 -1.046 . . . . 0.0 112.765 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.1 mt -64.98 -33.14 75.32 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.585 -1.322 . . . . 0.0 113.03 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.49 ' HZ3' ' CD ' ' A' ' 125' ' ' GLU . 81.1 mttt -66.4 -41.38 89.39 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.673 1.124 . . . . 0.0 111.51 171.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.8 -35.82 81.85 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.965 0.506 . . . . 0.0 112.203 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.4 tp -68.67 -56.45 8.14 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.068 0.947 . . . . 0.0 111.677 171.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -67.43 -31.63 71.95 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.71 1.204 . . . . 0.0 114.157 -172.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.21 -31.63 73.96 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.154 -0.803 . . . . 0.0 113.543 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -87.45 -33.71 18.95 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 117.888 0.844 . . . . 0.0 112.804 170.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.77 -34.91 78.23 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.041 1.291 . . . . 0.0 113.259 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -68.5 0.93 3.47 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 172.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.8 t -111.07 -37.42 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.599 1.559 . . . . 0.0 112.108 166.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -90.55 -17.16 27.49 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -172.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.98 -143.66 32.5 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-O 118.725 -1.041 . . . . 0.0 114.586 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.35 -18.45 49.91 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 124.794 3.663 . . . . 0.0 117.772 -119.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -118.16 171.03 8.39 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.399 1.08 . . . . 0.0 111.552 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.88 -6.04 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 120.146 -1.597 . . . . 0.0 113.037 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.52 ' CB ' ' HG1' ' A' ' 147' ' ' THR . . . -108.82 15.15 23.78 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.258 1.823 . . . . 0.0 114.301 162.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.81 -108.14 3.03 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 120.564 -1.335 . . . . 0.0 113.242 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -51.72 -41.61 61.64 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.882 1.673 . . . . 0.0 113.887 -172.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -152.93 165.25 36.1 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.868 1.667 . . . . 0.0 110.233 -166.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.9 mt -64.75 132.39 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.195 0.598 . . . . 0.0 109.939 166.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.52 ' HG1' ' CB ' ' A' ' 142' ' ' ALA . 24.5 p -138.91 -170.72 2.92 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.843 1.257 . . . . 0.0 110.699 168.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.05 -17.49 3.98 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.1 t -71.03 -45.06 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 119.978 1.263 . . . . 0.0 111.795 172.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.88 -45.72 92.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.859 1.264 . . . . 0.0 111.905 172.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.66 -17.34 60.32 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.216 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.8 m -91.65 -48.05 7.04 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.861 1.21 . . . . 0.0 112.619 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.6 mt -94.49 -36.84 11.68 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -167.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.52 -47.86 97.7 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.22 -21.14 20.54 Favored 'Trans proline' 0 C--N 1.351 0.682 0 CA-C-N 120.808 1.324 . . . . 0.0 113.426 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.446 ' HE2' ' CE1' ' A' ' 103' ' ' PHE . 67.5 mttm -81.0 -27.81 35.74 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.907 -1.121 . . . . 0.0 112.89 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.8 mt -64.83 -43.33 93.42 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.364 0.665 . . . . 0.0 112.204 164.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -59.7 -44.68 93.59 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.225 0.466 . . . . 0.0 111.877 172.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.407 ' HD1' ' HG3' ' A' ' 21' ' ' PRO . 10.5 t-160 -63.9 -31.37 72.53 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 71.6 mt -74.01 -49.01 26.28 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 118.004 -0.998 . . . . 0.0 113.488 171.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -61.4 -31.1 71.01 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.219 0.918 . . . . 0.0 112.203 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 95.6 t -88.95 -66.97 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.812 1.245 . . . . 0.0 113.27 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.59 -48.78 8.04 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -160.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 30.8 tp -62.83 -33.39 75.13 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.614 166.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -55.05 -28.65 49.69 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.937 1.256 . . . . 0.0 115.713 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -66.17 -22.23 66.36 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -128.04 -22.2 3.52 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -142.79 86.1 1.92 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.378 1.871 . . . . 0.0 108.486 167.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -61.58 86.03 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.178 1.391 . . . . 0.0 110.947 171.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -88.64 121.5 69.97 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.789 -163.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.71 109.93 2.77 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.579 1.519 . . . . 0.0 110.147 170.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.3 mm -59.36 108.34 1.33 Allowed Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 142.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -68.35 164.93 30.62 Favored 'Trans proline' 0 C--N 1.35 0.642 0 CA-C-N 120.553 1.233 . . . . 0.0 112.638 -165.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.52 -24.79 63.95 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.269 1.427 . . . . 0.0 113.27 171.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -66.39 -26.86 67.45 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.834 1.253 . . . . 0.0 113.775 171.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 67.6 mt -87.25 49.68 1.86 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.715 1.606 . . . . 0.0 111.065 169.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.23 -33.47 74.66 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.282 1.033 . . . . 0.0 113.343 -155.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -81.63 -37.66 27.2 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.785 0.721 . . . . 0.0 112.115 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.67 -39.57 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 121.587 -0.696 . . . . 0.0 111.613 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 43.0 tp -65.67 -40.24 92.16 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -68.48 -38.52 81.1 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.546 -0.721 . . . . 0.0 112.323 171.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -63.78 -29.38 70.59 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.252 1.021 . . . . 0.0 113.292 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 78.1 mt -59.07 -32.05 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 120.548 -1.345 . . . . 0.0 111.856 170.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -84.45 -10.68 57.29 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.473 -1.392 . . . . 0.0 113.607 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.94 -17.65 61.46 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.581 161.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.43 -14.26 61.93 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.671 1.123 . . . . 0.0 113.244 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -103.89 5.61 35.85 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.902 1.281 . . . . 0.0 113.316 174.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.6 p -111.33 -179.05 3.61 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.11 2.164 . . . . 0.0 113.964 -167.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 54.12 -159.72 0.16 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.489 1.516 . . . . 0.0 110.628 -172.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -85.8 -41.01 15.42 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.781 1.232 . . . . 0.0 109.139 160.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 78.4 p -68.55 -60.42 2.43 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 126.293 1.837 . . . . 0.0 114.436 -162.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -62.25 -45.37 93.61 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.518 0.599 . . . . 0.0 112.085 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -56.86 -35.48 68.93 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.304 1.042 . . . . 0.0 113.457 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -76.9 -13.45 59.99 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 176.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.6 p -77.83 -10.77 59.73 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.402 1.455 . . . . 0.0 113.384 171.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -67.24 83.31 0.14 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.683 1.593 . . . . 0.0 112.852 -170.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.26 131.02 49.03 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.298 1.039 . . . . 0.0 109.919 161.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.27 129.96 44.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.317 0.647 . . . . 0.0 111.346 -171.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 31.0 mp0 -59.08 -39.14 81.21 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -157.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -60.39 -36.95 79.29 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.872 1.269 . . . . 0.0 112.687 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -85.12 -6.69 59.29 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.568 1.547 . . . . 0.0 113.092 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 39.6 t -86.79 -44.5 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.215 162.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.1 mt -58.18 -51.2 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.696 1.199 . . . . 0.0 111.347 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.76 -15.0 62.64 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -83.78 -33.25 22.11 Favored Glycine 0 CA--C 1.533 1.216 0 O-C-N 120.874 -1.141 . . . . 0.0 113.175 169.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 44.9 t90 -84.93 -35.26 22.21 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.121 2.169 . . . . 0.0 114.675 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -53.42 -47.35 96.56 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.9 -24.27 29.2 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.498 1.466 . . . . 0.0 113.656 172.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -75.48 -11.68 60.08 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 117.672 -1.156 . . . . 0.0 114.014 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.414 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 48.1 t -59.39 -21.95 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.264 0.938 . . . . 0.0 110.934 160.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -106.73 -10.12 16.22 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 172.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.45 ' C ' ' HZ2' ' A' ' 111' ' ' LYS . . . . . . . . 0 C--O 1.248 0.986 0 C-N-CA 126.674 1.99 . . . . 0.0 112.386 -173.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' GSH . . . . . 0.415 ' C1 ' ' H ' ' A' ' 73' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.532 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 97.2 mtp . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.45 -178.63 0.13 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.801 1.64 . . . . 0.0 114.088 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 49.0 mt -103.45 143.6 32.49 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.446 1.117 . . . . 0.0 113.107 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -151.65 128.38 10.87 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.533 1.933 . . . . 0.0 108.382 172.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 pt -126.43 140.77 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.898 0.879 . . . . 0.0 109.92 -170.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.4 m -106.44 122.71 46.82 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.513 0.725 . . . . 0.0 109.335 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.39 164.0 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.597 1.559 . . . . 0.0 110.924 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -62.01 119.01 8.04 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.536 -0.727 . . . . 0.0 111.316 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.53 153.69 27.96 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.339 153.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.37 143.6 57.78 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.091 0.948 . . . . 0.0 112.18 170.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.6 t -70.51 136.65 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 168.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.78 -35.0 1.41 Allowed Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.814 -0.992 . . . . 0.0 114.775 -172.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.61 69.03 6.07 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 125.177 1.391 . . . . 0.0 112.478 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.37 -11.44 28.24 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.527 2.818 . . . . 0.0 115.413 -172.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -92.5 9.07 36.0 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.5 pt -130.32 163.09 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.593 1.157 . . . . 0.0 111.264 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.4 mt -62.68 146.02 53.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.299 0.64 . . . . 0.0 111.109 166.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.86 -169.16 12.47 Favored Glycine 0 N--CA 1.474 1.201 0 C-N-CA 125.233 1.397 . . . . 0.0 112.605 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -59.61 108.2 0.7 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.8 t -157.91 103.08 1.76 Allowed Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.637 1.175 . . . . 0.0 109.163 144.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -63.71 -18.95 66.29 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.249 2.633 . . . . 0.0 112.572 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -71.07 -30.6 66.78 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.4 -0.813 . . . . 0.0 112.602 172.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.3 m -70.35 -38.97 74.93 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.598 -1.314 . . . . 0.0 112.415 168.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -60.33 -26.89 66.91 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 118.143 -0.932 . . . . 0.0 113.155 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.504 HH12 ' CG ' ' A' ' 74' ' ' ASP . 46.6 mtp180 -57.89 -45.39 86.49 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.122 0.969 . . . . 0.0 112.52 171.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.54 -39.51 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.089 1.356 . . . . 0.0 111.322 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.82 -41.36 91.13 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.213 0.605 . . . . 0.0 111.258 172.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.4 tp -63.17 -54.5 36.6 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.06 1.344 . . . . 0.0 112.447 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.0 p -69.82 -38.31 76.52 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.462 1.028 . . . . 0.0 113.467 -171.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.6 mt -71.36 -38.96 71.54 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.412 ' HG2' ' HH ' ' A' ' 37' ' ' TYR . 65.7 mm-40 -75.62 -22.57 56.75 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 171.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -69.36 -47.01 65.61 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 120.536 -1.353 . . . . 0.0 111.145 170.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -69.74 -6.52 32.47 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.76 1.624 . . . . 0.0 114.652 169.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm 59.81 16.54 5.7 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.723 1.609 . . . . 0.0 114.804 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.9 mt -71.39 125.9 91.81 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.13 136.46 24.63 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.119 1.879 . . . . 0.0 111.4 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.412 ' HH ' ' HG2' ' A' ' 31' ' ' GLU . 37.8 p90 -136.17 151.08 49.37 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.664 1.585 . . . . 0.0 110.573 175.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -73.76 139.15 45.03 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.45 -0.781 . . . . 0.0 109.035 161.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.3 t -125.2 93.24 3.82 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.733 0.813 . . . . 0.0 111.162 -175.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -74.85 113.42 12.12 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.835 0.854 . . . . 0.0 110.464 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.8 mt -72.95 101.29 3.16 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.504 1.122 . . . . 0.0 110.02 164.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mm -97.1 111.29 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.629 0.771 . . . . 0.0 109.892 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -78.06 70.07 4.37 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.252 -0.905 . . . . 32.609999999999999 110.552 168.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.01 8.33 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 117.758 2.503 . . . . 40.049999999999997 117.758 -166.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.94 -44.46 91.67 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-N 119.825 1.193 . . . . 41.469999999999999 111.26 155.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -102.74 72.47 1.22 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.583 1.953 . . . . 47.170000000000002 110.068 166.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -81.24 110.96 20.62 Favored Pre-proline 0 N--CA 1.475 0.778 0 O-C-N 120.234 -1.541 . . . . 41.270000000000003 110.872 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.21 158.15 45.43 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.868 2.379 . . . . 40.289999999999999 112.481 -174.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -59.12 -34.5 72.11 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.419 1.266 . . . . 42.390000000000001 114.419 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -64.83 -32.15 73.72 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.188 0.904 . . . . 37.079999999999998 113.287 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -75.35 -34.53 61.17 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.689 -1.257 . . . . 35.880000000000003 112.782 170.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.89 -28.89 67.1 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.401 1.0 . . . . 33.609999999999999 113.285 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -68.61 -30.47 69.22 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.907 1.683 . . . . 33.789999999999999 112.537 170.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.7 mt -85.04 -33.15 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.96 1.304 . . . . 33.159999999999997 111.623 173.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.1 t -131.62 94.7 25.1 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 126.027 1.731 . . . . 33.579999999999998 110.586 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.86 -15.87 40.8 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.611 2.207 . . . . 37.899999999999999 113.842 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -81.87 -8.09 59.66 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.546 0.943 . . . . 38.990000000000002 113.546 168.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.28 13.42 64.92 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 120.933 -1.104 . . . . 35.469999999999999 114.789 -173.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -91.72 150.94 20.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.176 1.39 . . . . 34.490000000000002 112.763 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.7 m -110.96 153.94 43.6 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 126.176 1.79 . . . . 23.530000000000001 110.74 159.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -66.68 156.68 82.36 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-O 121.975 0.74 . . . . 22.879999999999999 112.925 -8.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 p -144.99 142.27 22.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.164 -1.38 . . . . 0.0 107.872 162.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 m -129.58 146.83 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.513 0.725 . . . . 0.0 110.67 -171.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -105.74 78.72 1.37 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.433 1.493 . . . . 0.0 109.724 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 34.4 mt -71.8 114.5 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.902 0.881 . . . . 0.0 109.564 -176.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.532 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 1.1 t70 52.47 39.36 27.61 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.96 0.885 . . . . 0.0 112.429 -165.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.8 t0 69.9 7.74 6.37 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 128.075 2.55 . . . . 0.0 116.622 -173.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -103.49 127.06 50.96 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 119.768 -1.833 . . . . 0.0 111.512 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.0 p-90 -70.18 142.48 52.46 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -170.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -143.04 128.4 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 127.722 2.409 . . . . 0.0 108.286 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.74 168.37 9.62 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.606 1.562 . . . . 0.0 112.131 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.9 t0 66.55 113.19 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.66 2.384 . . . . 22.16 114.346 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.3 p -63.11 -24.3 67.84 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 115.215 1.561 . . . . 21.16 115.215 -161.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.504 ' CG ' HH12 ' A' ' 25' ' ' ARG . 37.2 m-20 -73.18 -35.46 66.4 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.179 1.354 . . . . 24.969999999999999 113.307 170.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.62 -38.51 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 121.09 -1.006 . . . . 23.850000000000001 110.856 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.88 -45.94 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.314 1.046 . . . . 23.68 111.233 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.1 t -61.81 -41.4 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.26 1.024 . . . . 22.84 111.299 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.55 -20.26 55.61 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.782 -1.01 . . . . 23.329999999999998 114.932 175.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 98.5 mt -106.5 -44.14 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 119.073 1.436 . . . . 23.309999999999999 112.38 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.4 mt -65.72 -32.78 74.51 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 120.251 1.387 . . . . 23.48 112.947 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.13 -11.77 40.26 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 114.237 1.199 . . . . 24.239999999999998 114.237 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.438 ' OE2' ' HE3' ' A' ' 83' ' ' LYS . 75.0 tt0 -92.41 -41.07 10.52 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.103 1.361 . . . . 39.259999999999998 112.554 165.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.438 ' HE3' ' OE2' ' A' ' 82' ' ' GLU . 74.6 mttt -124.51 90.01 3.18 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.662 1.185 . . . . 24.449999999999999 111.977 -164.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -151.8 165.69 16.88 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.833 1.653 . . . . 0.0 109.474 168.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.21 -30.34 31.2 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.003 1.802 . . . . 0.0 112.031 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -73.7 152.87 89.39 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.82 1.248 . . . . 0.0 112.086 171.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -51.81 142.87 40.63 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.74 2.96 . . . . 0.0 115.053 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.31 131.53 25.17 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.272 1.981 . . . . 0.0 111.533 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.6 mt -105.29 4.48 31.05 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.223 1.409 . . . . 0.0 112.185 171.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.71 51.51 0.14 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.698 1.999 . . . . 0.0 112.178 162.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.1 p -123.79 70.76 49.11 Favored Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 125.021 1.329 . . . . 0.0 109.236 170.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.07 122.48 9.07 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.282 1.988 . . . . 0.0 110.227 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -73.98 179.59 5.58 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.874 2.383 . . . . 0.0 111.221 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.6 mp0 -55.09 -29.75 58.25 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.624 1.97 . . . . 0.0 113.08 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -53.77 -28.14 33.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.994 1.318 . . . . 0.0 113.842 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.27 -29.96 71.19 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.624 1.102 . . . . 0.0 113.21 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.9 p -68.45 -21.95 64.61 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.2 t -99.9 -41.11 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.835 1.254 . . . . 0.0 111.081 176.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.67 -31.52 81.07 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.729 -1.232 . . . . 0.0 114.435 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.9 p -69.62 -18.58 63.61 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -90.46 -32.66 16.29 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.842 1.257 . . . . 0.0 112.881 169.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 71.0 mt -70.27 -36.0 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.778 0.831 . . . . 0.0 111.629 173.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -55.44 -46.74 99.66 Favored Pre-proline 0 CA--C 1.547 0.829 0 O-C-N 120.379 -1.451 . . . . 0.0 114.344 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.65 -31.67 2.44 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.933 2.422 . . . . 0.0 114.116 171.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.6 p -71.46 -28.12 63.73 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 121.034 1.743 . . . . 0.0 113.005 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -58.72 -44.51 90.45 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 120.655 -1.278 . . . . 0.0 112.305 161.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.5 t -65.86 -35.05 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 119.639 1.109 . . . . 0.0 111.887 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.427 ' HZ1' ' CG ' ' A' ' 114' ' ' ASP . 60.9 tttt -66.54 -39.02 88.36 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.031 0.832 . . . . 0.0 112.047 171.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -70.11 -29.85 66.91 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.284 1.034 . . . . 0.0 112.426 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.9 mt -76.99 -9.06 58.44 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.673 1.589 . . . . 0.0 114.517 168.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -142.63 38.55 1.51 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.92 1.288 . . . . 0.0 112.839 -170.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.4 m -75.07 63.01 1.22 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -162.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -65.26 -38.07 89.15 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.05 1.34 . . . . 0.0 111.136 163.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.427 ' CG ' ' HZ1' ' A' ' 108' ' ' LYS . 19.6 t0 -83.89 115.97 62.43 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 154.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.59 154.24 70.15 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.675 2.917 . . . . 0.0 115.759 -144.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -66.9 -42.64 85.12 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 114.42 -1.264 . . . . 0.0 112.993 -165.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.71 -22.33 54.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.656 1.182 . . . . 0.0 113.32 -174.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.82 -34.6 27.12 Favored Glycine 0 CA--C 1.532 1.155 0 O-C-N 120.973 -1.079 . . . . 0.0 112.813 165.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 99.4 m -68.44 -27.09 65.87 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.596 -0.944 . . . . 0.0 112.729 171.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.59 -44.44 96.26 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.841 1.657 . . . . 0.0 111.928 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -66.7 -41.84 87.36 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.43 0.692 . . . . 0.0 112.059 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.77 -25.05 67.09 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 174.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.9 tp -82.51 -41.71 19.36 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.685 1.194 . . . . 0.0 112.17 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 26.9 mt -65.23 -40.08 93.61 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.713 1.205 . . . . 0.0 113.566 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -68.23 -33.83 75.12 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.927 1.239 . . . . 0.0 112.727 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -73.48 -38.76 65.31 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.063 -1.023 . . . . 0.0 112.722 170.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.1 mt -63.57 -35.55 80.86 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.782 -1.199 . . . . 0.0 112.849 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -65.06 -44.29 89.46 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.137 0.975 . . . . 0.0 111.598 172.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.61 -36.02 81.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.333 0.653 . . . . 0.0 112.224 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.1 tp -69.35 -56.95 6.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.377 1.071 . . . . 0.0 111.97 172.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.47 -30.57 69.45 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -171.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.33 -32.01 67.23 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.144 -0.809 . . . . 0.0 113.487 172.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -89.15 -33.88 16.9 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 117.75 0.775 . . . . 0.0 113.006 172.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.55 -35.95 81.07 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.912 1.233 . . . . 0.0 113.042 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.6 mtmt -65.81 -6.9 13.34 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 174.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.6 t -102.5 -36.72 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.961 1.305 . . . . 0.0 112.173 169.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -89.22 -19.32 25.55 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.31 -140.63 35.9 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.939 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -70.86 -15.71 32.95 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.785 3.657 . . . . 0.0 117.343 -108.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -122.08 170.98 9.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.926 1.29 . . . . 0.0 110.908 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.254 2.9 tt -77.9 7.29 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 119.855 -1.778 . . . . 0.0 113.132 -175.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.406 ' CB ' ' HG1' ' A' ' 147' ' ' THR . . . -114.61 6.95 15.91 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.91 2.484 . . . . 0.0 114.035 163.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.93 -122.33 6.64 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.82 -1.175 . . . . 0.0 113.185 -172.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -54.0 -36.69 63.22 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -169.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -146.76 157.87 43.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.318 1.447 . . . . 0.0 110.977 -166.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 56.0 mt -67.48 132.67 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.517 0.727 . . . . 0.0 110.414 171.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.406 ' HG1' ' CB ' ' A' ' 142' ' ' ALA . 30.0 p -143.5 -171.62 3.54 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.483 1.513 . . . . 0.0 111.15 176.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -54.58 -17.89 3.8 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.61 -42.48 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 120.211 1.369 . . . . 0.0 111.759 172.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.64 -45.08 95.56 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.933 1.293 . . . . 0.0 112.326 168.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.8 mt -62.08 -24.24 66.99 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 122.039 -0.413 . . . . 0.0 111.769 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.9 m -83.46 -50.56 8.18 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.887 -1.133 . . . . 0.0 112.597 175.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.3 mt -94.86 -36.0 11.82 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -165.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.8 -49.17 94.39 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.56 -22.5 15.8 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 120.725 1.295 . . . . 0.0 113.483 178.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -78.2 -28.92 48.16 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 117.714 -1.136 . . . . 0.0 112.859 174.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 46.7 mt -65.69 -44.65 85.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.89 0.876 . . . . 0.0 112.395 166.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -57.22 -41.66 79.91 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.161 0.505 . . . . 0.0 111.792 170.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -68.0 -29.61 68.67 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 9.2 mt -69.68 -52.48 25.35 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.419 1.008 . . . . 0.0 111.913 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -61.43 -35.51 77.78 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.017 0.927 . . . . 0.0 112.029 -174.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.7 t -90.56 -62.82 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.395 1.078 . . . . 0.0 113.14 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.21 -56.83 3.81 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.601 -0.687 . . . . 0.0 112.42 -162.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.42 -33.12 74.86 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.439 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.64 -23.29 49.28 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.129 1.347 . . . . 0.0 115.778 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -69.95 -22.26 63.19 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -124.94 -25.19 3.93 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -139.34 90.52 2.42 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.825 1.65 . . . . 0.0 108.353 166.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -65.3 83.78 0.05 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.583 1.153 . . . . 0.0 109.979 170.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -86.8 117.38 68.57 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.852 -169.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.34 110.63 2.9 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.585 1.524 . . . . 0.0 109.835 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.8 mm -55.39 109.32 1.54 Allowed Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 151.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -64.51 158.34 50.18 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 121.278 1.319 . . . . 0.0 112.442 -166.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.71 -19.06 64.63 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -66.36 -25.0 66.59 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.424 1.09 . . . . 0.0 113.693 168.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 62.5 mt -87.06 47.88 1.57 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.232 1.813 . . . . 0.0 111.388 170.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.7 -31.76 73.03 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.987 -1.071 . . . . 0.0 113.823 -155.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -80.45 -38.12 30.66 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.092 -1.005 . . . . 0.0 111.862 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 87.0 t -61.46 -42.32 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 121.436 -0.79 . . . . 0.0 111.559 171.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.8 -29.44 69.92 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -80.9 -37.45 29.65 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.595 -0.691 . . . . 0.0 112.507 170.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -63.76 -31.13 72.21 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.476 1.11 . . . . 0.0 113.473 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 79.6 mt -56.96 -37.1 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.139 -0.976 . . . . 0.0 111.904 169.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -77.5 -16.34 58.77 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 119.975 -1.703 . . . . 0.0 112.878 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 66.6 mt -77.0 -12.76 59.98 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 117.461 -1.257 . . . . 0.0 113.473 166.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.83 -18.9 65.61 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.414 1.461 . . . . 0.0 112.924 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -93.15 2.17 56.81 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 173.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.4 p -105.97 -179.57 3.98 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.168 2.187 . . . . 0.0 113.828 -170.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 43.8 mtp85 55.09 -161.95 0.15 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.347 1.459 . . . . 0.0 110.655 -172.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -86.03 -40.68 15.53 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.101 1.36 . . . . 0.0 109.209 157.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 72.5 p -70.7 -53.15 16.74 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.713 1.605 . . . . 0.0 114.727 -160.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -67.01 -46.17 75.3 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.17 0.896 . . . . 0.0 111.855 171.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 193' ' ' LYS . 26.7 ttmt -55.89 -38.28 69.98 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -74.46 -12.5 60.51 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.7 p -77.75 -11.74 59.91 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.329 1.422 . . . . 0.0 113.267 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -67.32 86.23 0.17 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.778 1.631 . . . . 0.0 112.721 -169.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.35 136.11 57.93 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.797 0.839 . . . . 0.0 109.99 159.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.2 132.47 53.77 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.104 0.562 . . . . 0.0 111.547 -173.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -60.02 -37.46 79.83 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.636 1.346 . . . . 0.0 114.636 -159.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.44 -38.28 83.59 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.901 -1.124 . . . . 0.0 112.462 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -86.49 -4.85 59.24 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.782 1.633 . . . . 0.0 112.998 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.3 t -85.02 -48.81 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.707 1.203 . . . . 0.0 109.89 162.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.8 mt -59.27 -53.37 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.852 1.261 . . . . 0.0 111.63 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.39 -15.53 62.37 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -81.78 -33.84 26.3 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 120.898 -1.126 . . . . 0.0 113.012 170.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 32.5 t90 -82.95 -32.75 26.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.521 1.928 . . . . 0.0 114.634 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -50.07 -48.84 78.19 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.53 -23.94 31.27 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.773 1.649 . . . . 0.0 113.71 173.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.08 -11.07 60.01 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.775 1.23 . . . . 0.0 113.901 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 57.6 t -58.95 -27.85 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 119.236 0.926 . . . . 0.0 110.688 161.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -97.91 -36.37 10.18 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 171.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.743 0 C-N-CA 126.052 1.741 . . . . 0.0 113.639 -177.344 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' GSH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.559 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 94.7 mtp . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.52 -168.49 0.17 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.589 1.556 . . . . 0.0 113.433 177.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 79.7 mt -109.72 131.81 54.72 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.391 1.076 . . . . 0.0 112.298 -175.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -122.21 145.6 48.05 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.574 1.15 . . . . 0.0 108.489 153.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.2 pt -130.22 138.84 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.967 0.907 . . . . 0.0 109.504 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.9 m -106.98 119.82 40.39 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.179 0.992 . . . . 0.0 109.621 173.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.81 163.8 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.018 1.327 . . . . 0.0 111.111 -169.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -60.58 119.14 7.5 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.758 -0.589 . . . . 0.0 111.23 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.41 147.01 31.18 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.051 151.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.93 139.47 58.75 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.757 0.789 . . . . 0.0 111.942 172.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.2 t -71.86 134.25 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 168.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.91 -27.74 2.97 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-O 118.665 -1.075 . . . . 0.0 114.677 -170.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -129.26 65.41 74.19 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-N 118.582 1.191 . . . . 0.0 112.564 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.12 -12.39 32.2 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.315 2.677 . . . . 0.0 115.468 -170.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -85.97 5.71 31.95 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.1 pt -132.37 163.33 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.733 1.213 . . . . 0.0 111.84 173.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.74 145.47 49.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.136 0.575 . . . . 0.0 110.888 166.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.63 -163.53 11.17 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.878 1.228 . . . . 0.0 111.981 166.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -56.96 105.4 0.21 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.6 t -157.64 107.4 1.81 Allowed Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.841 140.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.11 -14.29 42.83 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.178 2.585 . . . . 0.0 113.198 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -77.76 -29.39 50.98 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.207 -0.933 . . . . 0.0 112.401 171.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 99.7 m -70.81 -37.85 73.26 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.083 -1.636 . . . . 0.0 112.451 167.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -59.42 -26.69 65.38 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 118.399 -0.81 . . . . 0.0 113.006 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.491 HH12 ' CG ' ' A' ' 74' ' ' ASP . 53.8 mtp180 -58.14 -44.11 87.68 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.526 1.131 . . . . 0.0 112.641 171.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.5 t -77.0 -39.57 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.101 1.36 . . . . 0.0 111.299 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.31 -44.44 92.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.327 0.651 . . . . 0.0 111.121 171.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.0 tp -60.78 -53.75 53.55 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.991 1.316 . . . . 0.0 112.77 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 p -71.55 -36.85 71.11 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.708 1.14 . . . . 0.0 113.574 -173.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.17 -39.03 68.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.841 -0.599 . . . . 0.0 112.051 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' HG2' ' HH ' ' A' ' 37' ' ' TYR . 64.0 mm-40 -77.99 -17.39 57.2 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 172.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -70.16 -52.88 20.06 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.999 1.272 . . . . 0.0 110.896 167.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -73.24 -1.75 19.07 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.291 1.836 . . . . 0.0 114.468 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm 58.03 18.8 5.42 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.409 1.884 . . . . 0.0 115.106 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 58.5 mt -72.69 125.07 91.4 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 123.896 0.878 . . . . 0.0 108.868 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.72 144.84 35.88 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.473 2.116 . . . . 0.0 112.167 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.48 ' HH ' ' HG2' ' A' ' 31' ' ' GLU . 42.3 p90 -148.18 154.54 40.25 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.271 1.428 . . . . 0.0 111.01 177.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -78.55 121.1 24.18 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.332 -0.855 . . . . 0.0 109.686 163.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.8 t -95.42 94.41 7.8 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.538 0.735 . . . . 0.0 111.14 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -81.07 105.67 12.47 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.547 0.739 . . . . 0.0 110.067 178.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.9 mt -68.61 107.37 2.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.293 1.037 . . . . 0.0 109.963 168.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -105.05 114.9 45.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.125 0.97 . . . . 0.0 110.056 177.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -74.46 80.73 1.92 Allowed 'General case' 0 C--O 1.221 -0.437 0 O-C-N 121.438 -0.789 . . . . 32.609999999999999 109.629 165.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 pp -62.68 -4.26 1.94 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 116.622 2.082 . . . . 40.049999999999997 116.622 -170.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.65 -28.53 67.14 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-N 119.283 0.947 . . . . 41.469999999999999 112.576 166.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -116.42 54.15 0.85 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.31 2.644 . . . . 47.170000000000002 109.681 174.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -72.11 114.48 29.6 Favored Pre-proline 0 CA--C 1.546 0.803 0 O-C-N 119.745 -1.847 . . . . 41.270000000000003 111.059 -168.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.18 161.05 41.49 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.627 2.218 . . . . 40.289999999999999 112.209 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -61.85 -31.0 71.22 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.02 1.119 . . . . 42.390000000000001 114.02 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -61.52 -33.73 74.32 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.304 -0.873 . . . . 37.079999999999998 113.069 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -78.44 -35.14 47.24 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.22 -0.925 . . . . 35.880000000000003 112.769 172.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.14 -23.53 63.98 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.869 1.063 . . . . 33.609999999999999 113.869 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -67.48 -42.34 83.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.731 1.212 . . . . 33.789999999999999 111.418 168.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.7 mt -74.81 -32.78 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.348 1.059 . . . . 33.159999999999997 112.038 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.8 t -137.74 94.11 11.87 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 126.327 1.851 . . . . 33.579999999999998 111.351 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.83 -22.42 36.67 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.847 2.365 . . . . 37.899999999999999 113.586 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -78.93 -10.79 59.92 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.896 -1.128 . . . . 38.990000000000002 113.299 167.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.36 25.92 74.5 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.96 1.743 . . . . 35.469999999999999 115.015 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -105.21 149.14 26.21 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.938 1.369 . . . . 34.490000000000002 112.014 -172.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.5 m -106.84 146.68 33.58 Favored Pre-proline 0 N--CA 1.47 0.543 0 C-N-CA 123.913 0.885 . . . . 23.530000000000001 110.153 164.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.35 150.65 86.53 Favored 'Cis proline' 0 C--N 1.346 0.431 0 CA-C-N 119.032 0.69 . . . . 22.879999999999999 113.156 -7.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 p -138.76 145.54 27.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 113.618 -1.628 . . . . 0.0 107.16 156.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.77 160.8 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 O-C-N 121.449 -0.782 . . . . 0.0 111.13 -172.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.6 mtpt -119.85 73.47 0.97 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.258 1.423 . . . . 0.0 108.951 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.5 mt -71.49 117.3 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.443 1.097 . . . . 0.0 109.582 -174.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.559 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 15.4 t0 56.7 30.53 17.72 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 121.904 -0.498 . . . . 0.0 111.97 -165.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.8 t0 73.1 4.91 5.05 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 129.04 2.936 . . . . 0.0 116.37 -169.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -102.31 132.07 48.5 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.525 -1.36 . . . . 0.0 111.547 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -67.25 136.01 54.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.776 0.83 . . . . 0.0 113.056 -168.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -143.56 126.92 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.967 1.707 . . . . 0.0 109.449 170.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -107.08 172.04 7.04 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.832 1.653 . . . . 0.0 111.91 174.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 t0 65.69 111.48 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.89 2.476 . . . . 22.16 114.57 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.3 p -64.04 -21.41 66.5 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 115.696 1.739 . . . . 21.16 115.696 -161.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.491 ' CG ' HH12 ' A' ' 25' ' ' ARG . 35.6 m-20 -75.84 -31.74 59.47 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.494 1.497 . . . . 24.969999999999999 113.666 170.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.8 t -73.33 -38.64 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.932 -1.105 . . . . 23.850000000000001 110.823 170.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.22 -44.77 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.217 1.007 . . . . 23.68 110.962 174.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.4 t -62.59 -46.13 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.373 1.069 . . . . 22.84 111.378 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.09 -45.12 83.14 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 118.869 0.759 . . . . 23.329999999999998 112.99 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 99.1 mt -75.4 -46.48 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.709 -0.877 . . . . 23.309999999999999 112.388 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.6 mt -69.86 -30.09 67.48 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.23 1.377 . . . . 23.48 113.591 -176.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -89.99 -13.18 36.65 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.335 0.865 . . . . 24.239999999999998 113.335 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.51 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 56.6 tt0 -91.81 -47.08 7.53 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.758 1.623 . . . . 39.259999999999998 112.568 167.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.51 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 84.0 mttt -117.52 83.57 2.01 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.719 1.207 . . . . 24.449999999999999 112.024 -161.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -149.25 165.85 16.68 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.275 1.43 . . . . 0.0 110.274 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -70.05 -25.23 27.49 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.152 1.901 . . . . 0.0 112.438 172.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -73.29 156.18 89.34 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.45 1.5 . . . . 0.0 112.155 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -57.24 143.81 92.49 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.218 2.612 . . . . 0.0 114.21 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.57 130.98 24.84 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.436 2.091 . . . . 0.0 112.424 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.0 mt -110.32 1.56 18.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.425 1.49 . . . . 0.0 112.333 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.67 50.08 0.18 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.676 1.99 . . . . 0.0 111.891 160.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 67.9 p -125.12 70.54 61.54 Favored Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 125.63 1.572 . . . . 0.0 109.045 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -69.59 128.75 16.64 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.98 1.786 . . . . 0.0 111.194 -165.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.0 177.31 7.24 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.419 2.746 . . . . 0.0 111.318 170.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -55.58 -31.16 61.96 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 120.924 -1.11 . . . . 0.0 113.897 173.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -53.43 -25.59 16.56 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.293 1.437 . . . . 0.0 113.973 172.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.15 -33.92 74.18 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.577 1.08 . . . . 0.0 113.184 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 84.1 p -68.99 -24.28 64.21 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.385 1.074 . . . . 0.0 113.78 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 t -92.75 -40.74 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.264 1.425 . . . . 0.0 110.111 176.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.96 -30.97 79.02 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.83 1.681 . . . . 0.0 114.45 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 89.8 p -69.27 -17.53 63.75 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.024 1.412 . . . . 0.0 113.77 171.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -95.56 -33.15 12.51 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.105 1.362 . . . . 0.0 112.386 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 69.2 mt -70.2 -36.79 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.607 0.763 . . . . 0.0 111.979 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -56.19 -47.71 98.32 Favored Pre-proline 0 CA--C 1.545 0.758 0 O-C-N 120.223 -1.548 . . . . 0.0 113.898 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.65 -30.38 3.08 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.546 2.164 . . . . 0.0 114.045 171.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.3 p -72.57 -27.16 62.03 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 121.193 1.815 . . . . 0.0 113.273 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -59.03 -46.72 87.5 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.662 -1.274 . . . . 0.0 111.839 160.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.8 t -65.17 -32.65 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.336 0.971 . . . . 0.0 111.951 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.447 ' HZ3' ' CG ' ' A' ' 114' ' ' ASP . 72.2 tttt -67.73 -39.39 84.27 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.174 0.897 . . . . 0.0 112.393 168.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -70.71 -28.29 64.63 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.469 1.107 . . . . 0.0 112.783 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 20.6 mt -77.01 -15.24 59.69 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.869 1.668 . . . . 0.0 114.147 167.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.458 ' HZ3' ' C ' ' A' ' 212' ' ' ALA . 80.5 mttt -137.68 38.95 2.41 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.848 1.259 . . . . 0.0 112.533 -170.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.3 m -73.85 66.0 1.09 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -162.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -67.81 -39.36 83.98 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.401 1.08 . . . . 0.0 111.522 164.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.447 ' CG ' ' HZ3' ' A' ' 108' ' ' LYS . 13.6 t0 -79.44 111.77 23.4 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 153.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.48 155.85 66.62 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.578 2.852 . . . . 0.0 115.452 -143.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -65.3 -42.51 92.99 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.838 -1.074 . . . . 0.0 113.437 -165.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.75 -21.98 61.67 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.84 -36.9 17.72 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 120.998 -1.064 . . . . 0.0 112.495 167.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 98.4 m -67.82 -27.55 66.81 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.82 0.848 . . . . 0.0 113.042 172.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -58.76 -45.95 88.57 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.795 1.638 . . . . 0.0 111.616 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -68.68 -40.46 80.1 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.792 0.837 . . . . 0.0 111.433 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.91 -24.9 66.93 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.6 tp -82.92 -40.75 19.74 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.864 1.265 . . . . 0.0 111.94 172.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.9 mt -63.45 -41.36 98.63 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.676 1.191 . . . . 0.0 113.351 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.49 ' CD ' ' HZ3' ' A' ' 128' ' ' LYS . 13.7 mm-40 -66.58 -35.64 80.7 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.063 1.301 . . . . 0.0 112.774 -176.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -71.79 -39.5 69.85 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.122 -0.986 . . . . 0.0 112.592 171.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.6 mt -64.28 -33.6 76.19 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.837 -1.164 . . . . 0.0 113.121 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.49 ' HZ3' ' CD ' ' A' ' 125' ' ' GLU . 80.8 mttt -66.7 -44.28 82.11 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.588 1.086 . . . . 0.0 111.577 173.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.84 81.56 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.558 0.743 . . . . 0.0 112.218 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.2 tp -68.07 -56.75 7.75 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.27 1.028 . . . . 0.0 111.846 172.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.96 -33.44 74.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.576 1.15 . . . . 0.0 113.879 -171.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.42 -34.02 67.56 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.36 -0.689 . . . . 0.0 113.324 173.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -92.67 -29.35 16.13 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 77.4 mt -64.23 -33.74 76.5 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 120.465 -1.397 . . . . 0.0 113.225 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -65.94 -7.63 17.87 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.35 -38.37 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.144 1.378 . . . . 0.0 112.169 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -82.17 -17.38 46.46 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -172.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.2 -164.86 42.57 Favored Glycine 0 CA--C 1.542 1.721 0 CA-C-O 117.718 -1.601 . . . . 0.0 114.42 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.0 -10.67 23.09 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 125.281 3.987 . . . . 0.0 118.144 -119.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -110.32 167.21 10.37 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.175 0.99 . . . . 0.0 110.893 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.2 tt -75.57 6.86 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 120.275 -1.516 . . . . 0.0 112.997 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.454 ' CB ' ' HG1' ' A' ' 147' ' ' THR . . . -116.2 2.79 13.37 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 128.146 2.579 . . . . 0.0 114.422 165.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.93 -117.85 5.7 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.083 1.325 . . . . 0.0 113.251 -173.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -62.45 -35.81 80.44 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -168.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -142.49 162.32 35.76 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.76 1.624 . . . . 0.0 110.484 -171.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.8 mt -62.83 135.68 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.07 0.462 . . . . 0.0 110.528 165.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.454 ' HG1' ' CB ' ' A' ' 142' ' ' ALA . 28.7 p -138.59 -174.33 3.8 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.502 1.521 . . . . 0.0 110.814 171.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.95 -19.31 1.73 Allowed 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 169.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 18.4 t -74.27 -40.32 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 120.179 1.354 . . . . 0.0 112.496 174.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -61.5 -44.33 97.28 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.863 -1.148 . . . . 0.0 112.003 167.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.9 mt -62.19 -26.99 68.66 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 122.193 -0.317 . . . . 0.0 111.533 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 52.3 m -79.35 -47.43 15.81 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.845 -1.159 . . . . 0.0 112.694 175.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 51.5 mt -100.01 -37.98 8.77 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -164.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.24 88.48 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -173.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.97 -28.57 19.27 Favored 'Trans proline' 0 C--N 1.351 0.705 0 CA-C-N 120.784 1.316 . . . . 0.0 113.12 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -72.81 -30.55 64.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.611 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 51.6 mt -65.97 -46.61 77.45 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.741 0.816 . . . . 0.0 112.975 169.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -58.33 -36.31 73.22 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.828 0.823 . . . . 0.0 112.323 170.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -73.98 -22.79 59.49 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.867 -1.146 . . . . 0.0 113.76 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.33 -49.78 45.94 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.561 1.073 . . . . 0.0 111.398 162.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -58.1 -37.11 73.9 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.389 1.476 . . . . 0.0 112.479 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 70.4 t -96.87 -62.66 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.236 1.014 . . . . 0.0 113.545 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.05 -54.2 6.83 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.463 -0.773 . . . . 0.0 112.622 -164.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 38.6 tp -65.71 -34.69 78.78 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 119.349 -0.358 . . . . 0.0 111.155 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.03 -29.24 59.17 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.23 1.395 . . . . 0.0 115.336 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -66.48 -22.01 66.19 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -122.29 -21.19 5.92 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -148.33 94.94 2.38 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.291 1.836 . . . . 0.0 108.797 165.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -67.99 78.74 0.22 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.895 1.278 . . . . 0.0 111.171 173.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -76.98 118.2 70.23 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.24 1.016 . . . . 0.0 111.91 -168.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -73.37 110.36 3.04 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.949 1.766 . . . . 0.0 110.662 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 14.0 mm -58.03 115.42 11.14 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 160.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -63.13 153.49 73.6 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 121.634 1.556 . . . . 0.0 112.633 -172.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -61.15 -22.66 64.9 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 169.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -68.11 -25.45 65.32 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 170.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 47.4 mt -86.12 50.91 2.07 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.251 1.42 . . . . 0.0 111.104 167.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.8 -26.87 68.53 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.315 1.046 . . . . 0.0 113.315 -160.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -75.62 -50.66 14.85 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.017 0.826 . . . . 0.0 111.074 171.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 86.3 t -59.17 -39.93 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.757 0.823 . . . . 0.0 111.572 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.4 tp -61.01 -36.01 78.37 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.675 1.19 . . . . 0.0 113.397 174.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -81.0 -37.25 29.48 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -62.61 -33.92 75.99 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.687 1.195 . . . . 0.0 112.872 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.8 mt -59.89 -35.83 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.033 -1.042 . . . . 0.0 112.104 171.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -74.08 -17.83 60.9 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.225 -1.547 . . . . 0.0 112.941 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 51.0 mt -74.88 -15.95 60.69 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 118.339 -0.838 . . . . 0.0 113.148 168.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.6 mt -67.99 -17.69 64.5 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 120.011 1.278 . . . . 0.0 113.828 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -95.09 6.59 48.65 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.419 -1.425 . . . . 0.0 113.477 171.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.7 p -107.69 -179.07 3.8 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.956 1.703 . . . . 0.0 113.222 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 44.8 mtp85 56.46 -164.33 0.15 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.655 1.582 . . . . 0.0 111.335 -172.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -84.62 -41.15 16.66 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.964 1.306 . . . . 0.0 109.276 157.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 77.4 p -70.16 -54.67 11.91 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.867 1.667 . . . . 0.0 114.631 -159.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -67.46 -45.94 74.49 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.701 0.682 . . . . 0.0 111.977 171.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -56.63 -39.03 72.93 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.172 -0.955 . . . . 0.0 113.517 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -74.04 -8.84 57.61 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.4 p -77.51 -14.47 59.67 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.401 1.455 . . . . 0.0 113.231 170.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -65.85 101.59 0.67 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.639 1.109 . . . . 0.0 111.636 -174.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.24 159.96 30.2 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.671 0.788 . . . . 0.0 110.496 156.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.38 127.55 33.09 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.076 -0.39 . . . . 0.0 110.359 172.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 199' ' ' GLU . 1.9 pm0 -63.86 -31.75 73.03 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -161.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -61.89 -39.85 93.37 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.997 -1.064 . . . . 0.0 112.424 171.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -81.89 -2.25 50.55 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.552 -1.343 . . . . 0.0 114.242 173.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 85.4 t -85.83 -44.7 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.402 1.081 . . . . 0.0 110.294 163.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.2 mt -64.51 -56.63 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.864 1.266 . . . . 0.0 111.526 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.7 -13.65 62.28 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.474 1.11 . . . . 0.0 113.825 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -86.44 -36.54 9.56 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.808 -1.183 . . . . 0.0 113.484 170.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -78.04 -31.31 50.31 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.688 1.595 . . . . 0.0 113.615 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -53.59 -47.97 94.68 Favored Pre-proline 0 CA--C 1.553 1.066 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -175.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.93 -23.75 29.65 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 121.681 1.588 . . . . 0.0 113.919 171.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.427 ' HE2' HB23 ' A' ' 301' ' ' GSH . 57.2 mttp -74.33 -8.61 56.85 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 117.595 -1.193 . . . . 0.0 114.204 175.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 45.7 t -60.59 -21.36 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 119.274 0.943 . . . . 0.0 111.268 160.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -105.72 -12.17 16.01 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 170.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.458 ' C ' ' HZ3' ' A' ' 111' ' ' LYS . . . . . . . . 0 C--O 1.246 0.882 0 C-N-CA 125.394 1.478 . . . . 0.0 112.653 -170.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' GSH . . . . . 0.427 HB23 ' HE2' ' A' ' 209' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.471 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 88.2 mtp . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.02 -173.64 0.1 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.494 1.518 . . . . 0.0 114.019 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 74.8 mt -115.74 137.3 52.22 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.249 1.42 . . . . 0.0 111.188 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -130.59 144.37 51.37 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.681 1.192 . . . . 0.0 108.723 160.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.3 pt -128.62 135.35 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.999 0.92 . . . . 0.0 109.34 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 79.2 m -110.84 117.29 33.01 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.493 1.117 . . . . 0.0 109.459 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.9 m -132.45 158.78 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.773 1.229 . . . . 0.0 111.09 -165.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -59.62 114.99 3.01 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.986 -0.446 . . . . 0.0 110.685 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.94 149.65 29.3 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.984 154.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.96 142.89 57.18 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.921 0.867 . . . . 0.0 113.057 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.91 129.15 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 163.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.66 -18.99 12.4 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-O 118.405 -1.219 . . . . 0.0 115.41 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.67 65.97 26.55 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 119.114 1.457 . . . . 0.0 112.286 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -64.82 -5.16 9.97 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.705 2.937 . . . . 0.0 115.489 -172.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -89.96 3.63 52.54 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.6 pt -133.8 164.57 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.201 1.4 . . . . 0.0 111.704 173.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.19 150.03 39.94 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.817 0.847 . . . . 0.0 111.922 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.49 -164.86 10.09 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.592 1.568 . . . . 0.0 111.834 165.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -57.78 104.28 0.18 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.6 t -153.37 106.41 2.58 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 113.74 -1.573 . . . . 0.0 110.212 136.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -67.62 -15.3 44.44 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.822 2.348 . . . . 0.0 112.761 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -74.44 -29.39 61.46 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.374 -0.829 . . . . 0.0 112.369 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 89.1 m -70.15 -37.08 75.14 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.326 -1.484 . . . . 0.0 112.816 167.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -60.41 -28.08 67.97 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.457 HH11 ' CG ' ' A' ' 74' ' ' ASP . 57.3 mtp180 -56.76 -40.05 75.12 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.678 1.191 . . . . 0.0 112.691 171.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.3 -40.61 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.138 1.375 . . . . 0.0 111.52 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.51 -43.54 93.36 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.951 0.5 . . . . 0.0 111.132 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.8 tp -59.15 -46.59 87.97 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.353 1.061 . . . . 0.0 113.268 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.2 p -78.44 -37.96 42.4 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.35 -36.91 77.35 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.484 0.584 . . . . 0.0 111.621 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -77.98 -18.33 56.1 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -75.43 -46.33 33.38 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.142 -1.599 . . . . 0.0 111.534 166.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -76.52 -5.03 45.8 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.071 1.348 . . . . 0.0 114.343 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm 58.68 20.27 7.61 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.325 1.85 . . . . 0.0 114.477 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.1 mt -70.98 130.54 88.18 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.217 -0.896 . . . . 0.0 108.679 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.01 139.38 29.81 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.331 2.021 . . . . 0.0 111.99 173.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -144.67 154.42 42.75 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.857 1.663 . . . . 0.0 110.194 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -81.94 125.48 30.81 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.177 -0.952 . . . . 0.0 110.019 162.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.5 t -93.16 95.75 9.6 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.515 0.726 . . . . 0.0 110.999 169.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -79.97 99.06 7.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.676 0.79 . . . . 0.0 109.583 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.75 109.72 2.98 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.945 0.898 . . . . 0.0 109.599 169.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mm -120.23 111.88 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.736 1.215 . . . . 0.0 109.15 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -77.5 89.42 3.85 Favored 'General case' 0 C--O 1.222 -0.368 0 O-C-N 120.68 -1.263 . . . . 32.609999999999999 108.602 166.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.42 1.79 0.19 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 117.519 2.415 . . . . 40.049999999999997 117.519 -175.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -69.95 -24.02 76.68 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-N 119.918 1.235 . . . . 41.469999999999999 112.734 161.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -128.11 66.84 1.36 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.974 2.51 . . . . 47.170000000000002 108.823 171.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -80.63 116.49 62.45 Favored Pre-proline 0 N--CA 1.473 0.684 0 O-C-N 120.055 -1.653 . . . . 41.270000000000003 110.551 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.15 161.65 44.98 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.689 2.26 . . . . 40.289999999999999 111.638 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -61.82 -29.83 70.42 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.028 1.121 . . . . 42.390000000000001 114.028 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -60.72 -33.02 72.27 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.269 1.028 . . . . 37.079999999999998 113.362 170.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -79.38 -36.61 38.95 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.951 -1.093 . . . . 35.880000000000003 112.599 173.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.7 mt -68.12 -25.54 65.35 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.343 0.868 . . . . 33.609999999999999 113.343 174.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -64.14 -47.37 80.18 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.606 1.563 . . . . 33.789999999999999 111.457 168.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.2 mt -72.39 -37.38 57.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.894 0.877 . . . . 33.159999999999997 111.625 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.1 t -126.75 92.19 45.39 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 126.177 1.791 . . . . 33.579999999999998 110.746 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.03 -17.47 36.34 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.856 2.371 . . . . 37.899999999999999 113.965 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.461 ' CD ' ' HZ2' ' A' ' 59' ' ' LYS . 7.4 mt-10 -76.48 -11.58 59.9 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.102 -0.999 . . . . 38.990000000000002 113.533 165.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.98 21.35 76.8 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.548 1.07 . . . . 35.469999999999999 114.561 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HZ2' ' CD ' ' A' ' 57' ' ' GLU . 83.6 mttt -104.08 150.5 24.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.451 1.501 . . . . 34.490000000000002 113.688 -173.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.19 153.96 40.76 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 125.93 1.692 . . . . 23.530000000000001 111.046 162.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -63.66 149.37 68.0 Favored 'Cis proline' 0 C--N 1.347 0.48 0 CA-C-O 121.852 0.688 . . . . 22.879999999999999 112.608 -12.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.38 146.95 28.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 113.985 -1.461 . . . . 0.0 107.494 156.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.1 m -134.7 165.26 31.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 123.565 0.746 . . . . 0.0 111.004 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -124.06 71.7 1.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.757 1.623 . . . . 0.0 109.424 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.5 mt -74.74 117.51 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.395 1.078 . . . . 0.0 108.994 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.471 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 48.0 t0 53.8 40.47 31.56 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 121.227 0.537 . . . . 0.0 110.967 -164.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 t0 67.54 -5.84 0.73 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.445 2.298 . . . . 0.0 115.608 -172.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -92.77 135.51 34.06 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.261 -1.525 . . . . 0.0 112.296 -172.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -68.1 131.41 45.37 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.634 1.174 . . . . 0.0 112.465 -170.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.1 t -141.09 129.61 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.165 1.386 . . . . 0.0 109.588 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.29 171.14 7.65 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.929 1.691 . . . . 0.0 111.425 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.9 t0 66.08 111.17 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.527 2.331 . . . . 22.16 114.162 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.401 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 59.9 p -64.09 -21.65 66.62 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 115.15 1.537 . . . . 21.16 115.15 -162.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.457 ' CG ' HH11 ' A' ' 25' ' ' ARG . 38.0 m-20 -74.1 -34.01 63.82 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.023 1.283 . . . . 24.969999999999999 113.421 169.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -72.27 -38.71 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.086 -1.009 . . . . 23.850000000000001 110.785 171.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.56 -44.94 99.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.234 1.014 . . . . 23.68 111.072 175.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.6 t -62.99 -44.65 99.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.384 1.074 . . . . 22.84 111.286 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.43 -35.04 70.18 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 118.633 0.651 . . . . 23.329999999999998 113.91 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 94.8 mt -85.11 -49.9 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 118.339 1.07 . . . . 23.309999999999999 112.122 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.4 mt -65.75 -32.32 73.8 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.809 1.186 . . . . 23.48 113.314 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -90.88 -1.26 57.85 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.627 0.973 . . . . 24.239999999999998 113.627 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.526 ' CD ' ' HZ3' ' A' ' 83' ' ' LYS . 5.6 tt0 -110.88 -53.62 2.68 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.113 1.365 . . . . 39.259999999999998 112.092 167.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.526 ' HZ3' ' CD ' ' A' ' 82' ' ' GLU . 51.5 mttm -97.06 58.98 1.61 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.384 1.074 . . . . 24.449999999999999 112.847 -161.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -132.64 162.9 54.46 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.996 1.318 . . . . 0.0 111.355 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.08 -26.55 21.34 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.291 1.994 . . . . 0.0 112.398 172.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -72.96 150.57 90.4 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.467 1.107 . . . . 0.0 111.697 171.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -57.24 144.13 91.63 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.048 2.498 . . . . 0.0 115.032 -172.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.72 119.01 5.84 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.768 2.312 . . . . 0.0 113.222 -173.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.5 mt -89.45 2.04 55.06 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.504 1.121 . . . . 0.0 112.654 170.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.05 50.97 0.29 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.647 1.979 . . . . 0.0 110.949 159.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.8 p -125.03 62.78 38.38 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 126.246 1.818 . . . . 0.0 110.132 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -75.64 127.86 10.56 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.825 2.35 . . . . 0.0 111.164 -163.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.51 -176.9 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.532 2.822 . . . . 0.0 111.771 171.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -53.79 -29.31 39.75 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.038 1.335 . . . . 0.0 114.153 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -56.38 -21.61 25.96 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.103 1.361 . . . . 0.0 114.393 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.53 -30.92 71.97 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 120.16 1.346 . . . . 0.0 113.368 173.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.5 p -68.03 -23.79 65.02 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.421 -0.8 . . . . 0.0 113.119 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -95.23 -41.23 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.188 1.395 . . . . 0.0 110.868 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.84 -29.7 76.02 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.446 1.498 . . . . 0.0 114.398 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 88.2 p -67.91 -18.59 64.83 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.729 1.264 . . . . 0.0 114.049 170.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -95.5 -33.35 12.46 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.402 1.481 . . . . 0.0 112.873 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.1 mt -69.82 -37.52 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.642 0.777 . . . . 0.0 111.805 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -56.25 -47.97 97.84 Favored Pre-proline 0 CA--C 1.546 0.811 0 O-C-N 120.406 -1.434 . . . . 0.0 114.028 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.62 -30.83 3.66 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.709 2.273 . . . . 0.0 113.779 171.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.6 p -72.25 -28.05 62.89 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 121.386 1.903 . . . . 0.0 113.277 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -59.88 -45.42 92.55 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.668 -1.27 . . . . 0.0 112.192 161.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.1 t -68.49 -32.23 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.23 -0.919 . . . . 0.0 111.953 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.476 ' HZ1' ' CG ' ' A' ' 114' ' ' ASP . 66.1 tttt -67.11 -41.97 85.31 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.914 0.886 . . . . 0.0 111.836 169.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -63.65 -39.48 94.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.257 1.023 . . . . 0.0 111.693 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.28 -5.4 31.98 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 169.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.459 ' HZ3' ' C ' ' A' ' 212' ' ' ALA . 82.7 mttt -141.78 42.5 1.71 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.846 1.658 . . . . 0.0 111.617 -177.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.0 m -70.05 61.57 0.19 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.239 1.816 . . . . 0.0 115.53 -165.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.18 -37.06 72.18 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.647 1.179 . . . . 0.0 111.738 167.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.476 ' CG ' ' HZ1' ' A' ' 108' ' ' LYS . 6.5 t0 -81.38 115.4 56.29 Favored Pre-proline 0 CA--C 1.552 1.027 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 152.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.58 153.68 73.53 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.423 2.749 . . . . 0.0 115.084 -147.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -64.7 -42.83 95.0 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.425 -165.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.23 -17.18 60.92 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.403 1.081 . . . . 0.0 113.763 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -86.91 -39.33 7.56 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 121.442 -0.787 . . . . 0.0 112.68 166.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 54.0 m -65.46 -25.93 67.72 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.671 -0.899 . . . . 0.0 112.953 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -58.32 -44.83 88.79 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.908 1.683 . . . . 0.0 111.759 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -71.81 -38.93 70.16 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.523 0.729 . . . . 0.0 111.4 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.84 -23.88 66.77 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 171.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.4 tp -83.21 -41.21 18.67 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.727 1.211 . . . . 0.0 111.914 170.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 23.3 mt -64.2 -41.58 97.0 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.932 1.293 . . . . 0.0 113.478 -177.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.499 ' CD ' ' HZ3' ' A' ' 128' ' ' LYS . 11.4 mm-40 -65.15 -36.19 83.45 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.277 1.399 . . . . 0.0 112.598 -176.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -72.88 -38.75 66.87 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.229 -0.919 . . . . 0.0 112.691 172.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.31 -33.83 76.73 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.85 -1.156 . . . . 0.0 113.033 172.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.499 ' HZ3' ' CD ' ' A' ' 125' ' ' GLU . 79.5 mttt -66.71 -44.65 81.05 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.868 1.213 . . . . 0.0 111.614 172.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.14 86.05 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.511 0.724 . . . . 0.0 112.225 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.4 tp -66.46 -58.16 5.83 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.316 1.446 . . . . 0.0 111.903 170.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.05 -37.08 84.94 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.512 1.125 . . . . 0.0 113.777 -170.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.35 -36.02 74.36 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.235 -0.758 . . . . 0.0 113.528 178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -93.71 -26.33 17.06 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 23.0 mt -63.72 -31.94 73.27 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.592 -1.318 . . . . 0.0 113.584 172.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -64.16 -3.11 2.45 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 171.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.2 t -109.46 -36.5 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.505 1.522 . . . . 0.0 112.704 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -83.65 -28.67 28.23 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 -162.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 144.86 174.92 17.56 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 120.069 1.304 . . . . 0.0 113.926 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.77 -4.01 14.1 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 125.008 3.805 . . . . 0.0 116.417 -164.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -106.24 167.18 9.99 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.433 1.015 . . . . 0.0 110.964 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.0 4.67 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 120.627 -1.296 . . . . 0.0 113.214 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.413 ' CB ' ' HG1' ' A' ' 147' ' ' THR . . . -121.54 16.01 11.2 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.772 2.429 . . . . 0.0 113.649 167.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.34 -110.44 3.49 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 120.838 -1.164 . . . . 0.0 113.022 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -58.06 -34.85 70.55 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -168.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -155.34 162.33 40.86 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.941 1.696 . . . . 0.0 110.895 -156.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 13.9 mt -63.87 132.61 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 164.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.413 ' HG1' ' CB ' ' A' ' 142' ' ' ALA . 29.3 p -132.66 -177.16 4.36 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.354 1.462 . . . . 0.0 110.474 169.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.13 -20.92 2.82 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 167.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.6 t -73.44 -41.01 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 120.704 -1.248 . . . . 0.0 112.325 173.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.69 -42.7 99.29 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.618 1.167 . . . . 0.0 112.233 168.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.7 mt -62.61 -23.2 66.93 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.6 m -83.08 -45.56 13.85 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.041 -1.037 . . . . 0.0 112.537 175.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 39.3 mt -100.15 -35.79 9.54 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -166.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.38 -49.53 92.9 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -70.43 -27.07 23.72 Favored 'Trans proline' 0 C--N 1.35 0.623 0 CA-C-N 120.942 1.372 . . . . 0.0 113.026 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -74.88 -28.39 60.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.444 -1.265 . . . . 0.0 112.654 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.0 mt -66.56 -45.86 77.95 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.824 0.85 . . . . 0.0 112.937 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -57.56 -39.64 77.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.293 0.637 . . . . 0.0 111.837 170.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -70.13 -20.97 63.14 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 9.6 mt -76.1 -51.23 12.68 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.837 1.199 . . . . 0.0 111.172 167.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.75 -34.57 74.64 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.405 1.082 . . . . 0.0 112.283 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 96.5 t -87.64 -75.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.198 0.999 . . . . 0.0 112.462 174.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.26 -52.39 16.58 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.886 -1.133 . . . . 0.0 112.153 -154.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.0 tp -68.25 -25.44 65.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.459 0.704 . . . . 0.0 112.543 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.22 -25.67 48.19 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.745 1.164 . . . . 0.0 115.508 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -68.46 -21.24 64.64 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -120.47 -30.61 4.51 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.97 1.308 . . . . 0.0 112.774 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -147.93 94.63 2.37 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.231 1.812 . . . . 0.0 108.668 169.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -67.96 78.15 0.22 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.483 1.113 . . . . 0.0 110.668 168.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -73.16 118.69 70.74 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 124.404 1.082 . . . . 0.0 111.385 -169.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.16 107.51 2.27 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.031 1.821 . . . . 0.0 110.674 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 35.2 mm -60.04 113.43 7.32 Favored Pre-proline 0 CA--C 1.541 0.635 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 163.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -63.33 154.3 68.97 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.741 1.628 . . . . 0.0 112.846 -170.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.48 -23.75 67.53 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.628 1.171 . . . . 0.0 113.241 171.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -65.8 -28.45 69.02 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.665 1.186 . . . . 0.0 113.398 170.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 43.6 mt -84.49 52.68 2.43 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.054 1.342 . . . . 0.0 110.794 166.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.39 -25.82 68.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.085 0.954 . . . . 0.0 112.532 -165.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -75.67 -49.89 17.05 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.914 0.779 . . . . 0.0 111.781 171.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 62.6 t -59.98 -39.36 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.541 0.737 . . . . 0.0 111.207 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 47.7 tp -65.24 -41.33 94.44 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.272 1.029 . . . . 0.0 113.356 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -69.04 -41.24 77.93 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.627 -0.67 . . . . 0.0 112.322 172.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -65.65 -31.81 73.03 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.585 1.154 . . . . 0.0 112.772 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 53.4 mt -58.09 -35.33 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 120.918 -1.114 . . . . 0.0 111.881 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -82.28 -13.31 57.2 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.368 -1.458 . . . . 0.0 113.749 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.0 mt -73.94 -18.14 60.93 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 117.576 -1.202 . . . . 0.0 113.499 160.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.7 mt -66.3 -19.55 65.85 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.51 1.505 . . . . 0.0 113.922 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -95.85 10.81 35.92 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.873 -1.142 . . . . 0.0 113.132 174.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.9 p -119.9 179.3 4.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.079 1.752 . . . . 0.0 113.374 -171.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 50.6 mtp85 56.77 -167.62 0.12 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.489 1.516 . . . . 0.0 110.143 -168.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -81.87 -35.32 29.42 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 122.043 -0.41 . . . . 0.0 110.889 157.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.6 p -69.38 -58.43 4.02 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.692 1.597 . . . . 0.0 114.763 -163.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -67.71 -43.51 79.87 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.149 0.886 . . . . 0.0 112.123 173.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -53.68 -35.33 60.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.922 1.289 . . . . 0.0 113.865 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.76 -7.39 59.22 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 7.8 p -73.24 -21.74 60.56 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.474 1.488 . . . . 0.0 112.518 170.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -60.27 127.29 31.08 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.9 1.28 . . . . 0.0 112.101 -170.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -93.42 173.71 7.57 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.424 1.09 . . . . 0.0 110.558 165.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.83 123.41 21.9 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.84 164.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -57.96 -35.05 70.61 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -165.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -61.39 -39.26 90.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.742 1.217 . . . . 0.0 112.396 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -82.34 0.87 39.74 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.858 -1.151 . . . . 0.0 113.988 173.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.9 t -85.39 -54.76 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.313 0.645 . . . . 0.0 109.98 161.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -46.22 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.123 0.874 . . . . 0.0 112.616 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.5 -10.68 60.14 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -90.07 -31.73 10.58 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 120.861 -1.149 . . . . 0.0 113.301 169.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 16.4 t90 -87.14 -30.8 20.78 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.101 1.76 . . . . 0.0 114.22 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -48.74 -49.47 66.09 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.54 -24.9 35.45 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.651 1.567 . . . . 0.0 113.839 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.572 ' HE2' HB23 ' A' ' 301' ' ' GSH . 44.5 mttp -74.23 -7.36 52.43 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.55 1.14 . . . . 0.0 114.056 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 59.1 t -61.91 -22.14 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 119.518 1.054 . . . . 0.0 111.505 159.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -106.91 -11.7 15.65 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 171.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.459 ' C ' ' HZ3' ' A' ' 111' ' ' LYS . . . . . . . . 0 C--O 1.248 1.017 0 C-N-CA 124.484 1.114 . . . . 0.0 113.181 -173.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' GSH . . . . . 0.572 HB23 ' HE2' ' A' ' 209' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.465 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 88.6 mtp . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 118.71 -0.662 . . . . 0.0 111.345 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.23 -175.9 0.11 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.432 1.493 . . . . 0.0 113.949 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 73.3 mt -115.5 143.14 45.75 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.334 1.454 . . . . 0.0 110.809 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -138.01 149.39 46.03 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.679 1.191 . . . . 0.0 108.831 159.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 pt -130.85 139.05 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.082 0.953 . . . . 0.0 109.202 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.7 m -110.68 125.99 54.05 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.892 0.877 . . . . 0.0 109.635 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.98 157.81 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.858 1.263 . . . . 0.0 110.792 -166.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -60.5 115.26 3.45 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.053 -0.405 . . . . 0.0 110.371 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.97 153.16 27.63 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.06 155.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.76 147.26 46.81 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.199 0.999 . . . . 0.0 112.753 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.71 134.05 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 167.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.69 -26.72 1.64 Allowed Glycine 0 CA--C 1.54 1.594 0 CA-C-O 118.883 -0.954 . . . . 0.0 115.442 -173.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.61 72.38 77.97 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-N 118.603 1.201 . . . . 0.0 112.159 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.03 -12.3 33.99 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.246 2.63 . . . . 0.0 114.927 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -82.94 2.89 32.35 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.6 pt -135.38 161.26 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.101 1.36 . . . . 0.0 111.503 177.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.26 149.92 40.57 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.612 0.765 . . . . 0.0 111.516 167.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.27 -168.41 11.29 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.632 1.587 . . . . 0.0 111.656 166.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -59.06 105.29 0.31 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 118.61 1.205 . . . . 0.0 114.161 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.2 t -152.01 107.3 2.84 Favored Pre-proline 0 CA--C 1.552 1.025 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.207 135.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -67.75 -15.85 45.1 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.815 2.343 . . . . 0.0 112.874 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -72.13 -28.53 63.32 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.065 -1.022 . . . . 0.0 112.381 171.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.09 -37.28 75.36 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.277 -1.514 . . . . 0.0 112.997 168.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -60.76 -27.25 67.83 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.475 HH12 ' CG ' ' A' ' 74' ' ' ASP . 60.1 mtp180 -57.18 -40.87 78.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.56 1.144 . . . . 0.0 112.452 172.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -78.87 -40.29 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.137 1.375 . . . . 0.0 111.546 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.5 mt -59.13 -43.6 92.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.982 0.513 . . . . 0.0 111.328 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.22 -48.49 81.42 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.068 0.947 . . . . 0.0 113.08 -177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.6 p -76.49 -37.4 56.87 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.3 mt -70.34 -36.99 74.56 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.391 0.541 . . . . 0.0 111.775 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -77.56 -20.08 54.67 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -74.11 -47.42 36.39 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.243 -1.535 . . . . 0.0 111.654 167.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -76.74 -4.36 42.97 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.802 1.241 . . . . 0.0 114.022 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm 58.65 19.58 6.89 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 126.377 1.871 . . . . 0.0 114.426 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.0 mt -72.84 127.37 89.73 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 118.152 -0.928 . . . . 0.0 108.641 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.31 143.13 34.68 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.405 2.07 . . . . 0.0 112.191 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -146.98 155.2 42.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.959 1.704 . . . . 0.0 109.92 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -80.36 131.64 35.66 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.046 -1.034 . . . . 0.0 109.789 158.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 t -99.41 94.23 6.32 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.999 0.92 . . . . 0.0 110.505 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -77.43 100.73 6.1 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.711 0.767 . . . . 0.0 109.479 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 99.4 mt -67.28 107.0 2.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.558 1.143 . . . . 0.0 109.241 170.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.3 mm -118.62 108.4 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.671 1.189 . . . . 0.0 109.059 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -75.46 90.03 2.7 Favored 'General case' 0 C--O 1.219 -0.552 0 O-C-N 120.716 -1.24 . . . . 32.609999999999999 108.216 165.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 pp -63.51 1.77 0.51 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 117.837 2.532 . . . . 40.049999999999997 117.837 -171.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.66 -19.56 79.72 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-N 119.896 1.226 . . . . 41.469999999999999 112.874 160.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -126.13 49.86 1.94 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 129.914 3.286 . . . . 47.170000000000002 109.36 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -78.27 118.15 70.51 Favored Pre-proline 0 N--CA 1.472 0.627 0 O-C-N 119.464 -2.023 . . . . 41.270000000000003 111.253 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.52 160.01 50.91 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.647 2.232 . . . . 40.289999999999999 111.623 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -62.12 -28.94 69.99 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.851 -1.155 . . . . 42.390000000000001 113.853 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 81.8 t90 -61.73 -32.24 72.46 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.508 0.929 . . . . 37.079999999999998 113.508 170.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -79.76 -33.83 40.33 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.819 -1.176 . . . . 35.880000000000003 112.619 172.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.0 mt -68.64 -23.72 64.46 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.449 0.907 . . . . 33.609999999999999 113.449 173.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -65.89 -41.88 90.97 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.894 1.278 . . . . 33.789999999999999 111.974 167.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.0 mt -74.11 -35.89 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 124.306 1.042 . . . . 33.159999999999997 111.654 175.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.4 t -133.08 92.9 24.12 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 126.121 1.768 . . . . 33.579999999999998 110.96 -175.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.73 -15.36 37.17 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.636 2.224 . . . . 37.899999999999999 113.901 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' CD ' ' HZ2' ' A' ' 59' ' ' LYS . 7.0 mt-10 -76.55 -13.0 60.11 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.004 -1.06 . . . . 38.990000000000002 113.438 165.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.69 16.98 72.6 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.932 -1.105 . . . . 35.469999999999999 114.595 -172.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.442 ' HZ2' ' CD ' ' A' ' 57' ' ' GLU . 72.8 mttt -100.12 155.23 17.85 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.399 1.48 . . . . 34.490000000000002 114.266 -173.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.0 m -115.39 157.26 44.44 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 126.713 2.005 . . . . 23.530000000000001 111.125 163.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -62.16 149.57 59.59 Favored 'Cis proline' 0 C--N 1.349 0.575 0 CA-C-O 122.327 0.886 . . . . 22.879999999999999 112.861 -13.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.09 146.66 22.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 113.8 -1.546 . . . . 0.0 107.303 163.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.59 163.58 30.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 123.522 0.729 . . . . 0.0 111.416 -169.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -120.95 69.27 0.89 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.547 1.939 . . . . 0.0 109.749 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.9 mt -75.05 119.15 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.745 0.818 . . . . 0.0 108.848 -175.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.465 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 46.8 t0 54.14 39.95 31.2 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.147 0.498 . . . . 0.0 111.019 -164.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.4 t0 68.65 -6.75 0.8 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 127.362 2.265 . . . . 0.0 115.638 -171.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -92.98 136.72 33.0 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.293 -1.504 . . . . 0.0 112.568 -170.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -64.01 127.95 33.68 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.311 1.444 . . . . 0.0 112.874 -175.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -141.59 132.66 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.526 1.53 . . . . 0.0 109.558 170.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -112.63 173.56 6.32 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.731 1.612 . . . . 0.0 111.621 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.1 t0 67.04 110.58 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 127.628 2.371 . . . . 22.16 114.485 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.414 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 59.5 p -62.97 -24.96 68.14 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 115.322 1.601 . . . . 21.16 115.322 -164.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.475 ' CG ' HH12 ' A' ' 25' ' ' ARG . 36.9 m-20 -72.04 -36.43 69.64 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.189 1.359 . . . . 24.969999999999999 112.998 170.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.69 -38.69 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.23 -0.919 . . . . 23.850000000000001 110.95 173.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.12 -44.04 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.374 1.07 . . . . 23.68 111.213 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.68 -42.79 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.476 1.11 . . . . 22.84 111.318 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.97 -26.97 61.55 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.215 -0.77 . . . . 23.329999999999998 114.565 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 87.7 mt -92.49 -50.76 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 118.718 1.259 . . . . 23.309999999999999 112.059 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.5 mt -65.55 -29.46 70.09 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.618 1.099 . . . . 23.48 113.452 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -89.24 -2.02 58.31 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.697 0.999 . . . . 24.239999999999998 113.697 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.403 ' OE2' ' HE3' ' A' ' 83' ' ' LYS . 38.7 tt0 -115.06 -47.63 2.86 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.679 1.592 . . . . 39.259999999999998 112.513 173.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.403 ' HE3' ' OE2' ' A' ' 82' ' ' GLU . 84.2 mttt -104.92 64.45 0.72 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.977 1.311 . . . . 24.449999999999999 112.415 -165.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -138.64 164.15 41.83 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.366 1.466 . . . . 0.0 110.713 174.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.69 -26.27 23.38 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.23 1.954 . . . . 0.0 112.655 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -74.64 154.71 87.44 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.043 1.337 . . . . 0.0 111.872 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -56.16 140.79 87.77 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.992 2.461 . . . . 0.0 113.635 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.97 133.93 35.27 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.215 1.943 . . . . 0.0 112.139 -176.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.9 mt -107.61 1.52 23.29 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.628 1.571 . . . . 0.0 112.065 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.8 49.53 0.23 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.769 2.027 . . . . 0.0 111.497 159.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 44.8 p -123.42 67.28 36.59 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 125.077 1.351 . . . . 0.0 109.012 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -74.19 124.2 8.85 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.393 2.062 . . . . 0.0 110.032 -165.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.73 -176.79 2.18 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.72 2.28 . . . . 0.0 111.133 170.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.491 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 23.0 mp0 -56.06 -30.08 61.43 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.406 2.282 . . . . 0.0 112.785 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -54.72 -23.86 19.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.167 1.787 . . . . 0.0 114.203 171.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.47 -33.42 73.74 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.981 -1.074 . . . . 0.0 113.213 173.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 59.5 p -70.13 -20.52 63.16 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.9 t -92.8 -42.31 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.276 1.43 . . . . 0.0 110.342 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.99 -30.21 77.08 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.122 1.344 . . . . 0.0 114.587 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 97.7 p -66.94 -19.75 65.78 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.603 1.202 . . . . 0.0 113.958 171.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -95.79 -32.99 12.44 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.477 1.511 . . . . 0.0 112.814 172.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 61.9 mt -68.31 -37.85 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.55 0.74 . . . . 0.0 111.559 173.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -58.11 -47.29 99.12 Favored Pre-proline 0 CA--C 1.547 0.847 0 O-C-N 120.314 -1.492 . . . . 0.0 114.274 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.23 -30.33 5.59 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.703 2.269 . . . . 0.0 113.893 172.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.8 p -71.75 -27.96 63.32 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 121.009 1.731 . . . . 0.0 112.962 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -62.29 -42.34 99.27 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.329 -1.482 . . . . 0.0 112.787 161.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.45 -37.5 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-N 120.002 1.274 . . . . 0.0 111.348 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HZ1' ' CG ' ' A' ' 114' ' ' ASP . 65.3 tttt -65.97 -38.17 87.87 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.897 0.879 . . . . 0.0 112.2 172.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -71.79 -28.14 63.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.48 1.112 . . . . 0.0 112.646 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.8 mt -83.61 -2.74 56.75 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.555 1.542 . . . . 0.0 114.403 168.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -144.64 39.53 1.26 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.253 1.421 . . . . 0.0 112.925 -175.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 m -73.25 65.73 0.85 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -162.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.401 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 95.9 mttt -70.68 -35.5 72.85 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.92 1.288 . . . . 0.0 111.875 166.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.45 ' CG ' ' HZ1' ' A' ' 108' ' ' LYS . 8.1 t0 -79.52 117.79 69.03 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-O 117.102 -1.428 . . . . 0.0 107.431 152.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -53.89 149.62 33.27 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.27 2.647 . . . . 0.0 116.53 -154.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.38 -41.85 93.29 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.101 -170.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.62 -19.64 59.07 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.453 1.101 . . . . 0.0 113.634 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.79 -37.53 13.27 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 121.046 -1.034 . . . . 0.0 112.485 166.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 63.9 m -65.8 -29.4 69.89 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.011 0.924 . . . . 0.0 112.99 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -57.38 -43.64 83.79 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.67 1.588 . . . . 0.0 111.769 174.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -70.35 -40.31 74.14 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.891 0.876 . . . . 0.0 111.533 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.48 -21.89 65.5 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 173.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.7 tp -84.59 -40.3 17.67 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.078 1.351 . . . . 0.0 111.882 170.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.2 mt -64.15 -41.55 97.12 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.937 1.295 . . . . 0.0 113.449 -176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.01 -34.44 78.1 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.492 1.496 . . . . 0.0 112.87 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.52 -36.76 60.46 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.27 -0.894 . . . . 0.0 112.914 171.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.5 mt -64.89 -36.2 83.61 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.742 -1.224 . . . . 0.0 112.823 172.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -64.53 -42.99 95.4 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.456 1.103 . . . . 0.0 111.309 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.57 -37.5 87.56 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.39 0.676 . . . . 0.0 112.345 176.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 tp -66.62 -55.27 16.09 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.386 1.075 . . . . 0.0 111.643 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -66.68 -38.54 87.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.021 1.328 . . . . 0.0 113.766 -170.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.67 -33.68 83.35 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.24 -0.755 . . . . 0.0 113.494 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -91.23 -31.06 16.3 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 117.77 0.785 . . . . 0.0 113.004 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 16.0 mt -62.27 -31.69 72.3 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.564 -1.335 . . . . 0.0 113.247 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -65.36 0.59 1.4 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 172.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.2 t -109.32 -25.75 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.854 1.661 . . . . 0.0 113.22 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -106.11 -9.43 16.97 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 -161.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 122.33 171.2 13.84 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 119.863 1.211 . . . . 0.0 113.604 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -78.06 -4.69 14.6 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.683 3.589 . . . . 0.0 116.122 -160.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -98.8 167.41 10.78 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.082 -1.011 . . . . 0.0 111.649 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.4 mt -69.86 -4.16 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 120.576 -1.328 . . . . 0.0 113.055 174.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.469 ' CB ' ' HG1' ' A' ' 147' ' ' THR . . . -121.68 27.83 7.98 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.033 1.733 . . . . 0.0 113.707 165.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.42 -108.81 2.71 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.256 0.931 . . . . 0.0 113.023 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -60.28 -33.28 72.1 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -172.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -148.2 163.51 36.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.157 1.383 . . . . 0.0 111.694 -167.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 51.8 mt -64.79 135.21 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.602 0.761 . . . . 0.0 109.645 164.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.469 ' HG1' ' CB ' ' A' ' 142' ' ' ALA . 29.3 p -135.33 -176.56 4.31 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.914 1.286 . . . . 0.0 111.258 169.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.41 -22.3 2.9 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 167.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.0 t -72.12 -42.47 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 120.945 -1.097 . . . . 0.0 112.005 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -61.35 -43.67 98.48 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 120.964 -1.085 . . . . 0.0 112.373 169.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 25.1 mt -61.65 -21.91 64.82 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 24.8 m -82.0 -47.85 12.16 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.187 -0.946 . . . . 0.0 112.135 175.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 26.8 mt -97.05 -34.4 11.18 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -167.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.77 -49.24 94.9 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -174.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.06 -28.4 15.99 Favored 'Trans proline' 0 C--N 1.35 0.617 0 CA-C-N 120.996 1.391 . . . . 0.0 112.998 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -68.88 -30.52 69.04 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 117.487 -1.244 . . . . 0.0 112.572 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 56.3 mt -68.24 -45.5 73.05 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -56.98 -39.73 75.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.188 0.595 . . . . 0.0 111.477 170.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -70.46 -18.91 62.99 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.5 mt -76.44 -52.6 9.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.681 1.128 . . . . 0.0 111.261 166.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -62.97 -29.9 71.17 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.145 0.978 . . . . 0.0 112.395 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 76.0 t -89.64 -70.72 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.921 1.289 . . . . 0.0 113.168 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.32 -52.39 7.76 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.83 -0.544 . . . . 0.0 112.351 -158.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 42.8 tp -65.76 -31.08 71.87 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 118.948 -0.549 . . . . 0.0 111.344 171.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -55.64 -28.3 51.34 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.177 1.37 . . . . 0.0 115.804 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -71.08 -15.31 62.52 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -126.2 -28.45 3.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.604 1.162 . . . . 0.0 112.807 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -145.63 97.06 2.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.805 2.042 . . . . 0.0 108.518 164.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -68.34 78.93 0.26 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.204 1.002 . . . . 0.0 110.561 166.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -68.76 118.13 57.76 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.095 0.958 . . . . 0.0 110.956 -173.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.19 100.85 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.954 1.77 . . . . 0.0 110.301 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.4 mm -55.3 111.51 3.14 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.664 1.186 . . . . 0.0 108.119 167.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -63.24 149.93 89.98 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.323 1.349 . . . . 0.0 112.519 -168.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.29 -19.53 65.48 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.849 -1.157 . . . . 0.0 113.429 172.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -62.41 -36.02 81.03 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.99 1.316 . . . . 0.0 112.732 167.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 45.7 mt -80.75 52.55 1.72 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.59 1.556 . . . . 0.0 111.12 166.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -26.61 67.85 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.52 1.128 . . . . 0.0 112.353 -170.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -77.83 -48.58 16.15 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.457 -0.777 . . . . 0.0 112.069 174.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.75 -39.46 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.862 0.865 . . . . 0.0 110.944 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 56.1 tp -63.43 -40.61 97.63 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.816 0.847 . . . . 0.0 113.026 175.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -69.56 -41.89 75.26 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.466 0.706 . . . . 0.0 112.533 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -64.55 -32.39 74.02 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.533 1.133 . . . . 0.0 112.538 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.13 -35.03 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 120.993 -1.067 . . . . 0.0 111.851 169.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 40.7 mmtt -80.43 -16.79 53.57 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.332 -1.48 . . . . 0.0 112.867 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.66 -18.67 62.84 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.152 -0.928 . . . . 0.0 113.434 162.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 73.8 mt -66.29 -18.24 65.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.117 1.326 . . . . 0.0 113.988 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -98.04 9.32 43.11 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.763 1.225 . . . . 0.0 112.41 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.0 p -116.27 179.14 4.08 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.363 1.465 . . . . 0.0 113.622 -170.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.4 mtp85 57.17 -163.67 0.18 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.578 1.551 . . . . 0.0 110.079 -169.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -84.31 -31.11 25.04 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.966 -0.459 . . . . 0.0 111.428 156.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 35.2 p -75.36 -59.16 2.87 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.968 1.307 . . . . 0.0 114.351 -160.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -64.85 -42.33 94.97 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.799 0.727 . . . . 0.0 112.0 172.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -53.36 -33.8 55.04 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.308 1.443 . . . . 0.0 114.028 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -86.83 -8.14 57.59 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 4.1 p -73.73 -18.59 60.97 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.346 1.43 . . . . 0.0 112.425 169.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -58.94 132.49 54.15 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.833 1.253 . . . . 0.0 111.863 -175.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -106.85 176.96 5.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.048 1.339 . . . . 0.0 110.465 169.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.47 116.53 9.99 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.155 -0.965 . . . . 0.0 109.571 167.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -57.11 -34.44 68.35 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -167.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.65 -40.69 79.87 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.673 1.189 . . . . 0.0 111.778 174.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -86.53 -3.16 58.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.331 1.852 . . . . 0.0 112.809 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 25.8 t -84.99 -49.25 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.279 1.032 . . . . 0.0 110.091 159.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 12.7 mt -60.98 -54.59 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.509 1.123 . . . . 0.0 111.691 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.71 -15.98 63.25 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.269 1.027 . . . . 0.0 113.389 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.47 -27.44 43.34 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 118.616 -1.102 . . . . 0.0 113.48 171.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -90.0 -34.96 15.79 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.476 1.911 . . . . 0.0 114.262 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -48.1 -48.94 62.82 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.2 -24.83 27.23 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 121.577 1.518 . . . . 0.0 114.022 174.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -74.96 -6.64 50.38 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 175.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.401 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 61.5 t -60.29 -18.42 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.181 -0.95 . . . . 0.0 111.416 158.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -118.79 17.19 13.52 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.554 1.942 . . . . 0.0 115.052 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.922 0 C-N-CA 125.168 1.387 . . . . 0.0 110.386 171.395 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' GSH . . . . . 0.414 ' C1 ' ' H ' ' A' ' 73' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 75.9 mt -125.19 118.66 26.54 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.651 1.981 . . . . 0.0 109.582 -173.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -116.42 132.98 56.53 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.183 0.993 . . . . 0.0 109.589 173.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.7 pt -128.69 135.99 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 118.93 0.786 . . . . 0.0 110.957 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.0 m -111.95 122.27 47.3 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.097 0.959 . . . . 0.0 109.922 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.54 161.18 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.147 0.979 . . . . 0.0 112.018 -166.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -56.73 117.54 4.01 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.168 1.387 . . . . 0.0 111.753 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.413 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -75.11 148.67 39.51 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.138 155.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.16 151.12 47.63 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.132 0.968 . . . . 0.0 112.573 175.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.9 t -65.97 123.54 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.327 0.651 . . . . 0.0 109.311 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.91 -17.54 2.21 Favored Glycine 0 CA--C 1.54 1.612 0 N-CA-C 116.297 1.279 . . . . 0.0 116.297 -176.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.04 72.55 55.11 Favored Pre-proline 0 CA--C 1.548 0.867 0 CA-C-N 119.098 1.449 . . . . 0.0 111.622 -175.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.413 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 48.6 Cg_endo -64.35 -14.67 45.37 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.135 2.557 . . . . 0.0 115.265 -167.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -84.4 -0.39 52.54 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.0 pt -135.15 165.28 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.65 1.18 . . . . 0.0 112.081 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.0 mt -73.66 146.45 44.53 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.185 0.994 . . . . 0.0 111.665 173.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.48 -159.05 8.67 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.992 1.282 . . . . 0.0 112.15 167.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.428 ' CG ' ' HZ3' ' A' ' 209' ' ' LYS . 62.5 t0 -59.11 98.22 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 122.934 1.35 . . . . 0.0 113.788 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.2 t -153.26 95.85 2.91 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.425 1.49 . . . . 0.0 108.718 142.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.86 -20.01 64.38 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.163 1.909 . . . . 0.0 112.391 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -65.93 -37.34 85.8 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.669 1.188 . . . . 0.0 112.846 172.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 95.1 m -64.81 -38.15 90.0 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.723 -1.235 . . . . 0.0 112.142 169.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -65.92 -25.56 67.2 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 118.519 -0.753 . . . . 0.0 112.73 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -58.23 -43.42 87.76 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.603 1.161 . . . . 0.0 113.244 168.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.02 -40.13 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.287 1.035 . . . . 0.0 110.792 -175.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.8 mt -61.59 -40.55 95.17 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.917 -0.489 . . . . 0.0 111.684 170.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 tp -60.55 -47.71 84.98 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.775 1.23 . . . . 0.0 113.34 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.1 p -73.06 -33.42 65.66 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.9 1.227 . . . . 0.0 113.46 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.52 -40.82 96.33 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.525 -0.735 . . . . 0.0 111.986 173.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -80.34 -23.69 40.39 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -65.0 -45.08 87.08 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.073 -1.017 . . . . 0.0 111.597 164.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -68.85 -23.38 64.23 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.241 -0.912 . . . . 0.0 112.671 171.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.0 mtmm 59.64 19.56 8.19 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.351 1.861 . . . . 0.0 112.407 -170.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.4 tt -74.15 140.23 76.54 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.2 1.4 . . . . 0.0 109.884 -171.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -66.87 132.32 28.07 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 121.803 1.668 . . . . 0.0 112.02 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -141.65 169.88 16.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.085 1.754 . . . . 0.0 111.169 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.674 ' HE2' ' NE2' ' A' ' 40' ' ' HIS . 52.1 tttt -130.59 127.77 39.7 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.069 1.747 . . . . 0.0 109.015 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.521 ' C ' ' HD2' ' A' ' 40' ' ' HIS . 27.6 t -114.17 138.16 50.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.157 0.983 . . . . 0.0 112.939 -170.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.674 ' NE2' ' HE2' ' A' ' 38' ' ' LYS . 6.1 m170 -126.31 108.9 11.68 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.965 1.706 . . . . 0.0 108.416 -171.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.6 mt -76.89 107.66 9.38 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.267 0.627 . . . . 0.0 110.494 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.4 mm -91.34 119.45 38.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.654 1.181 . . . . 0.0 109.379 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -69.14 126.3 29.35 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.292 -0.632 . . . . 32.609999999999999 109.292 161.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.9 mt -88.58 -18.47 28.01 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.122 0.786 . . . . 40.049999999999997 113.122 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.55 -20.43 71.6 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 118.79 0.723 . . . . 41.469999999999999 114.344 172.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -147.49 90.44 1.86 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.836 1.655 . . . . 47.170000000000002 108.688 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -84.82 135.0 40.63 Favored Pre-proline 0 N--CA 1.469 0.491 0 C-N-CA 124.142 0.977 . . . . 41.270000000000003 110.034 -170.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -59.26 140.45 94.73 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.343 2.029 . . . . 40.289999999999999 111.737 171.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.06 -40.56 89.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.195 0.813 . . . . 42.390000000000001 113.195 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 31.7 p-90 -65.97 -13.41 59.76 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.233 1.198 . . . . 37.079999999999998 114.233 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -67.49 -26.88 66.58 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.242 -1.537 . . . . 35.880000000000003 112.62 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.9 mt -70.66 -21.08 62.65 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.368 0.877 . . . . 33.609999999999999 113.368 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.72 -16.36 61.19 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.192 0.997 . . . . 33.789999999999999 112.57 171.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.3 mt -102.58 -43.39 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.13 1.372 . . . . 33.159999999999997 110.7 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.4 t -124.8 104.24 30.49 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 125.451 1.5 . . . . 33.579999999999998 110.376 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.29 -19.64 38.12 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.51 2.14 . . . . 37.899999999999999 113.769 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -83.77 -5.87 59.3 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.77 1.026 . . . . 38.990000000000002 113.77 168.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.91 14.22 65.23 Favored Glycine 0 CA--C 1.534 1.276 0 O-C-N 120.878 -1.139 . . . . 35.469999999999999 114.773 -172.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -91.89 156.28 17.59 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.262 1.425 . . . . 34.490000000000002 112.818 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.0 m -109.44 156.49 39.42 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 126.096 1.759 . . . . 23.530000000000001 110.935 159.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.02 153.78 80.62 Favored 'Cis proline' 0 C--N 1.348 0.508 0 CA-C-O 122.299 0.875 . . . . 22.879999999999999 113.352 -10.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.6 p -143.71 146.74 20.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 113.304 -1.771 . . . . 0.0 107.31 159.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.01 163.62 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.596 0.758 . . . . 0.0 110.444 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -111.35 121.78 46.14 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.934 1.294 . . . . 0.0 109.748 157.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 95.8 mt -106.23 115.35 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.3 1.44 . . . . 0.0 107.693 170.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.404 ' O ' ' HE2' ' A' ' 68' ' ' LYS . 2.5 t70 53.25 43.58 31.31 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 122.529 1.156 . . . . 0.0 113.655 -167.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.2 t70 66.89 -7.97 0.44 Allowed 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -171.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 66' ' ' ASP . 20.4 mmtt -91.83 127.97 37.49 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 119.472 -2.018 . . . . 0.0 111.744 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 27.8 p-90 -74.6 147.57 41.53 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -167.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.0 t -141.57 126.11 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.204 1.801 . . . . 0.0 108.563 171.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -109.96 166.57 10.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.633 1.573 . . . . 0.0 111.534 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.0 t0 67.01 114.07 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.064 2.146 . . . . 22.16 113.935 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.2 p -64.0 -29.21 70.39 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 115.317 1.599 . . . . 21.16 115.317 -163.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -71.08 -29.88 65.85 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 120.135 1.334 . . . . 24.969999999999999 112.163 171.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.2 t -75.09 -42.05 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 O-C-N 120.623 -1.298 . . . . 23.850000000000001 111.645 170.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.01 -45.55 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.345 1.058 . . . . 23.68 110.63 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.9 t -63.1 -43.32 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.09 0.956 . . . . 22.84 111.353 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.97 93.33 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 118.654 0.661 . . . . 23.329999999999998 113.505 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 70.6 mt -77.08 -41.21 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 117.946 0.873 . . . . 23.309999999999999 112.278 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.1 mt -62.97 -37.05 85.55 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.132 1.333 . . . . 23.48 112.48 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -89.27 9.24 26.65 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.333 1.234 . . . . 24.239999999999998 114.333 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -123.04 -42.0 2.3 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.857 1.263 . . . . 39.259999999999998 112.654 173.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -126.25 65.57 1.23 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.77 1.628 . . . . 24.449999999999999 111.456 -167.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.62 165.38 28.71 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 124.815 1.246 . . . . 0.0 110.694 175.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.01 -27.17 8.67 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.965 2.443 . . . . 0.0 114.939 -174.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -77.68 160.91 73.58 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 118.93 0.786 . . . . 0.0 110.06 168.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -52.32 139.01 55.41 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.546 2.164 . . . . 0.0 114.642 -175.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.414 ' O ' HD23 ' A' ' 89' ' ' LEU . 78.7 Cg_endo -69.99 147.09 60.64 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.449 2.766 . . . . 0.0 111.29 176.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.637 HD22 ' HZ1' ' A' ' 145' ' ' LYS . 15.2 mt -131.49 9.87 4.74 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.103 1.361 . . . . 0.0 113.232 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.88 41.89 0.1 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.305 1.842 . . . . 0.0 114.578 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 90.5 m -105.78 103.39 43.72 Favored Pre-proline 0 N--CA 1.472 0.669 0 C-N-CA 125.107 1.363 . . . . 0.0 110.314 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -86.56 112.5 1.05 Allowed 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 124.148 3.232 . . . . 0.0 111.516 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -82.9 -170.46 0.92 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.863 3.042 . . . . 0.0 111.888 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 15.4 mp0 -52.32 -33.33 42.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.211 2.204 . . . . 0.0 113.171 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -57.92 -23.66 54.43 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.458 1.503 . . . . 0.0 114.14 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.55 -27.12 67.49 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.099 -1.001 . . . . 0.0 113.099 172.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 86.2 p -65.75 -47.95 73.53 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.153 -0.967 . . . . 0.0 112.149 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.2 t -77.33 -37.94 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 121.274 -0.891 . . . . 0.0 111.444 174.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.22 -31.34 80.51 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 121.265 -0.897 . . . . 0.0 114.137 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 89.0 p -73.06 -14.55 61.43 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -86.72 -39.83 15.63 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.536 1.135 . . . . 0.0 112.586 167.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.47 -37.52 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.289 1.436 . . . . 0.0 111.418 173.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -53.4 -54.38 45.94 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.915 1.686 . . . . 0.0 114.24 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.78 -34.83 0.87 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.118 2.545 . . . . 0.0 113.303 170.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.0 p -65.9 -31.06 71.77 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.403 1.456 . . . . 0.0 112.631 -173.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -79.58 -20.89 45.88 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.249 -1.532 . . . . 0.0 113.71 172.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.6 t -72.9 -38.2 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 120.399 -1.438 . . . . 0.0 110.744 164.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -69.58 -27.67 65.32 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -59.39 -41.46 89.45 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.097 1.359 . . . . 0.0 111.855 170.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.5 mt -80.14 4.19 18.14 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.819 1.648 . . . . 0.0 114.81 172.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -136.76 35.48 2.64 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 127.97 2.508 . . . . 0.0 111.277 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 p -82.23 58.02 3.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.585 1.954 . . . . 0.0 113.69 -169.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.53 -45.84 91.15 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.162 0.985 . . . . 0.0 110.096 161.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.6 119.52 60.82 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 128.157 2.583 . . . . 0.0 107.71 155.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.16 135.09 68.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.935 1.757 . . . . 0.0 115.843 -159.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -68.16 -32.62 73.01 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 117.779 -1.105 . . . . 0.0 112.115 170.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.74 -32.06 68.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.166 1.386 . . . . 0.0 114.024 174.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.05 -34.86 9.39 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.744 0.688 . . . . 0.0 113.499 172.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 61.4 m -64.94 -40.6 95.28 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.409 1.084 . . . . 0.0 112.107 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -59.58 -27.46 66.28 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.358 1.863 . . . . 0.0 113.655 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -69.2 -18.34 63.9 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.127 0.971 . . . . 0.0 112.885 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.18 -35.8 13.64 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.857 0.863 . . . . 0.0 112.551 165.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.6 mt -65.95 -34.6 78.49 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.69 -36.38 82.73 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.714 0.688 . . . . 0.0 112.076 173.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.77 -30.66 32.24 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.249 0.62 . . . . 0.0 112.425 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.16 -46.86 88.79 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.131 0.972 . . . . 0.0 111.741 166.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.0 mt -65.21 -40.69 94.48 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.774 -1.108 . . . . 0.0 112.128 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -62.66 -42.11 99.43 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.291 1.405 . . . . 0.0 112.576 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.69 -35.78 82.15 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.216 0.607 . . . . 0.0 112.257 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.2 tp -72.84 -54.46 8.75 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.68 0.792 . . . . 0.0 111.529 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -63.1 -35.4 80.14 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.498 1.919 . . . . 0.0 113.906 -173.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.34 -33.64 81.61 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 123.914 0.768 . . . . 0.0 113.731 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -94.98 -28.64 15.04 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.6 mt -66.25 -32.23 73.52 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.594 -1.316 . . . . 0.0 113.272 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -66.37 -11.0 48.95 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.55 -29.27 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.737 0.815 . . . . 0.0 111.928 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -94.65 -37.31 11.38 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.605 1.162 . . . . 0.0 113.303 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.33 -69.97 0.23 Allowed Glycine 0 CA--C 1.542 1.735 0 CA-C-O 116.609 -2.217 . . . . 0.0 116.525 166.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -102.04 -33.86 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.987 0 N-CA-C 117.825 2.202 . . . . 0.0 117.825 -156.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -134.16 156.68 47.89 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.416 1.462 . . . . 0.0 112.93 -167.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.4 mt -70.46 -12.91 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.67 -1.64 46.23 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 165.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.07 -135.15 10.19 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 120.154 1.343 . . . . 0.0 113.738 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -62.4 -25.36 67.89 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.637 ' HZ1' HD22 ' A' ' 89' ' ' LEU . 6.2 pttp -144.08 164.09 31.65 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.141 1.376 . . . . 0.0 110.403 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.3 mt -61.36 122.12 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 123.433 0.693 . . . . 0.0 110.467 169.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.7 p -140.21 -160.56 1.08 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.45 1.5 . . . . 0.0 108.901 160.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -49.5 -32.82 13.0 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -166.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.3 t -71.86 -37.48 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 120.725 1.602 . . . . 0.0 113.003 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -63.11 -44.04 96.78 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.34 -0.85 . . . . 0.0 111.587 167.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.5 mt -64.98 -27.36 68.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.009 0.524 . . . . 0.0 111.97 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 73.6 m -75.9 -31.94 59.41 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 120.201 -1.562 . . . . 0.0 113.654 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 68.6 mt -124.9 -33.84 2.88 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -162.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.61 -50.08 79.18 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -169.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -68.89 -25.7 32.52 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.479 1.452 . . . . 0.0 113.518 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -72.63 -29.47 63.5 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.224 -0.922 . . . . 0.0 112.198 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 38.0 mt -71.67 -44.09 64.89 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.788 0.835 . . . . 0.0 112.058 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -63.85 -38.5 91.33 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -64.19 -34.7 78.69 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.438 -1.414 . . . . 0.0 112.573 173.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.7 tp -68.83 -47.04 67.02 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.252 -0.905 . . . . 0.0 111.178 174.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -52.3 -45.18 65.43 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.442 1.497 . . . . 0.0 112.225 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.1 t -75.2 -58.88 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.919 0.888 . . . . 0.0 113.119 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.76 -36.07 37.74 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.993 -1.067 . . . . 0.0 113.463 -167.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.2 tp -72.83 -31.81 65.05 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.578 -0.702 . . . . 0.0 111.28 171.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.83 -27.98 37.96 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.837 1.208 . . . . 0.0 114.704 170.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -67.53 -19.49 65.3 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -141.5 -27.18 0.68 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -149.87 80.85 1.38 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.522 1.529 . . . . 0.0 109.355 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.9 75.85 0.08 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.388 1.475 . . . . 0.0 112.403 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -71.73 112.96 16.06 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.127 1.771 . . . . 0.0 112.32 -168.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.31 137.52 19.0 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.546 2.164 . . . . 0.0 111.845 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 46.7 mm -87.57 113.93 56.52 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.329 1.052 . . . . 0.0 109.025 164.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -71.06 155.86 60.85 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.254 1.969 . . . . 0.0 111.779 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.59 -12.39 44.79 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -62.05 -31.44 71.85 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.209 1.004 . . . . 0.0 112.835 166.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.2 mt -84.19 57.18 4.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.464 1.906 . . . . 0.0 110.835 167.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -22.86 64.6 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.62 1.168 . . . . 0.0 113.297 -161.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -75.52 -52.49 10.52 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.257 0.935 . . . . 0.0 110.303 165.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 33.7 t -57.53 -46.69 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 119.234 0.925 . . . . 0.0 112.711 -174.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.7 tp -64.36 -27.95 69.37 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -93.61 -29.48 15.44 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.143 -0.973 . . . . 0.0 113.272 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -64.0 -36.92 85.56 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.271 1.428 . . . . 0.0 112.925 173.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.5 mt -60.01 -37.43 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 O-C-N 121.336 -0.852 . . . . 0.0 111.641 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -67.01 -28.26 68.1 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.047 -1.658 . . . . 0.0 112.475 173.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.1 mt -71.5 -20.59 62.04 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.473 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 68.9 mt -65.65 -21.6 66.57 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 120.17 1.35 . . . . 0.0 112.751 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -85.71 19.1 2.57 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.456 1.502 . . . . 0.0 113.308 170.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.8 p -142.81 178.65 7.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.797 2.039 . . . . 0.0 112.947 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 65.7 mtp85 59.74 171.88 0.08 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.619 1.968 . . . . 0.0 113.561 -170.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 53.1 mp0 -64.83 -47.91 76.29 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.422 1.089 . . . . 0.0 110.286 159.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -39.29 89.78 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.681 1.992 . . . . 0.0 115.707 -170.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -96.67 -53.26 3.62 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.483 1.038 . . . . 0.0 111.746 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -62.31 -37.37 85.31 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -168.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.88 -22.85 66.55 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.15 0.886 . . . . 0.0 113.034 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 7.0 p -90.55 -7.09 53.81 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.647 1.179 . . . . 0.0 113.2 -173.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -60.61 114.68 3.12 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.458 1.503 . . . . 0.0 111.063 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -70.11 162.56 28.03 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.051 0.94 . . . . 0.0 112.579 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -75.39 125.81 29.74 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.848 -0.533 . . . . 0.0 110.684 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -73.84 -32.1 63.5 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -155.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.37 -36.42 83.66 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.812 1.245 . . . . 0.0 111.162 167.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -83.69 -8.43 59.28 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.009 1.724 . . . . 0.0 113.309 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.2 t -78.47 -51.89 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.347 1.059 . . . . 0.0 109.913 158.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 62.2 mt -62.32 -48.03 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.015 0.926 . . . . 0.0 111.974 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -5.39 41.74 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.874 1.27 . . . . 0.0 114.15 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -90.33 -32.75 9.25 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 121.133 -0.979 . . . . 0.0 113.134 164.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -83.22 -32.56 26.43 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.13 1.772 . . . . 0.0 114.802 -174.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -48.83 -55.15 21.55 Favored Pre-proline 0 N--CA 1.481 1.121 0 CA-C-N 120.254 1.388 . . . . 0.0 114.35 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.19 -20.8 32.34 Favored 'Trans proline' 0 C--N 1.351 0.678 0 CA-C-N 120.806 1.324 . . . . 0.0 111.979 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.428 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 45.6 mtpt -84.54 2.69 40.06 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.148 1.779 . . . . 0.0 114.274 174.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 63.4 t -66.58 -29.97 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 120.886 -1.134 . . . . 0.0 110.219 152.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -96.2 -52.34 4.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 117.183 -1.389 . . . . 0.0 114.265 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.865 2.066 . . . . 0.0 113.089 -177.239 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.912 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.99 136.73 34.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.903 1.281 . . . . 0.0 110.771 -170.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -139.21 151.42 46.54 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.412 1.485 . . . . 0.0 108.845 166.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.54 140.73 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.206 1.002 . . . . 0.0 109.148 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.9 m -113.56 122.29 46.8 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.086 0.954 . . . . 0.0 109.38 171.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -136.59 157.92 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.887 1.275 . . . . 0.0 110.699 -164.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -57.7 115.43 2.79 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.611 0.365 . . . . 0.0 110.839 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -81.49 151.24 27.9 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.964 154.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.73 151.53 33.68 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.256 1.026 . . . . 0.0 112.515 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.6 t -70.86 135.98 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 166.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.53 -33.85 1.37 Allowed Glycine 0 CA--C 1.539 1.538 0 CA-C-O 118.585 -1.119 . . . . 0.0 115.218 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.96 67.85 12.1 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.861 1.264 . . . . 0.0 112.529 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.504 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 70.8 Cg_endo -65.71 -7.47 16.59 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.268 2.645 . . . . 0.0 114.685 -175.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -81.17 -0.1 38.84 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.493 1.517 . . . . 0.0 114.452 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.4 pt -133.34 162.08 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.994 1.318 . . . . 0.0 111.546 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.8 mt -63.6 150.96 42.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.725 0.81 . . . . 0.0 111.648 168.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.0 -166.32 10.91 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.557 1.551 . . . . 0.0 111.949 166.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -56.61 107.96 0.44 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.4 t -158.89 103.48 1.59 Allowed Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.281 139.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -64.57 -20.82 65.9 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.294 1.996 . . . . 0.0 112.633 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -68.38 -26.41 65.55 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.906 -1.121 . . . . 0.0 112.829 172.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 81.7 m -74.04 -37.09 64.42 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.614 -1.304 . . . . 0.0 112.055 170.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -62.24 -26.8 68.58 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 118.339 -0.839 . . . . 0.0 112.938 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.54 HH12 ' CG ' ' A' ' 74' ' ' ASP . 59.1 mtp180 -57.01 -42.8 81.02 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.118 0.967 . . . . 0.0 112.471 170.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.78 -41.46 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.284 1.434 . . . . 0.0 111.381 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -58.94 -42.92 90.96 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.972 0.509 . . . . 0.0 111.401 172.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.02 -50.53 73.39 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.306 1.042 . . . . 0.0 112.748 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 p -75.71 -38.34 58.67 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -175.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.1 mt -65.91 -39.75 90.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.566 0.621 . . . . 0.0 111.32 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -77.85 -25.56 48.81 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -67.13 -48.66 67.41 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 120.741 -1.224 . . . . 0.0 111.325 169.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.423 ' HE3' HD12 ' A' ' 35' ' ' ILE . 51.2 mtmt -76.93 -0.33 23.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.016 1.726 . . . . 0.0 114.436 175.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm 57.79 20.67 6.71 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.785 1.634 . . . . 0.0 114.677 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.423 HD12 ' HE3' ' A' ' 33' ' ' LYS . 95.8 mt -69.77 128.8 91.7 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.504 1.122 . . . . 0.0 109.035 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.73 140.68 23.78 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.467 2.112 . . . . 0.0 111.737 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -145.11 152.03 39.43 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.604 1.562 . . . . 0.0 110.089 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -77.55 131.51 37.9 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.064 -1.022 . . . . 0.0 109.339 158.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.6 t -103.95 94.42 5.4 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.927 0.891 . . . . 0.0 110.755 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -81.26 99.06 8.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.775 0.83 . . . . 0.0 109.615 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 70.0 mt -66.98 108.79 2.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.528 0.731 . . . . 0.0 109.039 170.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.7 mm -120.66 114.88 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.529 1.132 . . . . 0.0 109.303 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -76.56 90.5 3.33 Favored 'General case' 0 C--O 1.22 -0.455 0 O-C-N 120.775 -1.203 . . . . 32.609999999999999 108.42 165.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.06 -7.34 1.76 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 117.173 2.286 . . . . 40.049999999999997 117.173 -170.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.56 -37.85 89.95 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 119.651 1.114 . . . . 41.469999999999999 111.762 165.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -105.58 47.77 0.86 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 129.452 3.101 . . . . 47.170000000000002 111.177 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -73.92 126.68 89.22 Favored Pre-proline 0 N--CA 1.475 0.779 0 O-C-N 119.695 -1.878 . . . . 41.270000000000003 111.689 -174.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.86 159.55 52.22 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.468 2.112 . . . . 40.289999999999999 110.982 170.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -62.45 -29.21 70.35 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.776 1.028 . . . . 42.390000000000001 113.776 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.4 t90 -56.28 -35.24 67.27 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.969 1.308 . . . . 37.079999999999998 113.957 168.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -79.41 -33.92 42.25 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.949 -1.094 . . . . 35.880000000000003 112.82 174.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 mt -71.02 -21.05 62.33 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.76 1.022 . . . . 33.609999999999999 113.76 173.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -66.38 -47.93 71.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.446 0.698 . . . . 33.789999999999999 110.752 166.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.6 mt -72.1 -33.21 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.308 1.043 . . . . 33.159999999999997 112.183 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.4 t -137.78 81.93 27.53 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 127.069 2.147 . . . . 33.579999999999998 110.507 -173.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -63.9 -23.51 68.29 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.231 2.621 . . . . 37.899999999999999 113.778 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -74.27 -10.94 60.09 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.805 -1.185 . . . . 38.990000000000002 113.845 167.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.89 22.58 76.65 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.463 1.506 . . . . 35.469999999999999 115.131 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -110.72 159.3 17.74 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.872 1.669 . . . . 34.490000000000002 113.921 -169.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.7 155.14 63.52 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.645 1.578 . . . . 23.530000000000001 111.85 172.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -63.51 152.75 71.37 Favored 'Cis proline' 0 C--N 1.349 0.575 0 CA-C-O 121.813 0.672 . . . . 22.879999999999999 112.611 -11.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.2 p -139.24 144.43 29.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.568 161.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.59 162.48 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 121.348 -0.845 . . . . 0.0 111.528 -169.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -123.21 63.91 1.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.103 1.761 . . . . 0.0 109.791 -174.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 81.4 mt -74.01 121.21 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.824 0.85 . . . . 0.0 108.76 -175.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.5 t0 55.15 35.89 25.79 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 121.862 -0.524 . . . . 0.0 111.447 -164.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t0 67.19 -8.74 0.43 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 127.628 2.371 . . . . 0.0 115.345 -170.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.3 mttt -83.93 133.56 34.7 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.443 1.497 . . . . 0.0 111.875 -173.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.2 m0 -73.72 128.6 35.94 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.018 1.327 . . . . 0.0 111.679 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.0 t -142.5 128.1 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.332 1.453 . . . . 0.0 109.776 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -103.53 175.18 5.56 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.692 1.597 . . . . 0.0 111.729 172.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.7 t0 66.44 108.79 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.829 2.452 . . . . 22.16 114.786 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.4 p -61.42 -23.95 66.19 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 115.226 1.565 . . . . 21.16 115.226 -168.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.54 ' CG ' HH12 ' A' ' 25' ' ' ARG . 38.1 m-20 -73.61 -37.47 65.41 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.745 1.157 . . . . 24.969999999999999 113.07 171.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -69.92 -39.0 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.409 -0.807 . . . . 23.850000000000001 111.039 171.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 89.6 mt -63.58 -44.11 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.302 1.041 . . . . 23.68 111.224 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.1 -41.07 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.181 0.993 . . . . 22.84 111.482 171.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.89 -12.64 49.27 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 115.786 1.074 . . . . 23.329999999999998 115.786 174.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 89.6 mt -102.38 -53.05 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 118.913 1.357 . . . . 23.309999999999999 111.011 168.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.6 -33.06 73.24 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.622 0.971 . . . . 23.48 113.622 -172.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -90.57 -2.91 57.88 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.71 1.004 . . . . 24.239999999999998 113.71 -173.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.434 ' CD ' ' HZ2' ' A' ' 83' ' ' LYS . 10.1 tt0 -117.33 -54.44 2.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.442 1.497 . . . . 39.259999999999998 112.05 172.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.434 ' HZ2' ' CD ' ' A' ' 82' ' ' GLU . 64.9 mttp -93.71 59.22 2.81 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.92 1.288 . . . . 24.449999999999999 112.152 -164.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -135.84 163.64 49.01 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.77 1.628 . . . . 0.0 110.997 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.15 -23.53 21.17 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.411 2.074 . . . . 0.0 112.562 172.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -74.57 147.02 84.36 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.039 1.336 . . . . 0.0 112.206 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -59.44 135.14 62.95 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.841 2.361 . . . . 0.0 113.645 -173.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.68 136.5 49.96 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.909 2.406 . . . . 0.0 113.867 -167.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 mt -103.83 -0.26 29.42 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.935 1.694 . . . . 0.0 112.088 169.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.81 51.64 0.5 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.559 1.944 . . . . 0.0 110.569 161.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -129.74 61.31 57.21 Favored Pre-proline 0 N--CA 1.467 0.41 0 C-N-CA 127.003 2.121 . . . . 0.0 109.104 -169.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -80.77 123.16 4.61 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.256 1.971 . . . . 0.0 111.23 -155.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -72.54 175.96 9.43 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.1 2.533 . . . . 0.0 111.504 167.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -59.38 -20.56 55.76 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -53.72 -24.87 16.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.472 1.509 . . . . 0.0 114.223 167.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.04 -31.29 71.68 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.719 -1.238 . . . . 0.0 112.993 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.0 p -69.04 -25.5 64.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.426 1.09 . . . . 0.0 112.975 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.4 t -89.24 -43.44 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.321 1.448 . . . . 0.0 110.57 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.65 -29.56 75.06 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.014 1.292 . . . . 0.0 114.631 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 88.9 p -66.88 -20.5 65.93 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.498 1.149 . . . . 0.0 114.019 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -94.83 -34.43 12.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.501 1.52 . . . . 0.0 112.874 172.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.1 mt -67.38 -37.98 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.511 0.724 . . . . 0.0 111.521 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -58.93 -47.97 97.67 Favored Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 120.303 -1.498 . . . . 0.0 114.136 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.52 -30.7 6.2 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.693 2.262 . . . . 0.0 113.976 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.3 p -70.72 -29.8 66.17 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.996 1.725 . . . . 0.0 112.761 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -62.22 -41.36 98.32 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.345 -1.472 . . . . 0.0 113.071 161.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.4 t -63.73 -37.48 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 120.248 1.385 . . . . 0.0 111.339 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -67.31 -37.65 83.69 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.607 0.763 . . . . 0.0 112.339 172.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -70.62 -30.22 66.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.408 1.083 . . . . 0.0 112.427 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.5 mt -83.42 1.38 41.81 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.73 1.612 . . . . 0.0 114.352 169.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -146.78 38.56 1.01 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.526 1.53 . . . . 0.0 113.082 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 m -73.8 63.71 0.9 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -161.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.34 -35.84 76.31 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.981 1.312 . . . . 0.0 111.798 165.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 12.0 t0 -81.89 119.05 74.34 Favored Pre-proline 0 CA--C 1.553 1.06 0 CA-C-O 117.125 -1.417 . . . . 0.0 107.221 153.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 114' ' ' ASP . 74.5 Cg_exo -53.66 150.92 26.73 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.419 2.746 . . . . 0.0 116.735 -153.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -66.34 -42.36 88.23 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.568 -174.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.12 -24.37 60.6 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.402 1.081 . . . . 0.0 113.417 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.31 -35.81 25.59 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.19 -0.944 . . . . 0.0 112.805 168.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 92.7 m -67.44 -27.19 66.84 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.655 -0.909 . . . . 0.0 112.687 169.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -58.75 -44.09 90.46 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 125.388 1.475 . . . . 0.0 111.814 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -70.44 -37.6 74.4 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.534 -0.729 . . . . 0.0 111.996 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.89 -16.09 63.67 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.2 tp -92.13 -40.71 10.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.379 1.471 . . . . 0.0 111.612 169.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.5 mt -65.02 -42.38 94.44 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.201 1.4 . . . . 0.0 113.558 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -65.27 -35.19 80.27 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.88 1.673 . . . . 0.0 112.469 -176.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -73.71 -37.26 65.21 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.43 -0.794 . . . . 0.0 112.83 172.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.3 mt -65.69 -36.4 83.53 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.688 -1.258 . . . . 0.0 112.656 171.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -64.57 -42.78 95.43 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.734 1.152 . . . . 0.0 111.253 173.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.21 -38.41 91.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.401 0.68 . . . . 0.0 112.131 175.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.6 tp -65.04 -52.81 53.74 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.045 0.938 . . . . 0.0 111.846 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -65.9 -38.41 88.66 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.214 1.405 . . . . 0.0 113.425 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -62.07 -36.05 92.35 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 119.284 -0.731 . . . . 0.0 113.845 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -87.45 -31.74 19.86 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 117.913 0.857 . . . . 0.0 112.879 175.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 12.8 mt -61.42 -36.23 79.76 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.004 -1.06 . . . . 0.0 113.436 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -65.21 -2.71 3.16 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.3 t -104.23 -27.76 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.591 1.556 . . . . 0.0 112.946 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -93.67 -50.94 5.15 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -168.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 158.95 172.41 26.02 Favored Glycine 0 CA--C 1.535 1.298 0 O-C-N 121.362 -0.836 . . . . 0.0 114.586 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -73.48 -15.25 24.9 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 124.669 3.579 . . . . 0.0 115.987 -163.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -89.95 167.45 12.8 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.379 0.99 . . . . 0.0 111.61 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -12.18 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.472 -1.393 . . . . 0.0 113.204 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -100.65 -4.1 29.04 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.8 1.408 . . . . 0.0 114.8 166.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 110.12 -122.95 6.51 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 119.871 1.214 . . . . 0.0 113.201 -175.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -70.43 -18.72 63.01 Favored 'General case' 0 CA--C 1.541 0.635 0 O-C-N 120.847 -1.384 . . . . 0.0 114.108 -168.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -141.35 155.74 45.9 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.907 1.683 . . . . 0.0 110.711 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 58.9 mt -62.73 129.31 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.592 0.757 . . . . 0.0 109.244 163.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.9 p -129.36 -175.41 3.57 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.8 0.84 . . . . 0.0 111.961 168.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.79 -19.1 3.83 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 172.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.6 t -70.32 -43.57 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.998 -1.064 . . . . 0.0 111.9 172.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -60.02 -45.19 93.61 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.471 1.108 . . . . 0.0 112.312 169.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 34.2 mt -61.06 -20.74 62.92 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 177.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.2 m -85.98 -43.99 12.71 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.37 -0.831 . . . . 0.0 112.047 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 29.5 mt -98.34 -33.53 11.03 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -168.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.49 -49.58 93.0 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.56 -22.35 18.34 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 121.095 1.427 . . . . 0.0 113.223 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -71.25 -33.25 69.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 117.47 -1.252 . . . . 0.0 112.077 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 68.9 mt -66.41 -43.17 86.49 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 169.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -58.33 -39.72 80.19 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.653 0.661 . . . . 0.0 111.588 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -70.81 -22.68 62.32 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.3 mt -71.98 -51.38 22.2 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.112 0.869 . . . . 0.0 111.496 168.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -64.8 -28.16 69.38 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.524 0.729 . . . . 0.0 112.461 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.3 t -94.21 -72.24 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.854 1.262 . . . . 0.0 113.159 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.98 -48.72 11.87 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.333 -0.854 . . . . 0.0 113.057 -158.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 63.4 tp -66.84 -34.0 76.84 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.825 -0.607 . . . . 0.0 111.074 166.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.38 -30.13 57.98 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.285 1.421 . . . . 0.0 115.505 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -64.34 -26.16 68.35 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 173.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -117.21 -28.09 6.28 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.547 1.139 . . . . 0.0 113.584 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -143.87 94.28 2.57 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.358 2.263 . . . . 0.0 108.032 167.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -68.35 80.68 0.25 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.077 0.951 . . . . 0.0 110.347 168.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -71.0 117.22 54.3 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.447 1.099 . . . . 0.0 110.966 -171.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.39 107.09 1.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.868 1.712 . . . . 0.0 110.352 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 30.5 mm -57.13 115.13 9.58 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 124.399 1.08 . . . . 0.0 108.445 169.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.59 146.62 92.79 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.6 1.534 . . . . 0.0 111.744 -174.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.88 -17.48 64.34 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 120.887 -1.133 . . . . 0.0 114.058 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -62.18 -35.33 78.49 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.807 1.243 . . . . 0.0 112.786 167.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 36.1 mt -80.54 50.81 1.36 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.802 1.641 . . . . 0.0 111.232 165.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -34.42 70.56 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.532 1.133 . . . . 0.0 111.746 -171.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -80.5 -37.86 30.89 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.255 1.022 . . . . 0.0 112.943 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 43.9 t -64.68 -40.61 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 119.512 1.051 . . . . 0.0 111.017 172.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.57 -41.2 96.44 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -65.47 -42.72 91.96 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 171.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -65.0 -33.27 75.65 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.431 1.092 . . . . 0.0 112.959 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 58.3 mt -58.62 -32.36 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.039 -1.038 . . . . 0.0 111.704 170.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -83.13 -11.63 57.76 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.33 -1.481 . . . . 0.0 113.613 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.81 -18.9 60.9 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 117.963 -1.018 . . . . 0.0 113.448 160.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 74.0 mt -66.06 -13.59 60.26 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.033 1.288 . . . . 0.0 114.281 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -106.35 10.74 31.52 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.931 1.292 . . . . 0.0 112.776 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.0 p -114.46 177.57 4.6 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.222 1.809 . . . . 0.0 113.763 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 52.8 mtp85 57.11 -166.31 0.14 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.813 1.645 . . . . 0.0 111.201 -172.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.454 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 8.7 mp0 -79.69 -33.77 40.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.449 0.7 . . . . 0.0 110.243 161.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 56.2 p -75.75 -66.85 0.73 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.909 1.683 . . . . 0.0 113.944 -162.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -61.68 -41.43 97.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.137 0.881 . . . . 0.0 112.268 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -56.68 -27.99 59.92 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -87.26 -11.2 50.35 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 11.8 p -74.76 -14.85 60.76 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.61 1.55 . . . . 0.0 112.931 173.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -59.49 134.45 57.02 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.773 1.229 . . . . 0.0 111.763 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -109.74 176.99 4.87 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.267 1.427 . . . . 0.0 110.562 168.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.69 113.84 8.18 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.812 -1.18 . . . . 0.0 109.352 168.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -57.57 -31.5 66.2 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -167.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.94 -40.28 88.44 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.481 1.112 . . . . 0.0 112.009 173.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -85.52 -3.12 58.77 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.133 1.773 . . . . 0.0 112.935 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 42.1 t -86.69 -48.84 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.753 1.221 . . . . 0.0 109.971 162.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.6 mt -57.96 -52.01 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.923 1.289 . . . . 0.0 111.512 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.3 -12.89 61.89 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.25 -32.34 10.67 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.148 -0.97 . . . . 0.0 113.371 171.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 57.1 t90 -80.26 -35.65 35.7 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.096 1.759 . . . . 0.0 114.224 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -51.05 -47.76 86.57 Favored Pre-proline 0 CA--C 1.552 1.027 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.82 -25.94 27.81 Favored 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 121.275 1.491 . . . . 0.0 113.688 172.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -76.06 -11.95 60.03 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 117.296 -1.335 . . . . 0.0 114.562 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 48.3 t -59.04 -23.33 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 119.151 0.887 . . . . 0.0 111.114 160.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -104.08 -7.94 19.87 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 177.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.294 0 C-N-CA 125.141 1.376 . . . . 0.0 112.935 -175.927 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.915 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 84.2 mt -125.22 128.42 48.29 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.131 1.772 . . . . 0.0 110.981 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -119.94 143.26 48.09 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.913 0.885 . . . . 0.0 108.784 158.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.2 pt -129.09 147.85 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.439 1.096 . . . . 0.0 109.966 176.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.3 m -120.14 120.96 37.71 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.348 1.459 . . . . 0.0 109.205 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -133.32 160.38 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.978 1.311 . . . . 0.0 111.781 -168.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.61 118.22 7.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.519 0.728 . . . . 0.0 111.56 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -78.02 151.95 33.28 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.08 0.552 . . . . 0.0 111.599 161.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.73 140.6 58.88 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.161 0.981 . . . . 0.0 113.029 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.5 t -66.25 121.86 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.95 -14.79 18.32 Favored Glycine 0 CA--C 1.538 1.498 0 CA-C-O 118.464 -1.187 . . . . 0.0 115.881 -173.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.26 62.72 62.43 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 119.053 1.426 . . . . 0.0 112.022 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.49 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 72.2 Cg_endo -65.39 -5.48 11.44 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.186 2.591 . . . . 0.0 114.962 -171.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -77.92 -3.18 40.5 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.425 1.89 . . . . 0.0 114.734 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.2 pt -136.13 165.69 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.947 1.299 . . . . 0.0 112.346 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.51 144.77 53.72 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.305 1.042 . . . . 0.0 111.565 171.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.21 -174.53 13.81 Favored Glycine 0 N--CA 1.469 0.857 0 C-N-CA 125.145 1.355 . . . . 0.0 114.489 175.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -62.73 105.29 0.63 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.4 t -163.18 95.07 1.11 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.485 1.514 . . . . 0.0 109.454 159.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.09 -22.97 75.16 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.837 1.691 . . . . 0.0 113.542 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -63.29 -32.72 74.2 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.606 -1.309 . . . . 0.0 113.432 169.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 67.4 m -72.2 -37.12 69.31 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.808 -1.183 . . . . 0.0 112.014 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -63.84 -22.51 66.95 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 117.57 -1.205 . . . . 0.0 112.994 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.463 HH12 ' CG ' ' A' ' 74' ' ' ASP . 64.3 mtp180 -57.98 -43.06 86.3 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.641 1.11 . . . . 0.0 112.644 169.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -80.76 -36.82 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.574 1.15 . . . . 0.0 111.673 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.4 -41.53 94.08 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 122.118 -0.364 . . . . 0.0 111.002 169.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.1 tp -61.15 -52.33 65.32 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.044 0.938 . . . . 0.0 112.604 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.9 p -75.45 -33.71 60.9 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 62.2 mt -73.52 -29.86 62.74 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.159 -0.963 . . . . 0.0 112.919 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -76.29 -34.14 59.08 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 169.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.16 -43.44 82.28 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.5 1.046 . . . . 0.0 112.768 172.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -73.6 1.53 9.91 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.791 -1.099 . . . . 0.0 113.573 166.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 pttt 46.85 22.3 0.19 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 127.952 2.501 . . . . 0.0 114.588 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.3 tt -91.03 131.16 37.88 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 125.325 1.45 . . . . 0.0 109.401 -164.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.56 119.3 6.3 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.462 1.441 . . . . 0.0 111.981 -173.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -129.72 154.12 47.49 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.693 1.597 . . . . 0.0 111.263 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -101.2 120.24 39.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.599 1.16 . . . . 0.0 110.064 176.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.5 t -95.24 112.79 24.45 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.479 0.712 . . . . 0.0 112.402 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -89.84 114.36 26.1 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.023 1.329 . . . . 0.0 110.337 169.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 98.8 mt -73.72 109.03 6.92 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.285 1.034 . . . . 0.0 110.13 166.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.0 mm -99.33 117.66 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.941 0.896 . . . . 0.0 110.33 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -77.16 52.67 0.92 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.51 1.524 . . . . 32.609999999999999 112.731 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.86 0.83 0.07 Allowed 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 120.378 3.473 . . . . 40.049999999999997 120.378 -151.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.65 -41.04 85.24 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 120.217 1.371 . . . . 41.469999999999999 111.467 159.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -99.85 62.7 1.17 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 128.025 2.53 . . . . 47.170000000000002 110.094 166.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.6 pttm -78.78 128.62 76.35 Favored Pre-proline 0 N--CA 1.476 0.845 0 O-C-N 119.907 -1.745 . . . . 41.270000000000003 110.868 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -62.37 154.4 64.15 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.845 2.363 . . . . 40.289999999999999 113.436 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -59.89 -42.13 93.11 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.455 -0.778 . . . . 42.390000000000001 112.928 172.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -65.88 -19.33 65.84 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.926 1.084 . . . . 37.079999999999998 113.926 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -76.07 -29.61 58.04 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.849 -1.157 . . . . 35.880000000000003 112.226 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.0 mt -69.12 -27.79 65.89 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.158 0.89 . . . . 33.609999999999999 112.46 170.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -73.79 -3.77 30.58 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.102 1.361 . . . . 33.789999999999999 113.036 173.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.3 mt -111.26 -43.14 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 126.223 1.809 . . . . 33.159999999999997 110.558 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -116.92 96.11 48.21 Favored Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 125.734 1.613 . . . . 33.579999999999998 110.855 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.17 -24.58 58.75 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.263 1.975 . . . . 37.899999999999999 113.062 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -76.38 -9.33 58.56 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.479 1.512 . . . . 38.990000000000002 113.54 172.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.92 4.32 33.68 Favored Glycine 0 CA--C 1.536 1.347 0 O-C-N 120.31 -1.494 . . . . 35.469999999999999 115.351 -169.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -77.05 152.06 35.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.712 1.605 . . . . 34.490000000000002 112.436 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.2 152.32 45.8 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.021 1.728 . . . . 23.530000000000001 110.723 156.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -66.18 156.03 80.83 Favored 'Cis proline' 0 C--N 1.348 0.51 0 CA-C-O 122.022 0.759 . . . . 22.879999999999999 112.799 -6.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.14 146.16 24.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.233 -1.348 . . . . 0.0 107.836 161.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.9 m -129.07 163.63 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.449 0.7 . . . . 0.0 110.975 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . 27.2 mtpt -120.98 75.66 1.16 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 126.046 1.738 . . . . 0.0 110.0 174.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 86.4 mt -68.48 119.9 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 57.66 33.8 23.69 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -172.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.272 23.0 t70 71.65 -0.31 3.21 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 127.455 2.302 . . . . 0.0 114.727 -170.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -107.76 130.22 54.98 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 119.232 -2.168 . . . . 0.0 112.76 -176.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -72.35 146.14 47.29 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -163.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.1 t -144.38 131.13 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 126.374 1.87 . . . . 0.0 109.015 175.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -120.94 163.09 18.78 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.093 1.757 . . . . 0.0 112.806 -174.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . 0.272 50.0 m-20 58.77 122.65 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 128.12 2.568 . . . . 22.16 114.464 -169.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.8 p -65.12 -24.79 67.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 115.522 1.675 . . . . 21.16 115.522 -162.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.463 ' CG ' HH12 ' A' ' 25' ' ' ARG . 38.8 m-20 -69.78 -37.1 76.23 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.065 1.302 . . . . 24.969999999999999 113.217 171.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.5 t -71.7 -39.07 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 121.27 -0.894 . . . . 23.850000000000001 110.669 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.38 -47.95 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.911 0.885 . . . . 23.68 111.0 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.23 -40.44 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.865 0.866 . . . . 22.84 111.117 174.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.65 -48.84 68.7 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 119.266 0.939 . . . . 23.329999999999998 113.531 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.4 mt -72.88 -41.19 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 117.954 0.877 . . . . 23.309999999999999 112.003 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.44 -33.85 76.91 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.853 1.206 . . . . 23.48 112.883 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -91.99 -10.96 37.41 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.287 1.218 . . . . 24.239999999999998 114.287 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -94.84 -40.63 9.63 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.521 1.128 . . . . 39.259999999999998 112.356 167.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -131.44 84.54 2.18 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.683 1.193 . . . . 24.449999999999999 111.611 -163.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -138.72 163.21 48.32 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 125.764 1.626 . . . . 0.0 110.737 165.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.88 -26.38 9.62 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.72 2.28 . . . . 0.0 112.696 172.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -82.93 151.66 64.33 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 124.054 0.942 . . . . 0.0 109.877 161.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -58.2 151.79 57.09 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.293 2.662 . . . . 0.0 117.078 -160.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.44 146.82 51.05 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.432 2.755 . . . . 0.0 112.992 174.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.8 mt -134.05 20.71 3.77 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.141 1.776 . . . . 0.0 112.366 172.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.21 51.82 0.24 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.891 1.676 . . . . 0.0 111.973 169.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.6 p -125.96 72.71 70.26 Favored Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 125.633 1.573 . . . . 0.0 110.016 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.43 117.31 5.07 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.747 2.298 . . . . 0.0 110.369 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -80.22 -170.41 1.0 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.814 3.009 . . . . 0.0 111.401 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -51.71 -33.87 36.3 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.135 1.374 . . . . 0.0 114.253 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -52.76 -30.08 30.81 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.743 1.617 . . . . 0.0 114.371 173.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.75 -29.2 69.97 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.16 -0.963 . . . . 0.0 113.322 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.2 m -71.68 -12.71 61.46 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 99.2 t -114.57 -37.63 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.499 1.52 . . . . 0.0 110.894 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.95 -30.93 76.76 Favored Glycine 0 CA--C 1.533 1.217 0 O-C-N 120.819 -1.176 . . . . 0.0 114.096 172.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 91.6 p -65.59 -22.42 66.68 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -85.14 -40.26 16.95 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.588 1.555 . . . . 0.0 112.036 172.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 81.1 mt -68.84 -36.19 73.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.935 1.294 . . . . 0.0 111.164 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -56.24 -44.34 99.67 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 125.097 1.359 . . . . 0.0 114.589 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -84.78 -31.36 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.525 2.817 . . . . 0.0 114.229 169.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 p -71.12 -26.93 63.23 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 121.148 1.794 . . . . 0.0 113.549 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -60.99 -38.93 87.72 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.859 -1.15 . . . . 0.0 112.521 162.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 41.3 t -69.03 -33.75 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 120.989 -1.07 . . . . 0.0 111.737 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -63.37 -46.88 84.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.087 0.858 . . . . 0.0 111.552 168.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -63.25 -40.55 97.74 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.499 1.12 . . . . 0.0 112.689 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.7 mt -76.96 -1.35 28.22 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.425 1.49 . . . . 0.0 114.708 171.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -135.12 40.31 2.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.035 1.734 . . . . 0.0 111.405 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 p -73.73 54.28 0.48 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.809 2.444 . . . . 0.0 115.283 -162.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 97.6 mttt -61.63 -34.54 75.84 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.607 1.563 . . . . 0.0 111.932 161.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 17.5 t0 -88.5 111.77 45.86 Favored Pre-proline 0 CA--C 1.553 1.077 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 157.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 114' ' ' ASP . 51.2 Cg_exo -53.27 150.49 25.47 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.126 2.55 . . . . 0.0 117.184 -154.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -66.2 -47.85 72.57 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.379 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -62.56 -26.82 68.77 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.8 -38.42 13.93 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 121.156 -0.965 . . . . 0.0 113.387 171.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.6 m -68.02 -34.85 77.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.579 1.151 . . . . 0.0 112.987 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -61.17 -38.12 85.36 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.753 1.621 . . . . 0.0 112.966 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -63.76 -44.87 92.16 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.262 0.625 . . . . 0.0 111.668 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.45 -34.27 76.85 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.75 -40.56 88.34 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.099 0.559 . . . . 0.0 112.225 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.4 mt -64.9 -35.1 80.06 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.888 0.767 . . . . 0.0 112.837 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -72.4 -37.7 68.63 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.472 1.033 . . . . 0.0 113.0 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -71.62 -33.94 69.4 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.928 -1.108 . . . . 0.0 112.868 170.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.1 mt -65.7 -34.98 79.46 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.636 -1.29 . . . . 0.0 112.347 170.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -65.89 -41.47 91.51 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.24 1.382 . . . . 0.0 111.952 170.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.56 -34.24 76.55 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.214 0.606 . . . . 0.0 112.124 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.66 -58.15 3.58 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.167 0.987 . . . . 0.0 111.584 170.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.76 -34.54 78.41 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.448 1.499 . . . . 0.0 114.022 -169.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.9 -38.68 89.76 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.045 0.831 . . . . 0.0 113.301 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -89.09 -25.87 21.67 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.714 0.806 . . . . 0.0 112.638 176.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.51 -32.35 73.65 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 120.562 -1.337 . . . . 0.0 112.923 172.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -67.7 -10.18 50.13 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 172.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 26.4 t -86.97 -31.81 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.129 0.972 . . . . 0.0 111.874 168.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -95.71 -30.21 13.86 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -173.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 102.39 -109.86 3.64 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 117.425 -1.764 . . . . 0.0 115.139 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -79.69 -26.73 4.49 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.682 2.921 . . . . 0.0 117.385 -146.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -130.85 163.08 28.2 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.159 1.345 . . . . 0.0 112.441 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.62 -8.36 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -168.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -95.92 -2.88 46.29 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 159.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 118.55 -118.39 4.01 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.653 1.115 . . . . 0.0 113.672 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -70.9 -23.91 62.37 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.651 1.18 . . . . 0.0 113.394 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -141.66 171.1 14.53 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.433 1.893 . . . . 0.0 111.059 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.8 mt -70.8 138.57 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.669 1.187 . . . . 0.0 109.431 168.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.2 p -140.09 -171.63 3.23 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 121.284 -0.885 . . . . 0.0 111.46 164.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.01 -18.88 1.56 Allowed 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 171.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.6 t -72.87 -42.92 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 O-C-N 120.701 -1.249 . . . . 0.0 112.325 172.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -62.09 -43.85 97.94 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.524 1.129 . . . . 0.0 111.993 168.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.3 mt -64.34 -10.82 26.79 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.0 m -97.97 -45.02 6.43 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.512 1.125 . . . . 0.0 112.308 173.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.22 -36.15 12.15 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.67 -48.22 97.6 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -172.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -72.14 -25.22 19.33 Favored 'Trans proline' 0 C--N 1.351 0.678 0 CA-C-N 120.875 1.348 . . . . 0.0 113.371 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -74.05 -30.11 62.24 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 117.423 -1.275 . . . . 0.0 112.429 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 57.1 mt -67.94 -38.2 82.54 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.132 0.878 . . . . 0.0 112.832 167.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -63.78 -52.13 61.71 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.079 0.854 . . . . 0.0 112.253 172.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -62.65 -26.62 68.73 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.945 0.898 . . . . 0.0 112.358 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.2 tp -71.82 -52.66 16.37 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.938 -1.101 . . . . 0.0 113.184 170.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -58.56 -34.22 70.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.321 0.964 . . . . 0.0 112.656 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 97.4 t -82.87 -62.12 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.184 0.994 . . . . 0.0 112.763 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.55 -35.01 25.1 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -165.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.92 -35.85 59.61 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.742 -0.599 . . . . 0.0 111.397 169.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.16 -25.27 53.81 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.266 0.936 . . . . 0.0 115.234 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -60.26 -31.89 70.65 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.166 1.386 . . . . 0.0 114.675 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -125.2 -20.8 4.76 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -147.08 84.0 1.58 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.997 2.119 . . . . 0.0 107.119 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -66.91 85.24 0.12 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.389 0.676 . . . . 0.0 110.186 171.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 34.7 t90 -83.82 113.15 45.62 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.084 1.354 . . . . 0.0 110.997 -168.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.42 118.3 5.6 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.82 1.68 . . . . 0.0 110.545 -176.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 47.0 mm -67.63 113.82 16.38 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 159.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -66.33 155.45 69.92 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.723 1.615 . . . . 0.0 111.094 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.14 -22.56 66.94 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.378 1.071 . . . . 0.0 113.765 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -67.07 -22.72 65.83 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.479 1.112 . . . . 0.0 113.953 170.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 67.5 mt -85.71 55.09 3.36 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.322 1.449 . . . . 0.0 110.742 165.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.2 m -67.69 -27.03 66.49 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.499 1.119 . . . . 0.0 112.932 -161.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 33.9 t60 -73.03 -52.44 14.38 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.855 0.752 . . . . 0.0 110.338 168.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 79.0 t -58.78 -41.14 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.344 0.975 . . . . 0.0 112.226 -173.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 62.7 tp -60.46 -42.1 95.5 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.574 1.15 . . . . 0.0 112.831 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -76.74 -36.96 56.78 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.514 0.726 . . . . 0.0 112.848 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -63.39 -36.47 83.82 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.941 1.296 . . . . 0.0 112.629 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.85 -34.59 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.457 -0.777 . . . . 0.0 111.789 171.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -82.9 -14.6 53.89 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.432 -1.418 . . . . 0.0 113.515 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 23.3 mt -71.54 -18.49 62.26 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.816 -1.177 . . . . 0.0 113.618 162.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 60.4 mt -65.9 -20.54 66.26 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.759 1.163 . . . . 0.0 113.347 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -93.98 11.11 30.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.955 1.302 . . . . 0.0 113.058 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 10.5 p -119.94 174.96 6.14 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.913 2.085 . . . . 0.0 112.333 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? 60.66 177.12 0.1 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.473 1.509 . . . . 0.0 111.64 -170.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.481 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 0.5 OUTLIER -70.98 -41.71 70.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.783 153.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 85.6 p -54.75 -68.64 0.17 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.153 1.381 . . . . 0.0 114.682 -170.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -70.66 -43.4 69.21 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.059 -1.026 . . . . 0.0 112.247 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -59.79 -32.76 70.91 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -172.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -81.0 -7.76 59.63 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.4 p -77.89 -13.15 59.98 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.067 1.303 . . . . 0.0 113.426 169.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -64.43 86.21 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.883 1.673 . . . . 0.0 112.96 -167.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.48 137.95 57.77 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.343 1.057 . . . . 0.0 110.21 164.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.24 128.04 35.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.618 0.767 . . . . 0.0 112.022 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -59.61 -34.66 73.04 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -162.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -65.23 -37.96 88.89 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.981 -1.075 . . . . 0.0 112.453 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -82.24 -7.52 59.63 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 171.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.58 -47.45 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 118.706 0.685 . . . . 0.0 110.05 163.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 65.0 mt -64.52 -52.59 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.889 1.276 . . . . 0.0 111.742 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.9 -11.53 60.68 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.24 -34.15 8.95 Favored Glycine 0 CA--C 1.535 1.304 0 O-C-N 120.942 -1.099 . . . . 0.0 113.36 168.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -75.6 -35.82 60.46 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.064 1.746 . . . . 0.0 113.524 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -51.51 -51.7 66.93 Favored Pre-proline 0 N--CA 1.477 0.899 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -174.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.39 -24.41 43.06 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 CA-C-N 121.476 1.563 . . . . 0.0 113.451 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -74.96 -8.25 55.94 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.412 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 60.2 t -60.59 -27.06 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 120.064 1.302 . . . . 0.0 110.624 160.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -103.2 -34.48 8.81 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 116.656 -1.64 . . . . 0.0 115.1 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.258 0 O-C-N 125.234 1.584 . . . . 0.0 113.015 179.292 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.922 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.1 mt -105.46 138.2 42.04 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.81 1.644 . . . . 0.0 112.683 -169.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -125.93 143.99 50.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.959 1.304 . . . . 0.0 109.456 157.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.4 pt -129.0 137.18 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.136 0.975 . . . . 0.0 110.287 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.8 m -109.68 123.97 50.4 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.555 1.142 . . . . 0.0 109.473 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -136.5 162.0 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.156 1.382 . . . . 0.0 111.311 -166.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -64.0 121.31 13.8 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.14 -0.975 . . . . 0.0 111.746 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.61 143.18 38.45 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.019 0.527 . . . . 0.0 111.035 157.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.28 138.01 58.35 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.648 0.737 . . . . 0.0 111.685 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -68.91 134.92 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.85 -32.75 1.69 Allowed Glycine 0 CA--C 1.537 1.427 0 CA-C-O 118.821 -0.989 . . . . 0.0 114.952 -172.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.6 60.67 19.75 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.839 1.255 . . . . 0.0 113.151 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.22 -3.95 9.59 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.976 2.451 . . . . 0.0 115.676 -171.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -73.23 -8.1 54.35 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 170.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.0 pt -131.16 163.63 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.643 1.177 . . . . 0.0 112.513 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.3 mt -63.41 138.68 58.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.14 0.976 . . . . 0.0 111.541 172.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.99 -168.19 13.47 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.034 1.302 . . . . 0.0 114.118 173.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -60.59 103.85 0.29 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 174.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.6 t -156.81 102.9 1.95 Allowed Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.149 141.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.54 -20.9 60.41 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.716 2.278 . . . . 0.0 112.862 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -66.22 -29.86 70.2 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 120.666 -1.271 . . . . 0.0 113.534 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 88.0 m -70.43 -36.64 74.11 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.536 -1.352 . . . . 0.0 112.076 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -67.68 -21.69 65.32 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 118.119 -0.944 . . . . 0.0 112.307 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.525 HH12 ' CG ' ' A' ' 74' ' ' ASP . 64.6 mtp180 -58.76 -45.07 90.6 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.359 1.064 . . . . 0.0 112.579 166.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -73.55 -43.01 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.557 1.143 . . . . 0.0 111.045 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.6 mt -57.66 -44.19 85.51 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.743 0.417 . . . . 0.0 111.54 172.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.4 tp -60.7 -48.42 81.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.106 0.962 . . . . 0.0 112.623 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.7 -36.06 67.77 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -174.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.7 mt -73.88 -41.45 62.16 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.323 0.51 . . . . 0.0 111.493 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -77.91 -14.43 59.55 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 176.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -76.55 -46.91 24.4 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.206 -1.559 . . . . 0.0 111.578 164.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -74.82 -12.81 60.47 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm 64.88 9.51 5.41 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 127.467 2.307 . . . . 0.0 114.886 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.3 tp -67.24 129.73 93.75 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.595 1.158 . . . . 0.0 110.481 175.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.39 147.95 33.16 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.658 2.239 . . . . 0.0 112.775 -174.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -147.23 151.48 36.76 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.316 1.446 . . . . 0.0 111.071 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -80.25 147.41 31.21 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.551 -0.718 . . . . 0.0 109.484 159.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -127.42 116.53 20.59 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.646 0.778 . . . . 0.0 111.24 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -104.05 110.73 23.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.668 1.587 . . . . 0.0 109.667 -175.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -74.0 106.48 5.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.579 1.152 . . . . 0.0 110.256 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 mm -95.14 116.06 35.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.791 0.837 . . . . 0.0 110.54 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -75.99 49.87 0.57 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.02 1.728 . . . . 32.609999999999999 112.853 174.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pp -60.4 3.07 0.08 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 120.532 3.53 . . . . 40.049999999999997 120.532 -148.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.22 -36.01 70.66 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 120.236 1.38 . . . . 41.469999999999999 111.787 158.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -101.98 67.46 1.08 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.043 2.137 . . . . 47.170000000000002 109.327 163.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -80.8 119.5 76.32 Favored Pre-proline 0 N--CA 1.474 0.754 0 O-C-N 119.603 -1.936 . . . . 41.270000000000003 111.636 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -62.92 154.8 64.29 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.656 2.237 . . . . 40.289999999999999 114.397 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -63.32 -42.07 98.96 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.991 0.916 . . . . 42.390000000000001 113.217 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 33.2 p-90 -64.25 -23.81 67.44 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.054 -1.029 . . . . 37.079999999999998 113.601 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -81.97 -31.62 31.07 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.252 -0.905 . . . . 35.880000000000003 112.462 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 mt -69.03 -26.9 65.23 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.198 0.908 . . . . 33.609999999999999 112.699 170.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -68.96 -15.19 63.42 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.373 1.069 . . . . 33.789999999999999 113.485 168.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.0 mt -99.31 -44.97 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.267 1.427 . . . . 33.159999999999997 110.602 172.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.4 t -112.77 100.17 50.0 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 125.907 1.683 . . . . 33.579999999999998 110.543 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.85 -19.23 46.9 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.209 1.939 . . . . 37.899999999999999 113.968 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -85.53 -9.21 57.71 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.267 -0.895 . . . . 38.990000000000002 113.279 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.66 19.23 62.52 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 120.67 -1.269 . . . . 35.469999999999999 114.645 -171.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -85.45 155.48 21.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.118 1.767 . . . . 34.490000000000002 111.509 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.7 m -110.89 154.52 43.31 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.171 1.788 . . . . 23.530000000000001 110.134 156.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -64.89 154.94 76.39 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 CA-C-O 122.019 0.758 . . . . 22.879999999999999 112.824 -9.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.43 147.45 22.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.013 -1.449 . . . . 0.0 107.363 156.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.15 165.71 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.649 -0.657 . . . . 0.0 110.373 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -122.79 97.6 5.52 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.441 1.497 . . . . 0.0 108.808 170.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 82.3 mt -86.82 121.3 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.137 0.975 . . . . 0.0 108.922 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 52.67 38.0 24.99 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.034 0.934 . . . . 0.0 112.834 -164.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 65.64 17.08 10.78 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.129 2.171 . . . . 0.0 116.319 -172.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -117.39 128.23 54.82 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 119.981 -1.699 . . . . 0.0 111.639 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -67.97 145.8 54.18 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -164.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -144.13 129.44 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.973 2.109 . . . . 0.0 108.679 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.69 165.55 12.69 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.672 1.589 . . . . 0.0 112.622 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.0 t0 65.54 115.65 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 128.079 2.552 . . . . 22.16 114.269 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.2 p -61.75 -25.57 67.54 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.325 1.602 . . . . 21.16 115.325 -165.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.525 ' CG ' HH12 ' A' ' 25' ' ' ARG . 31.8 m-20 -71.93 -35.77 69.75 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.876 1.216 . . . . 24.969999999999999 113.415 170.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.5 t -72.57 -39.01 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 121.432 -0.792 . . . . 23.850000000000001 111.114 172.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.18 -48.66 87.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.332 1.053 . . . . 23.68 110.914 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.43 -37.38 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.176 0.991 . . . . 22.84 111.467 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.92 -13.16 51.57 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.525 1.059 . . . . 23.329999999999998 115.585 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.6 mt -102.39 -48.46 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 118.925 1.362 . . . . 23.309999999999999 111.275 167.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.9 mt -62.52 -27.45 69.16 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.305 1.224 . . . . 23.48 114.305 -171.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -91.4 -0.3 57.62 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.785 1.032 . . . . 24.239999999999998 113.785 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -129.13 -25.51 2.73 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.544 1.138 . . . . 39.259999999999998 113.545 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -126.68 73.6 1.41 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.946 1.698 . . . . 24.449999999999999 111.923 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -141.32 165.33 29.59 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 126.112 1.765 . . . . 0.0 109.806 169.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.09 -26.45 18.14 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.333 2.022 . . . . 0.0 113.7 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.5 pm0 -75.46 160.89 78.57 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.458 1.103 . . . . 0.0 112.716 168.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.84 145.09 99.52 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.524 2.149 . . . . 0.0 113.915 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.78 145.19 62.07 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.162 2.575 . . . . 0.0 113.844 -174.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.1 mt -108.87 6.75 25.68 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.211 1.804 . . . . 0.0 112.926 169.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.4 50.57 0.17 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.85 2.06 . . . . 0.0 113.536 173.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 74.7 p -120.16 75.29 22.48 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 125.039 1.336 . . . . 0.0 110.214 170.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.09 117.93 5.27 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.346 2.031 . . . . 0.0 109.913 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.28 -173.26 1.71 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.661 2.907 . . . . 0.0 111.935 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.1 mp0 -51.13 -32.14 21.8 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.393 2.277 . . . . 0.0 113.632 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -54.79 -25.81 30.59 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.314 1.446 . . . . 0.0 114.109 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -29.35 70.58 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.742 -1.224 . . . . 0.0 113.363 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.1 p -67.99 -17.85 64.55 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.8 t -108.91 -41.57 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.581 1.552 . . . . 0.0 110.731 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.63 -30.76 77.68 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.844 1.211 . . . . 0.0 114.124 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.8 p -67.29 -19.0 65.43 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 171.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -87.51 -38.6 15.89 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.077 1.351 . . . . 0.0 112.168 169.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 69.1 mt -68.05 -37.13 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.558 1.143 . . . . 0.0 110.877 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -56.69 -45.79 99.9 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.535 1.534 . . . . 0.0 115.058 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -81.62 -32.78 0.78 Allowed 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 123.148 2.565 . . . . 0.0 113.69 170.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 56.9 p -73.18 -24.99 60.61 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 120.523 1.511 . . . . 0.0 114.127 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -58.83 -42.14 88.56 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.858 -1.151 . . . . 0.0 112.204 160.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.6 t -72.6 -31.53 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.467 -0.77 . . . . 0.0 111.862 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.401 ' HZ1' ' CG ' ' A' ' 114' ' ' ASP . 62.3 tttt -62.86 -47.24 84.24 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.004 0.82 . . . . 0.0 111.348 169.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -64.65 -39.82 94.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.157 0.983 . . . . 0.0 112.313 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 50.8 mt -68.42 -0.35 4.84 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.228 1.411 . . . . 0.0 114.736 168.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -142.56 36.58 1.47 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.116 1.766 . . . . 0.0 112.266 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.06 62.3 0.3 Allowed 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -166.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 90.8 mttt -63.75 -33.84 76.55 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.557 1.543 . . . . 0.0 110.957 158.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.401 ' CG ' ' HZ1' ' A' ' 108' ' ' LYS . 14.3 t0 -86.55 117.32 68.49 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 125.67 1.588 . . . . 0.0 107.941 158.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -51.95 149.65 20.06 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.421 2.747 . . . . 0.0 117.316 -159.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -70.39 -45.77 65.34 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.824 -172.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -68.3 -26.11 65.48 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.027 -1.671 . . . . 0.0 114.333 -172.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.62 -33.54 42.51 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 120.643 -1.285 . . . . 0.0 113.338 169.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 89.6 m -70.4 -35.37 73.42 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.422 1.089 . . . . 0.0 112.355 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -64.07 -39.85 94.99 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.546 1.539 . . . . 0.0 112.438 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -64.06 -46.7 83.2 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.517 0.599 . . . . 0.0 112.102 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.87 -36.25 83.3 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.4 tp -68.34 -42.34 79.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.25 1.02 . . . . 0.0 112.331 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 41.9 mt -66.66 -37.66 85.26 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.798 0.839 . . . . 0.0 113.253 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -69.99 -36.32 75.08 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.762 1.165 . . . . 0.0 112.786 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -72.79 -33.96 66.61 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 120.799 -1.188 . . . . 0.0 112.51 170.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.2 mt -63.43 -35.14 79.44 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.2 -1.563 . . . . 0.0 112.512 169.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -65.88 -40.38 91.53 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.31 1.414 . . . . 0.0 111.917 171.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.14 -35.92 82.36 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 118.435 0.562 . . . . 0.0 112.314 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.2 tp -69.57 -56.92 5.98 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.373 1.069 . . . . 0.0 111.468 170.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -66.41 -35.47 80.39 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.191 1.396 . . . . 0.0 114.028 -171.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.83 -34.81 79.53 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.207 0.908 . . . . 0.0 113.513 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -89.34 -30.47 18.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.446 0.699 . . . . 0.0 112.874 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.46 -33.77 76.29 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.807 -1.183 . . . . 0.0 113.449 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -64.88 -8.0 13.66 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 172.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.0 t -99.58 -35.16 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.915 1.286 . . . . 0.0 112.221 168.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -86.46 -28.41 23.5 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -173.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.63 -157.54 32.85 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 118.198 -1.335 . . . . 0.0 113.653 -173.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.8 -9.94 19.8 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.371 3.38 . . . . 0.0 117.473 -119.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -110.98 161.39 15.91 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 119.643 1.11 . . . . 0.0 111.323 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.08 -10.79 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 O-C-N 120.427 -1.421 . . . . 0.0 113.162 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -99.19 -2.04 37.78 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 161.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 107.25 -110.43 3.23 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 119.976 1.262 . . . . 0.0 113.652 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -73.49 -26.3 60.84 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -167.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -142.03 167.05 23.04 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.352 1.861 . . . . 0.0 111.163 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 26.2 mt -65.42 130.19 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.161 0.584 . . . . 0.0 109.997 163.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.8 p -135.07 -171.59 2.84 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.178 0.991 . . . . 0.0 110.866 166.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.96 -19.59 2.74 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.0 t -73.71 -43.35 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.877 1.217 . . . . 0.0 112.309 173.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.4 -46.02 91.91 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.994 -1.066 . . . . 0.0 112.113 168.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.3 mt -62.44 -17.9 60.45 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.334 0.654 . . . . 0.0 112.421 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 51.4 m -86.61 -50.92 6.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.931 0.892 . . . . 0.0 112.335 171.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.9 mt -90.54 -33.6 15.86 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -167.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.88 -49.6 92.82 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.86 -21.87 24.17 Favored 'Trans proline' 0 C--N 1.351 0.669 0 CA-C-N 121.144 1.444 . . . . 0.0 113.14 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -77.18 -28.66 54.09 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 117.584 -1.198 . . . . 0.0 112.549 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 53.7 mt -70.17 -39.22 75.42 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.758 0.823 . . . . 0.0 112.899 165.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -60.23 -46.75 88.69 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.885 0.766 . . . . 0.0 111.732 171.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -64.78 -23.71 67.33 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.951 0.9 . . . . 0.0 113.353 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 12.1 tp -80.05 -45.09 18.93 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.997 -1.064 . . . . 0.0 112.659 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.53 -37.25 86.9 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.177 0.899 . . . . 0.0 111.596 173.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.2 t -80.71 -63.92 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.51 -50.88 8.34 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.408 -0.808 . . . . 0.0 112.136 -162.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.35 -35.44 77.43 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.671 0.388 . . . . 0.0 111.382 174.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.16 -25.28 46.76 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.063 1.316 . . . . 0.0 115.7 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -65.34 -25.81 67.76 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -126.93 -18.87 4.56 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 21.8 tptt -147.76 80.55 1.49 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.895 2.078 . . . . 0.0 107.595 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -64.19 89.27 0.06 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.885 0.874 . . . . 0.0 110.669 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 33.3 t90 -88.29 117.37 68.31 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.073 0.949 . . . . 0.0 112.208 -162.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -73.58 112.53 3.55 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.199 1.933 . . . . 0.0 110.649 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 97.5 mt -71.77 108.34 3.92 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 159.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -68.55 161.01 46.92 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.415 1.41 . . . . 0.0 112.453 -166.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.32 -28.11 66.5 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.716 1.606 . . . . 0.0 114.063 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -68.16 -22.59 64.84 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.219 1.408 . . . . 0.0 114.086 173.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 71.0 mt -84.67 52.11 2.3 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.483 1.513 . . . . 0.0 110.36 165.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.0 m -63.27 -30.11 71.31 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.472 1.109 . . . . 0.0 112.601 -160.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 66.8 t-80 -77.24 -48.3 17.89 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.542 0.61 . . . . 0.0 111.534 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 66.0 t -60.36 -40.08 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 118.683 0.674 . . . . 0.0 111.618 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.0 tp -64.03 -43.24 96.16 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.338 1.055 . . . . 0.0 113.108 176.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -70.82 -32.99 70.22 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.372 -0.83 . . . . 0.0 112.838 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -63.31 -27.4 69.3 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.333 1.053 . . . . 0.0 112.843 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 29.2 mm -56.11 -34.82 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 120.868 -1.145 . . . . 0.0 111.935 169.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -90.91 -6.3 54.33 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.925 -1.109 . . . . 0.0 113.617 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 74.3 mt -73.43 -22.87 60.1 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 117.617 -1.182 . . . . 0.0 113.461 157.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 66.3 mt -62.57 -23.89 67.25 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.723 1.147 . . . . 0.0 113.283 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -96.11 9.01 42.27 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.514 1.126 . . . . 0.0 113.267 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.9 p -121.22 177.26 5.23 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.705 2.002 . . . . 0.0 113.417 -168.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.5 mtp85 54.88 -169.15 0.07 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.218 1.407 . . . . 0.0 110.276 -166.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.13 -34.22 37.94 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.05 -1.031 . . . . 0.0 110.17 159.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 77.6 p -72.45 -56.32 5.6 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.363 1.465 . . . . 0.0 114.115 -161.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -68.52 -44.56 74.38 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.984 0.811 . . . . 0.0 112.044 171.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -54.69 -34.23 62.03 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.69 1.196 . . . . 0.0 113.88 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -79.68 -14.85 58.47 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.5 p -79.88 -2.6 44.33 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.621 1.555 . . . . 0.0 113.93 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -68.91 75.93 0.31 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.235 1.814 . . . . 0.0 112.358 -173.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -59.34 132.19 53.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.263 0.625 . . . . 0.0 109.523 163.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.67 130.73 47.96 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.094 0.558 . . . . 0.0 112.024 -165.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -59.63 -39.72 85.26 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -160.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -62.31 -38.69 90.37 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.083 -1.01 . . . . 0.0 112.277 174.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -84.66 -5.93 59.34 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.308 1.443 . . . . 0.0 113.343 177.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 75.4 t -82.61 -46.8 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.982 0.913 . . . . 0.0 110.215 161.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.5 mt -61.89 -51.37 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.572 1.149 . . . . 0.0 111.845 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.73 -15.16 63.1 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.216 1.006 . . . . 0.0 113.693 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.47 -37.5 14.29 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 120.899 -1.125 . . . . 0.0 112.895 169.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 17.5 t90 -77.1 -35.49 56.4 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.186 1.794 . . . . 0.0 114.015 -174.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -49.56 -52.42 50.39 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.89 -24.5 39.9 Favored 'Trans proline' 0 C--N 1.353 0.799 0 CA-C-N 121.452 1.554 . . . . 0.0 113.461 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -78.29 -7.21 56.95 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 117.193 -1.384 . . . . 0.0 114.316 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.429 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 58.3 t -63.0 -30.83 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 120.037 1.29 . . . . 0.0 110.315 159.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -94.9 -34.66 12.34 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 115.745 1.758 . . . . 0.0 115.745 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 CA-C-O 117.604 -1.189 . . . . 0.0 113.163 172.516 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 61.9 mt -101.59 142.15 33.39 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.807 1.243 . . . . 0.0 113.26 -170.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -129.04 145.89 51.15 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.617 1.567 . . . . 0.0 109.02 157.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.5 pt -130.65 136.84 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.604 1.162 . . . . 0.0 109.647 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.7 m -111.73 119.27 38.07 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.777 1.231 . . . . 0.0 109.085 173.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.3 m -134.87 162.9 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.255 1.422 . . . . 0.0 111.229 -166.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -61.5 120.99 11.6 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.374 -0.829 . . . . 0.0 112.108 -175.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -79.34 149.61 31.68 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.049 0.54 . . . . 0.0 111.603 159.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.63 134.28 52.94 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.014 0.911 . . . . 0.0 112.111 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.7 t -67.36 126.27 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 173.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.54 -14.62 22.97 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-O 118.587 -1.118 . . . . 0.0 115.605 -172.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.88 61.65 29.85 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 119.161 1.48 . . . . 0.0 112.13 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.418 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 57.9 Cg_endo -65.47 -6.89 14.53 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.966 2.444 . . . . 0.0 115.795 -167.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -80.9 -1.21 42.51 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.9 pt -131.83 164.97 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.731 1.212 . . . . 0.0 112.114 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.94 143.69 57.46 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.239 1.016 . . . . 0.0 111.409 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.9 -173.48 13.48 Favored Glycine 0 N--CA 1.471 0.991 0 C-N-CA 125.176 1.37 . . . . 0.0 113.905 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -60.55 106.5 0.56 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.6 t -165.07 97.86 0.84 Allowed Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.776 157.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -62.92 -21.09 72.93 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.244 1.963 . . . . 0.0 113.041 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -66.68 -29.66 69.72 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 120.655 -1.278 . . . . 0.0 113.59 171.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 98.8 m -71.47 -37.76 71.31 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.578 -1.326 . . . . 0.0 112.179 171.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.0 -24.29 67.85 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 117.95 -1.024 . . . . 0.0 112.875 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.483 HH12 ' CG ' ' A' ' 74' ' ' ASP . 53.5 mtp180 -57.78 -46.97 83.84 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.46 1.027 . . . . 0.0 112.389 170.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.5 t -74.67 -40.6 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.042 1.337 . . . . 0.0 111.31 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.4 mt -61.38 -42.73 99.19 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.251 0.621 . . . . 0.0 111.545 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.1 tp -61.68 -49.12 77.77 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.076 0.95 . . . . 0.0 112.083 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.75 -43.2 69.31 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -174.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.66 -38.92 84.43 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.571 -0.706 . . . . 0.0 112.46 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -80.17 -20.09 45.63 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -69.79 -48.93 57.35 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.798 -1.189 . . . . 0.0 110.641 166.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -70.26 -9.61 56.47 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.46 1.904 . . . . 0.0 114.23 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm 61.85 18.92 10.2 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.48 1.912 . . . . 0.0 115.01 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -75.25 131.59 77.87 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 123.941 0.896 . . . . 0.0 109.613 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -74.66 143.71 30.65 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.662 2.242 . . . . 0.0 112.496 174.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -146.11 151.52 37.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.849 1.66 . . . . 0.0 110.072 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -78.66 130.59 36.04 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.318 -0.863 . . . . 0.0 109.196 163.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 t -111.92 108.64 18.07 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.535 0.734 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -100.79 112.46 24.87 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.728 1.211 . . . . 0.0 109.966 -177.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.13 112.13 13.47 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.156 0.982 . . . . 0.0 110.263 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.4 mm -102.29 116.04 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.321 1.048 . . . . 0.0 110.4 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -77.15 57.7 1.46 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.163 1.385 . . . . 32.609999999999999 111.977 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.14 4.59 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 120.083 3.364 . . . . 40.049999999999997 120.083 -154.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -69.3 -46.46 56.92 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 120.905 1.684 . . . . 41.469999999999999 110.871 156.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -93.03 63.02 3.67 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.214 2.606 . . . . 47.170000000000002 110.629 168.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 pttm -79.78 119.01 75.38 Favored Pre-proline 0 N--CA 1.476 0.827 0 O-C-N 119.921 -1.737 . . . . 41.270000000000003 111.386 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -64.13 155.7 63.4 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.699 2.266 . . . . 40.289999999999999 114.182 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tp60 -62.27 -39.48 93.05 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.672 0.99 . . . . 42.390000000000001 113.672 174.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -64.73 -23.95 67.41 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.069 0.766 . . . . 37.079999999999998 113.069 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -83.27 -32.13 26.57 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.655 0.782 . . . . 35.880000000000003 112.536 172.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.2 mt -67.26 -26.47 66.58 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.159 0.89 . . . . 33.609999999999999 112.672 170.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -71.63 -8.11 52.03 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.883 1.273 . . . . 33.789999999999999 113.858 168.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.7 mt -106.46 -44.65 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.597 1.559 . . . . 33.159999999999997 110.603 171.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.6 t -112.25 98.79 44.35 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 125.792 1.637 . . . . 33.579999999999998 110.956 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.49 -18.18 43.53 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.364 2.043 . . . . 37.899999999999999 113.408 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -83.75 -8.71 59.19 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.727 1.01 . . . . 38.990000000000002 113.727 170.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.93 8.57 49.54 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 120.87 -1.144 . . . . 35.469999999999999 115.067 -169.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -84.71 157.8 20.97 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.267 1.427 . . . . 34.490000000000002 112.491 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.2 m -113.58 156.22 43.78 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 126.383 1.873 . . . . 23.530000000000001 110.592 160.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -66.12 156.81 80.17 Favored 'Cis proline' 0 C--N 1.348 0.501 0 CA-C-O 122.015 0.756 . . . . 22.879999999999999 112.403 -10.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.4 p -141.05 147.26 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 159.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.11 163.71 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 121.43 -0.794 . . . . 0.0 110.611 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 mtpt -121.27 92.1 3.67 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.181 1.393 . . . . 0.0 109.054 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.3 mt -82.09 119.67 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.688 0.795 . . . . 0.0 108.907 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.75 38.82 27.41 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 122.284 1.04 . . . . 0.0 112.675 -165.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.3 t70 66.11 12.7 8.68 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.063 2.145 . . . . 0.0 116.476 -172.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -110.84 127.8 55.55 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 119.8 -1.813 . . . . 0.0 111.651 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -66.69 144.66 56.23 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -167.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.7 t -143.25 128.35 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.625 1.97 . . . . 0.0 108.593 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -112.69 166.5 11.29 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.746 1.618 . . . . 0.0 112.24 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.0 t0 65.11 113.62 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.821 2.449 . . . . 22.16 114.067 -175.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.7 p -62.74 -21.65 65.97 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 115.274 1.583 . . . . 21.16 115.274 -166.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.483 ' CG ' HH12 ' A' ' 25' ' ' ARG . 30.0 m-20 -71.46 -38.17 71.31 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.843 1.201 . . . . 24.969999999999999 113.056 169.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -70.49 -40.07 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.16 -0.962 . . . . 23.850000000000001 110.842 172.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.58 -48.62 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.955 0.902 . . . . 23.68 111.15 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.74 -38.54 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.611 0.764 . . . . 22.84 111.547 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.37 -39.95 95.42 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.531 -0.594 . . . . 23.329999999999998 113.596 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.7 mt -76.87 -48.22 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 118.379 1.09 . . . . 23.309999999999999 111.638 174.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.7 mt -62.32 -33.32 74.46 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.747 1.158 . . . . 23.48 113.399 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -92.66 -3.18 55.33 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 115.229 1.566 . . . . 24.239999999999998 115.229 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -108.56 -35.43 6.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.913 1.285 . . . . 39.259999999999998 112.489 169.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -125.47 70.98 1.19 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.513 1.525 . . . . 24.449999999999999 111.628 -167.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -136.99 167.59 20.4 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.641 1.976 . . . . 0.0 109.373 168.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.38 -33.44 38.16 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.677 1.585 . . . . 0.0 112.336 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -75.15 151.99 86.09 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.282 1.033 . . . . 0.0 111.976 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.2 144.62 29.11 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.543 2.829 . . . . 0.0 115.215 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.62 136.92 34.62 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.562 2.175 . . . . 0.0 112.249 -174.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.3 mt -108.55 8.18 27.09 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.934 1.294 . . . . 0.0 111.944 167.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.55 46.33 0.07 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.42 2.288 . . . . 0.0 112.696 163.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.1 p -123.9 67.52 42.16 Favored Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 125.452 1.501 . . . . 0.0 109.8 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.86 119.61 6.65 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.232 1.955 . . . . 0.0 109.951 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.97 -173.88 1.84 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.213 2.609 . . . . 0.0 111.775 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.3 mp0 -51.2 -33.89 29.47 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.65 2.38 . . . . 0.0 113.333 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -52.53 -28.87 22.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.913 1.685 . . . . 0.0 114.119 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.99 -28.97 70.17 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.931 -1.105 . . . . 0.0 113.513 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.6 p -67.53 -19.92 65.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.461 1.105 . . . . 0.0 113.568 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.6 t -102.0 -42.79 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.481 1.513 . . . . 0.0 110.68 175.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.27 -31.67 81.52 Favored Glycine 0 CA--C 1.532 1.102 0 O-C-N 120.842 -1.161 . . . . 0.0 114.594 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.2 p -66.24 -19.05 65.71 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -87.78 -39.26 15.04 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.934 1.294 . . . . 0.0 112.549 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.5 mt -66.37 -34.72 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.942 0.897 . . . . 0.0 110.906 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -56.13 -48.91 95.87 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 117.452 -1.261 . . . . 0.0 114.189 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.42 -31.56 2.66 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.926 2.417 . . . . 0.0 114.316 170.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 p -70.84 -27.8 64.12 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 121.279 1.854 . . . . 0.0 113.281 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -57.83 -47.8 81.61 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.107 -0.996 . . . . 0.0 112.084 161.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.73 -34.93 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 119.114 0.87 . . . . 0.0 111.918 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -63.09 -45.21 93.17 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.677 0.671 . . . . 0.0 111.464 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -64.12 -39.02 93.13 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.765 0.826 . . . . 0.0 112.44 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.6 mt -69.86 -7.36 39.51 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.979 1.711 . . . . 0.0 115.124 170.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -139.88 41.17 1.98 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.287 1.835 . . . . 0.0 111.663 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.4 m -68.46 56.47 0.08 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.285 1.834 . . . . 0.0 115.738 -168.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -69.38 -35.69 76.06 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.88 1.272 . . . . 0.0 111.265 165.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -81.87 114.82 53.25 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 153.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -54.71 154.19 21.56 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.192 2.594 . . . . 0.0 117.093 -154.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -69.34 -37.31 77.61 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 117.278 -1.344 . . . . 0.0 112.4 -172.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -67.3 -37.78 83.93 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 121.157 1.799 . . . . 0.0 113.825 -171.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.57 -31.54 60.63 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 120.645 -1.285 . . . . 0.0 112.905 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 91.7 m -69.77 -31.68 69.76 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.913 0.885 . . . . 0.0 112.62 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -70.31 -41.08 73.77 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 127.206 2.202 . . . . 0.0 111.953 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.29 -47.09 83.78 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.802 -0.561 . . . . 0.0 111.878 170.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.41 -31.27 72.38 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.6 tp -73.71 -45.36 52.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.669 1.188 . . . . 0.0 112.086 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 49.0 mt -64.67 -38.82 92.29 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.185 0.994 . . . . 0.0 113.126 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -69.99 -37.58 75.76 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 120.113 1.324 . . . . 0.0 113.275 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.28 -30.97 62.34 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.588 -1.32 . . . . 0.0 112.433 170.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.3 mt -64.87 -32.68 74.49 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.235 -1.541 . . . . 0.0 112.958 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -67.38 -40.68 85.7 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 120.298 1.408 . . . . 0.0 111.66 170.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.65 -32.76 73.87 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.97 0.508 . . . . 0.0 112.343 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.9 tp -71.56 -58.47 3.47 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.011 0.924 . . . . 0.0 111.538 169.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -67.28 -31.39 71.68 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -169.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.99 -31.87 69.47 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 119.248 -0.751 . . . . 0.0 113.401 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -91.6 -28.83 17.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.695 0.798 . . . . 0.0 113.033 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.11 -36.61 84.18 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.804 1.184 . . . . 0.0 112.456 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -67.67 -3.14 8.23 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 173.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.0 t -100.78 -38.38 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.876 1.27 . . . . 0.0 112.122 166.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -91.89 -22.93 19.8 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -171.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.9 -141.34 31.57 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 118.527 -1.152 . . . . 0.0 113.735 -175.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.7 -10.47 28.7 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 125.056 3.838 . . . . 0.0 117.728 -114.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -123.16 169.26 11.42 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.931 1.292 . . . . 0.0 111.791 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -72.68 -7.16 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.411 -1.431 . . . . 0.0 112.828 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.58 16.9 21.87 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.075 1.75 . . . . 0.0 114.079 162.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.25 -109.53 3.39 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.534 1.064 . . . . 0.0 113.627 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -55.84 -39.77 71.9 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.462 1.505 . . . . 0.0 113.736 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -147.46 166.38 27.42 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.032 1.733 . . . . 0.0 110.638 -168.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 16.8 mt -61.92 135.34 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 120.89 0.376 . . . . 0.0 110.117 163.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.1 p -136.76 -170.86 2.78 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.311 1.044 . . . . 0.0 110.439 163.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.79 -19.66 4.62 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.5 t -69.97 -46.4 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 120.169 1.35 . . . . 0.0 111.836 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.6 -46.49 89.64 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.855 1.262 . . . . 0.0 112.312 172.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.6 mt -64.08 -8.87 13.33 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.781 0.832 . . . . 0.0 112.839 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.1 m -101.03 -47.6 4.71 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.668 1.187 . . . . 0.0 112.564 173.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 38.3 mt -90.78 -35.0 15.1 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -170.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.0 97.32 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -173.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.78 -20.55 17.31 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 120.741 1.301 . . . . 0.0 113.448 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -75.91 -31.16 59.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 117.411 -1.281 . . . . 0.0 112.322 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 77.0 mt -64.97 -40.29 94.77 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.054 0.843 . . . . 0.0 112.726 166.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -60.75 -46.36 90.74 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.416 0.627 . . . . 0.0 111.711 173.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -66.6 -22.97 66.12 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 125.123 1.369 . . . . 0.0 113.421 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.4 mt -72.31 -58.48 3.37 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.072 1.306 . . . . 0.0 113.097 165.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -61.73 -31.81 72.0 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 118.646 0.657 . . . . 0.0 111.509 -173.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.9 t -86.74 -64.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 124.548 1.139 . . . . 0.0 112.907 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.66 -55.65 4.51 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.715 -0.616 . . . . 0.0 112.197 -160.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.1 tp -61.98 -32.56 73.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.62 0.368 . . . . 0.0 111.642 170.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -55.46 -27.13 47.06 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.201 1.382 . . . . 0.0 115.793 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -65.98 -24.43 66.78 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -125.34 -19.43 5.07 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -144.87 82.58 1.68 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.507 1.923 . . . . 0.0 108.254 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -61.38 90.02 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.535 1.134 . . . . 0.0 110.482 171.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -92.81 116.77 67.04 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.696 0.799 . . . . 0.0 111.907 -163.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.4 117.33 5.03 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.701 1.6 . . . . 0.0 110.319 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.78 109.93 4.64 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 149.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -66.62 164.38 29.23 Favored 'Trans proline' 0 C--N 1.35 0.643 0 CA-C-N 120.74 1.3 . . . . 0.0 112.488 -165.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -25.94 63.92 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.807 1.643 . . . . 0.0 113.911 177.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -70.55 -24.51 62.8 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.998 1.719 . . . . 0.0 114.283 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.3 mt -86.98 50.47 2.02 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.833 1.653 . . . . 0.0 110.251 166.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.6 m -59.65 -36.67 76.86 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.954 1.302 . . . . 0.0 113.03 -156.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -81.75 -38.94 24.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.874 -0.584 . . . . 0.0 112.091 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.72 -39.36 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 121.622 -0.673 . . . . 0.0 111.785 172.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 46.5 tp -63.61 -45.7 89.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.989 0.916 . . . . 0.0 112.697 175.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -66.52 -32.07 73.2 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.315 -0.866 . . . . 0.0 112.639 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -63.65 -28.82 70.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.729 0.812 . . . . 0.0 112.89 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 18.7 mt -58.36 -35.54 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 120.65 -1.281 . . . . 0.0 111.234 171.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -84.6 -9.72 58.04 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.461 -1.399 . . . . 0.0 113.998 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.99 -22.01 62.23 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.107 -0.949 . . . . 0.0 113.178 160.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 56.4 mt -65.29 -18.81 65.61 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.628 1.104 . . . . 0.0 113.754 -177.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -98.56 6.93 46.73 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.833 1.253 . . . . 0.0 112.933 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.8 p -117.68 -179.44 3.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.322 1.849 . . . . 0.0 113.715 -165.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 53.97 -162.27 0.12 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.567 1.547 . . . . 0.0 110.8 -169.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 10.8 mp0 -82.99 -38.12 23.08 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 124.118 0.967 . . . . 0.0 109.241 159.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 77.5 p -71.05 -60.51 2.19 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 126.093 1.757 . . . . 0.0 114.086 -161.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -63.82 -44.28 93.72 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.506 0.593 . . . . 0.0 112.175 173.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -55.41 -36.62 66.65 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.085 0.954 . . . . 0.0 113.334 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -76.75 -15.47 59.75 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.6 p -76.28 -11.74 59.96 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.513 1.506 . . . . 0.0 113.088 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -65.45 89.49 0.1 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.687 1.595 . . . . 0.0 112.609 -168.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.64 131.32 48.59 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.665 -0.683 . . . . 0.0 109.308 155.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.75 135.23 57.52 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.384 0.674 . . . . 0.0 111.78 -174.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -60.74 -37.6 82.33 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -157.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -38.2 87.14 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.935 -1.103 . . . . 0.0 113.149 172.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -76.81 -7.72 55.97 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 171.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.9 t -82.89 -49.56 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.774 0.83 . . . . 0.0 110.612 161.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.5 mt -59.92 -48.32 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.342 1.057 . . . . 0.0 111.5 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.25 -14.44 62.61 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.09 -33.67 9.42 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 120.917 -1.114 . . . . 0.0 113.364 170.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -78.95 -34.02 44.77 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.837 1.655 . . . . 0.0 113.885 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -51.34 -50.33 76.8 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.19 -24.92 27.17 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 121.637 1.558 . . . . 0.0 113.49 172.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -78.18 -10.39 59.62 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.147 1.379 . . . . 0.0 114.267 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.74 -31.03 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 119.249 0.931 . . . . 0.0 110.389 158.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -96.38 -20.12 18.7 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 177.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 C-N-CA 125.707 1.603 . . . . 0.0 112.629 -176.268 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.984 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.5 mt -111.85 139.63 47.17 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.421 1.488 . . . . 0.0 111.999 -175.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -139.78 134.88 32.42 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.984 1.313 . . . . 0.0 108.136 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.8 pt -127.57 142.34 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 120.999 -1.063 . . . . 0.0 110.5 -174.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.9 m -117.58 120.25 37.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.757 1.223 . . . . 0.0 109.689 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.27 163.03 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.998 1.319 . . . . 0.0 111.517 -165.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -59.54 116.2 3.83 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.609 -0.682 . . . . 0.0 110.865 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.482 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -78.06 149.78 33.89 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.935 154.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.05 146.88 49.02 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.203 1.002 . . . . 0.0 112.197 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 51.3 t -68.87 133.75 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 167.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.38 -33.9 1.56 Allowed Glycine 0 CA--C 1.537 1.453 0 CA-C-O 118.516 -1.158 . . . . 0.0 115.357 -174.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.13 69.03 9.75 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.824 1.25 . . . . 0.0 112.61 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.482 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 58.7 Cg_endo -63.41 -11.84 27.74 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.271 2.647 . . . . 0.0 114.816 -173.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -81.4 0.65 36.51 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.063 1.745 . . . . 0.0 114.737 175.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 pt -133.96 164.76 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.795 1.238 . . . . 0.0 111.801 174.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.39 146.7 54.56 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.59 0.756 . . . . 0.0 111.454 169.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -124.2 -164.28 11.92 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 125.25 1.405 . . . . 0.0 112.494 166.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -60.89 108.67 0.89 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 118.22 1.01 . . . . 0.0 113.593 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.1 t -157.63 108.26 1.81 Allowed Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.119 139.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.54 -21.5 59.78 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.14 1.893 . . . . 0.0 112.39 176.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -68.5 -29.9 68.61 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.61 0.764 . . . . 0.0 112.297 173.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 73.1 m -72.26 -37.58 69.05 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.372 -1.455 . . . . 0.0 112.669 168.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.53 -25.13 67.09 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 118.112 -0.947 . . . . 0.0 113.141 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.506 HH12 ' CG ' ' A' ' 74' ' ' ASP . 32.8 mtp180 -58.61 -43.3 89.56 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.319 1.048 . . . . 0.0 112.407 169.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.2 t -76.98 -37.43 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.855 1.262 . . . . 0.0 111.302 -176.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.55 -45.26 91.33 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.138 0.575 . . . . 0.0 111.478 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.68 -50.91 69.28 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.827 1.251 . . . . 0.0 112.408 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 p -63.08 -50.5 70.31 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.6 -35.8 73.18 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -76.53 -23.18 53.64 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 171.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -68.86 -46.23 69.01 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.072 1.305 . . . . 0.0 110.983 170.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -70.35 -7.24 41.18 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.48 1.512 . . . . 0.0 114.92 169.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.9 mmtm 61.46 15.39 6.61 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 126.032 1.733 . . . . 0.0 114.863 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.7 mt -72.69 128.6 88.1 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 123.598 0.759 . . . . 0.0 109.306 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.44 138.12 32.03 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.183 1.922 . . . . 0.0 111.516 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -141.67 153.44 44.7 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.231 1.412 . . . . 0.0 110.556 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -78.22 122.8 26.16 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.317 -0.864 . . . . 0.0 109.804 166.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.3 t -97.74 93.79 6.58 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.593 0.757 . . . . 0.0 111.559 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -82.83 105.68 14.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.903 0.881 . . . . 0.0 110.292 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.1 mt -73.24 113.95 10.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.944 0.898 . . . . 0.0 109.918 171.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.2 mm -108.97 115.8 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.739 1.216 . . . . 0.0 110.086 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -73.98 79.58 1.68 Allowed 'General case' 0 C--O 1.221 -0.411 0 O-C-N 121.4 -0.813 . . . . 32.609999999999999 109.756 166.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pp -65.05 0.7 1.17 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 117.601 2.445 . . . . 40.049999999999997 117.601 -165.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.51 -27.6 67.26 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-N 119.612 1.096 . . . . 41.469999999999999 112.871 161.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -120.45 53.91 1.08 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.934 2.894 . . . . 47.170000000000002 109.529 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -73.06 116.48 51.0 Favored Pre-proline 0 N--CA 1.472 0.667 0 O-C-N 119.757 -1.839 . . . . 41.270000000000003 110.317 -176.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.22 160.58 46.83 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.648 2.232 . . . . 40.289999999999999 112.144 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -61.46 -34.03 74.75 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.302 1.223 . . . . 42.390000000000001 114.302 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 30.5 p-90 -67.5 -21.37 65.5 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.691 -1.256 . . . . 37.079999999999998 114.097 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -82.74 -34.42 27.17 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.425 -0.797 . . . . 35.880000000000003 112.321 169.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.78 -24.97 65.38 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.551 0.74 . . . . 33.609999999999999 112.385 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -72.73 -1.45 16.47 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.794 1.637 . . . . 33.789999999999999 114.376 166.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.6 mt -115.73 -41.7 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.348 1.459 . . . . 33.159999999999997 110.314 173.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.1 t -114.43 100.4 52.9 Favored Pre-proline 0 N--CA 1.471 0.591 0 C-N-CA 125.808 1.643 . . . . 33.579999999999998 111.281 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.99 -20.55 44.53 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.941 2.428 . . . . 37.899999999999999 113.418 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.76 -0.08 57.52 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.396 1.079 . . . . 38.990000000000002 113.716 171.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.92 23.68 72.78 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.607 1.575 . . . . 35.469999999999999 115.866 176.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -104.15 158.63 16.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.889 1.675 . . . . 34.490000000000002 112.789 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.3 m -115.24 150.08 43.8 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.648 1.579 . . . . 23.530000000000001 111.151 164.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -68.46 153.62 89.27 Favored 'Cis proline' 0 C--N 1.349 0.562 0 CA-C-O 121.724 0.635 . . . . 22.879999999999999 112.629 -9.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.1 p -135.63 147.77 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 113.577 -1.647 . . . . 0.0 107.294 156.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.7 m -129.69 161.75 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.654 0.781 . . . . 0.0 110.474 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -116.03 98.93 6.91 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.428 1.491 . . . . 0.0 109.118 167.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 66.8 mt -87.49 114.85 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.415 1.086 . . . . 0.0 108.536 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.58 36.84 28.23 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 121.866 0.841 . . . . 0.0 112.457 -169.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.251 11.2 t0 66.77 10.72 7.75 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 128.292 2.637 . . . . 0.0 116.316 -170.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -104.12 123.18 46.8 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 119.412 -2.055 . . . . 0.0 110.688 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -69.36 143.49 53.71 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -170.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.4 t -142.86 126.66 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 126.695 1.998 . . . . 0.0 108.585 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -110.38 164.95 12.18 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.62 1.568 . . . . 0.0 112.136 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.2 t0 67.57 113.45 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.342 2.257 . . . . 22.16 114.191 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.5 p -65.16 -22.14 66.88 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 115.356 1.613 . . . . 21.16 115.356 -158.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.506 ' CG ' HH12 ' A' ' 25' ' ' ARG . 33.8 m-20 -70.47 -35.68 73.43 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.899 1.227 . . . . 24.969999999999999 112.696 170.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.62 -41.71 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 121.092 -1.005 . . . . 23.850000000000001 110.745 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.0 mt -63.75 -46.5 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.841 0.856 . . . . 23.68 111.227 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.1 t -63.15 -40.54 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.021 0.928 . . . . 22.84 111.314 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.19 -47.26 89.06 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 118.462 0.574 . . . . 23.329999999999998 113.1 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 75.9 mt -73.43 -47.24 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 117.846 0.823 . . . . 23.309999999999999 112.165 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.56 -32.23 73.79 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.046 1.294 . . . . 23.48 112.748 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -89.57 -14.37 35.21 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 114.614 1.338 . . . . 24.239999999999998 114.614 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.534 ' CD ' ' HE3' ' A' ' 83' ' ' LYS . 68.8 tt0 -89.54 -33.57 16.69 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.283 1.433 . . . . 39.259999999999998 112.606 165.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.534 ' HE3' ' CD ' ' A' ' 82' ' ' GLU . 65.2 mttt -135.3 85.33 2.16 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.619 1.168 . . . . 24.449999999999999 112.09 -161.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -150.42 166.02 16.09 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.149 1.78 . . . . 0.0 109.191 168.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.76 -33.36 44.31 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 121.919 1.746 . . . . 0.0 112.103 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -73.95 149.31 87.56 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.231 1.012 . . . . 0.0 111.649 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -52.31 143.02 44.96 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.408 2.739 . . . . 0.0 115.02 -172.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.98 133.49 29.22 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.673 2.249 . . . . 0.0 111.934 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 34.1 mt -103.34 8.51 38.16 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.608 1.163 . . . . 0.0 111.83 168.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.49 49.17 0.11 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.281 1.832 . . . . 0.0 112.373 163.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.7 p -123.31 65.07 29.47 Favored Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 125.381 1.473 . . . . 0.0 109.885 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.76 119.83 6.85 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.181 1.921 . . . . 0.0 109.962 -173.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -73.89 -176.37 2.57 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.917 2.412 . . . . 0.0 111.532 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -53.93 -29.23 41.46 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.184 2.194 . . . . 0.0 113.5 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -52.72 -28.5 22.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.8 1.64 . . . . 0.0 114.045 170.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.64 -29.41 70.65 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.658 1.117 . . . . 0.0 113.358 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 59.7 p -66.9 -25.16 66.25 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.789 0.836 . . . . 0.0 113.097 174.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.0 t -94.87 -42.04 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.978 1.311 . . . . 0.0 110.814 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.47 -31.09 79.58 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.7 1.143 . . . . 0.0 114.421 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 72.3 p -66.35 -20.6 66.13 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.762 1.281 . . . . 0.0 114.211 171.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -92.2 -33.26 14.76 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.113 1.365 . . . . 0.0 112.827 172.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.8 mt -70.45 -37.09 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.986 0.914 . . . . 0.0 111.655 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.453 ' CE1' ' HE2' ' A' ' 156' ' ' LYS . 83.0 t80 -54.68 -45.85 99.47 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.032 1.333 . . . . 0.0 114.505 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.78 -32.52 1.09 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.016 2.478 . . . . 0.0 114.069 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.2 p -71.76 -26.62 62.52 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 121.34 1.882 . . . . 0.0 113.207 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -58.4 -45.89 87.47 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.695 -1.253 . . . . 0.0 112.413 160.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.46 -31.72 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 121.374 -0.828 . . . . 0.0 112.069 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -64.67 -44.15 91.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.689 0.677 . . . . 0.0 111.365 168.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -67.79 -37.1 81.57 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.5 mt -64.21 -11.32 29.91 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.787 1.635 . . . . 0.0 114.435 167.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -142.31 41.03 1.62 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.641 1.976 . . . . 0.0 112.543 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.1 m -68.6 59.73 0.09 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -165.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 94.4 mttt -71.28 -35.75 71.44 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.562 -1.336 . . . . 0.0 111.995 168.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 15.4 t0 -81.01 112.78 35.4 Favored Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 152.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 114' ' ' ASP . 95.9 Cg_exo -57.24 158.68 17.62 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.977 2.451 . . . . 0.0 117.29 -148.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -56.91 -51.64 68.32 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.478 -174.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -79.67 -21.67 44.45 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -163.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.89 -36.08 29.5 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 121.355 -0.841 . . . . 0.0 112.772 165.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 62.3 m -66.81 -30.89 71.2 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.641 0.776 . . . . 0.0 112.799 171.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -65.24 -42.69 93.12 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 125.736 1.614 . . . . 0.0 111.841 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -65.62 -43.13 90.5 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.724 -0.61 . . . . 0.0 111.766 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.05 -25.68 68.22 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 174.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 49.8 tp -82.47 -42.63 18.24 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.848 1.259 . . . . 0.0 112.27 172.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 33.9 mt -67.23 -39.17 86.19 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.668 1.187 . . . . 0.0 113.241 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -67.01 -34.97 78.89 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.046 1.293 . . . . 0.0 112.389 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -72.29 -38.55 68.73 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.027 -1.046 . . . . 0.0 112.765 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.1 mt -64.98 -33.14 75.32 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.585 -1.322 . . . . 0.0 113.03 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -66.4 -41.38 89.39 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.673 1.124 . . . . 0.0 111.51 171.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.8 -35.82 81.85 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.965 0.506 . . . . 0.0 112.203 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.4 tp -68.67 -56.45 8.14 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.068 0.947 . . . . 0.0 111.677 171.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -67.43 -31.63 71.95 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.71 1.204 . . . . 0.0 114.157 -172.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.21 -31.63 73.96 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.154 -0.803 . . . . 0.0 113.543 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -87.45 -33.71 18.95 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 117.888 0.844 . . . . 0.0 112.804 170.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.77 -34.91 78.23 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.041 1.291 . . . . 0.0 113.259 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -68.5 0.93 3.47 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 172.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.8 t -111.07 -37.42 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.599 1.559 . . . . 0.0 112.108 166.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -90.55 -17.16 27.49 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -172.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.98 -143.66 32.5 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-O 118.725 -1.041 . . . . 0.0 114.586 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.35 -18.45 49.91 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 124.794 3.663 . . . . 0.0 117.772 -119.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -118.16 171.03 8.39 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.399 1.08 . . . . 0.0 111.552 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.88 -6.04 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 120.146 -1.597 . . . . 0.0 113.037 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -108.82 15.15 23.78 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.258 1.823 . . . . 0.0 114.301 162.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.81 -108.14 3.03 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 120.564 -1.335 . . . . 0.0 113.242 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -51.72 -41.61 61.64 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.882 1.673 . . . . 0.0 113.887 -172.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -152.93 165.25 36.1 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.868 1.667 . . . . 0.0 110.233 -166.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.9 mt -64.75 132.39 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.195 0.598 . . . . 0.0 109.939 166.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.5 p -138.91 -170.72 2.92 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.843 1.257 . . . . 0.0 110.699 168.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.05 -17.49 3.98 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.1 t -71.03 -45.06 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 119.978 1.263 . . . . 0.0 111.795 172.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.88 -45.72 92.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.859 1.264 . . . . 0.0 111.905 172.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.66 -17.34 60.32 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.216 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.8 m -91.65 -48.05 7.04 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.861 1.21 . . . . 0.0 112.619 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.6 mt -94.49 -36.84 11.68 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -167.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.52 -47.86 97.7 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.22 -21.14 20.54 Favored 'Trans proline' 0 C--N 1.351 0.682 0 CA-C-N 120.808 1.324 . . . . 0.0 113.426 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.453 ' HE2' ' CE1' ' A' ' 103' ' ' PHE . 67.5 mttm -81.0 -27.81 35.74 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.907 -1.121 . . . . 0.0 112.89 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.8 mt -64.83 -43.33 93.42 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.364 0.665 . . . . 0.0 112.204 164.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -59.7 -44.68 93.59 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.225 0.466 . . . . 0.0 111.877 172.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -63.9 -31.37 72.53 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 71.6 mt -74.01 -49.01 26.28 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 118.004 -0.998 . . . . 0.0 113.488 171.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -61.4 -31.1 71.01 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.219 0.918 . . . . 0.0 112.203 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 95.6 t -88.95 -66.97 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.812 1.245 . . . . 0.0 113.27 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.59 -48.78 8.04 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -160.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 30.8 tp -62.83 -33.39 75.13 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.614 166.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -55.05 -28.65 49.69 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.937 1.256 . . . . 0.0 115.713 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -66.17 -22.23 66.36 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -128.04 -22.2 3.52 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -142.79 86.1 1.92 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.378 1.871 . . . . 0.0 108.486 167.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -61.58 86.03 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.178 1.391 . . . . 0.0 110.947 171.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -88.64 121.5 69.97 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.789 -163.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.71 109.93 2.77 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.579 1.519 . . . . 0.0 110.147 170.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.3 mm -59.36 108.34 1.33 Allowed Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 142.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -68.35 164.93 30.62 Favored 'Trans proline' 0 C--N 1.35 0.642 0 CA-C-N 120.553 1.233 . . . . 0.0 112.638 -165.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.52 -24.79 63.95 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.269 1.427 . . . . 0.0 113.27 171.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -66.39 -26.86 67.45 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.834 1.253 . . . . 0.0 113.775 171.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 67.6 mt -87.25 49.68 1.86 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.715 1.606 . . . . 0.0 111.065 169.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.23 -33.47 74.66 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.282 1.033 . . . . 0.0 113.343 -155.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -81.63 -37.66 27.2 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.785 0.721 . . . . 0.0 112.115 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.67 -39.57 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 121.587 -0.696 . . . . 0.0 111.613 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 43.0 tp -65.67 -40.24 92.16 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -68.48 -38.52 81.1 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.546 -0.721 . . . . 0.0 112.323 171.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -63.78 -29.38 70.59 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.252 1.021 . . . . 0.0 113.292 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 78.1 mt -59.07 -32.05 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 120.548 -1.345 . . . . 0.0 111.856 170.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -84.45 -10.68 57.29 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.473 -1.392 . . . . 0.0 113.607 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.94 -17.65 61.46 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.581 161.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.43 -14.26 61.93 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.671 1.123 . . . . 0.0 113.244 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -103.89 5.61 35.85 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.902 1.281 . . . . 0.0 113.316 174.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.6 p -111.33 -179.05 3.61 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.11 2.164 . . . . 0.0 113.964 -167.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 54.12 -159.72 0.16 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.489 1.516 . . . . 0.0 110.628 -172.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.502 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 5.7 mp0 -85.8 -41.01 15.42 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.781 1.232 . . . . 0.0 109.139 160.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 78.4 p -68.55 -60.42 2.43 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 126.293 1.837 . . . . 0.0 114.436 -162.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -62.25 -45.37 93.61 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.518 0.599 . . . . 0.0 112.085 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -56.86 -35.48 68.93 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.304 1.042 . . . . 0.0 113.457 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -76.9 -13.45 59.99 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 176.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.6 p -77.83 -10.77 59.73 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.402 1.455 . . . . 0.0 113.384 171.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -67.24 83.31 0.14 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.683 1.593 . . . . 0.0 112.852 -170.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.26 131.02 49.03 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.298 1.039 . . . . 0.0 109.919 161.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.27 129.96 44.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.317 0.647 . . . . 0.0 111.346 -171.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 31.0 mp0 -59.08 -39.14 81.21 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -157.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -60.39 -36.95 79.29 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.872 1.269 . . . . 0.0 112.687 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -85.12 -6.69 59.29 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.568 1.547 . . . . 0.0 113.092 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 39.6 t -86.79 -44.5 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.215 162.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.1 mt -58.18 -51.2 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.696 1.199 . . . . 0.0 111.347 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.76 -15.0 62.64 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -83.78 -33.25 22.11 Favored Glycine 0 CA--C 1.533 1.216 0 O-C-N 120.874 -1.141 . . . . 0.0 113.175 169.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 44.9 t90 -84.93 -35.26 22.21 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.121 2.169 . . . . 0.0 114.675 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -53.42 -47.35 96.56 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.9 -24.27 29.2 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.498 1.466 . . . . 0.0 113.656 172.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -75.48 -11.68 60.08 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 117.672 -1.156 . . . . 0.0 114.014 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.412 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 48.1 t -59.39 -21.95 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.264 0.938 . . . . 0.0 110.934 160.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -106.73 -10.12 16.22 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 172.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 C-N-CA 126.674 1.99 . . . . 0.0 112.386 -173.746 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.851 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 49.0 mt -103.45 143.6 32.49 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.446 1.117 . . . . 0.0 113.107 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -151.65 128.38 10.87 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.533 1.933 . . . . 0.0 108.382 172.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 pt -126.43 140.77 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.898 0.879 . . . . 0.0 109.92 -170.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.4 m -106.44 122.71 46.82 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.513 0.725 . . . . 0.0 109.335 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.39 164.0 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.597 1.559 . . . . 0.0 110.924 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -62.01 119.01 8.04 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.536 -0.727 . . . . 0.0 111.316 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -80.53 153.69 27.96 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.339 153.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.37 143.6 57.78 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.091 0.948 . . . . 0.0 112.18 170.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.6 t -70.51 136.65 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 168.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.78 -35.0 1.41 Allowed Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.814 -0.992 . . . . 0.0 114.775 -172.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.61 69.03 6.07 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 125.177 1.391 . . . . 0.0 112.478 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.37 -11.44 28.24 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.527 2.818 . . . . 0.0 115.413 -172.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -92.5 9.07 36.0 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.5 pt -130.32 163.09 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.593 1.157 . . . . 0.0 111.264 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.4 mt -62.68 146.02 53.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.299 0.64 . . . . 0.0 111.109 166.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.86 -169.16 12.47 Favored Glycine 0 N--CA 1.474 1.201 0 C-N-CA 125.233 1.397 . . . . 0.0 112.605 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -59.61 108.2 0.7 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.8 t -157.91 103.08 1.76 Allowed Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.637 1.175 . . . . 0.0 109.163 144.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -63.71 -18.95 66.29 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.249 2.633 . . . . 0.0 112.572 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -71.07 -30.6 66.78 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.4 -0.813 . . . . 0.0 112.602 172.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.3 m -70.35 -38.97 74.93 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.598 -1.314 . . . . 0.0 112.415 168.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -60.33 -26.89 66.91 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 118.143 -0.932 . . . . 0.0 113.155 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.522 HH12 ' CG ' ' A' ' 74' ' ' ASP . 46.6 mtp180 -57.89 -45.39 86.49 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.122 0.969 . . . . 0.0 112.52 171.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.54 -39.51 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.089 1.356 . . . . 0.0 111.322 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.82 -41.36 91.13 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.213 0.605 . . . . 0.0 111.258 172.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.4 tp -63.17 -54.5 36.6 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.06 1.344 . . . . 0.0 112.447 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.0 p -69.82 -38.31 76.52 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.462 1.028 . . . . 0.0 113.467 -171.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.6 mt -71.36 -38.96 71.54 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -75.62 -22.57 56.75 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 171.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -69.36 -47.01 65.61 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 120.536 -1.353 . . . . 0.0 111.145 170.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -69.74 -6.52 32.47 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.76 1.624 . . . . 0.0 114.652 169.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm 59.81 16.54 5.7 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.723 1.609 . . . . 0.0 114.804 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.9 mt -71.39 125.9 91.81 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.13 136.46 24.63 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.119 1.879 . . . . 0.0 111.4 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -136.17 151.08 49.37 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.664 1.585 . . . . 0.0 110.573 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -73.76 139.15 45.03 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.45 -0.781 . . . . 0.0 109.035 161.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.3 t -125.2 93.24 3.82 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.733 0.813 . . . . 0.0 111.162 -175.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -74.85 113.42 12.12 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.835 0.854 . . . . 0.0 110.464 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 83.8 mt -72.95 101.29 3.16 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.504 1.122 . . . . 0.0 110.02 164.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mm -97.1 111.29 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.629 0.771 . . . . 0.0 109.892 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -78.06 70.07 4.37 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.252 -0.905 . . . . 32.609999999999999 110.552 168.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.01 8.33 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 117.758 2.503 . . . . 40.049999999999997 117.758 -166.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.94 -44.46 91.67 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-N 119.825 1.193 . . . . 41.469999999999999 111.26 155.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -102.74 72.47 1.22 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.583 1.953 . . . . 47.170000000000002 110.068 166.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -81.24 110.96 20.62 Favored Pre-proline 0 N--CA 1.475 0.778 0 O-C-N 120.234 -1.541 . . . . 41.270000000000003 110.872 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.21 158.15 45.43 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.868 2.379 . . . . 40.289999999999999 112.481 -174.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -59.12 -34.5 72.11 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.419 1.266 . . . . 42.390000000000001 114.419 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -64.83 -32.15 73.72 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.188 0.904 . . . . 37.079999999999998 113.287 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -75.35 -34.53 61.17 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.689 -1.257 . . . . 35.880000000000003 112.782 170.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.89 -28.89 67.1 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.401 1.0 . . . . 33.609999999999999 113.285 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -68.61 -30.47 69.22 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.907 1.683 . . . . 33.789999999999999 112.537 170.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.7 mt -85.04 -33.15 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.96 1.304 . . . . 33.159999999999997 111.623 173.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.1 t -131.62 94.7 25.1 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 126.027 1.731 . . . . 33.579999999999998 110.586 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.86 -15.87 40.8 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.611 2.207 . . . . 37.899999999999999 113.842 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -81.87 -8.09 59.66 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.546 0.943 . . . . 38.990000000000002 113.546 168.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.28 13.42 64.92 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 120.933 -1.104 . . . . 35.469999999999999 114.789 -173.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -91.72 150.94 20.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.176 1.39 . . . . 34.490000000000002 112.763 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.7 m -110.96 153.94 43.6 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 126.176 1.79 . . . . 23.530000000000001 110.74 159.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -66.68 156.68 82.36 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-O 121.975 0.74 . . . . 22.879999999999999 112.925 -8.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 p -144.99 142.27 22.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.164 -1.38 . . . . 0.0 107.872 162.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 m -129.58 146.83 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.513 0.725 . . . . 0.0 110.67 -171.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -105.74 78.72 1.37 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.433 1.493 . . . . 0.0 109.724 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 34.4 mt -71.8 114.5 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.902 0.881 . . . . 0.0 109.564 -176.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 t70 52.47 39.36 27.61 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.96 0.885 . . . . 0.0 112.429 -165.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.8 t0 69.9 7.74 6.37 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 128.075 2.55 . . . . 0.0 116.622 -173.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -103.49 127.06 50.96 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 119.768 -1.833 . . . . 0.0 111.512 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.0 p-90 -70.18 142.48 52.46 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -170.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -143.04 128.4 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 127.722 2.409 . . . . 0.0 108.286 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.74 168.37 9.62 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.606 1.562 . . . . 0.0 112.131 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.9 t0 66.55 113.19 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.66 2.384 . . . . 22.16 114.346 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.3 p -63.11 -24.3 67.84 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 115.215 1.561 . . . . 21.16 115.215 -161.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.522 ' CG ' HH12 ' A' ' 25' ' ' ARG . 37.2 m-20 -73.18 -35.46 66.4 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.179 1.354 . . . . 24.969999999999999 113.307 170.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.62 -38.51 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 121.09 -1.006 . . . . 23.850000000000001 110.856 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.88 -45.94 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.314 1.046 . . . . 23.68 111.233 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.1 t -61.81 -41.4 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.26 1.024 . . . . 22.84 111.299 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.55 -20.26 55.61 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.782 -1.01 . . . . 23.329999999999998 114.932 175.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 98.5 mt -106.5 -44.14 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 119.073 1.436 . . . . 23.309999999999999 112.38 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.4 mt -65.72 -32.78 74.51 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 120.251 1.387 . . . . 23.48 112.947 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.13 -11.77 40.26 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 114.237 1.199 . . . . 24.239999999999998 114.237 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.472 ' OE2' ' HE3' ' A' ' 83' ' ' LYS . 75.0 tt0 -92.41 -41.07 10.52 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.103 1.361 . . . . 39.259999999999998 112.554 165.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.472 ' HE3' ' OE2' ' A' ' 82' ' ' GLU . 74.6 mttt -124.51 90.01 3.18 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.662 1.185 . . . . 24.449999999999999 111.977 -164.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -151.8 165.69 16.88 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.833 1.653 . . . . 0.0 109.474 168.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.21 -30.34 31.2 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.003 1.802 . . . . 0.0 112.031 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -73.7 152.87 89.39 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.82 1.248 . . . . 0.0 112.086 171.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -51.81 142.87 40.63 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.74 2.96 . . . . 0.0 115.053 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.31 131.53 25.17 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.272 1.981 . . . . 0.0 111.533 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.6 mt -105.29 4.48 31.05 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.223 1.409 . . . . 0.0 112.185 171.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.71 51.51 0.14 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.698 1.999 . . . . 0.0 112.178 162.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.1 p -123.79 70.76 49.11 Favored Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 125.021 1.329 . . . . 0.0 109.236 170.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.07 122.48 9.07 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.282 1.988 . . . . 0.0 110.227 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -73.98 179.59 5.58 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.874 2.383 . . . . 0.0 111.221 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.6 mp0 -55.09 -29.75 58.25 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.624 1.97 . . . . 0.0 113.08 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -53.77 -28.14 33.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.994 1.318 . . . . 0.0 113.842 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.27 -29.96 71.19 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.624 1.102 . . . . 0.0 113.21 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.9 p -68.45 -21.95 64.61 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.2 t -99.9 -41.11 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.835 1.254 . . . . 0.0 111.081 176.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.67 -31.52 81.07 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.729 -1.232 . . . . 0.0 114.435 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.9 p -69.62 -18.58 63.61 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -90.46 -32.66 16.29 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.842 1.257 . . . . 0.0 112.881 169.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 71.0 mt -70.27 -36.0 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.778 0.831 . . . . 0.0 111.629 173.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -55.44 -46.74 99.66 Favored Pre-proline 0 CA--C 1.547 0.829 0 O-C-N 120.379 -1.451 . . . . 0.0 114.344 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.65 -31.67 2.44 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.933 2.422 . . . . 0.0 114.116 171.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.6 p -71.46 -28.12 63.73 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 121.034 1.743 . . . . 0.0 113.005 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -58.72 -44.51 90.45 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 120.655 -1.278 . . . . 0.0 112.305 161.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.5 t -65.86 -35.05 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 119.639 1.109 . . . . 0.0 111.887 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -66.54 -39.02 88.36 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.031 0.832 . . . . 0.0 112.047 171.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -70.11 -29.85 66.91 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.284 1.034 . . . . 0.0 112.426 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.9 mt -76.99 -9.06 58.44 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.673 1.589 . . . . 0.0 114.517 168.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -142.63 38.55 1.51 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.92 1.288 . . . . 0.0 112.839 -170.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.4 m -75.07 63.01 1.22 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -162.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -65.26 -38.07 89.15 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.05 1.34 . . . . 0.0 111.136 163.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -83.89 115.97 62.43 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 154.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.59 154.24 70.15 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.675 2.917 . . . . 0.0 115.759 -144.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -66.9 -42.64 85.12 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 114.42 -1.264 . . . . 0.0 112.993 -165.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.71 -22.33 54.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.656 1.182 . . . . 0.0 113.32 -174.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.82 -34.6 27.12 Favored Glycine 0 CA--C 1.532 1.155 0 O-C-N 120.973 -1.079 . . . . 0.0 112.813 165.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 99.4 m -68.44 -27.09 65.87 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.596 -0.944 . . . . 0.0 112.729 171.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.59 -44.44 96.26 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.841 1.657 . . . . 0.0 111.928 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -66.7 -41.84 87.36 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.43 0.692 . . . . 0.0 112.059 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.77 -25.05 67.09 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 174.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.9 tp -82.51 -41.71 19.36 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.685 1.194 . . . . 0.0 112.17 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 26.9 mt -65.23 -40.08 93.61 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.713 1.205 . . . . 0.0 113.566 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -68.23 -33.83 75.12 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.927 1.239 . . . . 0.0 112.727 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -73.48 -38.76 65.31 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.063 -1.023 . . . . 0.0 112.722 170.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.1 mt -63.57 -35.55 80.86 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.782 -1.199 . . . . 0.0 112.849 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -65.06 -44.29 89.46 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.137 0.975 . . . . 0.0 111.598 172.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.61 -36.02 81.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.333 0.653 . . . . 0.0 112.224 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.1 tp -69.35 -56.95 6.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.377 1.071 . . . . 0.0 111.97 172.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.47 -30.57 69.45 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -171.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.33 -32.01 67.23 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.144 -0.809 . . . . 0.0 113.487 172.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -89.15 -33.88 16.9 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 117.75 0.775 . . . . 0.0 113.006 172.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.55 -35.95 81.07 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.912 1.233 . . . . 0.0 113.042 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.6 mtmt -65.81 -6.9 13.34 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 174.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.6 t -102.5 -36.72 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.961 1.305 . . . . 0.0 112.173 169.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -89.22 -19.32 25.55 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.31 -140.63 35.9 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.939 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -70.86 -15.71 32.95 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.785 3.657 . . . . 0.0 117.343 -108.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -122.08 170.98 9.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.926 1.29 . . . . 0.0 110.908 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.254 2.9 tt -77.9 7.29 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 119.855 -1.778 . . . . 0.0 113.132 -175.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -114.61 6.95 15.91 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.91 2.484 . . . . 0.0 114.035 163.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.93 -122.33 6.64 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.82 -1.175 . . . . 0.0 113.185 -172.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -54.0 -36.69 63.22 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -169.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -146.76 157.87 43.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.318 1.447 . . . . 0.0 110.977 -166.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 56.0 mt -67.48 132.67 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.517 0.727 . . . . 0.0 110.414 171.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.0 p -143.5 -171.62 3.54 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.483 1.513 . . . . 0.0 111.15 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -54.58 -17.89 3.8 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.61 -42.48 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 120.211 1.369 . . . . 0.0 111.759 172.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.64 -45.08 95.56 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.933 1.293 . . . . 0.0 112.326 168.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.8 mt -62.08 -24.24 66.99 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 122.039 -0.413 . . . . 0.0 111.769 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.9 m -83.46 -50.56 8.18 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.887 -1.133 . . . . 0.0 112.597 175.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.3 mt -94.86 -36.0 11.82 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -165.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.8 -49.17 94.39 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.56 -22.5 15.8 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 120.725 1.295 . . . . 0.0 113.483 178.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -78.2 -28.92 48.16 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 117.714 -1.136 . . . . 0.0 112.859 174.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 46.7 mt -65.69 -44.65 85.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.89 0.876 . . . . 0.0 112.395 166.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -57.22 -41.66 79.91 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.161 0.505 . . . . 0.0 111.792 170.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -68.0 -29.61 68.67 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 9.2 mt -69.68 -52.48 25.35 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.419 1.008 . . . . 0.0 111.913 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -61.43 -35.51 77.78 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.017 0.927 . . . . 0.0 112.029 -174.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.7 t -90.56 -62.82 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.395 1.078 . . . . 0.0 113.14 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.21 -56.83 3.81 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.601 -0.687 . . . . 0.0 112.42 -162.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.42 -33.12 74.86 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.439 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.64 -23.29 49.28 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.129 1.347 . . . . 0.0 115.778 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -69.95 -22.26 63.19 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -124.94 -25.19 3.93 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -139.34 90.52 2.42 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.825 1.65 . . . . 0.0 108.353 166.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -65.3 83.78 0.05 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.583 1.153 . . . . 0.0 109.979 170.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -86.8 117.38 68.57 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.852 -169.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.34 110.63 2.9 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.585 1.524 . . . . 0.0 109.835 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.8 mm -55.39 109.32 1.54 Allowed Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 151.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -64.51 158.34 50.18 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 121.278 1.319 . . . . 0.0 112.442 -166.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.71 -19.06 64.63 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -66.36 -25.0 66.59 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.424 1.09 . . . . 0.0 113.693 168.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 62.5 mt -87.06 47.88 1.57 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.232 1.813 . . . . 0.0 111.388 170.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.7 -31.76 73.03 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.987 -1.071 . . . . 0.0 113.823 -155.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -80.45 -38.12 30.66 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.092 -1.005 . . . . 0.0 111.862 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 87.0 t -61.46 -42.32 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 121.436 -0.79 . . . . 0.0 111.559 171.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.8 -29.44 69.92 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -80.9 -37.45 29.65 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.595 -0.691 . . . . 0.0 112.507 170.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -63.76 -31.13 72.21 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.476 1.11 . . . . 0.0 113.473 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 79.6 mt -56.96 -37.1 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.139 -0.976 . . . . 0.0 111.904 169.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -77.5 -16.34 58.77 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 119.975 -1.703 . . . . 0.0 112.878 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 66.6 mt -77.0 -12.76 59.98 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 117.461 -1.257 . . . . 0.0 113.473 166.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.83 -18.9 65.61 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.414 1.461 . . . . 0.0 112.924 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -93.15 2.17 56.81 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 173.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.4 p -105.97 -179.57 3.98 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.168 2.187 . . . . 0.0 113.828 -170.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 43.8 mtp85 55.09 -161.95 0.15 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.347 1.459 . . . . 0.0 110.655 -172.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 8.0 mp0 -86.03 -40.68 15.53 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.101 1.36 . . . . 0.0 109.209 157.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 72.5 p -70.7 -53.15 16.74 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.713 1.605 . . . . 0.0 114.727 -160.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -67.01 -46.17 75.3 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.17 0.896 . . . . 0.0 111.855 171.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 193' ' ' LYS . 26.7 ttmt -55.89 -38.28 69.98 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -74.46 -12.5 60.51 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.7 p -77.75 -11.74 59.91 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.329 1.422 . . . . 0.0 113.267 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -67.32 86.23 0.17 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.778 1.631 . . . . 0.0 112.721 -169.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.35 136.11 57.93 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.797 0.839 . . . . 0.0 109.99 159.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.2 132.47 53.77 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.104 0.562 . . . . 0.0 111.547 -173.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -60.02 -37.46 79.83 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.636 1.346 . . . . 0.0 114.636 -159.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.44 -38.28 83.59 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.901 -1.124 . . . . 0.0 112.462 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -86.49 -4.85 59.24 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.782 1.633 . . . . 0.0 112.998 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.3 t -85.02 -48.81 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.707 1.203 . . . . 0.0 109.89 162.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.8 mt -59.27 -53.37 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.852 1.261 . . . . 0.0 111.63 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.39 -15.53 62.37 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -81.78 -33.84 26.3 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 120.898 -1.126 . . . . 0.0 113.012 170.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 32.5 t90 -82.95 -32.75 26.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.521 1.928 . . . . 0.0 114.634 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -50.07 -48.84 78.19 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.53 -23.94 31.27 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.773 1.649 . . . . 0.0 113.71 173.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.08 -11.07 60.01 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.775 1.23 . . . . 0.0 113.901 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 57.6 t -58.95 -27.85 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 119.236 0.926 . . . . 0.0 110.688 161.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -97.91 -36.37 10.18 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 171.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.743 0 C-N-CA 126.052 1.741 . . . . 0.0 113.639 -177.344 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.891 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 79.7 mt -109.72 131.81 54.72 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.391 1.076 . . . . 0.0 112.298 -175.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -122.21 145.6 48.05 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.574 1.15 . . . . 0.0 108.489 153.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.2 pt -130.22 138.84 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.967 0.907 . . . . 0.0 109.504 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.9 m -106.98 119.82 40.39 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.179 0.992 . . . . 0.0 109.621 173.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.81 163.8 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.018 1.327 . . . . 0.0 111.111 -169.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -60.58 119.14 7.5 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.758 -0.589 . . . . 0.0 111.23 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.41 147.01 31.18 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.051 151.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.93 139.47 58.75 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.757 0.789 . . . . 0.0 111.942 172.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.2 t -71.86 134.25 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 168.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.91 -27.74 2.97 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-O 118.665 -1.075 . . . . 0.0 114.677 -170.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -129.26 65.41 74.19 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-N 118.582 1.191 . . . . 0.0 112.564 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.12 -12.39 32.2 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.315 2.677 . . . . 0.0 115.468 -170.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -85.97 5.71 31.95 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.1 pt -132.37 163.33 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.733 1.213 . . . . 0.0 111.84 173.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.74 145.47 49.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.136 0.575 . . . . 0.0 110.888 166.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.63 -163.53 11.17 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.878 1.228 . . . . 0.0 111.981 166.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -56.96 105.4 0.21 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.6 t -157.64 107.4 1.81 Allowed Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.841 140.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.11 -14.29 42.83 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.178 2.585 . . . . 0.0 113.198 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -77.76 -29.39 50.98 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.207 -0.933 . . . . 0.0 112.401 171.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 99.7 m -70.81 -37.85 73.26 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.083 -1.636 . . . . 0.0 112.451 167.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -59.42 -26.69 65.38 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 118.399 -0.81 . . . . 0.0 113.006 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.502 HH12 ' CG ' ' A' ' 74' ' ' ASP . 53.8 mtp180 -58.14 -44.11 87.68 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.526 1.131 . . . . 0.0 112.641 171.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.5 t -77.0 -39.57 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.101 1.36 . . . . 0.0 111.299 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.31 -44.44 92.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.327 0.651 . . . . 0.0 111.121 171.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.0 tp -60.78 -53.75 53.55 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.991 1.316 . . . . 0.0 112.77 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 p -71.55 -36.85 71.11 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.708 1.14 . . . . 0.0 113.574 -173.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.17 -39.03 68.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.841 -0.599 . . . . 0.0 112.051 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -77.99 -17.39 57.2 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 172.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -70.16 -52.88 20.06 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.999 1.272 . . . . 0.0 110.896 167.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -73.24 -1.75 19.07 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.291 1.836 . . . . 0.0 114.468 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm 58.03 18.8 5.42 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.409 1.884 . . . . 0.0 115.106 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 58.5 mt -72.69 125.07 91.4 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 123.896 0.878 . . . . 0.0 108.868 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.72 144.84 35.88 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.473 2.116 . . . . 0.0 112.167 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -148.18 154.54 40.25 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.271 1.428 . . . . 0.0 111.01 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -78.55 121.1 24.18 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.332 -0.855 . . . . 0.0 109.686 163.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.8 t -95.42 94.41 7.8 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.538 0.735 . . . . 0.0 111.14 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -81.07 105.67 12.47 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.547 0.739 . . . . 0.0 110.067 178.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.9 mt -68.61 107.37 2.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.293 1.037 . . . . 0.0 109.963 168.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -105.05 114.9 45.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.125 0.97 . . . . 0.0 110.056 177.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -74.46 80.73 1.92 Allowed 'General case' 0 C--O 1.221 -0.437 0 O-C-N 121.438 -0.789 . . . . 32.609999999999999 109.629 165.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 pp -62.68 -4.26 1.94 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 116.622 2.082 . . . . 40.049999999999997 116.622 -170.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.65 -28.53 67.14 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-N 119.283 0.947 . . . . 41.469999999999999 112.576 166.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -116.42 54.15 0.85 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.31 2.644 . . . . 47.170000000000002 109.681 174.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -72.11 114.48 29.6 Favored Pre-proline 0 CA--C 1.546 0.803 0 O-C-N 119.745 -1.847 . . . . 41.270000000000003 111.059 -168.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.18 161.05 41.49 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.627 2.218 . . . . 40.289999999999999 112.209 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -61.85 -31.0 71.22 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.02 1.119 . . . . 42.390000000000001 114.02 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -61.52 -33.73 74.32 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.304 -0.873 . . . . 37.079999999999998 113.069 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -78.44 -35.14 47.24 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.22 -0.925 . . . . 35.880000000000003 112.769 172.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.14 -23.53 63.98 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.869 1.063 . . . . 33.609999999999999 113.869 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -67.48 -42.34 83.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.731 1.212 . . . . 33.789999999999999 111.418 168.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.7 mt -74.81 -32.78 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.348 1.059 . . . . 33.159999999999997 112.038 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.8 t -137.74 94.11 11.87 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 126.327 1.851 . . . . 33.579999999999998 111.351 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.83 -22.42 36.67 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.847 2.365 . . . . 37.899999999999999 113.586 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 1.1 pm0 -78.93 -10.79 59.92 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.896 -1.128 . . . . 38.990000000000002 113.299 167.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.36 25.92 74.5 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.96 1.743 . . . . 35.469999999999999 115.015 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -105.21 149.14 26.21 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.938 1.369 . . . . 34.490000000000002 112.014 -172.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.5 m -106.84 146.68 33.58 Favored Pre-proline 0 N--CA 1.47 0.543 0 C-N-CA 123.913 0.885 . . . . 23.530000000000001 110.153 164.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.35 150.65 86.53 Favored 'Cis proline' 0 C--N 1.346 0.431 0 CA-C-N 119.032 0.69 . . . . 22.879999999999999 113.156 -7.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 p -138.76 145.54 27.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 113.618 -1.628 . . . . 0.0 107.16 156.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.77 160.8 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 O-C-N 121.449 -0.782 . . . . 0.0 111.13 -172.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.6 mtpt -119.85 73.47 0.97 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.258 1.423 . . . . 0.0 108.951 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.5 mt -71.49 117.3 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.443 1.097 . . . . 0.0 109.582 -174.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.4 t0 56.7 30.53 17.72 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 121.904 -0.498 . . . . 0.0 111.97 -165.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.8 t0 73.1 4.91 5.05 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 129.04 2.936 . . . . 0.0 116.37 -169.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -102.31 132.07 48.5 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.525 -1.36 . . . . 0.0 111.547 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -67.25 136.01 54.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.776 0.83 . . . . 0.0 113.056 -168.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -143.56 126.92 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.967 1.707 . . . . 0.0 109.449 170.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -107.08 172.04 7.04 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.832 1.653 . . . . 0.0 111.91 174.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 t0 65.69 111.48 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.89 2.476 . . . . 22.16 114.57 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.3 p -64.04 -21.41 66.5 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 115.696 1.739 . . . . 21.16 115.696 -161.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.502 ' CG ' HH12 ' A' ' 25' ' ' ARG . 35.6 m-20 -75.84 -31.74 59.47 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.494 1.497 . . . . 24.969999999999999 113.666 170.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.8 t -73.33 -38.64 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.932 -1.105 . . . . 23.850000000000001 110.823 170.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.22 -44.77 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.217 1.007 . . . . 23.68 110.962 174.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.4 t -62.59 -46.13 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.373 1.069 . . . . 22.84 111.378 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.09 -45.12 83.14 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 118.869 0.759 . . . . 23.329999999999998 112.99 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 99.1 mt -75.4 -46.48 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.709 -0.877 . . . . 23.309999999999999 112.388 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.6 mt -69.86 -30.09 67.48 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.23 1.377 . . . . 23.48 113.591 -176.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -89.99 -13.18 36.65 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.335 0.865 . . . . 24.239999999999998 113.335 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.535 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 56.6 tt0 -91.81 -47.08 7.53 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.758 1.623 . . . . 39.259999999999998 112.568 167.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.535 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 84.0 mttt -117.52 83.57 2.01 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.719 1.207 . . . . 24.449999999999999 112.024 -161.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -149.25 165.85 16.68 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.275 1.43 . . . . 0.0 110.274 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -70.05 -25.23 27.49 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.152 1.901 . . . . 0.0 112.438 172.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -73.29 156.18 89.34 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.45 1.5 . . . . 0.0 112.155 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -57.24 143.81 92.49 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.218 2.612 . . . . 0.0 114.21 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.57 130.98 24.84 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.436 2.091 . . . . 0.0 112.424 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.0 mt -110.32 1.56 18.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.425 1.49 . . . . 0.0 112.333 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.67 50.08 0.18 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.676 1.99 . . . . 0.0 111.891 160.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 67.9 p -125.12 70.54 61.54 Favored Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 125.63 1.572 . . . . 0.0 109.045 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -69.59 128.75 16.64 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.98 1.786 . . . . 0.0 111.194 -165.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.0 177.31 7.24 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.419 2.746 . . . . 0.0 111.318 170.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -55.58 -31.16 61.96 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 120.924 -1.11 . . . . 0.0 113.897 173.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -53.43 -25.59 16.56 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.293 1.437 . . . . 0.0 113.973 172.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.15 -33.92 74.18 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.577 1.08 . . . . 0.0 113.184 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 84.1 p -68.99 -24.28 64.21 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.385 1.074 . . . . 0.0 113.78 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 t -92.75 -40.74 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.264 1.425 . . . . 0.0 110.111 176.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.96 -30.97 79.02 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.83 1.681 . . . . 0.0 114.45 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 89.8 p -69.27 -17.53 63.75 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.024 1.412 . . . . 0.0 113.77 171.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -95.56 -33.15 12.51 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.105 1.362 . . . . 0.0 112.386 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 69.2 mt -70.2 -36.79 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.607 0.763 . . . . 0.0 111.979 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -56.19 -47.71 98.32 Favored Pre-proline 0 CA--C 1.545 0.758 0 O-C-N 120.223 -1.548 . . . . 0.0 113.898 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.65 -30.38 3.08 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.546 2.164 . . . . 0.0 114.045 171.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.3 p -72.57 -27.16 62.03 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 121.193 1.815 . . . . 0.0 113.273 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -59.03 -46.72 87.5 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.662 -1.274 . . . . 0.0 111.839 160.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.8 t -65.17 -32.65 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.336 0.971 . . . . 0.0 111.951 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -67.73 -39.39 84.27 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.174 0.897 . . . . 0.0 112.393 168.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -70.71 -28.29 64.63 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.469 1.107 . . . . 0.0 112.783 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 20.6 mt -77.01 -15.24 59.69 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.869 1.668 . . . . 0.0 114.147 167.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -137.68 38.95 2.41 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.848 1.259 . . . . 0.0 112.533 -170.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.3 m -73.85 66.0 1.09 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -162.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -67.81 -39.36 83.98 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.401 1.08 . . . . 0.0 111.522 164.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -79.44 111.77 23.4 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 153.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.48 155.85 66.62 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.578 2.852 . . . . 0.0 115.452 -143.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -65.3 -42.51 92.99 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.838 -1.074 . . . . 0.0 113.437 -165.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.75 -21.98 61.67 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.84 -36.9 17.72 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 120.998 -1.064 . . . . 0.0 112.495 167.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 98.4 m -67.82 -27.55 66.81 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.82 0.848 . . . . 0.0 113.042 172.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -58.76 -45.95 88.57 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.795 1.638 . . . . 0.0 111.616 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -68.68 -40.46 80.1 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.792 0.837 . . . . 0.0 111.433 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.91 -24.9 66.93 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.6 tp -82.92 -40.75 19.74 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.864 1.265 . . . . 0.0 111.94 172.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.9 mt -63.45 -41.36 98.63 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.676 1.191 . . . . 0.0 113.351 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -66.58 -35.64 80.7 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.063 1.301 . . . . 0.0 112.774 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -71.79 -39.5 69.85 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.122 -0.986 . . . . 0.0 112.592 171.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.6 mt -64.28 -33.6 76.19 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.837 -1.164 . . . . 0.0 113.121 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -66.7 -44.28 82.11 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.588 1.086 . . . . 0.0 111.577 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.84 81.56 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.558 0.743 . . . . 0.0 112.218 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.2 tp -68.07 -56.75 7.75 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.27 1.028 . . . . 0.0 111.846 172.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.96 -33.44 74.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.576 1.15 . . . . 0.0 113.879 -171.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.42 -34.02 67.56 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.36 -0.689 . . . . 0.0 113.324 173.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -92.67 -29.35 16.13 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 77.4 mt -64.23 -33.74 76.5 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 120.465 -1.397 . . . . 0.0 113.225 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -65.94 -7.63 17.87 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.35 -38.37 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.144 1.378 . . . . 0.0 112.169 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -82.17 -17.38 46.46 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -172.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.2 -164.86 42.57 Favored Glycine 0 CA--C 1.542 1.721 0 CA-C-O 117.718 -1.601 . . . . 0.0 114.42 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.0 -10.67 23.09 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 125.281 3.987 . . . . 0.0 118.144 -119.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -110.32 167.21 10.37 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.175 0.99 . . . . 0.0 110.893 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.2 tt -75.57 6.86 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 120.275 -1.516 . . . . 0.0 112.997 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -116.2 2.79 13.37 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 128.146 2.579 . . . . 0.0 114.422 165.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.93 -117.85 5.7 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.083 1.325 . . . . 0.0 113.251 -173.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -62.45 -35.81 80.44 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -168.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -142.49 162.32 35.76 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.76 1.624 . . . . 0.0 110.484 -171.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.8 mt -62.83 135.68 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.07 0.462 . . . . 0.0 110.528 165.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.7 p -138.59 -174.33 3.8 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.502 1.521 . . . . 0.0 110.814 171.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.95 -19.31 1.73 Allowed 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 169.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 18.4 t -74.27 -40.32 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 120.179 1.354 . . . . 0.0 112.496 174.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -61.5 -44.33 97.28 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.863 -1.148 . . . . 0.0 112.003 167.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.9 mt -62.19 -26.99 68.66 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 122.193 -0.317 . . . . 0.0 111.533 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 52.3 m -79.35 -47.43 15.81 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.845 -1.159 . . . . 0.0 112.694 175.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 51.5 mt -100.01 -37.98 8.77 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -164.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.24 88.48 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -173.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.97 -28.57 19.27 Favored 'Trans proline' 0 C--N 1.351 0.705 0 CA-C-N 120.784 1.316 . . . . 0.0 113.12 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -72.81 -30.55 64.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.611 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 51.6 mt -65.97 -46.61 77.45 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.741 0.816 . . . . 0.0 112.975 169.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -58.33 -36.31 73.22 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.828 0.823 . . . . 0.0 112.323 170.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -73.98 -22.79 59.49 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.867 -1.146 . . . . 0.0 113.76 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.33 -49.78 45.94 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.561 1.073 . . . . 0.0 111.398 162.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -58.1 -37.11 73.9 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.389 1.476 . . . . 0.0 112.479 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 70.4 t -96.87 -62.66 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.236 1.014 . . . . 0.0 113.545 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.05 -54.2 6.83 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.463 -0.773 . . . . 0.0 112.622 -164.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 38.6 tp -65.71 -34.69 78.78 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 119.349 -0.358 . . . . 0.0 111.155 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.03 -29.24 59.17 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.23 1.395 . . . . 0.0 115.336 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -66.48 -22.01 66.19 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -122.29 -21.19 5.92 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -148.33 94.94 2.38 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.291 1.836 . . . . 0.0 108.797 165.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -67.99 78.74 0.22 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.895 1.278 . . . . 0.0 111.171 173.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -76.98 118.2 70.23 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.24 1.016 . . . . 0.0 111.91 -168.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -73.37 110.36 3.04 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.949 1.766 . . . . 0.0 110.662 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 14.0 mm -58.03 115.42 11.14 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 160.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -63.13 153.49 73.6 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 121.634 1.556 . . . . 0.0 112.633 -172.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -61.15 -22.66 64.9 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 169.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -68.11 -25.45 65.32 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 170.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 47.4 mt -86.12 50.91 2.07 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.251 1.42 . . . . 0.0 111.104 167.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.8 -26.87 68.53 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.315 1.046 . . . . 0.0 113.315 -160.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -75.62 -50.66 14.85 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.017 0.826 . . . . 0.0 111.074 171.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 86.3 t -59.17 -39.93 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.757 0.823 . . . . 0.0 111.572 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.4 tp -61.01 -36.01 78.37 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.675 1.19 . . . . 0.0 113.397 174.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -81.0 -37.25 29.48 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -62.61 -33.92 75.99 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.687 1.195 . . . . 0.0 112.872 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.8 mt -59.89 -35.83 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.033 -1.042 . . . . 0.0 112.104 171.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -74.08 -17.83 60.9 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.225 -1.547 . . . . 0.0 112.941 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 51.0 mt -74.88 -15.95 60.69 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 118.339 -0.838 . . . . 0.0 113.148 168.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.6 mt -67.99 -17.69 64.5 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 120.011 1.278 . . . . 0.0 113.828 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -95.09 6.59 48.65 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.419 -1.425 . . . . 0.0 113.477 171.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.7 p -107.69 -179.07 3.8 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.956 1.703 . . . . 0.0 113.222 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 44.8 mtp85 56.46 -164.33 0.15 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.655 1.582 . . . . 0.0 111.335 -172.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 11.5 mp0 -84.62 -41.15 16.66 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.964 1.306 . . . . 0.0 109.276 157.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 77.4 p -70.16 -54.67 11.91 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.867 1.667 . . . . 0.0 114.631 -159.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -67.46 -45.94 74.49 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.701 0.682 . . . . 0.0 111.977 171.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.421 ' HB2' ' HE3' ' A' ' 193' ' ' LYS . 26.1 ttmt -56.63 -39.03 72.93 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.172 -0.955 . . . . 0.0 113.517 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -74.04 -8.84 57.61 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.4 p -77.51 -14.47 59.67 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.401 1.455 . . . . 0.0 113.231 170.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -65.85 101.59 0.67 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.639 1.109 . . . . 0.0 111.636 -174.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.24 159.96 30.2 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.671 0.788 . . . . 0.0 110.496 156.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.38 127.55 33.09 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.076 -0.39 . . . . 0.0 110.359 172.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -63.86 -31.75 73.03 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -161.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -61.89 -39.85 93.37 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.997 -1.064 . . . . 0.0 112.424 171.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -81.89 -2.25 50.55 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.552 -1.343 . . . . 0.0 114.242 173.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 85.4 t -85.83 -44.7 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.402 1.081 . . . . 0.0 110.294 163.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.2 mt -64.51 -56.63 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.864 1.266 . . . . 0.0 111.526 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.7 -13.65 62.28 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.474 1.11 . . . . 0.0 113.825 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -86.44 -36.54 9.56 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.808 -1.183 . . . . 0.0 113.484 170.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -78.04 -31.31 50.31 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.688 1.595 . . . . 0.0 113.615 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -53.59 -47.97 94.68 Favored Pre-proline 0 CA--C 1.553 1.066 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -175.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.93 -23.75 29.65 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 121.681 1.588 . . . . 0.0 113.919 171.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -74.33 -8.61 56.85 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 117.595 -1.193 . . . . 0.0 114.204 175.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 45.7 t -60.59 -21.36 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 119.274 0.943 . . . . 0.0 111.268 160.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -105.72 -12.17 16.01 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 170.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.882 0 C-N-CA 125.394 1.478 . . . . 0.0 112.653 -170.852 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.892 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 74.8 mt -115.74 137.3 52.22 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.249 1.42 . . . . 0.0 111.188 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -130.59 144.37 51.37 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.681 1.192 . . . . 0.0 108.723 160.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.3 pt -128.62 135.35 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.999 0.92 . . . . 0.0 109.34 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 79.2 m -110.84 117.29 33.01 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.493 1.117 . . . . 0.0 109.459 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.9 m -132.45 158.78 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.773 1.229 . . . . 0.0 111.09 -165.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -59.62 114.99 3.01 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.986 -0.446 . . . . 0.0 110.685 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -80.94 149.65 29.3 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.984 154.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.96 142.89 57.18 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.921 0.867 . . . . 0.0 113.057 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.91 129.15 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 163.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.66 -18.99 12.4 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-O 118.405 -1.219 . . . . 0.0 115.41 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.67 65.97 26.55 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 119.114 1.457 . . . . 0.0 112.286 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 62.5 Cg_endo -64.82 -5.16 9.97 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.705 2.937 . . . . 0.0 115.489 -172.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -89.96 3.63 52.54 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.6 pt -133.8 164.57 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.201 1.4 . . . . 0.0 111.704 173.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.19 150.03 39.94 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.817 0.847 . . . . 0.0 111.922 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.49 -164.86 10.09 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.592 1.568 . . . . 0.0 111.834 165.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -57.78 104.28 0.18 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.6 t -153.37 106.41 2.58 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 113.74 -1.573 . . . . 0.0 110.212 136.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -67.62 -15.3 44.44 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.822 2.348 . . . . 0.0 112.761 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -74.44 -29.39 61.46 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.374 -0.829 . . . . 0.0 112.369 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 89.1 m -70.15 -37.08 75.14 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.326 -1.484 . . . . 0.0 112.816 167.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -60.41 -28.08 67.97 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.479 HH12 ' CG ' ' A' ' 74' ' ' ASP . 57.3 mtp180 -56.76 -40.05 75.12 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.678 1.191 . . . . 0.0 112.691 171.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.3 -40.61 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.138 1.375 . . . . 0.0 111.52 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.51 -43.54 93.36 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.951 0.5 . . . . 0.0 111.132 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.8 tp -59.15 -46.59 87.97 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.353 1.061 . . . . 0.0 113.268 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.2 p -78.44 -37.96 42.4 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.35 -36.91 77.35 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.484 0.584 . . . . 0.0 111.621 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -77.98 -18.33 56.1 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -75.43 -46.33 33.38 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.142 -1.599 . . . . 0.0 111.534 166.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -76.52 -5.03 45.8 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.071 1.348 . . . . 0.0 114.343 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm 58.68 20.27 7.61 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.325 1.85 . . . . 0.0 114.477 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.1 mt -70.98 130.54 88.18 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.217 -0.896 . . . . 0.0 108.679 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.01 139.38 29.81 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.331 2.021 . . . . 0.0 111.99 173.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -144.67 154.42 42.75 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.857 1.663 . . . . 0.0 110.194 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -81.94 125.48 30.81 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.177 -0.952 . . . . 0.0 110.019 162.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.5 t -93.16 95.75 9.6 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.515 0.726 . . . . 0.0 110.999 169.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -79.97 99.06 7.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.676 0.79 . . . . 0.0 109.583 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 82.2 mt -66.75 109.72 2.98 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.945 0.898 . . . . 0.0 109.599 169.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mm -120.23 111.88 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.736 1.215 . . . . 0.0 109.15 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -77.5 89.42 3.85 Favored 'General case' 0 C--O 1.222 -0.368 0 O-C-N 120.68 -1.263 . . . . 32.609999999999999 108.602 166.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.42 1.79 0.19 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 117.519 2.415 . . . . 40.049999999999997 117.519 -175.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -69.95 -24.02 76.68 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-N 119.918 1.235 . . . . 41.469999999999999 112.734 161.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -128.11 66.84 1.36 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.974 2.51 . . . . 47.170000000000002 108.823 171.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -80.63 116.49 62.45 Favored Pre-proline 0 N--CA 1.473 0.684 0 O-C-N 120.055 -1.653 . . . . 41.270000000000003 110.551 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.15 161.65 44.98 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.689 2.26 . . . . 40.289999999999999 111.638 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -61.82 -29.83 70.42 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.028 1.121 . . . . 42.390000000000001 114.028 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -60.72 -33.02 72.27 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.269 1.028 . . . . 37.079999999999998 113.362 170.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -79.38 -36.61 38.95 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.951 -1.093 . . . . 35.880000000000003 112.599 173.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.7 mt -68.12 -25.54 65.35 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.343 0.868 . . . . 33.609999999999999 113.343 174.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -64.14 -47.37 80.18 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.606 1.563 . . . . 33.789999999999999 111.457 168.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.2 mt -72.39 -37.38 57.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.894 0.877 . . . . 33.159999999999997 111.625 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.1 t -126.75 92.19 45.39 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 126.177 1.791 . . . . 33.579999999999998 110.746 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.03 -17.47 36.34 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.856 2.371 . . . . 37.899999999999999 113.965 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -76.48 -11.58 59.9 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.102 -0.999 . . . . 38.990000000000002 113.533 165.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.98 21.35 76.8 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.548 1.07 . . . . 35.469999999999999 114.561 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -104.08 150.5 24.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.451 1.501 . . . . 34.490000000000002 113.688 -173.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.19 153.96 40.76 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 125.93 1.692 . . . . 23.530000000000001 111.046 162.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -63.66 149.37 68.0 Favored 'Cis proline' 0 C--N 1.347 0.48 0 CA-C-O 121.852 0.688 . . . . 22.879999999999999 112.608 -12.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.38 146.95 28.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 113.985 -1.461 . . . . 0.0 107.494 156.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.1 m -134.7 165.26 31.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 123.565 0.746 . . . . 0.0 111.004 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -124.06 71.7 1.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.757 1.623 . . . . 0.0 109.424 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.5 mt -74.74 117.51 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.395 1.078 . . . . 0.0 108.994 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.0 t0 53.8 40.47 31.56 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 121.227 0.537 . . . . 0.0 110.967 -164.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 t0 67.54 -5.84 0.73 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.445 2.298 . . . . 0.0 115.608 -172.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -92.77 135.51 34.06 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.261 -1.525 . . . . 0.0 112.296 -172.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -68.1 131.41 45.37 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.634 1.174 . . . . 0.0 112.465 -170.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.1 t -141.09 129.61 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.165 1.386 . . . . 0.0 109.588 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.29 171.14 7.65 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.929 1.691 . . . . 0.0 111.425 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.9 t0 66.08 111.17 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.527 2.331 . . . . 22.16 114.162 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.9 p -64.09 -21.65 66.62 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 115.15 1.537 . . . . 21.16 115.15 -162.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.479 ' CG ' HH12 ' A' ' 25' ' ' ARG . 38.0 m-20 -74.1 -34.01 63.82 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.023 1.283 . . . . 24.969999999999999 113.421 169.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -72.27 -38.71 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.086 -1.009 . . . . 23.850000000000001 110.785 171.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.56 -44.94 99.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.234 1.014 . . . . 23.68 111.072 175.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.6 t -62.99 -44.65 99.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.384 1.074 . . . . 22.84 111.286 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.43 -35.04 70.18 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 118.633 0.651 . . . . 23.329999999999998 113.91 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 94.8 mt -85.11 -49.9 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 118.339 1.07 . . . . 23.309999999999999 112.122 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.4 mt -65.75 -32.32 73.8 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.809 1.186 . . . . 23.48 113.314 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -90.88 -1.26 57.85 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.627 0.973 . . . . 24.239999999999998 113.627 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -110.88 -53.62 2.68 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.113 1.365 . . . . 39.259999999999998 112.092 167.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -97.06 58.98 1.61 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.384 1.074 . . . . 24.449999999999999 112.847 -161.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -132.64 162.9 54.46 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.996 1.318 . . . . 0.0 111.355 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.08 -26.55 21.34 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.291 1.994 . . . . 0.0 112.398 172.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -72.96 150.57 90.4 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.467 1.107 . . . . 0.0 111.697 171.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -57.24 144.13 91.63 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.048 2.498 . . . . 0.0 115.032 -172.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.72 119.01 5.84 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.768 2.312 . . . . 0.0 113.222 -173.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.5 mt -89.45 2.04 55.06 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.504 1.121 . . . . 0.0 112.654 170.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.05 50.97 0.29 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.647 1.979 . . . . 0.0 110.949 159.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.8 p -125.03 62.78 38.38 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 126.246 1.818 . . . . 0.0 110.132 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -75.64 127.86 10.56 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.825 2.35 . . . . 0.0 111.164 -163.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.51 -176.9 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.532 2.822 . . . . 0.0 111.771 171.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -53.79 -29.31 39.75 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.038 1.335 . . . . 0.0 114.153 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -56.38 -21.61 25.96 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.103 1.361 . . . . 0.0 114.393 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.53 -30.92 71.97 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 120.16 1.346 . . . . 0.0 113.368 173.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.5 p -68.03 -23.79 65.02 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.421 -0.8 . . . . 0.0 113.119 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -95.23 -41.23 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.188 1.395 . . . . 0.0 110.868 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.84 -29.7 76.02 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.446 1.498 . . . . 0.0 114.398 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 88.2 p -67.91 -18.59 64.83 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.729 1.264 . . . . 0.0 114.049 170.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -95.5 -33.35 12.46 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.402 1.481 . . . . 0.0 112.873 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.1 mt -69.82 -37.52 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.642 0.777 . . . . 0.0 111.805 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -56.25 -47.97 97.84 Favored Pre-proline 0 CA--C 1.546 0.811 0 O-C-N 120.406 -1.434 . . . . 0.0 114.028 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.62 -30.83 3.66 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.709 2.273 . . . . 0.0 113.779 171.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.6 p -72.25 -28.05 62.89 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 121.386 1.903 . . . . 0.0 113.277 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -59.88 -45.42 92.55 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.668 -1.27 . . . . 0.0 112.192 161.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.1 t -68.49 -32.23 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.23 -0.919 . . . . 0.0 111.953 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -67.11 -41.97 85.31 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.914 0.886 . . . . 0.0 111.836 169.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -63.65 -39.48 94.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.257 1.023 . . . . 0.0 111.693 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.28 -5.4 31.98 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 169.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -141.78 42.5 1.71 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.846 1.658 . . . . 0.0 111.617 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.0 m -70.05 61.57 0.19 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.239 1.816 . . . . 0.0 115.53 -165.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.18 -37.06 72.18 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.647 1.179 . . . . 0.0 111.738 167.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -81.38 115.4 56.29 Favored Pre-proline 0 CA--C 1.552 1.027 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 152.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.58 153.68 73.53 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.423 2.749 . . . . 0.0 115.084 -147.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -64.7 -42.83 95.0 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.425 -165.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.23 -17.18 60.92 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.403 1.081 . . . . 0.0 113.763 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -86.91 -39.33 7.56 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 121.442 -0.787 . . . . 0.0 112.68 166.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 54.0 m -65.46 -25.93 67.72 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.671 -0.899 . . . . 0.0 112.953 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -58.32 -44.83 88.79 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.908 1.683 . . . . 0.0 111.759 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -71.81 -38.93 70.16 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.523 0.729 . . . . 0.0 111.4 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.84 -23.88 66.77 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 171.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.4 tp -83.21 -41.21 18.67 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.727 1.211 . . . . 0.0 111.914 170.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 23.3 mt -64.2 -41.58 97.0 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.932 1.293 . . . . 0.0 113.478 -177.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -65.15 -36.19 83.45 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.277 1.399 . . . . 0.0 112.598 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -72.88 -38.75 66.87 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.229 -0.919 . . . . 0.0 112.691 172.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.31 -33.83 76.73 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.85 -1.156 . . . . 0.0 113.033 172.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -66.71 -44.65 81.05 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.868 1.213 . . . . 0.0 111.614 172.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.14 86.05 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.511 0.724 . . . . 0.0 112.225 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.4 tp -66.46 -58.16 5.83 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.316 1.446 . . . . 0.0 111.903 170.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.05 -37.08 84.94 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.512 1.125 . . . . 0.0 113.777 -170.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.35 -36.02 74.36 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.235 -0.758 . . . . 0.0 113.528 178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -93.71 -26.33 17.06 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 23.0 mt -63.72 -31.94 73.27 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.592 -1.318 . . . . 0.0 113.584 172.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -64.16 -3.11 2.45 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 171.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.2 t -109.46 -36.5 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.505 1.522 . . . . 0.0 112.704 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -83.65 -28.67 28.23 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 -162.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 144.86 174.92 17.56 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 120.069 1.304 . . . . 0.0 113.926 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.77 -4.01 14.1 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 125.008 3.805 . . . . 0.0 116.417 -164.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -106.24 167.18 9.99 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.433 1.015 . . . . 0.0 110.964 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.0 4.67 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 120.627 -1.296 . . . . 0.0 113.214 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -121.54 16.01 11.2 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.772 2.429 . . . . 0.0 113.649 167.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.34 -110.44 3.49 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 120.838 -1.164 . . . . 0.0 113.022 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -58.06 -34.85 70.55 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -168.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -155.34 162.33 40.86 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.941 1.696 . . . . 0.0 110.895 -156.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 13.9 mt -63.87 132.61 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 164.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 29.3 p -132.66 -177.16 4.36 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.354 1.462 . . . . 0.0 110.474 169.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.13 -20.92 2.82 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 167.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.6 t -73.44 -41.01 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 120.704 -1.248 . . . . 0.0 112.325 173.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.69 -42.7 99.29 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.618 1.167 . . . . 0.0 112.233 168.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.7 mt -62.61 -23.2 66.93 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.6 m -83.08 -45.56 13.85 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.041 -1.037 . . . . 0.0 112.537 175.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 39.3 mt -100.15 -35.79 9.54 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -166.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.38 -49.53 92.9 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -70.43 -27.07 23.72 Favored 'Trans proline' 0 C--N 1.35 0.623 0 CA-C-N 120.942 1.372 . . . . 0.0 113.026 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -74.88 -28.39 60.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.444 -1.265 . . . . 0.0 112.654 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.0 mt -66.56 -45.86 77.95 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.824 0.85 . . . . 0.0 112.937 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -57.56 -39.64 77.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.293 0.637 . . . . 0.0 111.837 170.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -70.13 -20.97 63.14 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 9.6 mt -76.1 -51.23 12.68 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.837 1.199 . . . . 0.0 111.172 167.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.75 -34.57 74.64 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.405 1.082 . . . . 0.0 112.283 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 96.5 t -87.64 -75.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.198 0.999 . . . . 0.0 112.462 174.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.26 -52.39 16.58 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.886 -1.133 . . . . 0.0 112.153 -154.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.0 tp -68.25 -25.44 65.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.459 0.704 . . . . 0.0 112.543 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.22 -25.67 48.19 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.745 1.164 . . . . 0.0 115.508 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -68.46 -21.24 64.64 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -120.47 -30.61 4.51 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.97 1.308 . . . . 0.0 112.774 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -147.93 94.63 2.37 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.231 1.812 . . . . 0.0 108.668 169.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -67.96 78.15 0.22 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.483 1.113 . . . . 0.0 110.668 168.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -73.16 118.69 70.74 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 124.404 1.082 . . . . 0.0 111.385 -169.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.16 107.51 2.27 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.031 1.821 . . . . 0.0 110.674 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 35.2 mm -60.04 113.43 7.32 Favored Pre-proline 0 CA--C 1.541 0.635 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 163.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -63.33 154.3 68.97 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.741 1.628 . . . . 0.0 112.846 -170.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.48 -23.75 67.53 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.628 1.171 . . . . 0.0 113.241 171.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -65.8 -28.45 69.02 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.665 1.186 . . . . 0.0 113.398 170.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 43.6 mt -84.49 52.68 2.43 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.054 1.342 . . . . 0.0 110.794 166.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.39 -25.82 68.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.085 0.954 . . . . 0.0 112.532 -165.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -75.67 -49.89 17.05 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.914 0.779 . . . . 0.0 111.781 171.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 62.6 t -59.98 -39.36 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.541 0.737 . . . . 0.0 111.207 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 47.7 tp -65.24 -41.33 94.44 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.272 1.029 . . . . 0.0 113.356 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -69.04 -41.24 77.93 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.627 -0.67 . . . . 0.0 112.322 172.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -65.65 -31.81 73.03 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.585 1.154 . . . . 0.0 112.772 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 53.4 mt -58.09 -35.33 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 120.918 -1.114 . . . . 0.0 111.881 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -82.28 -13.31 57.2 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.368 -1.458 . . . . 0.0 113.749 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.0 mt -73.94 -18.14 60.93 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 117.576 -1.202 . . . . 0.0 113.499 160.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.7 mt -66.3 -19.55 65.85 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.51 1.505 . . . . 0.0 113.922 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -95.85 10.81 35.92 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.873 -1.142 . . . . 0.0 113.132 174.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.9 p -119.9 179.3 4.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.079 1.752 . . . . 0.0 113.374 -171.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 50.6 mtp85 56.77 -167.62 0.12 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.489 1.516 . . . . 0.0 110.143 -168.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -81.87 -35.32 29.42 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 122.043 -0.41 . . . . 0.0 110.889 157.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.6 p -69.38 -58.43 4.02 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.692 1.597 . . . . 0.0 114.763 -163.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -67.71 -43.51 79.87 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.149 0.886 . . . . 0.0 112.123 173.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -53.68 -35.33 60.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.922 1.289 . . . . 0.0 113.865 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.76 -7.39 59.22 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 7.8 p -73.24 -21.74 60.56 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.474 1.488 . . . . 0.0 112.518 170.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -60.27 127.29 31.08 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.9 1.28 . . . . 0.0 112.101 -170.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -93.42 173.71 7.57 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.424 1.09 . . . . 0.0 110.558 165.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.83 123.41 21.9 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.84 164.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -57.96 -35.05 70.61 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -165.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -61.39 -39.26 90.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.742 1.217 . . . . 0.0 112.396 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -82.34 0.87 39.74 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.858 -1.151 . . . . 0.0 113.988 173.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.9 t -85.39 -54.76 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.313 0.645 . . . . 0.0 109.98 161.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -46.22 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.123 0.874 . . . . 0.0 112.616 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.5 -10.68 60.14 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -90.07 -31.73 10.58 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 120.861 -1.149 . . . . 0.0 113.301 169.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 16.4 t90 -87.14 -30.8 20.78 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.101 1.76 . . . . 0.0 114.22 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -48.74 -49.47 66.09 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.54 -24.9 35.45 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.651 1.567 . . . . 0.0 113.839 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -74.23 -7.36 52.43 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.55 1.14 . . . . 0.0 114.056 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 59.1 t -61.91 -22.14 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 119.518 1.054 . . . . 0.0 111.505 159.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -106.91 -11.7 15.65 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 171.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 C-N-CA 124.484 1.114 . . . . 0.0 113.181 -173.592 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.834 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 73.3 mt -115.5 143.14 45.75 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.334 1.454 . . . . 0.0 110.809 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -138.01 149.39 46.03 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.679 1.191 . . . . 0.0 108.831 159.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 pt -130.85 139.05 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.082 0.953 . . . . 0.0 109.202 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.7 m -110.68 125.99 54.05 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.892 0.877 . . . . 0.0 109.635 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.98 157.81 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.858 1.263 . . . . 0.0 110.792 -166.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -60.5 115.26 3.45 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.053 -0.405 . . . . 0.0 110.371 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.447 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -80.97 153.16 27.63 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.06 155.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.76 147.26 46.81 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.199 0.999 . . . . 0.0 112.753 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.71 134.05 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 167.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.69 -26.72 1.64 Allowed Glycine 0 CA--C 1.54 1.594 0 CA-C-O 118.883 -0.954 . . . . 0.0 115.442 -173.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.61 72.38 77.97 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-N 118.603 1.201 . . . . 0.0 112.159 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.417 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 61.0 Cg_endo -65.03 -12.3 33.99 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.246 2.63 . . . . 0.0 114.927 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -82.94 2.89 32.35 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.6 pt -135.38 161.26 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.101 1.36 . . . . 0.0 111.503 177.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.26 149.92 40.57 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.612 0.765 . . . . 0.0 111.516 167.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.27 -168.41 11.29 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.632 1.587 . . . . 0.0 111.656 166.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -59.06 105.29 0.31 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 118.61 1.205 . . . . 0.0 114.161 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.2 t -152.01 107.3 2.84 Favored Pre-proline 0 CA--C 1.552 1.025 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.207 135.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -67.75 -15.85 45.1 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.815 2.343 . . . . 0.0 112.874 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -72.13 -28.53 63.32 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.065 -1.022 . . . . 0.0 112.381 171.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.09 -37.28 75.36 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.277 -1.514 . . . . 0.0 112.997 168.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -60.76 -27.25 67.83 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.491 HH12 ' CG ' ' A' ' 74' ' ' ASP . 60.1 mtp180 -57.18 -40.87 78.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.56 1.144 . . . . 0.0 112.452 172.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -78.87 -40.29 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.137 1.375 . . . . 0.0 111.546 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.5 mt -59.13 -43.6 92.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.982 0.513 . . . . 0.0 111.328 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.22 -48.49 81.42 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.068 0.947 . . . . 0.0 113.08 -177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.6 p -76.49 -37.4 56.87 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.3 mt -70.34 -36.99 74.56 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.391 0.541 . . . . 0.0 111.775 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -77.56 -20.08 54.67 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -74.11 -47.42 36.39 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.243 -1.535 . . . . 0.0 111.654 167.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -76.74 -4.36 42.97 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.802 1.241 . . . . 0.0 114.022 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm 58.65 19.58 6.89 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 126.377 1.871 . . . . 0.0 114.426 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.0 mt -72.84 127.37 89.73 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 118.152 -0.928 . . . . 0.0 108.641 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.31 143.13 34.68 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.405 2.07 . . . . 0.0 112.191 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -146.98 155.2 42.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.959 1.704 . . . . 0.0 109.92 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -80.36 131.64 35.66 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.046 -1.034 . . . . 0.0 109.789 158.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 t -99.41 94.23 6.32 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.999 0.92 . . . . 0.0 110.505 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -77.43 100.73 6.1 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.711 0.767 . . . . 0.0 109.479 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 99.4 mt -67.28 107.0 2.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.558 1.143 . . . . 0.0 109.241 170.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.3 mm -118.62 108.4 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.671 1.189 . . . . 0.0 109.059 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -75.46 90.03 2.7 Favored 'General case' 0 C--O 1.219 -0.552 0 O-C-N 120.716 -1.24 . . . . 32.609999999999999 108.216 165.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.418 HD23 HG22 ' A' ' 60' ' ' VAL . 1.5 pp -63.51 1.77 0.51 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 117.837 2.532 . . . . 40.049999999999997 117.837 -171.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.66 -19.56 79.72 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-N 119.896 1.226 . . . . 41.469999999999999 112.874 160.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -126.13 49.86 1.94 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 129.914 3.286 . . . . 47.170000000000002 109.36 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -78.27 118.15 70.51 Favored Pre-proline 0 N--CA 1.472 0.627 0 O-C-N 119.464 -2.023 . . . . 41.270000000000003 111.253 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.52 160.01 50.91 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.647 2.232 . . . . 40.289999999999999 111.623 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -62.12 -28.94 69.99 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.851 -1.155 . . . . 42.390000000000001 113.853 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 81.8 t90 -61.73 -32.24 72.46 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.508 0.929 . . . . 37.079999999999998 113.508 170.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -79.76 -33.83 40.33 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.819 -1.176 . . . . 35.880000000000003 112.619 172.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.0 mt -68.64 -23.72 64.46 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.449 0.907 . . . . 33.609999999999999 113.449 173.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -65.89 -41.88 90.97 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.894 1.278 . . . . 33.789999999999999 111.974 167.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.0 mt -74.11 -35.89 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 124.306 1.042 . . . . 33.159999999999997 111.654 175.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.4 t -133.08 92.9 24.12 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 126.121 1.768 . . . . 33.579999999999998 110.96 -175.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.73 -15.36 37.17 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.636 2.224 . . . . 37.899999999999999 113.901 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -76.55 -13.0 60.11 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.004 -1.06 . . . . 38.990000000000002 113.438 165.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.69 16.98 72.6 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.932 -1.105 . . . . 35.469999999999999 114.595 -172.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -100.12 155.23 17.85 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.399 1.48 . . . . 34.490000000000002 114.266 -173.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.418 HG22 HD23 ' A' ' 44' ' ' LEU . 33.0 m -115.39 157.26 44.44 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 126.713 2.005 . . . . 23.530000000000001 111.125 163.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -62.16 149.57 59.59 Favored 'Cis proline' 0 C--N 1.349 0.575 0 CA-C-O 122.327 0.886 . . . . 22.879999999999999 112.861 -13.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.09 146.66 22.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 113.8 -1.546 . . . . 0.0 107.303 163.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.59 163.58 30.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 123.522 0.729 . . . . 0.0 111.416 -169.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -120.95 69.27 0.89 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.547 1.939 . . . . 0.0 109.749 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.9 mt -75.05 119.15 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.745 0.818 . . . . 0.0 108.848 -175.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 46.8 t0 54.14 39.95 31.2 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.147 0.498 . . . . 0.0 111.019 -164.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.4 t0 68.65 -6.75 0.8 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 127.362 2.265 . . . . 0.0 115.638 -171.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -92.98 136.72 33.0 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.293 -1.504 . . . . 0.0 112.568 -170.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -64.01 127.95 33.68 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.311 1.444 . . . . 0.0 112.874 -175.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -141.59 132.66 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.526 1.53 . . . . 0.0 109.558 170.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -112.63 173.56 6.32 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.731 1.612 . . . . 0.0 111.621 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.1 t0 67.04 110.58 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 127.628 2.371 . . . . 22.16 114.485 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.5 p -62.97 -24.96 68.14 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 115.322 1.601 . . . . 21.16 115.322 -164.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.491 ' CG ' HH12 ' A' ' 25' ' ' ARG . 36.9 m-20 -72.04 -36.43 69.64 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.189 1.359 . . . . 24.969999999999999 112.998 170.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.69 -38.69 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.23 -0.919 . . . . 23.850000000000001 110.95 173.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.12 -44.04 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.374 1.07 . . . . 23.68 111.213 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.68 -42.79 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.476 1.11 . . . . 22.84 111.318 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.97 -26.97 61.55 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.215 -0.77 . . . . 23.329999999999998 114.565 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 87.7 mt -92.49 -50.76 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 118.718 1.259 . . . . 23.309999999999999 112.059 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.5 mt -65.55 -29.46 70.09 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.618 1.099 . . . . 23.48 113.452 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -89.24 -2.02 58.31 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.697 0.999 . . . . 24.239999999999998 113.697 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.402 ' OE2' ' HE3' ' A' ' 83' ' ' LYS . 38.7 tt0 -115.06 -47.63 2.86 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.679 1.592 . . . . 39.259999999999998 112.513 173.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.402 ' HE3' ' OE2' ' A' ' 82' ' ' GLU . 84.2 mttt -104.92 64.45 0.72 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.977 1.311 . . . . 24.449999999999999 112.415 -165.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -138.64 164.15 41.83 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.366 1.466 . . . . 0.0 110.713 174.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.69 -26.27 23.38 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.23 1.954 . . . . 0.0 112.655 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -74.64 154.71 87.44 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.043 1.337 . . . . 0.0 111.872 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -56.16 140.79 87.77 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.992 2.461 . . . . 0.0 113.635 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.97 133.93 35.27 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.215 1.943 . . . . 0.0 112.139 -176.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.9 mt -107.61 1.52 23.29 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.628 1.571 . . . . 0.0 112.065 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.8 49.53 0.23 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.769 2.027 . . . . 0.0 111.497 159.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 44.8 p -123.42 67.28 36.59 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 125.077 1.351 . . . . 0.0 109.012 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -74.19 124.2 8.85 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.393 2.062 . . . . 0.0 110.032 -165.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.73 -176.79 2.18 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.72 2.28 . . . . 0.0 111.133 170.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 23.0 mp0 -56.06 -30.08 61.43 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.406 2.282 . . . . 0.0 112.785 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -54.72 -23.86 19.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.167 1.787 . . . . 0.0 114.203 171.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.47 -33.42 73.74 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.981 -1.074 . . . . 0.0 113.213 173.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 59.5 p -70.13 -20.52 63.16 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.9 t -92.8 -42.31 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.276 1.43 . . . . 0.0 110.342 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.99 -30.21 77.08 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.122 1.344 . . . . 0.0 114.587 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 97.7 p -66.94 -19.75 65.78 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.603 1.202 . . . . 0.0 113.958 171.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -95.79 -32.99 12.44 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.477 1.511 . . . . 0.0 112.814 172.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 61.9 mt -68.31 -37.85 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.55 0.74 . . . . 0.0 111.559 173.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -58.11 -47.29 99.12 Favored Pre-proline 0 CA--C 1.547 0.847 0 O-C-N 120.314 -1.492 . . . . 0.0 114.274 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.23 -30.33 5.59 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.703 2.269 . . . . 0.0 113.893 172.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.8 p -71.75 -27.96 63.32 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 121.009 1.731 . . . . 0.0 112.962 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -62.29 -42.34 99.27 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.329 -1.482 . . . . 0.0 112.787 161.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.45 -37.5 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-N 120.002 1.274 . . . . 0.0 111.348 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -65.97 -38.17 87.87 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.897 0.879 . . . . 0.0 112.2 172.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -71.79 -28.14 63.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.48 1.112 . . . . 0.0 112.646 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.8 mt -83.61 -2.74 56.75 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.555 1.542 . . . . 0.0 114.403 168.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -144.64 39.53 1.26 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.253 1.421 . . . . 0.0 112.925 -175.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 m -73.25 65.73 0.85 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -162.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 95.9 mttt -70.68 -35.5 72.85 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.92 1.288 . . . . 0.0 111.875 166.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -79.52 117.79 69.03 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-O 117.102 -1.428 . . . . 0.0 107.431 152.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -53.89 149.62 33.27 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.27 2.647 . . . . 0.0 116.53 -154.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.38 -41.85 93.29 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.101 -170.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.62 -19.64 59.07 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.453 1.101 . . . . 0.0 113.634 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.79 -37.53 13.27 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 121.046 -1.034 . . . . 0.0 112.485 166.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 63.9 m -65.8 -29.4 69.89 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.011 0.924 . . . . 0.0 112.99 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -57.38 -43.64 83.79 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.67 1.588 . . . . 0.0 111.769 174.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -70.35 -40.31 74.14 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.891 0.876 . . . . 0.0 111.533 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.48 -21.89 65.5 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 173.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.7 tp -84.59 -40.3 17.67 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.078 1.351 . . . . 0.0 111.882 170.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.2 mt -64.15 -41.55 97.12 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.937 1.295 . . . . 0.0 113.449 -176.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.01 -34.44 78.1 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.492 1.496 . . . . 0.0 112.87 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.52 -36.76 60.46 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.27 -0.894 . . . . 0.0 112.914 171.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.5 mt -64.89 -36.2 83.61 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.742 -1.224 . . . . 0.0 112.823 172.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -64.53 -42.99 95.4 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.456 1.103 . . . . 0.0 111.309 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.57 -37.5 87.56 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.39 0.676 . . . . 0.0 112.345 176.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 tp -66.62 -55.27 16.09 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.386 1.075 . . . . 0.0 111.643 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -66.68 -38.54 87.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.021 1.328 . . . . 0.0 113.766 -170.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.67 -33.68 83.35 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.24 -0.755 . . . . 0.0 113.494 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -91.23 -31.06 16.3 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 117.77 0.785 . . . . 0.0 113.004 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 16.0 mt -62.27 -31.69 72.3 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.564 -1.335 . . . . 0.0 113.247 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -65.36 0.59 1.4 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 172.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.2 t -109.32 -25.75 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.854 1.661 . . . . 0.0 113.22 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -106.11 -9.43 16.97 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 -161.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 122.33 171.2 13.84 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 119.863 1.211 . . . . 0.0 113.604 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -78.06 -4.69 14.6 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.683 3.589 . . . . 0.0 116.122 -160.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -98.8 167.41 10.78 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.082 -1.011 . . . . 0.0 111.649 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.4 mt -69.86 -4.16 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 120.576 -1.328 . . . . 0.0 113.055 174.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -121.68 27.83 7.98 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.033 1.733 . . . . 0.0 113.707 165.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.42 -108.81 2.71 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.256 0.931 . . . . 0.0 113.023 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -60.28 -33.28 72.1 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -172.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -148.2 163.51 36.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.157 1.383 . . . . 0.0 111.694 -167.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 51.8 mt -64.79 135.21 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.602 0.761 . . . . 0.0 109.645 164.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 29.3 p -135.33 -176.56 4.31 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.914 1.286 . . . . 0.0 111.258 169.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.41 -22.3 2.9 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 167.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.0 t -72.12 -42.47 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 120.945 -1.097 . . . . 0.0 112.005 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -61.35 -43.67 98.48 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 120.964 -1.085 . . . . 0.0 112.373 169.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 25.1 mt -61.65 -21.91 64.82 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 24.8 m -82.0 -47.85 12.16 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.187 -0.946 . . . . 0.0 112.135 175.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 26.8 mt -97.05 -34.4 11.18 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -167.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.77 -49.24 94.9 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -174.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.06 -28.4 15.99 Favored 'Trans proline' 0 C--N 1.35 0.617 0 CA-C-N 120.996 1.391 . . . . 0.0 112.998 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -68.88 -30.52 69.04 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 117.487 -1.244 . . . . 0.0 112.572 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 56.3 mt -68.24 -45.5 73.05 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -56.98 -39.73 75.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.188 0.595 . . . . 0.0 111.477 170.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -70.46 -18.91 62.99 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.5 mt -76.44 -52.6 9.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.681 1.128 . . . . 0.0 111.261 166.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -62.97 -29.9 71.17 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.145 0.978 . . . . 0.0 112.395 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 76.0 t -89.64 -70.72 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.921 1.289 . . . . 0.0 113.168 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.32 -52.39 7.76 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.83 -0.544 . . . . 0.0 112.351 -158.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 42.8 tp -65.76 -31.08 71.87 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 118.948 -0.549 . . . . 0.0 111.344 171.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -55.64 -28.3 51.34 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.177 1.37 . . . . 0.0 115.804 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -71.08 -15.31 62.52 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -126.2 -28.45 3.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.604 1.162 . . . . 0.0 112.807 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -145.63 97.06 2.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.805 2.042 . . . . 0.0 108.518 164.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -68.34 78.93 0.26 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.204 1.002 . . . . 0.0 110.561 166.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -68.76 118.13 57.76 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.095 0.958 . . . . 0.0 110.956 -173.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.19 100.85 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.954 1.77 . . . . 0.0 110.301 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.4 mm -55.3 111.51 3.14 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.664 1.186 . . . . 0.0 108.119 167.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -63.24 149.93 89.98 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.323 1.349 . . . . 0.0 112.519 -168.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.29 -19.53 65.48 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.849 -1.157 . . . . 0.0 113.429 172.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -62.41 -36.02 81.03 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.99 1.316 . . . . 0.0 112.732 167.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 45.7 mt -80.75 52.55 1.72 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.59 1.556 . . . . 0.0 111.12 166.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -26.61 67.85 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.52 1.128 . . . . 0.0 112.353 -170.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -77.83 -48.58 16.15 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.457 -0.777 . . . . 0.0 112.069 174.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.75 -39.46 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.862 0.865 . . . . 0.0 110.944 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 56.1 tp -63.43 -40.61 97.63 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.816 0.847 . . . . 0.0 113.026 175.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -69.56 -41.89 75.26 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.466 0.706 . . . . 0.0 112.533 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -64.55 -32.39 74.02 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.533 1.133 . . . . 0.0 112.538 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.13 -35.03 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 120.993 -1.067 . . . . 0.0 111.851 169.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 40.7 mmtt -80.43 -16.79 53.57 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.332 -1.48 . . . . 0.0 112.867 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.66 -18.67 62.84 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.152 -0.928 . . . . 0.0 113.434 162.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 73.8 mt -66.29 -18.24 65.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.117 1.326 . . . . 0.0 113.988 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -98.04 9.32 43.11 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.763 1.225 . . . . 0.0 112.41 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.0 p -116.27 179.14 4.08 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.363 1.465 . . . . 0.0 113.622 -170.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.4 mtp85 57.17 -163.67 0.18 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.578 1.551 . . . . 0.0 110.079 -169.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -84.31 -31.11 25.04 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.966 -0.459 . . . . 0.0 111.428 156.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 35.2 p -75.36 -59.16 2.87 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.968 1.307 . . . . 0.0 114.351 -160.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -64.85 -42.33 94.97 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.799 0.727 . . . . 0.0 112.0 172.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -53.36 -33.8 55.04 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.308 1.443 . . . . 0.0 114.028 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -86.83 -8.14 57.59 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 4.1 p -73.73 -18.59 60.97 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.346 1.43 . . . . 0.0 112.425 169.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -58.94 132.49 54.15 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.833 1.253 . . . . 0.0 111.863 -175.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -106.85 176.96 5.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.048 1.339 . . . . 0.0 110.465 169.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.47 116.53 9.99 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.155 -0.965 . . . . 0.0 109.571 167.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -57.11 -34.44 68.35 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -167.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.65 -40.69 79.87 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.673 1.189 . . . . 0.0 111.778 174.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -86.53 -3.16 58.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.331 1.852 . . . . 0.0 112.809 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 25.8 t -84.99 -49.25 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.279 1.032 . . . . 0.0 110.091 159.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 12.7 mt -60.98 -54.59 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.509 1.123 . . . . 0.0 111.691 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.71 -15.98 63.25 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.269 1.027 . . . . 0.0 113.389 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.47 -27.44 43.34 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 118.616 -1.102 . . . . 0.0 113.48 171.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -90.0 -34.96 15.79 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.476 1.911 . . . . 0.0 114.262 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -48.1 -48.94 62.82 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.2 -24.83 27.23 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 121.577 1.518 . . . . 0.0 114.022 174.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -74.96 -6.64 50.38 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 175.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.409 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 61.5 t -60.29 -18.42 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.181 -0.95 . . . . 0.0 111.416 158.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -118.79 17.19 13.52 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.554 1.942 . . . . 0.0 115.052 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.922 0 C-N-CA 125.168 1.387 . . . . 0.0 110.386 171.395 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.42 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 99.0 mtp . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 117.845 -1.074 . . . . 0.0 109.995 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.64 -177.53 0.09 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.239 1.816 . . . . 0.0 115.053 171.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 75.9 mt -125.19 118.66 26.54 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.651 1.981 . . . . 0.0 109.582 -173.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -116.42 132.98 56.53 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.183 0.993 . . . . 0.0 109.589 173.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.7 pt -128.69 135.99 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 118.93 0.786 . . . . 0.0 110.957 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.0 m -111.95 122.27 47.3 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.097 0.959 . . . . 0.0 109.922 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.54 161.18 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.147 0.979 . . . . 0.0 112.018 -166.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -56.73 117.54 4.01 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.168 1.387 . . . . 0.0 111.753 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.413 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -75.11 148.67 39.51 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.138 155.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.16 151.12 47.63 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.132 0.968 . . . . 0.0 112.573 175.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.9 t -65.97 123.54 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.327 0.651 . . . . 0.0 109.311 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.91 -17.54 2.21 Favored Glycine 0 CA--C 1.54 1.612 0 N-CA-C 116.297 1.279 . . . . 0.0 116.297 -176.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.04 72.55 55.11 Favored Pre-proline 0 CA--C 1.548 0.867 0 CA-C-N 119.098 1.449 . . . . 0.0 111.622 -175.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.413 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 48.6 Cg_endo -64.35 -14.67 45.37 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.135 2.557 . . . . 0.0 115.265 -167.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -84.4 -0.39 52.54 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.0 pt -135.15 165.28 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.65 1.18 . . . . 0.0 112.081 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.0 mt -73.66 146.45 44.53 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.185 0.994 . . . . 0.0 111.665 173.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.48 -159.05 8.67 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.992 1.282 . . . . 0.0 112.15 167.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.428 ' CG ' ' HZ3' ' A' ' 209' ' ' LYS . 62.5 t0 -59.11 98.22 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 122.934 1.35 . . . . 0.0 113.788 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.2 t -153.26 95.85 2.91 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.425 1.49 . . . . 0.0 108.718 142.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.86 -20.01 64.38 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.163 1.909 . . . . 0.0 112.391 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -65.93 -37.34 85.8 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.669 1.188 . . . . 0.0 112.846 172.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 95.1 m -64.81 -38.15 90.0 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.723 -1.235 . . . . 0.0 112.142 169.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -65.92 -25.56 67.2 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 118.519 -0.753 . . . . 0.0 112.73 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -58.23 -43.42 87.76 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.603 1.161 . . . . 0.0 113.244 168.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.02 -40.13 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.287 1.035 . . . . 0.0 110.792 -175.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.8 mt -61.59 -40.55 95.17 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.917 -0.489 . . . . 0.0 111.684 170.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 tp -60.55 -47.71 84.98 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.775 1.23 . . . . 0.0 113.34 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.1 p -73.06 -33.42 65.66 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.9 1.227 . . . . 0.0 113.46 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.52 -40.82 96.33 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.525 -0.735 . . . . 0.0 111.986 173.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -80.34 -23.69 40.39 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -65.0 -45.08 87.08 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.073 -1.017 . . . . 0.0 111.597 164.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -68.85 -23.38 64.23 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.241 -0.912 . . . . 0.0 112.671 171.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.0 mtmm 59.64 19.56 8.19 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.351 1.861 . . . . 0.0 112.407 -170.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.4 tt -74.15 140.23 76.54 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.2 1.4 . . . . 0.0 109.884 -171.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -66.87 132.32 28.07 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 121.803 1.668 . . . . 0.0 112.02 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -141.65 169.88 16.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.085 1.754 . . . . 0.0 111.169 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.674 ' HE2' ' NE2' ' A' ' 40' ' ' HIS . 52.1 tttt -130.59 127.77 39.7 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.069 1.747 . . . . 0.0 109.015 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.521 ' C ' ' HD2' ' A' ' 40' ' ' HIS . 27.6 t -114.17 138.16 50.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.157 0.983 . . . . 0.0 112.939 -170.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.674 ' NE2' ' HE2' ' A' ' 38' ' ' LYS . 6.1 m170 -126.31 108.9 11.68 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.965 1.706 . . . . 0.0 108.416 -171.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.6 mt -76.89 107.66 9.38 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.267 0.627 . . . . 0.0 110.494 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.4 mm -91.34 119.45 38.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.654 1.181 . . . . 0.0 109.379 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -69.14 126.3 29.35 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.292 -0.632 . . . . 32.609999999999999 109.292 161.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.9 mt -88.58 -18.47 28.01 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.122 0.786 . . . . 40.049999999999997 113.122 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.55 -20.43 71.6 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 118.79 0.723 . . . . 41.469999999999999 114.344 172.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -147.49 90.44 1.86 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.836 1.655 . . . . 47.170000000000002 108.688 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -84.82 135.0 40.63 Favored Pre-proline 0 N--CA 1.469 0.491 0 C-N-CA 124.142 0.977 . . . . 41.270000000000003 110.034 -170.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -59.26 140.45 94.73 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.343 2.029 . . . . 40.289999999999999 111.737 171.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.06 -40.56 89.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.195 0.813 . . . . 42.390000000000001 113.195 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 31.7 p-90 -65.97 -13.41 59.76 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.233 1.198 . . . . 37.079999999999998 114.233 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -67.49 -26.88 66.58 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.242 -1.537 . . . . 35.880000000000003 112.62 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.9 mt -70.66 -21.08 62.65 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.368 0.877 . . . . 33.609999999999999 113.368 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.72 -16.36 61.19 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.192 0.997 . . . . 33.789999999999999 112.57 171.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.3 mt -102.58 -43.39 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.13 1.372 . . . . 33.159999999999997 110.7 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.4 t -124.8 104.24 30.49 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 125.451 1.5 . . . . 33.579999999999998 110.376 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.29 -19.64 38.12 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.51 2.14 . . . . 37.899999999999999 113.769 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -83.77 -5.87 59.3 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.77 1.026 . . . . 38.990000000000002 113.77 168.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.91 14.22 65.23 Favored Glycine 0 CA--C 1.534 1.276 0 O-C-N 120.878 -1.139 . . . . 35.469999999999999 114.773 -172.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -91.89 156.28 17.59 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.262 1.425 . . . . 34.490000000000002 112.818 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.0 m -109.44 156.49 39.42 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 126.096 1.759 . . . . 23.530000000000001 110.935 159.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.02 153.78 80.62 Favored 'Cis proline' 0 C--N 1.348 0.508 0 CA-C-O 122.299 0.875 . . . . 22.879999999999999 113.352 -10.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.6 p -143.71 146.74 20.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 113.304 -1.771 . . . . 0.0 107.31 159.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.01 163.62 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.596 0.758 . . . . 0.0 110.444 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -111.35 121.78 46.14 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.934 1.294 . . . . 0.0 109.748 157.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 95.8 mt -106.23 115.35 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.3 1.44 . . . . 0.0 107.693 170.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.42 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 2.5 t70 53.25 43.58 31.31 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 122.529 1.156 . . . . 0.0 113.655 -167.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.2 t70 66.89 -7.97 0.44 Allowed 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -171.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 66' ' ' ASP . 20.4 mmtt -91.83 127.97 37.49 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 119.472 -2.018 . . . . 0.0 111.744 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 27.8 p-90 -74.6 147.57 41.53 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -167.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.0 t -141.57 126.11 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.204 1.801 . . . . 0.0 108.563 171.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -109.96 166.57 10.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.633 1.573 . . . . 0.0 111.534 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.0 t0 67.01 114.07 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.064 2.146 . . . . 22.16 113.935 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.454 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 53.2 p -64.0 -29.21 70.39 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 115.317 1.599 . . . . 21.16 115.317 -163.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -71.08 -29.88 65.85 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 120.135 1.334 . . . . 24.969999999999999 112.163 171.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.2 t -75.09 -42.05 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 O-C-N 120.623 -1.298 . . . . 23.850000000000001 111.645 170.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.01 -45.55 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.345 1.058 . . . . 23.68 110.63 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.9 t -63.1 -43.32 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.09 0.956 . . . . 22.84 111.353 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.97 93.33 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 118.654 0.661 . . . . 23.329999999999998 113.505 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 70.6 mt -77.08 -41.21 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 117.946 0.873 . . . . 23.309999999999999 112.278 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.1 mt -62.97 -37.05 85.55 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.132 1.333 . . . . 23.48 112.48 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -89.27 9.24 26.65 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.333 1.234 . . . . 24.239999999999998 114.333 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -123.04 -42.0 2.3 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.857 1.263 . . . . 39.259999999999998 112.654 173.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -126.25 65.57 1.23 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.77 1.628 . . . . 24.449999999999999 111.456 -167.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.62 165.38 28.71 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 124.815 1.246 . . . . 0.0 110.694 175.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.01 -27.17 8.67 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.965 2.443 . . . . 0.0 114.939 -174.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -77.68 160.91 73.58 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 118.93 0.786 . . . . 0.0 110.06 168.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -52.32 139.01 55.41 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.546 2.164 . . . . 0.0 114.642 -175.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.414 ' O ' HD23 ' A' ' 89' ' ' LEU . 78.7 Cg_endo -69.99 147.09 60.64 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.449 2.766 . . . . 0.0 111.29 176.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.637 HD22 ' HZ1' ' A' ' 145' ' ' LYS . 15.2 mt -131.49 9.87 4.74 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.103 1.361 . . . . 0.0 113.232 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.88 41.89 0.1 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.305 1.842 . . . . 0.0 114.578 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 90.5 m -105.78 103.39 43.72 Favored Pre-proline 0 N--CA 1.472 0.669 0 C-N-CA 125.107 1.363 . . . . 0.0 110.314 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -86.56 112.5 1.05 Allowed 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 124.148 3.232 . . . . 0.0 111.516 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -82.9 -170.46 0.92 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.863 3.042 . . . . 0.0 111.888 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 15.4 mp0 -52.32 -33.33 42.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.211 2.204 . . . . 0.0 113.171 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -57.92 -23.66 54.43 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.458 1.503 . . . . 0.0 114.14 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.55 -27.12 67.49 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.099 -1.001 . . . . 0.0 113.099 172.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 86.2 p -65.75 -47.95 73.53 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.153 -0.967 . . . . 0.0 112.149 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.2 t -77.33 -37.94 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 121.274 -0.891 . . . . 0.0 111.444 174.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.22 -31.34 80.51 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 121.265 -0.897 . . . . 0.0 114.137 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 89.0 p -73.06 -14.55 61.43 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -86.72 -39.83 15.63 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.536 1.135 . . . . 0.0 112.586 167.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.47 -37.52 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.289 1.436 . . . . 0.0 111.418 173.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -53.4 -54.38 45.94 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.915 1.686 . . . . 0.0 114.24 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.78 -34.83 0.87 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.118 2.545 . . . . 0.0 113.303 170.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.0 p -65.9 -31.06 71.77 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.403 1.456 . . . . 0.0 112.631 -173.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -79.58 -20.89 45.88 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.249 -1.532 . . . . 0.0 113.71 172.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.6 t -72.9 -38.2 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 120.399 -1.438 . . . . 0.0 110.744 164.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -69.58 -27.67 65.32 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -59.39 -41.46 89.45 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.097 1.359 . . . . 0.0 111.855 170.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.5 mt -80.14 4.19 18.14 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.819 1.648 . . . . 0.0 114.81 172.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -136.76 35.48 2.64 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 127.97 2.508 . . . . 0.0 111.277 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 p -82.23 58.02 3.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.585 1.954 . . . . 0.0 113.69 -169.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.53 -45.84 91.15 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.162 0.985 . . . . 0.0 110.096 161.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.6 119.52 60.82 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 128.157 2.583 . . . . 0.0 107.71 155.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.16 135.09 68.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.935 1.757 . . . . 0.0 115.843 -159.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -68.16 -32.62 73.01 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 117.779 -1.105 . . . . 0.0 112.115 170.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.74 -32.06 68.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.166 1.386 . . . . 0.0 114.024 174.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.05 -34.86 9.39 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.744 0.688 . . . . 0.0 113.499 172.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 61.4 m -64.94 -40.6 95.28 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.409 1.084 . . . . 0.0 112.107 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -59.58 -27.46 66.28 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.358 1.863 . . . . 0.0 113.655 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -69.2 -18.34 63.9 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.127 0.971 . . . . 0.0 112.885 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.18 -35.8 13.64 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.857 0.863 . . . . 0.0 112.551 165.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.6 mt -65.95 -34.6 78.49 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.69 -36.38 82.73 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.714 0.688 . . . . 0.0 112.076 173.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.77 -30.66 32.24 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.249 0.62 . . . . 0.0 112.425 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.16 -46.86 88.79 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.131 0.972 . . . . 0.0 111.741 166.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.0 mt -65.21 -40.69 94.48 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.774 -1.108 . . . . 0.0 112.128 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -62.66 -42.11 99.43 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.291 1.405 . . . . 0.0 112.576 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.69 -35.78 82.15 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.216 0.607 . . . . 0.0 112.257 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.2 tp -72.84 -54.46 8.75 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.68 0.792 . . . . 0.0 111.529 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -63.1 -35.4 80.14 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.498 1.919 . . . . 0.0 113.906 -173.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.34 -33.64 81.61 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 123.914 0.768 . . . . 0.0 113.731 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -94.98 -28.64 15.04 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.6 mt -66.25 -32.23 73.52 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.594 -1.316 . . . . 0.0 113.272 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -66.37 -11.0 48.95 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.55 -29.27 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.737 0.815 . . . . 0.0 111.928 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -94.65 -37.31 11.38 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.605 1.162 . . . . 0.0 113.303 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.33 -69.97 0.23 Allowed Glycine 0 CA--C 1.542 1.735 0 CA-C-O 116.609 -2.217 . . . . 0.0 116.525 166.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -102.04 -33.86 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.987 0 N-CA-C 117.825 2.202 . . . . 0.0 117.825 -156.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -134.16 156.68 47.89 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.416 1.462 . . . . 0.0 112.93 -167.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.4 mt -70.46 -12.91 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.67 -1.64 46.23 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 165.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.07 -135.15 10.19 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 120.154 1.343 . . . . 0.0 113.738 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -62.4 -25.36 67.89 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.637 ' HZ1' HD22 ' A' ' 89' ' ' LEU . 6.2 pttp -144.08 164.09 31.65 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.141 1.376 . . . . 0.0 110.403 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.3 mt -61.36 122.12 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 123.433 0.693 . . . . 0.0 110.467 169.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.7 p -140.21 -160.56 1.08 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.45 1.5 . . . . 0.0 108.901 160.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -49.5 -32.82 13.0 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -166.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.3 t -71.86 -37.48 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 120.725 1.602 . . . . 0.0 113.003 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -63.11 -44.04 96.78 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.34 -0.85 . . . . 0.0 111.587 167.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.5 mt -64.98 -27.36 68.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.009 0.524 . . . . 0.0 111.97 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 73.6 m -75.9 -31.94 59.41 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 120.201 -1.562 . . . . 0.0 113.654 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 68.6 mt -124.9 -33.84 2.88 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -162.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.61 -50.08 79.18 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -169.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -68.89 -25.7 32.52 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.479 1.452 . . . . 0.0 113.518 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -72.63 -29.47 63.5 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.224 -0.922 . . . . 0.0 112.198 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 38.0 mt -71.67 -44.09 64.89 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.788 0.835 . . . . 0.0 112.058 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -63.85 -38.5 91.33 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -64.19 -34.7 78.69 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.438 -1.414 . . . . 0.0 112.573 173.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.7 tp -68.83 -47.04 67.02 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.252 -0.905 . . . . 0.0 111.178 174.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -52.3 -45.18 65.43 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.442 1.497 . . . . 0.0 112.225 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.1 t -75.2 -58.88 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.919 0.888 . . . . 0.0 113.119 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.76 -36.07 37.74 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.993 -1.067 . . . . 0.0 113.463 -167.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.2 tp -72.83 -31.81 65.05 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.578 -0.702 . . . . 0.0 111.28 171.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.83 -27.98 37.96 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.837 1.208 . . . . 0.0 114.704 170.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -67.53 -19.49 65.3 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -141.5 -27.18 0.68 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -149.87 80.85 1.38 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.522 1.529 . . . . 0.0 109.355 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.9 75.85 0.08 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.388 1.475 . . . . 0.0 112.403 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -71.73 112.96 16.06 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.127 1.771 . . . . 0.0 112.32 -168.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.31 137.52 19.0 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.546 2.164 . . . . 0.0 111.845 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 46.7 mm -87.57 113.93 56.52 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.329 1.052 . . . . 0.0 109.025 164.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -71.06 155.86 60.85 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.254 1.969 . . . . 0.0 111.779 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.59 -12.39 44.79 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -62.05 -31.44 71.85 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.209 1.004 . . . . 0.0 112.835 166.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.2 mt -84.19 57.18 4.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.464 1.906 . . . . 0.0 110.835 167.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -22.86 64.6 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.62 1.168 . . . . 0.0 113.297 -161.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -75.52 -52.49 10.52 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.257 0.935 . . . . 0.0 110.303 165.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 33.7 t -57.53 -46.69 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 119.234 0.925 . . . . 0.0 112.711 -174.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.7 tp -64.36 -27.95 69.37 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -93.61 -29.48 15.44 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.143 -0.973 . . . . 0.0 113.272 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -64.0 -36.92 85.56 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.271 1.428 . . . . 0.0 112.925 173.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.5 mt -60.01 -37.43 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 O-C-N 121.336 -0.852 . . . . 0.0 111.641 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -67.01 -28.26 68.1 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.047 -1.658 . . . . 0.0 112.475 173.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.1 mt -71.5 -20.59 62.04 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.473 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 68.9 mt -65.65 -21.6 66.57 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 120.17 1.35 . . . . 0.0 112.751 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -85.71 19.1 2.57 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.456 1.502 . . . . 0.0 113.308 170.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.8 p -142.81 178.65 7.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.797 2.039 . . . . 0.0 112.947 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 65.7 mtp85 59.74 171.88 0.08 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.619 1.968 . . . . 0.0 113.561 -170.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 53.1 mp0 -64.83 -47.91 76.29 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.422 1.089 . . . . 0.0 110.286 159.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -39.29 89.78 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.681 1.992 . . . . 0.0 115.707 -170.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -96.67 -53.26 3.62 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.483 1.038 . . . . 0.0 111.746 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -62.31 -37.37 85.31 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -168.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.88 -22.85 66.55 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.15 0.886 . . . . 0.0 113.034 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 7.0 p -90.55 -7.09 53.81 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.647 1.179 . . . . 0.0 113.2 -173.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -60.61 114.68 3.12 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.458 1.503 . . . . 0.0 111.063 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -70.11 162.56 28.03 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.051 0.94 . . . . 0.0 112.579 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -75.39 125.81 29.74 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.848 -0.533 . . . . 0.0 110.684 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -73.84 -32.1 63.5 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -155.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.37 -36.42 83.66 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.812 1.245 . . . . 0.0 111.162 167.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -83.69 -8.43 59.28 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.009 1.724 . . . . 0.0 113.309 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.2 t -78.47 -51.89 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.347 1.059 . . . . 0.0 109.913 158.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 62.2 mt -62.32 -48.03 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.015 0.926 . . . . 0.0 111.974 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -5.39 41.74 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.874 1.27 . . . . 0.0 114.15 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -90.33 -32.75 9.25 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 121.133 -0.979 . . . . 0.0 113.134 164.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -83.22 -32.56 26.43 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.13 1.772 . . . . 0.0 114.802 -174.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -48.83 -55.15 21.55 Favored Pre-proline 0 N--CA 1.481 1.121 0 CA-C-N 120.254 1.388 . . . . 0.0 114.35 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.19 -20.8 32.34 Favored 'Trans proline' 0 C--N 1.351 0.678 0 CA-C-N 120.806 1.324 . . . . 0.0 111.979 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.428 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 45.6 mtpt -84.54 2.69 40.06 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.148 1.779 . . . . 0.0 114.274 174.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 63.4 t -66.58 -29.97 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 120.886 -1.134 . . . . 0.0 110.219 152.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -96.2 -52.34 4.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 117.183 -1.389 . . . . 0.0 114.265 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.865 2.066 . . . . 0.0 113.089 -177.239 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 301' ' ' GSH . . . . . 0.454 ' C1 ' ' H ' ' A' ' 73' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.484 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 90.0 mtp . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 118.468 -0.777 . . . . 0.0 110.746 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.63 -161.51 0.25 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.917 1.287 . . . . 0.0 113.292 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.99 136.73 34.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.903 1.281 . . . . 0.0 110.771 -170.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -139.21 151.42 46.54 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.412 1.485 . . . . 0.0 108.845 166.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.54 140.73 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.206 1.002 . . . . 0.0 109.148 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.9 m -113.56 122.29 46.8 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.086 0.954 . . . . 0.0 109.38 171.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -136.59 157.92 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.887 1.275 . . . . 0.0 110.699 -164.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -57.7 115.43 2.79 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.611 0.365 . . . . 0.0 110.839 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -81.49 151.24 27.9 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.964 154.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.73 151.53 33.68 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.256 1.026 . . . . 0.0 112.515 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.6 t -70.86 135.98 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 166.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.53 -33.85 1.37 Allowed Glycine 0 CA--C 1.539 1.538 0 CA-C-O 118.585 -1.119 . . . . 0.0 115.218 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.96 67.85 12.1 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.861 1.264 . . . . 0.0 112.529 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.504 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 70.8 Cg_endo -65.71 -7.47 16.59 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.268 2.645 . . . . 0.0 114.685 -175.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -81.17 -0.1 38.84 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.493 1.517 . . . . 0.0 114.452 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.4 pt -133.34 162.08 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.994 1.318 . . . . 0.0 111.546 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.8 mt -63.6 150.96 42.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.725 0.81 . . . . 0.0 111.648 168.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.0 -166.32 10.91 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.557 1.551 . . . . 0.0 111.949 166.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -56.61 107.96 0.44 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.4 t -158.89 103.48 1.59 Allowed Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.281 139.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -64.57 -20.82 65.9 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.294 1.996 . . . . 0.0 112.633 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -68.38 -26.41 65.55 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.906 -1.121 . . . . 0.0 112.829 172.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 81.7 m -74.04 -37.09 64.42 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.614 -1.304 . . . . 0.0 112.055 170.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -62.24 -26.8 68.58 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 118.339 -0.839 . . . . 0.0 112.938 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.54 HH12 ' CG ' ' A' ' 74' ' ' ASP . 59.1 mtp180 -57.01 -42.8 81.02 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.118 0.967 . . . . 0.0 112.471 170.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.78 -41.46 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.284 1.434 . . . . 0.0 111.381 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -58.94 -42.92 90.96 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.972 0.509 . . . . 0.0 111.401 172.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.02 -50.53 73.39 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.306 1.042 . . . . 0.0 112.748 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 p -75.71 -38.34 58.67 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -175.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.1 mt -65.91 -39.75 90.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.566 0.621 . . . . 0.0 111.32 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -77.85 -25.56 48.81 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -67.13 -48.66 67.41 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 120.741 -1.224 . . . . 0.0 111.325 169.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.423 ' HE3' HD12 ' A' ' 35' ' ' ILE . 51.2 mtmt -76.93 -0.33 23.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.016 1.726 . . . . 0.0 114.436 175.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm 57.79 20.67 6.71 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.785 1.634 . . . . 0.0 114.677 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.423 HD12 ' HE3' ' A' ' 33' ' ' LYS . 95.8 mt -69.77 128.8 91.7 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.504 1.122 . . . . 0.0 109.035 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.73 140.68 23.78 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.467 2.112 . . . . 0.0 111.737 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -145.11 152.03 39.43 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.604 1.562 . . . . 0.0 110.089 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -77.55 131.51 37.9 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.064 -1.022 . . . . 0.0 109.339 158.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.6 t -103.95 94.42 5.4 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.927 0.891 . . . . 0.0 110.755 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -81.26 99.06 8.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.775 0.83 . . . . 0.0 109.615 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 70.0 mt -66.98 108.79 2.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.528 0.731 . . . . 0.0 109.039 170.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.7 mm -120.66 114.88 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.529 1.132 . . . . 0.0 109.303 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -76.56 90.5 3.33 Favored 'General case' 0 C--O 1.22 -0.455 0 O-C-N 120.775 -1.203 . . . . 32.609999999999999 108.42 165.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.06 -7.34 1.76 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 117.173 2.286 . . . . 40.049999999999997 117.173 -170.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.56 -37.85 89.95 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 119.651 1.114 . . . . 41.469999999999999 111.762 165.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -105.58 47.77 0.86 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 129.452 3.101 . . . . 47.170000000000002 111.177 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -73.92 126.68 89.22 Favored Pre-proline 0 N--CA 1.475 0.779 0 O-C-N 119.695 -1.878 . . . . 41.270000000000003 111.689 -174.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.86 159.55 52.22 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.468 2.112 . . . . 40.289999999999999 110.982 170.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -62.45 -29.21 70.35 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.776 1.028 . . . . 42.390000000000001 113.776 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.4 t90 -56.28 -35.24 67.27 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.969 1.308 . . . . 37.079999999999998 113.957 168.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -79.41 -33.92 42.25 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.949 -1.094 . . . . 35.880000000000003 112.82 174.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 mt -71.02 -21.05 62.33 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.76 1.022 . . . . 33.609999999999999 113.76 173.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -66.38 -47.93 71.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.446 0.698 . . . . 33.789999999999999 110.752 166.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.6 mt -72.1 -33.21 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.308 1.043 . . . . 33.159999999999997 112.183 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.4 t -137.78 81.93 27.53 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 127.069 2.147 . . . . 33.579999999999998 110.507 -173.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -63.9 -23.51 68.29 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.231 2.621 . . . . 37.899999999999999 113.778 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -74.27 -10.94 60.09 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.805 -1.185 . . . . 38.990000000000002 113.845 167.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.89 22.58 76.65 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.463 1.506 . . . . 35.469999999999999 115.131 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -110.72 159.3 17.74 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.872 1.669 . . . . 34.490000000000002 113.921 -169.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.7 155.14 63.52 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.645 1.578 . . . . 23.530000000000001 111.85 172.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -63.51 152.75 71.37 Favored 'Cis proline' 0 C--N 1.349 0.575 0 CA-C-O 121.813 0.672 . . . . 22.879999999999999 112.611 -11.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.2 p -139.24 144.43 29.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.568 161.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.59 162.48 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 121.348 -0.845 . . . . 0.0 111.528 -169.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -123.21 63.91 1.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.103 1.761 . . . . 0.0 109.791 -174.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 81.4 mt -74.01 121.21 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.824 0.85 . . . . 0.0 108.76 -175.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.484 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 45.5 t0 55.15 35.89 25.79 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 121.862 -0.524 . . . . 0.0 111.447 -164.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.448 ' HB2' ' H2 ' ' A' ' 1' ' ' MET . 19.5 t0 67.19 -8.74 0.43 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 127.628 2.371 . . . . 0.0 115.345 -170.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.3 mttt -83.93 133.56 34.7 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.443 1.497 . . . . 0.0 111.875 -173.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.2 m0 -73.72 128.6 35.94 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.018 1.327 . . . . 0.0 111.679 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.0 t -142.5 128.1 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.332 1.453 . . . . 0.0 109.776 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -103.53 175.18 5.56 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.692 1.597 . . . . 0.0 111.729 172.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.7 t0 66.44 108.79 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.829 2.452 . . . . 22.16 114.786 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.446 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 52.4 p -61.42 -23.95 66.19 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 115.226 1.565 . . . . 21.16 115.226 -168.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.54 ' CG ' HH12 ' A' ' 25' ' ' ARG . 38.1 m-20 -73.61 -37.47 65.41 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.745 1.157 . . . . 24.969999999999999 113.07 171.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -69.92 -39.0 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.409 -0.807 . . . . 23.850000000000001 111.039 171.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 89.6 mt -63.58 -44.11 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.302 1.041 . . . . 23.68 111.224 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.1 -41.07 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.181 0.993 . . . . 22.84 111.482 171.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.89 -12.64 49.27 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 115.786 1.074 . . . . 23.329999999999998 115.786 174.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 89.6 mt -102.38 -53.05 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 118.913 1.357 . . . . 23.309999999999999 111.011 168.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.6 -33.06 73.24 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.622 0.971 . . . . 23.48 113.622 -172.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -90.57 -2.91 57.88 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.71 1.004 . . . . 24.239999999999998 113.71 -173.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.434 ' CD ' ' HZ2' ' A' ' 83' ' ' LYS . 10.1 tt0 -117.33 -54.44 2.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.442 1.497 . . . . 39.259999999999998 112.05 172.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.434 ' HZ2' ' CD ' ' A' ' 82' ' ' GLU . 64.9 mttp -93.71 59.22 2.81 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.92 1.288 . . . . 24.449999999999999 112.152 -164.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -135.84 163.64 49.01 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.77 1.628 . . . . 0.0 110.997 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.15 -23.53 21.17 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.411 2.074 . . . . 0.0 112.562 172.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -74.57 147.02 84.36 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.039 1.336 . . . . 0.0 112.206 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -59.44 135.14 62.95 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.841 2.361 . . . . 0.0 113.645 -173.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.68 136.5 49.96 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.909 2.406 . . . . 0.0 113.867 -167.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 mt -103.83 -0.26 29.42 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.935 1.694 . . . . 0.0 112.088 169.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.81 51.64 0.5 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.559 1.944 . . . . 0.0 110.569 161.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -129.74 61.31 57.21 Favored Pre-proline 0 N--CA 1.467 0.41 0 C-N-CA 127.003 2.121 . . . . 0.0 109.104 -169.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -80.77 123.16 4.61 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.256 1.971 . . . . 0.0 111.23 -155.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -72.54 175.96 9.43 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.1 2.533 . . . . 0.0 111.504 167.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -59.38 -20.56 55.76 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -53.72 -24.87 16.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.472 1.509 . . . . 0.0 114.223 167.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.04 -31.29 71.68 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.719 -1.238 . . . . 0.0 112.993 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.0 p -69.04 -25.5 64.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.426 1.09 . . . . 0.0 112.975 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.4 t -89.24 -43.44 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.321 1.448 . . . . 0.0 110.57 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.65 -29.56 75.06 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.014 1.292 . . . . 0.0 114.631 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 88.9 p -66.88 -20.5 65.93 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.498 1.149 . . . . 0.0 114.019 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -94.83 -34.43 12.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.501 1.52 . . . . 0.0 112.874 172.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.1 mt -67.38 -37.98 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.511 0.724 . . . . 0.0 111.521 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -58.93 -47.97 97.67 Favored Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 120.303 -1.498 . . . . 0.0 114.136 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.52 -30.7 6.2 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.693 2.262 . . . . 0.0 113.976 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.3 p -70.72 -29.8 66.17 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.996 1.725 . . . . 0.0 112.761 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -62.22 -41.36 98.32 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.345 -1.472 . . . . 0.0 113.071 161.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.4 t -63.73 -37.48 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 120.248 1.385 . . . . 0.0 111.339 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -67.31 -37.65 83.69 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.607 0.763 . . . . 0.0 112.339 172.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -70.62 -30.22 66.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.408 1.083 . . . . 0.0 112.427 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.5 mt -83.42 1.38 41.81 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.73 1.612 . . . . 0.0 114.352 169.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -146.78 38.56 1.01 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.526 1.53 . . . . 0.0 113.082 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 m -73.8 63.71 0.9 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -161.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.34 -35.84 76.31 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.981 1.312 . . . . 0.0 111.798 165.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 12.0 t0 -81.89 119.05 74.34 Favored Pre-proline 0 CA--C 1.553 1.06 0 CA-C-O 117.125 -1.417 . . . . 0.0 107.221 153.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 114' ' ' ASP . 74.5 Cg_exo -53.66 150.92 26.73 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.419 2.746 . . . . 0.0 116.735 -153.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -66.34 -42.36 88.23 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.568 -174.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.12 -24.37 60.6 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.402 1.081 . . . . 0.0 113.417 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.31 -35.81 25.59 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.19 -0.944 . . . . 0.0 112.805 168.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 92.7 m -67.44 -27.19 66.84 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.655 -0.909 . . . . 0.0 112.687 169.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -58.75 -44.09 90.46 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 125.388 1.475 . . . . 0.0 111.814 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -70.44 -37.6 74.4 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.534 -0.729 . . . . 0.0 111.996 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.89 -16.09 63.67 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.2 tp -92.13 -40.71 10.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.379 1.471 . . . . 0.0 111.612 169.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.5 mt -65.02 -42.38 94.44 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.201 1.4 . . . . 0.0 113.558 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -65.27 -35.19 80.27 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.88 1.673 . . . . 0.0 112.469 -176.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -73.71 -37.26 65.21 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.43 -0.794 . . . . 0.0 112.83 172.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.3 mt -65.69 -36.4 83.53 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.688 -1.258 . . . . 0.0 112.656 171.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -64.57 -42.78 95.43 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.734 1.152 . . . . 0.0 111.253 173.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.21 -38.41 91.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.401 0.68 . . . . 0.0 112.131 175.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.6 tp -65.04 -52.81 53.74 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.045 0.938 . . . . 0.0 111.846 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -65.9 -38.41 88.66 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.214 1.405 . . . . 0.0 113.425 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -62.07 -36.05 92.35 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 119.284 -0.731 . . . . 0.0 113.845 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -87.45 -31.74 19.86 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 117.913 0.857 . . . . 0.0 112.879 175.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 12.8 mt -61.42 -36.23 79.76 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.004 -1.06 . . . . 0.0 113.436 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -65.21 -2.71 3.16 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.3 t -104.23 -27.76 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.591 1.556 . . . . 0.0 112.946 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -93.67 -50.94 5.15 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -168.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 158.95 172.41 26.02 Favored Glycine 0 CA--C 1.535 1.298 0 O-C-N 121.362 -0.836 . . . . 0.0 114.586 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -73.48 -15.25 24.9 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 124.669 3.579 . . . . 0.0 115.987 -163.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -89.95 167.45 12.8 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.379 0.99 . . . . 0.0 111.61 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -12.18 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.472 -1.393 . . . . 0.0 113.204 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -100.65 -4.1 29.04 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.8 1.408 . . . . 0.0 114.8 166.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 110.12 -122.95 6.51 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 119.871 1.214 . . . . 0.0 113.201 -175.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -70.43 -18.72 63.01 Favored 'General case' 0 CA--C 1.541 0.635 0 O-C-N 120.847 -1.384 . . . . 0.0 114.108 -168.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -141.35 155.74 45.9 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.907 1.683 . . . . 0.0 110.711 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 58.9 mt -62.73 129.31 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.592 0.757 . . . . 0.0 109.244 163.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.9 p -129.36 -175.41 3.57 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.8 0.84 . . . . 0.0 111.961 168.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.79 -19.1 3.83 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 172.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.6 t -70.32 -43.57 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.998 -1.064 . . . . 0.0 111.9 172.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -60.02 -45.19 93.61 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.471 1.108 . . . . 0.0 112.312 169.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 34.2 mt -61.06 -20.74 62.92 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 177.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.2 m -85.98 -43.99 12.71 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.37 -0.831 . . . . 0.0 112.047 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 29.5 mt -98.34 -33.53 11.03 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -168.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.49 -49.58 93.0 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.56 -22.35 18.34 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 121.095 1.427 . . . . 0.0 113.223 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -71.25 -33.25 69.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 117.47 -1.252 . . . . 0.0 112.077 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 68.9 mt -66.41 -43.17 86.49 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 169.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -58.33 -39.72 80.19 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.653 0.661 . . . . 0.0 111.588 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -70.81 -22.68 62.32 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.3 mt -71.98 -51.38 22.2 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.112 0.869 . . . . 0.0 111.496 168.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -64.8 -28.16 69.38 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.524 0.729 . . . . 0.0 112.461 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.3 t -94.21 -72.24 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.854 1.262 . . . . 0.0 113.159 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.98 -48.72 11.87 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.333 -0.854 . . . . 0.0 113.057 -158.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 63.4 tp -66.84 -34.0 76.84 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.825 -0.607 . . . . 0.0 111.074 166.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.38 -30.13 57.98 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.285 1.421 . . . . 0.0 115.505 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -64.34 -26.16 68.35 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 173.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -117.21 -28.09 6.28 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.547 1.139 . . . . 0.0 113.584 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -143.87 94.28 2.57 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.358 2.263 . . . . 0.0 108.032 167.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -68.35 80.68 0.25 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.077 0.951 . . . . 0.0 110.347 168.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -71.0 117.22 54.3 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.447 1.099 . . . . 0.0 110.966 -171.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.39 107.09 1.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.868 1.712 . . . . 0.0 110.352 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 30.5 mm -57.13 115.13 9.58 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 124.399 1.08 . . . . 0.0 108.445 169.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.59 146.62 92.79 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.6 1.534 . . . . 0.0 111.744 -174.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.88 -17.48 64.34 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 120.887 -1.133 . . . . 0.0 114.058 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -62.18 -35.33 78.49 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.807 1.243 . . . . 0.0 112.786 167.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 36.1 mt -80.54 50.81 1.36 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.802 1.641 . . . . 0.0 111.232 165.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -34.42 70.56 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.532 1.133 . . . . 0.0 111.746 -171.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -80.5 -37.86 30.89 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.255 1.022 . . . . 0.0 112.943 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 43.9 t -64.68 -40.61 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 119.512 1.051 . . . . 0.0 111.017 172.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.57 -41.2 96.44 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -65.47 -42.72 91.96 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 171.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -65.0 -33.27 75.65 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.431 1.092 . . . . 0.0 112.959 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 58.3 mt -58.62 -32.36 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.039 -1.038 . . . . 0.0 111.704 170.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -83.13 -11.63 57.76 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.33 -1.481 . . . . 0.0 113.613 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.81 -18.9 60.9 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 117.963 -1.018 . . . . 0.0 113.448 160.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 74.0 mt -66.06 -13.59 60.26 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.033 1.288 . . . . 0.0 114.281 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -106.35 10.74 31.52 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.931 1.292 . . . . 0.0 112.776 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.0 p -114.46 177.57 4.6 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.222 1.809 . . . . 0.0 113.763 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 52.8 mtp85 57.11 -166.31 0.14 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.813 1.645 . . . . 0.0 111.201 -172.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.454 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 8.7 mp0 -79.69 -33.77 40.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.449 0.7 . . . . 0.0 110.243 161.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 56.2 p -75.75 -66.85 0.73 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.909 1.683 . . . . 0.0 113.944 -162.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -61.68 -41.43 97.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.137 0.881 . . . . 0.0 112.268 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -56.68 -27.99 59.92 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -87.26 -11.2 50.35 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 11.8 p -74.76 -14.85 60.76 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.61 1.55 . . . . 0.0 112.931 173.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -59.49 134.45 57.02 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.773 1.229 . . . . 0.0 111.763 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -109.74 176.99 4.87 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.267 1.427 . . . . 0.0 110.562 168.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.69 113.84 8.18 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.812 -1.18 . . . . 0.0 109.352 168.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -57.57 -31.5 66.2 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -167.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.94 -40.28 88.44 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.481 1.112 . . . . 0.0 112.009 173.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -85.52 -3.12 58.77 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.133 1.773 . . . . 0.0 112.935 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 42.1 t -86.69 -48.84 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.753 1.221 . . . . 0.0 109.971 162.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.6 mt -57.96 -52.01 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.923 1.289 . . . . 0.0 111.512 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.3 -12.89 61.89 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.25 -32.34 10.67 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.148 -0.97 . . . . 0.0 113.371 171.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 57.1 t90 -80.26 -35.65 35.7 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.096 1.759 . . . . 0.0 114.224 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -51.05 -47.76 86.57 Favored Pre-proline 0 CA--C 1.552 1.027 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.82 -25.94 27.81 Favored 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 121.275 1.491 . . . . 0.0 113.688 172.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -76.06 -11.95 60.03 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 117.296 -1.335 . . . . 0.0 114.562 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 48.3 t -59.04 -23.33 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 119.151 0.887 . . . . 0.0 111.114 160.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -104.08 -7.94 19.87 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 177.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.294 0 C-N-CA 125.141 1.376 . . . . 0.0 112.935 -175.927 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 301' ' ' GSH . . . . . 0.446 ' C1 ' ' H ' ' A' ' 73' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.421 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 75.3 mtp . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 117.739 -1.124 . . . . 0.0 109.675 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.22 -174.71 0.11 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.025 1.73 . . . . 0.0 115.094 173.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 84.2 mt -125.22 128.42 48.29 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.131 1.772 . . . . 0.0 110.981 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -119.94 143.26 48.09 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.913 0.885 . . . . 0.0 108.784 158.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.2 pt -129.09 147.85 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.439 1.096 . . . . 0.0 109.966 176.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.3 m -120.14 120.96 37.71 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.348 1.459 . . . . 0.0 109.205 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -133.32 160.38 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.978 1.311 . . . . 0.0 111.781 -168.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.61 118.22 7.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.519 0.728 . . . . 0.0 111.56 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -78.02 151.95 33.28 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.08 0.552 . . . . 0.0 111.599 161.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.73 140.6 58.88 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.161 0.981 . . . . 0.0 113.029 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.5 t -66.25 121.86 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.95 -14.79 18.32 Favored Glycine 0 CA--C 1.538 1.498 0 CA-C-O 118.464 -1.187 . . . . 0.0 115.881 -173.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.26 62.72 62.43 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 119.053 1.426 . . . . 0.0 112.022 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.49 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 72.2 Cg_endo -65.39 -5.48 11.44 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.186 2.591 . . . . 0.0 114.962 -171.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -77.92 -3.18 40.5 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.425 1.89 . . . . 0.0 114.734 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.2 pt -136.13 165.69 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.947 1.299 . . . . 0.0 112.346 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.51 144.77 53.72 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.305 1.042 . . . . 0.0 111.565 171.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.21 -174.53 13.81 Favored Glycine 0 N--CA 1.469 0.857 0 C-N-CA 125.145 1.355 . . . . 0.0 114.489 175.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -62.73 105.29 0.63 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.4 t -163.18 95.07 1.11 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.485 1.514 . . . . 0.0 109.454 159.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.09 -22.97 75.16 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.837 1.691 . . . . 0.0 113.542 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -63.29 -32.72 74.2 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.606 -1.309 . . . . 0.0 113.432 169.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 67.4 m -72.2 -37.12 69.31 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.808 -1.183 . . . . 0.0 112.014 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -63.84 -22.51 66.95 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 117.57 -1.205 . . . . 0.0 112.994 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.463 HH12 ' CG ' ' A' ' 74' ' ' ASP . 64.3 mtp180 -57.98 -43.06 86.3 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.641 1.11 . . . . 0.0 112.644 169.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -80.76 -36.82 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.574 1.15 . . . . 0.0 111.673 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.4 -41.53 94.08 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 122.118 -0.364 . . . . 0.0 111.002 169.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.1 tp -61.15 -52.33 65.32 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.044 0.938 . . . . 0.0 112.604 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.9 p -75.45 -33.71 60.9 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 62.2 mt -73.52 -29.86 62.74 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.159 -0.963 . . . . 0.0 112.919 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -76.29 -34.14 59.08 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 169.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.16 -43.44 82.28 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.5 1.046 . . . . 0.0 112.768 172.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -73.6 1.53 9.91 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.791 -1.099 . . . . 0.0 113.573 166.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 pttt 46.85 22.3 0.19 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 127.952 2.501 . . . . 0.0 114.588 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.3 tt -91.03 131.16 37.88 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 125.325 1.45 . . . . 0.0 109.401 -164.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.56 119.3 6.3 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.462 1.441 . . . . 0.0 111.981 -173.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -129.72 154.12 47.49 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.693 1.597 . . . . 0.0 111.263 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -101.2 120.24 39.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.599 1.16 . . . . 0.0 110.064 176.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.5 t -95.24 112.79 24.45 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.479 0.712 . . . . 0.0 112.402 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -89.84 114.36 26.1 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.023 1.329 . . . . 0.0 110.337 169.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 98.8 mt -73.72 109.03 6.92 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.285 1.034 . . . . 0.0 110.13 166.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.0 mm -99.33 117.66 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.941 0.896 . . . . 0.0 110.33 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -77.16 52.67 0.92 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.51 1.524 . . . . 32.609999999999999 112.731 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.86 0.83 0.07 Allowed 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 120.378 3.473 . . . . 40.049999999999997 120.378 -151.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.65 -41.04 85.24 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 120.217 1.371 . . . . 41.469999999999999 111.467 159.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -99.85 62.7 1.17 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 128.025 2.53 . . . . 47.170000000000002 110.094 166.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.6 pttm -78.78 128.62 76.35 Favored Pre-proline 0 N--CA 1.476 0.845 0 O-C-N 119.907 -1.745 . . . . 41.270000000000003 110.868 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -62.37 154.4 64.15 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.845 2.363 . . . . 40.289999999999999 113.436 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -59.89 -42.13 93.11 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.455 -0.778 . . . . 42.390000000000001 112.928 172.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -65.88 -19.33 65.84 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.926 1.084 . . . . 37.079999999999998 113.926 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -76.07 -29.61 58.04 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.849 -1.157 . . . . 35.880000000000003 112.226 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.0 mt -69.12 -27.79 65.89 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.158 0.89 . . . . 33.609999999999999 112.46 170.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -73.79 -3.77 30.58 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.102 1.361 . . . . 33.789999999999999 113.036 173.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.3 mt -111.26 -43.14 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 126.223 1.809 . . . . 33.159999999999997 110.558 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -116.92 96.11 48.21 Favored Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 125.734 1.613 . . . . 33.579999999999998 110.855 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.17 -24.58 58.75 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.263 1.975 . . . . 37.899999999999999 113.062 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -76.38 -9.33 58.56 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.479 1.512 . . . . 38.990000000000002 113.54 172.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.92 4.32 33.68 Favored Glycine 0 CA--C 1.536 1.347 0 O-C-N 120.31 -1.494 . . . . 35.469999999999999 115.351 -169.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -77.05 152.06 35.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.712 1.605 . . . . 34.490000000000002 112.436 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.2 152.32 45.8 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.021 1.728 . . . . 23.530000000000001 110.723 156.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -66.18 156.03 80.83 Favored 'Cis proline' 0 C--N 1.348 0.51 0 CA-C-O 122.022 0.759 . . . . 22.879999999999999 112.799 -6.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.14 146.16 24.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.233 -1.348 . . . . 0.0 107.836 161.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.9 m -129.07 163.63 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.449 0.7 . . . . 0.0 110.975 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . 27.2 mtpt -120.98 75.66 1.16 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 126.046 1.738 . . . . 0.0 110.0 174.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 86.4 mt -68.48 119.9 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.421 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 1.0 OUTLIER 57.66 33.8 23.69 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -172.375 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.272 23.0 t70 71.65 -0.31 3.21 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 127.455 2.302 . . . . 0.0 114.727 -170.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -107.76 130.22 54.98 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 119.232 -2.168 . . . . 0.0 112.76 -176.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -72.35 146.14 47.29 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -163.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.1 t -144.38 131.13 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 126.374 1.87 . . . . 0.0 109.015 175.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -120.94 163.09 18.78 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.093 1.757 . . . . 0.0 112.806 -174.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . 0.272 50.0 m-20 58.77 122.65 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 128.12 2.568 . . . . 22.16 114.464 -169.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.448 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 77.8 p -65.12 -24.79 67.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 115.522 1.675 . . . . 21.16 115.522 -162.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.463 ' CG ' HH12 ' A' ' 25' ' ' ARG . 38.8 m-20 -69.78 -37.1 76.23 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.065 1.302 . . . . 24.969999999999999 113.217 171.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.5 t -71.7 -39.07 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 121.27 -0.894 . . . . 23.850000000000001 110.669 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.38 -47.95 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.911 0.885 . . . . 23.68 111.0 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.23 -40.44 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.865 0.866 . . . . 22.84 111.117 174.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.65 -48.84 68.7 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 119.266 0.939 . . . . 23.329999999999998 113.531 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.4 mt -72.88 -41.19 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 117.954 0.877 . . . . 23.309999999999999 112.003 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.44 -33.85 76.91 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.853 1.206 . . . . 23.48 112.883 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -91.99 -10.96 37.41 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.287 1.218 . . . . 24.239999999999998 114.287 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -94.84 -40.63 9.63 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.521 1.128 . . . . 39.259999999999998 112.356 167.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -131.44 84.54 2.18 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.683 1.193 . . . . 24.449999999999999 111.611 -163.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -138.72 163.21 48.32 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 125.764 1.626 . . . . 0.0 110.737 165.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.88 -26.38 9.62 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.72 2.28 . . . . 0.0 112.696 172.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -82.93 151.66 64.33 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 124.054 0.942 . . . . 0.0 109.877 161.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -58.2 151.79 57.09 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.293 2.662 . . . . 0.0 117.078 -160.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.44 146.82 51.05 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.432 2.755 . . . . 0.0 112.992 174.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.8 mt -134.05 20.71 3.77 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.141 1.776 . . . . 0.0 112.366 172.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.21 51.82 0.24 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.891 1.676 . . . . 0.0 111.973 169.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.6 p -125.96 72.71 70.26 Favored Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 125.633 1.573 . . . . 0.0 110.016 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.43 117.31 5.07 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.747 2.298 . . . . 0.0 110.369 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -80.22 -170.41 1.0 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.814 3.009 . . . . 0.0 111.401 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -51.71 -33.87 36.3 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.135 1.374 . . . . 0.0 114.253 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -52.76 -30.08 30.81 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.743 1.617 . . . . 0.0 114.371 173.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.75 -29.2 69.97 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.16 -0.963 . . . . 0.0 113.322 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.2 m -71.68 -12.71 61.46 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 99.2 t -114.57 -37.63 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.499 1.52 . . . . 0.0 110.894 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.95 -30.93 76.76 Favored Glycine 0 CA--C 1.533 1.217 0 O-C-N 120.819 -1.176 . . . . 0.0 114.096 172.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 91.6 p -65.59 -22.42 66.68 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -85.14 -40.26 16.95 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.588 1.555 . . . . 0.0 112.036 172.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 81.1 mt -68.84 -36.19 73.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.935 1.294 . . . . 0.0 111.164 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -56.24 -44.34 99.67 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 125.097 1.359 . . . . 0.0 114.589 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -84.78 -31.36 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.525 2.817 . . . . 0.0 114.229 169.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 p -71.12 -26.93 63.23 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 121.148 1.794 . . . . 0.0 113.549 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -60.99 -38.93 87.72 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.859 -1.15 . . . . 0.0 112.521 162.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 41.3 t -69.03 -33.75 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 120.989 -1.07 . . . . 0.0 111.737 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -63.37 -46.88 84.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.087 0.858 . . . . 0.0 111.552 168.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -63.25 -40.55 97.74 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.499 1.12 . . . . 0.0 112.689 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.7 mt -76.96 -1.35 28.22 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.425 1.49 . . . . 0.0 114.708 171.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -135.12 40.31 2.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.035 1.734 . . . . 0.0 111.405 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 p -73.73 54.28 0.48 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.809 2.444 . . . . 0.0 115.283 -162.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 97.6 mttt -61.63 -34.54 75.84 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.607 1.563 . . . . 0.0 111.932 161.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 17.5 t0 -88.5 111.77 45.86 Favored Pre-proline 0 CA--C 1.553 1.077 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 157.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 114' ' ' ASP . 51.2 Cg_exo -53.27 150.49 25.47 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.126 2.55 . . . . 0.0 117.184 -154.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -66.2 -47.85 72.57 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.379 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -62.56 -26.82 68.77 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.8 -38.42 13.93 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 121.156 -0.965 . . . . 0.0 113.387 171.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.6 m -68.02 -34.85 77.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.579 1.151 . . . . 0.0 112.987 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -61.17 -38.12 85.36 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.753 1.621 . . . . 0.0 112.966 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -63.76 -44.87 92.16 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.262 0.625 . . . . 0.0 111.668 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.45 -34.27 76.85 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.75 -40.56 88.34 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.099 0.559 . . . . 0.0 112.225 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.4 mt -64.9 -35.1 80.06 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.888 0.767 . . . . 0.0 112.837 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -72.4 -37.7 68.63 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.472 1.033 . . . . 0.0 113.0 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -71.62 -33.94 69.4 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.928 -1.108 . . . . 0.0 112.868 170.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.1 mt -65.7 -34.98 79.46 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.636 -1.29 . . . . 0.0 112.347 170.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -65.89 -41.47 91.51 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.24 1.382 . . . . 0.0 111.952 170.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.56 -34.24 76.55 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.214 0.606 . . . . 0.0 112.124 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.66 -58.15 3.58 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.167 0.987 . . . . 0.0 111.584 170.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.76 -34.54 78.41 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.448 1.499 . . . . 0.0 114.022 -169.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.9 -38.68 89.76 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.045 0.831 . . . . 0.0 113.301 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -89.09 -25.87 21.67 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.714 0.806 . . . . 0.0 112.638 176.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.51 -32.35 73.65 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 120.562 -1.337 . . . . 0.0 112.923 172.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -67.7 -10.18 50.13 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 172.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 26.4 t -86.97 -31.81 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.129 0.972 . . . . 0.0 111.874 168.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -95.71 -30.21 13.86 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -173.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 102.39 -109.86 3.64 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 117.425 -1.764 . . . . 0.0 115.139 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -79.69 -26.73 4.49 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.682 2.921 . . . . 0.0 117.385 -146.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -130.85 163.08 28.2 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.159 1.345 . . . . 0.0 112.441 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.62 -8.36 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -168.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -95.92 -2.88 46.29 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 159.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 118.55 -118.39 4.01 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.653 1.115 . . . . 0.0 113.672 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -70.9 -23.91 62.37 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.651 1.18 . . . . 0.0 113.394 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -141.66 171.1 14.53 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.433 1.893 . . . . 0.0 111.059 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.8 mt -70.8 138.57 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.669 1.187 . . . . 0.0 109.431 168.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.2 p -140.09 -171.63 3.23 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 121.284 -0.885 . . . . 0.0 111.46 164.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.01 -18.88 1.56 Allowed 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 171.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.6 t -72.87 -42.92 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 O-C-N 120.701 -1.249 . . . . 0.0 112.325 172.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -62.09 -43.85 97.94 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.524 1.129 . . . . 0.0 111.993 168.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.3 mt -64.34 -10.82 26.79 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.0 m -97.97 -45.02 6.43 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.512 1.125 . . . . 0.0 112.308 173.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.22 -36.15 12.15 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.67 -48.22 97.6 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -172.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -72.14 -25.22 19.33 Favored 'Trans proline' 0 C--N 1.351 0.678 0 CA-C-N 120.875 1.348 . . . . 0.0 113.371 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -74.05 -30.11 62.24 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 117.423 -1.275 . . . . 0.0 112.429 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 57.1 mt -67.94 -38.2 82.54 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.132 0.878 . . . . 0.0 112.832 167.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -63.78 -52.13 61.71 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.079 0.854 . . . . 0.0 112.253 172.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -62.65 -26.62 68.73 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.945 0.898 . . . . 0.0 112.358 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.2 tp -71.82 -52.66 16.37 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.938 -1.101 . . . . 0.0 113.184 170.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -58.56 -34.22 70.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.321 0.964 . . . . 0.0 112.656 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 97.4 t -82.87 -62.12 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.184 0.994 . . . . 0.0 112.763 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.55 -35.01 25.1 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -165.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.92 -35.85 59.61 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.742 -0.599 . . . . 0.0 111.397 169.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.16 -25.27 53.81 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.266 0.936 . . . . 0.0 115.234 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -60.26 -31.89 70.65 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.166 1.386 . . . . 0.0 114.675 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -125.2 -20.8 4.76 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -147.08 84.0 1.58 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.997 2.119 . . . . 0.0 107.119 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -66.91 85.24 0.12 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.389 0.676 . . . . 0.0 110.186 171.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 34.7 t90 -83.82 113.15 45.62 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.084 1.354 . . . . 0.0 110.997 -168.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.42 118.3 5.6 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.82 1.68 . . . . 0.0 110.545 -176.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 47.0 mm -67.63 113.82 16.38 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 159.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -66.33 155.45 69.92 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.723 1.615 . . . . 0.0 111.094 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.14 -22.56 66.94 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.378 1.071 . . . . 0.0 113.765 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -67.07 -22.72 65.83 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.479 1.112 . . . . 0.0 113.953 170.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 67.5 mt -85.71 55.09 3.36 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.322 1.449 . . . . 0.0 110.742 165.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.2 m -67.69 -27.03 66.49 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.499 1.119 . . . . 0.0 112.932 -161.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 33.9 t60 -73.03 -52.44 14.38 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.855 0.752 . . . . 0.0 110.338 168.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 79.0 t -58.78 -41.14 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.344 0.975 . . . . 0.0 112.226 -173.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 62.7 tp -60.46 -42.1 95.5 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.574 1.15 . . . . 0.0 112.831 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -76.74 -36.96 56.78 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.514 0.726 . . . . 0.0 112.848 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -63.39 -36.47 83.82 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.941 1.296 . . . . 0.0 112.629 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.85 -34.59 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.457 -0.777 . . . . 0.0 111.789 171.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -82.9 -14.6 53.89 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.432 -1.418 . . . . 0.0 113.515 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 23.3 mt -71.54 -18.49 62.26 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.816 -1.177 . . . . 0.0 113.618 162.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 60.4 mt -65.9 -20.54 66.26 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.759 1.163 . . . . 0.0 113.347 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -93.98 11.11 30.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.955 1.302 . . . . 0.0 113.058 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 10.5 p -119.94 174.96 6.14 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.913 2.085 . . . . 0.0 112.333 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? 60.66 177.12 0.1 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.473 1.509 . . . . 0.0 111.64 -170.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.481 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 0.5 OUTLIER -70.98 -41.71 70.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.783 153.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 85.6 p -54.75 -68.64 0.17 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.153 1.381 . . . . 0.0 114.682 -170.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -70.66 -43.4 69.21 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.059 -1.026 . . . . 0.0 112.247 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -59.79 -32.76 70.91 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -172.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -81.0 -7.76 59.63 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.4 p -77.89 -13.15 59.98 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.067 1.303 . . . . 0.0 113.426 169.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -64.43 86.21 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.883 1.673 . . . . 0.0 112.96 -167.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.48 137.95 57.77 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.343 1.057 . . . . 0.0 110.21 164.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.24 128.04 35.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.618 0.767 . . . . 0.0 112.022 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -59.61 -34.66 73.04 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -162.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -65.23 -37.96 88.89 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.981 -1.075 . . . . 0.0 112.453 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -82.24 -7.52 59.63 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 171.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.58 -47.45 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 118.706 0.685 . . . . 0.0 110.05 163.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 65.0 mt -64.52 -52.59 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.889 1.276 . . . . 0.0 111.742 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.9 -11.53 60.68 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.24 -34.15 8.95 Favored Glycine 0 CA--C 1.535 1.304 0 O-C-N 120.942 -1.099 . . . . 0.0 113.36 168.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -75.6 -35.82 60.46 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.064 1.746 . . . . 0.0 113.524 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -51.51 -51.7 66.93 Favored Pre-proline 0 N--CA 1.477 0.899 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -174.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.39 -24.41 43.06 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 CA-C-N 121.476 1.563 . . . . 0.0 113.451 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -74.96 -8.25 55.94 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.412 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 60.2 t -60.59 -27.06 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 120.064 1.302 . . . . 0.0 110.624 160.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -103.2 -34.48 8.81 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 116.656 -1.64 . . . . 0.0 115.1 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.258 0 O-C-N 125.234 1.584 . . . . 0.0 113.015 179.292 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 301' ' ' GSH . . . . . 0.448 ' C1 ' ' H ' ' A' ' 73' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.583 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 88.1 mtp . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 117.799 -1.096 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.62 -178.25 0.16 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.886 1.675 . . . . 0.0 115.01 176.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.1 mt -105.46 138.2 42.04 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.81 1.644 . . . . 0.0 112.683 -169.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -125.93 143.99 50.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.959 1.304 . . . . 0.0 109.456 157.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.4 pt -129.0 137.18 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.136 0.975 . . . . 0.0 110.287 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.8 m -109.68 123.97 50.4 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.555 1.142 . . . . 0.0 109.473 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -136.5 162.0 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.156 1.382 . . . . 0.0 111.311 -166.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -64.0 121.31 13.8 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.14 -0.975 . . . . 0.0 111.746 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.61 143.18 38.45 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.019 0.527 . . . . 0.0 111.035 157.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.28 138.01 58.35 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.648 0.737 . . . . 0.0 111.685 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -68.91 134.92 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.85 -32.75 1.69 Allowed Glycine 0 CA--C 1.537 1.427 0 CA-C-O 118.821 -0.989 . . . . 0.0 114.952 -172.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.6 60.67 19.75 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.839 1.255 . . . . 0.0 113.151 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.22 -3.95 9.59 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.976 2.451 . . . . 0.0 115.676 -171.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -73.23 -8.1 54.35 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 170.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.0 pt -131.16 163.63 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.643 1.177 . . . . 0.0 112.513 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.3 mt -63.41 138.68 58.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.14 0.976 . . . . 0.0 111.541 172.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.99 -168.19 13.47 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.034 1.302 . . . . 0.0 114.118 173.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -60.59 103.85 0.29 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 174.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.6 t -156.81 102.9 1.95 Allowed Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.149 141.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.54 -20.9 60.41 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.716 2.278 . . . . 0.0 112.862 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -66.22 -29.86 70.2 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 120.666 -1.271 . . . . 0.0 113.534 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 88.0 m -70.43 -36.64 74.11 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.536 -1.352 . . . . 0.0 112.076 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -67.68 -21.69 65.32 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 118.119 -0.944 . . . . 0.0 112.307 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.525 HH12 ' CG ' ' A' ' 74' ' ' ASP . 64.6 mtp180 -58.76 -45.07 90.6 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.359 1.064 . . . . 0.0 112.579 166.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -73.55 -43.01 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.557 1.143 . . . . 0.0 111.045 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.6 mt -57.66 -44.19 85.51 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.743 0.417 . . . . 0.0 111.54 172.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.4 tp -60.7 -48.42 81.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.106 0.962 . . . . 0.0 112.623 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.7 -36.06 67.77 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -174.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.7 mt -73.88 -41.45 62.16 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.323 0.51 . . . . 0.0 111.493 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -77.91 -14.43 59.55 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 176.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -76.55 -46.91 24.4 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.206 -1.559 . . . . 0.0 111.578 164.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -74.82 -12.81 60.47 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm 64.88 9.51 5.41 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 127.467 2.307 . . . . 0.0 114.886 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.3 tp -67.24 129.73 93.75 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.595 1.158 . . . . 0.0 110.481 175.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.39 147.95 33.16 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.658 2.239 . . . . 0.0 112.775 -174.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -147.23 151.48 36.76 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.316 1.446 . . . . 0.0 111.071 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -80.25 147.41 31.21 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.551 -0.718 . . . . 0.0 109.484 159.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -127.42 116.53 20.59 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.646 0.778 . . . . 0.0 111.24 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -104.05 110.73 23.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.668 1.587 . . . . 0.0 109.667 -175.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -74.0 106.48 5.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.579 1.152 . . . . 0.0 110.256 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 mm -95.14 116.06 35.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.791 0.837 . . . . 0.0 110.54 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -75.99 49.87 0.57 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.02 1.728 . . . . 32.609999999999999 112.853 174.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pp -60.4 3.07 0.08 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 120.532 3.53 . . . . 40.049999999999997 120.532 -148.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.22 -36.01 70.66 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 120.236 1.38 . . . . 41.469999999999999 111.787 158.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -101.98 67.46 1.08 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.043 2.137 . . . . 47.170000000000002 109.327 163.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -80.8 119.5 76.32 Favored Pre-proline 0 N--CA 1.474 0.754 0 O-C-N 119.603 -1.936 . . . . 41.270000000000003 111.636 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -62.92 154.8 64.29 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.656 2.237 . . . . 40.289999999999999 114.397 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -63.32 -42.07 98.96 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.991 0.916 . . . . 42.390000000000001 113.217 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 33.2 p-90 -64.25 -23.81 67.44 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.054 -1.029 . . . . 37.079999999999998 113.601 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -81.97 -31.62 31.07 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.252 -0.905 . . . . 35.880000000000003 112.462 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 mt -69.03 -26.9 65.23 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.198 0.908 . . . . 33.609999999999999 112.699 170.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -68.96 -15.19 63.42 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.373 1.069 . . . . 33.789999999999999 113.485 168.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.0 mt -99.31 -44.97 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.267 1.427 . . . . 33.159999999999997 110.602 172.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.4 t -112.77 100.17 50.0 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 125.907 1.683 . . . . 33.579999999999998 110.543 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.85 -19.23 46.9 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.209 1.939 . . . . 37.899999999999999 113.968 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -85.53 -9.21 57.71 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.267 -0.895 . . . . 38.990000000000002 113.279 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.66 19.23 62.52 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 120.67 -1.269 . . . . 35.469999999999999 114.645 -171.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -85.45 155.48 21.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.118 1.767 . . . . 34.490000000000002 111.509 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.7 m -110.89 154.52 43.31 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.171 1.788 . . . . 23.530000000000001 110.134 156.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -64.89 154.94 76.39 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 CA-C-O 122.019 0.758 . . . . 22.879999999999999 112.824 -9.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.43 147.45 22.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.013 -1.449 . . . . 0.0 107.363 156.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.15 165.71 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.649 -0.657 . . . . 0.0 110.373 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -122.79 97.6 5.52 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.441 1.497 . . . . 0.0 108.808 170.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 82.3 mt -86.82 121.3 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.137 0.975 . . . . 0.0 108.922 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.583 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER 52.67 38.0 24.99 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.034 0.934 . . . . 0.0 112.834 -164.623 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 65.64 17.08 10.78 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.129 2.171 . . . . 0.0 116.319 -172.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -117.39 128.23 54.82 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 119.981 -1.699 . . . . 0.0 111.639 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -67.97 145.8 54.18 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -164.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -144.13 129.44 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.973 2.109 . . . . 0.0 108.679 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.69 165.55 12.69 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.672 1.589 . . . . 0.0 112.622 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.0 t0 65.54 115.65 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 128.079 2.552 . . . . 22.16 114.269 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.433 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 53.2 p -61.75 -25.57 67.54 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.325 1.602 . . . . 21.16 115.325 -165.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.525 ' CG ' HH12 ' A' ' 25' ' ' ARG . 31.8 m-20 -71.93 -35.77 69.75 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.876 1.216 . . . . 24.969999999999999 113.415 170.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.5 t -72.57 -39.01 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 121.432 -0.792 . . . . 23.850000000000001 111.114 172.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.18 -48.66 87.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.332 1.053 . . . . 23.68 110.914 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.43 -37.38 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.176 0.991 . . . . 22.84 111.467 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.92 -13.16 51.57 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.525 1.059 . . . . 23.329999999999998 115.585 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.6 mt -102.39 -48.46 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 118.925 1.362 . . . . 23.309999999999999 111.275 167.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.9 mt -62.52 -27.45 69.16 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.305 1.224 . . . . 23.48 114.305 -171.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -91.4 -0.3 57.62 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.785 1.032 . . . . 24.239999999999998 113.785 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -129.13 -25.51 2.73 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.544 1.138 . . . . 39.259999999999998 113.545 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -126.68 73.6 1.41 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.946 1.698 . . . . 24.449999999999999 111.923 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -141.32 165.33 29.59 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 126.112 1.765 . . . . 0.0 109.806 169.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.09 -26.45 18.14 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.333 2.022 . . . . 0.0 113.7 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.5 pm0 -75.46 160.89 78.57 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.458 1.103 . . . . 0.0 112.716 168.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.84 145.09 99.52 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.524 2.149 . . . . 0.0 113.915 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.78 145.19 62.07 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.162 2.575 . . . . 0.0 113.844 -174.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.1 mt -108.87 6.75 25.68 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.211 1.804 . . . . 0.0 112.926 169.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.4 50.57 0.17 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.85 2.06 . . . . 0.0 113.536 173.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 74.7 p -120.16 75.29 22.48 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 125.039 1.336 . . . . 0.0 110.214 170.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.09 117.93 5.27 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.346 2.031 . . . . 0.0 109.913 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.28 -173.26 1.71 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.661 2.907 . . . . 0.0 111.935 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.1 mp0 -51.13 -32.14 21.8 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.393 2.277 . . . . 0.0 113.632 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -54.79 -25.81 30.59 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.314 1.446 . . . . 0.0 114.109 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -29.35 70.58 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.742 -1.224 . . . . 0.0 113.363 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.1 p -67.99 -17.85 64.55 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.8 t -108.91 -41.57 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.581 1.552 . . . . 0.0 110.731 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.63 -30.76 77.68 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.844 1.211 . . . . 0.0 114.124 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.8 p -67.29 -19.0 65.43 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 171.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -87.51 -38.6 15.89 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.077 1.351 . . . . 0.0 112.168 169.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 69.1 mt -68.05 -37.13 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.558 1.143 . . . . 0.0 110.877 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -56.69 -45.79 99.9 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.535 1.534 . . . . 0.0 115.058 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -81.62 -32.78 0.78 Allowed 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 123.148 2.565 . . . . 0.0 113.69 170.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 56.9 p -73.18 -24.99 60.61 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 120.523 1.511 . . . . 0.0 114.127 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -58.83 -42.14 88.56 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.858 -1.151 . . . . 0.0 112.204 160.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.6 t -72.6 -31.53 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.467 -0.77 . . . . 0.0 111.862 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.401 ' HZ1' ' CG ' ' A' ' 114' ' ' ASP . 62.3 tttt -62.86 -47.24 84.24 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.004 0.82 . . . . 0.0 111.348 169.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -64.65 -39.82 94.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.157 0.983 . . . . 0.0 112.313 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 50.8 mt -68.42 -0.35 4.84 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.228 1.411 . . . . 0.0 114.736 168.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -142.56 36.58 1.47 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.116 1.766 . . . . 0.0 112.266 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.06 62.3 0.3 Allowed 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -166.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 90.8 mttt -63.75 -33.84 76.55 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.557 1.543 . . . . 0.0 110.957 158.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.401 ' CG ' ' HZ1' ' A' ' 108' ' ' LYS . 14.3 t0 -86.55 117.32 68.49 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 125.67 1.588 . . . . 0.0 107.941 158.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -51.95 149.65 20.06 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.421 2.747 . . . . 0.0 117.316 -159.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -70.39 -45.77 65.34 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.824 -172.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -68.3 -26.11 65.48 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.027 -1.671 . . . . 0.0 114.333 -172.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.62 -33.54 42.51 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 120.643 -1.285 . . . . 0.0 113.338 169.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 89.6 m -70.4 -35.37 73.42 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.422 1.089 . . . . 0.0 112.355 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -64.07 -39.85 94.99 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.546 1.539 . . . . 0.0 112.438 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -64.06 -46.7 83.2 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.517 0.599 . . . . 0.0 112.102 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.87 -36.25 83.3 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.4 tp -68.34 -42.34 79.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.25 1.02 . . . . 0.0 112.331 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 41.9 mt -66.66 -37.66 85.26 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.798 0.839 . . . . 0.0 113.253 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -69.99 -36.32 75.08 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.762 1.165 . . . . 0.0 112.786 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -72.79 -33.96 66.61 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 120.799 -1.188 . . . . 0.0 112.51 170.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.2 mt -63.43 -35.14 79.44 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.2 -1.563 . . . . 0.0 112.512 169.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -65.88 -40.38 91.53 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.31 1.414 . . . . 0.0 111.917 171.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.14 -35.92 82.36 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 118.435 0.562 . . . . 0.0 112.314 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.2 tp -69.57 -56.92 5.98 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.373 1.069 . . . . 0.0 111.468 170.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -66.41 -35.47 80.39 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.191 1.396 . . . . 0.0 114.028 -171.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.83 -34.81 79.53 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.207 0.908 . . . . 0.0 113.513 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -89.34 -30.47 18.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.446 0.699 . . . . 0.0 112.874 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.46 -33.77 76.29 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.807 -1.183 . . . . 0.0 113.449 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -64.88 -8.0 13.66 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 172.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.0 t -99.58 -35.16 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.915 1.286 . . . . 0.0 112.221 168.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -86.46 -28.41 23.5 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -173.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.63 -157.54 32.85 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 118.198 -1.335 . . . . 0.0 113.653 -173.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.8 -9.94 19.8 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.371 3.38 . . . . 0.0 117.473 -119.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -110.98 161.39 15.91 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 119.643 1.11 . . . . 0.0 111.323 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.08 -10.79 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 O-C-N 120.427 -1.421 . . . . 0.0 113.162 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -99.19 -2.04 37.78 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 161.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 107.25 -110.43 3.23 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 119.976 1.262 . . . . 0.0 113.652 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -73.49 -26.3 60.84 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -167.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -142.03 167.05 23.04 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.352 1.861 . . . . 0.0 111.163 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 26.2 mt -65.42 130.19 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.161 0.584 . . . . 0.0 109.997 163.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.8 p -135.07 -171.59 2.84 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.178 0.991 . . . . 0.0 110.866 166.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.96 -19.59 2.74 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.0 t -73.71 -43.35 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.877 1.217 . . . . 0.0 112.309 173.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.4 -46.02 91.91 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.994 -1.066 . . . . 0.0 112.113 168.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.3 mt -62.44 -17.9 60.45 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.334 0.654 . . . . 0.0 112.421 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 51.4 m -86.61 -50.92 6.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.931 0.892 . . . . 0.0 112.335 171.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.9 mt -90.54 -33.6 15.86 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -167.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.88 -49.6 92.82 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.86 -21.87 24.17 Favored 'Trans proline' 0 C--N 1.351 0.669 0 CA-C-N 121.144 1.444 . . . . 0.0 113.14 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -77.18 -28.66 54.09 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 117.584 -1.198 . . . . 0.0 112.549 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 53.7 mt -70.17 -39.22 75.42 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.758 0.823 . . . . 0.0 112.899 165.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -60.23 -46.75 88.69 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.885 0.766 . . . . 0.0 111.732 171.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -64.78 -23.71 67.33 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.951 0.9 . . . . 0.0 113.353 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 12.1 tp -80.05 -45.09 18.93 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.997 -1.064 . . . . 0.0 112.659 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.53 -37.25 86.9 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.177 0.899 . . . . 0.0 111.596 173.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.2 t -80.71 -63.92 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.51 -50.88 8.34 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.408 -0.808 . . . . 0.0 112.136 -162.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.35 -35.44 77.43 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.671 0.388 . . . . 0.0 111.382 174.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.16 -25.28 46.76 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.063 1.316 . . . . 0.0 115.7 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -65.34 -25.81 67.76 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -126.93 -18.87 4.56 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 21.8 tptt -147.76 80.55 1.49 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.895 2.078 . . . . 0.0 107.595 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -64.19 89.27 0.06 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.885 0.874 . . . . 0.0 110.669 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 33.3 t90 -88.29 117.37 68.31 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.073 0.949 . . . . 0.0 112.208 -162.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -73.58 112.53 3.55 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.199 1.933 . . . . 0.0 110.649 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 97.5 mt -71.77 108.34 3.92 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 159.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -68.55 161.01 46.92 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.415 1.41 . . . . 0.0 112.453 -166.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.32 -28.11 66.5 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.716 1.606 . . . . 0.0 114.063 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -68.16 -22.59 64.84 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.219 1.408 . . . . 0.0 114.086 173.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 71.0 mt -84.67 52.11 2.3 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.483 1.513 . . . . 0.0 110.36 165.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.0 m -63.27 -30.11 71.31 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.472 1.109 . . . . 0.0 112.601 -160.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 66.8 t-80 -77.24 -48.3 17.89 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.542 0.61 . . . . 0.0 111.534 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 66.0 t -60.36 -40.08 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 118.683 0.674 . . . . 0.0 111.618 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.0 tp -64.03 -43.24 96.16 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.338 1.055 . . . . 0.0 113.108 176.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -70.82 -32.99 70.22 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.372 -0.83 . . . . 0.0 112.838 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -63.31 -27.4 69.3 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.333 1.053 . . . . 0.0 112.843 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 29.2 mm -56.11 -34.82 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 120.868 -1.145 . . . . 0.0 111.935 169.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -90.91 -6.3 54.33 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.925 -1.109 . . . . 0.0 113.617 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 74.3 mt -73.43 -22.87 60.1 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 117.617 -1.182 . . . . 0.0 113.461 157.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 66.3 mt -62.57 -23.89 67.25 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.723 1.147 . . . . 0.0 113.283 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -96.11 9.01 42.27 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.514 1.126 . . . . 0.0 113.267 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.9 p -121.22 177.26 5.23 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.705 2.002 . . . . 0.0 113.417 -168.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.5 mtp85 54.88 -169.15 0.07 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.218 1.407 . . . . 0.0 110.276 -166.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.13 -34.22 37.94 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.05 -1.031 . . . . 0.0 110.17 159.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 77.6 p -72.45 -56.32 5.6 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.363 1.465 . . . . 0.0 114.115 -161.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -68.52 -44.56 74.38 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.984 0.811 . . . . 0.0 112.044 171.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -54.69 -34.23 62.03 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.69 1.196 . . . . 0.0 113.88 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -79.68 -14.85 58.47 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.5 p -79.88 -2.6 44.33 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.621 1.555 . . . . 0.0 113.93 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -68.91 75.93 0.31 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.235 1.814 . . . . 0.0 112.358 -173.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -59.34 132.19 53.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.263 0.625 . . . . 0.0 109.523 163.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.67 130.73 47.96 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.094 0.558 . . . . 0.0 112.024 -165.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -59.63 -39.72 85.26 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -160.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -62.31 -38.69 90.37 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.083 -1.01 . . . . 0.0 112.277 174.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -84.66 -5.93 59.34 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.308 1.443 . . . . 0.0 113.343 177.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 75.4 t -82.61 -46.8 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.982 0.913 . . . . 0.0 110.215 161.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.5 mt -61.89 -51.37 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.572 1.149 . . . . 0.0 111.845 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.73 -15.16 63.1 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.216 1.006 . . . . 0.0 113.693 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.47 -37.5 14.29 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 120.899 -1.125 . . . . 0.0 112.895 169.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 17.5 t90 -77.1 -35.49 56.4 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.186 1.794 . . . . 0.0 114.015 -174.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -49.56 -52.42 50.39 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.89 -24.5 39.9 Favored 'Trans proline' 0 C--N 1.353 0.799 0 CA-C-N 121.452 1.554 . . . . 0.0 113.461 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -78.29 -7.21 56.95 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 117.193 -1.384 . . . . 0.0 114.316 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.429 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 58.3 t -63.0 -30.83 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 120.037 1.29 . . . . 0.0 110.315 159.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -94.9 -34.66 12.34 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 115.745 1.758 . . . . 0.0 115.745 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 CA-C-O 117.604 -1.189 . . . . 0.0 113.163 172.516 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 301' ' ' GSH . . . . . 0.433 ' C1 ' ' H ' ' A' ' 73' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.576 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 81.4 mtp . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.647 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.57 178.4 0.16 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.116 1.766 . . . . 0.0 114.609 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 61.9 mt -101.59 142.15 33.39 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.807 1.243 . . . . 0.0 113.26 -170.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -129.04 145.89 51.15 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.617 1.567 . . . . 0.0 109.02 157.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.5 pt -130.65 136.84 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.604 1.162 . . . . 0.0 109.647 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.7 m -111.73 119.27 38.07 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.777 1.231 . . . . 0.0 109.085 173.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.3 m -134.87 162.9 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.255 1.422 . . . . 0.0 111.229 -166.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -61.5 120.99 11.6 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.374 -0.829 . . . . 0.0 112.108 -175.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -79.34 149.61 31.68 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.049 0.54 . . . . 0.0 111.603 159.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.63 134.28 52.94 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.014 0.911 . . . . 0.0 112.111 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.7 t -67.36 126.27 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 173.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.54 -14.62 22.97 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-O 118.587 -1.118 . . . . 0.0 115.605 -172.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.88 61.65 29.85 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 119.161 1.48 . . . . 0.0 112.13 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.418 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 57.9 Cg_endo -65.47 -6.89 14.53 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.966 2.444 . . . . 0.0 115.795 -167.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -80.9 -1.21 42.51 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.9 pt -131.83 164.97 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.731 1.212 . . . . 0.0 112.114 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.94 143.69 57.46 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.239 1.016 . . . . 0.0 111.409 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.9 -173.48 13.48 Favored Glycine 0 N--CA 1.471 0.991 0 C-N-CA 125.176 1.37 . . . . 0.0 113.905 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -60.55 106.5 0.56 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.6 t -165.07 97.86 0.84 Allowed Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.776 157.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -62.92 -21.09 72.93 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.244 1.963 . . . . 0.0 113.041 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -66.68 -29.66 69.72 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 120.655 -1.278 . . . . 0.0 113.59 171.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 98.8 m -71.47 -37.76 71.31 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.578 -1.326 . . . . 0.0 112.179 171.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.0 -24.29 67.85 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 117.95 -1.024 . . . . 0.0 112.875 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.483 HH12 ' CG ' ' A' ' 74' ' ' ASP . 53.5 mtp180 -57.78 -46.97 83.84 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.46 1.027 . . . . 0.0 112.389 170.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.5 t -74.67 -40.6 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.042 1.337 . . . . 0.0 111.31 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.4 mt -61.38 -42.73 99.19 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.251 0.621 . . . . 0.0 111.545 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.1 tp -61.68 -49.12 77.77 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.076 0.95 . . . . 0.0 112.083 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.75 -43.2 69.31 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -174.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.66 -38.92 84.43 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.571 -0.706 . . . . 0.0 112.46 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -80.17 -20.09 45.63 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -69.79 -48.93 57.35 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.798 -1.189 . . . . 0.0 110.641 166.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -70.26 -9.61 56.47 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.46 1.904 . . . . 0.0 114.23 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm 61.85 18.92 10.2 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.48 1.912 . . . . 0.0 115.01 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -75.25 131.59 77.87 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 123.941 0.896 . . . . 0.0 109.613 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -74.66 143.71 30.65 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.662 2.242 . . . . 0.0 112.496 174.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -146.11 151.52 37.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.849 1.66 . . . . 0.0 110.072 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -78.66 130.59 36.04 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.318 -0.863 . . . . 0.0 109.196 163.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 t -111.92 108.64 18.07 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.535 0.734 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -100.79 112.46 24.87 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.728 1.211 . . . . 0.0 109.966 -177.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.13 112.13 13.47 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.156 0.982 . . . . 0.0 110.263 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.4 mm -102.29 116.04 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.321 1.048 . . . . 0.0 110.4 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -77.15 57.7 1.46 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.163 1.385 . . . . 32.609999999999999 111.977 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.14 4.59 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 120.083 3.364 . . . . 40.049999999999997 120.083 -154.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -69.3 -46.46 56.92 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 120.905 1.684 . . . . 41.469999999999999 110.871 156.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -93.03 63.02 3.67 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.214 2.606 . . . . 47.170000000000002 110.629 168.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 pttm -79.78 119.01 75.38 Favored Pre-proline 0 N--CA 1.476 0.827 0 O-C-N 119.921 -1.737 . . . . 41.270000000000003 111.386 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -64.13 155.7 63.4 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.699 2.266 . . . . 40.289999999999999 114.182 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tp60 -62.27 -39.48 93.05 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.672 0.99 . . . . 42.390000000000001 113.672 174.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -64.73 -23.95 67.41 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.069 0.766 . . . . 37.079999999999998 113.069 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -83.27 -32.13 26.57 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.655 0.782 . . . . 35.880000000000003 112.536 172.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.2 mt -67.26 -26.47 66.58 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.159 0.89 . . . . 33.609999999999999 112.672 170.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -71.63 -8.11 52.03 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.883 1.273 . . . . 33.789999999999999 113.858 168.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.7 mt -106.46 -44.65 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.597 1.559 . . . . 33.159999999999997 110.603 171.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.6 t -112.25 98.79 44.35 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 125.792 1.637 . . . . 33.579999999999998 110.956 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.49 -18.18 43.53 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.364 2.043 . . . . 37.899999999999999 113.408 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -83.75 -8.71 59.19 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.727 1.01 . . . . 38.990000000000002 113.727 170.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.93 8.57 49.54 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 120.87 -1.144 . . . . 35.469999999999999 115.067 -169.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -84.71 157.8 20.97 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.267 1.427 . . . . 34.490000000000002 112.491 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.2 m -113.58 156.22 43.78 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 126.383 1.873 . . . . 23.530000000000001 110.592 160.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -66.12 156.81 80.17 Favored 'Cis proline' 0 C--N 1.348 0.501 0 CA-C-O 122.015 0.756 . . . . 22.879999999999999 112.403 -10.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.4 p -141.05 147.26 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 159.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.11 163.71 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 121.43 -0.794 . . . . 0.0 110.611 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 mtpt -121.27 92.1 3.67 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.181 1.393 . . . . 0.0 109.054 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.3 mt -82.09 119.67 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.688 0.795 . . . . 0.0 108.907 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.576 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 0.9 OUTLIER 52.75 38.82 27.41 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 122.284 1.04 . . . . 0.0 112.675 -165.536 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.3 t70 66.11 12.7 8.68 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.063 2.145 . . . . 0.0 116.476 -172.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -110.84 127.8 55.55 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 119.8 -1.813 . . . . 0.0 111.651 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -66.69 144.66 56.23 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -167.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.7 t -143.25 128.35 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.625 1.97 . . . . 0.0 108.593 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -112.69 166.5 11.29 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.746 1.618 . . . . 0.0 112.24 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.0 t0 65.11 113.62 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.821 2.449 . . . . 22.16 114.067 -175.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.443 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 39.7 p -62.74 -21.65 65.97 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 115.274 1.583 . . . . 21.16 115.274 -166.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.483 ' CG ' HH12 ' A' ' 25' ' ' ARG . 30.0 m-20 -71.46 -38.17 71.31 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.843 1.201 . . . . 24.969999999999999 113.056 169.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -70.49 -40.07 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.16 -0.962 . . . . 23.850000000000001 110.842 172.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.58 -48.62 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.955 0.902 . . . . 23.68 111.15 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.74 -38.54 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.611 0.764 . . . . 22.84 111.547 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.37 -39.95 95.42 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.531 -0.594 . . . . 23.329999999999998 113.596 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.7 mt -76.87 -48.22 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 118.379 1.09 . . . . 23.309999999999999 111.638 174.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.7 mt -62.32 -33.32 74.46 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.747 1.158 . . . . 23.48 113.399 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -92.66 -3.18 55.33 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 115.229 1.566 . . . . 24.239999999999998 115.229 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -108.56 -35.43 6.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.913 1.285 . . . . 39.259999999999998 112.489 169.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -125.47 70.98 1.19 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.513 1.525 . . . . 24.449999999999999 111.628 -167.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -136.99 167.59 20.4 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.641 1.976 . . . . 0.0 109.373 168.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.38 -33.44 38.16 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.677 1.585 . . . . 0.0 112.336 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -75.15 151.99 86.09 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.282 1.033 . . . . 0.0 111.976 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.2 144.62 29.11 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.543 2.829 . . . . 0.0 115.215 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.62 136.92 34.62 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.562 2.175 . . . . 0.0 112.249 -174.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.3 mt -108.55 8.18 27.09 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.934 1.294 . . . . 0.0 111.944 167.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.55 46.33 0.07 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.42 2.288 . . . . 0.0 112.696 163.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.1 p -123.9 67.52 42.16 Favored Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 125.452 1.501 . . . . 0.0 109.8 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.86 119.61 6.65 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.232 1.955 . . . . 0.0 109.951 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.97 -173.88 1.84 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.213 2.609 . . . . 0.0 111.775 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.3 mp0 -51.2 -33.89 29.47 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.65 2.38 . . . . 0.0 113.333 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -52.53 -28.87 22.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.913 1.685 . . . . 0.0 114.119 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.99 -28.97 70.17 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.931 -1.105 . . . . 0.0 113.513 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.6 p -67.53 -19.92 65.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.461 1.105 . . . . 0.0 113.568 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.6 t -102.0 -42.79 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.481 1.513 . . . . 0.0 110.68 175.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.27 -31.67 81.52 Favored Glycine 0 CA--C 1.532 1.102 0 O-C-N 120.842 -1.161 . . . . 0.0 114.594 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.2 p -66.24 -19.05 65.71 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -87.78 -39.26 15.04 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.934 1.294 . . . . 0.0 112.549 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.5 mt -66.37 -34.72 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.942 0.897 . . . . 0.0 110.906 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -56.13 -48.91 95.87 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 117.452 -1.261 . . . . 0.0 114.189 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.42 -31.56 2.66 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.926 2.417 . . . . 0.0 114.316 170.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 p -70.84 -27.8 64.12 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 121.279 1.854 . . . . 0.0 113.281 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -57.83 -47.8 81.61 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.107 -0.996 . . . . 0.0 112.084 161.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.73 -34.93 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 119.114 0.87 . . . . 0.0 111.918 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -63.09 -45.21 93.17 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.677 0.671 . . . . 0.0 111.464 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -64.12 -39.02 93.13 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.765 0.826 . . . . 0.0 112.44 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.6 mt -69.86 -7.36 39.51 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.979 1.711 . . . . 0.0 115.124 170.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -139.88 41.17 1.98 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.287 1.835 . . . . 0.0 111.663 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.4 m -68.46 56.47 0.08 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.285 1.834 . . . . 0.0 115.738 -168.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -69.38 -35.69 76.06 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.88 1.272 . . . . 0.0 111.265 165.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -81.87 114.82 53.25 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 153.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -54.71 154.19 21.56 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.192 2.594 . . . . 0.0 117.093 -154.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -69.34 -37.31 77.61 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 117.278 -1.344 . . . . 0.0 112.4 -172.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -67.3 -37.78 83.93 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 121.157 1.799 . . . . 0.0 113.825 -171.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.57 -31.54 60.63 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 120.645 -1.285 . . . . 0.0 112.905 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 91.7 m -69.77 -31.68 69.76 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.913 0.885 . . . . 0.0 112.62 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -70.31 -41.08 73.77 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 127.206 2.202 . . . . 0.0 111.953 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.29 -47.09 83.78 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.802 -0.561 . . . . 0.0 111.878 170.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.41 -31.27 72.38 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.6 tp -73.71 -45.36 52.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.669 1.188 . . . . 0.0 112.086 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 49.0 mt -64.67 -38.82 92.29 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.185 0.994 . . . . 0.0 113.126 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -69.99 -37.58 75.76 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 120.113 1.324 . . . . 0.0 113.275 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.28 -30.97 62.34 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.588 -1.32 . . . . 0.0 112.433 170.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.3 mt -64.87 -32.68 74.49 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.235 -1.541 . . . . 0.0 112.958 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -67.38 -40.68 85.7 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 120.298 1.408 . . . . 0.0 111.66 170.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.65 -32.76 73.87 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.97 0.508 . . . . 0.0 112.343 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.9 tp -71.56 -58.47 3.47 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.011 0.924 . . . . 0.0 111.538 169.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -67.28 -31.39 71.68 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -169.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.99 -31.87 69.47 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 119.248 -0.751 . . . . 0.0 113.401 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -91.6 -28.83 17.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.695 0.798 . . . . 0.0 113.033 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.11 -36.61 84.18 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.804 1.184 . . . . 0.0 112.456 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -67.67 -3.14 8.23 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 173.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.0 t -100.78 -38.38 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.876 1.27 . . . . 0.0 112.122 166.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -91.89 -22.93 19.8 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -171.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.9 -141.34 31.57 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 118.527 -1.152 . . . . 0.0 113.735 -175.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.7 -10.47 28.7 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 125.056 3.838 . . . . 0.0 117.728 -114.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -123.16 169.26 11.42 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.931 1.292 . . . . 0.0 111.791 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -72.68 -7.16 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.411 -1.431 . . . . 0.0 112.828 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.58 16.9 21.87 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.075 1.75 . . . . 0.0 114.079 162.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.25 -109.53 3.39 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.534 1.064 . . . . 0.0 113.627 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -55.84 -39.77 71.9 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.462 1.505 . . . . 0.0 113.736 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -147.46 166.38 27.42 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.032 1.733 . . . . 0.0 110.638 -168.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 16.8 mt -61.92 135.34 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 120.89 0.376 . . . . 0.0 110.117 163.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.1 p -136.76 -170.86 2.78 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.311 1.044 . . . . 0.0 110.439 163.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.79 -19.66 4.62 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.5 t -69.97 -46.4 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 120.169 1.35 . . . . 0.0 111.836 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.6 -46.49 89.64 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.855 1.262 . . . . 0.0 112.312 172.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.6 mt -64.08 -8.87 13.33 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.781 0.832 . . . . 0.0 112.839 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.1 m -101.03 -47.6 4.71 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.668 1.187 . . . . 0.0 112.564 173.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 38.3 mt -90.78 -35.0 15.1 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -170.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.0 97.32 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -173.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.78 -20.55 17.31 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 120.741 1.301 . . . . 0.0 113.448 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -75.91 -31.16 59.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 117.411 -1.281 . . . . 0.0 112.322 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 77.0 mt -64.97 -40.29 94.77 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.054 0.843 . . . . 0.0 112.726 166.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -60.75 -46.36 90.74 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.416 0.627 . . . . 0.0 111.711 173.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -66.6 -22.97 66.12 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 125.123 1.369 . . . . 0.0 113.421 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.4 mt -72.31 -58.48 3.37 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.072 1.306 . . . . 0.0 113.097 165.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -61.73 -31.81 72.0 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 118.646 0.657 . . . . 0.0 111.509 -173.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.9 t -86.74 -64.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 124.548 1.139 . . . . 0.0 112.907 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.66 -55.65 4.51 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.715 -0.616 . . . . 0.0 112.197 -160.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.1 tp -61.98 -32.56 73.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.62 0.368 . . . . 0.0 111.642 170.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -55.46 -27.13 47.06 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.201 1.382 . . . . 0.0 115.793 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -65.98 -24.43 66.78 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -125.34 -19.43 5.07 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -144.87 82.58 1.68 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.507 1.923 . . . . 0.0 108.254 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -61.38 90.02 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.535 1.134 . . . . 0.0 110.482 171.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -92.81 116.77 67.04 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.696 0.799 . . . . 0.0 111.907 -163.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.4 117.33 5.03 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.701 1.6 . . . . 0.0 110.319 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.78 109.93 4.64 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 149.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -66.62 164.38 29.23 Favored 'Trans proline' 0 C--N 1.35 0.643 0 CA-C-N 120.74 1.3 . . . . 0.0 112.488 -165.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -25.94 63.92 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.807 1.643 . . . . 0.0 113.911 177.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -70.55 -24.51 62.8 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.998 1.719 . . . . 0.0 114.283 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.3 mt -86.98 50.47 2.02 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.833 1.653 . . . . 0.0 110.251 166.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.6 m -59.65 -36.67 76.86 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.954 1.302 . . . . 0.0 113.03 -156.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -81.75 -38.94 24.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.874 -0.584 . . . . 0.0 112.091 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.72 -39.36 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 121.622 -0.673 . . . . 0.0 111.785 172.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 46.5 tp -63.61 -45.7 89.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.989 0.916 . . . . 0.0 112.697 175.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -66.52 -32.07 73.2 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.315 -0.866 . . . . 0.0 112.639 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -63.65 -28.82 70.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.729 0.812 . . . . 0.0 112.89 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 18.7 mt -58.36 -35.54 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 120.65 -1.281 . . . . 0.0 111.234 171.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -84.6 -9.72 58.04 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.461 -1.399 . . . . 0.0 113.998 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.99 -22.01 62.23 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.107 -0.949 . . . . 0.0 113.178 160.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 56.4 mt -65.29 -18.81 65.61 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.628 1.104 . . . . 0.0 113.754 -177.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -98.56 6.93 46.73 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.833 1.253 . . . . 0.0 112.933 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.8 p -117.68 -179.44 3.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.322 1.849 . . . . 0.0 113.715 -165.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 53.97 -162.27 0.12 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.567 1.547 . . . . 0.0 110.8 -169.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 10.8 mp0 -82.99 -38.12 23.08 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 124.118 0.967 . . . . 0.0 109.241 159.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 77.5 p -71.05 -60.51 2.19 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 126.093 1.757 . . . . 0.0 114.086 -161.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -63.82 -44.28 93.72 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.506 0.593 . . . . 0.0 112.175 173.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -55.41 -36.62 66.65 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.085 0.954 . . . . 0.0 113.334 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -76.75 -15.47 59.75 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.6 p -76.28 -11.74 59.96 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.513 1.506 . . . . 0.0 113.088 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -65.45 89.49 0.1 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.687 1.595 . . . . 0.0 112.609 -168.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.64 131.32 48.59 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.665 -0.683 . . . . 0.0 109.308 155.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.75 135.23 57.52 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.384 0.674 . . . . 0.0 111.78 -174.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -60.74 -37.6 82.33 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -157.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -38.2 87.14 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.935 -1.103 . . . . 0.0 113.149 172.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -76.81 -7.72 55.97 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 171.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.9 t -82.89 -49.56 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.774 0.83 . . . . 0.0 110.612 161.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.5 mt -59.92 -48.32 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.342 1.057 . . . . 0.0 111.5 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.25 -14.44 62.61 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.09 -33.67 9.42 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 120.917 -1.114 . . . . 0.0 113.364 170.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -78.95 -34.02 44.77 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.837 1.655 . . . . 0.0 113.885 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -51.34 -50.33 76.8 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.19 -24.92 27.17 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 121.637 1.558 . . . . 0.0 113.49 172.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -78.18 -10.39 59.62 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.147 1.379 . . . . 0.0 114.267 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.74 -31.03 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 119.249 0.931 . . . . 0.0 110.389 158.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -96.38 -20.12 18.7 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 177.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 C-N-CA 125.707 1.603 . . . . 0.0 112.629 -176.268 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 301' ' ' GSH . . . . . 0.443 ' C1 ' ' H ' ' A' ' 73' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.583 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 86.4 mtp . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 117.203 -1.38 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.03 177.91 0.17 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.11 1.764 . . . . 0.0 115.469 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.5 mt -111.85 139.63 47.17 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.421 1.488 . . . . 0.0 111.999 -175.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -139.78 134.88 32.42 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.984 1.313 . . . . 0.0 108.136 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.8 pt -127.57 142.34 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 120.999 -1.063 . . . . 0.0 110.5 -174.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.9 m -117.58 120.25 37.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.757 1.223 . . . . 0.0 109.689 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.27 163.03 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.998 1.319 . . . . 0.0 111.517 -165.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -59.54 116.2 3.83 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.609 -0.682 . . . . 0.0 110.865 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.482 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -78.06 149.78 33.89 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.935 154.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.05 146.88 49.02 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.203 1.002 . . . . 0.0 112.197 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 51.3 t -68.87 133.75 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 167.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.38 -33.9 1.56 Allowed Glycine 0 CA--C 1.537 1.453 0 CA-C-O 118.516 -1.158 . . . . 0.0 115.357 -174.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.13 69.03 9.75 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.824 1.25 . . . . 0.0 112.61 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.482 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 58.7 Cg_endo -63.41 -11.84 27.74 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.271 2.647 . . . . 0.0 114.816 -173.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -81.4 0.65 36.51 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.063 1.745 . . . . 0.0 114.737 175.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 pt -133.96 164.76 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.795 1.238 . . . . 0.0 111.801 174.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.39 146.7 54.56 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.59 0.756 . . . . 0.0 111.454 169.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -124.2 -164.28 11.92 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 125.25 1.405 . . . . 0.0 112.494 166.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -60.89 108.67 0.89 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 118.22 1.01 . . . . 0.0 113.593 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.1 t -157.63 108.26 1.81 Allowed Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.119 139.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.54 -21.5 59.78 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.14 1.893 . . . . 0.0 112.39 176.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -68.5 -29.9 68.61 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.61 0.764 . . . . 0.0 112.297 173.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 73.1 m -72.26 -37.58 69.05 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.372 -1.455 . . . . 0.0 112.669 168.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.53 -25.13 67.09 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 118.112 -0.947 . . . . 0.0 113.141 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.506 HH12 ' CG ' ' A' ' 74' ' ' ASP . 32.8 mtp180 -58.61 -43.3 89.56 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.319 1.048 . . . . 0.0 112.407 169.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.2 t -76.98 -37.43 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.855 1.262 . . . . 0.0 111.302 -176.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.55 -45.26 91.33 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.138 0.575 . . . . 0.0 111.478 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.68 -50.91 69.28 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.827 1.251 . . . . 0.0 112.408 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 p -63.08 -50.5 70.31 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.6 -35.8 73.18 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -76.53 -23.18 53.64 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 171.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -68.86 -46.23 69.01 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.072 1.305 . . . . 0.0 110.983 170.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -70.35 -7.24 41.18 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.48 1.512 . . . . 0.0 114.92 169.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.9 mmtm 61.46 15.39 6.61 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 126.032 1.733 . . . . 0.0 114.863 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.7 mt -72.69 128.6 88.1 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 123.598 0.759 . . . . 0.0 109.306 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.44 138.12 32.03 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.183 1.922 . . . . 0.0 111.516 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -141.67 153.44 44.7 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.231 1.412 . . . . 0.0 110.556 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -78.22 122.8 26.16 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.317 -0.864 . . . . 0.0 109.804 166.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.3 t -97.74 93.79 6.58 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.593 0.757 . . . . 0.0 111.559 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -82.83 105.68 14.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.903 0.881 . . . . 0.0 110.292 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.1 mt -73.24 113.95 10.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.944 0.898 . . . . 0.0 109.918 171.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.2 mm -108.97 115.8 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.739 1.216 . . . . 0.0 110.086 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -73.98 79.58 1.68 Allowed 'General case' 0 C--O 1.221 -0.411 0 O-C-N 121.4 -0.813 . . . . 32.609999999999999 109.756 166.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pp -65.05 0.7 1.17 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 117.601 2.445 . . . . 40.049999999999997 117.601 -165.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.51 -27.6 67.26 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-N 119.612 1.096 . . . . 41.469999999999999 112.871 161.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -120.45 53.91 1.08 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.934 2.894 . . . . 47.170000000000002 109.529 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -73.06 116.48 51.0 Favored Pre-proline 0 N--CA 1.472 0.667 0 O-C-N 119.757 -1.839 . . . . 41.270000000000003 110.317 -176.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.22 160.58 46.83 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.648 2.232 . . . . 40.289999999999999 112.144 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -61.46 -34.03 74.75 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.302 1.223 . . . . 42.390000000000001 114.302 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 30.5 p-90 -67.5 -21.37 65.5 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.691 -1.256 . . . . 37.079999999999998 114.097 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -82.74 -34.42 27.17 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.425 -0.797 . . . . 35.880000000000003 112.321 169.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.78 -24.97 65.38 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.551 0.74 . . . . 33.609999999999999 112.385 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -72.73 -1.45 16.47 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.794 1.637 . . . . 33.789999999999999 114.376 166.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.6 mt -115.73 -41.7 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.348 1.459 . . . . 33.159999999999997 110.314 173.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.1 t -114.43 100.4 52.9 Favored Pre-proline 0 N--CA 1.471 0.591 0 C-N-CA 125.808 1.643 . . . . 33.579999999999998 111.281 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.99 -20.55 44.53 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.941 2.428 . . . . 37.899999999999999 113.418 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.76 -0.08 57.52 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.396 1.079 . . . . 38.990000000000002 113.716 171.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.92 23.68 72.78 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.607 1.575 . . . . 35.469999999999999 115.866 176.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -104.15 158.63 16.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.889 1.675 . . . . 34.490000000000002 112.789 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.3 m -115.24 150.08 43.8 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.648 1.579 . . . . 23.530000000000001 111.151 164.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -68.46 153.62 89.27 Favored 'Cis proline' 0 C--N 1.349 0.562 0 CA-C-O 121.724 0.635 . . . . 22.879999999999999 112.629 -9.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.1 p -135.63 147.77 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 113.577 -1.647 . . . . 0.0 107.294 156.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.7 m -129.69 161.75 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.654 0.781 . . . . 0.0 110.474 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -116.03 98.93 6.91 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.428 1.491 . . . . 0.0 109.118 167.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 66.8 mt -87.49 114.85 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.415 1.086 . . . . 0.0 108.536 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.583 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 0.9 OUTLIER 56.58 36.84 28.23 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 121.866 0.841 . . . . 0.0 112.457 -169.547 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.251 11.2 t0 66.77 10.72 7.75 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 128.292 2.637 . . . . 0.0 116.316 -170.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -104.12 123.18 46.8 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 119.412 -2.055 . . . . 0.0 110.688 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -69.36 143.49 53.71 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -170.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.4 t -142.86 126.66 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 126.695 1.998 . . . . 0.0 108.585 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -110.38 164.95 12.18 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.62 1.568 . . . . 0.0 112.136 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.2 t0 67.57 113.45 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.342 2.257 . . . . 22.16 114.191 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.495 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 26.5 p -65.16 -22.14 66.88 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 115.356 1.613 . . . . 21.16 115.356 -158.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.506 ' CG ' HH12 ' A' ' 25' ' ' ARG . 33.8 m-20 -70.47 -35.68 73.43 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.899 1.227 . . . . 24.969999999999999 112.696 170.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.62 -41.71 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 121.092 -1.005 . . . . 23.850000000000001 110.745 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.0 mt -63.75 -46.5 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.841 0.856 . . . . 23.68 111.227 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.1 t -63.15 -40.54 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.021 0.928 . . . . 22.84 111.314 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.19 -47.26 89.06 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 118.462 0.574 . . . . 23.329999999999998 113.1 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 75.9 mt -73.43 -47.24 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 117.846 0.823 . . . . 23.309999999999999 112.165 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.56 -32.23 73.79 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.046 1.294 . . . . 23.48 112.748 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -89.57 -14.37 35.21 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 114.614 1.338 . . . . 24.239999999999998 114.614 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.534 ' CD ' ' HE3' ' A' ' 83' ' ' LYS . 68.8 tt0 -89.54 -33.57 16.69 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.283 1.433 . . . . 39.259999999999998 112.606 165.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.534 ' HE3' ' CD ' ' A' ' 82' ' ' GLU . 65.2 mttt -135.3 85.33 2.16 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.619 1.168 . . . . 24.449999999999999 112.09 -161.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -150.42 166.02 16.09 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.149 1.78 . . . . 0.0 109.191 168.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.76 -33.36 44.31 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 121.919 1.746 . . . . 0.0 112.103 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -73.95 149.31 87.56 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.231 1.012 . . . . 0.0 111.649 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -52.31 143.02 44.96 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.408 2.739 . . . . 0.0 115.02 -172.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.98 133.49 29.22 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.673 2.249 . . . . 0.0 111.934 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 34.1 mt -103.34 8.51 38.16 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.608 1.163 . . . . 0.0 111.83 168.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.49 49.17 0.11 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.281 1.832 . . . . 0.0 112.373 163.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.7 p -123.31 65.07 29.47 Favored Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 125.381 1.473 . . . . 0.0 109.885 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.76 119.83 6.85 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.181 1.921 . . . . 0.0 109.962 -173.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -73.89 -176.37 2.57 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.917 2.412 . . . . 0.0 111.532 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -53.93 -29.23 41.46 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.184 2.194 . . . . 0.0 113.5 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -52.72 -28.5 22.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.8 1.64 . . . . 0.0 114.045 170.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.64 -29.41 70.65 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.658 1.117 . . . . 0.0 113.358 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 59.7 p -66.9 -25.16 66.25 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.789 0.836 . . . . 0.0 113.097 174.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.0 t -94.87 -42.04 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.978 1.311 . . . . 0.0 110.814 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.47 -31.09 79.58 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.7 1.143 . . . . 0.0 114.421 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 72.3 p -66.35 -20.6 66.13 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.762 1.281 . . . . 0.0 114.211 171.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -92.2 -33.26 14.76 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.113 1.365 . . . . 0.0 112.827 172.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.8 mt -70.45 -37.09 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.986 0.914 . . . . 0.0 111.655 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.453 ' CE1' ' HE2' ' A' ' 156' ' ' LYS . 83.0 t80 -54.68 -45.85 99.47 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.032 1.333 . . . . 0.0 114.505 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.78 -32.52 1.09 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.016 2.478 . . . . 0.0 114.069 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.2 p -71.76 -26.62 62.52 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 121.34 1.882 . . . . 0.0 113.207 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -58.4 -45.89 87.47 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.695 -1.253 . . . . 0.0 112.413 160.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.46 -31.72 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 121.374 -0.828 . . . . 0.0 112.069 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -64.67 -44.15 91.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.689 0.677 . . . . 0.0 111.365 168.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -67.79 -37.1 81.57 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.5 mt -64.21 -11.32 29.91 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.787 1.635 . . . . 0.0 114.435 167.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -142.31 41.03 1.62 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.641 1.976 . . . . 0.0 112.543 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.1 m -68.6 59.73 0.09 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -165.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 94.4 mttt -71.28 -35.75 71.44 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.562 -1.336 . . . . 0.0 111.995 168.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 15.4 t0 -81.01 112.78 35.4 Favored Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 152.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 114' ' ' ASP . 95.9 Cg_exo -57.24 158.68 17.62 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.977 2.451 . . . . 0.0 117.29 -148.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -56.91 -51.64 68.32 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.478 -174.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -79.67 -21.67 44.45 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -163.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.89 -36.08 29.5 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 121.355 -0.841 . . . . 0.0 112.772 165.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 62.3 m -66.81 -30.89 71.2 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.641 0.776 . . . . 0.0 112.799 171.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -65.24 -42.69 93.12 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 125.736 1.614 . . . . 0.0 111.841 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -65.62 -43.13 90.5 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.724 -0.61 . . . . 0.0 111.766 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.05 -25.68 68.22 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 174.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 49.8 tp -82.47 -42.63 18.24 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.848 1.259 . . . . 0.0 112.27 172.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 33.9 mt -67.23 -39.17 86.19 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.668 1.187 . . . . 0.0 113.241 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -67.01 -34.97 78.89 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.046 1.293 . . . . 0.0 112.389 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -72.29 -38.55 68.73 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.027 -1.046 . . . . 0.0 112.765 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.1 mt -64.98 -33.14 75.32 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.585 -1.322 . . . . 0.0 113.03 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -66.4 -41.38 89.39 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.673 1.124 . . . . 0.0 111.51 171.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.8 -35.82 81.85 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.965 0.506 . . . . 0.0 112.203 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.4 tp -68.67 -56.45 8.14 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.068 0.947 . . . . 0.0 111.677 171.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -67.43 -31.63 71.95 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.71 1.204 . . . . 0.0 114.157 -172.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.21 -31.63 73.96 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.154 -0.803 . . . . 0.0 113.543 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -87.45 -33.71 18.95 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 117.888 0.844 . . . . 0.0 112.804 170.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.77 -34.91 78.23 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.041 1.291 . . . . 0.0 113.259 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -68.5 0.93 3.47 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 172.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.8 t -111.07 -37.42 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.599 1.559 . . . . 0.0 112.108 166.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -90.55 -17.16 27.49 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -172.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.98 -143.66 32.5 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-O 118.725 -1.041 . . . . 0.0 114.586 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.35 -18.45 49.91 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 124.794 3.663 . . . . 0.0 117.772 -119.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -118.16 171.03 8.39 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.399 1.08 . . . . 0.0 111.552 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.88 -6.04 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 120.146 -1.597 . . . . 0.0 113.037 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -108.82 15.15 23.78 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.258 1.823 . . . . 0.0 114.301 162.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.81 -108.14 3.03 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 120.564 -1.335 . . . . 0.0 113.242 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -51.72 -41.61 61.64 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.882 1.673 . . . . 0.0 113.887 -172.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -152.93 165.25 36.1 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.868 1.667 . . . . 0.0 110.233 -166.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.9 mt -64.75 132.39 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.195 0.598 . . . . 0.0 109.939 166.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.5 p -138.91 -170.72 2.92 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.843 1.257 . . . . 0.0 110.699 168.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.05 -17.49 3.98 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.1 t -71.03 -45.06 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 119.978 1.263 . . . . 0.0 111.795 172.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.88 -45.72 92.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.859 1.264 . . . . 0.0 111.905 172.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.66 -17.34 60.32 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.216 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.8 m -91.65 -48.05 7.04 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.861 1.21 . . . . 0.0 112.619 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.6 mt -94.49 -36.84 11.68 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -167.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.52 -47.86 97.7 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.22 -21.14 20.54 Favored 'Trans proline' 0 C--N 1.351 0.682 0 CA-C-N 120.808 1.324 . . . . 0.0 113.426 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.453 ' HE2' ' CE1' ' A' ' 103' ' ' PHE . 67.5 mttm -81.0 -27.81 35.74 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.907 -1.121 . . . . 0.0 112.89 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.8 mt -64.83 -43.33 93.42 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.364 0.665 . . . . 0.0 112.204 164.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -59.7 -44.68 93.59 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.225 0.466 . . . . 0.0 111.877 172.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -63.9 -31.37 72.53 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 71.6 mt -74.01 -49.01 26.28 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 118.004 -0.998 . . . . 0.0 113.488 171.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -61.4 -31.1 71.01 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.219 0.918 . . . . 0.0 112.203 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 95.6 t -88.95 -66.97 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.812 1.245 . . . . 0.0 113.27 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.59 -48.78 8.04 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -160.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 30.8 tp -62.83 -33.39 75.13 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.614 166.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -55.05 -28.65 49.69 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.937 1.256 . . . . 0.0 115.713 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -66.17 -22.23 66.36 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -128.04 -22.2 3.52 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -142.79 86.1 1.92 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.378 1.871 . . . . 0.0 108.486 167.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -61.58 86.03 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.178 1.391 . . . . 0.0 110.947 171.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -88.64 121.5 69.97 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.789 -163.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.71 109.93 2.77 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.579 1.519 . . . . 0.0 110.147 170.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.3 mm -59.36 108.34 1.33 Allowed Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 142.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -68.35 164.93 30.62 Favored 'Trans proline' 0 C--N 1.35 0.642 0 CA-C-N 120.553 1.233 . . . . 0.0 112.638 -165.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.52 -24.79 63.95 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.269 1.427 . . . . 0.0 113.27 171.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -66.39 -26.86 67.45 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.834 1.253 . . . . 0.0 113.775 171.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 67.6 mt -87.25 49.68 1.86 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.715 1.606 . . . . 0.0 111.065 169.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.23 -33.47 74.66 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.282 1.033 . . . . 0.0 113.343 -155.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -81.63 -37.66 27.2 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.785 0.721 . . . . 0.0 112.115 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.67 -39.57 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 121.587 -0.696 . . . . 0.0 111.613 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 43.0 tp -65.67 -40.24 92.16 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -68.48 -38.52 81.1 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.546 -0.721 . . . . 0.0 112.323 171.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -63.78 -29.38 70.59 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.252 1.021 . . . . 0.0 113.292 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 78.1 mt -59.07 -32.05 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 120.548 -1.345 . . . . 0.0 111.856 170.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -84.45 -10.68 57.29 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.473 -1.392 . . . . 0.0 113.607 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.94 -17.65 61.46 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.581 161.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.43 -14.26 61.93 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.671 1.123 . . . . 0.0 113.244 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -103.89 5.61 35.85 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.902 1.281 . . . . 0.0 113.316 174.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.6 p -111.33 -179.05 3.61 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.11 2.164 . . . . 0.0 113.964 -167.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 54.12 -159.72 0.16 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.489 1.516 . . . . 0.0 110.628 -172.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.502 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 5.7 mp0 -85.8 -41.01 15.42 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.781 1.232 . . . . 0.0 109.139 160.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 78.4 p -68.55 -60.42 2.43 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 126.293 1.837 . . . . 0.0 114.436 -162.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -62.25 -45.37 93.61 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.518 0.599 . . . . 0.0 112.085 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -56.86 -35.48 68.93 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.304 1.042 . . . . 0.0 113.457 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -76.9 -13.45 59.99 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 176.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.6 p -77.83 -10.77 59.73 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.402 1.455 . . . . 0.0 113.384 171.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -67.24 83.31 0.14 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.683 1.593 . . . . 0.0 112.852 -170.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.26 131.02 49.03 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.298 1.039 . . . . 0.0 109.919 161.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.27 129.96 44.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.317 0.647 . . . . 0.0 111.346 -171.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 31.0 mp0 -59.08 -39.14 81.21 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -157.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -60.39 -36.95 79.29 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.872 1.269 . . . . 0.0 112.687 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -85.12 -6.69 59.29 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.568 1.547 . . . . 0.0 113.092 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 39.6 t -86.79 -44.5 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.215 162.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.1 mt -58.18 -51.2 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.696 1.199 . . . . 0.0 111.347 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.76 -15.0 62.64 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -83.78 -33.25 22.11 Favored Glycine 0 CA--C 1.533 1.216 0 O-C-N 120.874 -1.141 . . . . 0.0 113.175 169.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 44.9 t90 -84.93 -35.26 22.21 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.121 2.169 . . . . 0.0 114.675 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -53.42 -47.35 96.56 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.9 -24.27 29.2 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.498 1.466 . . . . 0.0 113.656 172.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -75.48 -11.68 60.08 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 117.672 -1.156 . . . . 0.0 114.014 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.412 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 48.1 t -59.39 -21.95 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.264 0.938 . . . . 0.0 110.934 160.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -106.73 -10.12 16.22 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 172.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 C-N-CA 126.674 1.99 . . . . 0.0 112.386 -173.746 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 301' ' ' GSH . . . . . 0.495 ' C1 ' ' H ' ' A' ' 73' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.535 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 97.2 mtp . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.45 -178.63 0.13 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.801 1.64 . . . . 0.0 114.088 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 49.0 mt -103.45 143.6 32.49 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.446 1.117 . . . . 0.0 113.107 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -151.65 128.38 10.87 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.533 1.933 . . . . 0.0 108.382 172.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 pt -126.43 140.77 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.898 0.879 . . . . 0.0 109.92 -170.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.4 m -106.44 122.71 46.82 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.513 0.725 . . . . 0.0 109.335 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.39 164.0 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.597 1.559 . . . . 0.0 110.924 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -62.01 119.01 8.04 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.536 -0.727 . . . . 0.0 111.316 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -80.53 153.69 27.96 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.339 153.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.37 143.6 57.78 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.091 0.948 . . . . 0.0 112.18 170.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.6 t -70.51 136.65 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 168.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.78 -35.0 1.41 Allowed Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.814 -0.992 . . . . 0.0 114.775 -172.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.61 69.03 6.07 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 125.177 1.391 . . . . 0.0 112.478 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.37 -11.44 28.24 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.527 2.818 . . . . 0.0 115.413 -172.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -92.5 9.07 36.0 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.5 pt -130.32 163.09 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.593 1.157 . . . . 0.0 111.264 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.4 mt -62.68 146.02 53.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.299 0.64 . . . . 0.0 111.109 166.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.86 -169.16 12.47 Favored Glycine 0 N--CA 1.474 1.201 0 C-N-CA 125.233 1.397 . . . . 0.0 112.605 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -59.61 108.2 0.7 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.8 t -157.91 103.08 1.76 Allowed Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.637 1.175 . . . . 0.0 109.163 144.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -63.71 -18.95 66.29 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.249 2.633 . . . . 0.0 112.572 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -71.07 -30.6 66.78 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.4 -0.813 . . . . 0.0 112.602 172.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.3 m -70.35 -38.97 74.93 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.598 -1.314 . . . . 0.0 112.415 168.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -60.33 -26.89 66.91 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 118.143 -0.932 . . . . 0.0 113.155 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.522 HH12 ' CG ' ' A' ' 74' ' ' ASP . 46.6 mtp180 -57.89 -45.39 86.49 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.122 0.969 . . . . 0.0 112.52 171.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.54 -39.51 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.089 1.356 . . . . 0.0 111.322 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.82 -41.36 91.13 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.213 0.605 . . . . 0.0 111.258 172.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.4 tp -63.17 -54.5 36.6 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.06 1.344 . . . . 0.0 112.447 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.0 p -69.82 -38.31 76.52 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.462 1.028 . . . . 0.0 113.467 -171.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.6 mt -71.36 -38.96 71.54 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -75.62 -22.57 56.75 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 171.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -69.36 -47.01 65.61 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 120.536 -1.353 . . . . 0.0 111.145 170.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -69.74 -6.52 32.47 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.76 1.624 . . . . 0.0 114.652 169.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm 59.81 16.54 5.7 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.723 1.609 . . . . 0.0 114.804 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.9 mt -71.39 125.9 91.81 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.13 136.46 24.63 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.119 1.879 . . . . 0.0 111.4 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -136.17 151.08 49.37 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.664 1.585 . . . . 0.0 110.573 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -73.76 139.15 45.03 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.45 -0.781 . . . . 0.0 109.035 161.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.3 t -125.2 93.24 3.82 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.733 0.813 . . . . 0.0 111.162 -175.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -74.85 113.42 12.12 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.835 0.854 . . . . 0.0 110.464 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 83.8 mt -72.95 101.29 3.16 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.504 1.122 . . . . 0.0 110.02 164.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mm -97.1 111.29 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.629 0.771 . . . . 0.0 109.892 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -78.06 70.07 4.37 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.252 -0.905 . . . . 32.609999999999999 110.552 168.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.01 8.33 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 117.758 2.503 . . . . 40.049999999999997 117.758 -166.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.94 -44.46 91.67 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-N 119.825 1.193 . . . . 41.469999999999999 111.26 155.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -102.74 72.47 1.22 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.583 1.953 . . . . 47.170000000000002 110.068 166.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -81.24 110.96 20.62 Favored Pre-proline 0 N--CA 1.475 0.778 0 O-C-N 120.234 -1.541 . . . . 41.270000000000003 110.872 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.21 158.15 45.43 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.868 2.379 . . . . 40.289999999999999 112.481 -174.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -59.12 -34.5 72.11 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.419 1.266 . . . . 42.390000000000001 114.419 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -64.83 -32.15 73.72 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.188 0.904 . . . . 37.079999999999998 113.287 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -75.35 -34.53 61.17 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.689 -1.257 . . . . 35.880000000000003 112.782 170.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.89 -28.89 67.1 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.401 1.0 . . . . 33.609999999999999 113.285 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -68.61 -30.47 69.22 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.907 1.683 . . . . 33.789999999999999 112.537 170.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.7 mt -85.04 -33.15 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.96 1.304 . . . . 33.159999999999997 111.623 173.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.1 t -131.62 94.7 25.1 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 126.027 1.731 . . . . 33.579999999999998 110.586 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.86 -15.87 40.8 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.611 2.207 . . . . 37.899999999999999 113.842 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -81.87 -8.09 59.66 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.546 0.943 . . . . 38.990000000000002 113.546 168.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.28 13.42 64.92 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 120.933 -1.104 . . . . 35.469999999999999 114.789 -173.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -91.72 150.94 20.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.176 1.39 . . . . 34.490000000000002 112.763 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.7 m -110.96 153.94 43.6 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 126.176 1.79 . . . . 23.530000000000001 110.74 159.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -66.68 156.68 82.36 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-O 121.975 0.74 . . . . 22.879999999999999 112.925 -8.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 p -144.99 142.27 22.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.164 -1.38 . . . . 0.0 107.872 162.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 m -129.58 146.83 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.513 0.725 . . . . 0.0 110.67 -171.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -105.74 78.72 1.37 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.433 1.493 . . . . 0.0 109.724 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 34.4 mt -71.8 114.5 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.902 0.881 . . . . 0.0 109.564 -176.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.535 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 1.1 t70 52.47 39.36 27.61 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.96 0.885 . . . . 0.0 112.429 -165.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.8 t0 69.9 7.74 6.37 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 128.075 2.55 . . . . 0.0 116.622 -173.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -103.49 127.06 50.96 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 119.768 -1.833 . . . . 0.0 111.512 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.0 p-90 -70.18 142.48 52.46 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -170.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -143.04 128.4 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 127.722 2.409 . . . . 0.0 108.286 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.74 168.37 9.62 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.606 1.562 . . . . 0.0 112.131 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.9 t0 66.55 113.19 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.66 2.384 . . . . 22.16 114.346 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.46 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 48.3 p -63.11 -24.3 67.84 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 115.215 1.561 . . . . 21.16 115.215 -161.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.522 ' CG ' HH12 ' A' ' 25' ' ' ARG . 37.2 m-20 -73.18 -35.46 66.4 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.179 1.354 . . . . 24.969999999999999 113.307 170.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.62 -38.51 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 121.09 -1.006 . . . . 23.850000000000001 110.856 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.88 -45.94 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.314 1.046 . . . . 23.68 111.233 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.1 t -61.81 -41.4 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.26 1.024 . . . . 22.84 111.299 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.55 -20.26 55.61 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.782 -1.01 . . . . 23.329999999999998 114.932 175.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 98.5 mt -106.5 -44.14 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 119.073 1.436 . . . . 23.309999999999999 112.38 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.4 mt -65.72 -32.78 74.51 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 120.251 1.387 . . . . 23.48 112.947 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.13 -11.77 40.26 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 114.237 1.199 . . . . 24.239999999999998 114.237 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.472 ' OE2' ' HE3' ' A' ' 83' ' ' LYS . 75.0 tt0 -92.41 -41.07 10.52 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.103 1.361 . . . . 39.259999999999998 112.554 165.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.472 ' HE3' ' OE2' ' A' ' 82' ' ' GLU . 74.6 mttt -124.51 90.01 3.18 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.662 1.185 . . . . 24.449999999999999 111.977 -164.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -151.8 165.69 16.88 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.833 1.653 . . . . 0.0 109.474 168.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.21 -30.34 31.2 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.003 1.802 . . . . 0.0 112.031 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -73.7 152.87 89.39 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.82 1.248 . . . . 0.0 112.086 171.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -51.81 142.87 40.63 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.74 2.96 . . . . 0.0 115.053 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.31 131.53 25.17 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.272 1.981 . . . . 0.0 111.533 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.6 mt -105.29 4.48 31.05 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.223 1.409 . . . . 0.0 112.185 171.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.71 51.51 0.14 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.698 1.999 . . . . 0.0 112.178 162.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.1 p -123.79 70.76 49.11 Favored Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 125.021 1.329 . . . . 0.0 109.236 170.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.07 122.48 9.07 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.282 1.988 . . . . 0.0 110.227 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -73.98 179.59 5.58 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.874 2.383 . . . . 0.0 111.221 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.6 mp0 -55.09 -29.75 58.25 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.624 1.97 . . . . 0.0 113.08 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -53.77 -28.14 33.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.994 1.318 . . . . 0.0 113.842 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.27 -29.96 71.19 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.624 1.102 . . . . 0.0 113.21 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.9 p -68.45 -21.95 64.61 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.2 t -99.9 -41.11 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.835 1.254 . . . . 0.0 111.081 176.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.67 -31.52 81.07 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.729 -1.232 . . . . 0.0 114.435 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.9 p -69.62 -18.58 63.61 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -90.46 -32.66 16.29 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.842 1.257 . . . . 0.0 112.881 169.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 71.0 mt -70.27 -36.0 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.778 0.831 . . . . 0.0 111.629 173.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -55.44 -46.74 99.66 Favored Pre-proline 0 CA--C 1.547 0.829 0 O-C-N 120.379 -1.451 . . . . 0.0 114.344 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.65 -31.67 2.44 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.933 2.422 . . . . 0.0 114.116 171.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.6 p -71.46 -28.12 63.73 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 121.034 1.743 . . . . 0.0 113.005 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -58.72 -44.51 90.45 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 120.655 -1.278 . . . . 0.0 112.305 161.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.5 t -65.86 -35.05 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 119.639 1.109 . . . . 0.0 111.887 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -66.54 -39.02 88.36 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.031 0.832 . . . . 0.0 112.047 171.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -70.11 -29.85 66.91 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.284 1.034 . . . . 0.0 112.426 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.9 mt -76.99 -9.06 58.44 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.673 1.589 . . . . 0.0 114.517 168.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -142.63 38.55 1.51 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.92 1.288 . . . . 0.0 112.839 -170.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.4 m -75.07 63.01 1.22 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -162.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -65.26 -38.07 89.15 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.05 1.34 . . . . 0.0 111.136 163.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -83.89 115.97 62.43 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 154.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.59 154.24 70.15 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.675 2.917 . . . . 0.0 115.759 -144.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -66.9 -42.64 85.12 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 114.42 -1.264 . . . . 0.0 112.993 -165.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.71 -22.33 54.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.656 1.182 . . . . 0.0 113.32 -174.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.82 -34.6 27.12 Favored Glycine 0 CA--C 1.532 1.155 0 O-C-N 120.973 -1.079 . . . . 0.0 112.813 165.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 99.4 m -68.44 -27.09 65.87 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.596 -0.944 . . . . 0.0 112.729 171.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.59 -44.44 96.26 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.841 1.657 . . . . 0.0 111.928 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -66.7 -41.84 87.36 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.43 0.692 . . . . 0.0 112.059 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.77 -25.05 67.09 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 174.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.9 tp -82.51 -41.71 19.36 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.685 1.194 . . . . 0.0 112.17 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 26.9 mt -65.23 -40.08 93.61 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.713 1.205 . . . . 0.0 113.566 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -68.23 -33.83 75.12 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.927 1.239 . . . . 0.0 112.727 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -73.48 -38.76 65.31 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.063 -1.023 . . . . 0.0 112.722 170.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.1 mt -63.57 -35.55 80.86 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.782 -1.199 . . . . 0.0 112.849 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -65.06 -44.29 89.46 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.137 0.975 . . . . 0.0 111.598 172.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.61 -36.02 81.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.333 0.653 . . . . 0.0 112.224 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.1 tp -69.35 -56.95 6.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.377 1.071 . . . . 0.0 111.97 172.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.47 -30.57 69.45 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -171.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.33 -32.01 67.23 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.144 -0.809 . . . . 0.0 113.487 172.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -89.15 -33.88 16.9 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 117.75 0.775 . . . . 0.0 113.006 172.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.55 -35.95 81.07 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.912 1.233 . . . . 0.0 113.042 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.6 mtmt -65.81 -6.9 13.34 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 174.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.6 t -102.5 -36.72 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.961 1.305 . . . . 0.0 112.173 169.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -89.22 -19.32 25.55 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.31 -140.63 35.9 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.939 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -70.86 -15.71 32.95 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.785 3.657 . . . . 0.0 117.343 -108.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -122.08 170.98 9.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.926 1.29 . . . . 0.0 110.908 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.254 2.9 tt -77.9 7.29 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 119.855 -1.778 . . . . 0.0 113.132 -175.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -114.61 6.95 15.91 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.91 2.484 . . . . 0.0 114.035 163.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.93 -122.33 6.64 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.82 -1.175 . . . . 0.0 113.185 -172.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -54.0 -36.69 63.22 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -169.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -146.76 157.87 43.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.318 1.447 . . . . 0.0 110.977 -166.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 56.0 mt -67.48 132.67 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.517 0.727 . . . . 0.0 110.414 171.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.0 p -143.5 -171.62 3.54 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.483 1.513 . . . . 0.0 111.15 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -54.58 -17.89 3.8 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.61 -42.48 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 120.211 1.369 . . . . 0.0 111.759 172.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.64 -45.08 95.56 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.933 1.293 . . . . 0.0 112.326 168.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.8 mt -62.08 -24.24 66.99 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 122.039 -0.413 . . . . 0.0 111.769 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.9 m -83.46 -50.56 8.18 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.887 -1.133 . . . . 0.0 112.597 175.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.3 mt -94.86 -36.0 11.82 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -165.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.8 -49.17 94.39 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.56 -22.5 15.8 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 120.725 1.295 . . . . 0.0 113.483 178.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -78.2 -28.92 48.16 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 117.714 -1.136 . . . . 0.0 112.859 174.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 46.7 mt -65.69 -44.65 85.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.89 0.876 . . . . 0.0 112.395 166.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -57.22 -41.66 79.91 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.161 0.505 . . . . 0.0 111.792 170.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -68.0 -29.61 68.67 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 9.2 mt -69.68 -52.48 25.35 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.419 1.008 . . . . 0.0 111.913 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -61.43 -35.51 77.78 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.017 0.927 . . . . 0.0 112.029 -174.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.7 t -90.56 -62.82 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.395 1.078 . . . . 0.0 113.14 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.21 -56.83 3.81 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.601 -0.687 . . . . 0.0 112.42 -162.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.42 -33.12 74.86 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.439 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.64 -23.29 49.28 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.129 1.347 . . . . 0.0 115.778 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -69.95 -22.26 63.19 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -124.94 -25.19 3.93 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -139.34 90.52 2.42 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.825 1.65 . . . . 0.0 108.353 166.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -65.3 83.78 0.05 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.583 1.153 . . . . 0.0 109.979 170.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -86.8 117.38 68.57 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.852 -169.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.34 110.63 2.9 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.585 1.524 . . . . 0.0 109.835 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.8 mm -55.39 109.32 1.54 Allowed Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 151.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -64.51 158.34 50.18 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 121.278 1.319 . . . . 0.0 112.442 -166.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.71 -19.06 64.63 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -66.36 -25.0 66.59 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.424 1.09 . . . . 0.0 113.693 168.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 62.5 mt -87.06 47.88 1.57 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.232 1.813 . . . . 0.0 111.388 170.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.7 -31.76 73.03 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.987 -1.071 . . . . 0.0 113.823 -155.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -80.45 -38.12 30.66 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.092 -1.005 . . . . 0.0 111.862 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 87.0 t -61.46 -42.32 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 121.436 -0.79 . . . . 0.0 111.559 171.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.8 -29.44 69.92 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -80.9 -37.45 29.65 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.595 -0.691 . . . . 0.0 112.507 170.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -63.76 -31.13 72.21 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.476 1.11 . . . . 0.0 113.473 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 79.6 mt -56.96 -37.1 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.139 -0.976 . . . . 0.0 111.904 169.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -77.5 -16.34 58.77 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 119.975 -1.703 . . . . 0.0 112.878 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 66.6 mt -77.0 -12.76 59.98 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 117.461 -1.257 . . . . 0.0 113.473 166.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.83 -18.9 65.61 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.414 1.461 . . . . 0.0 112.924 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -93.15 2.17 56.81 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 173.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.4 p -105.97 -179.57 3.98 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.168 2.187 . . . . 0.0 113.828 -170.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 43.8 mtp85 55.09 -161.95 0.15 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.347 1.459 . . . . 0.0 110.655 -172.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 8.0 mp0 -86.03 -40.68 15.53 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.101 1.36 . . . . 0.0 109.209 157.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 72.5 p -70.7 -53.15 16.74 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.713 1.605 . . . . 0.0 114.727 -160.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -67.01 -46.17 75.3 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.17 0.896 . . . . 0.0 111.855 171.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 193' ' ' LYS . 26.7 ttmt -55.89 -38.28 69.98 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -74.46 -12.5 60.51 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.7 p -77.75 -11.74 59.91 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.329 1.422 . . . . 0.0 113.267 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -67.32 86.23 0.17 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.778 1.631 . . . . 0.0 112.721 -169.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.35 136.11 57.93 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.797 0.839 . . . . 0.0 109.99 159.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.2 132.47 53.77 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.104 0.562 . . . . 0.0 111.547 -173.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -60.02 -37.46 79.83 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.636 1.346 . . . . 0.0 114.636 -159.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.44 -38.28 83.59 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.901 -1.124 . . . . 0.0 112.462 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -86.49 -4.85 59.24 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.782 1.633 . . . . 0.0 112.998 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.3 t -85.02 -48.81 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.707 1.203 . . . . 0.0 109.89 162.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.8 mt -59.27 -53.37 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.852 1.261 . . . . 0.0 111.63 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.39 -15.53 62.37 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -81.78 -33.84 26.3 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 120.898 -1.126 . . . . 0.0 113.012 170.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 32.5 t90 -82.95 -32.75 26.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.521 1.928 . . . . 0.0 114.634 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -50.07 -48.84 78.19 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.53 -23.94 31.27 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.773 1.649 . . . . 0.0 113.71 173.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.08 -11.07 60.01 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.775 1.23 . . . . 0.0 113.901 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 57.6 t -58.95 -27.85 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 119.236 0.926 . . . . 0.0 110.688 161.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -97.91 -36.37 10.18 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 171.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.743 0 C-N-CA 126.052 1.741 . . . . 0.0 113.639 -177.344 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 301' ' ' GSH . . . . . 0.46 ' C1 ' ' H ' ' A' ' 73' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.559 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 94.7 mtp . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.52 -168.49 0.17 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.589 1.556 . . . . 0.0 113.433 177.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 79.7 mt -109.72 131.81 54.72 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.391 1.076 . . . . 0.0 112.298 -175.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -122.21 145.6 48.05 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.574 1.15 . . . . 0.0 108.489 153.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.2 pt -130.22 138.84 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.967 0.907 . . . . 0.0 109.504 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.9 m -106.98 119.82 40.39 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.179 0.992 . . . . 0.0 109.621 173.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.81 163.8 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.018 1.327 . . . . 0.0 111.111 -169.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -60.58 119.14 7.5 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.758 -0.589 . . . . 0.0 111.23 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.41 147.01 31.18 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.051 151.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.93 139.47 58.75 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.757 0.789 . . . . 0.0 111.942 172.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.2 t -71.86 134.25 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 168.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.91 -27.74 2.97 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-O 118.665 -1.075 . . . . 0.0 114.677 -170.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -129.26 65.41 74.19 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-N 118.582 1.191 . . . . 0.0 112.564 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.12 -12.39 32.2 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.315 2.677 . . . . 0.0 115.468 -170.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -85.97 5.71 31.95 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.1 pt -132.37 163.33 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.733 1.213 . . . . 0.0 111.84 173.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.74 145.47 49.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.136 0.575 . . . . 0.0 110.888 166.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.63 -163.53 11.17 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.878 1.228 . . . . 0.0 111.981 166.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -56.96 105.4 0.21 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.6 t -157.64 107.4 1.81 Allowed Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.841 140.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.11 -14.29 42.83 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.178 2.585 . . . . 0.0 113.198 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -77.76 -29.39 50.98 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.207 -0.933 . . . . 0.0 112.401 171.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 99.7 m -70.81 -37.85 73.26 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.083 -1.636 . . . . 0.0 112.451 167.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -59.42 -26.69 65.38 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 118.399 -0.81 . . . . 0.0 113.006 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.502 HH12 ' CG ' ' A' ' 74' ' ' ASP . 53.8 mtp180 -58.14 -44.11 87.68 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.526 1.131 . . . . 0.0 112.641 171.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.5 t -77.0 -39.57 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.101 1.36 . . . . 0.0 111.299 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.31 -44.44 92.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.327 0.651 . . . . 0.0 111.121 171.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.0 tp -60.78 -53.75 53.55 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.991 1.316 . . . . 0.0 112.77 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 p -71.55 -36.85 71.11 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.708 1.14 . . . . 0.0 113.574 -173.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.17 -39.03 68.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.841 -0.599 . . . . 0.0 112.051 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -77.99 -17.39 57.2 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 172.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -70.16 -52.88 20.06 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.999 1.272 . . . . 0.0 110.896 167.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -73.24 -1.75 19.07 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.291 1.836 . . . . 0.0 114.468 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm 58.03 18.8 5.42 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.409 1.884 . . . . 0.0 115.106 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 58.5 mt -72.69 125.07 91.4 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 123.896 0.878 . . . . 0.0 108.868 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.72 144.84 35.88 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.473 2.116 . . . . 0.0 112.167 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -148.18 154.54 40.25 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.271 1.428 . . . . 0.0 111.01 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -78.55 121.1 24.18 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.332 -0.855 . . . . 0.0 109.686 163.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.8 t -95.42 94.41 7.8 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.538 0.735 . . . . 0.0 111.14 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -81.07 105.67 12.47 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.547 0.739 . . . . 0.0 110.067 178.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.9 mt -68.61 107.37 2.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.293 1.037 . . . . 0.0 109.963 168.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -105.05 114.9 45.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.125 0.97 . . . . 0.0 110.056 177.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -74.46 80.73 1.92 Allowed 'General case' 0 C--O 1.221 -0.437 0 O-C-N 121.438 -0.789 . . . . 32.609999999999999 109.629 165.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.54 HD13 HA32 ' A' ' 301' ' ' GSH . 3.6 pp -62.68 -4.26 1.94 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 116.622 2.082 . . . . 40.049999999999997 116.622 -170.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.65 -28.53 67.14 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-N 119.283 0.947 . . . . 41.469999999999999 112.576 166.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -116.42 54.15 0.85 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.31 2.644 . . . . 47.170000000000002 109.681 174.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -72.11 114.48 29.6 Favored Pre-proline 0 CA--C 1.546 0.803 0 O-C-N 119.745 -1.847 . . . . 41.270000000000003 111.059 -168.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.18 161.05 41.49 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.627 2.218 . . . . 40.289999999999999 112.209 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -61.85 -31.0 71.22 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.02 1.119 . . . . 42.390000000000001 114.02 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -61.52 -33.73 74.32 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.304 -0.873 . . . . 37.079999999999998 113.069 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -78.44 -35.14 47.24 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.22 -0.925 . . . . 35.880000000000003 112.769 172.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.14 -23.53 63.98 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.869 1.063 . . . . 33.609999999999999 113.869 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -67.48 -42.34 83.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.731 1.212 . . . . 33.789999999999999 111.418 168.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.7 mt -74.81 -32.78 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.348 1.059 . . . . 33.159999999999997 112.038 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.8 t -137.74 94.11 11.87 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 126.327 1.851 . . . . 33.579999999999998 111.351 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.83 -22.42 36.67 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.847 2.365 . . . . 37.899999999999999 113.586 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 1.1 pm0 -78.93 -10.79 59.92 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.896 -1.128 . . . . 38.990000000000002 113.299 167.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.36 25.92 74.5 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.96 1.743 . . . . 35.469999999999999 115.015 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -105.21 149.14 26.21 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.938 1.369 . . . . 34.490000000000002 112.014 -172.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.5 m -106.84 146.68 33.58 Favored Pre-proline 0 N--CA 1.47 0.543 0 C-N-CA 123.913 0.885 . . . . 23.530000000000001 110.153 164.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.35 150.65 86.53 Favored 'Cis proline' 0 C--N 1.346 0.431 0 CA-C-N 119.032 0.69 . . . . 22.879999999999999 113.156 -7.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 p -138.76 145.54 27.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 113.618 -1.628 . . . . 0.0 107.16 156.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.77 160.8 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 O-C-N 121.449 -0.782 . . . . 0.0 111.13 -172.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.6 mtpt -119.85 73.47 0.97 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.258 1.423 . . . . 0.0 108.951 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.5 mt -71.49 117.3 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.443 1.097 . . . . 0.0 109.582 -174.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.559 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 15.4 t0 56.7 30.53 17.72 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 121.904 -0.498 . . . . 0.0 111.97 -165.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.8 t0 73.1 4.91 5.05 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 129.04 2.936 . . . . 0.0 116.37 -169.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -102.31 132.07 48.5 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.525 -1.36 . . . . 0.0 111.547 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -67.25 136.01 54.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.776 0.83 . . . . 0.0 113.056 -168.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -143.56 126.92 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.967 1.707 . . . . 0.0 109.449 170.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -107.08 172.04 7.04 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.832 1.653 . . . . 0.0 111.91 174.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 t0 65.69 111.48 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.89 2.476 . . . . 22.16 114.57 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.457 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 54.3 p -64.04 -21.41 66.5 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 115.696 1.739 . . . . 21.16 115.696 -161.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.502 ' CG ' HH12 ' A' ' 25' ' ' ARG . 35.6 m-20 -75.84 -31.74 59.47 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.494 1.497 . . . . 24.969999999999999 113.666 170.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.8 t -73.33 -38.64 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.932 -1.105 . . . . 23.850000000000001 110.823 170.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.22 -44.77 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.217 1.007 . . . . 23.68 110.962 174.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.4 t -62.59 -46.13 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.373 1.069 . . . . 22.84 111.378 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.09 -45.12 83.14 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 118.869 0.759 . . . . 23.329999999999998 112.99 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 99.1 mt -75.4 -46.48 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.709 -0.877 . . . . 23.309999999999999 112.388 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.6 mt -69.86 -30.09 67.48 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.23 1.377 . . . . 23.48 113.591 -176.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -89.99 -13.18 36.65 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.335 0.865 . . . . 24.239999999999998 113.335 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.535 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 56.6 tt0 -91.81 -47.08 7.53 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.758 1.623 . . . . 39.259999999999998 112.568 167.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.535 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 84.0 mttt -117.52 83.57 2.01 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.719 1.207 . . . . 24.449999999999999 112.024 -161.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -149.25 165.85 16.68 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.275 1.43 . . . . 0.0 110.274 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -70.05 -25.23 27.49 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.152 1.901 . . . . 0.0 112.438 172.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -73.29 156.18 89.34 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.45 1.5 . . . . 0.0 112.155 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -57.24 143.81 92.49 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.218 2.612 . . . . 0.0 114.21 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.57 130.98 24.84 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.436 2.091 . . . . 0.0 112.424 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.0 mt -110.32 1.56 18.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.425 1.49 . . . . 0.0 112.333 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.67 50.08 0.18 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.676 1.99 . . . . 0.0 111.891 160.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 67.9 p -125.12 70.54 61.54 Favored Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 125.63 1.572 . . . . 0.0 109.045 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -69.59 128.75 16.64 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.98 1.786 . . . . 0.0 111.194 -165.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.0 177.31 7.24 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.419 2.746 . . . . 0.0 111.318 170.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -55.58 -31.16 61.96 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 120.924 -1.11 . . . . 0.0 113.897 173.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -53.43 -25.59 16.56 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.293 1.437 . . . . 0.0 113.973 172.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.15 -33.92 74.18 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.577 1.08 . . . . 0.0 113.184 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 84.1 p -68.99 -24.28 64.21 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.385 1.074 . . . . 0.0 113.78 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 t -92.75 -40.74 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.264 1.425 . . . . 0.0 110.111 176.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.96 -30.97 79.02 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.83 1.681 . . . . 0.0 114.45 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 89.8 p -69.27 -17.53 63.75 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.024 1.412 . . . . 0.0 113.77 171.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -95.56 -33.15 12.51 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.105 1.362 . . . . 0.0 112.386 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 69.2 mt -70.2 -36.79 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.607 0.763 . . . . 0.0 111.979 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -56.19 -47.71 98.32 Favored Pre-proline 0 CA--C 1.545 0.758 0 O-C-N 120.223 -1.548 . . . . 0.0 113.898 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.65 -30.38 3.08 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.546 2.164 . . . . 0.0 114.045 171.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.3 p -72.57 -27.16 62.03 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 121.193 1.815 . . . . 0.0 113.273 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -59.03 -46.72 87.5 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.662 -1.274 . . . . 0.0 111.839 160.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.8 t -65.17 -32.65 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.336 0.971 . . . . 0.0 111.951 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -67.73 -39.39 84.27 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.174 0.897 . . . . 0.0 112.393 168.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -70.71 -28.29 64.63 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.469 1.107 . . . . 0.0 112.783 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 20.6 mt -77.01 -15.24 59.69 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.869 1.668 . . . . 0.0 114.147 167.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -137.68 38.95 2.41 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.848 1.259 . . . . 0.0 112.533 -170.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.3 m -73.85 66.0 1.09 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -162.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -67.81 -39.36 83.98 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.401 1.08 . . . . 0.0 111.522 164.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -79.44 111.77 23.4 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 153.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.48 155.85 66.62 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.578 2.852 . . . . 0.0 115.452 -143.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -65.3 -42.51 92.99 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.838 -1.074 . . . . 0.0 113.437 -165.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.75 -21.98 61.67 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.84 -36.9 17.72 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 120.998 -1.064 . . . . 0.0 112.495 167.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 98.4 m -67.82 -27.55 66.81 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.82 0.848 . . . . 0.0 113.042 172.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -58.76 -45.95 88.57 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.795 1.638 . . . . 0.0 111.616 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -68.68 -40.46 80.1 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.792 0.837 . . . . 0.0 111.433 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.91 -24.9 66.93 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.6 tp -82.92 -40.75 19.74 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.864 1.265 . . . . 0.0 111.94 172.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.9 mt -63.45 -41.36 98.63 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.676 1.191 . . . . 0.0 113.351 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -66.58 -35.64 80.7 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.063 1.301 . . . . 0.0 112.774 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -71.79 -39.5 69.85 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.122 -0.986 . . . . 0.0 112.592 171.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.6 mt -64.28 -33.6 76.19 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.837 -1.164 . . . . 0.0 113.121 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -66.7 -44.28 82.11 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.588 1.086 . . . . 0.0 111.577 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.84 81.56 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.558 0.743 . . . . 0.0 112.218 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.2 tp -68.07 -56.75 7.75 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.27 1.028 . . . . 0.0 111.846 172.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.96 -33.44 74.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.576 1.15 . . . . 0.0 113.879 -171.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.42 -34.02 67.56 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.36 -0.689 . . . . 0.0 113.324 173.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -92.67 -29.35 16.13 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 77.4 mt -64.23 -33.74 76.5 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 120.465 -1.397 . . . . 0.0 113.225 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -65.94 -7.63 17.87 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.35 -38.37 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.144 1.378 . . . . 0.0 112.169 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -82.17 -17.38 46.46 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -172.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.2 -164.86 42.57 Favored Glycine 0 CA--C 1.542 1.721 0 CA-C-O 117.718 -1.601 . . . . 0.0 114.42 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.0 -10.67 23.09 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 125.281 3.987 . . . . 0.0 118.144 -119.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -110.32 167.21 10.37 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.175 0.99 . . . . 0.0 110.893 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.2 tt -75.57 6.86 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 120.275 -1.516 . . . . 0.0 112.997 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -116.2 2.79 13.37 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 128.146 2.579 . . . . 0.0 114.422 165.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.93 -117.85 5.7 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.083 1.325 . . . . 0.0 113.251 -173.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -62.45 -35.81 80.44 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -168.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -142.49 162.32 35.76 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.76 1.624 . . . . 0.0 110.484 -171.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.8 mt -62.83 135.68 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.07 0.462 . . . . 0.0 110.528 165.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.7 p -138.59 -174.33 3.8 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.502 1.521 . . . . 0.0 110.814 171.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.95 -19.31 1.73 Allowed 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 169.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 18.4 t -74.27 -40.32 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 120.179 1.354 . . . . 0.0 112.496 174.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -61.5 -44.33 97.28 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.863 -1.148 . . . . 0.0 112.003 167.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.9 mt -62.19 -26.99 68.66 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 122.193 -0.317 . . . . 0.0 111.533 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 52.3 m -79.35 -47.43 15.81 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.845 -1.159 . . . . 0.0 112.694 175.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 51.5 mt -100.01 -37.98 8.77 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -164.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.24 88.48 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -173.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.97 -28.57 19.27 Favored 'Trans proline' 0 C--N 1.351 0.705 0 CA-C-N 120.784 1.316 . . . . 0.0 113.12 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -72.81 -30.55 64.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.611 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 51.6 mt -65.97 -46.61 77.45 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.741 0.816 . . . . 0.0 112.975 169.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -58.33 -36.31 73.22 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.828 0.823 . . . . 0.0 112.323 170.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -73.98 -22.79 59.49 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.867 -1.146 . . . . 0.0 113.76 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.33 -49.78 45.94 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.561 1.073 . . . . 0.0 111.398 162.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -58.1 -37.11 73.9 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.389 1.476 . . . . 0.0 112.479 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 70.4 t -96.87 -62.66 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.236 1.014 . . . . 0.0 113.545 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.05 -54.2 6.83 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.463 -0.773 . . . . 0.0 112.622 -164.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 38.6 tp -65.71 -34.69 78.78 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 119.349 -0.358 . . . . 0.0 111.155 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.03 -29.24 59.17 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.23 1.395 . . . . 0.0 115.336 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -66.48 -22.01 66.19 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -122.29 -21.19 5.92 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -148.33 94.94 2.38 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.291 1.836 . . . . 0.0 108.797 165.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -67.99 78.74 0.22 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.895 1.278 . . . . 0.0 111.171 173.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -76.98 118.2 70.23 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.24 1.016 . . . . 0.0 111.91 -168.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -73.37 110.36 3.04 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.949 1.766 . . . . 0.0 110.662 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 14.0 mm -58.03 115.42 11.14 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 160.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -63.13 153.49 73.6 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 121.634 1.556 . . . . 0.0 112.633 -172.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -61.15 -22.66 64.9 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 169.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -68.11 -25.45 65.32 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 170.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 47.4 mt -86.12 50.91 2.07 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.251 1.42 . . . . 0.0 111.104 167.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.8 -26.87 68.53 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.315 1.046 . . . . 0.0 113.315 -160.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -75.62 -50.66 14.85 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.017 0.826 . . . . 0.0 111.074 171.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 86.3 t -59.17 -39.93 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.757 0.823 . . . . 0.0 111.572 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.4 tp -61.01 -36.01 78.37 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.675 1.19 . . . . 0.0 113.397 174.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -81.0 -37.25 29.48 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -62.61 -33.92 75.99 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.687 1.195 . . . . 0.0 112.872 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.8 mt -59.89 -35.83 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.033 -1.042 . . . . 0.0 112.104 171.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -74.08 -17.83 60.9 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.225 -1.547 . . . . 0.0 112.941 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 51.0 mt -74.88 -15.95 60.69 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 118.339 -0.838 . . . . 0.0 113.148 168.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.6 mt -67.99 -17.69 64.5 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 120.011 1.278 . . . . 0.0 113.828 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -95.09 6.59 48.65 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.419 -1.425 . . . . 0.0 113.477 171.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.7 p -107.69 -179.07 3.8 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.956 1.703 . . . . 0.0 113.222 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 44.8 mtp85 56.46 -164.33 0.15 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.655 1.582 . . . . 0.0 111.335 -172.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 11.5 mp0 -84.62 -41.15 16.66 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.964 1.306 . . . . 0.0 109.276 157.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 77.4 p -70.16 -54.67 11.91 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.867 1.667 . . . . 0.0 114.631 -159.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -67.46 -45.94 74.49 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.701 0.682 . . . . 0.0 111.977 171.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.421 ' HB2' ' HE3' ' A' ' 193' ' ' LYS . 26.1 ttmt -56.63 -39.03 72.93 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.172 -0.955 . . . . 0.0 113.517 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -74.04 -8.84 57.61 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.4 p -77.51 -14.47 59.67 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.401 1.455 . . . . 0.0 113.231 170.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -65.85 101.59 0.67 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.639 1.109 . . . . 0.0 111.636 -174.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.24 159.96 30.2 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.671 0.788 . . . . 0.0 110.496 156.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.38 127.55 33.09 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.076 -0.39 . . . . 0.0 110.359 172.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -63.86 -31.75 73.03 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -161.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -61.89 -39.85 93.37 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.997 -1.064 . . . . 0.0 112.424 171.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -81.89 -2.25 50.55 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.552 -1.343 . . . . 0.0 114.242 173.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 85.4 t -85.83 -44.7 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.402 1.081 . . . . 0.0 110.294 163.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.2 mt -64.51 -56.63 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.864 1.266 . . . . 0.0 111.526 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.7 -13.65 62.28 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.474 1.11 . . . . 0.0 113.825 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -86.44 -36.54 9.56 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.808 -1.183 . . . . 0.0 113.484 170.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -78.04 -31.31 50.31 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.688 1.595 . . . . 0.0 113.615 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -53.59 -47.97 94.68 Favored Pre-proline 0 CA--C 1.553 1.066 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -175.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.93 -23.75 29.65 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 121.681 1.588 . . . . 0.0 113.919 171.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.437 ' HE2' HB22 ' A' ' 301' ' ' GSH . 57.2 mttp -74.33 -8.61 56.85 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 117.595 -1.193 . . . . 0.0 114.204 175.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 45.7 t -60.59 -21.36 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 119.274 0.943 . . . . 0.0 111.268 160.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -105.72 -12.17 16.01 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 170.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.882 0 C-N-CA 125.394 1.478 . . . . 0.0 112.653 -170.852 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 301' ' ' GSH . . . . . 0.54 HA32 HD13 ' A' ' 44' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.559 ' H2 ' ' HB2' ' A' ' 67' ' ' ASP . 88.2 mtp . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.02 -173.64 0.1 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.494 1.518 . . . . 0.0 114.019 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 74.8 mt -115.74 137.3 52.22 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.249 1.42 . . . . 0.0 111.188 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -130.59 144.37 51.37 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.681 1.192 . . . . 0.0 108.723 160.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.3 pt -128.62 135.35 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.999 0.92 . . . . 0.0 109.34 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 79.2 m -110.84 117.29 33.01 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.493 1.117 . . . . 0.0 109.459 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.9 m -132.45 158.78 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.773 1.229 . . . . 0.0 111.09 -165.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -59.62 114.99 3.01 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.986 -0.446 . . . . 0.0 110.685 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -80.94 149.65 29.3 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.984 154.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.96 142.89 57.18 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.921 0.867 . . . . 0.0 113.057 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.91 129.15 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 163.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.66 -18.99 12.4 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-O 118.405 -1.219 . . . . 0.0 115.41 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.67 65.97 26.55 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 119.114 1.457 . . . . 0.0 112.286 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 62.5 Cg_endo -64.82 -5.16 9.97 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.705 2.937 . . . . 0.0 115.489 -172.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -89.96 3.63 52.54 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.6 pt -133.8 164.57 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.201 1.4 . . . . 0.0 111.704 173.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.19 150.03 39.94 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.817 0.847 . . . . 0.0 111.922 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.49 -164.86 10.09 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.592 1.568 . . . . 0.0 111.834 165.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -57.78 104.28 0.18 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.6 t -153.37 106.41 2.58 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 113.74 -1.573 . . . . 0.0 110.212 136.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -67.62 -15.3 44.44 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.822 2.348 . . . . 0.0 112.761 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -74.44 -29.39 61.46 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.374 -0.829 . . . . 0.0 112.369 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 89.1 m -70.15 -37.08 75.14 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.326 -1.484 . . . . 0.0 112.816 167.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -60.41 -28.08 67.97 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.479 HH12 ' CG ' ' A' ' 74' ' ' ASP . 57.3 mtp180 -56.76 -40.05 75.12 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.678 1.191 . . . . 0.0 112.691 171.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.3 -40.61 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.138 1.375 . . . . 0.0 111.52 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.51 -43.54 93.36 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.951 0.5 . . . . 0.0 111.132 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.8 tp -59.15 -46.59 87.97 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.353 1.061 . . . . 0.0 113.268 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.2 p -78.44 -37.96 42.4 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.35 -36.91 77.35 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.484 0.584 . . . . 0.0 111.621 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -77.98 -18.33 56.1 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -75.43 -46.33 33.38 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.142 -1.599 . . . . 0.0 111.534 166.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -76.52 -5.03 45.8 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.071 1.348 . . . . 0.0 114.343 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm 58.68 20.27 7.61 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.325 1.85 . . . . 0.0 114.477 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.1 mt -70.98 130.54 88.18 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.217 -0.896 . . . . 0.0 108.679 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.01 139.38 29.81 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.331 2.021 . . . . 0.0 111.99 173.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -144.67 154.42 42.75 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.857 1.663 . . . . 0.0 110.194 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -81.94 125.48 30.81 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.177 -0.952 . . . . 0.0 110.019 162.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.5 t -93.16 95.75 9.6 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.515 0.726 . . . . 0.0 110.999 169.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -79.97 99.06 7.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.676 0.79 . . . . 0.0 109.583 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 82.2 mt -66.75 109.72 2.98 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.945 0.898 . . . . 0.0 109.599 169.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mm -120.23 111.88 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.736 1.215 . . . . 0.0 109.15 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -77.5 89.42 3.85 Favored 'General case' 0 C--O 1.222 -0.368 0 O-C-N 120.68 -1.263 . . . . 32.609999999999999 108.602 166.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.42 1.79 0.19 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 117.519 2.415 . . . . 40.049999999999997 117.519 -175.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -69.95 -24.02 76.68 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-N 119.918 1.235 . . . . 41.469999999999999 112.734 161.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -128.11 66.84 1.36 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.974 2.51 . . . . 47.170000000000002 108.823 171.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -80.63 116.49 62.45 Favored Pre-proline 0 N--CA 1.473 0.684 0 O-C-N 120.055 -1.653 . . . . 41.270000000000003 110.551 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.15 161.65 44.98 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.689 2.26 . . . . 40.289999999999999 111.638 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -61.82 -29.83 70.42 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.028 1.121 . . . . 42.390000000000001 114.028 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -60.72 -33.02 72.27 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.269 1.028 . . . . 37.079999999999998 113.362 170.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -79.38 -36.61 38.95 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.951 -1.093 . . . . 35.880000000000003 112.599 173.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.7 mt -68.12 -25.54 65.35 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.343 0.868 . . . . 33.609999999999999 113.343 174.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -64.14 -47.37 80.18 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.606 1.563 . . . . 33.789999999999999 111.457 168.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.2 mt -72.39 -37.38 57.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.894 0.877 . . . . 33.159999999999997 111.625 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.1 t -126.75 92.19 45.39 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 126.177 1.791 . . . . 33.579999999999998 110.746 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.03 -17.47 36.34 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.856 2.371 . . . . 37.899999999999999 113.965 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -76.48 -11.58 59.9 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.102 -0.999 . . . . 38.990000000000002 113.533 165.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.98 21.35 76.8 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.548 1.07 . . . . 35.469999999999999 114.561 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -104.08 150.5 24.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.451 1.501 . . . . 34.490000000000002 113.688 -173.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.19 153.96 40.76 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 125.93 1.692 . . . . 23.530000000000001 111.046 162.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -63.66 149.37 68.0 Favored 'Cis proline' 0 C--N 1.347 0.48 0 CA-C-O 121.852 0.688 . . . . 22.879999999999999 112.608 -12.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.38 146.95 28.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 113.985 -1.461 . . . . 0.0 107.494 156.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.1 m -134.7 165.26 31.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 123.565 0.746 . . . . 0.0 111.004 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -124.06 71.7 1.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.757 1.623 . . . . 0.0 109.424 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.5 mt -74.74 117.51 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.395 1.078 . . . . 0.0 108.994 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.497 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 48.0 t0 53.8 40.47 31.56 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 121.227 0.537 . . . . 0.0 110.967 -164.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.559 ' HB2' ' H2 ' ' A' ' 1' ' ' MET . 21.6 t0 67.54 -5.84 0.73 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.445 2.298 . . . . 0.0 115.608 -172.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -92.77 135.51 34.06 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.261 -1.525 . . . . 0.0 112.296 -172.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -68.1 131.41 45.37 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.634 1.174 . . . . 0.0 112.465 -170.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.1 t -141.09 129.61 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.165 1.386 . . . . 0.0 109.588 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.29 171.14 7.65 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.929 1.691 . . . . 0.0 111.425 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.9 t0 66.08 111.17 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.527 2.331 . . . . 22.16 114.162 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.467 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 59.9 p -64.09 -21.65 66.62 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 115.15 1.537 . . . . 21.16 115.15 -162.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.479 ' CG ' HH12 ' A' ' 25' ' ' ARG . 38.0 m-20 -74.1 -34.01 63.82 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.023 1.283 . . . . 24.969999999999999 113.421 169.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -72.27 -38.71 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.086 -1.009 . . . . 23.850000000000001 110.785 171.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.56 -44.94 99.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.234 1.014 . . . . 23.68 111.072 175.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.6 t -62.99 -44.65 99.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.384 1.074 . . . . 22.84 111.286 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.43 -35.04 70.18 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 118.633 0.651 . . . . 23.329999999999998 113.91 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 94.8 mt -85.11 -49.9 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 118.339 1.07 . . . . 23.309999999999999 112.122 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.4 mt -65.75 -32.32 73.8 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.809 1.186 . . . . 23.48 113.314 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -90.88 -1.26 57.85 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.627 0.973 . . . . 24.239999999999998 113.627 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -110.88 -53.62 2.68 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.113 1.365 . . . . 39.259999999999998 112.092 167.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -97.06 58.98 1.61 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.384 1.074 . . . . 24.449999999999999 112.847 -161.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -132.64 162.9 54.46 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.996 1.318 . . . . 0.0 111.355 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.08 -26.55 21.34 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.291 1.994 . . . . 0.0 112.398 172.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -72.96 150.57 90.4 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.467 1.107 . . . . 0.0 111.697 171.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -57.24 144.13 91.63 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.048 2.498 . . . . 0.0 115.032 -172.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.72 119.01 5.84 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.768 2.312 . . . . 0.0 113.222 -173.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.5 mt -89.45 2.04 55.06 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.504 1.121 . . . . 0.0 112.654 170.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.05 50.97 0.29 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.647 1.979 . . . . 0.0 110.949 159.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.8 p -125.03 62.78 38.38 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 126.246 1.818 . . . . 0.0 110.132 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -75.64 127.86 10.56 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.825 2.35 . . . . 0.0 111.164 -163.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.51 -176.9 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.532 2.822 . . . . 0.0 111.771 171.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -53.79 -29.31 39.75 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.038 1.335 . . . . 0.0 114.153 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -56.38 -21.61 25.96 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.103 1.361 . . . . 0.0 114.393 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.53 -30.92 71.97 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 120.16 1.346 . . . . 0.0 113.368 173.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.5 p -68.03 -23.79 65.02 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.421 -0.8 . . . . 0.0 113.119 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -95.23 -41.23 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.188 1.395 . . . . 0.0 110.868 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.84 -29.7 76.02 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.446 1.498 . . . . 0.0 114.398 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 88.2 p -67.91 -18.59 64.83 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.729 1.264 . . . . 0.0 114.049 170.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -95.5 -33.35 12.46 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.402 1.481 . . . . 0.0 112.873 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.1 mt -69.82 -37.52 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.642 0.777 . . . . 0.0 111.805 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -56.25 -47.97 97.84 Favored Pre-proline 0 CA--C 1.546 0.811 0 O-C-N 120.406 -1.434 . . . . 0.0 114.028 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.62 -30.83 3.66 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.709 2.273 . . . . 0.0 113.779 171.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.6 p -72.25 -28.05 62.89 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 121.386 1.903 . . . . 0.0 113.277 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -59.88 -45.42 92.55 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.668 -1.27 . . . . 0.0 112.192 161.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.1 t -68.49 -32.23 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.23 -0.919 . . . . 0.0 111.953 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -67.11 -41.97 85.31 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.914 0.886 . . . . 0.0 111.836 169.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -63.65 -39.48 94.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.257 1.023 . . . . 0.0 111.693 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.28 -5.4 31.98 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 169.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -141.78 42.5 1.71 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.846 1.658 . . . . 0.0 111.617 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.0 m -70.05 61.57 0.19 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.239 1.816 . . . . 0.0 115.53 -165.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.18 -37.06 72.18 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.647 1.179 . . . . 0.0 111.738 167.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -81.38 115.4 56.29 Favored Pre-proline 0 CA--C 1.552 1.027 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 152.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.58 153.68 73.53 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.423 2.749 . . . . 0.0 115.084 -147.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -64.7 -42.83 95.0 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.425 -165.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.23 -17.18 60.92 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.403 1.081 . . . . 0.0 113.763 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -86.91 -39.33 7.56 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 121.442 -0.787 . . . . 0.0 112.68 166.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 54.0 m -65.46 -25.93 67.72 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.671 -0.899 . . . . 0.0 112.953 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -58.32 -44.83 88.79 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.908 1.683 . . . . 0.0 111.759 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -71.81 -38.93 70.16 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.523 0.729 . . . . 0.0 111.4 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.84 -23.88 66.77 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 171.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.4 tp -83.21 -41.21 18.67 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.727 1.211 . . . . 0.0 111.914 170.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 23.3 mt -64.2 -41.58 97.0 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.932 1.293 . . . . 0.0 113.478 -177.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -65.15 -36.19 83.45 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.277 1.399 . . . . 0.0 112.598 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -72.88 -38.75 66.87 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.229 -0.919 . . . . 0.0 112.691 172.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.31 -33.83 76.73 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.85 -1.156 . . . . 0.0 113.033 172.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -66.71 -44.65 81.05 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.868 1.213 . . . . 0.0 111.614 172.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.14 86.05 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.511 0.724 . . . . 0.0 112.225 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.4 tp -66.46 -58.16 5.83 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.316 1.446 . . . . 0.0 111.903 170.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.05 -37.08 84.94 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.512 1.125 . . . . 0.0 113.777 -170.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.35 -36.02 74.36 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.235 -0.758 . . . . 0.0 113.528 178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -93.71 -26.33 17.06 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 23.0 mt -63.72 -31.94 73.27 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.592 -1.318 . . . . 0.0 113.584 172.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -64.16 -3.11 2.45 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 171.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.2 t -109.46 -36.5 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.505 1.522 . . . . 0.0 112.704 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -83.65 -28.67 28.23 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 -162.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 144.86 174.92 17.56 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 120.069 1.304 . . . . 0.0 113.926 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.77 -4.01 14.1 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 125.008 3.805 . . . . 0.0 116.417 -164.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -106.24 167.18 9.99 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.433 1.015 . . . . 0.0 110.964 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.0 4.67 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 120.627 -1.296 . . . . 0.0 113.214 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -121.54 16.01 11.2 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.772 2.429 . . . . 0.0 113.649 167.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.34 -110.44 3.49 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 120.838 -1.164 . . . . 0.0 113.022 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -58.06 -34.85 70.55 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -168.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -155.34 162.33 40.86 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.941 1.696 . . . . 0.0 110.895 -156.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 13.9 mt -63.87 132.61 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 164.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 29.3 p -132.66 -177.16 4.36 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.354 1.462 . . . . 0.0 110.474 169.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.13 -20.92 2.82 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 167.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.6 t -73.44 -41.01 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 120.704 -1.248 . . . . 0.0 112.325 173.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.69 -42.7 99.29 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.618 1.167 . . . . 0.0 112.233 168.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.7 mt -62.61 -23.2 66.93 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.6 m -83.08 -45.56 13.85 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.041 -1.037 . . . . 0.0 112.537 175.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 39.3 mt -100.15 -35.79 9.54 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -166.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.38 -49.53 92.9 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -70.43 -27.07 23.72 Favored 'Trans proline' 0 C--N 1.35 0.623 0 CA-C-N 120.942 1.372 . . . . 0.0 113.026 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -74.88 -28.39 60.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.444 -1.265 . . . . 0.0 112.654 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.0 mt -66.56 -45.86 77.95 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.824 0.85 . . . . 0.0 112.937 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -57.56 -39.64 77.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.293 0.637 . . . . 0.0 111.837 170.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -70.13 -20.97 63.14 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 9.6 mt -76.1 -51.23 12.68 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.837 1.199 . . . . 0.0 111.172 167.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.75 -34.57 74.64 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.405 1.082 . . . . 0.0 112.283 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 96.5 t -87.64 -75.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.198 0.999 . . . . 0.0 112.462 174.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.26 -52.39 16.58 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.886 -1.133 . . . . 0.0 112.153 -154.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.0 tp -68.25 -25.44 65.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.459 0.704 . . . . 0.0 112.543 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.22 -25.67 48.19 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.745 1.164 . . . . 0.0 115.508 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -68.46 -21.24 64.64 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -120.47 -30.61 4.51 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.97 1.308 . . . . 0.0 112.774 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -147.93 94.63 2.37 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.231 1.812 . . . . 0.0 108.668 169.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -67.96 78.15 0.22 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.483 1.113 . . . . 0.0 110.668 168.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -73.16 118.69 70.74 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 124.404 1.082 . . . . 0.0 111.385 -169.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.16 107.51 2.27 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.031 1.821 . . . . 0.0 110.674 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 35.2 mm -60.04 113.43 7.32 Favored Pre-proline 0 CA--C 1.541 0.635 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 163.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -63.33 154.3 68.97 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.741 1.628 . . . . 0.0 112.846 -170.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.48 -23.75 67.53 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.628 1.171 . . . . 0.0 113.241 171.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -65.8 -28.45 69.02 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.665 1.186 . . . . 0.0 113.398 170.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 43.6 mt -84.49 52.68 2.43 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.054 1.342 . . . . 0.0 110.794 166.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.39 -25.82 68.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.085 0.954 . . . . 0.0 112.532 -165.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -75.67 -49.89 17.05 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.914 0.779 . . . . 0.0 111.781 171.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 62.6 t -59.98 -39.36 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.541 0.737 . . . . 0.0 111.207 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 47.7 tp -65.24 -41.33 94.44 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.272 1.029 . . . . 0.0 113.356 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -69.04 -41.24 77.93 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.627 -0.67 . . . . 0.0 112.322 172.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -65.65 -31.81 73.03 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.585 1.154 . . . . 0.0 112.772 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 53.4 mt -58.09 -35.33 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 120.918 -1.114 . . . . 0.0 111.881 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -82.28 -13.31 57.2 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.368 -1.458 . . . . 0.0 113.749 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.0 mt -73.94 -18.14 60.93 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 117.576 -1.202 . . . . 0.0 113.499 160.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.7 mt -66.3 -19.55 65.85 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.51 1.505 . . . . 0.0 113.922 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -95.85 10.81 35.92 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.873 -1.142 . . . . 0.0 113.132 174.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.9 p -119.9 179.3 4.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.079 1.752 . . . . 0.0 113.374 -171.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 50.6 mtp85 56.77 -167.62 0.12 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.489 1.516 . . . . 0.0 110.143 -168.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -81.87 -35.32 29.42 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 122.043 -0.41 . . . . 0.0 110.889 157.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.6 p -69.38 -58.43 4.02 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.692 1.597 . . . . 0.0 114.763 -163.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -67.71 -43.51 79.87 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.149 0.886 . . . . 0.0 112.123 173.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -53.68 -35.33 60.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.922 1.289 . . . . 0.0 113.865 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.76 -7.39 59.22 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 7.8 p -73.24 -21.74 60.56 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.474 1.488 . . . . 0.0 112.518 170.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -60.27 127.29 31.08 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.9 1.28 . . . . 0.0 112.101 -170.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -93.42 173.71 7.57 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.424 1.09 . . . . 0.0 110.558 165.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.83 123.41 21.9 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.84 164.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -57.96 -35.05 70.61 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -165.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -61.39 -39.26 90.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.742 1.217 . . . . 0.0 112.396 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -82.34 0.87 39.74 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.858 -1.151 . . . . 0.0 113.988 173.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.9 t -85.39 -54.76 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.313 0.645 . . . . 0.0 109.98 161.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -46.22 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.123 0.874 . . . . 0.0 112.616 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.5 -10.68 60.14 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -90.07 -31.73 10.58 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 120.861 -1.149 . . . . 0.0 113.301 169.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 16.4 t90 -87.14 -30.8 20.78 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.101 1.76 . . . . 0.0 114.22 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -48.74 -49.47 66.09 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.54 -24.9 35.45 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.651 1.567 . . . . 0.0 113.839 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.604 ' HE2' HB22 ' A' ' 301' ' ' GSH . 44.5 mttp -74.23 -7.36 52.43 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.55 1.14 . . . . 0.0 114.056 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 59.1 t -61.91 -22.14 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 119.518 1.054 . . . . 0.0 111.505 159.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -106.91 -11.7 15.65 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 171.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 C-N-CA 124.484 1.114 . . . . 0.0 113.181 -173.592 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 301' ' ' GSH . . . . . 0.604 HB22 ' HE2' ' A' ' 209' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.602 ' H2 ' ' HB2' ' A' ' 67' ' ' ASP . 88.6 mtp . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 118.71 -0.662 . . . . 0.0 111.345 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.23 -175.9 0.11 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.432 1.493 . . . . 0.0 113.949 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 73.3 mt -115.5 143.14 45.75 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.334 1.454 . . . . 0.0 110.809 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -138.01 149.39 46.03 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.679 1.191 . . . . 0.0 108.831 159.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 pt -130.85 139.05 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.082 0.953 . . . . 0.0 109.202 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.7 m -110.68 125.99 54.05 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.892 0.877 . . . . 0.0 109.635 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.98 157.81 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.858 1.263 . . . . 0.0 110.792 -166.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -60.5 115.26 3.45 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.053 -0.405 . . . . 0.0 110.371 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.447 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -80.97 153.16 27.63 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.06 155.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.76 147.26 46.81 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.199 0.999 . . . . 0.0 112.753 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.71 134.05 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 167.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.69 -26.72 1.64 Allowed Glycine 0 CA--C 1.54 1.594 0 CA-C-O 118.883 -0.954 . . . . 0.0 115.442 -173.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.61 72.38 77.97 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-N 118.603 1.201 . . . . 0.0 112.159 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.417 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 61.0 Cg_endo -65.03 -12.3 33.99 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.246 2.63 . . . . 0.0 114.927 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -82.94 2.89 32.35 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.6 pt -135.38 161.26 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.101 1.36 . . . . 0.0 111.503 177.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.26 149.92 40.57 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.612 0.765 . . . . 0.0 111.516 167.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.27 -168.41 11.29 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.632 1.587 . . . . 0.0 111.656 166.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -59.06 105.29 0.31 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 118.61 1.205 . . . . 0.0 114.161 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.2 t -152.01 107.3 2.84 Favored Pre-proline 0 CA--C 1.552 1.025 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.207 135.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -67.75 -15.85 45.1 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.815 2.343 . . . . 0.0 112.874 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -72.13 -28.53 63.32 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.065 -1.022 . . . . 0.0 112.381 171.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.09 -37.28 75.36 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.277 -1.514 . . . . 0.0 112.997 168.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -60.76 -27.25 67.83 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.491 HH12 ' CG ' ' A' ' 74' ' ' ASP . 60.1 mtp180 -57.18 -40.87 78.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.56 1.144 . . . . 0.0 112.452 172.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -78.87 -40.29 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.137 1.375 . . . . 0.0 111.546 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.5 mt -59.13 -43.6 92.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.982 0.513 . . . . 0.0 111.328 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.22 -48.49 81.42 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.068 0.947 . . . . 0.0 113.08 -177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.6 p -76.49 -37.4 56.87 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.3 mt -70.34 -36.99 74.56 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.391 0.541 . . . . 0.0 111.775 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -77.56 -20.08 54.67 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -74.11 -47.42 36.39 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.243 -1.535 . . . . 0.0 111.654 167.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -76.74 -4.36 42.97 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.802 1.241 . . . . 0.0 114.022 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm 58.65 19.58 6.89 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 126.377 1.871 . . . . 0.0 114.426 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.0 mt -72.84 127.37 89.73 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 118.152 -0.928 . . . . 0.0 108.641 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.31 143.13 34.68 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.405 2.07 . . . . 0.0 112.191 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -146.98 155.2 42.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.959 1.704 . . . . 0.0 109.92 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -80.36 131.64 35.66 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.046 -1.034 . . . . 0.0 109.789 158.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 t -99.41 94.23 6.32 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.999 0.92 . . . . 0.0 110.505 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -77.43 100.73 6.1 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.711 0.767 . . . . 0.0 109.479 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 99.4 mt -67.28 107.0 2.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.558 1.143 . . . . 0.0 109.241 170.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.3 mm -118.62 108.4 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.671 1.189 . . . . 0.0 109.059 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -75.46 90.03 2.7 Favored 'General case' 0 C--O 1.219 -0.552 0 O-C-N 120.716 -1.24 . . . . 32.609999999999999 108.216 165.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.418 HD23 HG22 ' A' ' 60' ' ' VAL . 1.5 pp -63.51 1.77 0.51 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 117.837 2.532 . . . . 40.049999999999997 117.837 -171.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.66 -19.56 79.72 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-N 119.896 1.226 . . . . 41.469999999999999 112.874 160.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -126.13 49.86 1.94 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 129.914 3.286 . . . . 47.170000000000002 109.36 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -78.27 118.15 70.51 Favored Pre-proline 0 N--CA 1.472 0.627 0 O-C-N 119.464 -2.023 . . . . 41.270000000000003 111.253 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.52 160.01 50.91 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.647 2.232 . . . . 40.289999999999999 111.623 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -62.12 -28.94 69.99 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.851 -1.155 . . . . 42.390000000000001 113.853 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 81.8 t90 -61.73 -32.24 72.46 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.508 0.929 . . . . 37.079999999999998 113.508 170.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -79.76 -33.83 40.33 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.819 -1.176 . . . . 35.880000000000003 112.619 172.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.0 mt -68.64 -23.72 64.46 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.449 0.907 . . . . 33.609999999999999 113.449 173.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -65.89 -41.88 90.97 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.894 1.278 . . . . 33.789999999999999 111.974 167.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.0 mt -74.11 -35.89 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 124.306 1.042 . . . . 33.159999999999997 111.654 175.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.4 t -133.08 92.9 24.12 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 126.121 1.768 . . . . 33.579999999999998 110.96 -175.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.73 -15.36 37.17 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.636 2.224 . . . . 37.899999999999999 113.901 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -76.55 -13.0 60.11 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.004 -1.06 . . . . 38.990000000000002 113.438 165.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.69 16.98 72.6 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.932 -1.105 . . . . 35.469999999999999 114.595 -172.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -100.12 155.23 17.85 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.399 1.48 . . . . 34.490000000000002 114.266 -173.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.418 HG22 HD23 ' A' ' 44' ' ' LEU . 33.0 m -115.39 157.26 44.44 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 126.713 2.005 . . . . 23.530000000000001 111.125 163.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -62.16 149.57 59.59 Favored 'Cis proline' 0 C--N 1.349 0.575 0 CA-C-O 122.327 0.886 . . . . 22.879999999999999 112.861 -13.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.09 146.66 22.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 113.8 -1.546 . . . . 0.0 107.303 163.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.59 163.58 30.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 123.522 0.729 . . . . 0.0 111.416 -169.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -120.95 69.27 0.89 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.547 1.939 . . . . 0.0 109.749 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.9 mt -75.05 119.15 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.745 0.818 . . . . 0.0 108.848 -175.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.492 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 46.8 t0 54.14 39.95 31.2 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.147 0.498 . . . . 0.0 111.019 -164.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.602 ' HB2' ' H2 ' ' A' ' 1' ' ' MET . 16.4 t0 68.65 -6.75 0.8 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 127.362 2.265 . . . . 0.0 115.638 -171.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -92.98 136.72 33.0 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.293 -1.504 . . . . 0.0 112.568 -170.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -64.01 127.95 33.68 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.311 1.444 . . . . 0.0 112.874 -175.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -141.59 132.66 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.526 1.53 . . . . 0.0 109.558 170.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -112.63 173.56 6.32 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.731 1.612 . . . . 0.0 111.621 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.1 t0 67.04 110.58 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 127.628 2.371 . . . . 22.16 114.485 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.483 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 59.5 p -62.97 -24.96 68.14 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 115.322 1.601 . . . . 21.16 115.322 -164.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.491 ' CG ' HH12 ' A' ' 25' ' ' ARG . 36.9 m-20 -72.04 -36.43 69.64 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.189 1.359 . . . . 24.969999999999999 112.998 170.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.69 -38.69 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.23 -0.919 . . . . 23.850000000000001 110.95 173.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.12 -44.04 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.374 1.07 . . . . 23.68 111.213 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.68 -42.79 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.476 1.11 . . . . 22.84 111.318 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.97 -26.97 61.55 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.215 -0.77 . . . . 23.329999999999998 114.565 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 87.7 mt -92.49 -50.76 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 118.718 1.259 . . . . 23.309999999999999 112.059 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.5 mt -65.55 -29.46 70.09 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.618 1.099 . . . . 23.48 113.452 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -89.24 -2.02 58.31 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.697 0.999 . . . . 24.239999999999998 113.697 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.402 ' OE2' ' HE3' ' A' ' 83' ' ' LYS . 38.7 tt0 -115.06 -47.63 2.86 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.679 1.592 . . . . 39.259999999999998 112.513 173.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.402 ' HE3' ' OE2' ' A' ' 82' ' ' GLU . 84.2 mttt -104.92 64.45 0.72 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.977 1.311 . . . . 24.449999999999999 112.415 -165.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -138.64 164.15 41.83 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.366 1.466 . . . . 0.0 110.713 174.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.69 -26.27 23.38 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.23 1.954 . . . . 0.0 112.655 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -74.64 154.71 87.44 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.043 1.337 . . . . 0.0 111.872 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -56.16 140.79 87.77 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.992 2.461 . . . . 0.0 113.635 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.97 133.93 35.27 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.215 1.943 . . . . 0.0 112.139 -176.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.9 mt -107.61 1.52 23.29 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.628 1.571 . . . . 0.0 112.065 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.8 49.53 0.23 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.769 2.027 . . . . 0.0 111.497 159.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 44.8 p -123.42 67.28 36.59 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 125.077 1.351 . . . . 0.0 109.012 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -74.19 124.2 8.85 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.393 2.062 . . . . 0.0 110.032 -165.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.73 -176.79 2.18 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.72 2.28 . . . . 0.0 111.133 170.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 23.0 mp0 -56.06 -30.08 61.43 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.406 2.282 . . . . 0.0 112.785 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -54.72 -23.86 19.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.167 1.787 . . . . 0.0 114.203 171.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.47 -33.42 73.74 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.981 -1.074 . . . . 0.0 113.213 173.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 59.5 p -70.13 -20.52 63.16 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.9 t -92.8 -42.31 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.276 1.43 . . . . 0.0 110.342 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.99 -30.21 77.08 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.122 1.344 . . . . 0.0 114.587 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 97.7 p -66.94 -19.75 65.78 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.603 1.202 . . . . 0.0 113.958 171.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -95.79 -32.99 12.44 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.477 1.511 . . . . 0.0 112.814 172.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 61.9 mt -68.31 -37.85 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.55 0.74 . . . . 0.0 111.559 173.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -58.11 -47.29 99.12 Favored Pre-proline 0 CA--C 1.547 0.847 0 O-C-N 120.314 -1.492 . . . . 0.0 114.274 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.23 -30.33 5.59 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.703 2.269 . . . . 0.0 113.893 172.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.8 p -71.75 -27.96 63.32 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 121.009 1.731 . . . . 0.0 112.962 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -62.29 -42.34 99.27 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.329 -1.482 . . . . 0.0 112.787 161.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.45 -37.5 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-N 120.002 1.274 . . . . 0.0 111.348 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -65.97 -38.17 87.87 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.897 0.879 . . . . 0.0 112.2 172.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -71.79 -28.14 63.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.48 1.112 . . . . 0.0 112.646 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.8 mt -83.61 -2.74 56.75 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.555 1.542 . . . . 0.0 114.403 168.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -144.64 39.53 1.26 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.253 1.421 . . . . 0.0 112.925 -175.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 m -73.25 65.73 0.85 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -162.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 95.9 mttt -70.68 -35.5 72.85 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.92 1.288 . . . . 0.0 111.875 166.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -79.52 117.79 69.03 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-O 117.102 -1.428 . . . . 0.0 107.431 152.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -53.89 149.62 33.27 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.27 2.647 . . . . 0.0 116.53 -154.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.38 -41.85 93.29 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.101 -170.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.62 -19.64 59.07 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.453 1.101 . . . . 0.0 113.634 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.79 -37.53 13.27 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 121.046 -1.034 . . . . 0.0 112.485 166.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 63.9 m -65.8 -29.4 69.89 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.011 0.924 . . . . 0.0 112.99 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -57.38 -43.64 83.79 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.67 1.588 . . . . 0.0 111.769 174.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -70.35 -40.31 74.14 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.891 0.876 . . . . 0.0 111.533 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.48 -21.89 65.5 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 173.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.7 tp -84.59 -40.3 17.67 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.078 1.351 . . . . 0.0 111.882 170.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.2 mt -64.15 -41.55 97.12 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.937 1.295 . . . . 0.0 113.449 -176.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.01 -34.44 78.1 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.492 1.496 . . . . 0.0 112.87 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.52 -36.76 60.46 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.27 -0.894 . . . . 0.0 112.914 171.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.5 mt -64.89 -36.2 83.61 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.742 -1.224 . . . . 0.0 112.823 172.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -64.53 -42.99 95.4 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.456 1.103 . . . . 0.0 111.309 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.57 -37.5 87.56 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.39 0.676 . . . . 0.0 112.345 176.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 tp -66.62 -55.27 16.09 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.386 1.075 . . . . 0.0 111.643 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -66.68 -38.54 87.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.021 1.328 . . . . 0.0 113.766 -170.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.67 -33.68 83.35 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.24 -0.755 . . . . 0.0 113.494 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -91.23 -31.06 16.3 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 117.77 0.785 . . . . 0.0 113.004 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 16.0 mt -62.27 -31.69 72.3 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.564 -1.335 . . . . 0.0 113.247 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -65.36 0.59 1.4 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 172.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.2 t -109.32 -25.75 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.854 1.661 . . . . 0.0 113.22 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -106.11 -9.43 16.97 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 -161.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 122.33 171.2 13.84 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 119.863 1.211 . . . . 0.0 113.604 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -78.06 -4.69 14.6 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.683 3.589 . . . . 0.0 116.122 -160.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -98.8 167.41 10.78 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.082 -1.011 . . . . 0.0 111.649 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.4 mt -69.86 -4.16 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 120.576 -1.328 . . . . 0.0 113.055 174.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -121.68 27.83 7.98 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.033 1.733 . . . . 0.0 113.707 165.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.42 -108.81 2.71 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.256 0.931 . . . . 0.0 113.023 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -60.28 -33.28 72.1 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -172.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -148.2 163.51 36.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.157 1.383 . . . . 0.0 111.694 -167.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 51.8 mt -64.79 135.21 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.602 0.761 . . . . 0.0 109.645 164.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 29.3 p -135.33 -176.56 4.31 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.914 1.286 . . . . 0.0 111.258 169.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.41 -22.3 2.9 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 167.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.0 t -72.12 -42.47 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 120.945 -1.097 . . . . 0.0 112.005 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -61.35 -43.67 98.48 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 120.964 -1.085 . . . . 0.0 112.373 169.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 25.1 mt -61.65 -21.91 64.82 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 24.8 m -82.0 -47.85 12.16 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.187 -0.946 . . . . 0.0 112.135 175.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 26.8 mt -97.05 -34.4 11.18 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -167.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.77 -49.24 94.9 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -174.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.06 -28.4 15.99 Favored 'Trans proline' 0 C--N 1.35 0.617 0 CA-C-N 120.996 1.391 . . . . 0.0 112.998 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -68.88 -30.52 69.04 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 117.487 -1.244 . . . . 0.0 112.572 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 56.3 mt -68.24 -45.5 73.05 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -56.98 -39.73 75.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.188 0.595 . . . . 0.0 111.477 170.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -70.46 -18.91 62.99 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.5 mt -76.44 -52.6 9.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.681 1.128 . . . . 0.0 111.261 166.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -62.97 -29.9 71.17 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.145 0.978 . . . . 0.0 112.395 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 76.0 t -89.64 -70.72 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.921 1.289 . . . . 0.0 113.168 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.32 -52.39 7.76 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.83 -0.544 . . . . 0.0 112.351 -158.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 42.8 tp -65.76 -31.08 71.87 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 118.948 -0.549 . . . . 0.0 111.344 171.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -55.64 -28.3 51.34 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.177 1.37 . . . . 0.0 115.804 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -71.08 -15.31 62.52 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -126.2 -28.45 3.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.604 1.162 . . . . 0.0 112.807 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -145.63 97.06 2.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.805 2.042 . . . . 0.0 108.518 164.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -68.34 78.93 0.26 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.204 1.002 . . . . 0.0 110.561 166.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -68.76 118.13 57.76 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.095 0.958 . . . . 0.0 110.956 -173.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.19 100.85 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.954 1.77 . . . . 0.0 110.301 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.4 mm -55.3 111.51 3.14 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.664 1.186 . . . . 0.0 108.119 167.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -63.24 149.93 89.98 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.323 1.349 . . . . 0.0 112.519 -168.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.29 -19.53 65.48 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.849 -1.157 . . . . 0.0 113.429 172.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -62.41 -36.02 81.03 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.99 1.316 . . . . 0.0 112.732 167.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 45.7 mt -80.75 52.55 1.72 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.59 1.556 . . . . 0.0 111.12 166.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -26.61 67.85 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.52 1.128 . . . . 0.0 112.353 -170.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -77.83 -48.58 16.15 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.457 -0.777 . . . . 0.0 112.069 174.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.75 -39.46 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.862 0.865 . . . . 0.0 110.944 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 56.1 tp -63.43 -40.61 97.63 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.816 0.847 . . . . 0.0 113.026 175.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -69.56 -41.89 75.26 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.466 0.706 . . . . 0.0 112.533 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -64.55 -32.39 74.02 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.533 1.133 . . . . 0.0 112.538 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.13 -35.03 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 120.993 -1.067 . . . . 0.0 111.851 169.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 40.7 mmtt -80.43 -16.79 53.57 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.332 -1.48 . . . . 0.0 112.867 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.66 -18.67 62.84 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.152 -0.928 . . . . 0.0 113.434 162.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 73.8 mt -66.29 -18.24 65.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.117 1.326 . . . . 0.0 113.988 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -98.04 9.32 43.11 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.763 1.225 . . . . 0.0 112.41 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.0 p -116.27 179.14 4.08 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.363 1.465 . . . . 0.0 113.622 -170.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.4 mtp85 57.17 -163.67 0.18 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.578 1.551 . . . . 0.0 110.079 -169.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -84.31 -31.11 25.04 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.966 -0.459 . . . . 0.0 111.428 156.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 35.2 p -75.36 -59.16 2.87 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.968 1.307 . . . . 0.0 114.351 -160.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -64.85 -42.33 94.97 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.799 0.727 . . . . 0.0 112.0 172.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -53.36 -33.8 55.04 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.308 1.443 . . . . 0.0 114.028 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -86.83 -8.14 57.59 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 4.1 p -73.73 -18.59 60.97 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.346 1.43 . . . . 0.0 112.425 169.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -58.94 132.49 54.15 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.833 1.253 . . . . 0.0 111.863 -175.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -106.85 176.96 5.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.048 1.339 . . . . 0.0 110.465 169.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.47 116.53 9.99 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.155 -0.965 . . . . 0.0 109.571 167.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -57.11 -34.44 68.35 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -167.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.65 -40.69 79.87 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.673 1.189 . . . . 0.0 111.778 174.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -86.53 -3.16 58.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.331 1.852 . . . . 0.0 112.809 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 25.8 t -84.99 -49.25 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.279 1.032 . . . . 0.0 110.091 159.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 12.7 mt -60.98 -54.59 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.509 1.123 . . . . 0.0 111.691 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.71 -15.98 63.25 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.269 1.027 . . . . 0.0 113.389 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.47 -27.44 43.34 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 118.616 -1.102 . . . . 0.0 113.48 171.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -90.0 -34.96 15.79 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.476 1.911 . . . . 0.0 114.262 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -48.1 -48.94 62.82 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.2 -24.83 27.23 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 121.577 1.518 . . . . 0.0 114.022 174.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.418 ' HE2' HB22 ' A' ' 301' ' ' GSH . 39.5 mttp -74.96 -6.64 50.38 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.409 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 61.5 t -60.29 -18.42 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.181 -0.95 . . . . 0.0 111.416 158.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -118.79 17.19 13.52 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.554 1.942 . . . . 0.0 115.052 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.922 0 C-N-CA 125.168 1.387 . . . . 0.0 110.386 171.395 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 301' ' ' GSH . . . . . 0.483 ' C1 ' ' H ' ' A' ' 73' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 75.9 mt -125.19 118.66 26.54 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.651 1.981 . . . . 0.0 109.582 -173.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -116.42 132.98 56.53 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.183 0.993 . . . . 0.0 109.589 173.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.7 pt -128.69 135.99 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 118.93 0.786 . . . . 0.0 110.957 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.0 m -111.95 122.27 47.3 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.097 0.959 . . . . 0.0 109.922 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.54 161.18 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.147 0.979 . . . . 0.0 112.018 -166.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -56.73 117.54 4.01 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.168 1.387 . . . . 0.0 111.753 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.413 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -75.11 148.67 39.51 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.138 155.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.16 151.12 47.63 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.132 0.968 . . . . 0.0 112.573 175.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.9 t -65.97 123.54 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.327 0.651 . . . . 0.0 109.311 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.91 -17.54 2.21 Favored Glycine 0 CA--C 1.54 1.612 0 N-CA-C 116.297 1.279 . . . . 0.0 116.297 -176.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.04 72.55 55.11 Favored Pre-proline 0 CA--C 1.548 0.867 0 CA-C-N 119.098 1.449 . . . . 0.0 111.622 -175.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.413 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 48.6 Cg_endo -64.35 -14.67 45.37 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.135 2.557 . . . . 0.0 115.265 -167.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -84.4 -0.39 52.54 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.0 pt -135.15 165.28 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.65 1.18 . . . . 0.0 112.081 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.0 mt -73.66 146.45 44.53 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.185 0.994 . . . . 0.0 111.665 173.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.48 -159.05 8.67 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.992 1.282 . . . . 0.0 112.15 167.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.428 ' CG ' ' HZ3' ' A' ' 209' ' ' LYS . 62.5 t0 -59.11 98.22 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 122.934 1.35 . . . . 0.0 113.788 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.2 t -153.26 95.85 2.91 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.425 1.49 . . . . 0.0 108.718 142.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.86 -20.01 64.38 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.163 1.909 . . . . 0.0 112.391 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -65.93 -37.34 85.8 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.669 1.188 . . . . 0.0 112.846 172.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 95.1 m -64.81 -38.15 90.0 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.723 -1.235 . . . . 0.0 112.142 169.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -65.92 -25.56 67.2 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 118.519 -0.753 . . . . 0.0 112.73 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -58.23 -43.42 87.76 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.603 1.161 . . . . 0.0 113.244 168.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.02 -40.13 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.287 1.035 . . . . 0.0 110.792 -175.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.8 mt -61.59 -40.55 95.17 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.917 -0.489 . . . . 0.0 111.684 170.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 tp -60.55 -47.71 84.98 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.775 1.23 . . . . 0.0 113.34 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.1 p -73.06 -33.42 65.66 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.9 1.227 . . . . 0.0 113.46 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.52 -40.82 96.33 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.525 -0.735 . . . . 0.0 111.986 173.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -80.34 -23.69 40.39 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -65.0 -45.08 87.08 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.073 -1.017 . . . . 0.0 111.597 164.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -68.85 -23.38 64.23 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.241 -0.912 . . . . 0.0 112.671 171.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.0 mtmm 59.64 19.56 8.19 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.351 1.861 . . . . 0.0 112.407 -170.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.4 tt -74.15 140.23 76.54 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.2 1.4 . . . . 0.0 109.884 -171.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -66.87 132.32 28.07 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 121.803 1.668 . . . . 0.0 112.02 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -141.65 169.88 16.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.085 1.754 . . . . 0.0 111.169 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.674 ' HE2' ' NE2' ' A' ' 40' ' ' HIS . 52.1 tttt -130.59 127.77 39.7 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.069 1.747 . . . . 0.0 109.015 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.521 ' C ' ' HD2' ' A' ' 40' ' ' HIS . 27.6 t -114.17 138.16 50.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.157 0.983 . . . . 0.0 112.939 -170.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.674 ' NE2' ' HE2' ' A' ' 38' ' ' LYS . 6.1 m170 -126.31 108.9 11.68 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.965 1.706 . . . . 0.0 108.416 -171.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.6 mt -76.89 107.66 9.38 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.267 0.627 . . . . 0.0 110.494 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.4 mm -91.34 119.45 38.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.654 1.181 . . . . 0.0 109.379 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -69.14 126.3 29.35 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.292 -0.632 . . . . 32.609999999999999 109.292 161.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.9 mt -88.58 -18.47 28.01 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.122 0.786 . . . . 40.049999999999997 113.122 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.55 -20.43 71.6 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 118.79 0.723 . . . . 41.469999999999999 114.344 172.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -147.49 90.44 1.86 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.836 1.655 . . . . 47.170000000000002 108.688 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -84.82 135.0 40.63 Favored Pre-proline 0 N--CA 1.469 0.491 0 C-N-CA 124.142 0.977 . . . . 41.270000000000003 110.034 -170.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -59.26 140.45 94.73 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.343 2.029 . . . . 40.289999999999999 111.737 171.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.06 -40.56 89.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.195 0.813 . . . . 42.390000000000001 113.195 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 31.7 p-90 -65.97 -13.41 59.76 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.233 1.198 . . . . 37.079999999999998 114.233 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -67.49 -26.88 66.58 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.242 -1.537 . . . . 35.880000000000003 112.62 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.9 mt -70.66 -21.08 62.65 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.368 0.877 . . . . 33.609999999999999 113.368 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.72 -16.36 61.19 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.192 0.997 . . . . 33.789999999999999 112.57 171.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.3 mt -102.58 -43.39 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.13 1.372 . . . . 33.159999999999997 110.7 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.4 t -124.8 104.24 30.49 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 125.451 1.5 . . . . 33.579999999999998 110.376 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.29 -19.64 38.12 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.51 2.14 . . . . 37.899999999999999 113.769 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -83.77 -5.87 59.3 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.77 1.026 . . . . 38.990000000000002 113.77 168.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.91 14.22 65.23 Favored Glycine 0 CA--C 1.534 1.276 0 O-C-N 120.878 -1.139 . . . . 35.469999999999999 114.773 -172.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -91.89 156.28 17.59 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.262 1.425 . . . . 34.490000000000002 112.818 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.0 m -109.44 156.49 39.42 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 126.096 1.759 . . . . 23.530000000000001 110.935 159.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.02 153.78 80.62 Favored 'Cis proline' 0 C--N 1.348 0.508 0 CA-C-O 122.299 0.875 . . . . 22.879999999999999 113.352 -10.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.6 p -143.71 146.74 20.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 113.304 -1.771 . . . . 0.0 107.31 159.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.01 163.62 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.596 0.758 . . . . 0.0 110.444 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -111.35 121.78 46.14 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.934 1.294 . . . . 0.0 109.748 157.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 95.8 mt -106.23 115.35 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.3 1.44 . . . . 0.0 107.693 170.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.404 ' O ' ' HE2' ' A' ' 68' ' ' LYS . 2.5 t70 53.25 43.58 31.31 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 122.529 1.156 . . . . 0.0 113.655 -167.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.2 t70 66.89 -7.97 0.44 Allowed 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -171.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 66' ' ' ASP . 20.4 mmtt -91.83 127.97 37.49 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 119.472 -2.018 . . . . 0.0 111.744 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 27.8 p-90 -74.6 147.57 41.53 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -167.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.0 t -141.57 126.11 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.204 1.801 . . . . 0.0 108.563 171.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -109.96 166.57 10.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.633 1.573 . . . . 0.0 111.534 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.0 t0 67.01 114.07 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.064 2.146 . . . . 22.16 113.935 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.2 p -64.0 -29.21 70.39 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 115.317 1.599 . . . . 21.16 115.317 -163.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -71.08 -29.88 65.85 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 120.135 1.334 . . . . 24.969999999999999 112.163 171.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.2 t -75.09 -42.05 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 O-C-N 120.623 -1.298 . . . . 23.850000000000001 111.645 170.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.01 -45.55 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.345 1.058 . . . . 23.68 110.63 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.9 t -63.1 -43.32 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.09 0.956 . . . . 22.84 111.353 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.97 93.33 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 118.654 0.661 . . . . 23.329999999999998 113.505 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 70.6 mt -77.08 -41.21 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 117.946 0.873 . . . . 23.309999999999999 112.278 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.1 mt -62.97 -37.05 85.55 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.132 1.333 . . . . 23.48 112.48 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -89.27 9.24 26.65 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.333 1.234 . . . . 24.239999999999998 114.333 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -123.04 -42.0 2.3 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.857 1.263 . . . . 39.259999999999998 112.654 173.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -126.25 65.57 1.23 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.77 1.628 . . . . 24.449999999999999 111.456 -167.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.62 165.38 28.71 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 124.815 1.246 . . . . 0.0 110.694 175.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.01 -27.17 8.67 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.965 2.443 . . . . 0.0 114.939 -174.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -77.68 160.91 73.58 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 118.93 0.786 . . . . 0.0 110.06 168.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -52.32 139.01 55.41 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.546 2.164 . . . . 0.0 114.642 -175.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.414 ' O ' HD23 ' A' ' 89' ' ' LEU . 78.7 Cg_endo -69.99 147.09 60.64 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.449 2.766 . . . . 0.0 111.29 176.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.637 HD22 ' HZ1' ' A' ' 145' ' ' LYS . 15.2 mt -131.49 9.87 4.74 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.103 1.361 . . . . 0.0 113.232 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.88 41.89 0.1 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.305 1.842 . . . . 0.0 114.578 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 90.5 m -105.78 103.39 43.72 Favored Pre-proline 0 N--CA 1.472 0.669 0 C-N-CA 125.107 1.363 . . . . 0.0 110.314 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -86.56 112.5 1.05 Allowed 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 124.148 3.232 . . . . 0.0 111.516 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -82.9 -170.46 0.92 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.863 3.042 . . . . 0.0 111.888 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 15.4 mp0 -52.32 -33.33 42.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.211 2.204 . . . . 0.0 113.171 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -57.92 -23.66 54.43 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.458 1.503 . . . . 0.0 114.14 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.55 -27.12 67.49 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.099 -1.001 . . . . 0.0 113.099 172.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 86.2 p -65.75 -47.95 73.53 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.153 -0.967 . . . . 0.0 112.149 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.2 t -77.33 -37.94 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 121.274 -0.891 . . . . 0.0 111.444 174.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.22 -31.34 80.51 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 121.265 -0.897 . . . . 0.0 114.137 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 89.0 p -73.06 -14.55 61.43 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -86.72 -39.83 15.63 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.536 1.135 . . . . 0.0 112.586 167.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.47 -37.52 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.289 1.436 . . . . 0.0 111.418 173.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -53.4 -54.38 45.94 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.915 1.686 . . . . 0.0 114.24 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.78 -34.83 0.87 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.118 2.545 . . . . 0.0 113.303 170.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.0 p -65.9 -31.06 71.77 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.403 1.456 . . . . 0.0 112.631 -173.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -79.58 -20.89 45.88 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.249 -1.532 . . . . 0.0 113.71 172.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.6 t -72.9 -38.2 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 120.399 -1.438 . . . . 0.0 110.744 164.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -69.58 -27.67 65.32 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -59.39 -41.46 89.45 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.097 1.359 . . . . 0.0 111.855 170.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.5 mt -80.14 4.19 18.14 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.819 1.648 . . . . 0.0 114.81 172.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -136.76 35.48 2.64 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 127.97 2.508 . . . . 0.0 111.277 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 p -82.23 58.02 3.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.585 1.954 . . . . 0.0 113.69 -169.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.53 -45.84 91.15 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.162 0.985 . . . . 0.0 110.096 161.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.6 119.52 60.82 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 128.157 2.583 . . . . 0.0 107.71 155.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.16 135.09 68.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.935 1.757 . . . . 0.0 115.843 -159.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -68.16 -32.62 73.01 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 117.779 -1.105 . . . . 0.0 112.115 170.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.74 -32.06 68.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.166 1.386 . . . . 0.0 114.024 174.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.05 -34.86 9.39 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.744 0.688 . . . . 0.0 113.499 172.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 61.4 m -64.94 -40.6 95.28 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.409 1.084 . . . . 0.0 112.107 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -59.58 -27.46 66.28 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.358 1.863 . . . . 0.0 113.655 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -69.2 -18.34 63.9 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.127 0.971 . . . . 0.0 112.885 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.18 -35.8 13.64 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.857 0.863 . . . . 0.0 112.551 165.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.6 mt -65.95 -34.6 78.49 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.69 -36.38 82.73 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.714 0.688 . . . . 0.0 112.076 173.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.77 -30.66 32.24 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.249 0.62 . . . . 0.0 112.425 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.16 -46.86 88.79 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.131 0.972 . . . . 0.0 111.741 166.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.0 mt -65.21 -40.69 94.48 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.774 -1.108 . . . . 0.0 112.128 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -62.66 -42.11 99.43 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.291 1.405 . . . . 0.0 112.576 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.69 -35.78 82.15 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.216 0.607 . . . . 0.0 112.257 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.2 tp -72.84 -54.46 8.75 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.68 0.792 . . . . 0.0 111.529 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -63.1 -35.4 80.14 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.498 1.919 . . . . 0.0 113.906 -173.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.34 -33.64 81.61 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 123.914 0.768 . . . . 0.0 113.731 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -94.98 -28.64 15.04 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.6 mt -66.25 -32.23 73.52 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.594 -1.316 . . . . 0.0 113.272 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -66.37 -11.0 48.95 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.55 -29.27 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.737 0.815 . . . . 0.0 111.928 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -94.65 -37.31 11.38 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.605 1.162 . . . . 0.0 113.303 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.33 -69.97 0.23 Allowed Glycine 0 CA--C 1.542 1.735 0 CA-C-O 116.609 -2.217 . . . . 0.0 116.525 166.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -102.04 -33.86 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.987 0 N-CA-C 117.825 2.202 . . . . 0.0 117.825 -156.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -134.16 156.68 47.89 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.416 1.462 . . . . 0.0 112.93 -167.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.4 mt -70.46 -12.91 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.67 -1.64 46.23 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 165.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.07 -135.15 10.19 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 120.154 1.343 . . . . 0.0 113.738 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -62.4 -25.36 67.89 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.637 ' HZ1' HD22 ' A' ' 89' ' ' LEU . 6.2 pttp -144.08 164.09 31.65 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.141 1.376 . . . . 0.0 110.403 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.3 mt -61.36 122.12 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 123.433 0.693 . . . . 0.0 110.467 169.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.7 p -140.21 -160.56 1.08 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.45 1.5 . . . . 0.0 108.901 160.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -49.5 -32.82 13.0 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -166.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.3 t -71.86 -37.48 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 120.725 1.602 . . . . 0.0 113.003 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -63.11 -44.04 96.78 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.34 -0.85 . . . . 0.0 111.587 167.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.5 mt -64.98 -27.36 68.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.009 0.524 . . . . 0.0 111.97 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 73.6 m -75.9 -31.94 59.41 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 120.201 -1.562 . . . . 0.0 113.654 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 68.6 mt -124.9 -33.84 2.88 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -162.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.61 -50.08 79.18 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -169.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -68.89 -25.7 32.52 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.479 1.452 . . . . 0.0 113.518 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -72.63 -29.47 63.5 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.224 -0.922 . . . . 0.0 112.198 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 38.0 mt -71.67 -44.09 64.89 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.788 0.835 . . . . 0.0 112.058 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -63.85 -38.5 91.33 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -64.19 -34.7 78.69 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.438 -1.414 . . . . 0.0 112.573 173.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.7 tp -68.83 -47.04 67.02 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.252 -0.905 . . . . 0.0 111.178 174.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -52.3 -45.18 65.43 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.442 1.497 . . . . 0.0 112.225 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.1 t -75.2 -58.88 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.919 0.888 . . . . 0.0 113.119 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.76 -36.07 37.74 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.993 -1.067 . . . . 0.0 113.463 -167.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.2 tp -72.83 -31.81 65.05 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.578 -0.702 . . . . 0.0 111.28 171.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.83 -27.98 37.96 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.837 1.208 . . . . 0.0 114.704 170.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -67.53 -19.49 65.3 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -141.5 -27.18 0.68 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -149.87 80.85 1.38 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.522 1.529 . . . . 0.0 109.355 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.9 75.85 0.08 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.388 1.475 . . . . 0.0 112.403 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -71.73 112.96 16.06 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.127 1.771 . . . . 0.0 112.32 -168.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.31 137.52 19.0 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.546 2.164 . . . . 0.0 111.845 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 46.7 mm -87.57 113.93 56.52 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.329 1.052 . . . . 0.0 109.025 164.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -71.06 155.86 60.85 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.254 1.969 . . . . 0.0 111.779 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.59 -12.39 44.79 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -62.05 -31.44 71.85 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.209 1.004 . . . . 0.0 112.835 166.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.2 mt -84.19 57.18 4.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.464 1.906 . . . . 0.0 110.835 167.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -22.86 64.6 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.62 1.168 . . . . 0.0 113.297 -161.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -75.52 -52.49 10.52 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.257 0.935 . . . . 0.0 110.303 165.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 33.7 t -57.53 -46.69 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 119.234 0.925 . . . . 0.0 112.711 -174.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.7 tp -64.36 -27.95 69.37 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -93.61 -29.48 15.44 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.143 -0.973 . . . . 0.0 113.272 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -64.0 -36.92 85.56 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.271 1.428 . . . . 0.0 112.925 173.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.5 mt -60.01 -37.43 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 O-C-N 121.336 -0.852 . . . . 0.0 111.641 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -67.01 -28.26 68.1 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.047 -1.658 . . . . 0.0 112.475 173.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.1 mt -71.5 -20.59 62.04 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.473 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 68.9 mt -65.65 -21.6 66.57 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 120.17 1.35 . . . . 0.0 112.751 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -85.71 19.1 2.57 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.456 1.502 . . . . 0.0 113.308 170.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.8 p -142.81 178.65 7.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.797 2.039 . . . . 0.0 112.947 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 65.7 mtp85 59.74 171.88 0.08 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.619 1.968 . . . . 0.0 113.561 -170.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 53.1 mp0 -64.83 -47.91 76.29 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.422 1.089 . . . . 0.0 110.286 159.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -39.29 89.78 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.681 1.992 . . . . 0.0 115.707 -170.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -96.67 -53.26 3.62 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.483 1.038 . . . . 0.0 111.746 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -62.31 -37.37 85.31 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -168.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.88 -22.85 66.55 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.15 0.886 . . . . 0.0 113.034 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 7.0 p -90.55 -7.09 53.81 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.647 1.179 . . . . 0.0 113.2 -173.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -60.61 114.68 3.12 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.458 1.503 . . . . 0.0 111.063 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -70.11 162.56 28.03 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.051 0.94 . . . . 0.0 112.579 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -75.39 125.81 29.74 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.848 -0.533 . . . . 0.0 110.684 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -73.84 -32.1 63.5 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -155.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.37 -36.42 83.66 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.812 1.245 . . . . 0.0 111.162 167.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -83.69 -8.43 59.28 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.009 1.724 . . . . 0.0 113.309 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.2 t -78.47 -51.89 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.347 1.059 . . . . 0.0 109.913 158.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 62.2 mt -62.32 -48.03 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.015 0.926 . . . . 0.0 111.974 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -5.39 41.74 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.874 1.27 . . . . 0.0 114.15 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -90.33 -32.75 9.25 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 121.133 -0.979 . . . . 0.0 113.134 164.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -83.22 -32.56 26.43 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.13 1.772 . . . . 0.0 114.802 -174.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -48.83 -55.15 21.55 Favored Pre-proline 0 N--CA 1.481 1.121 0 CA-C-N 120.254 1.388 . . . . 0.0 114.35 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.19 -20.8 32.34 Favored 'Trans proline' 0 C--N 1.351 0.678 0 CA-C-N 120.806 1.324 . . . . 0.0 111.979 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.428 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 45.6 mtpt -84.54 2.69 40.06 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.148 1.779 . . . . 0.0 114.274 174.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 63.4 t -66.58 -29.97 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 120.886 -1.134 . . . . 0.0 110.219 152.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -96.2 -52.34 4.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 117.183 -1.389 . . . . 0.0 114.265 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.865 2.066 . . . . 0.0 113.089 -177.239 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.912 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.99 136.73 34.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.903 1.281 . . . . 0.0 110.771 -170.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -139.21 151.42 46.54 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.412 1.485 . . . . 0.0 108.845 166.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.54 140.73 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.206 1.002 . . . . 0.0 109.148 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.9 m -113.56 122.29 46.8 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.086 0.954 . . . . 0.0 109.38 171.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -136.59 157.92 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.887 1.275 . . . . 0.0 110.699 -164.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -57.7 115.43 2.79 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.611 0.365 . . . . 0.0 110.839 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -81.49 151.24 27.9 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.964 154.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.73 151.53 33.68 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.256 1.026 . . . . 0.0 112.515 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.6 t -70.86 135.98 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 166.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.53 -33.85 1.37 Allowed Glycine 0 CA--C 1.539 1.538 0 CA-C-O 118.585 -1.119 . . . . 0.0 115.218 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.96 67.85 12.1 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.861 1.264 . . . . 0.0 112.529 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.504 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 70.8 Cg_endo -65.71 -7.47 16.59 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.268 2.645 . . . . 0.0 114.685 -175.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -81.17 -0.1 38.84 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.493 1.517 . . . . 0.0 114.452 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.4 pt -133.34 162.08 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.994 1.318 . . . . 0.0 111.546 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.8 mt -63.6 150.96 42.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.725 0.81 . . . . 0.0 111.648 168.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.0 -166.32 10.91 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.557 1.551 . . . . 0.0 111.949 166.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -56.61 107.96 0.44 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.4 t -158.89 103.48 1.59 Allowed Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.281 139.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -64.57 -20.82 65.9 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.294 1.996 . . . . 0.0 112.633 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -68.38 -26.41 65.55 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.906 -1.121 . . . . 0.0 112.829 172.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 81.7 m -74.04 -37.09 64.42 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.614 -1.304 . . . . 0.0 112.055 170.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -62.24 -26.8 68.58 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 118.339 -0.839 . . . . 0.0 112.938 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.54 HH12 ' CG ' ' A' ' 74' ' ' ASP . 59.1 mtp180 -57.01 -42.8 81.02 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.118 0.967 . . . . 0.0 112.471 170.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.78 -41.46 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.284 1.434 . . . . 0.0 111.381 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -58.94 -42.92 90.96 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.972 0.509 . . . . 0.0 111.401 172.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.02 -50.53 73.39 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.306 1.042 . . . . 0.0 112.748 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 p -75.71 -38.34 58.67 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -175.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.1 mt -65.91 -39.75 90.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.566 0.621 . . . . 0.0 111.32 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -77.85 -25.56 48.81 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -67.13 -48.66 67.41 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 120.741 -1.224 . . . . 0.0 111.325 169.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.423 ' HE3' HD12 ' A' ' 35' ' ' ILE . 51.2 mtmt -76.93 -0.33 23.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.016 1.726 . . . . 0.0 114.436 175.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm 57.79 20.67 6.71 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.785 1.634 . . . . 0.0 114.677 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.423 HD12 ' HE3' ' A' ' 33' ' ' LYS . 95.8 mt -69.77 128.8 91.7 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.504 1.122 . . . . 0.0 109.035 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.73 140.68 23.78 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.467 2.112 . . . . 0.0 111.737 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -145.11 152.03 39.43 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.604 1.562 . . . . 0.0 110.089 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -77.55 131.51 37.9 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.064 -1.022 . . . . 0.0 109.339 158.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.6 t -103.95 94.42 5.4 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.927 0.891 . . . . 0.0 110.755 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -81.26 99.06 8.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.775 0.83 . . . . 0.0 109.615 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 70.0 mt -66.98 108.79 2.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.528 0.731 . . . . 0.0 109.039 170.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.7 mm -120.66 114.88 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.529 1.132 . . . . 0.0 109.303 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -76.56 90.5 3.33 Favored 'General case' 0 C--O 1.22 -0.455 0 O-C-N 120.775 -1.203 . . . . 32.609999999999999 108.42 165.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.06 -7.34 1.76 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 117.173 2.286 . . . . 40.049999999999997 117.173 -170.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.56 -37.85 89.95 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 119.651 1.114 . . . . 41.469999999999999 111.762 165.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -105.58 47.77 0.86 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 129.452 3.101 . . . . 47.170000000000002 111.177 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -73.92 126.68 89.22 Favored Pre-proline 0 N--CA 1.475 0.779 0 O-C-N 119.695 -1.878 . . . . 41.270000000000003 111.689 -174.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.86 159.55 52.22 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.468 2.112 . . . . 40.289999999999999 110.982 170.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -62.45 -29.21 70.35 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.776 1.028 . . . . 42.390000000000001 113.776 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.4 t90 -56.28 -35.24 67.27 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.969 1.308 . . . . 37.079999999999998 113.957 168.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -79.41 -33.92 42.25 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.949 -1.094 . . . . 35.880000000000003 112.82 174.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 mt -71.02 -21.05 62.33 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.76 1.022 . . . . 33.609999999999999 113.76 173.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -66.38 -47.93 71.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.446 0.698 . . . . 33.789999999999999 110.752 166.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.6 mt -72.1 -33.21 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.308 1.043 . . . . 33.159999999999997 112.183 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.4 t -137.78 81.93 27.53 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 127.069 2.147 . . . . 33.579999999999998 110.507 -173.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -63.9 -23.51 68.29 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.231 2.621 . . . . 37.899999999999999 113.778 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -74.27 -10.94 60.09 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.805 -1.185 . . . . 38.990000000000002 113.845 167.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.89 22.58 76.65 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.463 1.506 . . . . 35.469999999999999 115.131 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -110.72 159.3 17.74 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.872 1.669 . . . . 34.490000000000002 113.921 -169.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.7 155.14 63.52 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.645 1.578 . . . . 23.530000000000001 111.85 172.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -63.51 152.75 71.37 Favored 'Cis proline' 0 C--N 1.349 0.575 0 CA-C-O 121.813 0.672 . . . . 22.879999999999999 112.611 -11.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.2 p -139.24 144.43 29.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.568 161.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.59 162.48 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 121.348 -0.845 . . . . 0.0 111.528 -169.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -123.21 63.91 1.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.103 1.761 . . . . 0.0 109.791 -174.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 81.4 mt -74.01 121.21 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.824 0.85 . . . . 0.0 108.76 -175.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 45.5 t0 55.15 35.89 25.79 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 121.862 -0.524 . . . . 0.0 111.447 -164.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t0 67.19 -8.74 0.43 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 127.628 2.371 . . . . 0.0 115.345 -170.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.3 mttt -83.93 133.56 34.7 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.443 1.497 . . . . 0.0 111.875 -173.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.2 m0 -73.72 128.6 35.94 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.018 1.327 . . . . 0.0 111.679 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.0 t -142.5 128.1 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.332 1.453 . . . . 0.0 109.776 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -103.53 175.18 5.56 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.692 1.597 . . . . 0.0 111.729 172.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.7 t0 66.44 108.79 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.829 2.452 . . . . 22.16 114.786 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.4 p -61.42 -23.95 66.19 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 115.226 1.565 . . . . 21.16 115.226 -168.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.54 ' CG ' HH12 ' A' ' 25' ' ' ARG . 38.1 m-20 -73.61 -37.47 65.41 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.745 1.157 . . . . 24.969999999999999 113.07 171.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -69.92 -39.0 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.409 -0.807 . . . . 23.850000000000001 111.039 171.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 89.6 mt -63.58 -44.11 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.302 1.041 . . . . 23.68 111.224 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.1 -41.07 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.181 0.993 . . . . 22.84 111.482 171.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.89 -12.64 49.27 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 115.786 1.074 . . . . 23.329999999999998 115.786 174.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 89.6 mt -102.38 -53.05 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 118.913 1.357 . . . . 23.309999999999999 111.011 168.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.6 -33.06 73.24 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.622 0.971 . . . . 23.48 113.622 -172.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -90.57 -2.91 57.88 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.71 1.004 . . . . 24.239999999999998 113.71 -173.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.434 ' CD ' ' HZ2' ' A' ' 83' ' ' LYS . 10.1 tt0 -117.33 -54.44 2.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.442 1.497 . . . . 39.259999999999998 112.05 172.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.434 ' HZ2' ' CD ' ' A' ' 82' ' ' GLU . 64.9 mttp -93.71 59.22 2.81 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.92 1.288 . . . . 24.449999999999999 112.152 -164.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -135.84 163.64 49.01 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.77 1.628 . . . . 0.0 110.997 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.15 -23.53 21.17 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.411 2.074 . . . . 0.0 112.562 172.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -74.57 147.02 84.36 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.039 1.336 . . . . 0.0 112.206 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -59.44 135.14 62.95 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.841 2.361 . . . . 0.0 113.645 -173.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.68 136.5 49.96 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.909 2.406 . . . . 0.0 113.867 -167.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 mt -103.83 -0.26 29.42 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.935 1.694 . . . . 0.0 112.088 169.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.81 51.64 0.5 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.559 1.944 . . . . 0.0 110.569 161.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -129.74 61.31 57.21 Favored Pre-proline 0 N--CA 1.467 0.41 0 C-N-CA 127.003 2.121 . . . . 0.0 109.104 -169.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -80.77 123.16 4.61 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.256 1.971 . . . . 0.0 111.23 -155.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -72.54 175.96 9.43 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.1 2.533 . . . . 0.0 111.504 167.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -59.38 -20.56 55.76 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -53.72 -24.87 16.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.472 1.509 . . . . 0.0 114.223 167.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.04 -31.29 71.68 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.719 -1.238 . . . . 0.0 112.993 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.0 p -69.04 -25.5 64.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.426 1.09 . . . . 0.0 112.975 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.4 t -89.24 -43.44 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.321 1.448 . . . . 0.0 110.57 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.65 -29.56 75.06 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.014 1.292 . . . . 0.0 114.631 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 88.9 p -66.88 -20.5 65.93 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.498 1.149 . . . . 0.0 114.019 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -94.83 -34.43 12.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.501 1.52 . . . . 0.0 112.874 172.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.1 mt -67.38 -37.98 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.511 0.724 . . . . 0.0 111.521 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -58.93 -47.97 97.67 Favored Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 120.303 -1.498 . . . . 0.0 114.136 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.52 -30.7 6.2 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.693 2.262 . . . . 0.0 113.976 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.3 p -70.72 -29.8 66.17 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.996 1.725 . . . . 0.0 112.761 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -62.22 -41.36 98.32 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.345 -1.472 . . . . 0.0 113.071 161.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.4 t -63.73 -37.48 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 120.248 1.385 . . . . 0.0 111.339 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -67.31 -37.65 83.69 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.607 0.763 . . . . 0.0 112.339 172.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -70.62 -30.22 66.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.408 1.083 . . . . 0.0 112.427 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.5 mt -83.42 1.38 41.81 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.73 1.612 . . . . 0.0 114.352 169.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -146.78 38.56 1.01 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.526 1.53 . . . . 0.0 113.082 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 m -73.8 63.71 0.9 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -161.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.34 -35.84 76.31 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.981 1.312 . . . . 0.0 111.798 165.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 12.0 t0 -81.89 119.05 74.34 Favored Pre-proline 0 CA--C 1.553 1.06 0 CA-C-O 117.125 -1.417 . . . . 0.0 107.221 153.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 114' ' ' ASP . 74.5 Cg_exo -53.66 150.92 26.73 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.419 2.746 . . . . 0.0 116.735 -153.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -66.34 -42.36 88.23 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.568 -174.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.12 -24.37 60.6 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.402 1.081 . . . . 0.0 113.417 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.31 -35.81 25.59 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.19 -0.944 . . . . 0.0 112.805 168.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 92.7 m -67.44 -27.19 66.84 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.655 -0.909 . . . . 0.0 112.687 169.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -58.75 -44.09 90.46 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 125.388 1.475 . . . . 0.0 111.814 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -70.44 -37.6 74.4 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.534 -0.729 . . . . 0.0 111.996 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.89 -16.09 63.67 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.2 tp -92.13 -40.71 10.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.379 1.471 . . . . 0.0 111.612 169.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.5 mt -65.02 -42.38 94.44 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.201 1.4 . . . . 0.0 113.558 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -65.27 -35.19 80.27 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.88 1.673 . . . . 0.0 112.469 -176.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -73.71 -37.26 65.21 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.43 -0.794 . . . . 0.0 112.83 172.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.3 mt -65.69 -36.4 83.53 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.688 -1.258 . . . . 0.0 112.656 171.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -64.57 -42.78 95.43 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.734 1.152 . . . . 0.0 111.253 173.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.21 -38.41 91.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.401 0.68 . . . . 0.0 112.131 175.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.6 tp -65.04 -52.81 53.74 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.045 0.938 . . . . 0.0 111.846 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -65.9 -38.41 88.66 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.214 1.405 . . . . 0.0 113.425 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -62.07 -36.05 92.35 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 119.284 -0.731 . . . . 0.0 113.845 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -87.45 -31.74 19.86 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 117.913 0.857 . . . . 0.0 112.879 175.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 12.8 mt -61.42 -36.23 79.76 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.004 -1.06 . . . . 0.0 113.436 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -65.21 -2.71 3.16 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.3 t -104.23 -27.76 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.591 1.556 . . . . 0.0 112.946 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -93.67 -50.94 5.15 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -168.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 158.95 172.41 26.02 Favored Glycine 0 CA--C 1.535 1.298 0 O-C-N 121.362 -0.836 . . . . 0.0 114.586 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -73.48 -15.25 24.9 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 124.669 3.579 . . . . 0.0 115.987 -163.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -89.95 167.45 12.8 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.379 0.99 . . . . 0.0 111.61 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -12.18 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.472 -1.393 . . . . 0.0 113.204 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -100.65 -4.1 29.04 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.8 1.408 . . . . 0.0 114.8 166.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 110.12 -122.95 6.51 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 119.871 1.214 . . . . 0.0 113.201 -175.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -70.43 -18.72 63.01 Favored 'General case' 0 CA--C 1.541 0.635 0 O-C-N 120.847 -1.384 . . . . 0.0 114.108 -168.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -141.35 155.74 45.9 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.907 1.683 . . . . 0.0 110.711 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 58.9 mt -62.73 129.31 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.592 0.757 . . . . 0.0 109.244 163.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.9 p -129.36 -175.41 3.57 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.8 0.84 . . . . 0.0 111.961 168.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.79 -19.1 3.83 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 172.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.6 t -70.32 -43.57 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.998 -1.064 . . . . 0.0 111.9 172.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -60.02 -45.19 93.61 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.471 1.108 . . . . 0.0 112.312 169.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 34.2 mt -61.06 -20.74 62.92 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 177.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.2 m -85.98 -43.99 12.71 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.37 -0.831 . . . . 0.0 112.047 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 29.5 mt -98.34 -33.53 11.03 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -168.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.49 -49.58 93.0 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.56 -22.35 18.34 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 121.095 1.427 . . . . 0.0 113.223 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -71.25 -33.25 69.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 117.47 -1.252 . . . . 0.0 112.077 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 68.9 mt -66.41 -43.17 86.49 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 169.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -58.33 -39.72 80.19 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.653 0.661 . . . . 0.0 111.588 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -70.81 -22.68 62.32 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.3 mt -71.98 -51.38 22.2 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.112 0.869 . . . . 0.0 111.496 168.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -64.8 -28.16 69.38 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.524 0.729 . . . . 0.0 112.461 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.3 t -94.21 -72.24 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.854 1.262 . . . . 0.0 113.159 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.98 -48.72 11.87 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.333 -0.854 . . . . 0.0 113.057 -158.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 63.4 tp -66.84 -34.0 76.84 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.825 -0.607 . . . . 0.0 111.074 166.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.38 -30.13 57.98 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.285 1.421 . . . . 0.0 115.505 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -64.34 -26.16 68.35 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 173.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -117.21 -28.09 6.28 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.547 1.139 . . . . 0.0 113.584 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -143.87 94.28 2.57 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.358 2.263 . . . . 0.0 108.032 167.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -68.35 80.68 0.25 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.077 0.951 . . . . 0.0 110.347 168.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -71.0 117.22 54.3 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.447 1.099 . . . . 0.0 110.966 -171.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.39 107.09 1.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.868 1.712 . . . . 0.0 110.352 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 30.5 mm -57.13 115.13 9.58 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 124.399 1.08 . . . . 0.0 108.445 169.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.59 146.62 92.79 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.6 1.534 . . . . 0.0 111.744 -174.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.88 -17.48 64.34 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 120.887 -1.133 . . . . 0.0 114.058 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -62.18 -35.33 78.49 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.807 1.243 . . . . 0.0 112.786 167.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 36.1 mt -80.54 50.81 1.36 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.802 1.641 . . . . 0.0 111.232 165.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -34.42 70.56 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.532 1.133 . . . . 0.0 111.746 -171.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -80.5 -37.86 30.89 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.255 1.022 . . . . 0.0 112.943 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 43.9 t -64.68 -40.61 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 119.512 1.051 . . . . 0.0 111.017 172.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.57 -41.2 96.44 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -65.47 -42.72 91.96 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 171.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -65.0 -33.27 75.65 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.431 1.092 . . . . 0.0 112.959 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 58.3 mt -58.62 -32.36 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.039 -1.038 . . . . 0.0 111.704 170.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -83.13 -11.63 57.76 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.33 -1.481 . . . . 0.0 113.613 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.81 -18.9 60.9 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 117.963 -1.018 . . . . 0.0 113.448 160.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 74.0 mt -66.06 -13.59 60.26 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.033 1.288 . . . . 0.0 114.281 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -106.35 10.74 31.52 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.931 1.292 . . . . 0.0 112.776 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.0 p -114.46 177.57 4.6 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.222 1.809 . . . . 0.0 113.763 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 52.8 mtp85 57.11 -166.31 0.14 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.813 1.645 . . . . 0.0 111.201 -172.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.454 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 8.7 mp0 -79.69 -33.77 40.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.449 0.7 . . . . 0.0 110.243 161.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 56.2 p -75.75 -66.85 0.73 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.909 1.683 . . . . 0.0 113.944 -162.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -61.68 -41.43 97.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.137 0.881 . . . . 0.0 112.268 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -56.68 -27.99 59.92 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -87.26 -11.2 50.35 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 11.8 p -74.76 -14.85 60.76 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.61 1.55 . . . . 0.0 112.931 173.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -59.49 134.45 57.02 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.773 1.229 . . . . 0.0 111.763 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -109.74 176.99 4.87 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.267 1.427 . . . . 0.0 110.562 168.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.69 113.84 8.18 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.812 -1.18 . . . . 0.0 109.352 168.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -57.57 -31.5 66.2 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -167.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.94 -40.28 88.44 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.481 1.112 . . . . 0.0 112.009 173.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -85.52 -3.12 58.77 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.133 1.773 . . . . 0.0 112.935 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 42.1 t -86.69 -48.84 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.753 1.221 . . . . 0.0 109.971 162.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.6 mt -57.96 -52.01 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.923 1.289 . . . . 0.0 111.512 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.3 -12.89 61.89 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.25 -32.34 10.67 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.148 -0.97 . . . . 0.0 113.371 171.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 57.1 t90 -80.26 -35.65 35.7 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.096 1.759 . . . . 0.0 114.224 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -51.05 -47.76 86.57 Favored Pre-proline 0 CA--C 1.552 1.027 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.82 -25.94 27.81 Favored 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 121.275 1.491 . . . . 0.0 113.688 172.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -76.06 -11.95 60.03 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 117.296 -1.335 . . . . 0.0 114.562 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 48.3 t -59.04 -23.33 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 119.151 0.887 . . . . 0.0 111.114 160.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -104.08 -7.94 19.87 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 177.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.294 0 C-N-CA 125.141 1.376 . . . . 0.0 112.935 -175.927 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.915 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 84.2 mt -125.22 128.42 48.29 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.131 1.772 . . . . 0.0 110.981 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -119.94 143.26 48.09 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.913 0.885 . . . . 0.0 108.784 158.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.2 pt -129.09 147.85 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.439 1.096 . . . . 0.0 109.966 176.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.3 m -120.14 120.96 37.71 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.348 1.459 . . . . 0.0 109.205 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -133.32 160.38 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.978 1.311 . . . . 0.0 111.781 -168.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.61 118.22 7.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.519 0.728 . . . . 0.0 111.56 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -78.02 151.95 33.28 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.08 0.552 . . . . 0.0 111.599 161.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.73 140.6 58.88 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.161 0.981 . . . . 0.0 113.029 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.5 t -66.25 121.86 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.95 -14.79 18.32 Favored Glycine 0 CA--C 1.538 1.498 0 CA-C-O 118.464 -1.187 . . . . 0.0 115.881 -173.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.26 62.72 62.43 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 119.053 1.426 . . . . 0.0 112.022 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.49 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 72.2 Cg_endo -65.39 -5.48 11.44 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.186 2.591 . . . . 0.0 114.962 -171.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -77.92 -3.18 40.5 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.425 1.89 . . . . 0.0 114.734 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.2 pt -136.13 165.69 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.947 1.299 . . . . 0.0 112.346 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.51 144.77 53.72 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.305 1.042 . . . . 0.0 111.565 171.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.21 -174.53 13.81 Favored Glycine 0 N--CA 1.469 0.857 0 C-N-CA 125.145 1.355 . . . . 0.0 114.489 175.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -62.73 105.29 0.63 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.4 t -163.18 95.07 1.11 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.485 1.514 . . . . 0.0 109.454 159.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.09 -22.97 75.16 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.837 1.691 . . . . 0.0 113.542 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -63.29 -32.72 74.2 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.606 -1.309 . . . . 0.0 113.432 169.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 67.4 m -72.2 -37.12 69.31 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.808 -1.183 . . . . 0.0 112.014 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -63.84 -22.51 66.95 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 117.57 -1.205 . . . . 0.0 112.994 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.463 HH12 ' CG ' ' A' ' 74' ' ' ASP . 64.3 mtp180 -57.98 -43.06 86.3 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.641 1.11 . . . . 0.0 112.644 169.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -80.76 -36.82 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.574 1.15 . . . . 0.0 111.673 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.4 -41.53 94.08 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 122.118 -0.364 . . . . 0.0 111.002 169.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.1 tp -61.15 -52.33 65.32 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.044 0.938 . . . . 0.0 112.604 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.9 p -75.45 -33.71 60.9 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 62.2 mt -73.52 -29.86 62.74 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.159 -0.963 . . . . 0.0 112.919 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -76.29 -34.14 59.08 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 169.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.16 -43.44 82.28 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.5 1.046 . . . . 0.0 112.768 172.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -73.6 1.53 9.91 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.791 -1.099 . . . . 0.0 113.573 166.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 pttt 46.85 22.3 0.19 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 127.952 2.501 . . . . 0.0 114.588 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.3 tt -91.03 131.16 37.88 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 125.325 1.45 . . . . 0.0 109.401 -164.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.56 119.3 6.3 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.462 1.441 . . . . 0.0 111.981 -173.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -129.72 154.12 47.49 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.693 1.597 . . . . 0.0 111.263 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -101.2 120.24 39.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.599 1.16 . . . . 0.0 110.064 176.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.5 t -95.24 112.79 24.45 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.479 0.712 . . . . 0.0 112.402 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -89.84 114.36 26.1 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.023 1.329 . . . . 0.0 110.337 169.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 98.8 mt -73.72 109.03 6.92 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.285 1.034 . . . . 0.0 110.13 166.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.0 mm -99.33 117.66 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.941 0.896 . . . . 0.0 110.33 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -77.16 52.67 0.92 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.51 1.524 . . . . 32.609999999999999 112.731 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.86 0.83 0.07 Allowed 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 120.378 3.473 . . . . 40.049999999999997 120.378 -151.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.65 -41.04 85.24 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 120.217 1.371 . . . . 41.469999999999999 111.467 159.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -99.85 62.7 1.17 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 128.025 2.53 . . . . 47.170000000000002 110.094 166.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.6 pttm -78.78 128.62 76.35 Favored Pre-proline 0 N--CA 1.476 0.845 0 O-C-N 119.907 -1.745 . . . . 41.270000000000003 110.868 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -62.37 154.4 64.15 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.845 2.363 . . . . 40.289999999999999 113.436 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -59.89 -42.13 93.11 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.455 -0.778 . . . . 42.390000000000001 112.928 172.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -65.88 -19.33 65.84 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.926 1.084 . . . . 37.079999999999998 113.926 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -76.07 -29.61 58.04 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.849 -1.157 . . . . 35.880000000000003 112.226 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.0 mt -69.12 -27.79 65.89 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.158 0.89 . . . . 33.609999999999999 112.46 170.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -73.79 -3.77 30.58 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.102 1.361 . . . . 33.789999999999999 113.036 173.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.3 mt -111.26 -43.14 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 126.223 1.809 . . . . 33.159999999999997 110.558 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -116.92 96.11 48.21 Favored Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 125.734 1.613 . . . . 33.579999999999998 110.855 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.17 -24.58 58.75 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.263 1.975 . . . . 37.899999999999999 113.062 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -76.38 -9.33 58.56 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.479 1.512 . . . . 38.990000000000002 113.54 172.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.92 4.32 33.68 Favored Glycine 0 CA--C 1.536 1.347 0 O-C-N 120.31 -1.494 . . . . 35.469999999999999 115.351 -169.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -77.05 152.06 35.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.712 1.605 . . . . 34.490000000000002 112.436 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.2 152.32 45.8 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.021 1.728 . . . . 23.530000000000001 110.723 156.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -66.18 156.03 80.83 Favored 'Cis proline' 0 C--N 1.348 0.51 0 CA-C-O 122.022 0.759 . . . . 22.879999999999999 112.799 -6.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.14 146.16 24.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.233 -1.348 . . . . 0.0 107.836 161.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.9 m -129.07 163.63 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.449 0.7 . . . . 0.0 110.975 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . 27.2 mtpt -120.98 75.66 1.16 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 126.046 1.738 . . . . 0.0 110.0 174.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 86.4 mt -68.48 119.9 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 57.66 33.8 23.69 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -172.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.272 23.0 t70 71.65 -0.31 3.21 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 127.455 2.302 . . . . 0.0 114.727 -170.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -107.76 130.22 54.98 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 119.232 -2.168 . . . . 0.0 112.76 -176.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -72.35 146.14 47.29 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -163.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.1 t -144.38 131.13 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 126.374 1.87 . . . . 0.0 109.015 175.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -120.94 163.09 18.78 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.093 1.757 . . . . 0.0 112.806 -174.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . 0.272 50.0 m-20 58.77 122.65 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 128.12 2.568 . . . . 22.16 114.464 -169.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.8 p -65.12 -24.79 67.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 115.522 1.675 . . . . 21.16 115.522 -162.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.463 ' CG ' HH12 ' A' ' 25' ' ' ARG . 38.8 m-20 -69.78 -37.1 76.23 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.065 1.302 . . . . 24.969999999999999 113.217 171.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.5 t -71.7 -39.07 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 121.27 -0.894 . . . . 23.850000000000001 110.669 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.38 -47.95 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.911 0.885 . . . . 23.68 111.0 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.23 -40.44 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.865 0.866 . . . . 22.84 111.117 174.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.65 -48.84 68.7 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 119.266 0.939 . . . . 23.329999999999998 113.531 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.4 mt -72.88 -41.19 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 117.954 0.877 . . . . 23.309999999999999 112.003 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.44 -33.85 76.91 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.853 1.206 . . . . 23.48 112.883 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -91.99 -10.96 37.41 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.287 1.218 . . . . 24.239999999999998 114.287 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -94.84 -40.63 9.63 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.521 1.128 . . . . 39.259999999999998 112.356 167.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -131.44 84.54 2.18 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.683 1.193 . . . . 24.449999999999999 111.611 -163.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -138.72 163.21 48.32 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 125.764 1.626 . . . . 0.0 110.737 165.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.88 -26.38 9.62 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.72 2.28 . . . . 0.0 112.696 172.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -82.93 151.66 64.33 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 124.054 0.942 . . . . 0.0 109.877 161.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -58.2 151.79 57.09 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.293 2.662 . . . . 0.0 117.078 -160.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.44 146.82 51.05 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.432 2.755 . . . . 0.0 112.992 174.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.8 mt -134.05 20.71 3.77 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.141 1.776 . . . . 0.0 112.366 172.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.21 51.82 0.24 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.891 1.676 . . . . 0.0 111.973 169.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.6 p -125.96 72.71 70.26 Favored Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 125.633 1.573 . . . . 0.0 110.016 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.43 117.31 5.07 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.747 2.298 . . . . 0.0 110.369 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -80.22 -170.41 1.0 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.814 3.009 . . . . 0.0 111.401 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -51.71 -33.87 36.3 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.135 1.374 . . . . 0.0 114.253 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -52.76 -30.08 30.81 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.743 1.617 . . . . 0.0 114.371 173.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.75 -29.2 69.97 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.16 -0.963 . . . . 0.0 113.322 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.2 m -71.68 -12.71 61.46 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 99.2 t -114.57 -37.63 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.499 1.52 . . . . 0.0 110.894 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.95 -30.93 76.76 Favored Glycine 0 CA--C 1.533 1.217 0 O-C-N 120.819 -1.176 . . . . 0.0 114.096 172.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 91.6 p -65.59 -22.42 66.68 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -85.14 -40.26 16.95 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.588 1.555 . . . . 0.0 112.036 172.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 81.1 mt -68.84 -36.19 73.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.935 1.294 . . . . 0.0 111.164 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -56.24 -44.34 99.67 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 125.097 1.359 . . . . 0.0 114.589 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -84.78 -31.36 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.525 2.817 . . . . 0.0 114.229 169.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 p -71.12 -26.93 63.23 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 121.148 1.794 . . . . 0.0 113.549 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -60.99 -38.93 87.72 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.859 -1.15 . . . . 0.0 112.521 162.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 41.3 t -69.03 -33.75 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 120.989 -1.07 . . . . 0.0 111.737 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -63.37 -46.88 84.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.087 0.858 . . . . 0.0 111.552 168.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -63.25 -40.55 97.74 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.499 1.12 . . . . 0.0 112.689 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.7 mt -76.96 -1.35 28.22 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.425 1.49 . . . . 0.0 114.708 171.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -135.12 40.31 2.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.035 1.734 . . . . 0.0 111.405 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 p -73.73 54.28 0.48 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.809 2.444 . . . . 0.0 115.283 -162.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 97.6 mttt -61.63 -34.54 75.84 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.607 1.563 . . . . 0.0 111.932 161.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 17.5 t0 -88.5 111.77 45.86 Favored Pre-proline 0 CA--C 1.553 1.077 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 157.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 114' ' ' ASP . 51.2 Cg_exo -53.27 150.49 25.47 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.126 2.55 . . . . 0.0 117.184 -154.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -66.2 -47.85 72.57 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.379 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -62.56 -26.82 68.77 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.8 -38.42 13.93 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 121.156 -0.965 . . . . 0.0 113.387 171.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.6 m -68.02 -34.85 77.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.579 1.151 . . . . 0.0 112.987 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -61.17 -38.12 85.36 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.753 1.621 . . . . 0.0 112.966 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -63.76 -44.87 92.16 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.262 0.625 . . . . 0.0 111.668 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.45 -34.27 76.85 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.75 -40.56 88.34 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.099 0.559 . . . . 0.0 112.225 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.4 mt -64.9 -35.1 80.06 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.888 0.767 . . . . 0.0 112.837 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -72.4 -37.7 68.63 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.472 1.033 . . . . 0.0 113.0 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -71.62 -33.94 69.4 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.928 -1.108 . . . . 0.0 112.868 170.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.1 mt -65.7 -34.98 79.46 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.636 -1.29 . . . . 0.0 112.347 170.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -65.89 -41.47 91.51 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.24 1.382 . . . . 0.0 111.952 170.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.56 -34.24 76.55 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.214 0.606 . . . . 0.0 112.124 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.66 -58.15 3.58 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.167 0.987 . . . . 0.0 111.584 170.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.76 -34.54 78.41 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.448 1.499 . . . . 0.0 114.022 -169.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.9 -38.68 89.76 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.045 0.831 . . . . 0.0 113.301 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -89.09 -25.87 21.67 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.714 0.806 . . . . 0.0 112.638 176.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.51 -32.35 73.65 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 120.562 -1.337 . . . . 0.0 112.923 172.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -67.7 -10.18 50.13 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 172.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 26.4 t -86.97 -31.81 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.129 0.972 . . . . 0.0 111.874 168.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -95.71 -30.21 13.86 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -173.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 102.39 -109.86 3.64 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 117.425 -1.764 . . . . 0.0 115.139 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -79.69 -26.73 4.49 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.682 2.921 . . . . 0.0 117.385 -146.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -130.85 163.08 28.2 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.159 1.345 . . . . 0.0 112.441 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.62 -8.36 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -168.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -95.92 -2.88 46.29 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 159.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 118.55 -118.39 4.01 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.653 1.115 . . . . 0.0 113.672 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -70.9 -23.91 62.37 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.651 1.18 . . . . 0.0 113.394 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -141.66 171.1 14.53 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.433 1.893 . . . . 0.0 111.059 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.8 mt -70.8 138.57 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.669 1.187 . . . . 0.0 109.431 168.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.2 p -140.09 -171.63 3.23 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 121.284 -0.885 . . . . 0.0 111.46 164.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.01 -18.88 1.56 Allowed 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 171.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.6 t -72.87 -42.92 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 O-C-N 120.701 -1.249 . . . . 0.0 112.325 172.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -62.09 -43.85 97.94 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.524 1.129 . . . . 0.0 111.993 168.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.3 mt -64.34 -10.82 26.79 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.0 m -97.97 -45.02 6.43 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.512 1.125 . . . . 0.0 112.308 173.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.22 -36.15 12.15 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.67 -48.22 97.6 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -172.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -72.14 -25.22 19.33 Favored 'Trans proline' 0 C--N 1.351 0.678 0 CA-C-N 120.875 1.348 . . . . 0.0 113.371 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -74.05 -30.11 62.24 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 117.423 -1.275 . . . . 0.0 112.429 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 57.1 mt -67.94 -38.2 82.54 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.132 0.878 . . . . 0.0 112.832 167.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -63.78 -52.13 61.71 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.079 0.854 . . . . 0.0 112.253 172.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -62.65 -26.62 68.73 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.945 0.898 . . . . 0.0 112.358 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.2 tp -71.82 -52.66 16.37 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.938 -1.101 . . . . 0.0 113.184 170.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -58.56 -34.22 70.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.321 0.964 . . . . 0.0 112.656 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 97.4 t -82.87 -62.12 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.184 0.994 . . . . 0.0 112.763 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.55 -35.01 25.1 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -165.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.92 -35.85 59.61 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.742 -0.599 . . . . 0.0 111.397 169.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.16 -25.27 53.81 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.266 0.936 . . . . 0.0 115.234 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -60.26 -31.89 70.65 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.166 1.386 . . . . 0.0 114.675 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -125.2 -20.8 4.76 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -147.08 84.0 1.58 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.997 2.119 . . . . 0.0 107.119 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -66.91 85.24 0.12 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.389 0.676 . . . . 0.0 110.186 171.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 34.7 t90 -83.82 113.15 45.62 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.084 1.354 . . . . 0.0 110.997 -168.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.42 118.3 5.6 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.82 1.68 . . . . 0.0 110.545 -176.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 47.0 mm -67.63 113.82 16.38 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 159.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -66.33 155.45 69.92 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.723 1.615 . . . . 0.0 111.094 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.14 -22.56 66.94 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.378 1.071 . . . . 0.0 113.765 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -67.07 -22.72 65.83 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.479 1.112 . . . . 0.0 113.953 170.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 67.5 mt -85.71 55.09 3.36 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.322 1.449 . . . . 0.0 110.742 165.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.2 m -67.69 -27.03 66.49 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.499 1.119 . . . . 0.0 112.932 -161.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 33.9 t60 -73.03 -52.44 14.38 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.855 0.752 . . . . 0.0 110.338 168.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 79.0 t -58.78 -41.14 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.344 0.975 . . . . 0.0 112.226 -173.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 62.7 tp -60.46 -42.1 95.5 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.574 1.15 . . . . 0.0 112.831 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -76.74 -36.96 56.78 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.514 0.726 . . . . 0.0 112.848 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -63.39 -36.47 83.82 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.941 1.296 . . . . 0.0 112.629 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.85 -34.59 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.457 -0.777 . . . . 0.0 111.789 171.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -82.9 -14.6 53.89 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.432 -1.418 . . . . 0.0 113.515 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 23.3 mt -71.54 -18.49 62.26 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.816 -1.177 . . . . 0.0 113.618 162.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 60.4 mt -65.9 -20.54 66.26 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.759 1.163 . . . . 0.0 113.347 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -93.98 11.11 30.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.955 1.302 . . . . 0.0 113.058 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 10.5 p -119.94 174.96 6.14 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.913 2.085 . . . . 0.0 112.333 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? 60.66 177.12 0.1 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.473 1.509 . . . . 0.0 111.64 -170.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.481 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 0.5 OUTLIER -70.98 -41.71 70.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.783 153.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 85.6 p -54.75 -68.64 0.17 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.153 1.381 . . . . 0.0 114.682 -170.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -70.66 -43.4 69.21 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.059 -1.026 . . . . 0.0 112.247 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -59.79 -32.76 70.91 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -172.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -81.0 -7.76 59.63 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.4 p -77.89 -13.15 59.98 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.067 1.303 . . . . 0.0 113.426 169.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -64.43 86.21 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.883 1.673 . . . . 0.0 112.96 -167.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.48 137.95 57.77 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.343 1.057 . . . . 0.0 110.21 164.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.24 128.04 35.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.618 0.767 . . . . 0.0 112.022 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -59.61 -34.66 73.04 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -162.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -65.23 -37.96 88.89 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.981 -1.075 . . . . 0.0 112.453 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -82.24 -7.52 59.63 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 171.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.58 -47.45 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 118.706 0.685 . . . . 0.0 110.05 163.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 65.0 mt -64.52 -52.59 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.889 1.276 . . . . 0.0 111.742 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.9 -11.53 60.68 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.24 -34.15 8.95 Favored Glycine 0 CA--C 1.535 1.304 0 O-C-N 120.942 -1.099 . . . . 0.0 113.36 168.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -75.6 -35.82 60.46 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.064 1.746 . . . . 0.0 113.524 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -51.51 -51.7 66.93 Favored Pre-proline 0 N--CA 1.477 0.899 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -174.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.39 -24.41 43.06 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 CA-C-N 121.476 1.563 . . . . 0.0 113.451 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -74.96 -8.25 55.94 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.412 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 60.2 t -60.59 -27.06 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 120.064 1.302 . . . . 0.0 110.624 160.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -103.2 -34.48 8.81 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 116.656 -1.64 . . . . 0.0 115.1 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.258 0 O-C-N 125.234 1.584 . . . . 0.0 113.015 179.292 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.922 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.1 mt -105.46 138.2 42.04 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.81 1.644 . . . . 0.0 112.683 -169.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -125.93 143.99 50.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.959 1.304 . . . . 0.0 109.456 157.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.4 pt -129.0 137.18 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.136 0.975 . . . . 0.0 110.287 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.8 m -109.68 123.97 50.4 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.555 1.142 . . . . 0.0 109.473 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -136.5 162.0 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.156 1.382 . . . . 0.0 111.311 -166.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -64.0 121.31 13.8 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.14 -0.975 . . . . 0.0 111.746 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.61 143.18 38.45 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.019 0.527 . . . . 0.0 111.035 157.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.28 138.01 58.35 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.648 0.737 . . . . 0.0 111.685 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -68.91 134.92 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.85 -32.75 1.69 Allowed Glycine 0 CA--C 1.537 1.427 0 CA-C-O 118.821 -0.989 . . . . 0.0 114.952 -172.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.6 60.67 19.75 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.839 1.255 . . . . 0.0 113.151 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.22 -3.95 9.59 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.976 2.451 . . . . 0.0 115.676 -171.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -73.23 -8.1 54.35 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 170.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.0 pt -131.16 163.63 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.643 1.177 . . . . 0.0 112.513 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.3 mt -63.41 138.68 58.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.14 0.976 . . . . 0.0 111.541 172.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.99 -168.19 13.47 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.034 1.302 . . . . 0.0 114.118 173.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -60.59 103.85 0.29 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 174.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.6 t -156.81 102.9 1.95 Allowed Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.149 141.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.54 -20.9 60.41 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.716 2.278 . . . . 0.0 112.862 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -66.22 -29.86 70.2 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 120.666 -1.271 . . . . 0.0 113.534 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 88.0 m -70.43 -36.64 74.11 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.536 -1.352 . . . . 0.0 112.076 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -67.68 -21.69 65.32 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 118.119 -0.944 . . . . 0.0 112.307 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.525 HH12 ' CG ' ' A' ' 74' ' ' ASP . 64.6 mtp180 -58.76 -45.07 90.6 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.359 1.064 . . . . 0.0 112.579 166.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -73.55 -43.01 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.557 1.143 . . . . 0.0 111.045 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.6 mt -57.66 -44.19 85.51 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.743 0.417 . . . . 0.0 111.54 172.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.4 tp -60.7 -48.42 81.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.106 0.962 . . . . 0.0 112.623 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.7 -36.06 67.77 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -174.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.7 mt -73.88 -41.45 62.16 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.323 0.51 . . . . 0.0 111.493 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -77.91 -14.43 59.55 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 176.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -76.55 -46.91 24.4 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.206 -1.559 . . . . 0.0 111.578 164.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -74.82 -12.81 60.47 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm 64.88 9.51 5.41 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 127.467 2.307 . . . . 0.0 114.886 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.3 tp -67.24 129.73 93.75 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.595 1.158 . . . . 0.0 110.481 175.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.39 147.95 33.16 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.658 2.239 . . . . 0.0 112.775 -174.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -147.23 151.48 36.76 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.316 1.446 . . . . 0.0 111.071 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -80.25 147.41 31.21 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.551 -0.718 . . . . 0.0 109.484 159.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -127.42 116.53 20.59 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.646 0.778 . . . . 0.0 111.24 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -104.05 110.73 23.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.668 1.587 . . . . 0.0 109.667 -175.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -74.0 106.48 5.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.579 1.152 . . . . 0.0 110.256 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 mm -95.14 116.06 35.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.791 0.837 . . . . 0.0 110.54 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -75.99 49.87 0.57 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.02 1.728 . . . . 32.609999999999999 112.853 174.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pp -60.4 3.07 0.08 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 120.532 3.53 . . . . 40.049999999999997 120.532 -148.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.22 -36.01 70.66 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 120.236 1.38 . . . . 41.469999999999999 111.787 158.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -101.98 67.46 1.08 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.043 2.137 . . . . 47.170000000000002 109.327 163.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -80.8 119.5 76.32 Favored Pre-proline 0 N--CA 1.474 0.754 0 O-C-N 119.603 -1.936 . . . . 41.270000000000003 111.636 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -62.92 154.8 64.29 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.656 2.237 . . . . 40.289999999999999 114.397 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -63.32 -42.07 98.96 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.991 0.916 . . . . 42.390000000000001 113.217 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 33.2 p-90 -64.25 -23.81 67.44 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.054 -1.029 . . . . 37.079999999999998 113.601 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -81.97 -31.62 31.07 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.252 -0.905 . . . . 35.880000000000003 112.462 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 mt -69.03 -26.9 65.23 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.198 0.908 . . . . 33.609999999999999 112.699 170.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -68.96 -15.19 63.42 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.373 1.069 . . . . 33.789999999999999 113.485 168.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.0 mt -99.31 -44.97 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.267 1.427 . . . . 33.159999999999997 110.602 172.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.4 t -112.77 100.17 50.0 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 125.907 1.683 . . . . 33.579999999999998 110.543 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.85 -19.23 46.9 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.209 1.939 . . . . 37.899999999999999 113.968 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -85.53 -9.21 57.71 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.267 -0.895 . . . . 38.990000000000002 113.279 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.66 19.23 62.52 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 120.67 -1.269 . . . . 35.469999999999999 114.645 -171.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -85.45 155.48 21.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.118 1.767 . . . . 34.490000000000002 111.509 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.7 m -110.89 154.52 43.31 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.171 1.788 . . . . 23.530000000000001 110.134 156.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -64.89 154.94 76.39 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 CA-C-O 122.019 0.758 . . . . 22.879999999999999 112.824 -9.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.43 147.45 22.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.013 -1.449 . . . . 0.0 107.363 156.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.15 165.71 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.649 -0.657 . . . . 0.0 110.373 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -122.79 97.6 5.52 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.441 1.497 . . . . 0.0 108.808 170.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 82.3 mt -86.82 121.3 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.137 0.975 . . . . 0.0 108.922 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 52.67 38.0 24.99 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.034 0.934 . . . . 0.0 112.834 -164.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 65.64 17.08 10.78 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.129 2.171 . . . . 0.0 116.319 -172.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -117.39 128.23 54.82 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 119.981 -1.699 . . . . 0.0 111.639 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -67.97 145.8 54.18 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -164.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -144.13 129.44 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.973 2.109 . . . . 0.0 108.679 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.69 165.55 12.69 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.672 1.589 . . . . 0.0 112.622 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.0 t0 65.54 115.65 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 128.079 2.552 . . . . 22.16 114.269 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.2 p -61.75 -25.57 67.54 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.325 1.602 . . . . 21.16 115.325 -165.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.525 ' CG ' HH12 ' A' ' 25' ' ' ARG . 31.8 m-20 -71.93 -35.77 69.75 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.876 1.216 . . . . 24.969999999999999 113.415 170.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.5 t -72.57 -39.01 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 121.432 -0.792 . . . . 23.850000000000001 111.114 172.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.18 -48.66 87.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.332 1.053 . . . . 23.68 110.914 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.43 -37.38 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.176 0.991 . . . . 22.84 111.467 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.92 -13.16 51.57 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.525 1.059 . . . . 23.329999999999998 115.585 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.6 mt -102.39 -48.46 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 118.925 1.362 . . . . 23.309999999999999 111.275 167.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.9 mt -62.52 -27.45 69.16 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.305 1.224 . . . . 23.48 114.305 -171.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -91.4 -0.3 57.62 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.785 1.032 . . . . 24.239999999999998 113.785 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -129.13 -25.51 2.73 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.544 1.138 . . . . 39.259999999999998 113.545 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -126.68 73.6 1.41 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.946 1.698 . . . . 24.449999999999999 111.923 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -141.32 165.33 29.59 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 126.112 1.765 . . . . 0.0 109.806 169.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.09 -26.45 18.14 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.333 2.022 . . . . 0.0 113.7 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.5 pm0 -75.46 160.89 78.57 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.458 1.103 . . . . 0.0 112.716 168.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.84 145.09 99.52 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.524 2.149 . . . . 0.0 113.915 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.78 145.19 62.07 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.162 2.575 . . . . 0.0 113.844 -174.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.1 mt -108.87 6.75 25.68 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.211 1.804 . . . . 0.0 112.926 169.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.4 50.57 0.17 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.85 2.06 . . . . 0.0 113.536 173.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 74.7 p -120.16 75.29 22.48 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 125.039 1.336 . . . . 0.0 110.214 170.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.09 117.93 5.27 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.346 2.031 . . . . 0.0 109.913 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.28 -173.26 1.71 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.661 2.907 . . . . 0.0 111.935 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.1 mp0 -51.13 -32.14 21.8 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.393 2.277 . . . . 0.0 113.632 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -54.79 -25.81 30.59 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.314 1.446 . . . . 0.0 114.109 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -29.35 70.58 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.742 -1.224 . . . . 0.0 113.363 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.1 p -67.99 -17.85 64.55 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.8 t -108.91 -41.57 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.581 1.552 . . . . 0.0 110.731 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.63 -30.76 77.68 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.844 1.211 . . . . 0.0 114.124 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.8 p -67.29 -19.0 65.43 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 171.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -87.51 -38.6 15.89 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.077 1.351 . . . . 0.0 112.168 169.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 69.1 mt -68.05 -37.13 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.558 1.143 . . . . 0.0 110.877 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -56.69 -45.79 99.9 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.535 1.534 . . . . 0.0 115.058 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -81.62 -32.78 0.78 Allowed 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 123.148 2.565 . . . . 0.0 113.69 170.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 56.9 p -73.18 -24.99 60.61 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 120.523 1.511 . . . . 0.0 114.127 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -58.83 -42.14 88.56 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.858 -1.151 . . . . 0.0 112.204 160.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.6 t -72.6 -31.53 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.467 -0.77 . . . . 0.0 111.862 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.401 ' HZ1' ' CG ' ' A' ' 114' ' ' ASP . 62.3 tttt -62.86 -47.24 84.24 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.004 0.82 . . . . 0.0 111.348 169.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -64.65 -39.82 94.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.157 0.983 . . . . 0.0 112.313 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 50.8 mt -68.42 -0.35 4.84 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.228 1.411 . . . . 0.0 114.736 168.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -142.56 36.58 1.47 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.116 1.766 . . . . 0.0 112.266 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.06 62.3 0.3 Allowed 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -166.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 90.8 mttt -63.75 -33.84 76.55 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.557 1.543 . . . . 0.0 110.957 158.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.401 ' CG ' ' HZ1' ' A' ' 108' ' ' LYS . 14.3 t0 -86.55 117.32 68.49 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 125.67 1.588 . . . . 0.0 107.941 158.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -51.95 149.65 20.06 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.421 2.747 . . . . 0.0 117.316 -159.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -70.39 -45.77 65.34 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.824 -172.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -68.3 -26.11 65.48 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.027 -1.671 . . . . 0.0 114.333 -172.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.62 -33.54 42.51 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 120.643 -1.285 . . . . 0.0 113.338 169.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 89.6 m -70.4 -35.37 73.42 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.422 1.089 . . . . 0.0 112.355 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -64.07 -39.85 94.99 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.546 1.539 . . . . 0.0 112.438 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -64.06 -46.7 83.2 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.517 0.599 . . . . 0.0 112.102 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.87 -36.25 83.3 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.4 tp -68.34 -42.34 79.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.25 1.02 . . . . 0.0 112.331 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 41.9 mt -66.66 -37.66 85.26 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.798 0.839 . . . . 0.0 113.253 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -69.99 -36.32 75.08 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.762 1.165 . . . . 0.0 112.786 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -72.79 -33.96 66.61 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 120.799 -1.188 . . . . 0.0 112.51 170.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.2 mt -63.43 -35.14 79.44 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.2 -1.563 . . . . 0.0 112.512 169.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -65.88 -40.38 91.53 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.31 1.414 . . . . 0.0 111.917 171.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.14 -35.92 82.36 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 118.435 0.562 . . . . 0.0 112.314 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.2 tp -69.57 -56.92 5.98 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.373 1.069 . . . . 0.0 111.468 170.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -66.41 -35.47 80.39 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.191 1.396 . . . . 0.0 114.028 -171.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.83 -34.81 79.53 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.207 0.908 . . . . 0.0 113.513 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -89.34 -30.47 18.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.446 0.699 . . . . 0.0 112.874 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.46 -33.77 76.29 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.807 -1.183 . . . . 0.0 113.449 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -64.88 -8.0 13.66 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 172.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.0 t -99.58 -35.16 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.915 1.286 . . . . 0.0 112.221 168.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -86.46 -28.41 23.5 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -173.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.63 -157.54 32.85 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 118.198 -1.335 . . . . 0.0 113.653 -173.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.8 -9.94 19.8 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.371 3.38 . . . . 0.0 117.473 -119.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -110.98 161.39 15.91 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 119.643 1.11 . . . . 0.0 111.323 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.08 -10.79 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 O-C-N 120.427 -1.421 . . . . 0.0 113.162 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -99.19 -2.04 37.78 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 161.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 107.25 -110.43 3.23 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 119.976 1.262 . . . . 0.0 113.652 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -73.49 -26.3 60.84 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -167.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -142.03 167.05 23.04 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.352 1.861 . . . . 0.0 111.163 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 26.2 mt -65.42 130.19 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.161 0.584 . . . . 0.0 109.997 163.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.8 p -135.07 -171.59 2.84 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.178 0.991 . . . . 0.0 110.866 166.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.96 -19.59 2.74 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.0 t -73.71 -43.35 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.877 1.217 . . . . 0.0 112.309 173.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.4 -46.02 91.91 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.994 -1.066 . . . . 0.0 112.113 168.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.3 mt -62.44 -17.9 60.45 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.334 0.654 . . . . 0.0 112.421 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 51.4 m -86.61 -50.92 6.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.931 0.892 . . . . 0.0 112.335 171.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.9 mt -90.54 -33.6 15.86 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -167.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.88 -49.6 92.82 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.86 -21.87 24.17 Favored 'Trans proline' 0 C--N 1.351 0.669 0 CA-C-N 121.144 1.444 . . . . 0.0 113.14 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -77.18 -28.66 54.09 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 117.584 -1.198 . . . . 0.0 112.549 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 53.7 mt -70.17 -39.22 75.42 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.758 0.823 . . . . 0.0 112.899 165.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -60.23 -46.75 88.69 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.885 0.766 . . . . 0.0 111.732 171.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -64.78 -23.71 67.33 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.951 0.9 . . . . 0.0 113.353 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 12.1 tp -80.05 -45.09 18.93 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.997 -1.064 . . . . 0.0 112.659 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.53 -37.25 86.9 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.177 0.899 . . . . 0.0 111.596 173.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.2 t -80.71 -63.92 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.51 -50.88 8.34 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.408 -0.808 . . . . 0.0 112.136 -162.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.35 -35.44 77.43 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.671 0.388 . . . . 0.0 111.382 174.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.16 -25.28 46.76 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.063 1.316 . . . . 0.0 115.7 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -65.34 -25.81 67.76 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -126.93 -18.87 4.56 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 21.8 tptt -147.76 80.55 1.49 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.895 2.078 . . . . 0.0 107.595 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -64.19 89.27 0.06 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.885 0.874 . . . . 0.0 110.669 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 33.3 t90 -88.29 117.37 68.31 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.073 0.949 . . . . 0.0 112.208 -162.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -73.58 112.53 3.55 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.199 1.933 . . . . 0.0 110.649 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 97.5 mt -71.77 108.34 3.92 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 159.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -68.55 161.01 46.92 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.415 1.41 . . . . 0.0 112.453 -166.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.32 -28.11 66.5 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.716 1.606 . . . . 0.0 114.063 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -68.16 -22.59 64.84 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.219 1.408 . . . . 0.0 114.086 173.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 71.0 mt -84.67 52.11 2.3 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.483 1.513 . . . . 0.0 110.36 165.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.0 m -63.27 -30.11 71.31 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.472 1.109 . . . . 0.0 112.601 -160.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 66.8 t-80 -77.24 -48.3 17.89 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.542 0.61 . . . . 0.0 111.534 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 66.0 t -60.36 -40.08 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 118.683 0.674 . . . . 0.0 111.618 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.0 tp -64.03 -43.24 96.16 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.338 1.055 . . . . 0.0 113.108 176.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -70.82 -32.99 70.22 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.372 -0.83 . . . . 0.0 112.838 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -63.31 -27.4 69.3 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.333 1.053 . . . . 0.0 112.843 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 29.2 mm -56.11 -34.82 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 120.868 -1.145 . . . . 0.0 111.935 169.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -90.91 -6.3 54.33 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.925 -1.109 . . . . 0.0 113.617 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 74.3 mt -73.43 -22.87 60.1 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 117.617 -1.182 . . . . 0.0 113.461 157.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 66.3 mt -62.57 -23.89 67.25 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.723 1.147 . . . . 0.0 113.283 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -96.11 9.01 42.27 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.514 1.126 . . . . 0.0 113.267 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.9 p -121.22 177.26 5.23 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.705 2.002 . . . . 0.0 113.417 -168.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.5 mtp85 54.88 -169.15 0.07 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.218 1.407 . . . . 0.0 110.276 -166.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.13 -34.22 37.94 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.05 -1.031 . . . . 0.0 110.17 159.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 77.6 p -72.45 -56.32 5.6 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.363 1.465 . . . . 0.0 114.115 -161.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -68.52 -44.56 74.38 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.984 0.811 . . . . 0.0 112.044 171.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -54.69 -34.23 62.03 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.69 1.196 . . . . 0.0 113.88 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -79.68 -14.85 58.47 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.5 p -79.88 -2.6 44.33 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.621 1.555 . . . . 0.0 113.93 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -68.91 75.93 0.31 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.235 1.814 . . . . 0.0 112.358 -173.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -59.34 132.19 53.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.263 0.625 . . . . 0.0 109.523 163.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.67 130.73 47.96 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.094 0.558 . . . . 0.0 112.024 -165.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -59.63 -39.72 85.26 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -160.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -62.31 -38.69 90.37 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.083 -1.01 . . . . 0.0 112.277 174.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -84.66 -5.93 59.34 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.308 1.443 . . . . 0.0 113.343 177.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 75.4 t -82.61 -46.8 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.982 0.913 . . . . 0.0 110.215 161.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.5 mt -61.89 -51.37 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.572 1.149 . . . . 0.0 111.845 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.73 -15.16 63.1 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.216 1.006 . . . . 0.0 113.693 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.47 -37.5 14.29 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 120.899 -1.125 . . . . 0.0 112.895 169.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 17.5 t90 -77.1 -35.49 56.4 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.186 1.794 . . . . 0.0 114.015 -174.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -49.56 -52.42 50.39 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.89 -24.5 39.9 Favored 'Trans proline' 0 C--N 1.353 0.799 0 CA-C-N 121.452 1.554 . . . . 0.0 113.461 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -78.29 -7.21 56.95 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 117.193 -1.384 . . . . 0.0 114.316 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.429 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 58.3 t -63.0 -30.83 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 120.037 1.29 . . . . 0.0 110.315 159.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -94.9 -34.66 12.34 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 115.745 1.758 . . . . 0.0 115.745 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 CA-C-O 117.604 -1.189 . . . . 0.0 113.163 172.516 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 61.9 mt -101.59 142.15 33.39 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.807 1.243 . . . . 0.0 113.26 -170.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -129.04 145.89 51.15 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.617 1.567 . . . . 0.0 109.02 157.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.5 pt -130.65 136.84 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.604 1.162 . . . . 0.0 109.647 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.7 m -111.73 119.27 38.07 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.777 1.231 . . . . 0.0 109.085 173.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.3 m -134.87 162.9 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.255 1.422 . . . . 0.0 111.229 -166.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -61.5 120.99 11.6 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.374 -0.829 . . . . 0.0 112.108 -175.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -79.34 149.61 31.68 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.049 0.54 . . . . 0.0 111.603 159.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.63 134.28 52.94 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.014 0.911 . . . . 0.0 112.111 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.7 t -67.36 126.27 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 173.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.54 -14.62 22.97 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-O 118.587 -1.118 . . . . 0.0 115.605 -172.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.88 61.65 29.85 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 119.161 1.48 . . . . 0.0 112.13 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.418 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 57.9 Cg_endo -65.47 -6.89 14.53 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.966 2.444 . . . . 0.0 115.795 -167.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -80.9 -1.21 42.51 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.9 pt -131.83 164.97 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.731 1.212 . . . . 0.0 112.114 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.94 143.69 57.46 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.239 1.016 . . . . 0.0 111.409 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.9 -173.48 13.48 Favored Glycine 0 N--CA 1.471 0.991 0 C-N-CA 125.176 1.37 . . . . 0.0 113.905 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -60.55 106.5 0.56 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.6 t -165.07 97.86 0.84 Allowed Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.776 157.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -62.92 -21.09 72.93 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.244 1.963 . . . . 0.0 113.041 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -66.68 -29.66 69.72 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 120.655 -1.278 . . . . 0.0 113.59 171.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 98.8 m -71.47 -37.76 71.31 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.578 -1.326 . . . . 0.0 112.179 171.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.0 -24.29 67.85 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 117.95 -1.024 . . . . 0.0 112.875 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.483 HH12 ' CG ' ' A' ' 74' ' ' ASP . 53.5 mtp180 -57.78 -46.97 83.84 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.46 1.027 . . . . 0.0 112.389 170.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.5 t -74.67 -40.6 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.042 1.337 . . . . 0.0 111.31 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.4 mt -61.38 -42.73 99.19 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.251 0.621 . . . . 0.0 111.545 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.1 tp -61.68 -49.12 77.77 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.076 0.95 . . . . 0.0 112.083 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.75 -43.2 69.31 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -174.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.66 -38.92 84.43 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.571 -0.706 . . . . 0.0 112.46 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -80.17 -20.09 45.63 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -69.79 -48.93 57.35 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.798 -1.189 . . . . 0.0 110.641 166.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -70.26 -9.61 56.47 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.46 1.904 . . . . 0.0 114.23 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm 61.85 18.92 10.2 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.48 1.912 . . . . 0.0 115.01 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -75.25 131.59 77.87 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 123.941 0.896 . . . . 0.0 109.613 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -74.66 143.71 30.65 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.662 2.242 . . . . 0.0 112.496 174.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -146.11 151.52 37.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.849 1.66 . . . . 0.0 110.072 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -78.66 130.59 36.04 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.318 -0.863 . . . . 0.0 109.196 163.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 t -111.92 108.64 18.07 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.535 0.734 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -100.79 112.46 24.87 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.728 1.211 . . . . 0.0 109.966 -177.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.13 112.13 13.47 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.156 0.982 . . . . 0.0 110.263 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.4 mm -102.29 116.04 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.321 1.048 . . . . 0.0 110.4 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -77.15 57.7 1.46 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.163 1.385 . . . . 32.609999999999999 111.977 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.14 4.59 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 120.083 3.364 . . . . 40.049999999999997 120.083 -154.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -69.3 -46.46 56.92 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 120.905 1.684 . . . . 41.469999999999999 110.871 156.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -93.03 63.02 3.67 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.214 2.606 . . . . 47.170000000000002 110.629 168.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 pttm -79.78 119.01 75.38 Favored Pre-proline 0 N--CA 1.476 0.827 0 O-C-N 119.921 -1.737 . . . . 41.270000000000003 111.386 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -64.13 155.7 63.4 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.699 2.266 . . . . 40.289999999999999 114.182 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tp60 -62.27 -39.48 93.05 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.672 0.99 . . . . 42.390000000000001 113.672 174.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -64.73 -23.95 67.41 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.069 0.766 . . . . 37.079999999999998 113.069 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -83.27 -32.13 26.57 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.655 0.782 . . . . 35.880000000000003 112.536 172.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.2 mt -67.26 -26.47 66.58 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.159 0.89 . . . . 33.609999999999999 112.672 170.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -71.63 -8.11 52.03 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.883 1.273 . . . . 33.789999999999999 113.858 168.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.7 mt -106.46 -44.65 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.597 1.559 . . . . 33.159999999999997 110.603 171.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.6 t -112.25 98.79 44.35 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 125.792 1.637 . . . . 33.579999999999998 110.956 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.49 -18.18 43.53 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.364 2.043 . . . . 37.899999999999999 113.408 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -83.75 -8.71 59.19 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.727 1.01 . . . . 38.990000000000002 113.727 170.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.93 8.57 49.54 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 120.87 -1.144 . . . . 35.469999999999999 115.067 -169.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -84.71 157.8 20.97 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.267 1.427 . . . . 34.490000000000002 112.491 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.2 m -113.58 156.22 43.78 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 126.383 1.873 . . . . 23.530000000000001 110.592 160.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -66.12 156.81 80.17 Favored 'Cis proline' 0 C--N 1.348 0.501 0 CA-C-O 122.015 0.756 . . . . 22.879999999999999 112.403 -10.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.4 p -141.05 147.26 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 159.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.11 163.71 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 121.43 -0.794 . . . . 0.0 110.611 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 mtpt -121.27 92.1 3.67 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.181 1.393 . . . . 0.0 109.054 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.3 mt -82.09 119.67 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.688 0.795 . . . . 0.0 108.907 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.75 38.82 27.41 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 122.284 1.04 . . . . 0.0 112.675 -165.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.3 t70 66.11 12.7 8.68 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.063 2.145 . . . . 0.0 116.476 -172.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -110.84 127.8 55.55 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 119.8 -1.813 . . . . 0.0 111.651 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -66.69 144.66 56.23 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -167.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.7 t -143.25 128.35 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.625 1.97 . . . . 0.0 108.593 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -112.69 166.5 11.29 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.746 1.618 . . . . 0.0 112.24 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.0 t0 65.11 113.62 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.821 2.449 . . . . 22.16 114.067 -175.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.7 p -62.74 -21.65 65.97 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 115.274 1.583 . . . . 21.16 115.274 -166.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.483 ' CG ' HH12 ' A' ' 25' ' ' ARG . 30.0 m-20 -71.46 -38.17 71.31 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.843 1.201 . . . . 24.969999999999999 113.056 169.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -70.49 -40.07 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.16 -0.962 . . . . 23.850000000000001 110.842 172.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.58 -48.62 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.955 0.902 . . . . 23.68 111.15 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.74 -38.54 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.611 0.764 . . . . 22.84 111.547 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.37 -39.95 95.42 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.531 -0.594 . . . . 23.329999999999998 113.596 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.7 mt -76.87 -48.22 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 118.379 1.09 . . . . 23.309999999999999 111.638 174.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.7 mt -62.32 -33.32 74.46 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.747 1.158 . . . . 23.48 113.399 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -92.66 -3.18 55.33 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 115.229 1.566 . . . . 24.239999999999998 115.229 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -108.56 -35.43 6.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.913 1.285 . . . . 39.259999999999998 112.489 169.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -125.47 70.98 1.19 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.513 1.525 . . . . 24.449999999999999 111.628 -167.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -136.99 167.59 20.4 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.641 1.976 . . . . 0.0 109.373 168.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.38 -33.44 38.16 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.677 1.585 . . . . 0.0 112.336 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -75.15 151.99 86.09 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.282 1.033 . . . . 0.0 111.976 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.2 144.62 29.11 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.543 2.829 . . . . 0.0 115.215 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.62 136.92 34.62 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.562 2.175 . . . . 0.0 112.249 -174.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.3 mt -108.55 8.18 27.09 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.934 1.294 . . . . 0.0 111.944 167.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.55 46.33 0.07 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.42 2.288 . . . . 0.0 112.696 163.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.1 p -123.9 67.52 42.16 Favored Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 125.452 1.501 . . . . 0.0 109.8 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.86 119.61 6.65 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.232 1.955 . . . . 0.0 109.951 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.97 -173.88 1.84 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.213 2.609 . . . . 0.0 111.775 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.3 mp0 -51.2 -33.89 29.47 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.65 2.38 . . . . 0.0 113.333 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -52.53 -28.87 22.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.913 1.685 . . . . 0.0 114.119 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.99 -28.97 70.17 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.931 -1.105 . . . . 0.0 113.513 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.6 p -67.53 -19.92 65.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.461 1.105 . . . . 0.0 113.568 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.6 t -102.0 -42.79 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.481 1.513 . . . . 0.0 110.68 175.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.27 -31.67 81.52 Favored Glycine 0 CA--C 1.532 1.102 0 O-C-N 120.842 -1.161 . . . . 0.0 114.594 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.2 p -66.24 -19.05 65.71 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -87.78 -39.26 15.04 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.934 1.294 . . . . 0.0 112.549 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.5 mt -66.37 -34.72 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.942 0.897 . . . . 0.0 110.906 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -56.13 -48.91 95.87 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 117.452 -1.261 . . . . 0.0 114.189 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.42 -31.56 2.66 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.926 2.417 . . . . 0.0 114.316 170.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 p -70.84 -27.8 64.12 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 121.279 1.854 . . . . 0.0 113.281 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -57.83 -47.8 81.61 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.107 -0.996 . . . . 0.0 112.084 161.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.73 -34.93 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 119.114 0.87 . . . . 0.0 111.918 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -63.09 -45.21 93.17 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.677 0.671 . . . . 0.0 111.464 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -64.12 -39.02 93.13 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.765 0.826 . . . . 0.0 112.44 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.559 HD13 ' CD2' ' A' ' 159' ' ' HIS . 11.6 mt -69.86 -7.36 39.51 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.979 1.711 . . . . 0.0 115.124 170.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -139.88 41.17 1.98 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.287 1.835 . . . . 0.0 111.663 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.4 m -68.46 56.47 0.08 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.285 1.834 . . . . 0.0 115.738 -168.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -69.38 -35.69 76.06 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.88 1.272 . . . . 0.0 111.265 165.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -81.87 114.82 53.25 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 153.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -54.71 154.19 21.56 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.192 2.594 . . . . 0.0 117.093 -154.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -69.34 -37.31 77.61 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 117.278 -1.344 . . . . 0.0 112.4 -172.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -67.3 -37.78 83.93 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 121.157 1.799 . . . . 0.0 113.825 -171.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.57 -31.54 60.63 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 120.645 -1.285 . . . . 0.0 112.905 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 91.7 m -69.77 -31.68 69.76 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.913 0.885 . . . . 0.0 112.62 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -70.31 -41.08 73.77 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 127.206 2.202 . . . . 0.0 111.953 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.29 -47.09 83.78 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.802 -0.561 . . . . 0.0 111.878 170.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.41 -31.27 72.38 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.6 tp -73.71 -45.36 52.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.669 1.188 . . . . 0.0 112.086 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 49.0 mt -64.67 -38.82 92.29 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.185 0.994 . . . . 0.0 113.126 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -69.99 -37.58 75.76 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 120.113 1.324 . . . . 0.0 113.275 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.28 -30.97 62.34 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.588 -1.32 . . . . 0.0 112.433 170.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.3 mt -64.87 -32.68 74.49 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.235 -1.541 . . . . 0.0 112.958 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -67.38 -40.68 85.7 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 120.298 1.408 . . . . 0.0 111.66 170.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.65 -32.76 73.87 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.97 0.508 . . . . 0.0 112.343 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.9 tp -71.56 -58.47 3.47 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.011 0.924 . . . . 0.0 111.538 169.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -67.28 -31.39 71.68 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -169.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.99 -31.87 69.47 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 119.248 -0.751 . . . . 0.0 113.401 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -91.6 -28.83 17.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.695 0.798 . . . . 0.0 113.033 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.11 -36.61 84.18 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.804 1.184 . . . . 0.0 112.456 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -67.67 -3.14 8.23 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 173.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.0 t -100.78 -38.38 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.876 1.27 . . . . 0.0 112.122 166.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -91.89 -22.93 19.8 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -171.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.9 -141.34 31.57 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 118.527 -1.152 . . . . 0.0 113.735 -175.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.7 -10.47 28.7 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 125.056 3.838 . . . . 0.0 117.728 -114.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -123.16 169.26 11.42 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.931 1.292 . . . . 0.0 111.791 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -72.68 -7.16 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.411 -1.431 . . . . 0.0 112.828 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.58 16.9 21.87 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.075 1.75 . . . . 0.0 114.079 162.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.25 -109.53 3.39 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.534 1.064 . . . . 0.0 113.627 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -55.84 -39.77 71.9 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.462 1.505 . . . . 0.0 113.736 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -147.46 166.38 27.42 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.032 1.733 . . . . 0.0 110.638 -168.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 16.8 mt -61.92 135.34 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 120.89 0.376 . . . . 0.0 110.117 163.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.1 p -136.76 -170.86 2.78 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.311 1.044 . . . . 0.0 110.439 163.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.79 -19.66 4.62 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.5 t -69.97 -46.4 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 120.169 1.35 . . . . 0.0 111.836 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.6 -46.49 89.64 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.855 1.262 . . . . 0.0 112.312 172.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.6 mt -64.08 -8.87 13.33 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.781 0.832 . . . . 0.0 112.839 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.1 m -101.03 -47.6 4.71 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.668 1.187 . . . . 0.0 112.564 173.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 38.3 mt -90.78 -35.0 15.1 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -170.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.0 97.32 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -173.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.78 -20.55 17.31 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 120.741 1.301 . . . . 0.0 113.448 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -75.91 -31.16 59.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 117.411 -1.281 . . . . 0.0 112.322 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 77.0 mt -64.97 -40.29 94.77 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.054 0.843 . . . . 0.0 112.726 166.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -60.75 -46.36 90.74 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.416 0.627 . . . . 0.0 111.711 173.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.559 ' CD2' HD13 ' A' ' 110' ' ' LEU . 68.6 t60 -66.6 -22.97 66.12 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 125.123 1.369 . . . . 0.0 113.421 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.4 mt -72.31 -58.48 3.37 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.072 1.306 . . . . 0.0 113.097 165.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -61.73 -31.81 72.0 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 118.646 0.657 . . . . 0.0 111.509 -173.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.9 t -86.74 -64.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 124.548 1.139 . . . . 0.0 112.907 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.66 -55.65 4.51 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.715 -0.616 . . . . 0.0 112.197 -160.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.1 tp -61.98 -32.56 73.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.62 0.368 . . . . 0.0 111.642 170.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -55.46 -27.13 47.06 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.201 1.382 . . . . 0.0 115.793 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -65.98 -24.43 66.78 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -125.34 -19.43 5.07 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -144.87 82.58 1.68 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.507 1.923 . . . . 0.0 108.254 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -61.38 90.02 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.535 1.134 . . . . 0.0 110.482 171.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -92.81 116.77 67.04 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.696 0.799 . . . . 0.0 111.907 -163.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.4 117.33 5.03 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.701 1.6 . . . . 0.0 110.319 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.78 109.93 4.64 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 149.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -66.62 164.38 29.23 Favored 'Trans proline' 0 C--N 1.35 0.643 0 CA-C-N 120.74 1.3 . . . . 0.0 112.488 -165.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -25.94 63.92 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.807 1.643 . . . . 0.0 113.911 177.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -70.55 -24.51 62.8 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.998 1.719 . . . . 0.0 114.283 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.3 mt -86.98 50.47 2.02 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.833 1.653 . . . . 0.0 110.251 166.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.6 m -59.65 -36.67 76.86 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.954 1.302 . . . . 0.0 113.03 -156.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -81.75 -38.94 24.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.874 -0.584 . . . . 0.0 112.091 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.72 -39.36 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 121.622 -0.673 . . . . 0.0 111.785 172.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 46.5 tp -63.61 -45.7 89.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.989 0.916 . . . . 0.0 112.697 175.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -66.52 -32.07 73.2 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.315 -0.866 . . . . 0.0 112.639 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -63.65 -28.82 70.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.729 0.812 . . . . 0.0 112.89 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 18.7 mt -58.36 -35.54 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 120.65 -1.281 . . . . 0.0 111.234 171.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -84.6 -9.72 58.04 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.461 -1.399 . . . . 0.0 113.998 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.99 -22.01 62.23 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.107 -0.949 . . . . 0.0 113.178 160.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 56.4 mt -65.29 -18.81 65.61 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.628 1.104 . . . . 0.0 113.754 -177.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -98.56 6.93 46.73 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.833 1.253 . . . . 0.0 112.933 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.8 p -117.68 -179.44 3.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.322 1.849 . . . . 0.0 113.715 -165.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 53.97 -162.27 0.12 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.567 1.547 . . . . 0.0 110.8 -169.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 10.8 mp0 -82.99 -38.12 23.08 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 124.118 0.967 . . . . 0.0 109.241 159.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 77.5 p -71.05 -60.51 2.19 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 126.093 1.757 . . . . 0.0 114.086 -161.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -63.82 -44.28 93.72 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.506 0.593 . . . . 0.0 112.175 173.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -55.41 -36.62 66.65 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.085 0.954 . . . . 0.0 113.334 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -76.75 -15.47 59.75 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.6 p -76.28 -11.74 59.96 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.513 1.506 . . . . 0.0 113.088 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -65.45 89.49 0.1 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.687 1.595 . . . . 0.0 112.609 -168.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.64 131.32 48.59 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.665 -0.683 . . . . 0.0 109.308 155.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.75 135.23 57.52 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.384 0.674 . . . . 0.0 111.78 -174.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -60.74 -37.6 82.33 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -157.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -38.2 87.14 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.935 -1.103 . . . . 0.0 113.149 172.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -76.81 -7.72 55.97 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 171.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.9 t -82.89 -49.56 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.774 0.83 . . . . 0.0 110.612 161.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.5 mt -59.92 -48.32 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.342 1.057 . . . . 0.0 111.5 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.25 -14.44 62.61 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.09 -33.67 9.42 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 120.917 -1.114 . . . . 0.0 113.364 170.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -78.95 -34.02 44.77 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.837 1.655 . . . . 0.0 113.885 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -51.34 -50.33 76.8 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.19 -24.92 27.17 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 121.637 1.558 . . . . 0.0 113.49 172.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -78.18 -10.39 59.62 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.147 1.379 . . . . 0.0 114.267 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.74 -31.03 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 119.249 0.931 . . . . 0.0 110.389 158.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -96.38 -20.12 18.7 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 177.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 C-N-CA 125.707 1.603 . . . . 0.0 112.629 -176.268 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.984 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.5 mt -111.85 139.63 47.17 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.421 1.488 . . . . 0.0 111.999 -175.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -139.78 134.88 32.42 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.984 1.313 . . . . 0.0 108.136 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.8 pt -127.57 142.34 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 120.999 -1.063 . . . . 0.0 110.5 -174.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.9 m -117.58 120.25 37.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.757 1.223 . . . . 0.0 109.689 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.27 163.03 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.998 1.319 . . . . 0.0 111.517 -165.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -59.54 116.2 3.83 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.609 -0.682 . . . . 0.0 110.865 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.482 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -78.06 149.78 33.89 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.935 154.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.05 146.88 49.02 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.203 1.002 . . . . 0.0 112.197 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 51.3 t -68.87 133.75 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 167.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.38 -33.9 1.56 Allowed Glycine 0 CA--C 1.537 1.453 0 CA-C-O 118.516 -1.158 . . . . 0.0 115.357 -174.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.13 69.03 9.75 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.824 1.25 . . . . 0.0 112.61 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.482 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 58.7 Cg_endo -63.41 -11.84 27.74 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.271 2.647 . . . . 0.0 114.816 -173.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -81.4 0.65 36.51 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.063 1.745 . . . . 0.0 114.737 175.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 pt -133.96 164.76 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.795 1.238 . . . . 0.0 111.801 174.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.39 146.7 54.56 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.59 0.756 . . . . 0.0 111.454 169.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -124.2 -164.28 11.92 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 125.25 1.405 . . . . 0.0 112.494 166.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -60.89 108.67 0.89 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 118.22 1.01 . . . . 0.0 113.593 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.1 t -157.63 108.26 1.81 Allowed Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.119 139.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.54 -21.5 59.78 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.14 1.893 . . . . 0.0 112.39 176.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -68.5 -29.9 68.61 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.61 0.764 . . . . 0.0 112.297 173.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 73.1 m -72.26 -37.58 69.05 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.372 -1.455 . . . . 0.0 112.669 168.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.53 -25.13 67.09 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 118.112 -0.947 . . . . 0.0 113.141 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.506 HH12 ' CG ' ' A' ' 74' ' ' ASP . 32.8 mtp180 -58.61 -43.3 89.56 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.319 1.048 . . . . 0.0 112.407 169.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.2 t -76.98 -37.43 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.855 1.262 . . . . 0.0 111.302 -176.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.55 -45.26 91.33 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.138 0.575 . . . . 0.0 111.478 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.68 -50.91 69.28 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.827 1.251 . . . . 0.0 112.408 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 p -63.08 -50.5 70.31 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.6 -35.8 73.18 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -76.53 -23.18 53.64 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 171.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -68.86 -46.23 69.01 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.072 1.305 . . . . 0.0 110.983 170.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -70.35 -7.24 41.18 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.48 1.512 . . . . 0.0 114.92 169.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.9 mmtm 61.46 15.39 6.61 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 126.032 1.733 . . . . 0.0 114.863 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.7 mt -72.69 128.6 88.1 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 123.598 0.759 . . . . 0.0 109.306 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.44 138.12 32.03 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.183 1.922 . . . . 0.0 111.516 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -141.67 153.44 44.7 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.231 1.412 . . . . 0.0 110.556 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -78.22 122.8 26.16 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.317 -0.864 . . . . 0.0 109.804 166.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.3 t -97.74 93.79 6.58 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.593 0.757 . . . . 0.0 111.559 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -82.83 105.68 14.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.903 0.881 . . . . 0.0 110.292 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.1 mt -73.24 113.95 10.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.944 0.898 . . . . 0.0 109.918 171.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.2 mm -108.97 115.8 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.739 1.216 . . . . 0.0 110.086 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -73.98 79.58 1.68 Allowed 'General case' 0 C--O 1.221 -0.411 0 O-C-N 121.4 -0.813 . . . . 32.609999999999999 109.756 166.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pp -65.05 0.7 1.17 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 117.601 2.445 . . . . 40.049999999999997 117.601 -165.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.51 -27.6 67.26 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-N 119.612 1.096 . . . . 41.469999999999999 112.871 161.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -120.45 53.91 1.08 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.934 2.894 . . . . 47.170000000000002 109.529 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -73.06 116.48 51.0 Favored Pre-proline 0 N--CA 1.472 0.667 0 O-C-N 119.757 -1.839 . . . . 41.270000000000003 110.317 -176.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.22 160.58 46.83 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.648 2.232 . . . . 40.289999999999999 112.144 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -61.46 -34.03 74.75 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.302 1.223 . . . . 42.390000000000001 114.302 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 30.5 p-90 -67.5 -21.37 65.5 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.691 -1.256 . . . . 37.079999999999998 114.097 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -82.74 -34.42 27.17 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.425 -0.797 . . . . 35.880000000000003 112.321 169.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.78 -24.97 65.38 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.551 0.74 . . . . 33.609999999999999 112.385 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -72.73 -1.45 16.47 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.794 1.637 . . . . 33.789999999999999 114.376 166.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.6 mt -115.73 -41.7 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.348 1.459 . . . . 33.159999999999997 110.314 173.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.1 t -114.43 100.4 52.9 Favored Pre-proline 0 N--CA 1.471 0.591 0 C-N-CA 125.808 1.643 . . . . 33.579999999999998 111.281 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.99 -20.55 44.53 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.941 2.428 . . . . 37.899999999999999 113.418 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.76 -0.08 57.52 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.396 1.079 . . . . 38.990000000000002 113.716 171.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.92 23.68 72.78 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.607 1.575 . . . . 35.469999999999999 115.866 176.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -104.15 158.63 16.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.889 1.675 . . . . 34.490000000000002 112.789 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.3 m -115.24 150.08 43.8 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.648 1.579 . . . . 23.530000000000001 111.151 164.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -68.46 153.62 89.27 Favored 'Cis proline' 0 C--N 1.349 0.562 0 CA-C-O 121.724 0.635 . . . . 22.879999999999999 112.629 -9.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.1 p -135.63 147.77 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 113.577 -1.647 . . . . 0.0 107.294 156.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.7 m -129.69 161.75 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.654 0.781 . . . . 0.0 110.474 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -116.03 98.93 6.91 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.428 1.491 . . . . 0.0 109.118 167.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 66.8 mt -87.49 114.85 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.415 1.086 . . . . 0.0 108.536 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.58 36.84 28.23 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 121.866 0.841 . . . . 0.0 112.457 -169.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.251 11.2 t0 66.77 10.72 7.75 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 128.292 2.637 . . . . 0.0 116.316 -170.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -104.12 123.18 46.8 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 119.412 -2.055 . . . . 0.0 110.688 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -69.36 143.49 53.71 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -170.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.4 t -142.86 126.66 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 126.695 1.998 . . . . 0.0 108.585 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -110.38 164.95 12.18 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.62 1.568 . . . . 0.0 112.136 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.2 t0 67.57 113.45 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.342 2.257 . . . . 22.16 114.191 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.5 p -65.16 -22.14 66.88 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 115.356 1.613 . . . . 21.16 115.356 -158.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.506 ' CG ' HH12 ' A' ' 25' ' ' ARG . 33.8 m-20 -70.47 -35.68 73.43 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.899 1.227 . . . . 24.969999999999999 112.696 170.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.62 -41.71 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 121.092 -1.005 . . . . 23.850000000000001 110.745 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.0 mt -63.75 -46.5 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.841 0.856 . . . . 23.68 111.227 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.1 t -63.15 -40.54 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.021 0.928 . . . . 22.84 111.314 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.19 -47.26 89.06 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 118.462 0.574 . . . . 23.329999999999998 113.1 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 75.9 mt -73.43 -47.24 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 117.846 0.823 . . . . 23.309999999999999 112.165 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.56 -32.23 73.79 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.046 1.294 . . . . 23.48 112.748 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -89.57 -14.37 35.21 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 114.614 1.338 . . . . 24.239999999999998 114.614 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.534 ' CD ' ' HE3' ' A' ' 83' ' ' LYS . 68.8 tt0 -89.54 -33.57 16.69 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.283 1.433 . . . . 39.259999999999998 112.606 165.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.534 ' HE3' ' CD ' ' A' ' 82' ' ' GLU . 65.2 mttt -135.3 85.33 2.16 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.619 1.168 . . . . 24.449999999999999 112.09 -161.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -150.42 166.02 16.09 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.149 1.78 . . . . 0.0 109.191 168.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.76 -33.36 44.31 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 121.919 1.746 . . . . 0.0 112.103 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -73.95 149.31 87.56 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.231 1.012 . . . . 0.0 111.649 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -52.31 143.02 44.96 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.408 2.739 . . . . 0.0 115.02 -172.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.98 133.49 29.22 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.673 2.249 . . . . 0.0 111.934 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 34.1 mt -103.34 8.51 38.16 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.608 1.163 . . . . 0.0 111.83 168.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.49 49.17 0.11 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.281 1.832 . . . . 0.0 112.373 163.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.7 p -123.31 65.07 29.47 Favored Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 125.381 1.473 . . . . 0.0 109.885 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.76 119.83 6.85 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.181 1.921 . . . . 0.0 109.962 -173.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -73.89 -176.37 2.57 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.917 2.412 . . . . 0.0 111.532 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -53.93 -29.23 41.46 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.184 2.194 . . . . 0.0 113.5 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -52.72 -28.5 22.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.8 1.64 . . . . 0.0 114.045 170.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.64 -29.41 70.65 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.658 1.117 . . . . 0.0 113.358 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 59.7 p -66.9 -25.16 66.25 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.789 0.836 . . . . 0.0 113.097 174.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.0 t -94.87 -42.04 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.978 1.311 . . . . 0.0 110.814 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.47 -31.09 79.58 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.7 1.143 . . . . 0.0 114.421 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 72.3 p -66.35 -20.6 66.13 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.762 1.281 . . . . 0.0 114.211 171.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -92.2 -33.26 14.76 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.113 1.365 . . . . 0.0 112.827 172.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.8 mt -70.45 -37.09 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.986 0.914 . . . . 0.0 111.655 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.453 ' CE1' ' HE2' ' A' ' 156' ' ' LYS . 83.0 t80 -54.68 -45.85 99.47 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.032 1.333 . . . . 0.0 114.505 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.78 -32.52 1.09 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.016 2.478 . . . . 0.0 114.069 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.2 p -71.76 -26.62 62.52 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 121.34 1.882 . . . . 0.0 113.207 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -58.4 -45.89 87.47 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.695 -1.253 . . . . 0.0 112.413 160.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.46 -31.72 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 121.374 -0.828 . . . . 0.0 112.069 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -64.67 -44.15 91.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.689 0.677 . . . . 0.0 111.365 168.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -67.79 -37.1 81.57 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.5 mt -64.21 -11.32 29.91 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.787 1.635 . . . . 0.0 114.435 167.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -142.31 41.03 1.62 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.641 1.976 . . . . 0.0 112.543 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.1 m -68.6 59.73 0.09 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -165.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 94.4 mttt -71.28 -35.75 71.44 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.562 -1.336 . . . . 0.0 111.995 168.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 15.4 t0 -81.01 112.78 35.4 Favored Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 152.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 114' ' ' ASP . 95.9 Cg_exo -57.24 158.68 17.62 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.977 2.451 . . . . 0.0 117.29 -148.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -56.91 -51.64 68.32 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.478 -174.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -79.67 -21.67 44.45 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -163.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.89 -36.08 29.5 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 121.355 -0.841 . . . . 0.0 112.772 165.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 62.3 m -66.81 -30.89 71.2 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.641 0.776 . . . . 0.0 112.799 171.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -65.24 -42.69 93.12 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 125.736 1.614 . . . . 0.0 111.841 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -65.62 -43.13 90.5 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.724 -0.61 . . . . 0.0 111.766 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.05 -25.68 68.22 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 174.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 49.8 tp -82.47 -42.63 18.24 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.848 1.259 . . . . 0.0 112.27 172.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 33.9 mt -67.23 -39.17 86.19 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.668 1.187 . . . . 0.0 113.241 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -67.01 -34.97 78.89 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.046 1.293 . . . . 0.0 112.389 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -72.29 -38.55 68.73 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.027 -1.046 . . . . 0.0 112.765 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.1 mt -64.98 -33.14 75.32 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.585 -1.322 . . . . 0.0 113.03 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -66.4 -41.38 89.39 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.673 1.124 . . . . 0.0 111.51 171.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.8 -35.82 81.85 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.965 0.506 . . . . 0.0 112.203 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.4 tp -68.67 -56.45 8.14 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.068 0.947 . . . . 0.0 111.677 171.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -67.43 -31.63 71.95 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.71 1.204 . . . . 0.0 114.157 -172.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.21 -31.63 73.96 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.154 -0.803 . . . . 0.0 113.543 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -87.45 -33.71 18.95 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 117.888 0.844 . . . . 0.0 112.804 170.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.77 -34.91 78.23 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.041 1.291 . . . . 0.0 113.259 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -68.5 0.93 3.47 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 172.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.8 t -111.07 -37.42 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.599 1.559 . . . . 0.0 112.108 166.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -90.55 -17.16 27.49 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -172.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.98 -143.66 32.5 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-O 118.725 -1.041 . . . . 0.0 114.586 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.35 -18.45 49.91 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 124.794 3.663 . . . . 0.0 117.772 -119.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -118.16 171.03 8.39 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.399 1.08 . . . . 0.0 111.552 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.88 -6.04 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 120.146 -1.597 . . . . 0.0 113.037 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -108.82 15.15 23.78 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.258 1.823 . . . . 0.0 114.301 162.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.81 -108.14 3.03 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 120.564 -1.335 . . . . 0.0 113.242 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -51.72 -41.61 61.64 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.882 1.673 . . . . 0.0 113.887 -172.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -152.93 165.25 36.1 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.868 1.667 . . . . 0.0 110.233 -166.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.9 mt -64.75 132.39 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.195 0.598 . . . . 0.0 109.939 166.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.5 p -138.91 -170.72 2.92 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.843 1.257 . . . . 0.0 110.699 168.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.05 -17.49 3.98 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.1 t -71.03 -45.06 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 119.978 1.263 . . . . 0.0 111.795 172.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.88 -45.72 92.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.859 1.264 . . . . 0.0 111.905 172.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.66 -17.34 60.32 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.216 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.8 m -91.65 -48.05 7.04 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.861 1.21 . . . . 0.0 112.619 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.6 mt -94.49 -36.84 11.68 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -167.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.52 -47.86 97.7 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.22 -21.14 20.54 Favored 'Trans proline' 0 C--N 1.351 0.682 0 CA-C-N 120.808 1.324 . . . . 0.0 113.426 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.453 ' HE2' ' CE1' ' A' ' 103' ' ' PHE . 67.5 mttm -81.0 -27.81 35.74 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.907 -1.121 . . . . 0.0 112.89 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.8 mt -64.83 -43.33 93.42 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.364 0.665 . . . . 0.0 112.204 164.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -59.7 -44.68 93.59 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.225 0.466 . . . . 0.0 111.877 172.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -63.9 -31.37 72.53 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 71.6 mt -74.01 -49.01 26.28 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 118.004 -0.998 . . . . 0.0 113.488 171.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -61.4 -31.1 71.01 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.219 0.918 . . . . 0.0 112.203 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 95.6 t -88.95 -66.97 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.812 1.245 . . . . 0.0 113.27 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.59 -48.78 8.04 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -160.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 30.8 tp -62.83 -33.39 75.13 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.614 166.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -55.05 -28.65 49.69 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.937 1.256 . . . . 0.0 115.713 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -66.17 -22.23 66.36 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -128.04 -22.2 3.52 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -142.79 86.1 1.92 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.378 1.871 . . . . 0.0 108.486 167.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -61.58 86.03 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.178 1.391 . . . . 0.0 110.947 171.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -88.64 121.5 69.97 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.789 -163.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.71 109.93 2.77 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.579 1.519 . . . . 0.0 110.147 170.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.3 mm -59.36 108.34 1.33 Allowed Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 142.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -68.35 164.93 30.62 Favored 'Trans proline' 0 C--N 1.35 0.642 0 CA-C-N 120.553 1.233 . . . . 0.0 112.638 -165.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.52 -24.79 63.95 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.269 1.427 . . . . 0.0 113.27 171.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -66.39 -26.86 67.45 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.834 1.253 . . . . 0.0 113.775 171.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 67.6 mt -87.25 49.68 1.86 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.715 1.606 . . . . 0.0 111.065 169.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.23 -33.47 74.66 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.282 1.033 . . . . 0.0 113.343 -155.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -81.63 -37.66 27.2 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.785 0.721 . . . . 0.0 112.115 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.67 -39.57 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 121.587 -0.696 . . . . 0.0 111.613 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 43.0 tp -65.67 -40.24 92.16 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -68.48 -38.52 81.1 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.546 -0.721 . . . . 0.0 112.323 171.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -63.78 -29.38 70.59 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.252 1.021 . . . . 0.0 113.292 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 78.1 mt -59.07 -32.05 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 120.548 -1.345 . . . . 0.0 111.856 170.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -84.45 -10.68 57.29 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.473 -1.392 . . . . 0.0 113.607 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.94 -17.65 61.46 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.581 161.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.43 -14.26 61.93 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.671 1.123 . . . . 0.0 113.244 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -103.89 5.61 35.85 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.902 1.281 . . . . 0.0 113.316 174.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.6 p -111.33 -179.05 3.61 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.11 2.164 . . . . 0.0 113.964 -167.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 54.12 -159.72 0.16 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.489 1.516 . . . . 0.0 110.628 -172.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.502 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 5.7 mp0 -85.8 -41.01 15.42 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.781 1.232 . . . . 0.0 109.139 160.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 78.4 p -68.55 -60.42 2.43 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 126.293 1.837 . . . . 0.0 114.436 -162.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -62.25 -45.37 93.61 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.518 0.599 . . . . 0.0 112.085 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -56.86 -35.48 68.93 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.304 1.042 . . . . 0.0 113.457 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -76.9 -13.45 59.99 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 176.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.6 p -77.83 -10.77 59.73 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.402 1.455 . . . . 0.0 113.384 171.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -67.24 83.31 0.14 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.683 1.593 . . . . 0.0 112.852 -170.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.26 131.02 49.03 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.298 1.039 . . . . 0.0 109.919 161.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.27 129.96 44.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.317 0.647 . . . . 0.0 111.346 -171.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 31.0 mp0 -59.08 -39.14 81.21 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -157.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -60.39 -36.95 79.29 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.872 1.269 . . . . 0.0 112.687 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -85.12 -6.69 59.29 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.568 1.547 . . . . 0.0 113.092 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 39.6 t -86.79 -44.5 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.215 162.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.1 mt -58.18 -51.2 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.696 1.199 . . . . 0.0 111.347 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.76 -15.0 62.64 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -83.78 -33.25 22.11 Favored Glycine 0 CA--C 1.533 1.216 0 O-C-N 120.874 -1.141 . . . . 0.0 113.175 169.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 44.9 t90 -84.93 -35.26 22.21 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.121 2.169 . . . . 0.0 114.675 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -53.42 -47.35 96.56 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.9 -24.27 29.2 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.498 1.466 . . . . 0.0 113.656 172.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -75.48 -11.68 60.08 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 117.672 -1.156 . . . . 0.0 114.014 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.412 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 48.1 t -59.39 -21.95 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.264 0.938 . . . . 0.0 110.934 160.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -106.73 -10.12 16.22 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 172.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 C-N-CA 126.674 1.99 . . . . 0.0 112.386 -173.746 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.851 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 49.0 mt -103.45 143.6 32.49 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.446 1.117 . . . . 0.0 113.107 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -151.65 128.38 10.87 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.533 1.933 . . . . 0.0 108.382 172.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 pt -126.43 140.77 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.898 0.879 . . . . 0.0 109.92 -170.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.4 m -106.44 122.71 46.82 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.513 0.725 . . . . 0.0 109.335 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.39 164.0 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.597 1.559 . . . . 0.0 110.924 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -62.01 119.01 8.04 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.536 -0.727 . . . . 0.0 111.316 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -80.53 153.69 27.96 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.339 153.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.37 143.6 57.78 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.091 0.948 . . . . 0.0 112.18 170.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.6 t -70.51 136.65 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 168.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.78 -35.0 1.41 Allowed Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.814 -0.992 . . . . 0.0 114.775 -172.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.61 69.03 6.07 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 125.177 1.391 . . . . 0.0 112.478 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.37 -11.44 28.24 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.527 2.818 . . . . 0.0 115.413 -172.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -92.5 9.07 36.0 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.5 pt -130.32 163.09 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.593 1.157 . . . . 0.0 111.264 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.4 mt -62.68 146.02 53.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.299 0.64 . . . . 0.0 111.109 166.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.86 -169.16 12.47 Favored Glycine 0 N--CA 1.474 1.201 0 C-N-CA 125.233 1.397 . . . . 0.0 112.605 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -59.61 108.2 0.7 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.8 t -157.91 103.08 1.76 Allowed Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.637 1.175 . . . . 0.0 109.163 144.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -63.71 -18.95 66.29 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.249 2.633 . . . . 0.0 112.572 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -71.07 -30.6 66.78 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.4 -0.813 . . . . 0.0 112.602 172.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.3 m -70.35 -38.97 74.93 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.598 -1.314 . . . . 0.0 112.415 168.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -60.33 -26.89 66.91 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 118.143 -0.932 . . . . 0.0 113.155 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.522 HH12 ' CG ' ' A' ' 74' ' ' ASP . 46.6 mtp180 -57.89 -45.39 86.49 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.122 0.969 . . . . 0.0 112.52 171.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.54 -39.51 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.089 1.356 . . . . 0.0 111.322 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.82 -41.36 91.13 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.213 0.605 . . . . 0.0 111.258 172.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.4 tp -63.17 -54.5 36.6 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.06 1.344 . . . . 0.0 112.447 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.0 p -69.82 -38.31 76.52 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.462 1.028 . . . . 0.0 113.467 -171.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.6 mt -71.36 -38.96 71.54 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -75.62 -22.57 56.75 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 171.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -69.36 -47.01 65.61 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 120.536 -1.353 . . . . 0.0 111.145 170.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -69.74 -6.52 32.47 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.76 1.624 . . . . 0.0 114.652 169.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm 59.81 16.54 5.7 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.723 1.609 . . . . 0.0 114.804 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.9 mt -71.39 125.9 91.81 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.13 136.46 24.63 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.119 1.879 . . . . 0.0 111.4 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -136.17 151.08 49.37 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.664 1.585 . . . . 0.0 110.573 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -73.76 139.15 45.03 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.45 -0.781 . . . . 0.0 109.035 161.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.3 t -125.2 93.24 3.82 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.733 0.813 . . . . 0.0 111.162 -175.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -74.85 113.42 12.12 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.835 0.854 . . . . 0.0 110.464 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 83.8 mt -72.95 101.29 3.16 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.504 1.122 . . . . 0.0 110.02 164.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mm -97.1 111.29 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.629 0.771 . . . . 0.0 109.892 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -78.06 70.07 4.37 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.252 -0.905 . . . . 32.609999999999999 110.552 168.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.01 8.33 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 117.758 2.503 . . . . 40.049999999999997 117.758 -166.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.94 -44.46 91.67 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-N 119.825 1.193 . . . . 41.469999999999999 111.26 155.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -102.74 72.47 1.22 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.583 1.953 . . . . 47.170000000000002 110.068 166.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -81.24 110.96 20.62 Favored Pre-proline 0 N--CA 1.475 0.778 0 O-C-N 120.234 -1.541 . . . . 41.270000000000003 110.872 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.21 158.15 45.43 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.868 2.379 . . . . 40.289999999999999 112.481 -174.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -59.12 -34.5 72.11 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.419 1.266 . . . . 42.390000000000001 114.419 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -64.83 -32.15 73.72 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.188 0.904 . . . . 37.079999999999998 113.287 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -75.35 -34.53 61.17 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.689 -1.257 . . . . 35.880000000000003 112.782 170.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.89 -28.89 67.1 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.401 1.0 . . . . 33.609999999999999 113.285 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -68.61 -30.47 69.22 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.907 1.683 . . . . 33.789999999999999 112.537 170.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.7 mt -85.04 -33.15 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.96 1.304 . . . . 33.159999999999997 111.623 173.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.1 t -131.62 94.7 25.1 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 126.027 1.731 . . . . 33.579999999999998 110.586 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.86 -15.87 40.8 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.611 2.207 . . . . 37.899999999999999 113.842 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -81.87 -8.09 59.66 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.546 0.943 . . . . 38.990000000000002 113.546 168.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.28 13.42 64.92 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 120.933 -1.104 . . . . 35.469999999999999 114.789 -173.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -91.72 150.94 20.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.176 1.39 . . . . 34.490000000000002 112.763 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.7 m -110.96 153.94 43.6 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 126.176 1.79 . . . . 23.530000000000001 110.74 159.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -66.68 156.68 82.36 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-O 121.975 0.74 . . . . 22.879999999999999 112.925 -8.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 p -144.99 142.27 22.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.164 -1.38 . . . . 0.0 107.872 162.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 m -129.58 146.83 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.513 0.725 . . . . 0.0 110.67 -171.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -105.74 78.72 1.37 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.433 1.493 . . . . 0.0 109.724 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 34.4 mt -71.8 114.5 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.902 0.881 . . . . 0.0 109.564 -176.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 t70 52.47 39.36 27.61 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.96 0.885 . . . . 0.0 112.429 -165.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.8 t0 69.9 7.74 6.37 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 128.075 2.55 . . . . 0.0 116.622 -173.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -103.49 127.06 50.96 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 119.768 -1.833 . . . . 0.0 111.512 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.0 p-90 -70.18 142.48 52.46 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -170.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -143.04 128.4 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 127.722 2.409 . . . . 0.0 108.286 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.74 168.37 9.62 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.606 1.562 . . . . 0.0 112.131 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.9 t0 66.55 113.19 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.66 2.384 . . . . 22.16 114.346 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.3 p -63.11 -24.3 67.84 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 115.215 1.561 . . . . 21.16 115.215 -161.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.522 ' CG ' HH12 ' A' ' 25' ' ' ARG . 37.2 m-20 -73.18 -35.46 66.4 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.179 1.354 . . . . 24.969999999999999 113.307 170.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.62 -38.51 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 121.09 -1.006 . . . . 23.850000000000001 110.856 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.88 -45.94 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.314 1.046 . . . . 23.68 111.233 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.1 t -61.81 -41.4 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.26 1.024 . . . . 22.84 111.299 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.55 -20.26 55.61 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.782 -1.01 . . . . 23.329999999999998 114.932 175.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 98.5 mt -106.5 -44.14 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 119.073 1.436 . . . . 23.309999999999999 112.38 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.4 mt -65.72 -32.78 74.51 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 120.251 1.387 . . . . 23.48 112.947 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.13 -11.77 40.26 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 114.237 1.199 . . . . 24.239999999999998 114.237 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.472 ' OE2' ' HE3' ' A' ' 83' ' ' LYS . 75.0 tt0 -92.41 -41.07 10.52 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.103 1.361 . . . . 39.259999999999998 112.554 165.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.472 ' HE3' ' OE2' ' A' ' 82' ' ' GLU . 74.6 mttt -124.51 90.01 3.18 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.662 1.185 . . . . 24.449999999999999 111.977 -164.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -151.8 165.69 16.88 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.833 1.653 . . . . 0.0 109.474 168.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.21 -30.34 31.2 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.003 1.802 . . . . 0.0 112.031 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -73.7 152.87 89.39 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.82 1.248 . . . . 0.0 112.086 171.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -51.81 142.87 40.63 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.74 2.96 . . . . 0.0 115.053 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.31 131.53 25.17 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.272 1.981 . . . . 0.0 111.533 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.6 mt -105.29 4.48 31.05 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.223 1.409 . . . . 0.0 112.185 171.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.71 51.51 0.14 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.698 1.999 . . . . 0.0 112.178 162.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.1 p -123.79 70.76 49.11 Favored Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 125.021 1.329 . . . . 0.0 109.236 170.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.07 122.48 9.07 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.282 1.988 . . . . 0.0 110.227 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -73.98 179.59 5.58 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.874 2.383 . . . . 0.0 111.221 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.6 mp0 -55.09 -29.75 58.25 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.624 1.97 . . . . 0.0 113.08 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -53.77 -28.14 33.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.994 1.318 . . . . 0.0 113.842 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.27 -29.96 71.19 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.624 1.102 . . . . 0.0 113.21 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.9 p -68.45 -21.95 64.61 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.2 t -99.9 -41.11 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.835 1.254 . . . . 0.0 111.081 176.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.67 -31.52 81.07 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.729 -1.232 . . . . 0.0 114.435 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.9 p -69.62 -18.58 63.61 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -90.46 -32.66 16.29 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.842 1.257 . . . . 0.0 112.881 169.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 71.0 mt -70.27 -36.0 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.778 0.831 . . . . 0.0 111.629 173.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -55.44 -46.74 99.66 Favored Pre-proline 0 CA--C 1.547 0.829 0 O-C-N 120.379 -1.451 . . . . 0.0 114.344 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.65 -31.67 2.44 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.933 2.422 . . . . 0.0 114.116 171.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.6 p -71.46 -28.12 63.73 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 121.034 1.743 . . . . 0.0 113.005 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -58.72 -44.51 90.45 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 120.655 -1.278 . . . . 0.0 112.305 161.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.5 t -65.86 -35.05 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 119.639 1.109 . . . . 0.0 111.887 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -66.54 -39.02 88.36 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.031 0.832 . . . . 0.0 112.047 171.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -70.11 -29.85 66.91 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.284 1.034 . . . . 0.0 112.426 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.9 mt -76.99 -9.06 58.44 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.673 1.589 . . . . 0.0 114.517 168.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -142.63 38.55 1.51 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.92 1.288 . . . . 0.0 112.839 -170.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.4 m -75.07 63.01 1.22 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -162.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -65.26 -38.07 89.15 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.05 1.34 . . . . 0.0 111.136 163.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -83.89 115.97 62.43 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 154.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.59 154.24 70.15 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.675 2.917 . . . . 0.0 115.759 -144.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -66.9 -42.64 85.12 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 114.42 -1.264 . . . . 0.0 112.993 -165.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.71 -22.33 54.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.656 1.182 . . . . 0.0 113.32 -174.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.82 -34.6 27.12 Favored Glycine 0 CA--C 1.532 1.155 0 O-C-N 120.973 -1.079 . . . . 0.0 112.813 165.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 99.4 m -68.44 -27.09 65.87 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.596 -0.944 . . . . 0.0 112.729 171.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.59 -44.44 96.26 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.841 1.657 . . . . 0.0 111.928 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -66.7 -41.84 87.36 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.43 0.692 . . . . 0.0 112.059 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.77 -25.05 67.09 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 174.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.9 tp -82.51 -41.71 19.36 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.685 1.194 . . . . 0.0 112.17 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 26.9 mt -65.23 -40.08 93.61 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.713 1.205 . . . . 0.0 113.566 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -68.23 -33.83 75.12 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.927 1.239 . . . . 0.0 112.727 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -73.48 -38.76 65.31 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.063 -1.023 . . . . 0.0 112.722 170.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.1 mt -63.57 -35.55 80.86 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.782 -1.199 . . . . 0.0 112.849 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -65.06 -44.29 89.46 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.137 0.975 . . . . 0.0 111.598 172.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.61 -36.02 81.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.333 0.653 . . . . 0.0 112.224 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.1 tp -69.35 -56.95 6.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.377 1.071 . . . . 0.0 111.97 172.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.47 -30.57 69.45 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -171.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.33 -32.01 67.23 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.144 -0.809 . . . . 0.0 113.487 172.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -89.15 -33.88 16.9 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 117.75 0.775 . . . . 0.0 113.006 172.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.55 -35.95 81.07 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.912 1.233 . . . . 0.0 113.042 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.6 mtmt -65.81 -6.9 13.34 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 174.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.6 t -102.5 -36.72 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.961 1.305 . . . . 0.0 112.173 169.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -89.22 -19.32 25.55 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.31 -140.63 35.9 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.939 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -70.86 -15.71 32.95 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.785 3.657 . . . . 0.0 117.343 -108.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -122.08 170.98 9.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.926 1.29 . . . . 0.0 110.908 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.254 2.9 tt -77.9 7.29 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 119.855 -1.778 . . . . 0.0 113.132 -175.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -114.61 6.95 15.91 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.91 2.484 . . . . 0.0 114.035 163.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.93 -122.33 6.64 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.82 -1.175 . . . . 0.0 113.185 -172.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -54.0 -36.69 63.22 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -169.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -146.76 157.87 43.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.318 1.447 . . . . 0.0 110.977 -166.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 56.0 mt -67.48 132.67 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.517 0.727 . . . . 0.0 110.414 171.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.0 p -143.5 -171.62 3.54 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.483 1.513 . . . . 0.0 111.15 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -54.58 -17.89 3.8 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.61 -42.48 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 120.211 1.369 . . . . 0.0 111.759 172.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.64 -45.08 95.56 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.933 1.293 . . . . 0.0 112.326 168.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.8 mt -62.08 -24.24 66.99 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 122.039 -0.413 . . . . 0.0 111.769 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.9 m -83.46 -50.56 8.18 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.887 -1.133 . . . . 0.0 112.597 175.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.3 mt -94.86 -36.0 11.82 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -165.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.8 -49.17 94.39 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.56 -22.5 15.8 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 120.725 1.295 . . . . 0.0 113.483 178.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -78.2 -28.92 48.16 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 117.714 -1.136 . . . . 0.0 112.859 174.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 46.7 mt -65.69 -44.65 85.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.89 0.876 . . . . 0.0 112.395 166.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -57.22 -41.66 79.91 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.161 0.505 . . . . 0.0 111.792 170.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -68.0 -29.61 68.67 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 9.2 mt -69.68 -52.48 25.35 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.419 1.008 . . . . 0.0 111.913 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -61.43 -35.51 77.78 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.017 0.927 . . . . 0.0 112.029 -174.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.7 t -90.56 -62.82 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.395 1.078 . . . . 0.0 113.14 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.21 -56.83 3.81 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.601 -0.687 . . . . 0.0 112.42 -162.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.42 -33.12 74.86 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.439 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.64 -23.29 49.28 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.129 1.347 . . . . 0.0 115.778 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -69.95 -22.26 63.19 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -124.94 -25.19 3.93 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -139.34 90.52 2.42 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.825 1.65 . . . . 0.0 108.353 166.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -65.3 83.78 0.05 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.583 1.153 . . . . 0.0 109.979 170.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -86.8 117.38 68.57 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.852 -169.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.34 110.63 2.9 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.585 1.524 . . . . 0.0 109.835 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.8 mm -55.39 109.32 1.54 Allowed Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 151.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -64.51 158.34 50.18 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 121.278 1.319 . . . . 0.0 112.442 -166.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.71 -19.06 64.63 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -66.36 -25.0 66.59 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.424 1.09 . . . . 0.0 113.693 168.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 62.5 mt -87.06 47.88 1.57 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.232 1.813 . . . . 0.0 111.388 170.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.7 -31.76 73.03 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.987 -1.071 . . . . 0.0 113.823 -155.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -80.45 -38.12 30.66 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.092 -1.005 . . . . 0.0 111.862 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 87.0 t -61.46 -42.32 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 121.436 -0.79 . . . . 0.0 111.559 171.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.8 -29.44 69.92 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -80.9 -37.45 29.65 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.595 -0.691 . . . . 0.0 112.507 170.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -63.76 -31.13 72.21 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.476 1.11 . . . . 0.0 113.473 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 79.6 mt -56.96 -37.1 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.139 -0.976 . . . . 0.0 111.904 169.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -77.5 -16.34 58.77 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 119.975 -1.703 . . . . 0.0 112.878 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 66.6 mt -77.0 -12.76 59.98 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 117.461 -1.257 . . . . 0.0 113.473 166.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.83 -18.9 65.61 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.414 1.461 . . . . 0.0 112.924 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -93.15 2.17 56.81 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 173.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.4 p -105.97 -179.57 3.98 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.168 2.187 . . . . 0.0 113.828 -170.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 43.8 mtp85 55.09 -161.95 0.15 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.347 1.459 . . . . 0.0 110.655 -172.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 8.0 mp0 -86.03 -40.68 15.53 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.101 1.36 . . . . 0.0 109.209 157.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 72.5 p -70.7 -53.15 16.74 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.713 1.605 . . . . 0.0 114.727 -160.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -67.01 -46.17 75.3 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.17 0.896 . . . . 0.0 111.855 171.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 193' ' ' LYS . 26.7 ttmt -55.89 -38.28 69.98 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -74.46 -12.5 60.51 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.7 p -77.75 -11.74 59.91 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.329 1.422 . . . . 0.0 113.267 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -67.32 86.23 0.17 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.778 1.631 . . . . 0.0 112.721 -169.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.35 136.11 57.93 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.797 0.839 . . . . 0.0 109.99 159.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.2 132.47 53.77 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.104 0.562 . . . . 0.0 111.547 -173.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -60.02 -37.46 79.83 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.636 1.346 . . . . 0.0 114.636 -159.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.44 -38.28 83.59 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.901 -1.124 . . . . 0.0 112.462 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -86.49 -4.85 59.24 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.782 1.633 . . . . 0.0 112.998 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.3 t -85.02 -48.81 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.707 1.203 . . . . 0.0 109.89 162.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.8 mt -59.27 -53.37 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.852 1.261 . . . . 0.0 111.63 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.39 -15.53 62.37 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -81.78 -33.84 26.3 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 120.898 -1.126 . . . . 0.0 113.012 170.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 32.5 t90 -82.95 -32.75 26.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.521 1.928 . . . . 0.0 114.634 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -50.07 -48.84 78.19 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.53 -23.94 31.27 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.773 1.649 . . . . 0.0 113.71 173.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.08 -11.07 60.01 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.775 1.23 . . . . 0.0 113.901 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 57.6 t -58.95 -27.85 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 119.236 0.926 . . . . 0.0 110.688 161.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -97.91 -36.37 10.18 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 171.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.743 0 C-N-CA 126.052 1.741 . . . . 0.0 113.639 -177.344 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.891 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 79.7 mt -109.72 131.81 54.72 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.391 1.076 . . . . 0.0 112.298 -175.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -122.21 145.6 48.05 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.574 1.15 . . . . 0.0 108.489 153.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.2 pt -130.22 138.84 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.967 0.907 . . . . 0.0 109.504 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.9 m -106.98 119.82 40.39 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.179 0.992 . . . . 0.0 109.621 173.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.81 163.8 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.018 1.327 . . . . 0.0 111.111 -169.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -60.58 119.14 7.5 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.758 -0.589 . . . . 0.0 111.23 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.41 147.01 31.18 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.051 151.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.93 139.47 58.75 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.757 0.789 . . . . 0.0 111.942 172.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.2 t -71.86 134.25 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 168.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.91 -27.74 2.97 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-O 118.665 -1.075 . . . . 0.0 114.677 -170.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -129.26 65.41 74.19 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-N 118.582 1.191 . . . . 0.0 112.564 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.12 -12.39 32.2 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.315 2.677 . . . . 0.0 115.468 -170.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -85.97 5.71 31.95 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.1 pt -132.37 163.33 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.733 1.213 . . . . 0.0 111.84 173.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.74 145.47 49.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.136 0.575 . . . . 0.0 110.888 166.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.63 -163.53 11.17 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.878 1.228 . . . . 0.0 111.981 166.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -56.96 105.4 0.21 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.6 t -157.64 107.4 1.81 Allowed Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.841 140.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.11 -14.29 42.83 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.178 2.585 . . . . 0.0 113.198 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -77.76 -29.39 50.98 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.207 -0.933 . . . . 0.0 112.401 171.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 99.7 m -70.81 -37.85 73.26 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.083 -1.636 . . . . 0.0 112.451 167.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -59.42 -26.69 65.38 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 118.399 -0.81 . . . . 0.0 113.006 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.502 HH12 ' CG ' ' A' ' 74' ' ' ASP . 53.8 mtp180 -58.14 -44.11 87.68 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.526 1.131 . . . . 0.0 112.641 171.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.5 t -77.0 -39.57 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.101 1.36 . . . . 0.0 111.299 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.31 -44.44 92.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.327 0.651 . . . . 0.0 111.121 171.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.0 tp -60.78 -53.75 53.55 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.991 1.316 . . . . 0.0 112.77 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 p -71.55 -36.85 71.11 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.708 1.14 . . . . 0.0 113.574 -173.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.17 -39.03 68.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.841 -0.599 . . . . 0.0 112.051 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -77.99 -17.39 57.2 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 172.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -70.16 -52.88 20.06 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.999 1.272 . . . . 0.0 110.896 167.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -73.24 -1.75 19.07 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.291 1.836 . . . . 0.0 114.468 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm 58.03 18.8 5.42 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.409 1.884 . . . . 0.0 115.106 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 58.5 mt -72.69 125.07 91.4 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 123.896 0.878 . . . . 0.0 108.868 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.72 144.84 35.88 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.473 2.116 . . . . 0.0 112.167 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -148.18 154.54 40.25 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.271 1.428 . . . . 0.0 111.01 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -78.55 121.1 24.18 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.332 -0.855 . . . . 0.0 109.686 163.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.8 t -95.42 94.41 7.8 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.538 0.735 . . . . 0.0 111.14 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -81.07 105.67 12.47 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.547 0.739 . . . . 0.0 110.067 178.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.9 mt -68.61 107.37 2.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.293 1.037 . . . . 0.0 109.963 168.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -105.05 114.9 45.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.125 0.97 . . . . 0.0 110.056 177.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -74.46 80.73 1.92 Allowed 'General case' 0 C--O 1.221 -0.437 0 O-C-N 121.438 -0.789 . . . . 32.609999999999999 109.629 165.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 pp -62.68 -4.26 1.94 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 116.622 2.082 . . . . 40.049999999999997 116.622 -170.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.65 -28.53 67.14 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-N 119.283 0.947 . . . . 41.469999999999999 112.576 166.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -116.42 54.15 0.85 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.31 2.644 . . . . 47.170000000000002 109.681 174.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -72.11 114.48 29.6 Favored Pre-proline 0 CA--C 1.546 0.803 0 O-C-N 119.745 -1.847 . . . . 41.270000000000003 111.059 -168.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.18 161.05 41.49 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.627 2.218 . . . . 40.289999999999999 112.209 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -61.85 -31.0 71.22 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.02 1.119 . . . . 42.390000000000001 114.02 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -61.52 -33.73 74.32 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.304 -0.873 . . . . 37.079999999999998 113.069 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -78.44 -35.14 47.24 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.22 -0.925 . . . . 35.880000000000003 112.769 172.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.14 -23.53 63.98 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.869 1.063 . . . . 33.609999999999999 113.869 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -67.48 -42.34 83.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.731 1.212 . . . . 33.789999999999999 111.418 168.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.7 mt -74.81 -32.78 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.348 1.059 . . . . 33.159999999999997 112.038 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.8 t -137.74 94.11 11.87 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 126.327 1.851 . . . . 33.579999999999998 111.351 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.83 -22.42 36.67 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.847 2.365 . . . . 37.899999999999999 113.586 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 1.1 pm0 -78.93 -10.79 59.92 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.896 -1.128 . . . . 38.990000000000002 113.299 167.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.36 25.92 74.5 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.96 1.743 . . . . 35.469999999999999 115.015 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -105.21 149.14 26.21 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.938 1.369 . . . . 34.490000000000002 112.014 -172.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.5 m -106.84 146.68 33.58 Favored Pre-proline 0 N--CA 1.47 0.543 0 C-N-CA 123.913 0.885 . . . . 23.530000000000001 110.153 164.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.35 150.65 86.53 Favored 'Cis proline' 0 C--N 1.346 0.431 0 CA-C-N 119.032 0.69 . . . . 22.879999999999999 113.156 -7.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 p -138.76 145.54 27.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 113.618 -1.628 . . . . 0.0 107.16 156.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.77 160.8 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 O-C-N 121.449 -0.782 . . . . 0.0 111.13 -172.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.6 mtpt -119.85 73.47 0.97 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.258 1.423 . . . . 0.0 108.951 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.5 mt -71.49 117.3 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.443 1.097 . . . . 0.0 109.582 -174.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.4 t0 56.7 30.53 17.72 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 121.904 -0.498 . . . . 0.0 111.97 -165.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.8 t0 73.1 4.91 5.05 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 129.04 2.936 . . . . 0.0 116.37 -169.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -102.31 132.07 48.5 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.525 -1.36 . . . . 0.0 111.547 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -67.25 136.01 54.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.776 0.83 . . . . 0.0 113.056 -168.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -143.56 126.92 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.967 1.707 . . . . 0.0 109.449 170.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -107.08 172.04 7.04 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.832 1.653 . . . . 0.0 111.91 174.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 t0 65.69 111.48 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.89 2.476 . . . . 22.16 114.57 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.3 p -64.04 -21.41 66.5 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 115.696 1.739 . . . . 21.16 115.696 -161.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.502 ' CG ' HH12 ' A' ' 25' ' ' ARG . 35.6 m-20 -75.84 -31.74 59.47 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.494 1.497 . . . . 24.969999999999999 113.666 170.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.8 t -73.33 -38.64 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.932 -1.105 . . . . 23.850000000000001 110.823 170.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.22 -44.77 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.217 1.007 . . . . 23.68 110.962 174.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.4 t -62.59 -46.13 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.373 1.069 . . . . 22.84 111.378 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.09 -45.12 83.14 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 118.869 0.759 . . . . 23.329999999999998 112.99 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 99.1 mt -75.4 -46.48 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.709 -0.877 . . . . 23.309999999999999 112.388 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.6 mt -69.86 -30.09 67.48 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.23 1.377 . . . . 23.48 113.591 -176.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -89.99 -13.18 36.65 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.335 0.865 . . . . 24.239999999999998 113.335 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.535 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 56.6 tt0 -91.81 -47.08 7.53 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.758 1.623 . . . . 39.259999999999998 112.568 167.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.535 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 84.0 mttt -117.52 83.57 2.01 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.719 1.207 . . . . 24.449999999999999 112.024 -161.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -149.25 165.85 16.68 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.275 1.43 . . . . 0.0 110.274 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -70.05 -25.23 27.49 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.152 1.901 . . . . 0.0 112.438 172.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -73.29 156.18 89.34 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.45 1.5 . . . . 0.0 112.155 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -57.24 143.81 92.49 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.218 2.612 . . . . 0.0 114.21 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.57 130.98 24.84 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.436 2.091 . . . . 0.0 112.424 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.0 mt -110.32 1.56 18.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.425 1.49 . . . . 0.0 112.333 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.67 50.08 0.18 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.676 1.99 . . . . 0.0 111.891 160.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 67.9 p -125.12 70.54 61.54 Favored Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 125.63 1.572 . . . . 0.0 109.045 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -69.59 128.75 16.64 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.98 1.786 . . . . 0.0 111.194 -165.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.0 177.31 7.24 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.419 2.746 . . . . 0.0 111.318 170.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -55.58 -31.16 61.96 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 120.924 -1.11 . . . . 0.0 113.897 173.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -53.43 -25.59 16.56 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.293 1.437 . . . . 0.0 113.973 172.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.15 -33.92 74.18 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.577 1.08 . . . . 0.0 113.184 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 84.1 p -68.99 -24.28 64.21 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.385 1.074 . . . . 0.0 113.78 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 t -92.75 -40.74 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.264 1.425 . . . . 0.0 110.111 176.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.96 -30.97 79.02 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.83 1.681 . . . . 0.0 114.45 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 89.8 p -69.27 -17.53 63.75 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.024 1.412 . . . . 0.0 113.77 171.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -95.56 -33.15 12.51 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.105 1.362 . . . . 0.0 112.386 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 69.2 mt -70.2 -36.79 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.607 0.763 . . . . 0.0 111.979 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -56.19 -47.71 98.32 Favored Pre-proline 0 CA--C 1.545 0.758 0 O-C-N 120.223 -1.548 . . . . 0.0 113.898 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.65 -30.38 3.08 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.546 2.164 . . . . 0.0 114.045 171.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.3 p -72.57 -27.16 62.03 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 121.193 1.815 . . . . 0.0 113.273 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -59.03 -46.72 87.5 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.662 -1.274 . . . . 0.0 111.839 160.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.8 t -65.17 -32.65 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.336 0.971 . . . . 0.0 111.951 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -67.73 -39.39 84.27 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.174 0.897 . . . . 0.0 112.393 168.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -70.71 -28.29 64.63 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.469 1.107 . . . . 0.0 112.783 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 20.6 mt -77.01 -15.24 59.69 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.869 1.668 . . . . 0.0 114.147 167.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -137.68 38.95 2.41 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.848 1.259 . . . . 0.0 112.533 -170.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.3 m -73.85 66.0 1.09 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -162.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -67.81 -39.36 83.98 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.401 1.08 . . . . 0.0 111.522 164.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -79.44 111.77 23.4 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 153.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.48 155.85 66.62 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.578 2.852 . . . . 0.0 115.452 -143.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -65.3 -42.51 92.99 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.838 -1.074 . . . . 0.0 113.437 -165.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.75 -21.98 61.67 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.84 -36.9 17.72 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 120.998 -1.064 . . . . 0.0 112.495 167.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 98.4 m -67.82 -27.55 66.81 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.82 0.848 . . . . 0.0 113.042 172.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -58.76 -45.95 88.57 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.795 1.638 . . . . 0.0 111.616 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -68.68 -40.46 80.1 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.792 0.837 . . . . 0.0 111.433 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.91 -24.9 66.93 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.6 tp -82.92 -40.75 19.74 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.864 1.265 . . . . 0.0 111.94 172.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.9 mt -63.45 -41.36 98.63 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.676 1.191 . . . . 0.0 113.351 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -66.58 -35.64 80.7 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.063 1.301 . . . . 0.0 112.774 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -71.79 -39.5 69.85 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.122 -0.986 . . . . 0.0 112.592 171.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.6 mt -64.28 -33.6 76.19 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.837 -1.164 . . . . 0.0 113.121 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -66.7 -44.28 82.11 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.588 1.086 . . . . 0.0 111.577 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.84 81.56 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.558 0.743 . . . . 0.0 112.218 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.2 tp -68.07 -56.75 7.75 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.27 1.028 . . . . 0.0 111.846 172.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.96 -33.44 74.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.576 1.15 . . . . 0.0 113.879 -171.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.42 -34.02 67.56 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.36 -0.689 . . . . 0.0 113.324 173.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -92.67 -29.35 16.13 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 77.4 mt -64.23 -33.74 76.5 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 120.465 -1.397 . . . . 0.0 113.225 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -65.94 -7.63 17.87 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.35 -38.37 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.144 1.378 . . . . 0.0 112.169 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -82.17 -17.38 46.46 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -172.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.2 -164.86 42.57 Favored Glycine 0 CA--C 1.542 1.721 0 CA-C-O 117.718 -1.601 . . . . 0.0 114.42 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.0 -10.67 23.09 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 125.281 3.987 . . . . 0.0 118.144 -119.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -110.32 167.21 10.37 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.175 0.99 . . . . 0.0 110.893 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.2 tt -75.57 6.86 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 120.275 -1.516 . . . . 0.0 112.997 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -116.2 2.79 13.37 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 128.146 2.579 . . . . 0.0 114.422 165.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.93 -117.85 5.7 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.083 1.325 . . . . 0.0 113.251 -173.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -62.45 -35.81 80.44 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -168.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -142.49 162.32 35.76 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.76 1.624 . . . . 0.0 110.484 -171.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.8 mt -62.83 135.68 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.07 0.462 . . . . 0.0 110.528 165.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.7 p -138.59 -174.33 3.8 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.502 1.521 . . . . 0.0 110.814 171.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.95 -19.31 1.73 Allowed 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 169.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 18.4 t -74.27 -40.32 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 120.179 1.354 . . . . 0.0 112.496 174.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -61.5 -44.33 97.28 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.863 -1.148 . . . . 0.0 112.003 167.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.9 mt -62.19 -26.99 68.66 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 122.193 -0.317 . . . . 0.0 111.533 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 52.3 m -79.35 -47.43 15.81 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.845 -1.159 . . . . 0.0 112.694 175.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 51.5 mt -100.01 -37.98 8.77 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -164.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.24 88.48 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -173.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.97 -28.57 19.27 Favored 'Trans proline' 0 C--N 1.351 0.705 0 CA-C-N 120.784 1.316 . . . . 0.0 113.12 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -72.81 -30.55 64.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.611 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 51.6 mt -65.97 -46.61 77.45 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.741 0.816 . . . . 0.0 112.975 169.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -58.33 -36.31 73.22 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.828 0.823 . . . . 0.0 112.323 170.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -73.98 -22.79 59.49 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.867 -1.146 . . . . 0.0 113.76 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.33 -49.78 45.94 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.561 1.073 . . . . 0.0 111.398 162.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -58.1 -37.11 73.9 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.389 1.476 . . . . 0.0 112.479 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 70.4 t -96.87 -62.66 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.236 1.014 . . . . 0.0 113.545 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.05 -54.2 6.83 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.463 -0.773 . . . . 0.0 112.622 -164.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 38.6 tp -65.71 -34.69 78.78 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 119.349 -0.358 . . . . 0.0 111.155 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.03 -29.24 59.17 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.23 1.395 . . . . 0.0 115.336 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -66.48 -22.01 66.19 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -122.29 -21.19 5.92 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -148.33 94.94 2.38 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.291 1.836 . . . . 0.0 108.797 165.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -67.99 78.74 0.22 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.895 1.278 . . . . 0.0 111.171 173.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -76.98 118.2 70.23 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.24 1.016 . . . . 0.0 111.91 -168.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -73.37 110.36 3.04 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.949 1.766 . . . . 0.0 110.662 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 14.0 mm -58.03 115.42 11.14 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 160.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -63.13 153.49 73.6 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 121.634 1.556 . . . . 0.0 112.633 -172.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -61.15 -22.66 64.9 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 169.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -68.11 -25.45 65.32 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 170.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 47.4 mt -86.12 50.91 2.07 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.251 1.42 . . . . 0.0 111.104 167.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.8 -26.87 68.53 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.315 1.046 . . . . 0.0 113.315 -160.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -75.62 -50.66 14.85 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.017 0.826 . . . . 0.0 111.074 171.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 86.3 t -59.17 -39.93 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.757 0.823 . . . . 0.0 111.572 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.4 tp -61.01 -36.01 78.37 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.675 1.19 . . . . 0.0 113.397 174.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -81.0 -37.25 29.48 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -62.61 -33.92 75.99 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.687 1.195 . . . . 0.0 112.872 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.8 mt -59.89 -35.83 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.033 -1.042 . . . . 0.0 112.104 171.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -74.08 -17.83 60.9 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.225 -1.547 . . . . 0.0 112.941 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 51.0 mt -74.88 -15.95 60.69 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 118.339 -0.838 . . . . 0.0 113.148 168.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.6 mt -67.99 -17.69 64.5 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 120.011 1.278 . . . . 0.0 113.828 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -95.09 6.59 48.65 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.419 -1.425 . . . . 0.0 113.477 171.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.7 p -107.69 -179.07 3.8 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.956 1.703 . . . . 0.0 113.222 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 44.8 mtp85 56.46 -164.33 0.15 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.655 1.582 . . . . 0.0 111.335 -172.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 11.5 mp0 -84.62 -41.15 16.66 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.964 1.306 . . . . 0.0 109.276 157.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 77.4 p -70.16 -54.67 11.91 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.867 1.667 . . . . 0.0 114.631 -159.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -67.46 -45.94 74.49 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.701 0.682 . . . . 0.0 111.977 171.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.421 ' HB2' ' HE3' ' A' ' 193' ' ' LYS . 26.1 ttmt -56.63 -39.03 72.93 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.172 -0.955 . . . . 0.0 113.517 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -74.04 -8.84 57.61 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.4 p -77.51 -14.47 59.67 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.401 1.455 . . . . 0.0 113.231 170.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -65.85 101.59 0.67 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.639 1.109 . . . . 0.0 111.636 -174.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.24 159.96 30.2 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.671 0.788 . . . . 0.0 110.496 156.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.38 127.55 33.09 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.076 -0.39 . . . . 0.0 110.359 172.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -63.86 -31.75 73.03 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -161.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -61.89 -39.85 93.37 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.997 -1.064 . . . . 0.0 112.424 171.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -81.89 -2.25 50.55 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.552 -1.343 . . . . 0.0 114.242 173.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 85.4 t -85.83 -44.7 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.402 1.081 . . . . 0.0 110.294 163.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.2 mt -64.51 -56.63 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.864 1.266 . . . . 0.0 111.526 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.7 -13.65 62.28 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.474 1.11 . . . . 0.0 113.825 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -86.44 -36.54 9.56 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.808 -1.183 . . . . 0.0 113.484 170.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -78.04 -31.31 50.31 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.688 1.595 . . . . 0.0 113.615 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -53.59 -47.97 94.68 Favored Pre-proline 0 CA--C 1.553 1.066 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -175.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.93 -23.75 29.65 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 121.681 1.588 . . . . 0.0 113.919 171.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -74.33 -8.61 56.85 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 117.595 -1.193 . . . . 0.0 114.204 175.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 45.7 t -60.59 -21.36 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 119.274 0.943 . . . . 0.0 111.268 160.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -105.72 -12.17 16.01 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 170.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.882 0 C-N-CA 125.394 1.478 . . . . 0.0 112.653 -170.852 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.892 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 74.8 mt -115.74 137.3 52.22 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.249 1.42 . . . . 0.0 111.188 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -130.59 144.37 51.37 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.681 1.192 . . . . 0.0 108.723 160.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.3 pt -128.62 135.35 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.999 0.92 . . . . 0.0 109.34 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 79.2 m -110.84 117.29 33.01 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.493 1.117 . . . . 0.0 109.459 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.9 m -132.45 158.78 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.773 1.229 . . . . 0.0 111.09 -165.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -59.62 114.99 3.01 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.986 -0.446 . . . . 0.0 110.685 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -80.94 149.65 29.3 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.984 154.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.96 142.89 57.18 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.921 0.867 . . . . 0.0 113.057 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.91 129.15 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 163.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.66 -18.99 12.4 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-O 118.405 -1.219 . . . . 0.0 115.41 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.67 65.97 26.55 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 119.114 1.457 . . . . 0.0 112.286 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 62.5 Cg_endo -64.82 -5.16 9.97 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.705 2.937 . . . . 0.0 115.489 -172.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -89.96 3.63 52.54 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.6 pt -133.8 164.57 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.201 1.4 . . . . 0.0 111.704 173.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.19 150.03 39.94 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.817 0.847 . . . . 0.0 111.922 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.49 -164.86 10.09 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.592 1.568 . . . . 0.0 111.834 165.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -57.78 104.28 0.18 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.6 t -153.37 106.41 2.58 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 113.74 -1.573 . . . . 0.0 110.212 136.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -67.62 -15.3 44.44 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.822 2.348 . . . . 0.0 112.761 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -74.44 -29.39 61.46 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.374 -0.829 . . . . 0.0 112.369 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 89.1 m -70.15 -37.08 75.14 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.326 -1.484 . . . . 0.0 112.816 167.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -60.41 -28.08 67.97 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.479 HH12 ' CG ' ' A' ' 74' ' ' ASP . 57.3 mtp180 -56.76 -40.05 75.12 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.678 1.191 . . . . 0.0 112.691 171.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.3 -40.61 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.138 1.375 . . . . 0.0 111.52 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.51 -43.54 93.36 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.951 0.5 . . . . 0.0 111.132 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.8 tp -59.15 -46.59 87.97 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.353 1.061 . . . . 0.0 113.268 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.2 p -78.44 -37.96 42.4 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.35 -36.91 77.35 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.484 0.584 . . . . 0.0 111.621 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -77.98 -18.33 56.1 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -75.43 -46.33 33.38 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.142 -1.599 . . . . 0.0 111.534 166.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -76.52 -5.03 45.8 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.071 1.348 . . . . 0.0 114.343 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm 58.68 20.27 7.61 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.325 1.85 . . . . 0.0 114.477 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.1 mt -70.98 130.54 88.18 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.217 -0.896 . . . . 0.0 108.679 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.01 139.38 29.81 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.331 2.021 . . . . 0.0 111.99 173.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -144.67 154.42 42.75 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.857 1.663 . . . . 0.0 110.194 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -81.94 125.48 30.81 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.177 -0.952 . . . . 0.0 110.019 162.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.5 t -93.16 95.75 9.6 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.515 0.726 . . . . 0.0 110.999 169.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -79.97 99.06 7.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.676 0.79 . . . . 0.0 109.583 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 82.2 mt -66.75 109.72 2.98 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.945 0.898 . . . . 0.0 109.599 169.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mm -120.23 111.88 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.736 1.215 . . . . 0.0 109.15 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -77.5 89.42 3.85 Favored 'General case' 0 C--O 1.222 -0.368 0 O-C-N 120.68 -1.263 . . . . 32.609999999999999 108.602 166.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.42 1.79 0.19 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 117.519 2.415 . . . . 40.049999999999997 117.519 -175.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -69.95 -24.02 76.68 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-N 119.918 1.235 . . . . 41.469999999999999 112.734 161.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -128.11 66.84 1.36 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.974 2.51 . . . . 47.170000000000002 108.823 171.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -80.63 116.49 62.45 Favored Pre-proline 0 N--CA 1.473 0.684 0 O-C-N 120.055 -1.653 . . . . 41.270000000000003 110.551 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.15 161.65 44.98 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.689 2.26 . . . . 40.289999999999999 111.638 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -61.82 -29.83 70.42 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.028 1.121 . . . . 42.390000000000001 114.028 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -60.72 -33.02 72.27 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.269 1.028 . . . . 37.079999999999998 113.362 170.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -79.38 -36.61 38.95 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.951 -1.093 . . . . 35.880000000000003 112.599 173.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.7 mt -68.12 -25.54 65.35 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.343 0.868 . . . . 33.609999999999999 113.343 174.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -64.14 -47.37 80.18 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.606 1.563 . . . . 33.789999999999999 111.457 168.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.2 mt -72.39 -37.38 57.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.894 0.877 . . . . 33.159999999999997 111.625 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.1 t -126.75 92.19 45.39 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 126.177 1.791 . . . . 33.579999999999998 110.746 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.03 -17.47 36.34 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.856 2.371 . . . . 37.899999999999999 113.965 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -76.48 -11.58 59.9 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.102 -0.999 . . . . 38.990000000000002 113.533 165.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.98 21.35 76.8 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.548 1.07 . . . . 35.469999999999999 114.561 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -104.08 150.5 24.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.451 1.501 . . . . 34.490000000000002 113.688 -173.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.19 153.96 40.76 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 125.93 1.692 . . . . 23.530000000000001 111.046 162.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -63.66 149.37 68.0 Favored 'Cis proline' 0 C--N 1.347 0.48 0 CA-C-O 121.852 0.688 . . . . 22.879999999999999 112.608 -12.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.38 146.95 28.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 113.985 -1.461 . . . . 0.0 107.494 156.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.1 m -134.7 165.26 31.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 123.565 0.746 . . . . 0.0 111.004 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -124.06 71.7 1.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.757 1.623 . . . . 0.0 109.424 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.5 mt -74.74 117.51 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.395 1.078 . . . . 0.0 108.994 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.0 t0 53.8 40.47 31.56 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 121.227 0.537 . . . . 0.0 110.967 -164.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.6 t0 67.54 -5.84 0.73 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.445 2.298 . . . . 0.0 115.608 -172.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -92.77 135.51 34.06 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.261 -1.525 . . . . 0.0 112.296 -172.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -68.1 131.41 45.37 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.634 1.174 . . . . 0.0 112.465 -170.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.1 t -141.09 129.61 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.165 1.386 . . . . 0.0 109.588 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.29 171.14 7.65 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.929 1.691 . . . . 0.0 111.425 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.9 t0 66.08 111.17 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.527 2.331 . . . . 22.16 114.162 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.9 p -64.09 -21.65 66.62 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 115.15 1.537 . . . . 21.16 115.15 -162.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.479 ' CG ' HH12 ' A' ' 25' ' ' ARG . 38.0 m-20 -74.1 -34.01 63.82 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.023 1.283 . . . . 24.969999999999999 113.421 169.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -72.27 -38.71 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.086 -1.009 . . . . 23.850000000000001 110.785 171.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.56 -44.94 99.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.234 1.014 . . . . 23.68 111.072 175.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.6 t -62.99 -44.65 99.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.384 1.074 . . . . 22.84 111.286 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.43 -35.04 70.18 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 118.633 0.651 . . . . 23.329999999999998 113.91 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 94.8 mt -85.11 -49.9 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 118.339 1.07 . . . . 23.309999999999999 112.122 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.4 mt -65.75 -32.32 73.8 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.809 1.186 . . . . 23.48 113.314 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -90.88 -1.26 57.85 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.627 0.973 . . . . 24.239999999999998 113.627 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -110.88 -53.62 2.68 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.113 1.365 . . . . 39.259999999999998 112.092 167.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -97.06 58.98 1.61 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.384 1.074 . . . . 24.449999999999999 112.847 -161.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -132.64 162.9 54.46 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.996 1.318 . . . . 0.0 111.355 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.08 -26.55 21.34 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.291 1.994 . . . . 0.0 112.398 172.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -72.96 150.57 90.4 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.467 1.107 . . . . 0.0 111.697 171.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -57.24 144.13 91.63 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.048 2.498 . . . . 0.0 115.032 -172.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.72 119.01 5.84 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.768 2.312 . . . . 0.0 113.222 -173.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.5 mt -89.45 2.04 55.06 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.504 1.121 . . . . 0.0 112.654 170.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.05 50.97 0.29 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.647 1.979 . . . . 0.0 110.949 159.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.8 p -125.03 62.78 38.38 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 126.246 1.818 . . . . 0.0 110.132 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -75.64 127.86 10.56 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.825 2.35 . . . . 0.0 111.164 -163.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.51 -176.9 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.532 2.822 . . . . 0.0 111.771 171.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -53.79 -29.31 39.75 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.038 1.335 . . . . 0.0 114.153 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -56.38 -21.61 25.96 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.103 1.361 . . . . 0.0 114.393 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.53 -30.92 71.97 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 120.16 1.346 . . . . 0.0 113.368 173.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.5 p -68.03 -23.79 65.02 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.421 -0.8 . . . . 0.0 113.119 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -95.23 -41.23 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.188 1.395 . . . . 0.0 110.868 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.84 -29.7 76.02 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.446 1.498 . . . . 0.0 114.398 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 88.2 p -67.91 -18.59 64.83 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.729 1.264 . . . . 0.0 114.049 170.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -95.5 -33.35 12.46 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.402 1.481 . . . . 0.0 112.873 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.1 mt -69.82 -37.52 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.642 0.777 . . . . 0.0 111.805 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -56.25 -47.97 97.84 Favored Pre-proline 0 CA--C 1.546 0.811 0 O-C-N 120.406 -1.434 . . . . 0.0 114.028 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.62 -30.83 3.66 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.709 2.273 . . . . 0.0 113.779 171.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.6 p -72.25 -28.05 62.89 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 121.386 1.903 . . . . 0.0 113.277 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -59.88 -45.42 92.55 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.668 -1.27 . . . . 0.0 112.192 161.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.1 t -68.49 -32.23 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.23 -0.919 . . . . 0.0 111.953 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -67.11 -41.97 85.31 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.914 0.886 . . . . 0.0 111.836 169.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -63.65 -39.48 94.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.257 1.023 . . . . 0.0 111.693 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.28 -5.4 31.98 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 169.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -141.78 42.5 1.71 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.846 1.658 . . . . 0.0 111.617 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.0 m -70.05 61.57 0.19 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.239 1.816 . . . . 0.0 115.53 -165.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.18 -37.06 72.18 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.647 1.179 . . . . 0.0 111.738 167.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -81.38 115.4 56.29 Favored Pre-proline 0 CA--C 1.552 1.027 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 152.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.58 153.68 73.53 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.423 2.749 . . . . 0.0 115.084 -147.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -64.7 -42.83 95.0 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.425 -165.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.23 -17.18 60.92 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.403 1.081 . . . . 0.0 113.763 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -86.91 -39.33 7.56 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 121.442 -0.787 . . . . 0.0 112.68 166.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 54.0 m -65.46 -25.93 67.72 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.671 -0.899 . . . . 0.0 112.953 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -58.32 -44.83 88.79 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.908 1.683 . . . . 0.0 111.759 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -71.81 -38.93 70.16 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.523 0.729 . . . . 0.0 111.4 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.84 -23.88 66.77 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 171.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.4 tp -83.21 -41.21 18.67 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.727 1.211 . . . . 0.0 111.914 170.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 23.3 mt -64.2 -41.58 97.0 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.932 1.293 . . . . 0.0 113.478 -177.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -65.15 -36.19 83.45 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.277 1.399 . . . . 0.0 112.598 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -72.88 -38.75 66.87 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.229 -0.919 . . . . 0.0 112.691 172.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.31 -33.83 76.73 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.85 -1.156 . . . . 0.0 113.033 172.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -66.71 -44.65 81.05 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.868 1.213 . . . . 0.0 111.614 172.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.14 86.05 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.511 0.724 . . . . 0.0 112.225 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.4 tp -66.46 -58.16 5.83 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.316 1.446 . . . . 0.0 111.903 170.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.05 -37.08 84.94 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.512 1.125 . . . . 0.0 113.777 -170.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.35 -36.02 74.36 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.235 -0.758 . . . . 0.0 113.528 178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -93.71 -26.33 17.06 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 23.0 mt -63.72 -31.94 73.27 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.592 -1.318 . . . . 0.0 113.584 172.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -64.16 -3.11 2.45 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 171.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.2 t -109.46 -36.5 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.505 1.522 . . . . 0.0 112.704 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -83.65 -28.67 28.23 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 -162.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 144.86 174.92 17.56 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 120.069 1.304 . . . . 0.0 113.926 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.77 -4.01 14.1 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 125.008 3.805 . . . . 0.0 116.417 -164.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -106.24 167.18 9.99 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.433 1.015 . . . . 0.0 110.964 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.0 4.67 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 120.627 -1.296 . . . . 0.0 113.214 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -121.54 16.01 11.2 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.772 2.429 . . . . 0.0 113.649 167.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.34 -110.44 3.49 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 120.838 -1.164 . . . . 0.0 113.022 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -58.06 -34.85 70.55 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -168.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -155.34 162.33 40.86 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.941 1.696 . . . . 0.0 110.895 -156.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 13.9 mt -63.87 132.61 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 164.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 29.3 p -132.66 -177.16 4.36 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.354 1.462 . . . . 0.0 110.474 169.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.13 -20.92 2.82 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 167.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.6 t -73.44 -41.01 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 120.704 -1.248 . . . . 0.0 112.325 173.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.69 -42.7 99.29 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.618 1.167 . . . . 0.0 112.233 168.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.7 mt -62.61 -23.2 66.93 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.6 m -83.08 -45.56 13.85 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.041 -1.037 . . . . 0.0 112.537 175.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 39.3 mt -100.15 -35.79 9.54 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -166.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.38 -49.53 92.9 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -70.43 -27.07 23.72 Favored 'Trans proline' 0 C--N 1.35 0.623 0 CA-C-N 120.942 1.372 . . . . 0.0 113.026 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -74.88 -28.39 60.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.444 -1.265 . . . . 0.0 112.654 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.0 mt -66.56 -45.86 77.95 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.824 0.85 . . . . 0.0 112.937 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -57.56 -39.64 77.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.293 0.637 . . . . 0.0 111.837 170.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -70.13 -20.97 63.14 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 9.6 mt -76.1 -51.23 12.68 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.837 1.199 . . . . 0.0 111.172 167.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.75 -34.57 74.64 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.405 1.082 . . . . 0.0 112.283 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 96.5 t -87.64 -75.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.198 0.999 . . . . 0.0 112.462 174.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.26 -52.39 16.58 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.886 -1.133 . . . . 0.0 112.153 -154.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.0 tp -68.25 -25.44 65.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.459 0.704 . . . . 0.0 112.543 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.22 -25.67 48.19 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.745 1.164 . . . . 0.0 115.508 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -68.46 -21.24 64.64 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -120.47 -30.61 4.51 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.97 1.308 . . . . 0.0 112.774 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -147.93 94.63 2.37 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.231 1.812 . . . . 0.0 108.668 169.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -67.96 78.15 0.22 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.483 1.113 . . . . 0.0 110.668 168.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -73.16 118.69 70.74 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 124.404 1.082 . . . . 0.0 111.385 -169.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.16 107.51 2.27 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.031 1.821 . . . . 0.0 110.674 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 35.2 mm -60.04 113.43 7.32 Favored Pre-proline 0 CA--C 1.541 0.635 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 163.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -63.33 154.3 68.97 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.741 1.628 . . . . 0.0 112.846 -170.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.48 -23.75 67.53 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.628 1.171 . . . . 0.0 113.241 171.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -65.8 -28.45 69.02 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.665 1.186 . . . . 0.0 113.398 170.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 43.6 mt -84.49 52.68 2.43 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.054 1.342 . . . . 0.0 110.794 166.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.39 -25.82 68.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.085 0.954 . . . . 0.0 112.532 -165.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -75.67 -49.89 17.05 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.914 0.779 . . . . 0.0 111.781 171.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 62.6 t -59.98 -39.36 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.541 0.737 . . . . 0.0 111.207 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 47.7 tp -65.24 -41.33 94.44 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.272 1.029 . . . . 0.0 113.356 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -69.04 -41.24 77.93 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.627 -0.67 . . . . 0.0 112.322 172.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -65.65 -31.81 73.03 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.585 1.154 . . . . 0.0 112.772 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 53.4 mt -58.09 -35.33 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 120.918 -1.114 . . . . 0.0 111.881 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -82.28 -13.31 57.2 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.368 -1.458 . . . . 0.0 113.749 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.0 mt -73.94 -18.14 60.93 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 117.576 -1.202 . . . . 0.0 113.499 160.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.7 mt -66.3 -19.55 65.85 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.51 1.505 . . . . 0.0 113.922 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -95.85 10.81 35.92 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.873 -1.142 . . . . 0.0 113.132 174.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.9 p -119.9 179.3 4.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.079 1.752 . . . . 0.0 113.374 -171.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 50.6 mtp85 56.77 -167.62 0.12 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.489 1.516 . . . . 0.0 110.143 -168.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -81.87 -35.32 29.42 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 122.043 -0.41 . . . . 0.0 110.889 157.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.6 p -69.38 -58.43 4.02 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.692 1.597 . . . . 0.0 114.763 -163.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -67.71 -43.51 79.87 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.149 0.886 . . . . 0.0 112.123 173.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -53.68 -35.33 60.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.922 1.289 . . . . 0.0 113.865 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.76 -7.39 59.22 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 7.8 p -73.24 -21.74 60.56 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.474 1.488 . . . . 0.0 112.518 170.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -60.27 127.29 31.08 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.9 1.28 . . . . 0.0 112.101 -170.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -93.42 173.71 7.57 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.424 1.09 . . . . 0.0 110.558 165.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.83 123.41 21.9 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.84 164.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -57.96 -35.05 70.61 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -165.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -61.39 -39.26 90.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.742 1.217 . . . . 0.0 112.396 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -82.34 0.87 39.74 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.858 -1.151 . . . . 0.0 113.988 173.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.9 t -85.39 -54.76 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.313 0.645 . . . . 0.0 109.98 161.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -46.22 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.123 0.874 . . . . 0.0 112.616 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.5 -10.68 60.14 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -90.07 -31.73 10.58 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 120.861 -1.149 . . . . 0.0 113.301 169.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 16.4 t90 -87.14 -30.8 20.78 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.101 1.76 . . . . 0.0 114.22 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -48.74 -49.47 66.09 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.54 -24.9 35.45 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.651 1.567 . . . . 0.0 113.839 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -74.23 -7.36 52.43 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.55 1.14 . . . . 0.0 114.056 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 59.1 t -61.91 -22.14 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 119.518 1.054 . . . . 0.0 111.505 159.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -106.91 -11.7 15.65 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 171.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 C-N-CA 124.484 1.114 . . . . 0.0 113.181 -173.592 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.834 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 73.3 mt -115.5 143.14 45.75 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.334 1.454 . . . . 0.0 110.809 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -138.01 149.39 46.03 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.679 1.191 . . . . 0.0 108.831 159.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 pt -130.85 139.05 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.082 0.953 . . . . 0.0 109.202 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.7 m -110.68 125.99 54.05 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.892 0.877 . . . . 0.0 109.635 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.98 157.81 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.858 1.263 . . . . 0.0 110.792 -166.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -60.5 115.26 3.45 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.053 -0.405 . . . . 0.0 110.371 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.447 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -80.97 153.16 27.63 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.06 155.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.76 147.26 46.81 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.199 0.999 . . . . 0.0 112.753 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.71 134.05 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 167.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.69 -26.72 1.64 Allowed Glycine 0 CA--C 1.54 1.594 0 CA-C-O 118.883 -0.954 . . . . 0.0 115.442 -173.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.61 72.38 77.97 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-N 118.603 1.201 . . . . 0.0 112.159 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.417 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 61.0 Cg_endo -65.03 -12.3 33.99 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.246 2.63 . . . . 0.0 114.927 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -82.94 2.89 32.35 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.6 pt -135.38 161.26 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.101 1.36 . . . . 0.0 111.503 177.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.26 149.92 40.57 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.612 0.765 . . . . 0.0 111.516 167.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.27 -168.41 11.29 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.632 1.587 . . . . 0.0 111.656 166.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -59.06 105.29 0.31 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 118.61 1.205 . . . . 0.0 114.161 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.2 t -152.01 107.3 2.84 Favored Pre-proline 0 CA--C 1.552 1.025 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.207 135.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -67.75 -15.85 45.1 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.815 2.343 . . . . 0.0 112.874 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -72.13 -28.53 63.32 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.065 -1.022 . . . . 0.0 112.381 171.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.09 -37.28 75.36 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.277 -1.514 . . . . 0.0 112.997 168.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -60.76 -27.25 67.83 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.491 HH12 ' CG ' ' A' ' 74' ' ' ASP . 60.1 mtp180 -57.18 -40.87 78.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.56 1.144 . . . . 0.0 112.452 172.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -78.87 -40.29 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.137 1.375 . . . . 0.0 111.546 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.5 mt -59.13 -43.6 92.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.982 0.513 . . . . 0.0 111.328 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.22 -48.49 81.42 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.068 0.947 . . . . 0.0 113.08 -177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.6 p -76.49 -37.4 56.87 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.3 mt -70.34 -36.99 74.56 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.391 0.541 . . . . 0.0 111.775 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -77.56 -20.08 54.67 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -74.11 -47.42 36.39 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.243 -1.535 . . . . 0.0 111.654 167.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -76.74 -4.36 42.97 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.802 1.241 . . . . 0.0 114.022 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm 58.65 19.58 6.89 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 126.377 1.871 . . . . 0.0 114.426 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.0 mt -72.84 127.37 89.73 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 118.152 -0.928 . . . . 0.0 108.641 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.31 143.13 34.68 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.405 2.07 . . . . 0.0 112.191 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -146.98 155.2 42.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.959 1.704 . . . . 0.0 109.92 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -80.36 131.64 35.66 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.046 -1.034 . . . . 0.0 109.789 158.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 t -99.41 94.23 6.32 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.999 0.92 . . . . 0.0 110.505 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -77.43 100.73 6.1 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.711 0.767 . . . . 0.0 109.479 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 99.4 mt -67.28 107.0 2.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.558 1.143 . . . . 0.0 109.241 170.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.3 mm -118.62 108.4 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.671 1.189 . . . . 0.0 109.059 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -75.46 90.03 2.7 Favored 'General case' 0 C--O 1.219 -0.552 0 O-C-N 120.716 -1.24 . . . . 32.609999999999999 108.216 165.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.418 HD23 HG22 ' A' ' 60' ' ' VAL . 1.5 pp -63.51 1.77 0.51 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 117.837 2.532 . . . . 40.049999999999997 117.837 -171.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.66 -19.56 79.72 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-N 119.896 1.226 . . . . 41.469999999999999 112.874 160.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -126.13 49.86 1.94 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 129.914 3.286 . . . . 47.170000000000002 109.36 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -78.27 118.15 70.51 Favored Pre-proline 0 N--CA 1.472 0.627 0 O-C-N 119.464 -2.023 . . . . 41.270000000000003 111.253 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.52 160.01 50.91 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.647 2.232 . . . . 40.289999999999999 111.623 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -62.12 -28.94 69.99 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.851 -1.155 . . . . 42.390000000000001 113.853 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 81.8 t90 -61.73 -32.24 72.46 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.508 0.929 . . . . 37.079999999999998 113.508 170.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -79.76 -33.83 40.33 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.819 -1.176 . . . . 35.880000000000003 112.619 172.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.0 mt -68.64 -23.72 64.46 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.449 0.907 . . . . 33.609999999999999 113.449 173.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -65.89 -41.88 90.97 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.894 1.278 . . . . 33.789999999999999 111.974 167.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.0 mt -74.11 -35.89 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 124.306 1.042 . . . . 33.159999999999997 111.654 175.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.4 t -133.08 92.9 24.12 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 126.121 1.768 . . . . 33.579999999999998 110.96 -175.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.73 -15.36 37.17 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.636 2.224 . . . . 37.899999999999999 113.901 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -76.55 -13.0 60.11 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.004 -1.06 . . . . 38.990000000000002 113.438 165.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.69 16.98 72.6 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.932 -1.105 . . . . 35.469999999999999 114.595 -172.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -100.12 155.23 17.85 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.399 1.48 . . . . 34.490000000000002 114.266 -173.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.418 HG22 HD23 ' A' ' 44' ' ' LEU . 33.0 m -115.39 157.26 44.44 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 126.713 2.005 . . . . 23.530000000000001 111.125 163.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -62.16 149.57 59.59 Favored 'Cis proline' 0 C--N 1.349 0.575 0 CA-C-O 122.327 0.886 . . . . 22.879999999999999 112.861 -13.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.09 146.66 22.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 113.8 -1.546 . . . . 0.0 107.303 163.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.59 163.58 30.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 123.522 0.729 . . . . 0.0 111.416 -169.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -120.95 69.27 0.89 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.547 1.939 . . . . 0.0 109.749 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.9 mt -75.05 119.15 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.745 0.818 . . . . 0.0 108.848 -175.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 46.8 t0 54.14 39.95 31.2 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.147 0.498 . . . . 0.0 111.019 -164.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.4 t0 68.65 -6.75 0.8 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 127.362 2.265 . . . . 0.0 115.638 -171.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -92.98 136.72 33.0 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.293 -1.504 . . . . 0.0 112.568 -170.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -64.01 127.95 33.68 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.311 1.444 . . . . 0.0 112.874 -175.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -141.59 132.66 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.526 1.53 . . . . 0.0 109.558 170.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -112.63 173.56 6.32 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.731 1.612 . . . . 0.0 111.621 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.1 t0 67.04 110.58 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 127.628 2.371 . . . . 22.16 114.485 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.5 p -62.97 -24.96 68.14 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 115.322 1.601 . . . . 21.16 115.322 -164.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.491 ' CG ' HH12 ' A' ' 25' ' ' ARG . 36.9 m-20 -72.04 -36.43 69.64 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.189 1.359 . . . . 24.969999999999999 112.998 170.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.69 -38.69 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.23 -0.919 . . . . 23.850000000000001 110.95 173.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.12 -44.04 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.374 1.07 . . . . 23.68 111.213 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.68 -42.79 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.476 1.11 . . . . 22.84 111.318 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.97 -26.97 61.55 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.215 -0.77 . . . . 23.329999999999998 114.565 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 87.7 mt -92.49 -50.76 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 118.718 1.259 . . . . 23.309999999999999 112.059 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.5 mt -65.55 -29.46 70.09 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.618 1.099 . . . . 23.48 113.452 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -89.24 -2.02 58.31 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.697 0.999 . . . . 24.239999999999998 113.697 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.402 ' OE2' ' HE3' ' A' ' 83' ' ' LYS . 38.7 tt0 -115.06 -47.63 2.86 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.679 1.592 . . . . 39.259999999999998 112.513 173.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.402 ' HE3' ' OE2' ' A' ' 82' ' ' GLU . 84.2 mttt -104.92 64.45 0.72 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.977 1.311 . . . . 24.449999999999999 112.415 -165.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -138.64 164.15 41.83 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.366 1.466 . . . . 0.0 110.713 174.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.69 -26.27 23.38 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.23 1.954 . . . . 0.0 112.655 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -74.64 154.71 87.44 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.043 1.337 . . . . 0.0 111.872 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -56.16 140.79 87.77 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.992 2.461 . . . . 0.0 113.635 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.97 133.93 35.27 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.215 1.943 . . . . 0.0 112.139 -176.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.9 mt -107.61 1.52 23.29 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.628 1.571 . . . . 0.0 112.065 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.8 49.53 0.23 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.769 2.027 . . . . 0.0 111.497 159.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 44.8 p -123.42 67.28 36.59 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 125.077 1.351 . . . . 0.0 109.012 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -74.19 124.2 8.85 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.393 2.062 . . . . 0.0 110.032 -165.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.73 -176.79 2.18 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.72 2.28 . . . . 0.0 111.133 170.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 23.0 mp0 -56.06 -30.08 61.43 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.406 2.282 . . . . 0.0 112.785 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -54.72 -23.86 19.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.167 1.787 . . . . 0.0 114.203 171.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.47 -33.42 73.74 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.981 -1.074 . . . . 0.0 113.213 173.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 59.5 p -70.13 -20.52 63.16 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.9 t -92.8 -42.31 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.276 1.43 . . . . 0.0 110.342 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.99 -30.21 77.08 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.122 1.344 . . . . 0.0 114.587 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 97.7 p -66.94 -19.75 65.78 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.603 1.202 . . . . 0.0 113.958 171.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -95.79 -32.99 12.44 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.477 1.511 . . . . 0.0 112.814 172.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 61.9 mt -68.31 -37.85 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.55 0.74 . . . . 0.0 111.559 173.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -58.11 -47.29 99.12 Favored Pre-proline 0 CA--C 1.547 0.847 0 O-C-N 120.314 -1.492 . . . . 0.0 114.274 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.23 -30.33 5.59 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.703 2.269 . . . . 0.0 113.893 172.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.8 p -71.75 -27.96 63.32 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 121.009 1.731 . . . . 0.0 112.962 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -62.29 -42.34 99.27 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.329 -1.482 . . . . 0.0 112.787 161.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.45 -37.5 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-N 120.002 1.274 . . . . 0.0 111.348 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -65.97 -38.17 87.87 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.897 0.879 . . . . 0.0 112.2 172.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -71.79 -28.14 63.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.48 1.112 . . . . 0.0 112.646 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.8 mt -83.61 -2.74 56.75 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.555 1.542 . . . . 0.0 114.403 168.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -144.64 39.53 1.26 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.253 1.421 . . . . 0.0 112.925 -175.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 m -73.25 65.73 0.85 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -162.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 95.9 mttt -70.68 -35.5 72.85 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.92 1.288 . . . . 0.0 111.875 166.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -79.52 117.79 69.03 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-O 117.102 -1.428 . . . . 0.0 107.431 152.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -53.89 149.62 33.27 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.27 2.647 . . . . 0.0 116.53 -154.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.38 -41.85 93.29 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.101 -170.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.62 -19.64 59.07 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.453 1.101 . . . . 0.0 113.634 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.79 -37.53 13.27 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 121.046 -1.034 . . . . 0.0 112.485 166.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 63.9 m -65.8 -29.4 69.89 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.011 0.924 . . . . 0.0 112.99 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -57.38 -43.64 83.79 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.67 1.588 . . . . 0.0 111.769 174.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -70.35 -40.31 74.14 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.891 0.876 . . . . 0.0 111.533 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.48 -21.89 65.5 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 173.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.7 tp -84.59 -40.3 17.67 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.078 1.351 . . . . 0.0 111.882 170.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.2 mt -64.15 -41.55 97.12 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.937 1.295 . . . . 0.0 113.449 -176.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.01 -34.44 78.1 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.492 1.496 . . . . 0.0 112.87 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.52 -36.76 60.46 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.27 -0.894 . . . . 0.0 112.914 171.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.5 mt -64.89 -36.2 83.61 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.742 -1.224 . . . . 0.0 112.823 172.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -64.53 -42.99 95.4 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.456 1.103 . . . . 0.0 111.309 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.57 -37.5 87.56 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.39 0.676 . . . . 0.0 112.345 176.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 tp -66.62 -55.27 16.09 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.386 1.075 . . . . 0.0 111.643 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -66.68 -38.54 87.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.021 1.328 . . . . 0.0 113.766 -170.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.67 -33.68 83.35 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.24 -0.755 . . . . 0.0 113.494 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -91.23 -31.06 16.3 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 117.77 0.785 . . . . 0.0 113.004 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 16.0 mt -62.27 -31.69 72.3 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.564 -1.335 . . . . 0.0 113.247 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -65.36 0.59 1.4 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 172.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.2 t -109.32 -25.75 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.854 1.661 . . . . 0.0 113.22 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -106.11 -9.43 16.97 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 -161.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 122.33 171.2 13.84 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 119.863 1.211 . . . . 0.0 113.604 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -78.06 -4.69 14.6 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.683 3.589 . . . . 0.0 116.122 -160.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -98.8 167.41 10.78 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.082 -1.011 . . . . 0.0 111.649 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.4 mt -69.86 -4.16 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 120.576 -1.328 . . . . 0.0 113.055 174.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -121.68 27.83 7.98 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.033 1.733 . . . . 0.0 113.707 165.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.42 -108.81 2.71 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.256 0.931 . . . . 0.0 113.023 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -60.28 -33.28 72.1 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -172.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -148.2 163.51 36.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.157 1.383 . . . . 0.0 111.694 -167.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 51.8 mt -64.79 135.21 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.602 0.761 . . . . 0.0 109.645 164.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 29.3 p -135.33 -176.56 4.31 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.914 1.286 . . . . 0.0 111.258 169.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.41 -22.3 2.9 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 167.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.0 t -72.12 -42.47 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 120.945 -1.097 . . . . 0.0 112.005 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -61.35 -43.67 98.48 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 120.964 -1.085 . . . . 0.0 112.373 169.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 25.1 mt -61.65 -21.91 64.82 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 24.8 m -82.0 -47.85 12.16 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.187 -0.946 . . . . 0.0 112.135 175.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 26.8 mt -97.05 -34.4 11.18 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -167.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.77 -49.24 94.9 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -174.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.06 -28.4 15.99 Favored 'Trans proline' 0 C--N 1.35 0.617 0 CA-C-N 120.996 1.391 . . . . 0.0 112.998 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -68.88 -30.52 69.04 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 117.487 -1.244 . . . . 0.0 112.572 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 56.3 mt -68.24 -45.5 73.05 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -56.98 -39.73 75.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.188 0.595 . . . . 0.0 111.477 170.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -70.46 -18.91 62.99 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.5 mt -76.44 -52.6 9.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.681 1.128 . . . . 0.0 111.261 166.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -62.97 -29.9 71.17 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.145 0.978 . . . . 0.0 112.395 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 76.0 t -89.64 -70.72 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.921 1.289 . . . . 0.0 113.168 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.32 -52.39 7.76 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.83 -0.544 . . . . 0.0 112.351 -158.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 42.8 tp -65.76 -31.08 71.87 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 118.948 -0.549 . . . . 0.0 111.344 171.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -55.64 -28.3 51.34 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.177 1.37 . . . . 0.0 115.804 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -71.08 -15.31 62.52 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -126.2 -28.45 3.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.604 1.162 . . . . 0.0 112.807 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -145.63 97.06 2.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.805 2.042 . . . . 0.0 108.518 164.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -68.34 78.93 0.26 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.204 1.002 . . . . 0.0 110.561 166.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -68.76 118.13 57.76 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.095 0.958 . . . . 0.0 110.956 -173.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.19 100.85 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.954 1.77 . . . . 0.0 110.301 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.4 mm -55.3 111.51 3.14 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.664 1.186 . . . . 0.0 108.119 167.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -63.24 149.93 89.98 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.323 1.349 . . . . 0.0 112.519 -168.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.29 -19.53 65.48 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.849 -1.157 . . . . 0.0 113.429 172.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -62.41 -36.02 81.03 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.99 1.316 . . . . 0.0 112.732 167.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 45.7 mt -80.75 52.55 1.72 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.59 1.556 . . . . 0.0 111.12 166.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -26.61 67.85 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.52 1.128 . . . . 0.0 112.353 -170.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -77.83 -48.58 16.15 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.457 -0.777 . . . . 0.0 112.069 174.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.75 -39.46 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.862 0.865 . . . . 0.0 110.944 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 56.1 tp -63.43 -40.61 97.63 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.816 0.847 . . . . 0.0 113.026 175.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -69.56 -41.89 75.26 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.466 0.706 . . . . 0.0 112.533 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -64.55 -32.39 74.02 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.533 1.133 . . . . 0.0 112.538 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.13 -35.03 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 120.993 -1.067 . . . . 0.0 111.851 169.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 40.7 mmtt -80.43 -16.79 53.57 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.332 -1.48 . . . . 0.0 112.867 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.66 -18.67 62.84 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.152 -0.928 . . . . 0.0 113.434 162.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 73.8 mt -66.29 -18.24 65.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.117 1.326 . . . . 0.0 113.988 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -98.04 9.32 43.11 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.763 1.225 . . . . 0.0 112.41 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.0 p -116.27 179.14 4.08 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.363 1.465 . . . . 0.0 113.622 -170.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.4 mtp85 57.17 -163.67 0.18 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.578 1.551 . . . . 0.0 110.079 -169.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -84.31 -31.11 25.04 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.966 -0.459 . . . . 0.0 111.428 156.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 35.2 p -75.36 -59.16 2.87 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.968 1.307 . . . . 0.0 114.351 -160.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -64.85 -42.33 94.97 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.799 0.727 . . . . 0.0 112.0 172.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -53.36 -33.8 55.04 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.308 1.443 . . . . 0.0 114.028 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -86.83 -8.14 57.59 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 4.1 p -73.73 -18.59 60.97 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.346 1.43 . . . . 0.0 112.425 169.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -58.94 132.49 54.15 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.833 1.253 . . . . 0.0 111.863 -175.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -106.85 176.96 5.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.048 1.339 . . . . 0.0 110.465 169.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.47 116.53 9.99 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.155 -0.965 . . . . 0.0 109.571 167.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -57.11 -34.44 68.35 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -167.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.65 -40.69 79.87 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.673 1.189 . . . . 0.0 111.778 174.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -86.53 -3.16 58.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.331 1.852 . . . . 0.0 112.809 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 25.8 t -84.99 -49.25 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.279 1.032 . . . . 0.0 110.091 159.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 12.7 mt -60.98 -54.59 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.509 1.123 . . . . 0.0 111.691 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.71 -15.98 63.25 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.269 1.027 . . . . 0.0 113.389 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.47 -27.44 43.34 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 118.616 -1.102 . . . . 0.0 113.48 171.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -90.0 -34.96 15.79 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.476 1.911 . . . . 0.0 114.262 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -48.1 -48.94 62.82 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.2 -24.83 27.23 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 121.577 1.518 . . . . 0.0 114.022 174.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -74.96 -6.64 50.38 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 175.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.409 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 61.5 t -60.29 -18.42 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.181 -0.95 . . . . 0.0 111.416 158.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -118.79 17.19 13.52 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.554 1.942 . . . . 0.0 115.052 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.922 0 C-N-CA 125.168 1.387 . . . . 0.0 110.386 171.395 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.42 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 99.0 mtp . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 117.845 -1.074 . . . . 0.0 109.995 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.64 -177.53 0.09 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.239 1.816 . . . . 0.0 115.053 171.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 75.9 mt -125.19 118.66 26.54 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.651 1.981 . . . . 0.0 109.582 -173.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -116.42 132.98 56.53 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.183 0.993 . . . . 0.0 109.589 173.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.7 pt -128.69 135.99 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 118.93 0.786 . . . . 0.0 110.957 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.0 m -111.95 122.27 47.3 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.097 0.959 . . . . 0.0 109.922 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.54 161.18 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.147 0.979 . . . . 0.0 112.018 -166.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -56.73 117.54 4.01 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.168 1.387 . . . . 0.0 111.753 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.413 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -75.11 148.67 39.51 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.138 155.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.16 151.12 47.63 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.132 0.968 . . . . 0.0 112.573 175.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.9 t -65.97 123.54 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.327 0.651 . . . . 0.0 109.311 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.91 -17.54 2.21 Favored Glycine 0 CA--C 1.54 1.612 0 N-CA-C 116.297 1.279 . . . . 0.0 116.297 -176.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.04 72.55 55.11 Favored Pre-proline 0 CA--C 1.548 0.867 0 CA-C-N 119.098 1.449 . . . . 0.0 111.622 -175.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.413 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 48.6 Cg_endo -64.35 -14.67 45.37 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.135 2.557 . . . . 0.0 115.265 -167.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -84.4 -0.39 52.54 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.0 pt -135.15 165.28 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.65 1.18 . . . . 0.0 112.081 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.0 mt -73.66 146.45 44.53 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.185 0.994 . . . . 0.0 111.665 173.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.48 -159.05 8.67 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.992 1.282 . . . . 0.0 112.15 167.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.428 ' CG ' ' HZ3' ' A' ' 209' ' ' LYS . 62.5 t0 -59.11 98.22 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 122.934 1.35 . . . . 0.0 113.788 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.2 t -153.26 95.85 2.91 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.425 1.49 . . . . 0.0 108.718 142.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.86 -20.01 64.38 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.163 1.909 . . . . 0.0 112.391 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -65.93 -37.34 85.8 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.669 1.188 . . . . 0.0 112.846 172.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 95.1 m -64.81 -38.15 90.0 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.723 -1.235 . . . . 0.0 112.142 169.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -65.92 -25.56 67.2 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 118.519 -0.753 . . . . 0.0 112.73 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -58.23 -43.42 87.76 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.603 1.161 . . . . 0.0 113.244 168.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.02 -40.13 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.287 1.035 . . . . 0.0 110.792 -175.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.8 mt -61.59 -40.55 95.17 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.917 -0.489 . . . . 0.0 111.684 170.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 tp -60.55 -47.71 84.98 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.775 1.23 . . . . 0.0 113.34 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.1 p -73.06 -33.42 65.66 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.9 1.227 . . . . 0.0 113.46 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.52 -40.82 96.33 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.525 -0.735 . . . . 0.0 111.986 173.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -80.34 -23.69 40.39 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -65.0 -45.08 87.08 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.073 -1.017 . . . . 0.0 111.597 164.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -68.85 -23.38 64.23 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.241 -0.912 . . . . 0.0 112.671 171.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.0 mtmm 59.64 19.56 8.19 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.351 1.861 . . . . 0.0 112.407 -170.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.4 tt -74.15 140.23 76.54 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.2 1.4 . . . . 0.0 109.884 -171.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -66.87 132.32 28.07 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 121.803 1.668 . . . . 0.0 112.02 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -141.65 169.88 16.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.085 1.754 . . . . 0.0 111.169 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.674 ' HE2' ' NE2' ' A' ' 40' ' ' HIS . 52.1 tttt -130.59 127.77 39.7 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.069 1.747 . . . . 0.0 109.015 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.521 ' C ' ' HD2' ' A' ' 40' ' ' HIS . 27.6 t -114.17 138.16 50.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.157 0.983 . . . . 0.0 112.939 -170.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.674 ' NE2' ' HE2' ' A' ' 38' ' ' LYS . 6.1 m170 -126.31 108.9 11.68 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.965 1.706 . . . . 0.0 108.416 -171.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.6 mt -76.89 107.66 9.38 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.267 0.627 . . . . 0.0 110.494 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.4 mm -91.34 119.45 38.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.654 1.181 . . . . 0.0 109.379 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -69.14 126.3 29.35 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.292 -0.632 . . . . 32.609999999999999 109.292 161.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.9 mt -88.58 -18.47 28.01 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.122 0.786 . . . . 40.049999999999997 113.122 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.55 -20.43 71.6 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 118.79 0.723 . . . . 41.469999999999999 114.344 172.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -147.49 90.44 1.86 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.836 1.655 . . . . 47.170000000000002 108.688 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -84.82 135.0 40.63 Favored Pre-proline 0 N--CA 1.469 0.491 0 C-N-CA 124.142 0.977 . . . . 41.270000000000003 110.034 -170.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -59.26 140.45 94.73 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.343 2.029 . . . . 40.289999999999999 111.737 171.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -60.06 -40.56 89.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.195 0.813 . . . . 42.390000000000001 113.195 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 31.7 p-90 -65.97 -13.41 59.76 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.233 1.198 . . . . 37.079999999999998 114.233 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -67.49 -26.88 66.58 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.242 -1.537 . . . . 35.880000000000003 112.62 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.9 mt -70.66 -21.08 62.65 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.368 0.877 . . . . 33.609999999999999 113.368 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.72 -16.36 61.19 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.192 0.997 . . . . 33.789999999999999 112.57 171.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.3 mt -102.58 -43.39 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.13 1.372 . . . . 33.159999999999997 110.7 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.4 t -124.8 104.24 30.49 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 125.451 1.5 . . . . 33.579999999999998 110.376 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.29 -19.64 38.12 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.51 2.14 . . . . 37.899999999999999 113.769 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -83.77 -5.87 59.3 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.77 1.026 . . . . 38.990000000000002 113.77 168.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.91 14.22 65.23 Favored Glycine 0 CA--C 1.534 1.276 0 O-C-N 120.878 -1.139 . . . . 35.469999999999999 114.773 -172.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -91.89 156.28 17.59 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.262 1.425 . . . . 34.490000000000002 112.818 -176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.0 m -109.44 156.49 39.42 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 126.096 1.759 . . . . 23.530000000000001 110.935 159.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.02 153.78 80.62 Favored 'Cis proline' 0 C--N 1.348 0.508 0 CA-C-O 122.299 0.875 . . . . 22.879999999999999 113.352 -10.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.6 p -143.71 146.74 20.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 113.304 -1.771 . . . . 0.0 107.31 159.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.01 163.62 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.596 0.758 . . . . 0.0 110.444 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -111.35 121.78 46.14 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.934 1.294 . . . . 0.0 109.748 157.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 95.8 mt -106.23 115.35 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.3 1.44 . . . . 0.0 107.693 170.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.42 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 2.5 t70 53.25 43.58 31.31 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 122.529 1.156 . . . . 0.0 113.655 -167.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.2 t70 66.89 -7.97 0.44 Allowed 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -171.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 66' ' ' ASP . 20.4 mmtt -91.83 127.97 37.49 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 119.472 -2.018 . . . . 0.0 111.744 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 27.8 p-90 -74.6 147.57 41.53 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -167.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.0 t -141.57 126.11 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.204 1.801 . . . . 0.0 108.563 171.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -109.96 166.57 10.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.633 1.573 . . . . 0.0 111.534 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.0 t0 67.01 114.07 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.064 2.146 . . . . 22.16 113.935 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.454 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 53.2 p -64.0 -29.21 70.39 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 115.317 1.599 . . . . 21.16 115.317 -163.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -71.08 -29.88 65.85 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 120.135 1.334 . . . . 24.969999999999999 112.163 171.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.2 t -75.09 -42.05 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 O-C-N 120.623 -1.298 . . . . 23.850000000000001 111.645 170.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.01 -45.55 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.345 1.058 . . . . 23.68 110.63 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.9 t -63.1 -43.32 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.09 0.956 . . . . 22.84 111.353 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.97 93.33 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 118.654 0.661 . . . . 23.329999999999998 113.505 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 70.6 mt -77.08 -41.21 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 117.946 0.873 . . . . 23.309999999999999 112.278 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.1 mt -62.97 -37.05 85.55 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.132 1.333 . . . . 23.48 112.48 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -89.27 9.24 26.65 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.333 1.234 . . . . 24.239999999999998 114.333 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -123.04 -42.0 2.3 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.857 1.263 . . . . 39.259999999999998 112.654 173.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -126.25 65.57 1.23 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.77 1.628 . . . . 24.449999999999999 111.456 -167.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.62 165.38 28.71 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 124.815 1.246 . . . . 0.0 110.694 175.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.01 -27.17 8.67 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.965 2.443 . . . . 0.0 114.939 -174.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -77.68 160.91 73.58 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 118.93 0.786 . . . . 0.0 110.06 168.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -52.32 139.01 55.41 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.546 2.164 . . . . 0.0 114.642 -175.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.414 ' O ' HD23 ' A' ' 89' ' ' LEU . 78.7 Cg_endo -69.99 147.09 60.64 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.449 2.766 . . . . 0.0 111.29 176.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.637 HD22 ' HZ1' ' A' ' 145' ' ' LYS . 15.2 mt -131.49 9.87 4.74 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.103 1.361 . . . . 0.0 113.232 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.88 41.89 0.1 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.305 1.842 . . . . 0.0 114.578 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 90.5 m -105.78 103.39 43.72 Favored Pre-proline 0 N--CA 1.472 0.669 0 C-N-CA 125.107 1.363 . . . . 0.0 110.314 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -86.56 112.5 1.05 Allowed 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 124.148 3.232 . . . . 0.0 111.516 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -82.9 -170.46 0.92 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.863 3.042 . . . . 0.0 111.888 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 15.4 mp0 -52.32 -33.33 42.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.211 2.204 . . . . 0.0 113.171 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -57.92 -23.66 54.43 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.458 1.503 . . . . 0.0 114.14 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.55 -27.12 67.49 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.099 -1.001 . . . . 0.0 113.099 172.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 86.2 p -65.75 -47.95 73.53 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.153 -0.967 . . . . 0.0 112.149 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.2 t -77.33 -37.94 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 121.274 -0.891 . . . . 0.0 111.444 174.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.22 -31.34 80.51 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 121.265 -0.897 . . . . 0.0 114.137 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 89.0 p -73.06 -14.55 61.43 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -86.72 -39.83 15.63 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.536 1.135 . . . . 0.0 112.586 167.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.47 -37.52 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.289 1.436 . . . . 0.0 111.418 173.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -53.4 -54.38 45.94 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.915 1.686 . . . . 0.0 114.24 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.78 -34.83 0.87 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.118 2.545 . . . . 0.0 113.303 170.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.0 p -65.9 -31.06 71.77 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.403 1.456 . . . . 0.0 112.631 -173.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -79.58 -20.89 45.88 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.249 -1.532 . . . . 0.0 113.71 172.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.6 t -72.9 -38.2 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 120.399 -1.438 . . . . 0.0 110.744 164.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -69.58 -27.67 65.32 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -59.39 -41.46 89.45 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.097 1.359 . . . . 0.0 111.855 170.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.5 mt -80.14 4.19 18.14 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.819 1.648 . . . . 0.0 114.81 172.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -136.76 35.48 2.64 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 127.97 2.508 . . . . 0.0 111.277 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 p -82.23 58.02 3.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.585 1.954 . . . . 0.0 113.69 -169.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.53 -45.84 91.15 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.162 0.985 . . . . 0.0 110.096 161.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.6 119.52 60.82 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 128.157 2.583 . . . . 0.0 107.71 155.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.16 135.09 68.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.935 1.757 . . . . 0.0 115.843 -159.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -68.16 -32.62 73.01 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 117.779 -1.105 . . . . 0.0 112.115 170.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.74 -32.06 68.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.166 1.386 . . . . 0.0 114.024 174.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.05 -34.86 9.39 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.744 0.688 . . . . 0.0 113.499 172.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 61.4 m -64.94 -40.6 95.28 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.409 1.084 . . . . 0.0 112.107 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -59.58 -27.46 66.28 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.358 1.863 . . . . 0.0 113.655 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -69.2 -18.34 63.9 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.127 0.971 . . . . 0.0 112.885 175.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.18 -35.8 13.64 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.857 0.863 . . . . 0.0 112.551 165.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.6 mt -65.95 -34.6 78.49 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.69 -36.38 82.73 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.714 0.688 . . . . 0.0 112.076 173.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.77 -30.66 32.24 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.249 0.62 . . . . 0.0 112.425 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.16 -46.86 88.79 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.131 0.972 . . . . 0.0 111.741 166.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.0 mt -65.21 -40.69 94.48 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.774 -1.108 . . . . 0.0 112.128 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -62.66 -42.11 99.43 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 120.291 1.405 . . . . 0.0 112.576 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.69 -35.78 82.15 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.216 0.607 . . . . 0.0 112.257 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.2 tp -72.84 -54.46 8.75 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.68 0.792 . . . . 0.0 111.529 172.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -63.1 -35.4 80.14 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.498 1.919 . . . . 0.0 113.906 -173.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.34 -33.64 81.61 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 123.914 0.768 . . . . 0.0 113.731 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -94.98 -28.64 15.04 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.6 mt -66.25 -32.23 73.52 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.594 -1.316 . . . . 0.0 113.272 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -66.37 -11.0 48.95 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.55 -29.27 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.737 0.815 . . . . 0.0 111.928 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -94.65 -37.31 11.38 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.605 1.162 . . . . 0.0 113.303 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.33 -69.97 0.23 Allowed Glycine 0 CA--C 1.542 1.735 0 CA-C-O 116.609 -2.217 . . . . 0.0 116.525 166.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -102.04 -33.86 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.987 0 N-CA-C 117.825 2.202 . . . . 0.0 117.825 -156.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -134.16 156.68 47.89 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.416 1.462 . . . . 0.0 112.93 -167.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.4 mt -70.46 -12.91 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.67 -1.64 46.23 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 165.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.07 -135.15 10.19 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 120.154 1.343 . . . . 0.0 113.738 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -62.4 -25.36 67.89 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.637 ' HZ1' HD22 ' A' ' 89' ' ' LEU . 6.2 pttp -144.08 164.09 31.65 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.141 1.376 . . . . 0.0 110.403 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.3 mt -61.36 122.12 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 123.433 0.693 . . . . 0.0 110.467 169.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.7 p -140.21 -160.56 1.08 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.45 1.5 . . . . 0.0 108.901 160.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -49.5 -32.82 13.0 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -166.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.3 t -71.86 -37.48 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 120.725 1.602 . . . . 0.0 113.003 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -63.11 -44.04 96.78 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.34 -0.85 . . . . 0.0 111.587 167.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.5 mt -64.98 -27.36 68.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.009 0.524 . . . . 0.0 111.97 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 73.6 m -75.9 -31.94 59.41 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 120.201 -1.562 . . . . 0.0 113.654 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 68.6 mt -124.9 -33.84 2.88 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -162.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.61 -50.08 79.18 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -169.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -68.89 -25.7 32.52 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.479 1.452 . . . . 0.0 113.518 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -72.63 -29.47 63.5 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.224 -0.922 . . . . 0.0 112.198 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 38.0 mt -71.67 -44.09 64.89 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.788 0.835 . . . . 0.0 112.058 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -63.85 -38.5 91.33 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -64.19 -34.7 78.69 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.438 -1.414 . . . . 0.0 112.573 173.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.7 tp -68.83 -47.04 67.02 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.252 -0.905 . . . . 0.0 111.178 174.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -52.3 -45.18 65.43 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.442 1.497 . . . . 0.0 112.225 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.1 t -75.2 -58.88 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.919 0.888 . . . . 0.0 113.119 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.76 -36.07 37.74 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 120.993 -1.067 . . . . 0.0 113.463 -167.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.2 tp -72.83 -31.81 65.05 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.578 -0.702 . . . . 0.0 111.28 171.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.83 -27.98 37.96 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.837 1.208 . . . . 0.0 114.704 170.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -67.53 -19.49 65.3 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -141.5 -27.18 0.68 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -149.87 80.85 1.38 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.522 1.529 . . . . 0.0 109.355 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.9 75.85 0.08 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.388 1.475 . . . . 0.0 112.403 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -71.73 112.96 16.06 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.127 1.771 . . . . 0.0 112.32 -168.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.31 137.52 19.0 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.546 2.164 . . . . 0.0 111.845 -173.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 46.7 mm -87.57 113.93 56.52 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.329 1.052 . . . . 0.0 109.025 164.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -71.06 155.86 60.85 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.254 1.969 . . . . 0.0 111.779 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.59 -12.39 44.79 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -62.05 -31.44 71.85 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.209 1.004 . . . . 0.0 112.835 166.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 96.2 mt -84.19 57.18 4.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.464 1.906 . . . . 0.0 110.835 167.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -22.86 64.6 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.62 1.168 . . . . 0.0 113.297 -161.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -75.52 -52.49 10.52 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.257 0.935 . . . . 0.0 110.303 165.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 33.7 t -57.53 -46.69 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 119.234 0.925 . . . . 0.0 112.711 -174.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.7 tp -64.36 -27.95 69.37 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -93.61 -29.48 15.44 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.143 -0.973 . . . . 0.0 113.272 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -64.0 -36.92 85.56 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.271 1.428 . . . . 0.0 112.925 173.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 68.5 mt -60.01 -37.43 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 O-C-N 121.336 -0.852 . . . . 0.0 111.641 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -67.01 -28.26 68.1 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 120.047 -1.658 . . . . 0.0 112.475 173.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 70.1 mt -71.5 -20.59 62.04 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.473 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 68.9 mt -65.65 -21.6 66.57 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 120.17 1.35 . . . . 0.0 112.751 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -85.71 19.1 2.57 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.456 1.502 . . . . 0.0 113.308 170.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.8 p -142.81 178.65 7.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.797 2.039 . . . . 0.0 112.947 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 65.7 mtp85 59.74 171.88 0.08 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.619 1.968 . . . . 0.0 113.561 -170.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 53.1 mp0 -64.83 -47.91 76.29 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.422 1.089 . . . . 0.0 110.286 159.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -39.29 89.78 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.681 1.992 . . . . 0.0 115.707 -170.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -96.67 -53.26 3.62 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.483 1.038 . . . . 0.0 111.746 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -62.31 -37.37 85.31 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -168.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.88 -22.85 66.55 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.15 0.886 . . . . 0.0 113.034 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 7.0 p -90.55 -7.09 53.81 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.647 1.179 . . . . 0.0 113.2 -173.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -60.61 114.68 3.12 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.458 1.503 . . . . 0.0 111.063 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -70.11 162.56 28.03 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.051 0.94 . . . . 0.0 112.579 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -75.39 125.81 29.74 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.848 -0.533 . . . . 0.0 110.684 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -73.84 -32.1 63.5 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -155.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.37 -36.42 83.66 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.812 1.245 . . . . 0.0 111.162 167.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -83.69 -8.43 59.28 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.009 1.724 . . . . 0.0 113.309 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 58.2 t -78.47 -51.89 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.347 1.059 . . . . 0.0 109.913 158.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 62.2 mt -62.32 -48.03 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.015 0.926 . . . . 0.0 111.974 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -5.39 41.74 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.874 1.27 . . . . 0.0 114.15 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -90.33 -32.75 9.25 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 121.133 -0.979 . . . . 0.0 113.134 164.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 14.1 t90 -83.22 -32.56 26.43 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.13 1.772 . . . . 0.0 114.802 -174.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -48.83 -55.15 21.55 Favored Pre-proline 0 N--CA 1.481 1.121 0 CA-C-N 120.254 1.388 . . . . 0.0 114.35 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.19 -20.8 32.34 Favored 'Trans proline' 0 C--N 1.351 0.678 0 CA-C-N 120.806 1.324 . . . . 0.0 111.979 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.428 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 45.6 mtpt -84.54 2.69 40.06 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.148 1.779 . . . . 0.0 114.274 174.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 63.4 t -66.58 -29.97 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 120.886 -1.134 . . . . 0.0 110.219 152.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -96.2 -52.34 4.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 117.183 -1.389 . . . . 0.0 114.265 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.865 2.066 . . . . 0.0 113.089 -177.239 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' GSH . . . . . 0.454 ' C1 ' ' H ' ' A' ' 73' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.484 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 90.0 mtp . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 118.468 -0.777 . . . . 0.0 110.746 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.63 -161.51 0.25 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.917 1.287 . . . . 0.0 113.292 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.99 136.73 34.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.903 1.281 . . . . 0.0 110.771 -170.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -139.21 151.42 46.54 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.412 1.485 . . . . 0.0 108.845 166.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.54 140.73 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.206 1.002 . . . . 0.0 109.148 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.9 m -113.56 122.29 46.8 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.086 0.954 . . . . 0.0 109.38 171.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -136.59 157.92 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.887 1.275 . . . . 0.0 110.699 -164.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -57.7 115.43 2.79 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.611 0.365 . . . . 0.0 110.839 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -81.49 151.24 27.9 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.964 154.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.73 151.53 33.68 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 122.256 1.026 . . . . 0.0 112.515 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.6 t -70.86 135.98 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 166.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.53 -33.85 1.37 Allowed Glycine 0 CA--C 1.539 1.538 0 CA-C-O 118.585 -1.119 . . . . 0.0 115.218 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.96 67.85 12.1 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 124.861 1.264 . . . . 0.0 112.529 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.504 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 70.8 Cg_endo -65.71 -7.47 16.59 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.268 2.645 . . . . 0.0 114.685 -175.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -81.17 -0.1 38.84 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.493 1.517 . . . . 0.0 114.452 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.4 pt -133.34 162.08 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.994 1.318 . . . . 0.0 111.546 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.8 mt -63.6 150.96 42.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.725 0.81 . . . . 0.0 111.648 168.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.0 -166.32 10.91 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.557 1.551 . . . . 0.0 111.949 166.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -56.61 107.96 0.44 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.4 t -158.89 103.48 1.59 Allowed Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 113.669 -1.605 . . . . 0.0 109.281 139.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -64.57 -20.82 65.9 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.294 1.996 . . . . 0.0 112.633 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -68.38 -26.41 65.55 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 120.906 -1.121 . . . . 0.0 112.829 172.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 81.7 m -74.04 -37.09 64.42 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.614 -1.304 . . . . 0.0 112.055 170.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -62.24 -26.8 68.58 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 118.339 -0.839 . . . . 0.0 112.938 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.54 HH12 ' CG ' ' A' ' 74' ' ' ASP . 59.1 mtp180 -57.01 -42.8 81.02 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.118 0.967 . . . . 0.0 112.471 170.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.78 -41.46 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.284 1.434 . . . . 0.0 111.381 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.9 mt -58.94 -42.92 90.96 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.972 0.509 . . . . 0.0 111.401 172.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.02 -50.53 73.39 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.306 1.042 . . . . 0.0 112.748 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 p -75.71 -38.34 58.67 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -175.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.1 mt -65.91 -39.75 90.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.566 0.621 . . . . 0.0 111.32 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -77.85 -25.56 48.81 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -67.13 -48.66 67.41 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 120.741 -1.224 . . . . 0.0 111.325 169.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.423 ' HE3' HD12 ' A' ' 35' ' ' ILE . 51.2 mtmt -76.93 -0.33 23.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.016 1.726 . . . . 0.0 114.436 175.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm 57.79 20.67 6.71 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.785 1.634 . . . . 0.0 114.677 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.423 HD12 ' HE3' ' A' ' 33' ' ' LYS . 95.8 mt -69.77 128.8 91.7 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.504 1.122 . . . . 0.0 109.035 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.73 140.68 23.78 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.467 2.112 . . . . 0.0 111.737 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -145.11 152.03 39.43 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.604 1.562 . . . . 0.0 110.089 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -77.55 131.51 37.9 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.064 -1.022 . . . . 0.0 109.339 158.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.6 t -103.95 94.42 5.4 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.927 0.891 . . . . 0.0 110.755 174.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -81.26 99.06 8.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.775 0.83 . . . . 0.0 109.615 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 70.0 mt -66.98 108.79 2.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.528 0.731 . . . . 0.0 109.039 170.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.7 mm -120.66 114.88 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.529 1.132 . . . . 0.0 109.303 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -76.56 90.5 3.33 Favored 'General case' 0 C--O 1.22 -0.455 0 O-C-N 120.775 -1.203 . . . . 32.609999999999999 108.42 165.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.06 -7.34 1.76 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 117.173 2.286 . . . . 40.049999999999997 117.173 -170.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.56 -37.85 89.95 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 119.651 1.114 . . . . 41.469999999999999 111.762 165.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -105.58 47.77 0.86 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 129.452 3.101 . . . . 47.170000000000002 111.177 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -73.92 126.68 89.22 Favored Pre-proline 0 N--CA 1.475 0.779 0 O-C-N 119.695 -1.878 . . . . 41.270000000000003 111.689 -174.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.86 159.55 52.22 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.468 2.112 . . . . 40.289999999999999 110.982 170.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -62.45 -29.21 70.35 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.776 1.028 . . . . 42.390000000000001 113.776 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.4 t90 -56.28 -35.24 67.27 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.969 1.308 . . . . 37.079999999999998 113.957 168.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -79.41 -33.92 42.25 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.949 -1.094 . . . . 35.880000000000003 112.82 174.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.0 mt -71.02 -21.05 62.33 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.76 1.022 . . . . 33.609999999999999 113.76 173.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -66.38 -47.93 71.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.446 0.698 . . . . 33.789999999999999 110.752 166.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.6 mt -72.1 -33.21 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.308 1.043 . . . . 33.159999999999997 112.183 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.4 t -137.78 81.93 27.53 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 127.069 2.147 . . . . 33.579999999999998 110.507 -173.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -63.9 -23.51 68.29 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.231 2.621 . . . . 37.899999999999999 113.778 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -74.27 -10.94 60.09 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.805 -1.185 . . . . 38.990000000000002 113.845 167.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.89 22.58 76.65 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.463 1.506 . . . . 35.469999999999999 115.131 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -110.72 159.3 17.74 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.872 1.669 . . . . 34.490000000000002 113.921 -169.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.7 155.14 63.52 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.645 1.578 . . . . 23.530000000000001 111.85 172.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -63.51 152.75 71.37 Favored 'Cis proline' 0 C--N 1.349 0.575 0 CA-C-O 121.813 0.672 . . . . 22.879999999999999 112.611 -11.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.2 p -139.24 144.43 29.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.568 161.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.59 162.48 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 121.348 -0.845 . . . . 0.0 111.528 -169.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -123.21 63.91 1.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.103 1.761 . . . . 0.0 109.791 -174.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 81.4 mt -74.01 121.21 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.824 0.85 . . . . 0.0 108.76 -175.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.484 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 45.5 t0 55.15 35.89 25.79 Favored 'General case' 0 CA--C 1.549 0.933 0 O-C-N 121.862 -0.524 . . . . 0.0 111.447 -164.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.448 ' HB2' ' H2 ' ' A' ' 1' ' ' MET . 19.5 t0 67.19 -8.74 0.43 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 127.628 2.371 . . . . 0.0 115.345 -170.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.3 mttt -83.93 133.56 34.7 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.443 1.497 . . . . 0.0 111.875 -173.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.2 m0 -73.72 128.6 35.94 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.018 1.327 . . . . 0.0 111.679 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.0 t -142.5 128.1 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.332 1.453 . . . . 0.0 109.776 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -103.53 175.18 5.56 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.692 1.597 . . . . 0.0 111.729 172.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.7 t0 66.44 108.79 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.829 2.452 . . . . 22.16 114.786 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.446 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 52.4 p -61.42 -23.95 66.19 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 115.226 1.565 . . . . 21.16 115.226 -168.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.54 ' CG ' HH12 ' A' ' 25' ' ' ARG . 38.1 m-20 -73.61 -37.47 65.41 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.745 1.157 . . . . 24.969999999999999 113.07 171.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -69.92 -39.0 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.409 -0.807 . . . . 23.850000000000001 111.039 171.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 89.6 mt -63.58 -44.11 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.302 1.041 . . . . 23.68 111.224 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.1 -41.07 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.181 0.993 . . . . 22.84 111.482 171.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.89 -12.64 49.27 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 115.786 1.074 . . . . 23.329999999999998 115.786 174.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 89.6 mt -102.38 -53.05 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 118.913 1.357 . . . . 23.309999999999999 111.011 168.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.6 -33.06 73.24 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.622 0.971 . . . . 23.48 113.622 -172.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -90.57 -2.91 57.88 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.71 1.004 . . . . 24.239999999999998 113.71 -173.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.434 ' CD ' ' HZ2' ' A' ' 83' ' ' LYS . 10.1 tt0 -117.33 -54.44 2.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.442 1.497 . . . . 39.259999999999998 112.05 172.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.434 ' HZ2' ' CD ' ' A' ' 82' ' ' GLU . 64.9 mttp -93.71 59.22 2.81 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.92 1.288 . . . . 24.449999999999999 112.152 -164.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -135.84 163.64 49.01 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.77 1.628 . . . . 0.0 110.997 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.15 -23.53 21.17 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.411 2.074 . . . . 0.0 112.562 172.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -74.57 147.02 84.36 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.039 1.336 . . . . 0.0 112.206 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -59.44 135.14 62.95 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.841 2.361 . . . . 0.0 113.645 -173.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.68 136.5 49.96 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.909 2.406 . . . . 0.0 113.867 -167.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 mt -103.83 -0.26 29.42 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.935 1.694 . . . . 0.0 112.088 169.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.81 51.64 0.5 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.559 1.944 . . . . 0.0 110.569 161.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -129.74 61.31 57.21 Favored Pre-proline 0 N--CA 1.467 0.41 0 C-N-CA 127.003 2.121 . . . . 0.0 109.104 -169.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -80.77 123.16 4.61 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.256 1.971 . . . . 0.0 111.23 -155.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -72.54 175.96 9.43 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.1 2.533 . . . . 0.0 111.504 167.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -59.38 -20.56 55.76 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -53.72 -24.87 16.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.472 1.509 . . . . 0.0 114.223 167.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.04 -31.29 71.68 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.719 -1.238 . . . . 0.0 112.993 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.0 p -69.04 -25.5 64.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.426 1.09 . . . . 0.0 112.975 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.4 t -89.24 -43.44 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.321 1.448 . . . . 0.0 110.57 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.65 -29.56 75.06 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.014 1.292 . . . . 0.0 114.631 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 88.9 p -66.88 -20.5 65.93 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.498 1.149 . . . . 0.0 114.019 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -94.83 -34.43 12.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.501 1.52 . . . . 0.0 112.874 172.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.1 mt -67.38 -37.98 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.511 0.724 . . . . 0.0 111.521 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -58.93 -47.97 97.67 Favored Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 120.303 -1.498 . . . . 0.0 114.136 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.52 -30.7 6.2 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.693 2.262 . . . . 0.0 113.976 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.3 p -70.72 -29.8 66.17 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.996 1.725 . . . . 0.0 112.761 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -62.22 -41.36 98.32 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.345 -1.472 . . . . 0.0 113.071 161.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 72.4 t -63.73 -37.48 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 120.248 1.385 . . . . 0.0 111.339 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -67.31 -37.65 83.69 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.607 0.763 . . . . 0.0 112.339 172.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -70.62 -30.22 66.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.408 1.083 . . . . 0.0 112.427 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.5 mt -83.42 1.38 41.81 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.73 1.612 . . . . 0.0 114.352 169.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -146.78 38.56 1.01 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.526 1.53 . . . . 0.0 113.082 -177.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 m -73.8 63.71 0.9 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -161.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.34 -35.84 76.31 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.981 1.312 . . . . 0.0 111.798 165.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 12.0 t0 -81.89 119.05 74.34 Favored Pre-proline 0 CA--C 1.553 1.06 0 CA-C-O 117.125 -1.417 . . . . 0.0 107.221 153.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 114' ' ' ASP . 74.5 Cg_exo -53.66 150.92 26.73 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.419 2.746 . . . . 0.0 116.735 -153.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -66.34 -42.36 88.23 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.568 -174.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.12 -24.37 60.6 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.402 1.081 . . . . 0.0 113.417 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.31 -35.81 25.59 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.19 -0.944 . . . . 0.0 112.805 168.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 92.7 m -67.44 -27.19 66.84 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.655 -0.909 . . . . 0.0 112.687 169.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -58.75 -44.09 90.46 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 125.388 1.475 . . . . 0.0 111.814 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -70.44 -37.6 74.4 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.534 -0.729 . . . . 0.0 111.996 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.89 -16.09 63.67 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.2 tp -92.13 -40.71 10.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.379 1.471 . . . . 0.0 111.612 169.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.5 mt -65.02 -42.38 94.44 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.201 1.4 . . . . 0.0 113.558 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -65.27 -35.19 80.27 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.88 1.673 . . . . 0.0 112.469 -176.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -73.71 -37.26 65.21 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.43 -0.794 . . . . 0.0 112.83 172.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.3 mt -65.69 -36.4 83.53 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 120.688 -1.258 . . . . 0.0 112.656 171.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -64.57 -42.78 95.43 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.734 1.152 . . . . 0.0 111.253 173.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.21 -38.41 91.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.401 0.68 . . . . 0.0 112.131 175.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.6 tp -65.04 -52.81 53.74 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.045 0.938 . . . . 0.0 111.846 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -65.9 -38.41 88.66 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.214 1.405 . . . . 0.0 113.425 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -62.07 -36.05 92.35 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 119.284 -0.731 . . . . 0.0 113.845 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -87.45 -31.74 19.86 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 117.913 0.857 . . . . 0.0 112.879 175.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 12.8 mt -61.42 -36.23 79.76 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.004 -1.06 . . . . 0.0 113.436 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -65.21 -2.71 3.16 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.3 t -104.23 -27.76 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.591 1.556 . . . . 0.0 112.946 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -93.67 -50.94 5.15 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -168.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 158.95 172.41 26.02 Favored Glycine 0 CA--C 1.535 1.298 0 O-C-N 121.362 -0.836 . . . . 0.0 114.586 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -73.48 -15.25 24.9 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 124.669 3.579 . . . . 0.0 115.987 -163.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -89.95 167.45 12.8 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.379 0.99 . . . . 0.0 111.61 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -12.18 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.472 -1.393 . . . . 0.0 113.204 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -100.65 -4.1 29.04 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.8 1.408 . . . . 0.0 114.8 166.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 110.12 -122.95 6.51 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 119.871 1.214 . . . . 0.0 113.201 -175.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -70.43 -18.72 63.01 Favored 'General case' 0 CA--C 1.541 0.635 0 O-C-N 120.847 -1.384 . . . . 0.0 114.108 -168.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -141.35 155.74 45.9 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.907 1.683 . . . . 0.0 110.711 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 58.9 mt -62.73 129.31 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.592 0.757 . . . . 0.0 109.244 163.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.9 p -129.36 -175.41 3.57 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.8 0.84 . . . . 0.0 111.961 168.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.79 -19.1 3.83 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 172.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.6 t -70.32 -43.57 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.998 -1.064 . . . . 0.0 111.9 172.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -60.02 -45.19 93.61 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.471 1.108 . . . . 0.0 112.312 169.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 34.2 mt -61.06 -20.74 62.92 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 177.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.2 m -85.98 -43.99 12.71 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.37 -0.831 . . . . 0.0 112.047 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 29.5 mt -98.34 -33.53 11.03 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -168.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.49 -49.58 93.0 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.56 -22.35 18.34 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 121.095 1.427 . . . . 0.0 113.223 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -71.25 -33.25 69.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 117.47 -1.252 . . . . 0.0 112.077 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 68.9 mt -66.41 -43.17 86.49 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 169.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -58.33 -39.72 80.19 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.653 0.661 . . . . 0.0 111.588 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -70.81 -22.68 62.32 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 177.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.3 mt -71.98 -51.38 22.2 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.112 0.869 . . . . 0.0 111.496 168.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -64.8 -28.16 69.38 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.524 0.729 . . . . 0.0 112.461 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.3 t -94.21 -72.24 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.854 1.262 . . . . 0.0 113.159 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.98 -48.72 11.87 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.333 -0.854 . . . . 0.0 113.057 -158.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 63.4 tp -66.84 -34.0 76.84 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.825 -0.607 . . . . 0.0 111.074 166.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.38 -30.13 57.98 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.285 1.421 . . . . 0.0 115.505 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -64.34 -26.16 68.35 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 173.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -117.21 -28.09 6.28 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.547 1.139 . . . . 0.0 113.584 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -143.87 94.28 2.57 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.358 2.263 . . . . 0.0 108.032 167.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -68.35 80.68 0.25 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.077 0.951 . . . . 0.0 110.347 168.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -71.0 117.22 54.3 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.447 1.099 . . . . 0.0 110.966 -171.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.39 107.09 1.9 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.868 1.712 . . . . 0.0 110.352 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 30.5 mm -57.13 115.13 9.58 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 124.399 1.08 . . . . 0.0 108.445 169.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.59 146.62 92.79 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.6 1.534 . . . . 0.0 111.744 -174.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.88 -17.48 64.34 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 120.887 -1.133 . . . . 0.0 114.058 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -62.18 -35.33 78.49 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.807 1.243 . . . . 0.0 112.786 167.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 36.1 mt -80.54 50.81 1.36 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.802 1.641 . . . . 0.0 111.232 165.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -34.42 70.56 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.532 1.133 . . . . 0.0 111.746 -171.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -80.5 -37.86 30.89 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.255 1.022 . . . . 0.0 112.943 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 43.9 t -64.68 -40.61 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 119.512 1.051 . . . . 0.0 111.017 172.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.57 -41.2 96.44 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -65.47 -42.72 91.96 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 171.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -65.0 -33.27 75.65 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.431 1.092 . . . . 0.0 112.959 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 58.3 mt -58.62 -32.36 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.039 -1.038 . . . . 0.0 111.704 170.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -83.13 -11.63 57.76 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.33 -1.481 . . . . 0.0 113.613 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.81 -18.9 60.9 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 117.963 -1.018 . . . . 0.0 113.448 160.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 74.0 mt -66.06 -13.59 60.26 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.033 1.288 . . . . 0.0 114.281 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -106.35 10.74 31.52 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.931 1.292 . . . . 0.0 112.776 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.0 p -114.46 177.57 4.6 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.222 1.809 . . . . 0.0 113.763 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 52.8 mtp85 57.11 -166.31 0.14 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.813 1.645 . . . . 0.0 111.201 -172.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.454 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 8.7 mp0 -79.69 -33.77 40.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.449 0.7 . . . . 0.0 110.243 161.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 56.2 p -75.75 -66.85 0.73 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.909 1.683 . . . . 0.0 113.944 -162.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -61.68 -41.43 97.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.137 0.881 . . . . 0.0 112.268 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -56.68 -27.99 59.92 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -87.26 -11.2 50.35 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 175.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 11.8 p -74.76 -14.85 60.76 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.61 1.55 . . . . 0.0 112.931 173.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -59.49 134.45 57.02 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.773 1.229 . . . . 0.0 111.763 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -109.74 176.99 4.87 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.267 1.427 . . . . 0.0 110.562 168.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.69 113.84 8.18 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.812 -1.18 . . . . 0.0 109.352 168.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -57.57 -31.5 66.2 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -167.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.94 -40.28 88.44 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.481 1.112 . . . . 0.0 112.009 173.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -85.52 -3.12 58.77 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.133 1.773 . . . . 0.0 112.935 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 42.1 t -86.69 -48.84 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.753 1.221 . . . . 0.0 109.971 162.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 31.6 mt -57.96 -52.01 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.923 1.289 . . . . 0.0 111.512 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.3 -12.89 61.89 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.25 -32.34 10.67 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.148 -0.97 . . . . 0.0 113.371 171.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 57.1 t90 -80.26 -35.65 35.7 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.096 1.759 . . . . 0.0 114.224 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -51.05 -47.76 86.57 Favored Pre-proline 0 CA--C 1.552 1.027 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.82 -25.94 27.81 Favored 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 121.275 1.491 . . . . 0.0 113.688 172.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -76.06 -11.95 60.03 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 117.296 -1.335 . . . . 0.0 114.562 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 48.3 t -59.04 -23.33 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 119.151 0.887 . . . . 0.0 111.114 160.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -104.08 -7.94 19.87 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 177.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.294 0 C-N-CA 125.141 1.376 . . . . 0.0 112.935 -175.927 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' GSH . . . . . 0.446 ' C1 ' ' H ' ' A' ' 73' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.421 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 75.3 mtp . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 117.739 -1.124 . . . . 0.0 109.675 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.22 -174.71 0.11 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.025 1.73 . . . . 0.0 115.094 173.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 84.2 mt -125.22 128.42 48.29 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.131 1.772 . . . . 0.0 110.981 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -119.94 143.26 48.09 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.913 0.885 . . . . 0.0 108.784 158.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.2 pt -129.09 147.85 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.439 1.096 . . . . 0.0 109.966 176.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.3 m -120.14 120.96 37.71 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.348 1.459 . . . . 0.0 109.205 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -133.32 160.38 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.978 1.311 . . . . 0.0 111.781 -168.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.61 118.22 7.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.519 0.728 . . . . 0.0 111.56 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -78.02 151.95 33.28 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.08 0.552 . . . . 0.0 111.599 161.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.73 140.6 58.88 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.161 0.981 . . . . 0.0 113.029 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.5 t -66.25 121.86 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.95 -14.79 18.32 Favored Glycine 0 CA--C 1.538 1.498 0 CA-C-O 118.464 -1.187 . . . . 0.0 115.881 -173.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.26 62.72 62.43 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 119.053 1.426 . . . . 0.0 112.022 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.49 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 72.2 Cg_endo -65.39 -5.48 11.44 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.186 2.591 . . . . 0.0 114.962 -171.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -77.92 -3.18 40.5 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.425 1.89 . . . . 0.0 114.734 171.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.2 pt -136.13 165.69 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.947 1.299 . . . . 0.0 112.346 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.51 144.77 53.72 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.305 1.042 . . . . 0.0 111.565 171.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.21 -174.53 13.81 Favored Glycine 0 N--CA 1.469 0.857 0 C-N-CA 125.145 1.355 . . . . 0.0 114.489 175.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -62.73 105.29 0.63 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.4 t -163.18 95.07 1.11 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.485 1.514 . . . . 0.0 109.454 159.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.09 -22.97 75.16 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.837 1.691 . . . . 0.0 113.542 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -63.29 -32.72 74.2 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.606 -1.309 . . . . 0.0 113.432 169.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 67.4 m -72.2 -37.12 69.31 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.808 -1.183 . . . . 0.0 112.014 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -63.84 -22.51 66.95 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 117.57 -1.205 . . . . 0.0 112.994 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.463 HH12 ' CG ' ' A' ' 74' ' ' ASP . 64.3 mtp180 -57.98 -43.06 86.3 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 119.641 1.11 . . . . 0.0 112.644 169.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -80.76 -36.82 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.574 1.15 . . . . 0.0 111.673 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.4 -41.53 94.08 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 122.118 -0.364 . . . . 0.0 111.002 169.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.1 tp -61.15 -52.33 65.32 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.044 0.938 . . . . 0.0 112.604 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.9 p -75.45 -33.71 60.9 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 62.2 mt -73.52 -29.86 62.74 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.159 -0.963 . . . . 0.0 112.919 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -76.29 -34.14 59.08 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 169.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.16 -43.44 82.28 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.5 1.046 . . . . 0.0 112.768 172.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -73.6 1.53 9.91 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 117.791 -1.099 . . . . 0.0 113.573 166.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 pttt 46.85 22.3 0.19 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 127.952 2.501 . . . . 0.0 114.588 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.3 tt -91.03 131.16 37.88 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 125.325 1.45 . . . . 0.0 109.401 -164.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.56 119.3 6.3 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.462 1.441 . . . . 0.0 111.981 -173.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -129.72 154.12 47.49 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.693 1.597 . . . . 0.0 111.263 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -101.2 120.24 39.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.599 1.16 . . . . 0.0 110.064 176.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.5 t -95.24 112.79 24.45 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.479 0.712 . . . . 0.0 112.402 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -89.84 114.36 26.1 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.023 1.329 . . . . 0.0 110.337 169.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 98.8 mt -73.72 109.03 6.92 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.285 1.034 . . . . 0.0 110.13 166.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.0 mm -99.33 117.66 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.941 0.896 . . . . 0.0 110.33 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -77.16 52.67 0.92 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.51 1.524 . . . . 32.609999999999999 112.731 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.86 0.83 0.07 Allowed 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 120.378 3.473 . . . . 40.049999999999997 120.378 -151.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.65 -41.04 85.24 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 120.217 1.371 . . . . 41.469999999999999 111.467 159.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -99.85 62.7 1.17 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 128.025 2.53 . . . . 47.170000000000002 110.094 166.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.6 pttm -78.78 128.62 76.35 Favored Pre-proline 0 N--CA 1.476 0.845 0 O-C-N 119.907 -1.745 . . . . 41.270000000000003 110.868 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -62.37 154.4 64.15 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.845 2.363 . . . . 40.289999999999999 113.436 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -59.89 -42.13 93.11 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.455 -0.778 . . . . 42.390000000000001 112.928 172.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -65.88 -19.33 65.84 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.926 1.084 . . . . 37.079999999999998 113.926 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -76.07 -29.61 58.04 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.849 -1.157 . . . . 35.880000000000003 112.226 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.0 mt -69.12 -27.79 65.89 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.158 0.89 . . . . 33.609999999999999 112.46 170.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -73.79 -3.77 30.58 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.102 1.361 . . . . 33.789999999999999 113.036 173.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.3 mt -111.26 -43.14 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 126.223 1.809 . . . . 33.159999999999997 110.558 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t -116.92 96.11 48.21 Favored Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 125.734 1.613 . . . . 33.579999999999998 110.855 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.17 -24.58 58.75 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.263 1.975 . . . . 37.899999999999999 113.062 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -76.38 -9.33 58.56 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.479 1.512 . . . . 38.990000000000002 113.54 172.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.92 4.32 33.68 Favored Glycine 0 CA--C 1.536 1.347 0 O-C-N 120.31 -1.494 . . . . 35.469999999999999 115.351 -169.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -77.05 152.06 35.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.712 1.605 . . . . 34.490000000000002 112.436 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.2 152.32 45.8 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.021 1.728 . . . . 23.530000000000001 110.723 156.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -66.18 156.03 80.83 Favored 'Cis proline' 0 C--N 1.348 0.51 0 CA-C-O 122.022 0.759 . . . . 22.879999999999999 112.799 -6.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.14 146.16 24.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 114.233 -1.348 . . . . 0.0 107.836 161.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.9 m -129.07 163.63 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.449 0.7 . . . . 0.0 110.975 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . 27.2 mtpt -120.98 75.66 1.16 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 126.046 1.738 . . . . 0.0 110.0 174.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 86.4 mt -68.48 119.9 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.421 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 1.0 OUTLIER 57.66 33.8 23.69 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -172.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.272 23.0 t70 71.65 -0.31 3.21 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 127.455 2.302 . . . . 0.0 114.727 -170.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -107.76 130.22 54.98 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 119.232 -2.168 . . . . 0.0 112.76 -176.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -72.35 146.14 47.29 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -163.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.1 t -144.38 131.13 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 126.374 1.87 . . . . 0.0 109.015 175.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -120.94 163.09 18.78 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.093 1.757 . . . . 0.0 112.806 -174.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . 0.272 50.0 m-20 58.77 122.65 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 128.12 2.568 . . . . 22.16 114.464 -169.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.448 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 77.8 p -65.12 -24.79 67.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 115.522 1.675 . . . . 21.16 115.522 -162.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.463 ' CG ' HH12 ' A' ' 25' ' ' ARG . 38.8 m-20 -69.78 -37.1 76.23 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.065 1.302 . . . . 24.969999999999999 113.217 171.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.5 t -71.7 -39.07 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 121.27 -0.894 . . . . 23.850000000000001 110.669 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.38 -47.95 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.911 0.885 . . . . 23.68 111.0 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.9 t -63.23 -40.44 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.865 0.866 . . . . 22.84 111.117 174.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.65 -48.84 68.7 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 119.266 0.939 . . . . 23.329999999999998 113.531 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.4 mt -72.88 -41.19 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 117.954 0.877 . . . . 23.309999999999999 112.003 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.44 -33.85 76.91 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.853 1.206 . . . . 23.48 112.883 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -91.99 -10.96 37.41 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.287 1.218 . . . . 24.239999999999998 114.287 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -94.84 -40.63 9.63 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.521 1.128 . . . . 39.259999999999998 112.356 167.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -131.44 84.54 2.18 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.683 1.193 . . . . 24.449999999999999 111.611 -163.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -138.72 163.21 48.32 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 125.764 1.626 . . . . 0.0 110.737 165.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.88 -26.38 9.62 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.72 2.28 . . . . 0.0 112.696 172.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -82.93 151.66 64.33 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 124.054 0.942 . . . . 0.0 109.877 161.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -58.2 151.79 57.09 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.293 2.662 . . . . 0.0 117.078 -160.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.44 146.82 51.05 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.432 2.755 . . . . 0.0 112.992 174.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.8 mt -134.05 20.71 3.77 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.141 1.776 . . . . 0.0 112.366 172.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.21 51.82 0.24 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.891 1.676 . . . . 0.0 111.973 169.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.6 p -125.96 72.71 70.26 Favored Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 125.633 1.573 . . . . 0.0 110.016 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.43 117.31 5.07 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.747 2.298 . . . . 0.0 110.369 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -80.22 -170.41 1.0 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.814 3.009 . . . . 0.0 111.401 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -51.71 -33.87 36.3 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.135 1.374 . . . . 0.0 114.253 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -52.76 -30.08 30.81 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.743 1.617 . . . . 0.0 114.371 173.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.75 -29.2 69.97 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.16 -0.963 . . . . 0.0 113.322 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.2 m -71.68 -12.71 61.46 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 99.2 t -114.57 -37.63 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.499 1.52 . . . . 0.0 110.894 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.95 -30.93 76.76 Favored Glycine 0 CA--C 1.533 1.217 0 O-C-N 120.819 -1.176 . . . . 0.0 114.096 172.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 91.6 p -65.59 -22.42 66.68 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -85.14 -40.26 16.95 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.588 1.555 . . . . 0.0 112.036 172.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 81.1 mt -68.84 -36.19 73.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.935 1.294 . . . . 0.0 111.164 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -56.24 -44.34 99.67 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 125.097 1.359 . . . . 0.0 114.589 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -84.78 -31.36 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.525 2.817 . . . . 0.0 114.229 169.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 p -71.12 -26.93 63.23 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 121.148 1.794 . . . . 0.0 113.549 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -60.99 -38.93 87.72 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.859 -1.15 . . . . 0.0 112.521 162.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 41.3 t -69.03 -33.75 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 120.989 -1.07 . . . . 0.0 111.737 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -63.37 -46.88 84.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.087 0.858 . . . . 0.0 111.552 168.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -63.25 -40.55 97.74 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.499 1.12 . . . . 0.0 112.689 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.7 mt -76.96 -1.35 28.22 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.425 1.49 . . . . 0.0 114.708 171.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -135.12 40.31 2.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.035 1.734 . . . . 0.0 111.405 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 p -73.73 54.28 0.48 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.809 2.444 . . . . 0.0 115.283 -162.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 97.6 mttt -61.63 -34.54 75.84 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.607 1.563 . . . . 0.0 111.932 161.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 17.5 t0 -88.5 111.77 45.86 Favored Pre-proline 0 CA--C 1.553 1.077 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 157.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 114' ' ' ASP . 51.2 Cg_exo -53.27 150.49 25.47 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.126 2.55 . . . . 0.0 117.184 -154.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -66.2 -47.85 72.57 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.379 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -62.56 -26.82 68.77 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.8 -38.42 13.93 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 121.156 -0.965 . . . . 0.0 113.387 171.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 87.6 m -68.02 -34.85 77.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.579 1.151 . . . . 0.0 112.987 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -61.17 -38.12 85.36 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.753 1.621 . . . . 0.0 112.966 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -63.76 -44.87 92.16 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.262 0.625 . . . . 0.0 111.668 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.45 -34.27 76.85 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.75 -40.56 88.34 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.099 0.559 . . . . 0.0 112.225 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.4 mt -64.9 -35.1 80.06 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.888 0.767 . . . . 0.0 112.837 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -72.4 -37.7 68.63 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.472 1.033 . . . . 0.0 113.0 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -71.62 -33.94 69.4 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.928 -1.108 . . . . 0.0 112.868 170.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.1 mt -65.7 -34.98 79.46 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.636 -1.29 . . . . 0.0 112.347 170.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -65.89 -41.47 91.51 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.24 1.382 . . . . 0.0 111.952 170.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.56 -34.24 76.55 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.214 0.606 . . . . 0.0 112.124 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.66 -58.15 3.58 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.167 0.987 . . . . 0.0 111.584 170.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.76 -34.54 78.41 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.448 1.499 . . . . 0.0 114.022 -169.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.9 -38.68 89.76 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.045 0.831 . . . . 0.0 113.301 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -89.09 -25.87 21.67 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.714 0.806 . . . . 0.0 112.638 176.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.51 -32.35 73.65 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 120.562 -1.337 . . . . 0.0 112.923 172.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -67.7 -10.18 50.13 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 172.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 26.4 t -86.97 -31.81 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.129 0.972 . . . . 0.0 111.874 168.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -95.71 -30.21 13.86 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -173.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 102.39 -109.86 3.64 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 117.425 -1.764 . . . . 0.0 115.139 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -79.69 -26.73 4.49 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.682 2.921 . . . . 0.0 117.385 -146.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -130.85 163.08 28.2 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.159 1.345 . . . . 0.0 112.441 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.62 -8.36 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -168.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -95.92 -2.88 46.29 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 159.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 118.55 -118.39 4.01 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.653 1.115 . . . . 0.0 113.672 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -70.9 -23.91 62.37 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.651 1.18 . . . . 0.0 113.394 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -141.66 171.1 14.53 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.433 1.893 . . . . 0.0 111.059 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.8 mt -70.8 138.57 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.669 1.187 . . . . 0.0 109.431 168.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.2 p -140.09 -171.63 3.23 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 121.284 -0.885 . . . . 0.0 111.46 164.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.01 -18.88 1.56 Allowed 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 171.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.6 t -72.87 -42.92 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 O-C-N 120.701 -1.249 . . . . 0.0 112.325 172.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -62.09 -43.85 97.94 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.524 1.129 . . . . 0.0 111.993 168.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.3 mt -64.34 -10.82 26.79 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.0 m -97.97 -45.02 6.43 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.512 1.125 . . . . 0.0 112.308 173.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.22 -36.15 12.15 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.67 -48.22 97.6 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -172.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -72.14 -25.22 19.33 Favored 'Trans proline' 0 C--N 1.351 0.678 0 CA-C-N 120.875 1.348 . . . . 0.0 113.371 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -74.05 -30.11 62.24 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 117.423 -1.275 . . . . 0.0 112.429 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 57.1 mt -67.94 -38.2 82.54 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.132 0.878 . . . . 0.0 112.832 167.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -63.78 -52.13 61.71 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.079 0.854 . . . . 0.0 112.253 172.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 41.7 t60 -62.65 -26.62 68.73 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.945 0.898 . . . . 0.0 112.358 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.2 tp -71.82 -52.66 16.37 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.938 -1.101 . . . . 0.0 113.184 170.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -58.56 -34.22 70.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.321 0.964 . . . . 0.0 112.656 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 97.4 t -82.87 -62.12 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.184 0.994 . . . . 0.0 112.763 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.55 -35.01 25.1 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -165.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.92 -35.85 59.61 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.742 -0.599 . . . . 0.0 111.397 169.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.16 -25.27 53.81 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.266 0.936 . . . . 0.0 115.234 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -60.26 -31.89 70.65 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.166 1.386 . . . . 0.0 114.675 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -125.2 -20.8 4.76 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -147.08 84.0 1.58 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.997 2.119 . . . . 0.0 107.119 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -66.91 85.24 0.12 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.389 0.676 . . . . 0.0 110.186 171.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 34.7 t90 -83.82 113.15 45.62 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.084 1.354 . . . . 0.0 110.997 -168.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.42 118.3 5.6 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.82 1.68 . . . . 0.0 110.545 -176.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 47.0 mm -67.63 113.82 16.38 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 159.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -66.33 155.45 69.92 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.723 1.615 . . . . 0.0 111.094 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.14 -22.56 66.94 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.378 1.071 . . . . 0.0 113.765 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -67.07 -22.72 65.83 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.479 1.112 . . . . 0.0 113.953 170.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 67.5 mt -85.71 55.09 3.36 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.322 1.449 . . . . 0.0 110.742 165.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.2 m -67.69 -27.03 66.49 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.499 1.119 . . . . 0.0 112.932 -161.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 33.9 t60 -73.03 -52.44 14.38 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.855 0.752 . . . . 0.0 110.338 168.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 79.0 t -58.78 -41.14 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 119.344 0.975 . . . . 0.0 112.226 -173.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 62.7 tp -60.46 -42.1 95.5 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.574 1.15 . . . . 0.0 112.831 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -76.74 -36.96 56.78 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.514 0.726 . . . . 0.0 112.848 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -63.39 -36.47 83.82 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.941 1.296 . . . . 0.0 112.629 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.85 -34.59 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.457 -0.777 . . . . 0.0 111.789 171.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -82.9 -14.6 53.89 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.432 -1.418 . . . . 0.0 113.515 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 23.3 mt -71.54 -18.49 62.26 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.816 -1.177 . . . . 0.0 113.618 162.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 60.4 mt -65.9 -20.54 66.26 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.759 1.163 . . . . 0.0 113.347 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -93.98 11.11 30.79 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.955 1.302 . . . . 0.0 113.058 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 10.5 p -119.94 174.96 6.14 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.913 2.085 . . . . 0.0 112.333 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? 60.66 177.12 0.1 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.473 1.509 . . . . 0.0 111.64 -170.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.481 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 0.5 OUTLIER -70.98 -41.71 70.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.783 153.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 85.6 p -54.75 -68.64 0.17 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.153 1.381 . . . . 0.0 114.682 -170.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -70.66 -43.4 69.21 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.059 -1.026 . . . . 0.0 112.247 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -59.79 -32.76 70.91 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -172.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -81.0 -7.76 59.63 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.4 p -77.89 -13.15 59.98 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.067 1.303 . . . . 0.0 113.426 169.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -64.43 86.21 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.883 1.673 . . . . 0.0 112.96 -167.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.48 137.95 57.77 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.343 1.057 . . . . 0.0 110.21 164.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.24 128.04 35.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.618 0.767 . . . . 0.0 112.022 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -59.61 -34.66 73.04 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -162.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -65.23 -37.96 88.89 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.981 -1.075 . . . . 0.0 112.453 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -82.24 -7.52 59.63 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 171.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 86.3 t -79.58 -47.45 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 118.706 0.685 . . . . 0.0 110.05 163.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 65.0 mt -64.52 -52.59 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.889 1.276 . . . . 0.0 111.742 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.9 -11.53 60.68 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.24 -34.15 8.95 Favored Glycine 0 CA--C 1.535 1.304 0 O-C-N 120.942 -1.099 . . . . 0.0 113.36 168.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -75.6 -35.82 60.46 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.064 1.746 . . . . 0.0 113.524 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -51.51 -51.7 66.93 Favored Pre-proline 0 N--CA 1.477 0.899 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -174.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.39 -24.41 43.06 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 CA-C-N 121.476 1.563 . . . . 0.0 113.451 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -74.96 -8.25 55.94 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.412 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 60.2 t -60.59 -27.06 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 120.064 1.302 . . . . 0.0 110.624 160.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -103.2 -34.48 8.81 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 116.656 -1.64 . . . . 0.0 115.1 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.258 0 O-C-N 125.234 1.584 . . . . 0.0 113.015 179.292 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' GSH . . . . . 0.448 ' C1 ' ' H ' ' A' ' 73' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.583 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 88.1 mtp . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 117.799 -1.096 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.62 -178.25 0.16 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.886 1.675 . . . . 0.0 115.01 176.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.1 mt -105.46 138.2 42.04 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.81 1.644 . . . . 0.0 112.683 -169.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -125.93 143.99 50.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.959 1.304 . . . . 0.0 109.456 157.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.4 pt -129.0 137.18 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.136 0.975 . . . . 0.0 110.287 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.8 m -109.68 123.97 50.4 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.555 1.142 . . . . 0.0 109.473 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -136.5 162.0 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.156 1.382 . . . . 0.0 111.311 -166.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -64.0 121.31 13.8 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.14 -0.975 . . . . 0.0 111.746 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.61 143.18 38.45 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.019 0.527 . . . . 0.0 111.035 157.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.28 138.01 58.35 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.648 0.737 . . . . 0.0 111.685 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 67.6 t -68.91 134.92 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.85 -32.75 1.69 Allowed Glycine 0 CA--C 1.537 1.427 0 CA-C-O 118.821 -0.989 . . . . 0.0 114.952 -172.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.6 60.67 19.75 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.839 1.255 . . . . 0.0 113.151 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.22 -3.95 9.59 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.976 2.451 . . . . 0.0 115.676 -171.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -73.23 -8.1 54.35 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 170.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.0 pt -131.16 163.63 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.643 1.177 . . . . 0.0 112.513 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.3 mt -63.41 138.68 58.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.14 0.976 . . . . 0.0 111.541 172.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.99 -168.19 13.47 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.034 1.302 . . . . 0.0 114.118 173.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -60.59 103.85 0.29 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 174.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.6 t -156.81 102.9 1.95 Allowed Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.149 141.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.54 -20.9 60.41 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.716 2.278 . . . . 0.0 112.862 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -66.22 -29.86 70.2 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 120.666 -1.271 . . . . 0.0 113.534 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 88.0 m -70.43 -36.64 74.11 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.536 -1.352 . . . . 0.0 112.076 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -67.68 -21.69 65.32 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 118.119 -0.944 . . . . 0.0 112.307 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.525 HH12 ' CG ' ' A' ' 74' ' ' ASP . 64.6 mtp180 -58.76 -45.07 90.6 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.359 1.064 . . . . 0.0 112.579 166.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -73.55 -43.01 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.557 1.143 . . . . 0.0 111.045 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.6 mt -57.66 -44.19 85.51 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.743 0.417 . . . . 0.0 111.54 172.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.4 tp -60.7 -48.42 81.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.106 0.962 . . . . 0.0 112.623 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.7 -36.06 67.77 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -174.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 74.7 mt -73.88 -41.45 62.16 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.323 0.51 . . . . 0.0 111.493 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -77.91 -14.43 59.55 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 176.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -76.55 -46.91 24.4 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 120.206 -1.559 . . . . 0.0 111.578 164.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -74.82 -12.81 60.47 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm 64.88 9.51 5.41 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 127.467 2.307 . . . . 0.0 114.886 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.3 tp -67.24 129.73 93.75 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.595 1.158 . . . . 0.0 110.481 175.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.39 147.95 33.16 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.658 2.239 . . . . 0.0 112.775 -174.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -147.23 151.48 36.76 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.316 1.446 . . . . 0.0 111.071 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -80.25 147.41 31.21 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.551 -0.718 . . . . 0.0 109.484 159.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -127.42 116.53 20.59 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.646 0.778 . . . . 0.0 111.24 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -104.05 110.73 23.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.668 1.587 . . . . 0.0 109.667 -175.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -74.0 106.48 5.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.579 1.152 . . . . 0.0 110.256 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 mm -95.14 116.06 35.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.791 0.837 . . . . 0.0 110.54 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -75.99 49.87 0.57 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.02 1.728 . . . . 32.609999999999999 112.853 174.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pp -60.4 3.07 0.08 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 120.532 3.53 . . . . 40.049999999999997 120.532 -148.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.22 -36.01 70.66 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 120.236 1.38 . . . . 41.469999999999999 111.787 158.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -101.98 67.46 1.08 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.043 2.137 . . . . 47.170000000000002 109.327 163.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -80.8 119.5 76.32 Favored Pre-proline 0 N--CA 1.474 0.754 0 O-C-N 119.603 -1.936 . . . . 41.270000000000003 111.636 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -62.92 154.8 64.29 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.656 2.237 . . . . 40.289999999999999 114.397 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -63.32 -42.07 98.96 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.991 0.916 . . . . 42.390000000000001 113.217 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 33.2 p-90 -64.25 -23.81 67.44 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.054 -1.029 . . . . 37.079999999999998 113.601 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -81.97 -31.62 31.07 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.252 -0.905 . . . . 35.880000000000003 112.462 172.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 mt -69.03 -26.9 65.23 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.198 0.908 . . . . 33.609999999999999 112.699 170.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -68.96 -15.19 63.42 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.373 1.069 . . . . 33.789999999999999 113.485 168.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.0 mt -99.31 -44.97 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.267 1.427 . . . . 33.159999999999997 110.602 172.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.4 t -112.77 100.17 50.0 Favored Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 125.907 1.683 . . . . 33.579999999999998 110.543 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.85 -19.23 46.9 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.209 1.939 . . . . 37.899999999999999 113.968 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -85.53 -9.21 57.71 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.267 -0.895 . . . . 38.990000000000002 113.279 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.66 19.23 62.52 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 120.67 -1.269 . . . . 35.469999999999999 114.645 -171.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -85.45 155.48 21.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.118 1.767 . . . . 34.490000000000002 111.509 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.7 m -110.89 154.52 43.31 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.171 1.788 . . . . 23.530000000000001 110.134 156.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -64.89 154.94 76.39 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 CA-C-O 122.019 0.758 . . . . 22.879999999999999 112.824 -9.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.43 147.45 22.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.013 -1.449 . . . . 0.0 107.363 156.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.9 m -126.15 165.71 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.649 -0.657 . . . . 0.0 110.373 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -122.79 97.6 5.52 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.441 1.497 . . . . 0.0 108.808 170.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 82.3 mt -86.82 121.3 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.137 0.975 . . . . 0.0 108.922 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.583 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER 52.67 38.0 24.99 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.034 0.934 . . . . 0.0 112.834 -164.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 65.64 17.08 10.78 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.129 2.171 . . . . 0.0 116.319 -172.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -117.39 128.23 54.82 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 119.981 -1.699 . . . . 0.0 111.639 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -67.97 145.8 54.18 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -164.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -144.13 129.44 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.973 2.109 . . . . 0.0 108.679 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.69 165.55 12.69 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.672 1.589 . . . . 0.0 112.622 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.0 t0 65.54 115.65 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 128.079 2.552 . . . . 22.16 114.269 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.433 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 53.2 p -61.75 -25.57 67.54 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.325 1.602 . . . . 21.16 115.325 -165.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.525 ' CG ' HH12 ' A' ' 25' ' ' ARG . 31.8 m-20 -71.93 -35.77 69.75 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.876 1.216 . . . . 24.969999999999999 113.415 170.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.5 t -72.57 -39.01 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 121.432 -0.792 . . . . 23.850000000000001 111.114 172.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.18 -48.66 87.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.332 1.053 . . . . 23.68 110.914 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.43 -37.38 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.176 0.991 . . . . 22.84 111.467 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.92 -13.16 51.57 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.525 1.059 . . . . 23.329999999999998 115.585 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.6 mt -102.39 -48.46 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 118.925 1.362 . . . . 23.309999999999999 111.275 167.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.9 mt -62.52 -27.45 69.16 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.305 1.224 . . . . 23.48 114.305 -171.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -91.4 -0.3 57.62 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.785 1.032 . . . . 24.239999999999998 113.785 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -129.13 -25.51 2.73 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.544 1.138 . . . . 39.259999999999998 113.545 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -126.68 73.6 1.41 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.946 1.698 . . . . 24.449999999999999 111.923 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -141.32 165.33 29.59 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 126.112 1.765 . . . . 0.0 109.806 169.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.09 -26.45 18.14 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.333 2.022 . . . . 0.0 113.7 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.5 pm0 -75.46 160.89 78.57 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.458 1.103 . . . . 0.0 112.716 168.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.84 145.09 99.52 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.524 2.149 . . . . 0.0 113.915 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.78 145.19 62.07 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.162 2.575 . . . . 0.0 113.844 -174.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.1 mt -108.87 6.75 25.68 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.211 1.804 . . . . 0.0 112.926 169.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.4 50.57 0.17 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.85 2.06 . . . . 0.0 113.536 173.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 74.7 p -120.16 75.29 22.48 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 125.039 1.336 . . . . 0.0 110.214 170.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.09 117.93 5.27 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.346 2.031 . . . . 0.0 109.913 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.28 -173.26 1.71 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.661 2.907 . . . . 0.0 111.935 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.1 mp0 -51.13 -32.14 21.8 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.393 2.277 . . . . 0.0 113.632 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -54.79 -25.81 30.59 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.314 1.446 . . . . 0.0 114.109 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -29.35 70.58 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.742 -1.224 . . . . 0.0 113.363 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.1 p -67.99 -17.85 64.55 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.8 t -108.91 -41.57 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.581 1.552 . . . . 0.0 110.731 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.63 -30.76 77.68 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.844 1.211 . . . . 0.0 114.124 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.8 p -67.29 -19.0 65.43 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 171.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -87.51 -38.6 15.89 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.077 1.351 . . . . 0.0 112.168 169.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 69.1 mt -68.05 -37.13 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 124.558 1.143 . . . . 0.0 110.877 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -56.69 -45.79 99.9 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.535 1.534 . . . . 0.0 115.058 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -81.62 -32.78 0.78 Allowed 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 123.148 2.565 . . . . 0.0 113.69 170.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 56.9 p -73.18 -24.99 60.61 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 120.523 1.511 . . . . 0.0 114.127 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -58.83 -42.14 88.56 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.858 -1.151 . . . . 0.0 112.204 160.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.6 t -72.6 -31.53 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.467 -0.77 . . . . 0.0 111.862 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.401 ' HZ1' ' CG ' ' A' ' 114' ' ' ASP . 62.3 tttt -62.86 -47.24 84.24 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.004 0.82 . . . . 0.0 111.348 169.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -64.65 -39.82 94.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.157 0.983 . . . . 0.0 112.313 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 50.8 mt -68.42 -0.35 4.84 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.228 1.411 . . . . 0.0 114.736 168.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -142.56 36.58 1.47 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.116 1.766 . . . . 0.0 112.266 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.06 62.3 0.3 Allowed 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -166.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 90.8 mttt -63.75 -33.84 76.55 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.557 1.543 . . . . 0.0 110.957 158.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.401 ' CG ' ' HZ1' ' A' ' 108' ' ' LYS . 14.3 t0 -86.55 117.32 68.49 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 125.67 1.588 . . . . 0.0 107.941 158.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -51.95 149.65 20.06 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.421 2.747 . . . . 0.0 117.316 -159.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -70.39 -45.77 65.34 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.824 -172.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -68.3 -26.11 65.48 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.027 -1.671 . . . . 0.0 114.333 -172.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.62 -33.54 42.51 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 120.643 -1.285 . . . . 0.0 113.338 169.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 89.6 m -70.4 -35.37 73.42 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.422 1.089 . . . . 0.0 112.355 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -64.07 -39.85 94.99 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.546 1.539 . . . . 0.0 112.438 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -64.06 -46.7 83.2 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.517 0.599 . . . . 0.0 112.102 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.87 -36.25 83.3 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.4 tp -68.34 -42.34 79.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.25 1.02 . . . . 0.0 112.331 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 41.9 mt -66.66 -37.66 85.26 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.798 0.839 . . . . 0.0 113.253 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -69.99 -36.32 75.08 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.762 1.165 . . . . 0.0 112.786 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -72.79 -33.96 66.61 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 120.799 -1.188 . . . . 0.0 112.51 170.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.2 mt -63.43 -35.14 79.44 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.2 -1.563 . . . . 0.0 112.512 169.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -65.88 -40.38 91.53 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.31 1.414 . . . . 0.0 111.917 171.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.14 -35.92 82.36 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 118.435 0.562 . . . . 0.0 112.314 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.2 tp -69.57 -56.92 5.98 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.373 1.069 . . . . 0.0 111.468 170.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -66.41 -35.47 80.39 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.191 1.396 . . . . 0.0 114.028 -171.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.83 -34.81 79.53 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.207 0.908 . . . . 0.0 113.513 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -89.34 -30.47 18.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.446 0.699 . . . . 0.0 112.874 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.46 -33.77 76.29 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.807 -1.183 . . . . 0.0 113.449 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -64.88 -8.0 13.66 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 172.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.0 t -99.58 -35.16 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.915 1.286 . . . . 0.0 112.221 168.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -86.46 -28.41 23.5 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -173.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.63 -157.54 32.85 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 118.198 -1.335 . . . . 0.0 113.653 -173.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.8 -9.94 19.8 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.371 3.38 . . . . 0.0 117.473 -119.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -110.98 161.39 15.91 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 119.643 1.11 . . . . 0.0 111.323 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.08 -10.79 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 O-C-N 120.427 -1.421 . . . . 0.0 113.162 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -99.19 -2.04 37.78 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 161.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 107.25 -110.43 3.23 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 119.976 1.262 . . . . 0.0 113.652 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -73.49 -26.3 60.84 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -167.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.8 pttt -142.03 167.05 23.04 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.352 1.861 . . . . 0.0 111.163 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 26.2 mt -65.42 130.19 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.161 0.584 . . . . 0.0 109.997 163.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.8 p -135.07 -171.59 2.84 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.178 0.991 . . . . 0.0 110.866 166.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.96 -19.59 2.74 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.0 t -73.71 -43.35 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.877 1.217 . . . . 0.0 112.309 173.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.4 -46.02 91.91 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.994 -1.066 . . . . 0.0 112.113 168.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.3 mt -62.44 -17.9 60.45 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.334 0.654 . . . . 0.0 112.421 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 51.4 m -86.61 -50.92 6.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.931 0.892 . . . . 0.0 112.335 171.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.9 mt -90.54 -33.6 15.86 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -167.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.88 -49.6 92.82 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.86 -21.87 24.17 Favored 'Trans proline' 0 C--N 1.351 0.669 0 CA-C-N 121.144 1.444 . . . . 0.0 113.14 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -77.18 -28.66 54.09 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 117.584 -1.198 . . . . 0.0 112.549 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 53.7 mt -70.17 -39.22 75.42 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.758 0.823 . . . . 0.0 112.899 165.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -60.23 -46.75 88.69 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.885 0.766 . . . . 0.0 111.732 171.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -64.78 -23.71 67.33 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.951 0.9 . . . . 0.0 113.353 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 12.1 tp -80.05 -45.09 18.93 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.997 -1.064 . . . . 0.0 112.659 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.53 -37.25 86.9 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.177 0.899 . . . . 0.0 111.596 173.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.2 t -80.71 -63.92 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.51 -50.88 8.34 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.408 -0.808 . . . . 0.0 112.136 -162.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.35 -35.44 77.43 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.671 0.388 . . . . 0.0 111.382 174.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.16 -25.28 46.76 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.063 1.316 . . . . 0.0 115.7 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -65.34 -25.81 67.76 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -126.93 -18.87 4.56 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 21.8 tptt -147.76 80.55 1.49 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.895 2.078 . . . . 0.0 107.595 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -64.19 89.27 0.06 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.885 0.874 . . . . 0.0 110.669 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 33.3 t90 -88.29 117.37 68.31 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.073 0.949 . . . . 0.0 112.208 -162.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -73.58 112.53 3.55 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.199 1.933 . . . . 0.0 110.649 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 97.5 mt -71.77 108.34 3.92 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 159.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -68.55 161.01 46.92 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.415 1.41 . . . . 0.0 112.453 -166.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.32 -28.11 66.5 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.716 1.606 . . . . 0.0 114.063 -178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -68.16 -22.59 64.84 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.219 1.408 . . . . 0.0 114.086 173.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 71.0 mt -84.67 52.11 2.3 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.483 1.513 . . . . 0.0 110.36 165.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.0 m -63.27 -30.11 71.31 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.472 1.109 . . . . 0.0 112.601 -160.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 66.8 t-80 -77.24 -48.3 17.89 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.542 0.61 . . . . 0.0 111.534 173.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 66.0 t -60.36 -40.08 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 118.683 0.674 . . . . 0.0 111.618 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.0 tp -64.03 -43.24 96.16 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.338 1.055 . . . . 0.0 113.108 176.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -70.82 -32.99 70.22 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.372 -0.83 . . . . 0.0 112.838 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -63.31 -27.4 69.3 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.333 1.053 . . . . 0.0 112.843 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 29.2 mm -56.11 -34.82 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 120.868 -1.145 . . . . 0.0 111.935 169.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -90.91 -6.3 54.33 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.925 -1.109 . . . . 0.0 113.617 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 74.3 mt -73.43 -22.87 60.1 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 117.617 -1.182 . . . . 0.0 113.461 157.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 66.3 mt -62.57 -23.89 67.25 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.723 1.147 . . . . 0.0 113.283 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -96.11 9.01 42.27 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.514 1.126 . . . . 0.0 113.267 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.9 p -121.22 177.26 5.23 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.705 2.002 . . . . 0.0 113.417 -168.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.5 mtp85 54.88 -169.15 0.07 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.218 1.407 . . . . 0.0 110.276 -166.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.13 -34.22 37.94 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.05 -1.031 . . . . 0.0 110.17 159.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 77.6 p -72.45 -56.32 5.6 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.363 1.465 . . . . 0.0 114.115 -161.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -68.52 -44.56 74.38 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.984 0.811 . . . . 0.0 112.044 171.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -54.69 -34.23 62.03 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.69 1.196 . . . . 0.0 113.88 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -79.68 -14.85 58.47 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.5 p -79.88 -2.6 44.33 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.621 1.555 . . . . 0.0 113.93 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -68.91 75.93 0.31 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.235 1.814 . . . . 0.0 112.358 -173.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -59.34 132.19 53.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.263 0.625 . . . . 0.0 109.523 163.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -60.67 130.73 47.96 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.094 0.558 . . . . 0.0 112.024 -165.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -59.63 -39.72 85.26 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -160.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -62.31 -38.69 90.37 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.083 -1.01 . . . . 0.0 112.277 174.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -84.66 -5.93 59.34 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.308 1.443 . . . . 0.0 113.343 177.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 75.4 t -82.61 -46.8 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.982 0.913 . . . . 0.0 110.215 161.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.5 mt -61.89 -51.37 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.572 1.149 . . . . 0.0 111.845 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.73 -15.16 63.1 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.216 1.006 . . . . 0.0 113.693 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.47 -37.5 14.29 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 120.899 -1.125 . . . . 0.0 112.895 169.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 17.5 t90 -77.1 -35.49 56.4 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.186 1.794 . . . . 0.0 114.015 -174.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -49.56 -52.42 50.39 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.89 -24.5 39.9 Favored 'Trans proline' 0 C--N 1.353 0.799 0 CA-C-N 121.452 1.554 . . . . 0.0 113.461 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -78.29 -7.21 56.95 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 117.193 -1.384 . . . . 0.0 114.316 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.429 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 58.3 t -63.0 -30.83 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 120.037 1.29 . . . . 0.0 110.315 159.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -94.9 -34.66 12.34 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 115.745 1.758 . . . . 0.0 115.745 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 CA-C-O 117.604 -1.189 . . . . 0.0 113.163 172.516 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' GSH . . . . . 0.433 ' C1 ' ' H ' ' A' ' 73' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.576 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 81.4 mtp . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.647 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.57 178.4 0.16 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.116 1.766 . . . . 0.0 114.609 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 61.9 mt -101.59 142.15 33.39 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.807 1.243 . . . . 0.0 113.26 -170.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -129.04 145.89 51.15 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.617 1.567 . . . . 0.0 109.02 157.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.5 pt -130.65 136.84 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.604 1.162 . . . . 0.0 109.647 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.7 m -111.73 119.27 38.07 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.777 1.231 . . . . 0.0 109.085 173.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.3 m -134.87 162.9 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.255 1.422 . . . . 0.0 111.229 -166.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -61.5 120.99 11.6 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.374 -0.829 . . . . 0.0 112.108 -175.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -79.34 149.61 31.68 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.049 0.54 . . . . 0.0 111.603 159.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.63 134.28 52.94 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.014 0.911 . . . . 0.0 112.111 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.7 t -67.36 126.27 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 173.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.54 -14.62 22.97 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-O 118.587 -1.118 . . . . 0.0 115.605 -172.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.88 61.65 29.85 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 119.161 1.48 . . . . 0.0 112.13 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.418 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 57.9 Cg_endo -65.47 -6.89 14.53 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.966 2.444 . . . . 0.0 115.795 -167.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -80.9 -1.21 42.51 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.9 pt -131.83 164.97 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.731 1.212 . . . . 0.0 112.114 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.94 143.69 57.46 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.239 1.016 . . . . 0.0 111.409 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.9 -173.48 13.48 Favored Glycine 0 N--CA 1.471 0.991 0 C-N-CA 125.176 1.37 . . . . 0.0 113.905 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -60.55 106.5 0.56 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.6 t -165.07 97.86 0.84 Allowed Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.776 157.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -62.92 -21.09 72.93 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.244 1.963 . . . . 0.0 113.041 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -66.68 -29.66 69.72 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 120.655 -1.278 . . . . 0.0 113.59 171.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 98.8 m -71.47 -37.76 71.31 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.578 -1.326 . . . . 0.0 112.179 171.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.0 -24.29 67.85 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 117.95 -1.024 . . . . 0.0 112.875 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.483 HH12 ' CG ' ' A' ' 74' ' ' ASP . 53.5 mtp180 -57.78 -46.97 83.84 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.46 1.027 . . . . 0.0 112.389 170.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.5 t -74.67 -40.6 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.042 1.337 . . . . 0.0 111.31 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.4 mt -61.38 -42.73 99.19 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.251 0.621 . . . . 0.0 111.545 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.1 tp -61.68 -49.12 77.77 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.076 0.95 . . . . 0.0 112.083 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.75 -43.2 69.31 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -174.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.66 -38.92 84.43 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.571 -0.706 . . . . 0.0 112.46 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -80.17 -20.09 45.63 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -69.79 -48.93 57.35 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.798 -1.189 . . . . 0.0 110.641 166.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -70.26 -9.61 56.47 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.46 1.904 . . . . 0.0 114.23 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm 61.85 18.92 10.2 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.48 1.912 . . . . 0.0 115.01 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -75.25 131.59 77.87 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 123.941 0.896 . . . . 0.0 109.613 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -74.66 143.71 30.65 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.662 2.242 . . . . 0.0 112.496 174.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -146.11 151.52 37.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.849 1.66 . . . . 0.0 110.072 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -78.66 130.59 36.04 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.318 -0.863 . . . . 0.0 109.196 163.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 t -111.92 108.64 18.07 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.535 0.734 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -100.79 112.46 24.87 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.728 1.211 . . . . 0.0 109.966 -177.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.13 112.13 13.47 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.156 0.982 . . . . 0.0 110.263 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.4 mm -102.29 116.04 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.321 1.048 . . . . 0.0 110.4 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -77.15 57.7 1.46 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.163 1.385 . . . . 32.609999999999999 111.977 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.14 4.59 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 120.083 3.364 . . . . 40.049999999999997 120.083 -154.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -69.3 -46.46 56.92 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 120.905 1.684 . . . . 41.469999999999999 110.871 156.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -93.03 63.02 3.67 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.214 2.606 . . . . 47.170000000000002 110.629 168.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 pttm -79.78 119.01 75.38 Favored Pre-proline 0 N--CA 1.476 0.827 0 O-C-N 119.921 -1.737 . . . . 41.270000000000003 111.386 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -64.13 155.7 63.4 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.699 2.266 . . . . 40.289999999999999 114.182 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tp60 -62.27 -39.48 93.05 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.672 0.99 . . . . 42.390000000000001 113.672 174.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -64.73 -23.95 67.41 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.069 0.766 . . . . 37.079999999999998 113.069 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -83.27 -32.13 26.57 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.655 0.782 . . . . 35.880000000000003 112.536 172.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.2 mt -67.26 -26.47 66.58 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.159 0.89 . . . . 33.609999999999999 112.672 170.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -71.63 -8.11 52.03 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.883 1.273 . . . . 33.789999999999999 113.858 168.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.7 mt -106.46 -44.65 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.597 1.559 . . . . 33.159999999999997 110.603 171.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.6 t -112.25 98.79 44.35 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 125.792 1.637 . . . . 33.579999999999998 110.956 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.49 -18.18 43.53 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.364 2.043 . . . . 37.899999999999999 113.408 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -83.75 -8.71 59.19 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.727 1.01 . . . . 38.990000000000002 113.727 170.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.93 8.57 49.54 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 120.87 -1.144 . . . . 35.469999999999999 115.067 -169.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -84.71 157.8 20.97 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.267 1.427 . . . . 34.490000000000002 112.491 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.2 m -113.58 156.22 43.78 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 126.383 1.873 . . . . 23.530000000000001 110.592 160.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -66.12 156.81 80.17 Favored 'Cis proline' 0 C--N 1.348 0.501 0 CA-C-O 122.015 0.756 . . . . 22.879999999999999 112.403 -10.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.4 p -141.05 147.26 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 159.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.11 163.71 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 121.43 -0.794 . . . . 0.0 110.611 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.1 mtpt -121.27 92.1 3.67 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.181 1.393 . . . . 0.0 109.054 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.3 mt -82.09 119.67 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.688 0.795 . . . . 0.0 108.907 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.576 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 0.9 OUTLIER 52.75 38.82 27.41 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 122.284 1.04 . . . . 0.0 112.675 -165.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.3 t70 66.11 12.7 8.68 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.063 2.145 . . . . 0.0 116.476 -172.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -110.84 127.8 55.55 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 119.8 -1.813 . . . . 0.0 111.651 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -66.69 144.66 56.23 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -167.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.7 t -143.25 128.35 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.625 1.97 . . . . 0.0 108.593 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -112.69 166.5 11.29 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.746 1.618 . . . . 0.0 112.24 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.0 t0 65.11 113.62 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.821 2.449 . . . . 22.16 114.067 -175.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.443 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 39.7 p -62.74 -21.65 65.97 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 115.274 1.583 . . . . 21.16 115.274 -166.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.483 ' CG ' HH12 ' A' ' 25' ' ' ARG . 30.0 m-20 -71.46 -38.17 71.31 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.843 1.201 . . . . 24.969999999999999 113.056 169.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.1 t -70.49 -40.07 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.16 -0.962 . . . . 23.850000000000001 110.842 172.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.58 -48.62 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.955 0.902 . . . . 23.68 111.15 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.74 -38.54 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.611 0.764 . . . . 22.84 111.547 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.37 -39.95 95.42 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.531 -0.594 . . . . 23.329999999999998 113.596 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.7 mt -76.87 -48.22 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 118.379 1.09 . . . . 23.309999999999999 111.638 174.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.7 mt -62.32 -33.32 74.46 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.747 1.158 . . . . 23.48 113.399 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -92.66 -3.18 55.33 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 115.229 1.566 . . . . 24.239999999999998 115.229 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -108.56 -35.43 6.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.913 1.285 . . . . 39.259999999999998 112.489 169.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -125.47 70.98 1.19 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.513 1.525 . . . . 24.449999999999999 111.628 -167.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -136.99 167.59 20.4 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.641 1.976 . . . . 0.0 109.373 168.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.38 -33.44 38.16 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.677 1.585 . . . . 0.0 112.336 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -75.15 151.99 86.09 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.282 1.033 . . . . 0.0 111.976 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.2 144.62 29.11 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.543 2.829 . . . . 0.0 115.215 -176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.62 136.92 34.62 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.562 2.175 . . . . 0.0 112.249 -174.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.3 mt -108.55 8.18 27.09 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.934 1.294 . . . . 0.0 111.944 167.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.55 46.33 0.07 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.42 2.288 . . . . 0.0 112.696 163.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.1 p -123.9 67.52 42.16 Favored Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 125.452 1.501 . . . . 0.0 109.8 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.86 119.61 6.65 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.232 1.955 . . . . 0.0 109.951 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.97 -173.88 1.84 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.213 2.609 . . . . 0.0 111.775 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.3 mp0 -51.2 -33.89 29.47 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.65 2.38 . . . . 0.0 113.333 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -52.53 -28.87 22.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.913 1.685 . . . . 0.0 114.119 173.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.99 -28.97 70.17 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.931 -1.105 . . . . 0.0 113.513 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.6 p -67.53 -19.92 65.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.461 1.105 . . . . 0.0 113.568 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.6 t -102.0 -42.79 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.481 1.513 . . . . 0.0 110.68 175.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.27 -31.67 81.52 Favored Glycine 0 CA--C 1.532 1.102 0 O-C-N 120.842 -1.161 . . . . 0.0 114.594 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.2 p -66.24 -19.05 65.71 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -87.78 -39.26 15.04 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.934 1.294 . . . . 0.0 112.549 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.5 mt -66.37 -34.72 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.942 0.897 . . . . 0.0 110.906 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -56.13 -48.91 95.87 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 117.452 -1.261 . . . . 0.0 114.189 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.42 -31.56 2.66 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.926 2.417 . . . . 0.0 114.316 170.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 p -70.84 -27.8 64.12 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 121.279 1.854 . . . . 0.0 113.281 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -57.83 -47.8 81.61 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.107 -0.996 . . . . 0.0 112.084 161.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.73 -34.93 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 119.114 0.87 . . . . 0.0 111.918 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -63.09 -45.21 93.17 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.677 0.671 . . . . 0.0 111.464 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -64.12 -39.02 93.13 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.765 0.826 . . . . 0.0 112.44 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.559 HD13 ' CD2' ' A' ' 159' ' ' HIS . 11.6 mt -69.86 -7.36 39.51 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.979 1.711 . . . . 0.0 115.124 170.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -139.88 41.17 1.98 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.287 1.835 . . . . 0.0 111.663 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.4 m -68.46 56.47 0.08 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.285 1.834 . . . . 0.0 115.738 -168.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -69.38 -35.69 76.06 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.88 1.272 . . . . 0.0 111.265 165.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -81.87 114.82 53.25 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 153.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -54.71 154.19 21.56 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.192 2.594 . . . . 0.0 117.093 -154.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -69.34 -37.31 77.61 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 117.278 -1.344 . . . . 0.0 112.4 -172.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -67.3 -37.78 83.93 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 121.157 1.799 . . . . 0.0 113.825 -171.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.57 -31.54 60.63 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 120.645 -1.285 . . . . 0.0 112.905 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 91.7 m -69.77 -31.68 69.76 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.913 0.885 . . . . 0.0 112.62 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -70.31 -41.08 73.77 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 127.206 2.202 . . . . 0.0 111.953 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.29 -47.09 83.78 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.802 -0.561 . . . . 0.0 111.878 170.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.41 -31.27 72.38 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.6 tp -73.71 -45.36 52.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.669 1.188 . . . . 0.0 112.086 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 49.0 mt -64.67 -38.82 92.29 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.185 0.994 . . . . 0.0 113.126 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -69.99 -37.58 75.76 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 120.113 1.324 . . . . 0.0 113.275 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -74.28 -30.97 62.34 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.588 -1.32 . . . . 0.0 112.433 170.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.3 mt -64.87 -32.68 74.49 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.235 -1.541 . . . . 0.0 112.958 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -67.38 -40.68 85.7 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 120.298 1.408 . . . . 0.0 111.66 170.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.65 -32.76 73.87 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.97 0.508 . . . . 0.0 112.343 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.9 tp -71.56 -58.47 3.47 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.011 0.924 . . . . 0.0 111.538 169.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -67.28 -31.39 71.68 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -169.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.99 -31.87 69.47 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 119.248 -0.751 . . . . 0.0 113.401 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -91.6 -28.83 17.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.695 0.798 . . . . 0.0 113.033 173.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.11 -36.61 84.18 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.804 1.184 . . . . 0.0 112.456 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -67.67 -3.14 8.23 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 173.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.0 t -100.78 -38.38 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.876 1.27 . . . . 0.0 112.122 166.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -91.89 -22.93 19.8 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -171.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.9 -141.34 31.57 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 118.527 -1.152 . . . . 0.0 113.735 -175.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.7 -10.47 28.7 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 125.056 3.838 . . . . 0.0 117.728 -114.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -123.16 169.26 11.42 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.931 1.292 . . . . 0.0 111.791 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -72.68 -7.16 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 120.411 -1.431 . . . . 0.0 112.828 178.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.58 16.9 21.87 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.075 1.75 . . . . 0.0 114.079 162.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.25 -109.53 3.39 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.534 1.064 . . . . 0.0 113.627 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -55.84 -39.77 71.9 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.462 1.505 . . . . 0.0 113.736 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -147.46 166.38 27.42 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.032 1.733 . . . . 0.0 110.638 -168.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 16.8 mt -61.92 135.34 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 120.89 0.376 . . . . 0.0 110.117 163.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.1 p -136.76 -170.86 2.78 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.311 1.044 . . . . 0.0 110.439 163.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.79 -19.66 4.62 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.5 t -69.97 -46.4 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 120.169 1.35 . . . . 0.0 111.836 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.6 -46.49 89.64 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.855 1.262 . . . . 0.0 112.312 172.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.6 mt -64.08 -8.87 13.33 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.781 0.832 . . . . 0.0 112.839 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.1 m -101.03 -47.6 4.71 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.668 1.187 . . . . 0.0 112.564 173.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 38.3 mt -90.78 -35.0 15.1 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -170.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.0 97.32 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -173.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.78 -20.55 17.31 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 120.741 1.301 . . . . 0.0 113.448 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -75.91 -31.16 59.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 117.411 -1.281 . . . . 0.0 112.322 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 77.0 mt -64.97 -40.29 94.77 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.054 0.843 . . . . 0.0 112.726 166.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -60.75 -46.36 90.74 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.416 0.627 . . . . 0.0 111.711 173.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.559 ' CD2' HD13 ' A' ' 110' ' ' LEU . 68.6 t60 -66.6 -22.97 66.12 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 125.123 1.369 . . . . 0.0 113.421 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.4 mt -72.31 -58.48 3.37 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.072 1.306 . . . . 0.0 113.097 165.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -61.73 -31.81 72.0 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 118.646 0.657 . . . . 0.0 111.509 -173.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 93.9 t -86.74 -64.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 124.548 1.139 . . . . 0.0 112.907 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.66 -55.65 4.51 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.715 -0.616 . . . . 0.0 112.197 -160.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.1 tp -61.98 -32.56 73.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.62 0.368 . . . . 0.0 111.642 170.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -55.46 -27.13 47.06 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.201 1.382 . . . . 0.0 115.793 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -65.98 -24.43 66.78 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -125.34 -19.43 5.07 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -144.87 82.58 1.68 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.507 1.923 . . . . 0.0 108.254 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -61.38 90.02 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.535 1.134 . . . . 0.0 110.482 171.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -92.81 116.77 67.04 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.696 0.799 . . . . 0.0 111.907 -163.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.4 117.33 5.03 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.701 1.6 . . . . 0.0 110.319 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.78 109.93 4.64 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 149.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -66.62 164.38 29.23 Favored 'Trans proline' 0 C--N 1.35 0.643 0 CA-C-N 120.74 1.3 . . . . 0.0 112.488 -165.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -25.94 63.92 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.807 1.643 . . . . 0.0 113.911 177.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -70.55 -24.51 62.8 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.998 1.719 . . . . 0.0 114.283 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.3 mt -86.98 50.47 2.02 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.833 1.653 . . . . 0.0 110.251 166.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.6 m -59.65 -36.67 76.86 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.954 1.302 . . . . 0.0 113.03 -156.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -81.75 -38.94 24.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.874 -0.584 . . . . 0.0 112.091 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.72 -39.36 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 121.622 -0.673 . . . . 0.0 111.785 172.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 46.5 tp -63.61 -45.7 89.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.989 0.916 . . . . 0.0 112.697 175.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -66.52 -32.07 73.2 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.315 -0.866 . . . . 0.0 112.639 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -63.65 -28.82 70.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.729 0.812 . . . . 0.0 112.89 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 18.7 mt -58.36 -35.54 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 120.65 -1.281 . . . . 0.0 111.234 171.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -84.6 -9.72 58.04 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.461 -1.399 . . . . 0.0 113.998 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.99 -22.01 62.23 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.107 -0.949 . . . . 0.0 113.178 160.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 56.4 mt -65.29 -18.81 65.61 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.628 1.104 . . . . 0.0 113.754 -177.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -98.56 6.93 46.73 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.833 1.253 . . . . 0.0 112.933 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.8 p -117.68 -179.44 3.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.322 1.849 . . . . 0.0 113.715 -165.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 53.97 -162.27 0.12 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.567 1.547 . . . . 0.0 110.8 -169.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 10.8 mp0 -82.99 -38.12 23.08 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 124.118 0.967 . . . . 0.0 109.241 159.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 77.5 p -71.05 -60.51 2.19 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 126.093 1.757 . . . . 0.0 114.086 -161.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -63.82 -44.28 93.72 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.506 0.593 . . . . 0.0 112.175 173.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -55.41 -36.62 66.65 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.085 0.954 . . . . 0.0 113.334 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -76.75 -15.47 59.75 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.6 p -76.28 -11.74 59.96 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.513 1.506 . . . . 0.0 113.088 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -65.45 89.49 0.1 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.687 1.595 . . . . 0.0 112.609 -168.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.64 131.32 48.59 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.665 -0.683 . . . . 0.0 109.308 155.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.75 135.23 57.52 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.384 0.674 . . . . 0.0 111.78 -174.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -60.74 -37.6 82.33 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -157.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -38.2 87.14 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.935 -1.103 . . . . 0.0 113.149 172.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -76.81 -7.72 55.97 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 171.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.9 t -82.89 -49.56 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.774 0.83 . . . . 0.0 110.612 161.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 37.5 mt -59.92 -48.32 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.342 1.057 . . . . 0.0 111.5 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.25 -14.44 62.61 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -89.09 -33.67 9.42 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 120.917 -1.114 . . . . 0.0 113.364 170.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 42.4 t90 -78.95 -34.02 44.77 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.837 1.655 . . . . 0.0 113.885 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -51.34 -50.33 76.8 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.19 -24.92 27.17 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 121.637 1.558 . . . . 0.0 113.49 172.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -78.18 -10.39 59.62 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.147 1.379 . . . . 0.0 114.267 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.74 -31.03 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 119.249 0.931 . . . . 0.0 110.389 158.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -96.38 -20.12 18.7 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 177.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 C-N-CA 125.707 1.603 . . . . 0.0 112.629 -176.268 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' GSH . . . . . 0.443 ' C1 ' ' H ' ' A' ' 73' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.583 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 86.4 mtp . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 117.203 -1.38 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.03 177.91 0.17 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.11 1.764 . . . . 0.0 115.469 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.5 mt -111.85 139.63 47.17 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.421 1.488 . . . . 0.0 111.999 -175.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -139.78 134.88 32.42 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.984 1.313 . . . . 0.0 108.136 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.8 pt -127.57 142.34 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 120.999 -1.063 . . . . 0.0 110.5 -174.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.9 m -117.58 120.25 37.47 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.757 1.223 . . . . 0.0 109.689 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.27 163.03 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.998 1.319 . . . . 0.0 111.517 -165.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -59.54 116.2 3.83 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.609 -0.682 . . . . 0.0 110.865 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.482 ' HB1' ' HA ' ' A' ' 14' ' ' PRO . . . -78.06 149.78 33.89 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.935 154.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.05 146.88 49.02 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.203 1.002 . . . . 0.0 112.197 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 51.3 t -68.87 133.75 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 167.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.38 -33.9 1.56 Allowed Glycine 0 CA--C 1.537 1.453 0 CA-C-O 118.516 -1.158 . . . . 0.0 115.357 -174.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.13 69.03 9.75 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.824 1.25 . . . . 0.0 112.61 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.482 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 58.7 Cg_endo -63.41 -11.84 27.74 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.271 2.647 . . . . 0.0 114.816 -173.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -81.4 0.65 36.51 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.063 1.745 . . . . 0.0 114.737 175.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 pt -133.96 164.76 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.795 1.238 . . . . 0.0 111.801 174.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.39 146.7 54.56 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.59 0.756 . . . . 0.0 111.454 169.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -124.2 -164.28 11.92 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 125.25 1.405 . . . . 0.0 112.494 166.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -60.89 108.67 0.89 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 118.22 1.01 . . . . 0.0 113.593 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.1 t -157.63 108.26 1.81 Allowed Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.119 139.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.54 -21.5 59.78 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.14 1.893 . . . . 0.0 112.39 176.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -68.5 -29.9 68.61 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.61 0.764 . . . . 0.0 112.297 173.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 73.1 m -72.26 -37.58 69.05 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.372 -1.455 . . . . 0.0 112.669 168.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.53 -25.13 67.09 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 118.112 -0.947 . . . . 0.0 113.141 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.506 HH12 ' CG ' ' A' ' 74' ' ' ASP . 32.8 mtp180 -58.61 -43.3 89.56 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.319 1.048 . . . . 0.0 112.407 169.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.2 t -76.98 -37.43 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.855 1.262 . . . . 0.0 111.302 -176.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.55 -45.26 91.33 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.138 0.575 . . . . 0.0 111.478 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.68 -50.91 69.28 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.827 1.251 . . . . 0.0 112.408 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 p -63.08 -50.5 70.31 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.6 -35.8 73.18 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -76.53 -23.18 53.64 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 171.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -68.86 -46.23 69.01 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 120.072 1.305 . . . . 0.0 110.983 170.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -70.35 -7.24 41.18 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.48 1.512 . . . . 0.0 114.92 169.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.9 mmtm 61.46 15.39 6.61 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 126.032 1.733 . . . . 0.0 114.863 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.7 mt -72.69 128.6 88.1 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 123.598 0.759 . . . . 0.0 109.306 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.44 138.12 32.03 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.183 1.922 . . . . 0.0 111.516 175.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -141.67 153.44 44.7 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.231 1.412 . . . . 0.0 110.556 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -78.22 122.8 26.16 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.317 -0.864 . . . . 0.0 109.804 166.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.3 t -97.74 93.79 6.58 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.593 0.757 . . . . 0.0 111.559 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -82.83 105.68 14.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.903 0.881 . . . . 0.0 110.292 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.1 mt -73.24 113.95 10.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.944 0.898 . . . . 0.0 109.918 171.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.2 mm -108.97 115.8 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.739 1.216 . . . . 0.0 110.086 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -73.98 79.58 1.68 Allowed 'General case' 0 C--O 1.221 -0.411 0 O-C-N 121.4 -0.813 . . . . 32.609999999999999 109.756 166.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pp -65.05 0.7 1.17 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 117.601 2.445 . . . . 40.049999999999997 117.601 -165.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.51 -27.6 67.26 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-N 119.612 1.096 . . . . 41.469999999999999 112.871 161.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -120.45 53.91 1.08 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.934 2.894 . . . . 47.170000000000002 109.529 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -73.06 116.48 51.0 Favored Pre-proline 0 N--CA 1.472 0.667 0 O-C-N 119.757 -1.839 . . . . 41.270000000000003 110.317 -176.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.22 160.58 46.83 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.648 2.232 . . . . 40.289999999999999 112.144 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -61.46 -34.03 74.75 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.302 1.223 . . . . 42.390000000000001 114.302 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 30.5 p-90 -67.5 -21.37 65.5 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.691 -1.256 . . . . 37.079999999999998 114.097 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -82.74 -34.42 27.17 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.425 -0.797 . . . . 35.880000000000003 112.321 169.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.78 -24.97 65.38 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.551 0.74 . . . . 33.609999999999999 112.385 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -72.73 -1.45 16.47 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.794 1.637 . . . . 33.789999999999999 114.376 166.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.6 mt -115.73 -41.7 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 125.348 1.459 . . . . 33.159999999999997 110.314 173.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.1 t -114.43 100.4 52.9 Favored Pre-proline 0 N--CA 1.471 0.591 0 C-N-CA 125.808 1.643 . . . . 33.579999999999998 111.281 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.99 -20.55 44.53 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.941 2.428 . . . . 37.899999999999999 113.418 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.76 -0.08 57.52 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.396 1.079 . . . . 38.990000000000002 113.716 171.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.92 23.68 72.78 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.607 1.575 . . . . 35.469999999999999 115.866 176.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -104.15 158.63 16.31 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.889 1.675 . . . . 34.490000000000002 112.789 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.3 m -115.24 150.08 43.8 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.648 1.579 . . . . 23.530000000000001 111.151 164.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -68.46 153.62 89.27 Favored 'Cis proline' 0 C--N 1.349 0.562 0 CA-C-O 121.724 0.635 . . . . 22.879999999999999 112.629 -9.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.1 p -135.63 147.77 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 113.577 -1.647 . . . . 0.0 107.294 156.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.7 m -129.69 161.75 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.654 0.781 . . . . 0.0 110.474 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -116.03 98.93 6.91 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.428 1.491 . . . . 0.0 109.118 167.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 66.8 mt -87.49 114.85 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.415 1.086 . . . . 0.0 108.536 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.583 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 0.9 OUTLIER 56.58 36.84 28.23 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 121.866 0.841 . . . . 0.0 112.457 -169.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . 0.251 11.2 t0 66.77 10.72 7.75 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 128.292 2.637 . . . . 0.0 116.316 -170.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -104.12 123.18 46.8 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 119.412 -2.055 . . . . 0.0 110.688 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -69.36 143.49 53.71 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -170.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.4 t -142.86 126.66 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 126.695 1.998 . . . . 0.0 108.585 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -110.38 164.95 12.18 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.62 1.568 . . . . 0.0 112.136 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.2 t0 67.57 113.45 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.342 2.257 . . . . 22.16 114.191 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.495 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 26.5 p -65.16 -22.14 66.88 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 115.356 1.613 . . . . 21.16 115.356 -158.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.506 ' CG ' HH12 ' A' ' 25' ' ' ARG . 33.8 m-20 -70.47 -35.68 73.43 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.899 1.227 . . . . 24.969999999999999 112.696 170.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.62 -41.71 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 121.092 -1.005 . . . . 23.850000000000001 110.745 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 90.0 mt -63.75 -46.5 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.841 0.856 . . . . 23.68 111.227 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.1 t -63.15 -40.54 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.021 0.928 . . . . 22.84 111.314 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.19 -47.26 89.06 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 118.462 0.574 . . . . 23.329999999999998 113.1 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 75.9 mt -73.43 -47.24 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 117.846 0.823 . . . . 23.309999999999999 112.165 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.56 -32.23 73.79 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.046 1.294 . . . . 23.48 112.748 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -89.57 -14.37 35.21 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 114.614 1.338 . . . . 24.239999999999998 114.614 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.534 ' CD ' ' HE3' ' A' ' 83' ' ' LYS . 68.8 tt0 -89.54 -33.57 16.69 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.283 1.433 . . . . 39.259999999999998 112.606 165.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.534 ' HE3' ' CD ' ' A' ' 82' ' ' GLU . 65.2 mttt -135.3 85.33 2.16 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.619 1.168 . . . . 24.449999999999999 112.09 -161.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -150.42 166.02 16.09 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.149 1.78 . . . . 0.0 109.191 168.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -65.76 -33.36 44.31 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 121.919 1.746 . . . . 0.0 112.103 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -73.95 149.31 87.56 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.231 1.012 . . . . 0.0 111.649 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -52.31 143.02 44.96 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.408 2.739 . . . . 0.0 115.02 -172.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.98 133.49 29.22 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.673 2.249 . . . . 0.0 111.934 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 34.1 mt -103.34 8.51 38.16 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.608 1.163 . . . . 0.0 111.83 168.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.49 49.17 0.11 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.281 1.832 . . . . 0.0 112.373 163.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.7 p -123.31 65.07 29.47 Favored Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 125.381 1.473 . . . . 0.0 109.885 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.76 119.83 6.85 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.181 1.921 . . . . 0.0 109.962 -173.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -73.89 -176.37 2.57 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.917 2.412 . . . . 0.0 111.532 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.3 mp0 -53.93 -29.23 41.46 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.184 2.194 . . . . 0.0 113.5 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -52.72 -28.5 22.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.8 1.64 . . . . 0.0 114.045 170.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.64 -29.41 70.65 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.658 1.117 . . . . 0.0 113.358 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 59.7 p -66.9 -25.16 66.25 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.789 0.836 . . . . 0.0 113.097 174.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.0 t -94.87 -42.04 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.978 1.311 . . . . 0.0 110.814 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.47 -31.09 79.58 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.7 1.143 . . . . 0.0 114.421 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 72.3 p -66.35 -20.6 66.13 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.762 1.281 . . . . 0.0 114.211 171.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -92.2 -33.26 14.76 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.113 1.365 . . . . 0.0 112.827 172.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.8 mt -70.45 -37.09 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.986 0.914 . . . . 0.0 111.655 174.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.453 ' CE1' ' HE2' ' A' ' 156' ' ' LYS . 83.0 t80 -54.68 -45.85 99.47 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.032 1.333 . . . . 0.0 114.505 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.78 -32.52 1.09 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.016 2.478 . . . . 0.0 114.069 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.2 p -71.76 -26.62 62.52 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 121.34 1.882 . . . . 0.0 113.207 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -58.4 -45.89 87.47 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.695 -1.253 . . . . 0.0 112.413 160.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.46 -31.72 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 121.374 -0.828 . . . . 0.0 112.069 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -64.67 -44.15 91.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.689 0.677 . . . . 0.0 111.365 168.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -67.79 -37.1 81.57 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.5 mt -64.21 -11.32 29.91 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.787 1.635 . . . . 0.0 114.435 167.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -142.31 41.03 1.62 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.641 1.976 . . . . 0.0 112.543 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.1 m -68.6 59.73 0.09 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -165.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 94.4 mttt -71.28 -35.75 71.44 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.562 -1.336 . . . . 0.0 111.995 168.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 15.4 t0 -81.01 112.78 35.4 Favored Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 152.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 114' ' ' ASP . 95.9 Cg_exo -57.24 158.68 17.62 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.977 2.451 . . . . 0.0 117.29 -148.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -56.91 -51.64 68.32 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.478 -174.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -79.67 -21.67 44.45 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -163.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.89 -36.08 29.5 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 121.355 -0.841 . . . . 0.0 112.772 165.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 62.3 m -66.81 -30.89 71.2 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.641 0.776 . . . . 0.0 112.799 171.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -65.24 -42.69 93.12 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 125.736 1.614 . . . . 0.0 111.841 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -65.62 -43.13 90.5 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.724 -0.61 . . . . 0.0 111.766 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.05 -25.68 68.22 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 174.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 49.8 tp -82.47 -42.63 18.24 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.848 1.259 . . . . 0.0 112.27 172.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 33.9 mt -67.23 -39.17 86.19 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.668 1.187 . . . . 0.0 113.241 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -67.01 -34.97 78.89 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.046 1.293 . . . . 0.0 112.389 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -72.29 -38.55 68.73 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.027 -1.046 . . . . 0.0 112.765 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.1 mt -64.98 -33.14 75.32 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.585 -1.322 . . . . 0.0 113.03 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -66.4 -41.38 89.39 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.673 1.124 . . . . 0.0 111.51 171.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.8 -35.82 81.85 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.965 0.506 . . . . 0.0 112.203 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.4 tp -68.67 -56.45 8.14 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.068 0.947 . . . . 0.0 111.677 171.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -67.43 -31.63 71.95 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.71 1.204 . . . . 0.0 114.157 -172.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.21 -31.63 73.96 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.154 -0.803 . . . . 0.0 113.543 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -87.45 -33.71 18.95 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 117.888 0.844 . . . . 0.0 112.804 170.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.77 -34.91 78.23 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.041 1.291 . . . . 0.0 113.259 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -68.5 0.93 3.47 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 172.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.8 t -111.07 -37.42 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.599 1.559 . . . . 0.0 112.108 166.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -90.55 -17.16 27.49 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -172.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.98 -143.66 32.5 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-O 118.725 -1.041 . . . . 0.0 114.586 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.35 -18.45 49.91 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 124.794 3.663 . . . . 0.0 117.772 -119.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -118.16 171.03 8.39 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.399 1.08 . . . . 0.0 111.552 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.88 -6.04 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 120.146 -1.597 . . . . 0.0 113.037 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -108.82 15.15 23.78 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.258 1.823 . . . . 0.0 114.301 162.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.81 -108.14 3.03 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 120.564 -1.335 . . . . 0.0 113.242 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -51.72 -41.61 61.64 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.882 1.673 . . . . 0.0 113.887 -172.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -152.93 165.25 36.1 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.868 1.667 . . . . 0.0 110.233 -166.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.9 mt -64.75 132.39 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.195 0.598 . . . . 0.0 109.939 166.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.5 p -138.91 -170.72 2.92 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.843 1.257 . . . . 0.0 110.699 168.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.05 -17.49 3.98 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.1 t -71.03 -45.06 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 119.978 1.263 . . . . 0.0 111.795 172.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.88 -45.72 92.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.859 1.264 . . . . 0.0 111.905 172.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.66 -17.34 60.32 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.216 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.8 m -91.65 -48.05 7.04 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.861 1.21 . . . . 0.0 112.619 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.6 mt -94.49 -36.84 11.68 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -167.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.52 -47.86 97.7 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.22 -21.14 20.54 Favored 'Trans proline' 0 C--N 1.351 0.682 0 CA-C-N 120.808 1.324 . . . . 0.0 113.426 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.453 ' HE2' ' CE1' ' A' ' 103' ' ' PHE . 67.5 mttm -81.0 -27.81 35.74 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.907 -1.121 . . . . 0.0 112.89 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.8 mt -64.83 -43.33 93.42 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.364 0.665 . . . . 0.0 112.204 164.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -59.7 -44.68 93.59 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.225 0.466 . . . . 0.0 111.877 172.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -63.9 -31.37 72.53 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 71.6 mt -74.01 -49.01 26.28 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 118.004 -0.998 . . . . 0.0 113.488 171.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -61.4 -31.1 71.01 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.219 0.918 . . . . 0.0 112.203 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 95.6 t -88.95 -66.97 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.812 1.245 . . . . 0.0 113.27 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.59 -48.78 8.04 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -160.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 30.8 tp -62.83 -33.39 75.13 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.614 166.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -55.05 -28.65 49.69 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.937 1.256 . . . . 0.0 115.713 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -66.17 -22.23 66.36 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -128.04 -22.2 3.52 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -142.79 86.1 1.92 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.378 1.871 . . . . 0.0 108.486 167.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -61.58 86.03 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.178 1.391 . . . . 0.0 110.947 171.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -88.64 121.5 69.97 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.789 -163.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.71 109.93 2.77 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.579 1.519 . . . . 0.0 110.147 170.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.3 mm -59.36 108.34 1.33 Allowed Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 142.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -68.35 164.93 30.62 Favored 'Trans proline' 0 C--N 1.35 0.642 0 CA-C-N 120.553 1.233 . . . . 0.0 112.638 -165.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.52 -24.79 63.95 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.269 1.427 . . . . 0.0 113.27 171.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -66.39 -26.86 67.45 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.834 1.253 . . . . 0.0 113.775 171.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 67.6 mt -87.25 49.68 1.86 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.715 1.606 . . . . 0.0 111.065 169.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.23 -33.47 74.66 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.282 1.033 . . . . 0.0 113.343 -155.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -81.63 -37.66 27.2 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.785 0.721 . . . . 0.0 112.115 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.67 -39.57 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 121.587 -0.696 . . . . 0.0 111.613 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 43.0 tp -65.67 -40.24 92.16 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -68.48 -38.52 81.1 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.546 -0.721 . . . . 0.0 112.323 171.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -63.78 -29.38 70.59 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.252 1.021 . . . . 0.0 113.292 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 78.1 mt -59.07 -32.05 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 120.548 -1.345 . . . . 0.0 111.856 170.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -84.45 -10.68 57.29 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.473 -1.392 . . . . 0.0 113.607 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.94 -17.65 61.46 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.581 161.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.43 -14.26 61.93 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.671 1.123 . . . . 0.0 113.244 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -103.89 5.61 35.85 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.902 1.281 . . . . 0.0 113.316 174.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.6 p -111.33 -179.05 3.61 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.11 2.164 . . . . 0.0 113.964 -167.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 54.12 -159.72 0.16 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.489 1.516 . . . . 0.0 110.628 -172.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.502 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 5.7 mp0 -85.8 -41.01 15.42 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.781 1.232 . . . . 0.0 109.139 160.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 78.4 p -68.55 -60.42 2.43 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 126.293 1.837 . . . . 0.0 114.436 -162.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -62.25 -45.37 93.61 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.518 0.599 . . . . 0.0 112.085 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -56.86 -35.48 68.93 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.304 1.042 . . . . 0.0 113.457 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -76.9 -13.45 59.99 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 176.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.6 p -77.83 -10.77 59.73 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.402 1.455 . . . . 0.0 113.384 171.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -67.24 83.31 0.14 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.683 1.593 . . . . 0.0 112.852 -170.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.26 131.02 49.03 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.298 1.039 . . . . 0.0 109.919 161.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -59.27 129.96 44.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.317 0.647 . . . . 0.0 111.346 -171.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 31.0 mp0 -59.08 -39.14 81.21 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -157.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -60.39 -36.95 79.29 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.872 1.269 . . . . 0.0 112.687 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -85.12 -6.69 59.29 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.568 1.547 . . . . 0.0 113.092 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 39.6 t -86.79 -44.5 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.215 162.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 28.1 mt -58.18 -51.2 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.696 1.199 . . . . 0.0 111.347 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.76 -15.0 62.64 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -83.78 -33.25 22.11 Favored Glycine 0 CA--C 1.533 1.216 0 O-C-N 120.874 -1.141 . . . . 0.0 113.175 169.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 44.9 t90 -84.93 -35.26 22.21 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.121 2.169 . . . . 0.0 114.675 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -53.42 -47.35 96.56 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -175.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.9 -24.27 29.2 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.498 1.466 . . . . 0.0 113.656 172.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -75.48 -11.68 60.08 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 117.672 -1.156 . . . . 0.0 114.014 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.412 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 48.1 t -59.39 -21.95 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.264 0.938 . . . . 0.0 110.934 160.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -106.73 -10.12 16.22 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 172.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 C-N-CA 126.674 1.99 . . . . 0.0 112.386 -173.746 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' GSH . . . . . 0.495 ' C1 ' ' H ' ' A' ' 73' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.535 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 97.2 mtp . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.45 -178.63 0.13 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.801 1.64 . . . . 0.0 114.088 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 49.0 mt -103.45 143.6 32.49 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.446 1.117 . . . . 0.0 113.107 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -151.65 128.38 10.87 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.533 1.933 . . . . 0.0 108.382 172.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.1 pt -126.43 140.77 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.898 0.879 . . . . 0.0 109.92 -170.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.4 m -106.44 122.71 46.82 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.513 0.725 . . . . 0.0 109.335 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.39 164.0 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.597 1.559 . . . . 0.0 110.924 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -62.01 119.01 8.04 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.536 -0.727 . . . . 0.0 111.316 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -80.53 153.69 27.96 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.339 153.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.37 143.6 57.78 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.091 0.948 . . . . 0.0 112.18 170.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.6 t -70.51 136.65 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 168.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.78 -35.0 1.41 Allowed Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.814 -0.992 . . . . 0.0 114.775 -172.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.61 69.03 6.07 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 125.177 1.391 . . . . 0.0 112.478 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.37 -11.44 28.24 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.527 2.818 . . . . 0.0 115.413 -172.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -92.5 9.07 36.0 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.5 pt -130.32 163.09 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.593 1.157 . . . . 0.0 111.264 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.4 mt -62.68 146.02 53.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.299 0.64 . . . . 0.0 111.109 166.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.86 -169.16 12.47 Favored Glycine 0 N--CA 1.474 1.201 0 C-N-CA 125.233 1.397 . . . . 0.0 112.605 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -59.61 108.2 0.7 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.8 t -157.91 103.08 1.76 Allowed Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.637 1.175 . . . . 0.0 109.163 144.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -63.71 -18.95 66.29 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.249 2.633 . . . . 0.0 112.572 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -71.07 -30.6 66.78 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.4 -0.813 . . . . 0.0 112.602 172.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.3 m -70.35 -38.97 74.93 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.598 -1.314 . . . . 0.0 112.415 168.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -60.33 -26.89 66.91 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 118.143 -0.932 . . . . 0.0 113.155 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.522 HH12 ' CG ' ' A' ' 74' ' ' ASP . 46.6 mtp180 -57.89 -45.39 86.49 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.122 0.969 . . . . 0.0 112.52 171.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.54 -39.51 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.089 1.356 . . . . 0.0 111.322 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.82 -41.36 91.13 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.213 0.605 . . . . 0.0 111.258 172.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.4 tp -63.17 -54.5 36.6 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.06 1.344 . . . . 0.0 112.447 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.0 p -69.82 -38.31 76.52 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.462 1.028 . . . . 0.0 113.467 -171.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.6 mt -71.36 -38.96 71.54 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -75.62 -22.57 56.75 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 171.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -69.36 -47.01 65.61 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 120.536 -1.353 . . . . 0.0 111.145 170.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -69.74 -6.52 32.47 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.76 1.624 . . . . 0.0 114.652 169.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm 59.81 16.54 5.7 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.723 1.609 . . . . 0.0 114.804 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.9 mt -71.39 125.9 91.81 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.13 136.46 24.63 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.119 1.879 . . . . 0.0 111.4 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -136.17 151.08 49.37 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.664 1.585 . . . . 0.0 110.573 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -73.76 139.15 45.03 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.45 -0.781 . . . . 0.0 109.035 161.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.3 t -125.2 93.24 3.82 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.733 0.813 . . . . 0.0 111.162 -175.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -74.85 113.42 12.12 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.835 0.854 . . . . 0.0 110.464 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 83.8 mt -72.95 101.29 3.16 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.504 1.122 . . . . 0.0 110.02 164.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mm -97.1 111.29 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.629 0.771 . . . . 0.0 109.892 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -78.06 70.07 4.37 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.252 -0.905 . . . . 32.609999999999999 110.552 168.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.01 8.33 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 117.758 2.503 . . . . 40.049999999999997 117.758 -166.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.94 -44.46 91.67 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-N 119.825 1.193 . . . . 41.469999999999999 111.26 155.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -102.74 72.47 1.22 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.583 1.953 . . . . 47.170000000000002 110.068 166.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -81.24 110.96 20.62 Favored Pre-proline 0 N--CA 1.475 0.778 0 O-C-N 120.234 -1.541 . . . . 41.270000000000003 110.872 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.21 158.15 45.43 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.868 2.379 . . . . 40.289999999999999 112.481 -174.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -59.12 -34.5 72.11 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.419 1.266 . . . . 42.390000000000001 114.419 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -64.83 -32.15 73.72 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.188 0.904 . . . . 37.079999999999998 113.287 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -75.35 -34.53 61.17 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.689 -1.257 . . . . 35.880000000000003 112.782 170.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.89 -28.89 67.1 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.401 1.0 . . . . 33.609999999999999 113.285 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -68.61 -30.47 69.22 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.907 1.683 . . . . 33.789999999999999 112.537 170.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.7 mt -85.04 -33.15 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.96 1.304 . . . . 33.159999999999997 111.623 173.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.1 t -131.62 94.7 25.1 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 126.027 1.731 . . . . 33.579999999999998 110.586 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.86 -15.87 40.8 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.611 2.207 . . . . 37.899999999999999 113.842 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -81.87 -8.09 59.66 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.546 0.943 . . . . 38.990000000000002 113.546 168.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.28 13.42 64.92 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 120.933 -1.104 . . . . 35.469999999999999 114.789 -173.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -91.72 150.94 20.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.176 1.39 . . . . 34.490000000000002 112.763 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.7 m -110.96 153.94 43.6 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 126.176 1.79 . . . . 23.530000000000001 110.74 159.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -66.68 156.68 82.36 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-O 121.975 0.74 . . . . 22.879999999999999 112.925 -8.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 p -144.99 142.27 22.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.164 -1.38 . . . . 0.0 107.872 162.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 m -129.58 146.83 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.513 0.725 . . . . 0.0 110.67 -171.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -105.74 78.72 1.37 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.433 1.493 . . . . 0.0 109.724 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 34.4 mt -71.8 114.5 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.902 0.881 . . . . 0.0 109.564 -176.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.535 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 1.1 t70 52.47 39.36 27.61 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.96 0.885 . . . . 0.0 112.429 -165.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.8 t0 69.9 7.74 6.37 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 128.075 2.55 . . . . 0.0 116.622 -173.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -103.49 127.06 50.96 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 119.768 -1.833 . . . . 0.0 111.512 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.0 p-90 -70.18 142.48 52.46 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -170.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -143.04 128.4 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 127.722 2.409 . . . . 0.0 108.286 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.74 168.37 9.62 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.606 1.562 . . . . 0.0 112.131 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.9 t0 66.55 113.19 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.66 2.384 . . . . 22.16 114.346 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.46 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 48.3 p -63.11 -24.3 67.84 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 115.215 1.561 . . . . 21.16 115.215 -161.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.522 ' CG ' HH12 ' A' ' 25' ' ' ARG . 37.2 m-20 -73.18 -35.46 66.4 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.179 1.354 . . . . 24.969999999999999 113.307 170.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.62 -38.51 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 121.09 -1.006 . . . . 23.850000000000001 110.856 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.88 -45.94 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.314 1.046 . . . . 23.68 111.233 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.1 t -61.81 -41.4 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.26 1.024 . . . . 22.84 111.299 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.55 -20.26 55.61 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.782 -1.01 . . . . 23.329999999999998 114.932 175.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 98.5 mt -106.5 -44.14 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 119.073 1.436 . . . . 23.309999999999999 112.38 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.4 mt -65.72 -32.78 74.51 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 120.251 1.387 . . . . 23.48 112.947 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -90.13 -11.77 40.26 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 114.237 1.199 . . . . 24.239999999999998 114.237 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.472 ' OE2' ' HE3' ' A' ' 83' ' ' LYS . 75.0 tt0 -92.41 -41.07 10.52 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.103 1.361 . . . . 39.259999999999998 112.554 165.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.472 ' HE3' ' OE2' ' A' ' 82' ' ' GLU . 74.6 mttt -124.51 90.01 3.18 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.662 1.185 . . . . 24.449999999999999 111.977 -164.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -151.8 165.69 16.88 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.833 1.653 . . . . 0.0 109.474 168.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.21 -30.34 31.2 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.003 1.802 . . . . 0.0 112.031 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -73.7 152.87 89.39 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.82 1.248 . . . . 0.0 112.086 171.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -51.81 142.87 40.63 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.74 2.96 . . . . 0.0 115.053 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.31 131.53 25.17 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.272 1.981 . . . . 0.0 111.533 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.6 mt -105.29 4.48 31.05 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.223 1.409 . . . . 0.0 112.185 171.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.71 51.51 0.14 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.698 1.999 . . . . 0.0 112.178 162.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.1 p -123.79 70.76 49.11 Favored Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 125.021 1.329 . . . . 0.0 109.236 170.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.07 122.48 9.07 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.282 1.988 . . . . 0.0 110.227 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -73.98 179.59 5.58 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.874 2.383 . . . . 0.0 111.221 171.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.6 mp0 -55.09 -29.75 58.25 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.624 1.97 . . . . 0.0 113.08 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -53.77 -28.14 33.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.994 1.318 . . . . 0.0 113.842 172.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.27 -29.96 71.19 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.624 1.102 . . . . 0.0 113.21 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.9 p -68.45 -21.95 64.61 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.2 t -99.9 -41.11 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.835 1.254 . . . . 0.0 111.081 176.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.67 -31.52 81.07 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.729 -1.232 . . . . 0.0 114.435 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.9 p -69.62 -18.58 63.61 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -90.46 -32.66 16.29 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.842 1.257 . . . . 0.0 112.881 169.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 71.0 mt -70.27 -36.0 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.778 0.831 . . . . 0.0 111.629 173.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -55.44 -46.74 99.66 Favored Pre-proline 0 CA--C 1.547 0.829 0 O-C-N 120.379 -1.451 . . . . 0.0 114.344 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.65 -31.67 2.44 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.933 2.422 . . . . 0.0 114.116 171.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.6 p -71.46 -28.12 63.73 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 121.034 1.743 . . . . 0.0 113.005 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -58.72 -44.51 90.45 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 120.655 -1.278 . . . . 0.0 112.305 161.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.5 t -65.86 -35.05 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 119.639 1.109 . . . . 0.0 111.887 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -66.54 -39.02 88.36 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.031 0.832 . . . . 0.0 112.047 171.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -70.11 -29.85 66.91 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.284 1.034 . . . . 0.0 112.426 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.9 mt -76.99 -9.06 58.44 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.673 1.589 . . . . 0.0 114.517 168.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -142.63 38.55 1.51 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.92 1.288 . . . . 0.0 112.839 -170.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.4 m -75.07 63.01 1.22 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -162.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -65.26 -38.07 89.15 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.05 1.34 . . . . 0.0 111.136 163.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -83.89 115.97 62.43 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 154.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.59 154.24 70.15 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.675 2.917 . . . . 0.0 115.759 -144.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -66.9 -42.64 85.12 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 114.42 -1.264 . . . . 0.0 112.993 -165.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.71 -22.33 54.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.656 1.182 . . . . 0.0 113.32 -174.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.82 -34.6 27.12 Favored Glycine 0 CA--C 1.532 1.155 0 O-C-N 120.973 -1.079 . . . . 0.0 112.813 165.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 99.4 m -68.44 -27.09 65.87 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.596 -0.944 . . . . 0.0 112.729 171.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.59 -44.44 96.26 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.841 1.657 . . . . 0.0 111.928 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -66.7 -41.84 87.36 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.43 0.692 . . . . 0.0 112.059 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.77 -25.05 67.09 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 174.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.9 tp -82.51 -41.71 19.36 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.685 1.194 . . . . 0.0 112.17 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 26.9 mt -65.23 -40.08 93.61 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.713 1.205 . . . . 0.0 113.566 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -68.23 -33.83 75.12 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.927 1.239 . . . . 0.0 112.727 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -73.48 -38.76 65.31 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.063 -1.023 . . . . 0.0 112.722 170.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.1 mt -63.57 -35.55 80.86 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.782 -1.199 . . . . 0.0 112.849 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -65.06 -44.29 89.46 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.137 0.975 . . . . 0.0 111.598 172.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.61 -36.02 81.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.333 0.653 . . . . 0.0 112.224 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.1 tp -69.35 -56.95 6.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.377 1.071 . . . . 0.0 111.97 172.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.47 -30.57 69.45 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -171.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -58.33 -32.01 67.23 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.144 -0.809 . . . . 0.0 113.487 172.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -89.15 -33.88 16.9 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 117.75 0.775 . . . . 0.0 113.006 172.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.55 -35.95 81.07 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.912 1.233 . . . . 0.0 113.042 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.6 mtmt -65.81 -6.9 13.34 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 174.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.6 t -102.5 -36.72 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.961 1.305 . . . . 0.0 112.173 169.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -89.22 -19.32 25.55 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.31 -140.63 35.9 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.939 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -70.86 -15.71 32.95 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.785 3.657 . . . . 0.0 117.343 -108.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -122.08 170.98 9.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.926 1.29 . . . . 0.0 110.908 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . 0.254 2.9 tt -77.9 7.29 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 119.855 -1.778 . . . . 0.0 113.132 -175.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -114.61 6.95 15.91 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.91 2.484 . . . . 0.0 114.035 163.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.93 -122.33 6.64 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.82 -1.175 . . . . 0.0 113.185 -172.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -54.0 -36.69 63.22 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -169.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -146.76 157.87 43.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.318 1.447 . . . . 0.0 110.977 -166.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 56.0 mt -67.48 132.67 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.517 0.727 . . . . 0.0 110.414 171.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.0 p -143.5 -171.62 3.54 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.483 1.513 . . . . 0.0 111.15 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -54.58 -17.89 3.8 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.61 -42.48 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 120.211 1.369 . . . . 0.0 111.759 172.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.64 -45.08 95.56 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.933 1.293 . . . . 0.0 112.326 168.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.8 mt -62.08 -24.24 66.99 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 122.039 -0.413 . . . . 0.0 111.769 175.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.9 m -83.46 -50.56 8.18 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.887 -1.133 . . . . 0.0 112.597 175.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.3 mt -94.86 -36.0 11.82 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -165.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -55.8 -49.17 94.39 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.56 -22.5 15.8 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 120.725 1.295 . . . . 0.0 113.483 178.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -78.2 -28.92 48.16 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 117.714 -1.136 . . . . 0.0 112.859 174.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 46.7 mt -65.69 -44.65 85.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.89 0.876 . . . . 0.0 112.395 166.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -57.22 -41.66 79.91 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.161 0.505 . . . . 0.0 111.792 170.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -68.0 -29.61 68.67 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 9.2 mt -69.68 -52.48 25.35 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.419 1.008 . . . . 0.0 111.913 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -61.43 -35.51 77.78 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.017 0.927 . . . . 0.0 112.029 -174.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 85.7 t -90.56 -62.82 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.395 1.078 . . . . 0.0 113.14 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.21 -56.83 3.81 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.601 -0.687 . . . . 0.0 112.42 -162.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.42 -33.12 74.86 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 119.307 -0.378 . . . . 0.0 111.439 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.64 -23.29 49.28 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.129 1.347 . . . . 0.0 115.778 176.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -69.95 -22.26 63.19 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -124.94 -25.19 3.93 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -139.34 90.52 2.42 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.825 1.65 . . . . 0.0 108.353 166.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -65.3 83.78 0.05 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.583 1.153 . . . . 0.0 109.979 170.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -86.8 117.38 68.57 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.852 -169.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.34 110.63 2.9 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.585 1.524 . . . . 0.0 109.835 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 6.8 mm -55.39 109.32 1.54 Allowed Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 151.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -64.51 158.34 50.18 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 121.278 1.319 . . . . 0.0 112.442 -166.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.71 -19.06 64.63 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -66.36 -25.0 66.59 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.424 1.09 . . . . 0.0 113.693 168.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 62.5 mt -87.06 47.88 1.57 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.232 1.813 . . . . 0.0 111.388 170.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.7 -31.76 73.03 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.987 -1.071 . . . . 0.0 113.823 -155.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -80.45 -38.12 30.66 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.092 -1.005 . . . . 0.0 111.862 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 87.0 t -61.46 -42.32 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 121.436 -0.79 . . . . 0.0 111.559 171.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 46.5 tp -65.8 -29.44 69.92 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -80.9 -37.45 29.65 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.595 -0.691 . . . . 0.0 112.507 170.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -63.76 -31.13 72.21 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.476 1.11 . . . . 0.0 113.473 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 79.6 mt -56.96 -37.1 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.139 -0.976 . . . . 0.0 111.904 169.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -77.5 -16.34 58.77 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 119.975 -1.703 . . . . 0.0 112.878 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 66.6 mt -77.0 -12.76 59.98 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 117.461 -1.257 . . . . 0.0 113.473 166.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.83 -18.9 65.61 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.414 1.461 . . . . 0.0 112.924 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -93.15 2.17 56.81 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 173.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.4 p -105.97 -179.57 3.98 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.168 2.187 . . . . 0.0 113.828 -170.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 43.8 mtp85 55.09 -161.95 0.15 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.347 1.459 . . . . 0.0 110.655 -172.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 8.0 mp0 -86.03 -40.68 15.53 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.101 1.36 . . . . 0.0 109.209 157.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 72.5 p -70.7 -53.15 16.74 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.713 1.605 . . . . 0.0 114.727 -160.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -67.01 -46.17 75.3 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.17 0.896 . . . . 0.0 111.855 171.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 193' ' ' LYS . 26.7 ttmt -55.89 -38.28 69.98 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -74.46 -12.5 60.51 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.7 p -77.75 -11.74 59.91 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.329 1.422 . . . . 0.0 113.267 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -67.32 86.23 0.17 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.778 1.631 . . . . 0.0 112.721 -169.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.35 136.11 57.93 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.797 0.839 . . . . 0.0 109.99 159.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.2 132.47 53.77 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.104 0.562 . . . . 0.0 111.547 -173.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -60.02 -37.46 79.83 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.636 1.346 . . . . 0.0 114.636 -159.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.44 -38.28 83.59 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.901 -1.124 . . . . 0.0 112.462 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -86.49 -4.85 59.24 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.782 1.633 . . . . 0.0 112.998 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 98.3 t -85.02 -48.81 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.707 1.203 . . . . 0.0 109.89 162.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.8 mt -59.27 -53.37 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.852 1.261 . . . . 0.0 111.63 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.39 -15.53 62.37 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -81.78 -33.84 26.3 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 120.898 -1.126 . . . . 0.0 113.012 170.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 32.5 t90 -82.95 -32.75 26.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.521 1.928 . . . . 0.0 114.634 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -50.07 -48.84 78.19 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 114.471 1.285 . . . . 0.0 114.471 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.53 -23.94 31.27 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.773 1.649 . . . . 0.0 113.71 173.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.08 -11.07 60.01 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.775 1.23 . . . . 0.0 113.901 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 57.6 t -58.95 -27.85 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 119.236 0.926 . . . . 0.0 110.688 161.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -97.91 -36.37 10.18 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 171.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.743 0 C-N-CA 126.052 1.741 . . . . 0.0 113.639 -177.344 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' GSH . . . . . 0.46 ' C1 ' ' H ' ' A' ' 73' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.559 ' HA ' ' OD1' ' A' ' 66' ' ' ASP . 94.7 mtp . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.52 -168.49 0.17 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.589 1.556 . . . . 0.0 113.433 177.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 79.7 mt -109.72 131.81 54.72 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.391 1.076 . . . . 0.0 112.298 -175.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -122.21 145.6 48.05 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.574 1.15 . . . . 0.0 108.489 153.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.2 pt -130.22 138.84 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.967 0.907 . . . . 0.0 109.504 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.9 m -106.98 119.82 40.39 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.179 0.992 . . . . 0.0 109.621 173.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.81 163.8 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.018 1.327 . . . . 0.0 111.111 -169.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -60.58 119.14 7.5 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.758 -0.589 . . . . 0.0 111.23 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.41 147.01 31.18 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.051 151.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.93 139.47 58.75 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.757 0.789 . . . . 0.0 111.942 172.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.2 t -71.86 134.25 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 168.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.91 -27.74 2.97 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-O 118.665 -1.075 . . . . 0.0 114.677 -170.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -129.26 65.41 74.19 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-N 118.582 1.191 . . . . 0.0 112.564 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.12 -12.39 32.2 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.315 2.677 . . . . 0.0 115.468 -170.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -85.97 5.71 31.95 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.1 pt -132.37 163.33 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.733 1.213 . . . . 0.0 111.84 173.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.74 145.47 49.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.136 0.575 . . . . 0.0 110.888 166.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.63 -163.53 11.17 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.878 1.228 . . . . 0.0 111.981 166.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -56.96 105.4 0.21 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.6 t -157.64 107.4 1.81 Allowed Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.841 140.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.11 -14.29 42.83 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.178 2.585 . . . . 0.0 113.198 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -77.76 -29.39 50.98 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.207 -0.933 . . . . 0.0 112.401 171.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 99.7 m -70.81 -37.85 73.26 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.083 -1.636 . . . . 0.0 112.451 167.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -59.42 -26.69 65.38 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 118.399 -0.81 . . . . 0.0 113.006 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.502 HH12 ' CG ' ' A' ' 74' ' ' ASP . 53.8 mtp180 -58.14 -44.11 87.68 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.526 1.131 . . . . 0.0 112.641 171.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.5 t -77.0 -39.57 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.101 1.36 . . . . 0.0 111.299 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.31 -44.44 92.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.327 0.651 . . . . 0.0 111.121 171.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.0 tp -60.78 -53.75 53.55 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.991 1.316 . . . . 0.0 112.77 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 p -71.55 -36.85 71.11 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.708 1.14 . . . . 0.0 113.574 -173.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.17 -39.03 68.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 118.841 -0.599 . . . . 0.0 112.051 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -77.99 -17.39 57.2 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 172.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -70.16 -52.88 20.06 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.999 1.272 . . . . 0.0 110.896 167.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -73.24 -1.75 19.07 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.291 1.836 . . . . 0.0 114.468 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm 58.03 18.8 5.42 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.409 1.884 . . . . 0.0 115.106 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 58.5 mt -72.69 125.07 91.4 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 123.896 0.878 . . . . 0.0 108.868 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.72 144.84 35.88 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.473 2.116 . . . . 0.0 112.167 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -148.18 154.54 40.25 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.271 1.428 . . . . 0.0 111.01 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -78.55 121.1 24.18 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.332 -0.855 . . . . 0.0 109.686 163.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.8 t -95.42 94.41 7.8 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.538 0.735 . . . . 0.0 111.14 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -81.07 105.67 12.47 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.547 0.739 . . . . 0.0 110.067 178.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.9 mt -68.61 107.37 2.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.293 1.037 . . . . 0.0 109.963 168.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -105.05 114.9 45.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 124.125 0.97 . . . . 0.0 110.056 177.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -74.46 80.73 1.92 Allowed 'General case' 0 C--O 1.221 -0.437 0 O-C-N 121.438 -0.789 . . . . 32.609999999999999 109.629 165.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.54 HD13 HA32 ' A' ' 301' ' ' GSH . 3.6 pp -62.68 -4.26 1.94 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 116.622 2.082 . . . . 40.049999999999997 116.622 -170.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.65 -28.53 67.14 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-N 119.283 0.947 . . . . 41.469999999999999 112.576 166.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -116.42 54.15 0.85 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.31 2.644 . . . . 47.170000000000002 109.681 174.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -72.11 114.48 29.6 Favored Pre-proline 0 CA--C 1.546 0.803 0 O-C-N 119.745 -1.847 . . . . 41.270000000000003 111.059 -168.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.18 161.05 41.49 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.627 2.218 . . . . 40.289999999999999 112.209 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -61.85 -31.0 71.22 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.02 1.119 . . . . 42.390000000000001 114.02 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -61.52 -33.73 74.32 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.304 -0.873 . . . . 37.079999999999998 113.069 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -78.44 -35.14 47.24 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.22 -0.925 . . . . 35.880000000000003 112.769 172.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.14 -23.53 63.98 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.869 1.063 . . . . 33.609999999999999 113.869 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -67.48 -42.34 83.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.731 1.212 . . . . 33.789999999999999 111.418 168.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.7 mt -74.81 -32.78 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.348 1.059 . . . . 33.159999999999997 112.038 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.8 t -137.74 94.11 11.87 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 126.327 1.851 . . . . 33.579999999999998 111.351 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.83 -22.42 36.67 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.847 2.365 . . . . 37.899999999999999 113.586 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 1.1 pm0 -78.93 -10.79 59.92 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.896 -1.128 . . . . 38.990000000000002 113.299 167.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.36 25.92 74.5 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.96 1.743 . . . . 35.469999999999999 115.015 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -105.21 149.14 26.21 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 118.938 1.369 . . . . 34.490000000000002 112.014 -172.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.5 m -106.84 146.68 33.58 Favored Pre-proline 0 N--CA 1.47 0.543 0 C-N-CA 123.913 0.885 . . . . 23.530000000000001 110.153 164.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.35 150.65 86.53 Favored 'Cis proline' 0 C--N 1.346 0.431 0 CA-C-N 119.032 0.69 . . . . 22.879999999999999 113.156 -7.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 p -138.76 145.54 27.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 113.618 -1.628 . . . . 0.0 107.16 156.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.77 160.8 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 O-C-N 121.449 -0.782 . . . . 0.0 111.13 -172.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.6 mtpt -119.85 73.47 0.97 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.258 1.423 . . . . 0.0 108.951 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.5 mt -71.49 117.3 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.443 1.097 . . . . 0.0 109.582 -174.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.559 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 15.4 t0 56.7 30.53 17.72 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 121.904 -0.498 . . . . 0.0 111.97 -165.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.8 t0 73.1 4.91 5.05 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 129.04 2.936 . . . . 0.0 116.37 -169.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -102.31 132.07 48.5 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.525 -1.36 . . . . 0.0 111.547 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -67.25 136.01 54.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.776 0.83 . . . . 0.0 113.056 -168.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -143.56 126.92 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.967 1.707 . . . . 0.0 109.449 170.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -107.08 172.04 7.04 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.832 1.653 . . . . 0.0 111.91 174.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 t0 65.69 111.48 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.89 2.476 . . . . 22.16 114.57 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.457 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 54.3 p -64.04 -21.41 66.5 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 115.696 1.739 . . . . 21.16 115.696 -161.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.502 ' CG ' HH12 ' A' ' 25' ' ' ARG . 35.6 m-20 -75.84 -31.74 59.47 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.494 1.497 . . . . 24.969999999999999 113.666 170.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.8 t -73.33 -38.64 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.932 -1.105 . . . . 23.850000000000001 110.823 170.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.22 -44.77 99.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.217 1.007 . . . . 23.68 110.962 174.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.4 t -62.59 -46.13 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.373 1.069 . . . . 22.84 111.378 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.09 -45.12 83.14 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 118.869 0.759 . . . . 23.329999999999998 112.99 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 99.1 mt -75.4 -46.48 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.709 -0.877 . . . . 23.309999999999999 112.388 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.6 mt -69.86 -30.09 67.48 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.23 1.377 . . . . 23.48 113.591 -176.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -89.99 -13.18 36.65 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.335 0.865 . . . . 24.239999999999998 113.335 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.535 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 56.6 tt0 -91.81 -47.08 7.53 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.758 1.623 . . . . 39.259999999999998 112.568 167.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.535 ' HE3' ' OE1' ' A' ' 82' ' ' GLU . 84.0 mttt -117.52 83.57 2.01 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.719 1.207 . . . . 24.449999999999999 112.024 -161.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -149.25 165.85 16.68 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.275 1.43 . . . . 0.0 110.274 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -70.05 -25.23 27.49 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.152 1.901 . . . . 0.0 112.438 172.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -73.29 156.18 89.34 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.45 1.5 . . . . 0.0 112.155 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -57.24 143.81 92.49 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.218 2.612 . . . . 0.0 114.21 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.57 130.98 24.84 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.436 2.091 . . . . 0.0 112.424 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.0 mt -110.32 1.56 18.58 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.425 1.49 . . . . 0.0 112.333 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.67 50.08 0.18 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.676 1.99 . . . . 0.0 111.891 160.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 67.9 p -125.12 70.54 61.54 Favored Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 125.63 1.572 . . . . 0.0 109.045 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -69.59 128.75 16.64 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.98 1.786 . . . . 0.0 111.194 -165.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.0 177.31 7.24 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.419 2.746 . . . . 0.0 111.318 170.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -55.58 -31.16 61.96 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 120.924 -1.11 . . . . 0.0 113.897 173.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -53.43 -25.59 16.56 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.293 1.437 . . . . 0.0 113.973 172.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.15 -33.92 74.18 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.577 1.08 . . . . 0.0 113.184 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 84.1 p -68.99 -24.28 64.21 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.385 1.074 . . . . 0.0 113.78 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 t -92.75 -40.74 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.264 1.425 . . . . 0.0 110.111 176.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -62.96 -30.97 79.02 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.83 1.681 . . . . 0.0 114.45 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 89.8 p -69.27 -17.53 63.75 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.024 1.412 . . . . 0.0 113.77 171.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -95.56 -33.15 12.51 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.105 1.362 . . . . 0.0 112.386 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 69.2 mt -70.2 -36.79 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.607 0.763 . . . . 0.0 111.979 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -56.19 -47.71 98.32 Favored Pre-proline 0 CA--C 1.545 0.758 0 O-C-N 120.223 -1.548 . . . . 0.0 113.898 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.65 -30.38 3.08 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.546 2.164 . . . . 0.0 114.045 171.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.3 p -72.57 -27.16 62.03 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 121.193 1.815 . . . . 0.0 113.273 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -59.03 -46.72 87.5 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.662 -1.274 . . . . 0.0 111.839 160.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.8 t -65.17 -32.65 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.336 0.971 . . . . 0.0 111.951 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -67.73 -39.39 84.27 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.174 0.897 . . . . 0.0 112.393 168.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -70.71 -28.29 64.63 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.469 1.107 . . . . 0.0 112.783 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 20.6 mt -77.01 -15.24 59.69 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.869 1.668 . . . . 0.0 114.147 167.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -137.68 38.95 2.41 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.848 1.259 . . . . 0.0 112.533 -170.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.3 m -73.85 66.0 1.09 Allowed 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -162.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -67.81 -39.36 83.98 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.401 1.08 . . . . 0.0 111.522 164.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -79.44 111.77 23.4 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 153.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.48 155.85 66.62 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.578 2.852 . . . . 0.0 115.452 -143.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -65.3 -42.51 92.99 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.838 -1.074 . . . . 0.0 113.437 -165.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.75 -21.98 61.67 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.84 -36.9 17.72 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 120.998 -1.064 . . . . 0.0 112.495 167.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 98.4 m -67.82 -27.55 66.81 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.82 0.848 . . . . 0.0 113.042 172.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -58.76 -45.95 88.57 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.795 1.638 . . . . 0.0 111.616 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -68.68 -40.46 80.1 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.792 0.837 . . . . 0.0 111.433 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.91 -24.9 66.93 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.6 tp -82.92 -40.75 19.74 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.864 1.265 . . . . 0.0 111.94 172.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.9 mt -63.45 -41.36 98.63 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.676 1.191 . . . . 0.0 113.351 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -66.58 -35.64 80.7 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.063 1.301 . . . . 0.0 112.774 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -71.79 -39.5 69.85 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.122 -0.986 . . . . 0.0 112.592 171.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.6 mt -64.28 -33.6 76.19 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.837 -1.164 . . . . 0.0 113.121 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -66.7 -44.28 82.11 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.588 1.086 . . . . 0.0 111.577 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.84 81.56 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.558 0.743 . . . . 0.0 112.218 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.2 tp -68.07 -56.75 7.75 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.27 1.028 . . . . 0.0 111.846 172.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.96 -33.44 74.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.576 1.15 . . . . 0.0 113.879 -171.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.42 -34.02 67.56 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.36 -0.689 . . . . 0.0 113.324 173.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -92.67 -29.35 16.13 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 77.4 mt -64.23 -33.74 76.5 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 120.465 -1.397 . . . . 0.0 113.225 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -65.94 -7.63 17.87 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.35 -38.37 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.144 1.378 . . . . 0.0 112.169 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -82.17 -17.38 46.46 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -172.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.2 -164.86 42.57 Favored Glycine 0 CA--C 1.542 1.721 0 CA-C-O 117.718 -1.601 . . . . 0.0 114.42 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.0 -10.67 23.09 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 125.281 3.987 . . . . 0.0 118.144 -119.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -110.32 167.21 10.37 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.175 0.99 . . . . 0.0 110.893 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.2 tt -75.57 6.86 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 120.275 -1.516 . . . . 0.0 112.997 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -116.2 2.79 13.37 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 128.146 2.579 . . . . 0.0 114.422 165.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.93 -117.85 5.7 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.083 1.325 . . . . 0.0 113.251 -173.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -62.45 -35.81 80.44 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -168.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -142.49 162.32 35.76 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.76 1.624 . . . . 0.0 110.484 -171.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.8 mt -62.83 135.68 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.07 0.462 . . . . 0.0 110.528 165.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.7 p -138.59 -174.33 3.8 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.502 1.521 . . . . 0.0 110.814 171.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.95 -19.31 1.73 Allowed 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 169.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 18.4 t -74.27 -40.32 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 120.179 1.354 . . . . 0.0 112.496 174.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -61.5 -44.33 97.28 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.863 -1.148 . . . . 0.0 112.003 167.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.9 mt -62.19 -26.99 68.66 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 122.193 -0.317 . . . . 0.0 111.533 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 52.3 m -79.35 -47.43 15.81 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.845 -1.159 . . . . 0.0 112.694 175.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 51.5 mt -100.01 -37.98 8.77 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -164.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.24 88.48 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -173.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.97 -28.57 19.27 Favored 'Trans proline' 0 C--N 1.351 0.705 0 CA-C-N 120.784 1.316 . . . . 0.0 113.12 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -72.81 -30.55 64.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.611 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 51.6 mt -65.97 -46.61 77.45 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.741 0.816 . . . . 0.0 112.975 169.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -58.33 -36.31 73.22 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.828 0.823 . . . . 0.0 112.323 170.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -73.98 -22.79 59.49 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.867 -1.146 . . . . 0.0 113.76 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.33 -49.78 45.94 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.561 1.073 . . . . 0.0 111.398 162.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -58.1 -37.11 73.9 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.389 1.476 . . . . 0.0 112.479 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 70.4 t -96.87 -62.66 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.236 1.014 . . . . 0.0 113.545 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.05 -54.2 6.83 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.463 -0.773 . . . . 0.0 112.622 -164.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 38.6 tp -65.71 -34.69 78.78 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 119.349 -0.358 . . . . 0.0 111.155 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.03 -29.24 59.17 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.23 1.395 . . . . 0.0 115.336 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -66.48 -22.01 66.19 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -122.29 -21.19 5.92 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -148.33 94.94 2.38 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.291 1.836 . . . . 0.0 108.797 165.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -67.99 78.74 0.22 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.895 1.278 . . . . 0.0 111.171 173.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -76.98 118.2 70.23 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.24 1.016 . . . . 0.0 111.91 -168.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -73.37 110.36 3.04 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.949 1.766 . . . . 0.0 110.662 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 14.0 mm -58.03 115.42 11.14 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 160.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -63.13 153.49 73.6 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 121.634 1.556 . . . . 0.0 112.633 -172.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -61.15 -22.66 64.9 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 169.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -68.11 -25.45 65.32 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 170.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 47.4 mt -86.12 50.91 2.07 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.251 1.42 . . . . 0.0 111.104 167.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.8 -26.87 68.53 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.315 1.046 . . . . 0.0 113.315 -160.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -75.62 -50.66 14.85 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.017 0.826 . . . . 0.0 111.074 171.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 86.3 t -59.17 -39.93 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.757 0.823 . . . . 0.0 111.572 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 60.4 tp -61.01 -36.01 78.37 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.675 1.19 . . . . 0.0 113.397 174.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -81.0 -37.25 29.48 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -62.61 -33.92 75.99 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.687 1.195 . . . . 0.0 112.872 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 67.8 mt -59.89 -35.83 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.033 -1.042 . . . . 0.0 112.104 171.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -74.08 -17.83 60.9 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.225 -1.547 . . . . 0.0 112.941 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 51.0 mt -74.88 -15.95 60.69 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 118.339 -0.838 . . . . 0.0 113.148 168.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.6 mt -67.99 -17.69 64.5 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 120.011 1.278 . . . . 0.0 113.828 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -95.09 6.59 48.65 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.419 -1.425 . . . . 0.0 113.477 171.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.7 p -107.69 -179.07 3.8 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.956 1.703 . . . . 0.0 113.222 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 44.8 mtp85 56.46 -164.33 0.15 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.655 1.582 . . . . 0.0 111.335 -172.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 190' ' ' GLU . 11.5 mp0 -84.62 -41.15 16.66 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.964 1.306 . . . . 0.0 109.276 157.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 77.4 p -70.16 -54.67 11.91 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.867 1.667 . . . . 0.0 114.631 -159.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -67.46 -45.94 74.49 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.701 0.682 . . . . 0.0 111.977 171.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.421 ' HB2' ' HE3' ' A' ' 193' ' ' LYS . 26.1 ttmt -56.63 -39.03 72.93 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.172 -0.955 . . . . 0.0 113.517 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -74.04 -8.84 57.61 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.4 p -77.51 -14.47 59.67 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.401 1.455 . . . . 0.0 113.231 170.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -65.85 101.59 0.67 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.639 1.109 . . . . 0.0 111.636 -174.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.24 159.96 30.2 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.671 0.788 . . . . 0.0 110.496 156.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.38 127.55 33.09 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.076 -0.39 . . . . 0.0 110.359 172.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -63.86 -31.75 73.03 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -161.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -61.89 -39.85 93.37 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.997 -1.064 . . . . 0.0 112.424 171.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -81.89 -2.25 50.55 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.552 -1.343 . . . . 0.0 114.242 173.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 85.4 t -85.83 -44.7 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.402 1.081 . . . . 0.0 110.294 163.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.2 mt -64.51 -56.63 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.864 1.266 . . . . 0.0 111.526 175.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.7 -13.65 62.28 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.474 1.11 . . . . 0.0 113.825 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -86.44 -36.54 9.56 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.808 -1.183 . . . . 0.0 113.484 170.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -78.04 -31.31 50.31 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.688 1.595 . . . . 0.0 113.615 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -53.59 -47.97 94.68 Favored Pre-proline 0 CA--C 1.553 1.066 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -175.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.93 -23.75 29.65 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 121.681 1.588 . . . . 0.0 113.919 171.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.437 ' HE2' HB22 ' A' ' 301' ' ' GSH . 57.2 mttp -74.33 -8.61 56.85 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 117.595 -1.193 . . . . 0.0 114.204 175.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 45.7 t -60.59 -21.36 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 119.274 0.943 . . . . 0.0 111.268 160.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -105.72 -12.17 16.01 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 170.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.882 0 C-N-CA 125.394 1.478 . . . . 0.0 112.653 -170.852 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' GSH . . . . . 0.54 HA32 HD13 ' A' ' 44' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.559 ' H2 ' ' HB2' ' A' ' 67' ' ' ASP . 88.2 mtp . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.02 -173.64 0.1 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.494 1.518 . . . . 0.0 114.019 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 74.8 mt -115.74 137.3 52.22 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.249 1.42 . . . . 0.0 111.188 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -130.59 144.37 51.37 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.681 1.192 . . . . 0.0 108.723 160.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.3 pt -128.62 135.35 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 123.999 0.92 . . . . 0.0 109.34 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 79.2 m -110.84 117.29 33.01 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.493 1.117 . . . . 0.0 109.459 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.9 m -132.45 158.78 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.773 1.229 . . . . 0.0 111.09 -165.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -59.62 114.99 3.01 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.986 -0.446 . . . . 0.0 110.685 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -80.94 149.65 29.3 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.984 154.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.96 142.89 57.18 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.921 0.867 . . . . 0.0 113.057 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.91 129.15 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 163.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.66 -18.99 12.4 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-O 118.405 -1.219 . . . . 0.0 115.41 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.67 65.97 26.55 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 119.114 1.457 . . . . 0.0 112.286 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 62.5 Cg_endo -64.82 -5.16 9.97 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.705 2.937 . . . . 0.0 115.489 -172.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -89.96 3.63 52.54 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.6 pt -133.8 164.57 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.201 1.4 . . . . 0.0 111.704 173.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.19 150.03 39.94 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.817 0.847 . . . . 0.0 111.922 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.49 -164.86 10.09 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.592 1.568 . . . . 0.0 111.834 165.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -57.78 104.28 0.18 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.6 t -153.37 106.41 2.58 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 113.74 -1.573 . . . . 0.0 110.212 136.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -67.62 -15.3 44.44 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.822 2.348 . . . . 0.0 112.761 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -74.44 -29.39 61.46 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.374 -0.829 . . . . 0.0 112.369 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 89.1 m -70.15 -37.08 75.14 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.326 -1.484 . . . . 0.0 112.816 167.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -60.41 -28.08 67.97 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.479 HH12 ' CG ' ' A' ' 74' ' ' ASP . 57.3 mtp180 -56.76 -40.05 75.12 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.678 1.191 . . . . 0.0 112.691 171.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.3 -40.61 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.138 1.375 . . . . 0.0 111.52 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.51 -43.54 93.36 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.951 0.5 . . . . 0.0 111.132 171.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.8 tp -59.15 -46.59 87.97 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.353 1.061 . . . . 0.0 113.268 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.2 p -78.44 -37.96 42.4 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.35 -36.91 77.35 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.484 0.584 . . . . 0.0 111.621 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -77.98 -18.33 56.1 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -75.43 -46.33 33.38 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.142 -1.599 . . . . 0.0 111.534 166.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -76.52 -5.03 45.8 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.071 1.348 . . . . 0.0 114.343 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm 58.68 20.27 7.61 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.325 1.85 . . . . 0.0 114.477 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.1 mt -70.98 130.54 88.18 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.217 -0.896 . . . . 0.0 108.679 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.01 139.38 29.81 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.331 2.021 . . . . 0.0 111.99 173.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -144.67 154.42 42.75 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.857 1.663 . . . . 0.0 110.194 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -81.94 125.48 30.81 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.177 -0.952 . . . . 0.0 110.019 162.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.5 t -93.16 95.75 9.6 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.515 0.726 . . . . 0.0 110.999 169.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -79.97 99.06 7.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.676 0.79 . . . . 0.0 109.583 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 82.2 mt -66.75 109.72 2.98 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.945 0.898 . . . . 0.0 109.599 169.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mm -120.23 111.88 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.736 1.215 . . . . 0.0 109.15 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -77.5 89.42 3.85 Favored 'General case' 0 C--O 1.222 -0.368 0 O-C-N 120.68 -1.263 . . . . 32.609999999999999 108.602 166.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.42 1.79 0.19 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 117.519 2.415 . . . . 40.049999999999997 117.519 -175.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -69.95 -24.02 76.68 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-N 119.918 1.235 . . . . 41.469999999999999 112.734 161.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -128.11 66.84 1.36 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.974 2.51 . . . . 47.170000000000002 108.823 171.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -80.63 116.49 62.45 Favored Pre-proline 0 N--CA 1.473 0.684 0 O-C-N 120.055 -1.653 . . . . 41.270000000000003 110.551 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.15 161.65 44.98 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.689 2.26 . . . . 40.289999999999999 111.638 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -61.82 -29.83 70.42 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.028 1.121 . . . . 42.390000000000001 114.028 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -60.72 -33.02 72.27 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.269 1.028 . . . . 37.079999999999998 113.362 170.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -79.38 -36.61 38.95 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.951 -1.093 . . . . 35.880000000000003 112.599 173.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.7 mt -68.12 -25.54 65.35 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.343 0.868 . . . . 33.609999999999999 113.343 174.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -64.14 -47.37 80.18 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.606 1.563 . . . . 33.789999999999999 111.457 168.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.2 mt -72.39 -37.38 57.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.894 0.877 . . . . 33.159999999999997 111.625 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.1 t -126.75 92.19 45.39 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 126.177 1.791 . . . . 33.579999999999998 110.746 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.03 -17.47 36.34 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.856 2.371 . . . . 37.899999999999999 113.965 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -76.48 -11.58 59.9 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.102 -0.999 . . . . 38.990000000000002 113.533 165.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.98 21.35 76.8 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.548 1.07 . . . . 35.469999999999999 114.561 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -104.08 150.5 24.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.451 1.501 . . . . 34.490000000000002 113.688 -173.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.19 153.96 40.76 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 125.93 1.692 . . . . 23.530000000000001 111.046 162.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -63.66 149.37 68.0 Favored 'Cis proline' 0 C--N 1.347 0.48 0 CA-C-O 121.852 0.688 . . . . 22.879999999999999 112.608 -12.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.38 146.95 28.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 113.985 -1.461 . . . . 0.0 107.494 156.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.1 m -134.7 165.26 31.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 123.565 0.746 . . . . 0.0 111.004 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -124.06 71.7 1.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.757 1.623 . . . . 0.0 109.424 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.5 mt -74.74 117.51 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.395 1.078 . . . . 0.0 108.994 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.497 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 48.0 t0 53.8 40.47 31.56 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 121.227 0.537 . . . . 0.0 110.967 -164.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.559 ' HB2' ' H2 ' ' A' ' 1' ' ' MET . 21.6 t0 67.54 -5.84 0.73 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.445 2.298 . . . . 0.0 115.608 -172.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -92.77 135.51 34.06 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.261 -1.525 . . . . 0.0 112.296 -172.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -68.1 131.41 45.37 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.634 1.174 . . . . 0.0 112.465 -170.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.1 t -141.09 129.61 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.165 1.386 . . . . 0.0 109.588 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.29 171.14 7.65 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.929 1.691 . . . . 0.0 111.425 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.9 t0 66.08 111.17 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.527 2.331 . . . . 22.16 114.162 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.467 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 59.9 p -64.09 -21.65 66.62 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 115.15 1.537 . . . . 21.16 115.15 -162.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.479 ' CG ' HH12 ' A' ' 25' ' ' ARG . 38.0 m-20 -74.1 -34.01 63.82 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.023 1.283 . . . . 24.969999999999999 113.421 169.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -72.27 -38.71 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.086 -1.009 . . . . 23.850000000000001 110.785 171.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.56 -44.94 99.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.234 1.014 . . . . 23.68 111.072 175.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.6 t -62.99 -44.65 99.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.384 1.074 . . . . 22.84 111.286 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.43 -35.04 70.18 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 118.633 0.651 . . . . 23.329999999999998 113.91 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 94.8 mt -85.11 -49.9 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 118.339 1.07 . . . . 23.309999999999999 112.122 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.4 mt -65.75 -32.32 73.8 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.809 1.186 . . . . 23.48 113.314 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -90.88 -1.26 57.85 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.627 0.973 . . . . 24.239999999999998 113.627 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -110.88 -53.62 2.68 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.113 1.365 . . . . 39.259999999999998 112.092 167.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -97.06 58.98 1.61 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.384 1.074 . . . . 24.449999999999999 112.847 -161.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -132.64 162.9 54.46 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.996 1.318 . . . . 0.0 111.355 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.08 -26.55 21.34 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.291 1.994 . . . . 0.0 112.398 172.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -72.96 150.57 90.4 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.467 1.107 . . . . 0.0 111.697 171.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -57.24 144.13 91.63 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.048 2.498 . . . . 0.0 115.032 -172.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.72 119.01 5.84 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.768 2.312 . . . . 0.0 113.222 -173.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.5 mt -89.45 2.04 55.06 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.504 1.121 . . . . 0.0 112.654 170.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.05 50.97 0.29 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.647 1.979 . . . . 0.0 110.949 159.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.8 p -125.03 62.78 38.38 Favored Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 126.246 1.818 . . . . 0.0 110.132 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -75.64 127.86 10.56 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.825 2.35 . . . . 0.0 111.164 -163.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.51 -176.9 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.532 2.822 . . . . 0.0 111.771 171.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -53.79 -29.31 39.75 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.038 1.335 . . . . 0.0 114.153 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -56.38 -21.61 25.96 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.103 1.361 . . . . 0.0 114.393 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.53 -30.92 71.97 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 120.16 1.346 . . . . 0.0 113.368 173.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.5 p -68.03 -23.79 65.02 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.421 -0.8 . . . . 0.0 113.119 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.1 t -95.23 -41.23 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.188 1.395 . . . . 0.0 110.868 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -64.84 -29.7 76.02 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.446 1.498 . . . . 0.0 114.398 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 88.2 p -67.91 -18.59 64.83 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 118.729 1.264 . . . . 0.0 114.049 170.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -95.5 -33.35 12.46 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.402 1.481 . . . . 0.0 112.873 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 57.1 mt -69.82 -37.52 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.642 0.777 . . . . 0.0 111.805 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -56.25 -47.97 97.84 Favored Pre-proline 0 CA--C 1.546 0.811 0 O-C-N 120.406 -1.434 . . . . 0.0 114.028 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.62 -30.83 3.66 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.709 2.273 . . . . 0.0 113.779 171.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.6 p -72.25 -28.05 62.89 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 121.386 1.903 . . . . 0.0 113.277 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -59.88 -45.42 92.55 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.668 -1.27 . . . . 0.0 112.192 161.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 82.1 t -68.49 -32.23 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 121.23 -0.919 . . . . 0.0 111.953 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -67.11 -41.97 85.31 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.914 0.886 . . . . 0.0 111.836 169.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -63.65 -39.48 94.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.257 1.023 . . . . 0.0 111.693 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.28 -5.4 31.98 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 169.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -141.78 42.5 1.71 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.846 1.658 . . . . 0.0 111.617 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.0 m -70.05 61.57 0.19 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.239 1.816 . . . . 0.0 115.53 -165.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.18 -37.06 72.18 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.647 1.179 . . . . 0.0 111.738 167.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -81.38 115.4 56.29 Favored Pre-proline 0 CA--C 1.552 1.027 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 152.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.58 153.68 73.53 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.423 2.749 . . . . 0.0 115.084 -147.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -64.7 -42.83 95.0 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.425 -165.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.23 -17.18 60.92 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.403 1.081 . . . . 0.0 113.763 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -86.91 -39.33 7.56 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 121.442 -0.787 . . . . 0.0 112.68 166.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 54.0 m -65.46 -25.93 67.72 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.671 -0.899 . . . . 0.0 112.953 171.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -58.32 -44.83 88.79 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.908 1.683 . . . . 0.0 111.759 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -71.81 -38.93 70.16 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.523 0.729 . . . . 0.0 111.4 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.84 -23.88 66.77 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 171.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.4 tp -83.21 -41.21 18.67 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.727 1.211 . . . . 0.0 111.914 170.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 23.3 mt -64.2 -41.58 97.0 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.932 1.293 . . . . 0.0 113.478 -177.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -65.15 -36.19 83.45 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.277 1.399 . . . . 0.0 112.598 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -72.88 -38.75 66.87 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.229 -0.919 . . . . 0.0 112.691 172.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.31 -33.83 76.73 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 120.85 -1.156 . . . . 0.0 113.033 172.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -66.71 -44.65 81.05 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.868 1.213 . . . . 0.0 111.614 172.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.14 86.05 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.511 0.724 . . . . 0.0 112.225 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.4 tp -66.46 -58.16 5.83 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.316 1.446 . . . . 0.0 111.903 170.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.05 -37.08 84.94 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.512 1.125 . . . . 0.0 113.777 -170.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -57.35 -36.02 74.36 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.235 -0.758 . . . . 0.0 113.528 178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -93.71 -26.33 17.06 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 23.0 mt -63.72 -31.94 73.27 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.592 -1.318 . . . . 0.0 113.584 172.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -64.16 -3.11 2.45 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 171.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.2 t -109.46 -36.5 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.505 1.522 . . . . 0.0 112.704 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -83.65 -28.67 28.23 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 -162.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 144.86 174.92 17.56 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 120.069 1.304 . . . . 0.0 113.926 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.77 -4.01 14.1 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 125.008 3.805 . . . . 0.0 116.417 -164.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -106.24 167.18 9.99 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.433 1.015 . . . . 0.0 110.964 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.0 4.67 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 120.627 -1.296 . . . . 0.0 113.214 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -121.54 16.01 11.2 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.772 2.429 . . . . 0.0 113.649 167.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.34 -110.44 3.49 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 120.838 -1.164 . . . . 0.0 113.022 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -58.06 -34.85 70.55 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -168.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -155.34 162.33 40.86 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.941 1.696 . . . . 0.0 110.895 -156.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 13.9 mt -63.87 132.61 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 164.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 29.3 p -132.66 -177.16 4.36 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.354 1.462 . . . . 0.0 110.474 169.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.13 -20.92 2.82 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 167.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.6 t -73.44 -41.01 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 120.704 -1.248 . . . . 0.0 112.325 173.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.69 -42.7 99.29 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.618 1.167 . . . . 0.0 112.233 168.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.7 mt -62.61 -23.2 66.93 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.6 m -83.08 -45.56 13.85 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.041 -1.037 . . . . 0.0 112.537 175.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 39.3 mt -100.15 -35.79 9.54 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -166.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.38 -49.53 92.9 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -174.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -70.43 -27.07 23.72 Favored 'Trans proline' 0 C--N 1.35 0.623 0 CA-C-N 120.942 1.372 . . . . 0.0 113.026 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -74.88 -28.39 60.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.444 -1.265 . . . . 0.0 112.654 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.0 mt -66.56 -45.86 77.95 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.824 0.85 . . . . 0.0 112.937 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -57.56 -39.64 77.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.293 0.637 . . . . 0.0 111.837 170.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -70.13 -20.97 63.14 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 9.6 mt -76.1 -51.23 12.68 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.837 1.199 . . . . 0.0 111.172 167.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.75 -34.57 74.64 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.405 1.082 . . . . 0.0 112.283 -176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 96.5 t -87.64 -75.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.198 0.999 . . . . 0.0 112.462 174.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.26 -52.39 16.58 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.886 -1.133 . . . . 0.0 112.153 -154.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.0 tp -68.25 -25.44 65.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.459 0.704 . . . . 0.0 112.543 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.22 -25.67 48.19 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.745 1.164 . . . . 0.0 115.508 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -68.46 -21.24 64.64 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -120.47 -30.61 4.51 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.97 1.308 . . . . 0.0 112.774 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -147.93 94.63 2.37 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.231 1.812 . . . . 0.0 108.668 169.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -67.96 78.15 0.22 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.483 1.113 . . . . 0.0 110.668 168.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -73.16 118.69 70.74 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 124.404 1.082 . . . . 0.0 111.385 -169.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.16 107.51 2.27 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.031 1.821 . . . . 0.0 110.674 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 35.2 mm -60.04 113.43 7.32 Favored Pre-proline 0 CA--C 1.541 0.635 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 163.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -63.33 154.3 68.97 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.741 1.628 . . . . 0.0 112.846 -170.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.48 -23.75 67.53 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.628 1.171 . . . . 0.0 113.241 171.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -65.8 -28.45 69.02 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.665 1.186 . . . . 0.0 113.398 170.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 43.6 mt -84.49 52.68 2.43 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.054 1.342 . . . . 0.0 110.794 166.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.39 -25.82 68.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.085 0.954 . . . . 0.0 112.532 -165.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -75.67 -49.89 17.05 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.914 0.779 . . . . 0.0 111.781 171.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 62.6 t -59.98 -39.36 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.541 0.737 . . . . 0.0 111.207 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 47.7 tp -65.24 -41.33 94.44 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.272 1.029 . . . . 0.0 113.356 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -69.04 -41.24 77.93 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.627 -0.67 . . . . 0.0 112.322 172.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -65.65 -31.81 73.03 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.585 1.154 . . . . 0.0 112.772 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 53.4 mt -58.09 -35.33 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 120.918 -1.114 . . . . 0.0 111.881 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -82.28 -13.31 57.2 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.368 -1.458 . . . . 0.0 113.749 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.0 mt -73.94 -18.14 60.93 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 117.576 -1.202 . . . . 0.0 113.499 160.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.7 mt -66.3 -19.55 65.85 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.51 1.505 . . . . 0.0 113.922 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -95.85 10.81 35.92 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.873 -1.142 . . . . 0.0 113.132 174.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.9 p -119.9 179.3 4.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.079 1.752 . . . . 0.0 113.374 -171.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 50.6 mtp85 56.77 -167.62 0.12 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.489 1.516 . . . . 0.0 110.143 -168.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -81.87 -35.32 29.42 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 122.043 -0.41 . . . . 0.0 110.889 157.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.6 p -69.38 -58.43 4.02 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.692 1.597 . . . . 0.0 114.763 -163.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -67.71 -43.51 79.87 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.149 0.886 . . . . 0.0 112.123 173.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -53.68 -35.33 60.95 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.922 1.289 . . . . 0.0 113.865 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.76 -7.39 59.22 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 7.8 p -73.24 -21.74 60.56 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 120.474 1.488 . . . . 0.0 112.518 170.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -60.27 127.29 31.08 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.9 1.28 . . . . 0.0 112.101 -170.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -93.42 173.71 7.57 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.424 1.09 . . . . 0.0 110.558 165.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -70.83 123.41 21.9 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.192 -0.943 . . . . 0.0 109.84 164.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -57.96 -35.05 70.61 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -165.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -61.39 -39.26 90.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.742 1.217 . . . . 0.0 112.396 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -82.34 0.87 39.74 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 120.858 -1.151 . . . . 0.0 113.988 173.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.9 t -85.39 -54.76 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.313 0.645 . . . . 0.0 109.98 161.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -46.22 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.123 0.874 . . . . 0.0 112.616 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.5 -10.68 60.14 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -90.07 -31.73 10.58 Favored Glycine 0 CA--C 1.533 1.164 0 O-C-N 120.861 -1.149 . . . . 0.0 113.301 169.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 16.4 t90 -87.14 -30.8 20.78 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.101 1.76 . . . . 0.0 114.22 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -48.74 -49.47 66.09 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.54 -24.9 35.45 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.651 1.567 . . . . 0.0 113.839 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.604 ' HE2' HB22 ' A' ' 301' ' ' GSH . 44.5 mttp -74.23 -7.36 52.43 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.55 1.14 . . . . 0.0 114.056 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 59.1 t -61.91 -22.14 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 119.518 1.054 . . . . 0.0 111.505 159.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -106.91 -11.7 15.65 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 171.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 C-N-CA 124.484 1.114 . . . . 0.0 113.181 -173.592 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' GSH . . . . . 0.604 HB22 ' HE2' ' A' ' 209' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.602 ' H2 ' ' HB2' ' A' ' 67' ' ' ASP . 88.6 mtp . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 118.71 -0.662 . . . . 0.0 111.345 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.23 -175.9 0.11 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.432 1.493 . . . . 0.0 113.949 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 73.3 mt -115.5 143.14 45.75 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.334 1.454 . . . . 0.0 110.809 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -138.01 149.39 46.03 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.679 1.191 . . . . 0.0 108.831 159.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 pt -130.85 139.05 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 124.082 0.953 . . . . 0.0 109.202 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.7 m -110.68 125.99 54.05 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.892 0.877 . . . . 0.0 109.635 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.98 157.81 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.858 1.263 . . . . 0.0 110.792 -166.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -60.5 115.26 3.45 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.053 -0.405 . . . . 0.0 110.371 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.447 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -80.97 153.16 27.63 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.06 155.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.76 147.26 46.81 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.199 0.999 . . . . 0.0 112.753 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.71 134.05 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 167.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.69 -26.72 1.64 Allowed Glycine 0 CA--C 1.54 1.594 0 CA-C-O 118.883 -0.954 . . . . 0.0 115.442 -173.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.61 72.38 77.97 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-N 118.603 1.201 . . . . 0.0 112.159 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.417 ' HA ' ' HB1' ' A' ' 9' ' ' ALA . 61.0 Cg_endo -65.03 -12.3 33.99 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.246 2.63 . . . . 0.0 114.927 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -82.94 2.89 32.35 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.6 pt -135.38 161.26 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.101 1.36 . . . . 0.0 111.503 177.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.26 149.92 40.57 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.612 0.765 . . . . 0.0 111.516 167.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.27 -168.41 11.29 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.632 1.587 . . . . 0.0 111.656 166.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -59.06 105.29 0.31 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 118.61 1.205 . . . . 0.0 114.161 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.2 t -152.01 107.3 2.84 Favored Pre-proline 0 CA--C 1.552 1.025 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.207 135.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -67.75 -15.85 45.1 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.815 2.343 . . . . 0.0 112.874 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -72.13 -28.53 63.32 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.065 -1.022 . . . . 0.0 112.381 171.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.09 -37.28 75.36 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.277 -1.514 . . . . 0.0 112.997 168.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -60.76 -27.25 67.83 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.491 HH12 ' CG ' ' A' ' 74' ' ' ASP . 60.1 mtp180 -57.18 -40.87 78.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.56 1.144 . . . . 0.0 112.452 172.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -78.87 -40.29 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.137 1.375 . . . . 0.0 111.546 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.5 mt -59.13 -43.6 92.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.982 0.513 . . . . 0.0 111.328 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.22 -48.49 81.42 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.068 0.947 . . . . 0.0 113.08 -177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.6 p -76.49 -37.4 56.87 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.3 mt -70.34 -36.99 74.56 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.391 0.541 . . . . 0.0 111.775 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -77.56 -20.08 54.67 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -74.11 -47.42 36.39 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.243 -1.535 . . . . 0.0 111.654 167.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -76.74 -4.36 42.97 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.802 1.241 . . . . 0.0 114.022 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm 58.65 19.58 6.89 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 126.377 1.871 . . . . 0.0 114.426 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.0 mt -72.84 127.37 89.73 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 118.152 -0.928 . . . . 0.0 108.641 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.31 143.13 34.68 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.405 2.07 . . . . 0.0 112.191 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -146.98 155.2 42.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.959 1.704 . . . . 0.0 109.92 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -80.36 131.64 35.66 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.046 -1.034 . . . . 0.0 109.789 158.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 t -99.41 94.23 6.32 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.999 0.92 . . . . 0.0 110.505 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -77.43 100.73 6.1 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.711 0.767 . . . . 0.0 109.479 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 99.4 mt -67.28 107.0 2.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.558 1.143 . . . . 0.0 109.241 170.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.3 mm -118.62 108.4 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.671 1.189 . . . . 0.0 109.059 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -75.46 90.03 2.7 Favored 'General case' 0 C--O 1.219 -0.552 0 O-C-N 120.716 -1.24 . . . . 32.609999999999999 108.216 165.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.418 HD23 HG22 ' A' ' 60' ' ' VAL . 1.5 pp -63.51 1.77 0.51 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 117.837 2.532 . . . . 40.049999999999997 117.837 -171.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.66 -19.56 79.72 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-N 119.896 1.226 . . . . 41.469999999999999 112.874 160.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -126.13 49.86 1.94 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 129.914 3.286 . . . . 47.170000000000002 109.36 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -78.27 118.15 70.51 Favored Pre-proline 0 N--CA 1.472 0.627 0 O-C-N 119.464 -2.023 . . . . 41.270000000000003 111.253 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.52 160.01 50.91 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.647 2.232 . . . . 40.289999999999999 111.623 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -62.12 -28.94 69.99 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.851 -1.155 . . . . 42.390000000000001 113.853 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 81.8 t90 -61.73 -32.24 72.46 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.508 0.929 . . . . 37.079999999999998 113.508 170.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -79.76 -33.83 40.33 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.819 -1.176 . . . . 35.880000000000003 112.619 172.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.0 mt -68.64 -23.72 64.46 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.449 0.907 . . . . 33.609999999999999 113.449 173.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -65.89 -41.88 90.97 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.894 1.278 . . . . 33.789999999999999 111.974 167.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.0 mt -74.11 -35.89 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 124.306 1.042 . . . . 33.159999999999997 111.654 175.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.4 t -133.08 92.9 24.12 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 126.121 1.768 . . . . 33.579999999999998 110.96 -175.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.73 -15.36 37.17 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.636 2.224 . . . . 37.899999999999999 113.901 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -76.55 -13.0 60.11 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.004 -1.06 . . . . 38.990000000000002 113.438 165.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.69 16.98 72.6 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.932 -1.105 . . . . 35.469999999999999 114.595 -172.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -100.12 155.23 17.85 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.399 1.48 . . . . 34.490000000000002 114.266 -173.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.418 HG22 HD23 ' A' ' 44' ' ' LEU . 33.0 m -115.39 157.26 44.44 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 126.713 2.005 . . . . 23.530000000000001 111.125 163.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -62.16 149.57 59.59 Favored 'Cis proline' 0 C--N 1.349 0.575 0 CA-C-O 122.327 0.886 . . . . 22.879999999999999 112.861 -13.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.09 146.66 22.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 113.8 -1.546 . . . . 0.0 107.303 163.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.59 163.58 30.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 123.522 0.729 . . . . 0.0 111.416 -169.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -120.95 69.27 0.89 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 126.547 1.939 . . . . 0.0 109.749 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.9 mt -75.05 119.15 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.745 0.818 . . . . 0.0 108.848 -175.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.492 ' OD1' ' HA ' ' A' ' 1' ' ' MET . 46.8 t0 54.14 39.95 31.2 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.147 0.498 . . . . 0.0 111.019 -164.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.602 ' HB2' ' H2 ' ' A' ' 1' ' ' MET . 16.4 t0 68.65 -6.75 0.8 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 127.362 2.265 . . . . 0.0 115.638 -171.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -92.98 136.72 33.0 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.293 -1.504 . . . . 0.0 112.568 -170.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.8 m0 -64.01 127.95 33.68 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.311 1.444 . . . . 0.0 112.874 -175.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -141.59 132.66 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.526 1.53 . . . . 0.0 109.558 170.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -112.63 173.56 6.32 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.731 1.612 . . . . 0.0 111.621 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.1 t0 67.04 110.58 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 127.628 2.371 . . . . 22.16 114.485 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.483 ' H ' ' C1 ' ' A' ' 301' ' ' GSH . 59.5 p -62.97 -24.96 68.14 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 115.322 1.601 . . . . 21.16 115.322 -164.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.491 ' CG ' HH12 ' A' ' 25' ' ' ARG . 36.9 m-20 -72.04 -36.43 69.64 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.189 1.359 . . . . 24.969999999999999 112.998 170.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.69 -38.69 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.23 -0.919 . . . . 23.850000000000001 110.95 173.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.12 -44.04 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.374 1.07 . . . . 23.68 111.213 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.68 -42.79 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.476 1.11 . . . . 22.84 111.318 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.97 -26.97 61.55 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.215 -0.77 . . . . 23.329999999999998 114.565 175.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 87.7 mt -92.49 -50.76 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 118.718 1.259 . . . . 23.309999999999999 112.059 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.5 mt -65.55 -29.46 70.09 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.618 1.099 . . . . 23.48 113.452 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -89.24 -2.02 58.31 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.697 0.999 . . . . 24.239999999999998 113.697 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.402 ' OE2' ' HE3' ' A' ' 83' ' ' LYS . 38.7 tt0 -115.06 -47.63 2.86 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.679 1.592 . . . . 39.259999999999998 112.513 173.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.402 ' HE3' ' OE2' ' A' ' 82' ' ' GLU . 84.2 mttt -104.92 64.45 0.72 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.977 1.311 . . . . 24.449999999999999 112.415 -165.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -138.64 164.15 41.83 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.366 1.466 . . . . 0.0 110.713 174.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.69 -26.27 23.38 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.23 1.954 . . . . 0.0 112.655 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -74.64 154.71 87.44 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 125.043 1.337 . . . . 0.0 111.872 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -56.16 140.79 87.77 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.992 2.461 . . . . 0.0 113.635 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.97 133.93 35.27 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.215 1.943 . . . . 0.0 112.139 -176.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.9 mt -107.61 1.52 23.29 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.628 1.571 . . . . 0.0 112.065 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.8 49.53 0.23 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.769 2.027 . . . . 0.0 111.497 159.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 44.8 p -123.42 67.28 36.59 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 125.077 1.351 . . . . 0.0 109.012 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -74.19 124.2 8.85 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.393 2.062 . . . . 0.0 110.032 -165.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.73 -176.79 2.18 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.72 2.28 . . . . 0.0 111.133 170.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 23.0 mp0 -56.06 -30.08 61.43 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.406 2.282 . . . . 0.0 112.785 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -54.72 -23.86 19.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.167 1.787 . . . . 0.0 114.203 171.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.47 -33.42 73.74 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.981 -1.074 . . . . 0.0 113.213 173.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 59.5 p -70.13 -20.52 63.16 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.9 t -92.8 -42.31 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.276 1.43 . . . . 0.0 110.342 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.99 -30.21 77.08 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.122 1.344 . . . . 0.0 114.587 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 97.7 p -66.94 -19.75 65.78 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.603 1.202 . . . . 0.0 113.958 171.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -95.79 -32.99 12.44 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.477 1.511 . . . . 0.0 112.814 172.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 61.9 mt -68.31 -37.85 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.55 0.74 . . . . 0.0 111.559 173.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -58.11 -47.29 99.12 Favored Pre-proline 0 CA--C 1.547 0.847 0 O-C-N 120.314 -1.492 . . . . 0.0 114.274 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.23 -30.33 5.59 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.703 2.269 . . . . 0.0 113.893 172.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.8 p -71.75 -27.96 63.32 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 121.009 1.731 . . . . 0.0 112.962 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -62.29 -42.34 99.27 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 120.329 -1.482 . . . . 0.0 112.787 161.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.45 -37.5 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-N 120.002 1.274 . . . . 0.0 111.348 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -65.97 -38.17 87.87 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.897 0.879 . . . . 0.0 112.2 172.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -71.79 -28.14 63.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.48 1.112 . . . . 0.0 112.646 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.8 mt -83.61 -2.74 56.75 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.555 1.542 . . . . 0.0 114.403 168.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -144.64 39.53 1.26 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.253 1.421 . . . . 0.0 112.925 -175.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 m -73.25 65.73 0.85 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -162.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' A' ' 210' ' ' VAL . 95.9 mttt -70.68 -35.5 72.85 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.92 1.288 . . . . 0.0 111.875 166.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -79.52 117.79 69.03 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-O 117.102 -1.428 . . . . 0.0 107.431 152.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -53.89 149.62 33.27 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.27 2.647 . . . . 0.0 116.53 -154.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -65.38 -41.85 93.29 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.101 -170.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.62 -19.64 59.07 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.453 1.101 . . . . 0.0 113.634 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.79 -37.53 13.27 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 121.046 -1.034 . . . . 0.0 112.485 166.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 63.9 m -65.8 -29.4 69.89 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.011 0.924 . . . . 0.0 112.99 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -57.38 -43.64 83.79 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.67 1.588 . . . . 0.0 111.769 174.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -70.35 -40.31 74.14 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.891 0.876 . . . . 0.0 111.533 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.48 -21.89 65.5 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 173.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.7 tp -84.59 -40.3 17.67 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.078 1.351 . . . . 0.0 111.882 170.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.2 mt -64.15 -41.55 97.12 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.937 1.295 . . . . 0.0 113.449 -176.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.01 -34.44 78.1 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.492 1.496 . . . . 0.0 112.87 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.52 -36.76 60.46 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.27 -0.894 . . . . 0.0 112.914 171.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.5 mt -64.89 -36.2 83.61 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.742 -1.224 . . . . 0.0 112.823 172.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -64.53 -42.99 95.4 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.456 1.103 . . . . 0.0 111.309 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.57 -37.5 87.56 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.39 0.676 . . . . 0.0 112.345 176.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 tp -66.62 -55.27 16.09 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.386 1.075 . . . . 0.0 111.643 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -66.68 -38.54 87.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.021 1.328 . . . . 0.0 113.766 -170.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -60.67 -33.68 83.35 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.24 -0.755 . . . . 0.0 113.494 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -91.23 -31.06 16.3 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 117.77 0.785 . . . . 0.0 113.004 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 16.0 mt -62.27 -31.69 72.3 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.564 -1.335 . . . . 0.0 113.247 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -65.36 0.59 1.4 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 172.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.2 t -109.32 -25.75 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.854 1.661 . . . . 0.0 113.22 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -106.11 -9.43 16.97 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 -161.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 122.33 171.2 13.84 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 119.863 1.211 . . . . 0.0 113.604 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -78.06 -4.69 14.6 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.683 3.589 . . . . 0.0 116.122 -160.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -98.8 167.41 10.78 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.082 -1.011 . . . . 0.0 111.649 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.4 mt -69.86 -4.16 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 120.576 -1.328 . . . . 0.0 113.055 174.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -121.68 27.83 7.98 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.033 1.733 . . . . 0.0 113.707 165.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.42 -108.81 2.71 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.256 0.931 . . . . 0.0 113.023 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -60.28 -33.28 72.1 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -172.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -148.2 163.51 36.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.157 1.383 . . . . 0.0 111.694 -167.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 51.8 mt -64.79 135.21 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.602 0.761 . . . . 0.0 109.645 164.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 29.3 p -135.33 -176.56 4.31 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.914 1.286 . . . . 0.0 111.258 169.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.41 -22.3 2.9 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 167.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.0 t -72.12 -42.47 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 120.945 -1.097 . . . . 0.0 112.005 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -61.35 -43.67 98.48 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 120.964 -1.085 . . . . 0.0 112.373 169.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 25.1 mt -61.65 -21.91 64.82 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 24.8 m -82.0 -47.85 12.16 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.187 -0.946 . . . . 0.0 112.135 175.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 26.8 mt -97.05 -34.4 11.18 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -167.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.77 -49.24 94.9 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -174.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.06 -28.4 15.99 Favored 'Trans proline' 0 C--N 1.35 0.617 0 CA-C-N 120.996 1.391 . . . . 0.0 112.998 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -68.88 -30.52 69.04 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 117.487 -1.244 . . . . 0.0 112.572 173.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 56.3 mt -68.24 -45.5 73.05 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 170.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -56.98 -39.73 75.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.188 0.595 . . . . 0.0 111.477 170.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -70.46 -18.91 62.99 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.5 mt -76.44 -52.6 9.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.681 1.128 . . . . 0.0 111.261 166.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -62.97 -29.9 71.17 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.145 0.978 . . . . 0.0 112.395 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 76.0 t -89.64 -70.72 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.921 1.289 . . . . 0.0 113.168 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.32 -52.39 7.76 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 121.83 -0.544 . . . . 0.0 112.351 -158.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 42.8 tp -65.76 -31.08 71.87 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 118.948 -0.549 . . . . 0.0 111.344 171.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -55.64 -28.3 51.34 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.177 1.37 . . . . 0.0 115.804 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -71.08 -15.31 62.52 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -126.2 -28.45 3.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.604 1.162 . . . . 0.0 112.807 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -145.63 97.06 2.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.805 2.042 . . . . 0.0 108.518 164.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -68.34 78.93 0.26 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.204 1.002 . . . . 0.0 110.561 166.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -68.76 118.13 57.76 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.095 0.958 . . . . 0.0 110.956 -173.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.19 100.85 1.03 Allowed 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.954 1.77 . . . . 0.0 110.301 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.4 mm -55.3 111.51 3.14 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.664 1.186 . . . . 0.0 108.119 167.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -63.24 149.93 89.98 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.323 1.349 . . . . 0.0 112.519 -168.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.29 -19.53 65.48 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.849 -1.157 . . . . 0.0 113.429 172.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -62.41 -36.02 81.03 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.99 1.316 . . . . 0.0 112.732 167.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 45.7 mt -80.75 52.55 1.72 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.59 1.556 . . . . 0.0 111.12 166.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -26.61 67.85 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.52 1.128 . . . . 0.0 112.353 -170.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -77.83 -48.58 16.15 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.457 -0.777 . . . . 0.0 112.069 174.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.75 -39.46 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.862 0.865 . . . . 0.0 110.944 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 56.1 tp -63.43 -40.61 97.63 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.816 0.847 . . . . 0.0 113.026 175.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -69.56 -41.89 75.26 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.466 0.706 . . . . 0.0 112.533 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -64.55 -32.39 74.02 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.533 1.133 . . . . 0.0 112.538 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.13 -35.03 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 120.993 -1.067 . . . . 0.0 111.851 169.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 40.7 mmtt -80.43 -16.79 53.57 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.332 -1.48 . . . . 0.0 112.867 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.66 -18.67 62.84 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 118.152 -0.928 . . . . 0.0 113.434 162.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 73.8 mt -66.29 -18.24 65.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.117 1.326 . . . . 0.0 113.988 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -98.04 9.32 43.11 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.763 1.225 . . . . 0.0 112.41 173.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.0 p -116.27 179.14 4.08 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.363 1.465 . . . . 0.0 113.622 -170.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 55.4 mtp85 57.17 -163.67 0.18 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.578 1.551 . . . . 0.0 110.079 -169.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -84.31 -31.11 25.04 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.966 -0.459 . . . . 0.0 111.428 156.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 35.2 p -75.36 -59.16 2.87 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.968 1.307 . . . . 0.0 114.351 -160.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -64.85 -42.33 94.97 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.799 0.727 . . . . 0.0 112.0 172.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -53.36 -33.8 55.04 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.308 1.443 . . . . 0.0 114.028 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -86.83 -8.14 57.59 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 4.1 p -73.73 -18.59 60.97 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.346 1.43 . . . . 0.0 112.425 169.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -58.94 132.49 54.15 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.833 1.253 . . . . 0.0 111.863 -175.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -106.85 176.96 5.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.048 1.339 . . . . 0.0 110.465 169.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -69.47 116.53 9.99 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.155 -0.965 . . . . 0.0 109.571 167.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -57.11 -34.44 68.35 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -167.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.65 -40.69 79.87 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.673 1.189 . . . . 0.0 111.778 174.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -86.53 -3.16 58.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.331 1.852 . . . . 0.0 112.809 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 25.8 t -84.99 -49.25 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.279 1.032 . . . . 0.0 110.091 159.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 12.7 mt -60.98 -54.59 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.509 1.123 . . . . 0.0 111.691 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.71 -15.98 63.25 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.269 1.027 . . . . 0.0 113.389 176.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -82.47 -27.44 43.34 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 118.616 -1.102 . . . . 0.0 113.48 171.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . . . . . . . . . 19.8 t90 -90.0 -34.96 15.79 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.476 1.911 . . . . 0.0 114.262 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -48.1 -48.94 62.82 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.2 -24.83 27.23 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 121.577 1.518 . . . . 0.0 114.022 174.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.418 ' HE2' HB22 ' A' ' 301' ' ' GSH . 39.5 mttp -74.96 -6.64 50.38 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.409 ' O ' ' HE3' ' A' ' 113' ' ' LYS . 61.5 t -60.29 -18.42 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.181 -0.95 . . . . 0.0 111.416 158.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -118.79 17.19 13.52 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.554 1.942 . . . . 0.0 115.052 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.922 0 C-N-CA 125.168 1.387 . . . . 0.0 110.386 171.395 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' GSH . . . . . 0.483 ' C1 ' ' H ' ' A' ' 73' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_